PMID,OWN,STAT,DCOM,LR,IS,VI,IP,DP,TI,PG,LID,AB,CI,FAU,AU,AD,LA,PT,DEP,PL,TA,JT,JID,SB,MH,PMC,OTO,OT,EDAT,MHDA,CRDT,PHST,AID,PST,SO,COIS,AUID,RN,EIN,CIN,RF,GR,CON,TT,MID,CN,OID,FIR,IR,GN,PS,FPS
31027668,NLM,MEDLINE,20191121,20230302,1558-1357 (Electronic) 0029-6465 (Print) 0029-6465 (Linking),54,2,2019 Jun,Emerging Infectious Diseases.,297-311,S0029-6465(19)30006-4 [pii] 10.1016/j.cnur.2019.02.006 [doi],"Emerging infectious diseases (EID) and reemerging infectious diseases are increasing globally. Zoonotic diseases are transmitted from animals to humans through direct contact or through food, water, and the environment. Vector-borne diseases are major sources of mortality and morbidity globally. Three mosquito-borne viruses are yellow fever, chikungunya virus, and dengue virus. Recent EIDs include Candida auris, Elizabethkingia anopheles, The Lone Star tick, and avian influenza H7N2. In addition, mcr-1 may contribute to the dissemination of drug resistance to gram-negative bacteria. Nurses play a major role in the identification and prevention of EID within health care settings.",['Copyright (c) 2019 Elsevier Inc. All rights reserved.'],"['McArthur, Donna Behler']",['McArthur DB'],"['University of Arizona College of Nursing and Department of Neurology, College of Medicine, 1305 North Martin Avenue, Tucson, AZ 85721, USA; Vanderbilt University School of Nursing, 461 21st Avenue South, Nashville, TN 37240, USA. Electronic address: dbmcarth@email.arizona.edu.']",['eng'],"['Journal Article', 'Review']",20190327,United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,IM,"['Adult', 'Animals', 'Communicable Diseases/diagnosis/*epidemiology/*nursing', 'Communicable Diseases, Emerging/*diagnosis/*epidemiology/*nursing', 'Female', 'Humans', 'Male', 'Middle Aged', ""Nurse's Role"", 'Zoonoses/diagnosis/*epidemiology/*nursing']",PMC7096727,['NOTNLM'],"['Avian influenza', 'Candida auris', 'Elizabethkingia anopheles', 'Emerging infections', 'Vector-borne diseases', 'Zoonotic diseases', 'mcr-1']",2019/04/28 06:00,2019/11/22 06:00,['2019/04/28 06:00'],"['2019/04/28 06:00 [entrez]', '2019/04/28 06:00 [pubmed]', '2019/11/22 06:00 [medline]']","['S0029-6465(19)30006-4 [pii]', '10.1016/j.cnur.2019.02.006 [doi]']",ppublish,Nurs Clin North Am. 2019 Jun;54(2):297-311. doi: 10.1016/j.cnur.2019.02.006. Epub 2019 Mar 27.,,,,,,,,,,,,,,,,,
27598145,NLM,MEDLINE,20170323,20181113,1422-0067 (Electronic) 1422-0067 (Linking),17,9,2016 Sep 2,"Infectious Diseases: Pathophysiology, Diagnostics and Prevention.",,10.3390/ijms17091464 [doi] 1464,Infectious diseases occur very frequently in children and adults. Novel diagnostic methods have permitted us to expand our knowledge on their epidemiology and pathophysiology [1].[...].,,"['Esposito, Susanna']",['Esposito S'],"[""Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. susanna.esposito@unimi.it.""]",['eng'],"['Editorial', 'Introductory Journal Article']",20160902,Switzerland,Int J Mol Sci,International journal of molecular sciences,101092791,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/*etiology/therapy', 'Humans']",PMC5037742,,,2016/09/07 06:00,2017/03/24 06:00,['2016/09/07 06:00'],"['2016/07/26 00:00 [received]', '2016/08/29 00:00 [revised]', '2016/08/29 00:00 [accepted]', '2016/09/07 06:00 [entrez]', '2016/09/07 06:00 [pubmed]', '2017/03/24 06:00 [medline]']","['ijms17091464 [pii]', 'ijms-17-01464 [pii]', '10.3390/ijms17091464 [doi]']",epublish,Int J Mol Sci. 2016 Sep 2;17(9):1464. doi: 10.3390/ijms17091464.,['The author declares no conflict of interest.'],,,,,,,,,,,,,,,,
28286767,NLM,MEDLINE,20170317,20220316,2314-6141 (Electronic) 2314-6133 (Print),2017,,2017,"Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.",5245021,10.1155/2017/5245021 [doi] 5245021,"Infectious diseases are a significant burden on public health and economic stability of societies all over the world. They have for centuries been among the leading causes of death and disability and presented growing challenges to health security and human progress. The threat posed by infectious diseases is further deepened by the continued emergence of new, unrecognized, and old infectious disease epidemics of global impact. Over the past three and half decades at least 30 new infectious agents affecting humans have emerged, most of which are zoonotic and their origins have been shown to correlate significantly with socioeconomic, environmental, and ecological factors. As these factors continue to increase, putting people in increased contact with the disease causing pathogens, there is concern that infectious diseases may continue to present a formidable challenge. Constant awareness and pursuance of effective strategies for controlling infectious diseases and disease emergence thus remain crucial. This review presents current updates on emerging and neglected infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with particular focus on WHO top priority emerging infectious diseases (EIDs) and neglected tropical infectious diseases.",,"['Nii-Trebi, Nicholas Israel']",['Nii-Trebi NI'],"['Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.']",['eng'],"['Journal Article', 'Review']",20170213,United States,Biomed Res Int,BioMed research international,101600173,IM,"['*Communicable Diseases, Emerging/diagnosis/economics/epidemiology/therapy', '*Cost of Illness', 'Humans', '*Neglected Diseases/diagnosis/economics/epidemiology/therapy']",PMC5327784,,,2017/03/14 06:00,2017/03/18 06:00,['2017/03/14 06:00'],"['2016/08/13 00:00 [received]', '2017/01/05 00:00 [revised]', '2017/01/16 00:00 [accepted]', '2017/03/14 06:00 [entrez]', '2017/03/14 06:00 [pubmed]', '2017/03/18 06:00 [medline]']",['10.1155/2017/5245021 [doi]'],ppublish,Biomed Res Int. 2017;2017:5245021. doi: 10.1155/2017/5245021. Epub 2017 Feb 13.,"['The author declares that there is no conflict of interests regarding the', 'publication of this paper.']",['ORCID: 0000-0001-5012-9564'],,,,,,,,,,,,,,,
22997875,NLM,MEDLINE,20121011,20151119,0300-5038 (Print) 0300-5038 (Linking),,163,2011,Infectious diseases.,421-40,,"Molecular tools have enhanced our understanding of the epidemiology of infectious diseases by describing the transmission system, including identifying novel transmission modes and reservoirs, identifying characteristics of the infectious agent that lead to transmission and pathogenesis, identifying potential vaccine candidates and targets for therapeutics, and recognizing new infectious agents. Applications of molecular fingerprinting to public health practice have enhanced outbreak investigation by objectively confirming epidemiologic evidence, and distinguishing between time-space clusters and sporadic cases. Clinically, moleculartools are used to rapidly detect infectious agents and predict disease course. Integration of molecular tools into etiologic studies has identified infectious causes of chronic diseases, and characteristics of the agent and host that modify disease risk. The combination of molecular tools with epidemiologic methods provides essential information to guide clinical treatment, and to design and implement programmes to prevent and control infectious diseases. However, incorporating molecular tools into epidemiologic studies of infectious diseases impacts study design, conduct, and analysis.",,"['Foxman, Betsy']",['Foxman B'],"['University of Michigan School of Public Health, Ann Arbor, Michigan, USA. bfoxman@umich.edu']",['eng'],"['Journal Article', 'Review']",,France,IARC Sci Publ,IARC scientific publications,8009542,IM,"['Biomarkers/*analysis', 'Communicable Diseases/*diagnosis/epidemiology/*transmission', 'Disease Susceptibility', 'Humans', '*Molecular Epidemiology', 'Risk Factors']",,,,2011/01/01 00:00,2012/10/12 06:00,['2012/09/25 06:00'],"['2012/09/25 06:00 [entrez]', '2011/01/01 00:00 [pubmed]', '2012/10/12 06:00 [medline]']",,ppublish,IARC Sci Publ. 2011;(163):421-40.,,,['0 (Biomarkers)'],,,,,,,,,,,,,,
26479830,NLM,MEDLINE,20160711,20220330,1873-6750 (Electronic) 0160-4120 (Linking),86,,2016 Jan,Impact of climate change on human infectious diseases: Empirical evidence and human adaptation.,14-23,S0160-4120(15)30048-9 [pii] 10.1016/j.envint.2015.09.007 [doi],"Climate change refers to long-term shifts in weather conditions and patterns of extreme weather events. It may lead to changes in health threat to human beings, multiplying existing health problems. This review examines the scientific evidences on the impact of climate change on human infectious diseases. It identifies research progress and gaps on how human society may respond to, adapt to, and prepare for the related changes. Based on a survey of related publications between 1990 and 2015, the terms used for literature selection reflect three aspects--the components of infectious diseases, climate variables, and selected infectious diseases. Humans' vulnerability to the potential health impacts by climate change is evident in literature. As an active agent, human beings may control the related health effects that may be effectively controlled through adopting proactive measures, including better understanding of the climate change patterns and of the compound disease-specific health effects, and effective allocation of technologies and resources to promote healthy lifestyles and public awareness. The following adaptation measures are recommended: 1) to go beyond empirical observations of the association between climate change and infectious diseases and develop more scientific explanations, 2) to improve the prediction of spatial-temporal process of climate change and the associated shifts in infectious diseases at various spatial and temporal scales, and 3) to establish locally effective early warning systems for the health effects of predicated climate change.",['Copyright (c) 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.'],"['Wu, Xiaoxu', 'Lu, Yongmei', 'Zhou, Sen', 'Chen, Lifan', 'Xu, Bing']","['Wu X', 'Lu Y', 'Zhou S', 'Chen L', 'Xu B']","['State Key Laboratory of Remote Sensing Science, College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875, China.', 'Department of Geography, Texas State University, San Marcos, TX 78666-4684, USA. Electronic address: yl10@txstate.edu.', 'Center for Earth System Sciences, Tsinghua University Beijing, 100084, China.', 'State Key Laboratory of Remote Sensing Science, College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875, China.', 'State Key Laboratory of Remote Sensing Science, College of Global Change and Earth System Science, Beijing Normal University, Beijing 100875, China; Center for Earth System Sciences, Tsinghua University Beijing, 100084, China; Department of Geography, University of Utah, Salt Lake City, UT 84112, USA. Electronic address: bingxu@tsinghua.edu.cn.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20151018,Netherlands,Environ Int,Environment international,7807270,IM,"['*Adaptation, Physiological', 'Animals', 'Climate', '*Climate Change', 'Communicable Diseases/*epidemiology/microbiology/parasitology/transmission', 'Disease Vectors', 'Humans', 'Weather']",,['NOTNLM'],"['Adaptation', 'Climate change', 'Health impact', 'Human infectious diseases', 'Pathogen', 'Transmission']",2015/10/20 06:00,2016/07/12 06:00,['2015/10/20 06:00'],"['2015/03/22 00:00 [received]', '2015/08/28 00:00 [revised]', '2015/09/02 00:00 [accepted]', '2015/10/20 06:00 [entrez]', '2015/10/20 06:00 [pubmed]', '2016/07/12 06:00 [medline]']","['S0160-4120(15)30048-9 [pii]', '10.1016/j.envint.2015.09.007 [doi]']",ppublish,Environ Int. 2016 Jan;86:14-23. doi: 10.1016/j.envint.2015.09.007. Epub 2015 Oct 18.,,,,,,,,,,,,,,,,,
10642539,NLM,MEDLINE,20000207,20220330,0036-8075 (Print) 0036-8075 (Linking),287,5452,2000 Jan 21,Emerging infectious diseases of wildlife--threats to biodiversity and human health.,443-9,,"Emerging infectious diseases (EIDs) of free-living wild animals can be classified into three major groups on the basis of key epizootiological criteria: (i) EIDs associated with ""spill-over"" from domestic animals to wildlife populations living in proximity; (ii) EIDs related directly to human intervention, via host or parasite translocations; and (iii) EIDs with no overt human or domestic animal involvement. These phenomena have two major biological implications: first, many wildlife species are reservoirs of pathogens that threaten domestic animal and human health; second, wildlife EIDs pose a substantial threat to the conservation of global biodiversity.",,"['Daszak, P', 'Cunningham, A A', 'Hyatt, A D']","['Daszak P', 'Cunningham AA', 'Hyatt AD']","['Institute of Ecology, University of Georgia, Athens, GA 30602, USA. daszak@uga.edu']",['eng'],"['Journal Article', 'Review']",,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Agriculture', 'Animals', 'Animals, Domestic', '*Animals, Wild', 'Climate', 'Communicable Diseases/epidemiology/etiology/transmission/*veterinary', 'Conservation of Natural Resources', 'Disease Reservoirs', '*Ecosystem', 'Humans', 'Zoonoses']",,,,2000/01/22 00:00,2000/01/22 00:01,['2000/01/22 00:00'],"['2000/01/22 00:00 [pubmed]', '2000/01/22 00:01 [medline]', '2000/01/22 00:00 [entrez]']","['8209 [pii]', '10.1126/science.287.5452.443 [doi]']",ppublish,Science. 2000 Jan 21;287(5452):443-9. doi: 10.1126/science.287.5452.443.,,,,['Science 2000 Mar 10;287(5459):1756'],['Science. 2000 Jun 30;288(5475):2319-20. PMID: 10917829'],73,,,,,,,,,,,
35421047,NLM,MEDLINE,20220610,20220624,1532-0987 (Electronic) 0891-3668 (Linking),41,7,2022 Jul 1,"Imported Infectious Diseases, Tropical Diseases and Local Endemic Infectious Diseases in Japan.",e275-e282,10.1097/INF.0000000000003541 [doi],"We aimed to describe the historical perspectives and the current epidemiology of tropical, imported and local endemic infectious diseases in Japan in this review. Public health legislation for infectious diseases and immigration statistics were overviewed to provide the background of the infectious disease situation in Japan. Many tropical diseases were successfully controlled and eliminated in the latter half of the 20th century and the majority of those diseases are imported today. The trend of the main 15 imported infectious diseases before the advent of COVID-19 was summarized as well as local endemic infectious diseases in Japan. Transmission risks of traditional cuisines, lifestyles and nature exposures in Japan are introduced to guide clinicians for travel advice to prevent those local infectious diseases.","['Copyright (c) 2022 Wolters Kluwer Health, Inc. All rights reserved.']","['Toizumi, Michiko', 'Horikoshi, Yuho']","['Toizumi M', 'Horikoshi Y']","['From the Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.', ""Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.""]",['eng'],"['Journal Article', 'Review']",20220607,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,IM,"['*COVID-19/epidemiology', '*Communicable Diseases/epidemiology', '*Communicable Diseases, Imported/epidemiology/prevention & control', 'Humans', 'Japan/epidemiology', 'Travel']",,,,2022/04/15 06:00,2022/06/11 06:00,['2022/04/14 17:12'],"['2022/04/15 06:00 [pubmed]', '2022/06/11 06:00 [medline]', '2022/04/14 17:12 [entrez]']","['00006454-202207000-00017 [pii]', '10.1097/INF.0000000000003541 [doi]']",ppublish,Pediatr Infect Dis J. 2022 Jul 1;41(7):e275-e282. doi: 10.1097/INF.0000000000003541. Epub 2022 Jun 7.,['The authors have no funding or conflicts of interest to disclose'],"['ORCID: 0000-0002-8401-9344', 'ORCID: 0000-0001-5875-1024']",,,,,,,,,,,,,,,
15071364,NLM,MEDLINE,20040617,20191108,1070-5287 (Print) 1070-5287 (Linking),10,3,2004 May,Infectious diseases.,157-8,,,,"['Zumla, Alimuddin']",['Zumla A'],,['eng'],"['Editorial', 'Review']",,United States,Curr Opin Pulm Med,Current opinion in pulmonary medicine,9503765,IM,"['Communicable Diseases/*diagnosis/*therapy/transmission', 'Humans']",,,,2004/04/09 05:00,2004/06/18 05:00,['2004/04/09 05:00'],"['2004/04/09 05:00 [pubmed]', '2004/06/18 05:00 [medline]', '2004/04/09 05:00 [entrez]']","['00063198-200405000-00002 [pii]', '10.1097/00063198-200405000-00002 [doi]']",ppublish,Curr Opin Pulm Med. 2004 May;10(3):157-8. doi: 10.1097/00063198-200405000-00002.,,,,,,10,,,,,,,,,,,
29040428,NLM,MEDLINE,20190924,20220410,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),66,5,2018 Feb 10,Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases.,778-788,10.1093/cid/cix881 [doi],"Agnostic metagenomic next-generation sequencing (mNGS) has emerged as a promising single, universal pathogen detection method for infectious disease diagnostics. This methodology allows for identification and genomic characterization of bacteria, fungi, parasites, and viruses without the need for a priori knowledge of a specific pathogen directly from clinical specimens. Although there are increasing reports of mNGS successes, several hurdles need to be addressed, such as differentiation of colonization from infection, extraneous sources of nucleic acid, method standardization, and data storage, protection, analysis, and interpretation. As more commercial and clinical microbiology laboratories develop mNGS assays, it is important for treating practitioners to understand both the power and limitations of this method as a diagnostic tool for infectious diseases.",,"['Simner, Patricia J', 'Miller, Steven', 'Carroll, Karen C']","['Simner PJ', 'Miller S', 'Carroll KC']","['Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.', 'Department of Laboratory Medicine, University of California, San Francisco.', 'Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Animals', 'Communicable Diseases/*diagnosis/*microbiology/parasitology', 'Humans', '*Metagenomics', 'Nucleic Acid Amplification Techniques/*trends']",PMC7108102,,,2017/10/19 06:00,2019/09/26 06:00,['2017/10/18 06:00'],"['2017/07/28 00:00 [received]', '2017/10/11 00:00 [accepted]', '2017/10/19 06:00 [pubmed]', '2019/09/26 06:00 [medline]', '2017/10/18 06:00 [entrez]']","['4460112 [pii]', 'cix881 [pii]', '10.1093/cid/cix881 [doi]']",ppublish,Clin Infect Dis. 2018 Feb 10;66(5):778-788. doi: 10.1093/cid/cix881.,,,,,,,,,,,,,,,,,
33854221,NLM,MEDLINE,20210803,20210803,1748-3395 (Electronic) 1748-3387 (Linking),16,4,2021 Apr,Nanotechnology for infectious diseases.,1,10.1038/s41565-021-00909-0 [doi],,,,,,['eng'],['Editorial'],,England,Nat Nanotechnol,Nature nanotechnology,101283273,IM,"['Communicable Diseases/microbiology/*therapy', 'Humans', 'Nanotechnology/*trends']",,,,2021/04/16 06:00,2021/08/04 06:00,['2021/04/15 07:12'],"['2021/04/15 07:12 [entrez]', '2021/04/16 06:00 [pubmed]', '2021/08/04 06:00 [medline]']","['10.1038/s41565-021-00909-0 [pii]', '10.1038/s41565-021-00909-0 [doi]']",ppublish,Nat Nanotechnol. 2021 Apr;16(4):1. doi: 10.1038/s41565-021-00909-0.,,,,,,,,,,,,,,,,,
33573529,NLM,MEDLINE,20210506,20231111,2047-7732 (Electronic) 2047-7724 (Print) 2047-7724 (Linking),115,3,2021 May,Protection against severe infectious disease in the past.,151-167,10.1080/20477724.2021.1878443 [doi],"Before the 20(th) century many deaths in England, and most likely a majority, were caused by infectious diseases. The focus here is on the biggest killers, plague, typhus, smallpox, tuberculosis, cholera, typhoid, dysentery, childhood infections, pneumonia, and influenza. Many other infectious diseases including puerperal fever, relapsing fever, malaria, syphilis, meningitis, tetanus and gangrene caused thousands of deaths. This review of preventive measures, public health interventions and changes in behavior that reduced the risk of severe infections puts the response to recent epidemic challenges in historical perspective. Two new respiratory viruses have recently caused pandemics: an H1N1 influenza virus genetically related to pig viruses, and a bat-derived coronavirus causing COVID-19. Studies of infectious diseases emerging in human populations in recent decades indicate that the majority were zoonotic, and many of the causal pathogens had a wildlife origin. As hunter-gatherers, humans contracted pathogens from other species, and then from domesticated animals and rodents when they began to live in settled communities based on agriculture. In the modern world of large inter-connected urban populations and rapid transport, the risk of global transmission of new infectious diseases is high. Past and recent experience indicates that surveillance, prevention and control of infectious diseases are critical for global health. Effective interventions are required to control activities that risk dangerous pathogens transferring to humans from wild animals and those reared for food.",,"['Mercer, Alexander']",['Mercer A'],"['Independent Researcher. Cambridgeshire, England.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",20210211,England,Pathog Glob Health,Pathogens and global health,101583421,IM,"['Animals', 'Communicable Disease Control/*history', 'Communicable Diseases/epidemiology/*history/microbiology/virology', 'History, 15th Century', 'History, 16th Century', 'History, 17th Century', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'History, Ancient', 'History, Medieval', 'Humans', 'Public Health/history']",PMC8079125,['NOTNLM'],"['Pandemic', 'emerging disease', 'infectious disease', 'prevention', 'public health', 'zoonotic']",2021/02/13 06:00,2021/05/07 06:00,['2021/02/12 05:39'],"['2021/02/13 06:00 [pubmed]', '2021/05/07 06:00 [medline]', '2021/02/12 05:39 [entrez]']","['1878443 [pii]', '10.1080/20477724.2021.1878443 [doi]']",ppublish,Pathog Glob Health. 2021 May;115(3):151-167. doi: 10.1080/20477724.2021.1878443. Epub 2021 Feb 11.,['No potential conflict of interest.'],,,,,,,,,,,,,,,,
16582669,NLM,MEDLINE,20060615,20061115,1070-5287 (Print) 1070-5287 (Linking),12,3,2006 May,Infectious diseases.,165-6,,,,"['Zumla, Alimuddin']",['Zumla A'],,['eng'],"['Comparative Study', 'Editorial']",,United States,Curr Opin Pulm Med,Current opinion in pulmonary medicine,9503765,IM,"['Anti-Infective Agents/therapeutic use', '*Communicable Diseases/drug therapy/epidemiology/transmission', 'Humans', 'Incidence', 'Prognosis']",,,,2006/04/04 09:00,2006/06/16 09:00,['2006/04/04 09:00'],"['2006/04/04 09:00 [pubmed]', '2006/06/16 09:00 [medline]', '2006/04/04 09:00 [entrez]']","['00063198-200605000-00002 [pii]', '10.1097/01.mcp.0000219263.42686.07 [doi]']",ppublish,Curr Opin Pulm Med. 2006 May;12(3):165-6. doi: 10.1097/01.mcp.0000219263.42686.07.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
29785478,NLM,MEDLINE,20181120,20200407,0065-2598 (Print) 0065-2598 (Linking),1052,,2018,Changing Trend of Infectious Diseases in Nepal.,19-38,10.1007/978-981-10-7572-8_3 [doi],"Many infectious/communicable diseases (IDs) are endemic in Nepal. Until a decade and half ago, IDs were the major cause of both morbidity and mortality accounting 70% for both. However, as a result of various preventive measures implemented by both the state and non-state actors, the overall IDs have shown a changing (declining) trend. The most impressive decline has been seen in the intestinal helminth infection. Though the overall burden of IDs is decreasing, several newer infectious diseases (emerging infections) namely, dengue fever, scrub typhus, influenza (H5N1 and H1N1), and others are posing a great public health problem. On the other hand, though sporadic, outbreaks of endemic diseases together with HIV-TB coinfection and infection with drug resistance microbes during recent years have constituted a serious public health as well as medical problem. On the contrary, with the decline of IDs, noninfectious diseases (noncommunicable disease, NCD) namely, diabetes, cancer (and cancer therapy), and others are on the rise particularly in urban areas. Hence, currently Nepal is trapped in ""double burden"" of diseases. Risk of opportunistic infection has increased in immunocompromised person with NCD. To address the present situation, the multi-sectoral plan and strategies developed must be implemented effectively.",,"['Rai, Shiba Kumar']",['Rai SK'],"['Nepal Medical College, Attarkehl, Gokarneswor-8, Kathmandu, Nepal. drshibakrai.nepal@gmail.com.', 'National Institute of Tropical Medicine and Public Health Research, ShiGan International College of Science and Technology, Narayangopal Chok, Kathmandu, Nepal. drshibakrai.nepal@gmail.com.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['Communicable Diseases/*epidemiology/microbiology/parasitology/virology', 'Endemic Diseases/statistics & numerical data', 'Humans', 'Nepal/epidemiology', 'Public Health']",PMC7122567,['NOTNLM'],"['Communicable diseases', 'Infectious diseases', 'Nepal']",2018/05/23 06:00,2018/11/21 06:00,['2018/05/23 06:00'],"['2018/05/23 06:00 [entrez]', '2018/05/23 06:00 [pubmed]', '2018/11/21 06:00 [medline]']","['3 [pii]', '10.1007/978-981-10-7572-8_3 [doi]']",ppublish,Adv Exp Med Biol. 2018;1052:19-38. doi: 10.1007/978-981-10-7572-8_3.,,,,,,,,,,,,,,,,,
31894736,NLM,MEDLINE,20200608,20200608,1563-5244 (Electronic) 0883-0185 (Linking),39,1,2020,Therapeutic approaches for genetic and infectious diseases.,1-2,10.1080/08830185.2019.1707479 [doi],,,"['Kumar, Himanshu']",['Kumar H'],"['Editor-in-Chief, International Reviews of Immunology & Principal Investigator, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER), Bhopal, India.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Int Rev Immunol,International reviews of immunology,8712260,IM,"['Communicable Diseases/*genetics/immunology/*therapy', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Mutation/genetics/immunology']",,,,2020/01/03 06:00,2020/06/09 06:00,['2020/01/03 06:00'],"['2020/01/03 06:00 [entrez]', '2020/01/03 06:00 [pubmed]', '2020/06/09 06:00 [medline]']",['10.1080/08830185.2019.1707479 [doi]'],ppublish,Int Rev Immunol. 2020;39(1):1-2. doi: 10.1080/08830185.2019.1707479.,,,,,,,,,,,,,,,,,
31659752,NLM,MEDLINE,20200708,20200708,1749-6632 (Electronic) 0077-8923 (Linking),1462,1,2020 Feb,Vaccine innovations for emerging infectious diseases-a symposium report.,14-26,10.1111/nyas.14235 [doi],"Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled ""Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,"" held on May 20, 2019.",['(c) 2019 New York Academy of Sciences.'],"['Cable, Jennifer', 'Srikantiah, Padmini', 'Crowe, James E Jr', 'Pulendran, Bali', 'Hill, Adrian', 'Ginsberg, Ann', 'Koff, Wayne', 'Mathew, Anuja', 'Ng, Tony', 'Jansen, Kathrin', 'Glenn, Gregory', 'Permar, Sallie', 'Wilson, Ian', 'Weiner, David B', 'Weissman, Drew', 'Rappuoli, Rino']","['Cable J', 'Srikantiah P', 'Crowe JE Jr', 'Pulendran B', 'Hill A', 'Ginsberg A', 'Koff W', 'Mathew A', 'Ng T', 'Jansen K', 'Glenn G', 'Permar S', 'Wilson I', 'Weiner DB', 'Weissman D', 'Rappuoli R']","['Science Writer, New York, New York.', 'Bill & Melinda Gates Foundation, Seattle, Washington.', 'Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center; and Vanderbilt University, Nashville, Tennessee.', 'Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University, Stanford, California.', 'The Jenner Institute, University of Oxford, Oxford, United Kingdom.', 'International AIDS Vaccine Initiative, New York, New York.', 'The Human Vaccines Project, New York, New York.', 'Department of Cell and Molecular Biology, The University of Rhode Island, Kingston, Rhode Island.', 'Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York, New York.', 'Pfizer, New York, New York.', 'Novavax, Rockville, Maryland.', 'Duke University, Durham, North Carolina.', 'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, San Diego, California.', 'Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania.', 'Department of Medicine, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.', 'GlaxoSmithKline, Brentford, United Kingdom.']",['eng'],"['Journal Article', 'Review']",20191028,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,IM,"['Animals', 'Clinical Trials as Topic/methods', 'Communicable Disease Control', 'Communicable Diseases/drug therapy/epidemiology', 'Communicable Diseases, Emerging/epidemiology/*prevention & control', 'Congresses as Topic/*trends', 'Humans', 'New York City', 'Research Report/*trends', 'Therapies, Investigational/methods/*trends', 'Vaccines/*administration & dosage']",,['NOTNLM'],"['CMV', 'DNA vaccine', 'Ebola', 'HIV', 'MERS', 'RNA vaccine', 'RSV', 'Zika', 'antimicrobial resistance', 'infectious disease', 'influenza', 'malaria', 'maternal immunization', 'monoclonal antibodies', 'systems vaccinology', 'tuberculosis', 'vaccine', 'vaccinology']",2019/10/30 06:00,2020/07/09 06:00,['2019/10/30 06:00'],"['2019/08/28 00:00 [received]', '2019/08/28 00:00 [accepted]', '2019/10/30 06:00 [pubmed]', '2020/07/09 06:00 [medline]', '2019/10/30 06:00 [entrez]']",['10.1111/nyas.14235 [doi]'],ppublish,Ann N Y Acad Sci. 2020 Feb;1462(1):14-26. doi: 10.1111/nyas.14235. Epub 2019 Oct 28.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
28674818,NLM,MEDLINE,20180926,20200325,1863-2300 (Electronic) 1863-2297 (Print) 1863-2297 (Linking),39,5,2017 Jul,Cytokine storms in infectious diseases.,501-503,10.1007/s00281-017-0640-2 [doi],,,"['Teijaro, John R']",['Teijaro JR'],"['Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, San Diego, CA, 92037, USA. teijaro@scripps.edu.']",['eng'],"['Editorial', 'Introductory Journal Article']",20170703,Germany,Semin Immunopathol,Seminars in immunopathology,101308769,IM,"['Animals', 'Communicable Diseases/*blood/diagnosis/*etiology/therapy', 'Cytokines/*blood', 'Humans', 'Immune System/cytology/immunology/metabolism']",PMC7079934,,,2017/07/05 06:00,2018/09/27 06:00,['2017/07/05 06:00'],"['2017/05/04 00:00 [received]', '2017/05/08 00:00 [accepted]', '2017/07/05 06:00 [entrez]', '2017/07/05 06:00 [pubmed]', '2018/09/27 06:00 [medline]']","['10.1007/s00281-017-0640-2 [pii]', '640 [pii]', '10.1007/s00281-017-0640-2 [doi]']",ppublish,Semin Immunopathol. 2017 Jul;39(5):501-503. doi: 10.1007/s00281-017-0640-2. Epub 2017 Jul 3.,,,['0 (Cytokines)'],,,,,,,,,,,,,,
34629175,NLM,MEDLINE,20211203,20230214,1879-114X (Electronic) 0149-2918 (Print) 0149-2918 (Linking),43,10,2021 Oct,Electronic Health Record Network Research in Infectious Diseases.,1668-1681,S0149-2918(21)00354-4 [pii] 10.1016/j.clinthera.2021.09.002 [doi],"With the marked increases in electronic health record (EHR) use for providing clinical care, there have been parallel efforts to leverage EHR data for research. EHR repositories offer the promise of vast amounts of clinical data not easily captured with traditional research methods and facilitate clinical epidemiology and comparative effectiveness research, including analyses to identify patients at higher risk for complications or who are better candidates for treatment. These types of studies have been relatively slow to penetrate the field of infectious diseases, but the need for rapid turnaround during the COVID-19 global pandemic has accelerated the uptake. This review discusses the rationale for her network projects, opportunities and challenges that such networks present, and some prior studies within the field of infectious diseases.",['Copyright (c) 2021 Elsevier Inc. All rights reserved.'],"['Jhaveri, Ravi', 'John, Jordan', 'Rosenman, Marc']","['Jhaveri R', 'John J', 'Rosenman M']","[""Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: ravi.jhaveri@northwestern.edu."", 'Northwestern University Feinberg School of Medicine, Chicago, Illinois.', ""Northwestern University Feinberg School of Medicine, Chicago, Illinois; Mary Ann & J. Milburn Smith Child Health Outcomes, Research, and Evaluation Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.""]",['eng'],"['Journal Article', 'Review']",20211008,United States,Clin Ther,Clinical therapeutics,7706726,IM,"['*COVID-19', '*Communicable Diseases/diagnosis/drug therapy/epidemiology', 'Comparative Effectiveness Research', 'Electronic Health Records', 'Female', 'Humans', 'SARS-CoV-2']",PMC8498653,['NOTNLM'],"['EHR network', 'PCORnet', 'electronic health records', 'infectious diseases']",2021/10/12 06:00,2021/12/15 06:00,['2021/10/11 05:35'],"['2021/07/06 00:00 [received]', '2021/08/30 00:00 [revised]', '2021/09/02 00:00 [accepted]', '2021/10/12 06:00 [pubmed]', '2021/12/15 06:00 [medline]', '2021/10/11 05:35 [entrez]']","['S0149-2918(21)00354-4 [pii]', '10.1016/j.clinthera.2021.09.002 [doi]']",ppublish,Clin Ther. 2021 Oct;43(10):1668-1681. doi: 10.1016/j.clinthera.2021.09.002. Epub 2021 Oct 8.,,,,,,,,,,,,,,,,,
35104357,NLM,MEDLINE,20220221,20230202,1098-4275 (Electronic) 0031-4005 (Print) 0031-4005 (Linking),149,2,2022 Feb 1,Risks of Infectious Diseases in Newborns Exposed to Alternative Perinatal Practices.,,10.1542/peds.2021-055554 [doi] e2021055554,The purpose of this report is to educate providers about the risk of infectious diseases associated with emerging alternative peripartum and neonatal practices. This report will provide information pediatricians may use to counsel families before birth and to appropriately evaluate and treat neonates who have been exposed to these practices.,['Copyright (c) 2022 by the American Academy of Pediatrics.'],"['Nolt, Dawn', ""O'Leary, Sean T"", 'Aucott, Susan W']","['Nolt D', ""O'Leary ST"", 'Aucott SW']","['Division of Infectious Diseases, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon.', ""Divisions of Infectious Diseases and General Academic Pediatrics, Department of Pediatrics, University of Colorado Denver Anschutz Medical Campus/Children's Hospital Colorado, Aurora, Colorado."", 'Division of Neonatology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatrics,Pediatrics,0376422,IM,"['Communicable Diseases/diagnosis/epidemiology/transmission', 'Complementary Therapies/adverse effects/*trends', 'Female', 'Humans', 'Infant Health/*trends', 'Infant, Newborn', 'Pregnancy', 'Pregnancy Complications, Infectious/*diagnosis/*epidemiology', 'Risk Factors']",PMC9645715,,,2022/02/02 06:00,2022/02/22 06:00,['2022/02/01 17:10'],"['2022/02/01 17:10 [entrez]', '2022/02/02 06:00 [pubmed]', '2022/02/22 06:00 [medline]']","['184545 [pii]', 'peds.2021-055554.149.2 [pii]', '10.1542/peds.2021-055554 [doi]']",ppublish,Pediatrics. 2022 Feb 1;149(2):e2021055554. doi: 10.1542/peds.2021-055554.,"['FINANCIAL DISCLOSURE: The authors have indicated they do not have a financial', 'relationship relevant to this article to disclose.']",,,,,,,,,,,,,,,,
31477200,NLM,MEDLINE,20191031,20200514,1878-1306 (Electronic) 0195-5616 (Linking),49,4,2019 Jul,Small Animal Infectious Diseases.,xiii-xiv,S0195-5616(19)30067-1 [pii] 10.1016/j.cvsm.2019.04.001 [doi],,,"['Litster, Annette L']",['Litster AL'],"['Zoetis Petcare, Parsippany, NJ 07054, USA. Electronic address: Annette.Litster@zoetis.com.']",['eng'],['Introductory Journal Article'],20190503,United States,Vet Clin North Am Small Anim Pract,The Veterinary clinics of North America. Small animal practice,7809942,IM,"['Animals', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/transmission/*veterinary']",,,,2019/09/04 06:00,2019/11/02 06:00,['2019/09/04 06:00'],"['2019/09/04 06:00 [entrez]', '2019/09/04 06:00 [pubmed]', '2019/11/02 06:00 [medline]']","['S0195-5616(19)30067-1 [pii]', '10.1016/j.cvsm.2019.04.001 [doi]']",ppublish,Vet Clin North Am Small Anim Pract. 2019 Jul;49(4):xiii-xiv. doi: 10.1016/j.cvsm.2019.04.001. Epub 2019 May 3.,,,,,,,,,,,,,,,,,
30460966,NLM,MEDLINE,20190312,20200825,2972-4066 (Electronic) 0304-4602 (Linking),47,10,2018 Oct,Climate Change and Infectious Diseases: The Next 50 Years.,401-404,,,,"['Dennis, Sophie', 'Fisher, Dale']","['Dennis S', 'Fisher D']","['Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore.']",['eng'],"['Editorial', 'Review']",,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,IM,"['Asia, Southeastern/epidemiology', '*Climate Change', 'Communicable Disease Control/*organization & administration', 'Communicable Diseases/diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Forecasting', 'Humans', 'Male', 'Time Factors']",,,,2018/11/22 06:00,2019/03/13 06:00,['2018/11/22 06:00'],"['2018/11/22 06:00 [entrez]', '2018/11/22 06:00 [pubmed]', '2019/03/13 06:00 [medline]']",,ppublish,Ann Acad Med Singap. 2018 Oct;47(10):401-404.,,,,,,,,,,,,,,,,,
28362950,NLM,MEDLINE,20190325,20230815,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),64,7,2017 Apr 1,Crisis in Infectious Diseases: 2 Decades Later.,823-828,10.1093/cid/cix067 [doi],"The development of nontoxic broad-spectrum antimicrobial drugs in the mid-20th century led to a culture of empiricism, underdevelopment of diagnostics, neglect of immunotherapy, and selection for drug resistance, which together created the conditions that underlie the current crisis. In 1996 an article in this journal predicted a crisis in infectious diseases, which subsequently unfolded with a paucity of new drugs, increases in antimicrobial resistance, and underdevelopment in both immunotherapy and diagnostics. This article argues that the root cause of the current-day problems lies in the enormous success of the mid-20th century antibiotic revolution. The availability of low-toxicity broad-spectrum drugs fostered a culture of empiricism and widespread use, which in turn stunted the development of both the specialty and rapid diagnostics while promoting increases in resistance. Two decades later, there are promising signs that widespread recognition of these problems is leading to fundamental changes in the approach to the therapy of infectious diseases. Ultimately, a concerted effort to simultaneously develop pathogen-specific drugs, immunotherapy, and improved diagnostics could provide a qualitatively new platform for confronting the challenge of infectious diseases, which now also includes host dysbiosis.",,"['Casadevall, Arturo']",['Casadevall A'],"['Department of Molecular Microbiology and Immunology and Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Anti-Infective Agents/isolation & purification/*pharmacology/*therapeutic use', 'Communicable Diseases/*drug therapy/*epidemiology', 'Communicable Diseases, Emerging/drug therapy/epidemiology', '*Drug Resistance, Microbial', '*Global Health', 'Humans', 'Technology, Pharmaceutical/trends']",PMC5849092,['NOTNLM'],"['Immunotherapy', 'antimicrobial therapy', 'immunosuppressed hosts.', 'microbial resistance']",2017/04/01 06:00,2019/03/26 06:00,['2017/04/01 06:00'],"['2017/01/02 00:00 [received]', '2017/02/22 00:00 [accepted]', '2017/04/01 06:00 [entrez]', '2017/04/01 06:00 [pubmed]', '2019/03/26 06:00 [medline]']","['3064671 [pii]', 'cix067 [pii]', '10.1093/cid/cix067 [doi]']",ppublish,Clin Infect Dis. 2017 Apr 1;64(7):823-828. doi: 10.1093/cid/cix067.,,,['0 (Anti-Infective Agents)'],,,,"['R01 HL059842/HL/NHLBI NIH HHS/United States', 'R37 AI033142/AI/NIAID NIH HHS/United States']",,,,,,,,,,
32849578,NLM,MEDLINE,20210413,20210413,1664-3224 (Electronic) 1664-3224 (Linking),11,,2020,Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases.,1670,10.3389/fimmu.2020.01670 [doi] 1670,,,"['Sautto, Giuseppe A', 'Diotti, Roberta A']","['Sautto GA', 'Diotti RA']","['Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States.', 'Microbiology and Virology Unit, ""Vita-Salute San Raffaele"" University, Milan, Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",20200728,Switzerland,Front Immunol,Frontiers in immunology,101560960,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/diagnosis/immunology/*therapy', 'Humans', '*Immunotherapy', 'Prognosis', 'Vaccination', 'Vaccines/*therapeutic use']",PMC7399054,['NOTNLM'],"['antiviral drugs', 'chimeric antigen receptor (CAR)', 'infectious diseases', 'monoclonal antibodies', 'vaccines']",2020/08/28 06:00,2021/04/14 06:00,['2020/08/28 06:00'],"['2020/05/29 00:00 [received]', '2020/06/22 00:00 [accepted]', '2020/08/28 06:00 [entrez]', '2020/08/28 06:00 [pubmed]', '2021/04/14 06:00 [medline]']",['10.3389/fimmu.2020.01670 [doi]'],epublish,Front Immunol. 2020 Jul 28;11:1670. doi: 10.3389/fimmu.2020.01670. eCollection 2020.,,,"['0 (Anti-Infective Agents)', '0 (Vaccines)']",,,,,"['Editorial on the Research Topic Immunotherapeutic and Immunoprophylactic', 'Strategies for Infectious Diseases']",,,,,,,,,
35485889,NLM,MEDLINE,20220503,20220513,1958-5381 (Electronic) 0767-0974 (Linking),38,4,2022 Apr,[Fighting infectious diseases: A never-ended renewed challenge].,335-336,10.1051/medsci/2022056 [doi],,,"['Raoul, Herve', 'Yazdanpanah, Yazdan']","['Raoul H', 'Yazdanpanah Y']","['ANRS-Maladies infectieuses emergentes, Paris, France et Laboratoire P4 Inserm Jean Merieux, Lyon, France.', 'ANRS - Maladies infectieuses emergentes, Paris, France.']",['fre'],['Editorial'],20220429,France,Med Sci (Paris),Medecine sciences : M/S,8710980,IM,"['*Communicable Diseases/epidemiology/therapy', 'Humans']",,,,2022/04/30 06:00,2022/05/04 06:00,['2022/04/29 09:13'],"['2022/04/29 09:13 [entrez]', '2022/04/30 06:00 [pubmed]', '2022/05/04 06:00 [medline]']","['msc220081 [pii]', '10.1051/medsci/2022056 [doi]']",ppublish,Med Sci (Paris). 2022 Apr;38(4):335-336. doi: 10.1051/medsci/2022056. Epub 2022 Apr 29.,,,,,,,,,Repondre aux maladies infectieuses : un defi toujours renouvele.,,,,,,,,
9465188,NLM,MEDLINE,19980226,20190611,0140-6736 (Print) 0140-6736 (Linking),350 Suppl 3,,1997 Dec 20-27,Infectious diseases. More surprises.,SIII12,,,,"[""O'Connor, S"", 'Hughes, J M']","[""O'Connor S"", 'Hughes JM']","['National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.']",['eng'],"['Journal Article', 'Review']",,England,Lancet,"Lancet (London, England)",2985213R,IM,"['Communicable Diseases/epidemiology/*microbiology', 'Disease Outbreaks', 'Global Health', 'Heart Diseases/microbiology', 'Humans']",,,,1998/02/18 00:00,1998/02/18 00:01,['1998/02/18 00:00'],"['1998/02/18 00:00 [pubmed]', '1998/02/18 00:01 [medline]', '1998/02/18 00:00 [entrez]']","['S0140-6736(97)90045-3 [pii]', '10.1016/s0140-6736(97)90045-3 [doi]']",ppublish,Lancet. 1997 Dec 20-27;350 Suppl 3:SIII12. doi: 10.1016/s0140-6736(97)90045-3.,,,,,,5,,,,,,,,,,,
28820471,NLM,MEDLINE,20180426,20230928,1420-3049 (Electronic) 1420-3049 (Linking),22,8,2017 Aug 18,Metal-Based Nanoparticles for the Treatment of Infectious Diseases.,,10.3390/molecules22081370 [doi] 1370,"Infectious diseases can be transmitted and they cause a significant burden on public health globally. They are the greatest world killers and it is estimated that they are responsible for the demise of over 17 million people annually. The impact of these diseases is greater in the developing countries. People with compromised immune systems and children are the most affected. Infectious diseases may be caused by bacteria, viruses, and protozoa. The treatment of infectious diseases is hampered by simultaneous resistance to multiple drugs, indicating that there is a serious and pressing need to develop new therapeutics that can overcome drug resistance. This review will focus on the recent reports of metal-based nanoparticles that are potential therapeutics for the treatment of infectious diseases and their biological efficacy (in vitro and in vivo).",,"['Aderibigbe, Blessing Atim']",['Aderibigbe BA'],"['Department of Chemistry, University of Fort Hare, Alice Campus, Eastern Cape 5700, South Africa. blessingaderibigbe@gmail.com.']",['eng'],"['Journal Article', 'Review']",20170818,Switzerland,Molecules,"Molecules (Basel, Switzerland)",100964009,IM,"['Bacteria/drug effects/pathogenicity', 'Communicable Diseases/*drug therapy/microbiology/parasitology/virology', '*Drug Resistance, Multiple', 'Humans', 'Metal Nanoparticles/*therapeutic use', 'Viruses/drug effects/pathogenicity']",PMC6152252,['NOTNLM'],"['HIV', 'cervical cancer', 'herpes', 'infectious diseases', 'influenza', 'malaria', 'metal-based therapeutics', 'tuberculosis']",2017/08/19 06:00,2018/04/27 06:00,['2017/08/19 06:00'],"['2017/07/24 00:00 [received]', '2017/08/15 00:00 [accepted]', '2017/08/19 06:00 [entrez]', '2017/08/19 06:00 [pubmed]', '2018/04/27 06:00 [medline]']","['molecules22081370 [pii]', 'molecules-22-01370 [pii]', '10.3390/molecules22081370 [doi]']",epublish,Molecules. 2017 Aug 18;22(8):1370. doi: 10.3390/molecules22081370.,['The author declares no conflict of interest.'],,,,,,,,,,,,,,,,
2540355,NLM,MEDLINE,19890608,20161017,0098-7484 (Print) 0098-7484 (Linking),261,19,1989 May 19,Infectious diseases.,2851-3,,,,"['Douglas, R G Jr']",['Douglas RG Jr'],,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,IM,"['Acquired Immunodeficiency Syndrome', '*Communicable Diseases/drug therapy/etiology', 'Cytomegalovirus Infections/drug therapy', 'Humans', 'Lyme Disease', 'Vaccines']",,,,1989/05/19 00:00,2001/03/28 10:01,['1989/05/19 00:00'],"['1989/05/19 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1989/05/19 00:00 [entrez]']",,ppublish,JAMA. 1989 May 19;261(19):2851-3.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
29368266,NLM,MEDLINE,20180906,20200324,2095-0225 (Electronic) 2095-0217 (Print) 2095-0217 (Linking),12,1,2018 Feb,"Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior.",3-22,10.1007/s11684-017-0605-9 [doi],"For the past several decades, the infectious disease profile in China has been shifting with rapid developments in social and economic aspects, environment, quality of food, water, housing, and public health infrastructure. Notably, 5 notifiable infectious diseases have been almost eradicated, and the incidence of 18 additional notifiable infectious diseases has been significantly reduced. Unexpectedly, the incidence of over 10 notifiable infectious diseases, including HIV, brucellosis, syphilis, and dengue fever, has been increasing. Nevertheless, frequent infectious disease outbreaks/events have been reported almost every year, and imported infectious diseases have increased since 2015. New pathogens and over 100 new genotypes or serotypes of known pathogens have been identified. Some infectious diseases seem to be exacerbated by various factors, including rapid urbanization, large numbers of migrant workers, changes in climate, ecology, and policies, such as returning farmland to forests. This review summarizes the current experiences and lessons from China in managing emerging and re-emerging infectious diseases, especially the effects of ecology, climate, and behavior, which should have merits in helping other countries to control and prevent infectious diseases.",,"['Liu, Qiyong', 'Xu, Wenbo', 'Lu, Shan', 'Jiang, Jiafu', 'Zhou, Jieping', 'Shao, Zhujun', 'Liu, Xiaobo', 'Xu, Lei', 'Xiong, Yanwen', 'Zheng, Han', 'Jin, Sun', 'Jiang, Hai', 'Cao, Wuchun', 'Xu, Jianguo']","['Liu Q', 'Xu W', 'Lu S', 'Jiang J', 'Zhou J', 'Shao Z', 'Liu X', 'Xu L', 'Xiong Y', 'Zheng H', 'Jin S', 'Jiang H', 'Cao W', 'Xu J']","['State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'National Institute for Viral Disease Control and Prevention, China CDC, Beijing, 102206, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, 100071, China.', 'The Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences, Beijing, 100094, China.', 'State Key Laboratory of Remote Sensing Science, Jointly Sponsored by Institute of Remote Sensing and Digital Earth of Chinese Academy of Sciences and Beijing Normal University, Beijing, 100094, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'The Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences, Beijing, 100094, China.', 'State Key Laboratory of Remote Sensing Science, Jointly Sponsored by Institute of Remote Sensing and Digital Earth of Chinese Academy of Sciences and Beijing Normal University, Beijing, 100094, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.', 'Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, 100071, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. xujianguo@icdc.cn.']",['eng'],"['Journal Article', 'Review']",20180124,China,Front Med,Frontiers of medicine,101549428,IM,"['Behavior', 'China/epidemiology', 'Climate', 'Communicable Diseases/*classification/*epidemiology', 'Communicable Diseases, Emerging/*epidemiology', '*Disease Outbreaks', 'Ecology', '*Forecasting', 'Humans', 'Incidence']",PMC7089168,['NOTNLM'],"['emerging infectious diseases', 'infectious disease profile', 'influence factor']",2018/01/26 06:00,2018/09/07 06:00,['2018/01/26 06:00'],"['2017/08/30 00:00 [received]', '2017/10/24 00:00 [accepted]', '2018/01/26 06:00 [pubmed]', '2018/09/07 06:00 [medline]', '2018/01/26 06:00 [entrez]']","['10.1007/s11684-017-0605-9 [pii]', '605 [pii]', '10.1007/s11684-017-0605-9 [doi]']",ppublish,Front Med. 2018 Feb;12(1):3-22. doi: 10.1007/s11684-017-0605-9. Epub 2018 Jan 24.,,,,,,,,,,,,,,,,,
31632404,NLM,MEDLINE,20201030,20210110,1664-3224 (Electronic) 1664-3224 (Linking),10,,2019,Syrian Hamster as an Animal Model for the Study on Infectious Diseases.,2329,10.3389/fimmu.2019.02329 [doi] 2329,"Infectious diseases still remain one of the biggest challenges for human health. In order to gain a better understanding of the pathogenesis of infectious diseases and develop effective diagnostic tools, therapeutic agents, and preventive vaccines, a suitable animal model which can represent the characteristics of infectious is required. The Syrian hamster immune responses to infectious pathogens are similar to humans and as such, this model is advantageous for studying pathogenesis of infection including post-bacterial, viral and parasitic pathogens, along with assessing the efficacy and interactions of medications and vaccines for those pathogens. This review summarizes the current status of Syrian hamster models and their use for understanding the underlying mechanisms of pathogen infection, in addition to their use as a drug discovery platform and provides a strong rationale for the selection of Syrian hamster as animal models in biomedical research. The challenges of using Syrian hamster as an alternative animal model for the research of infectious diseases are also addressed.","['Copyright (c) 2019 Miao, Chard, Wang and Wang.']","['Miao, Jinxin', 'Chard, Louisa S', 'Wang, Zhimin', 'Wang, Yaohe']","['Miao J', 'Chard LS', 'Wang Z', 'Wang Y']","['Department of Science and Technology, Henan University of Chinese Medicine, Zhengzhou, China.', 'Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.', 'Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.', 'Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.', 'Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.', 'Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",20191001,Switzerland,Front Immunol,Frontiers in immunology,101560960,IM,"['Animals', 'Communicable Diseases/diagnosis/*etiology/therapy', 'Cricetinae', 'Disease Models, Animal', 'Disease Susceptibility', 'Host-Parasite Interactions', 'Host-Pathogen Interactions', 'Research']",PMC6781508,['NOTNLM'],"['Syrian hamster', 'biomedical research', 'drug discovery', 'infection mechanism', 'infectious diseases']",2019/10/22 06:00,2020/10/31 06:00,['2019/10/22 06:00'],"['2019/03/01 00:00 [received]', '2019/09/16 00:00 [accepted]', '2019/10/22 06:00 [entrez]', '2019/10/22 06:00 [pubmed]', '2020/10/31 06:00 [medline]']",['10.3389/fimmu.2019.02329 [doi]'],epublish,Front Immunol. 2019 Oct 1;10:2329. doi: 10.3389/fimmu.2019.02329. eCollection 2019.,,,,,,,"['MR/M015696/1/MRC_/Medical Research Council/United Kingdom', 'MR/N027655/1/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,
20621213,NLM,MEDLINE,20100812,20100712,1557-8194 (Electronic) 0011-5029 (Linking),56,7,2010 Jul,Infectious diseases in the athlete: an overview.,404-6,10.1016/j.disamonth.2010.03.002 [doi],,,"['Decker, Catherine F']",['Decker CF'],"['Uniformed Services University of the Health Sciences, Division of Infectious Diseases, Department of Internal Medicine, National Naval Medical Center, Bethesda, Maryland, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Dis Mon,Disease-a-month : DM,0370657,IM,"['*Athletes', 'Communicable Disease Control/*organization & administration', 'Communicable Diseases/*diagnosis/therapy/*transmission', 'Humans', '*Sports']",,,,2010/07/14 06:00,2010/08/13 06:00,['2010/07/13 06:00'],"['2010/07/13 06:00 [entrez]', '2010/07/14 06:00 [pubmed]', '2010/08/13 06:00 [medline]']","['S0011-5029(10)00041-6 [pii]', '10.1016/j.disamonth.2010.03.002 [doi]']",ppublish,Dis Mon. 2010 Jul;56(7):404-6. doi: 10.1016/j.disamonth.2010.03.002.,,,,,,9,,,,,,,,,,,
35283327,NLM,MEDLINE,20220426,20220601,1095-9130 (Electronic) 1046-2023 (Linking),201,,2022 May,Digital PCR: Methods and applications in infectious diseases.,1-4,S1046-2023(22)00063-9 [pii] 10.1016/j.ymeth.2022.02.008 [doi],,,"['Long, Samuel']",['Long S'],,['eng'],['Editorial'],20220310,United States,Methods,"Methods (San Diego, Calif.)",9426302,IM,"['*Communicable Diseases/diagnosis/genetics', 'Humans', 'Polymerase Chain Reaction']",,,,2022/03/15 06:00,2022/04/27 06:00,['2022/03/14 05:43'],"['2022/03/15 06:00 [pubmed]', '2022/04/27 06:00 [medline]', '2022/03/14 05:43 [entrez]']","['S1046-2023(22)00063-9 [pii]', '10.1016/j.ymeth.2022.02.008 [doi]']",ppublish,Methods. 2022 May;201:1-4. doi: 10.1016/j.ymeth.2022.02.008. Epub 2022 Mar 10.,,,,,,,,,,,,,,,,,
26017093,NLM,MEDLINE,20160307,20150611,1756-591X (Electronic) 1756-5901 (Linking),7,6,2015 Jun,Metals in infectious diseases and nutritional immunity.,926-8,10.1039/c5mt90021b [doi],,,"['Skaar, Eric P', 'Raffatellu, Manuela']","['Skaar EP', 'Raffatellu M']","['School of Medicine, Vanderbilt University, USA. eric.skaar@vanderbilt.edu.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Metallomics,Metallomics : integrated biometal science,101478346,IM,"['Animals', 'Bacteria/metabolism', 'Communicable Diseases/*metabolism/microbiology', 'Humans', '*Immunity', 'Metals/*metabolism', '*Nutritional Physiological Phenomena']",,,,2015/05/29 06:00,2016/03/08 06:00,['2015/05/29 06:00'],"['2015/05/29 06:00 [entrez]', '2015/05/29 06:00 [pubmed]', '2016/03/08 06:00 [medline]']",['10.1039/c5mt90021b [doi]'],ppublish,Metallomics. 2015 Jun;7(6):926-8. doi: 10.1039/c5mt90021b.,,,['0 (Metals)'],,,,,,,,,,,,,,
25064610,NLM,MEDLINE,20150716,20211021,1432-1831 (Electronic) 0300-8584 (Linking),203,6,2014 Dec,Vaccination against infectious diseases: what is promising?,365-71,10.1007/s00430-014-0346-1 [doi],"Vaccination has proven to be one of the best weapons protecting the mankind against infectious diseases. Along with the huge progress in microbiology, numerous highly efficacious and safe vaccines have been produced by conventional technology (cultivation), by the use of molecular biology (genetic modification), or by synthetic chemistry. Sterilising prevention is achieved by the stimulation of antibody production, while the stimulation of cell-mediated immune responses may prevent the outbreak of disease in consequence of an acute or reactivated infection. From several examples, two rules are deduced to evaluate the perspectives of future vaccine developments: They are promising, if (1) the natural infectious disease induces immunity or (2) passive immunisation (transfer of antibodies, adoptive transfer of lymphocytes) is successful in preventing infection.",,"['Doerr, Hans Wilhelm', 'Berger, Annemarie']","['Doerr HW', 'Berger A']","['Institute for Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Str. 40, 60596, Frankfurt/M., Germany, H.W.Doerr@em.uni-frankfurt.de.']",['eng'],"['Journal Article', 'Review']",20140727,Germany,Med Microbiol Immunol,Medical microbiology and immunology,0314524,IM,"['Communicable Diseases/*epidemiology/immunology/therapy/*transmission', 'Disease Transmission, Infectious/*prevention & control', 'Humans', 'Immunization, Passive/*methods', '*Vaccination']",,,,2014/07/30 06:00,2015/07/17 06:00,['2014/07/28 06:00'],"['2014/05/06 00:00 [received]', '2014/06/10 00:00 [accepted]', '2014/07/28 06:00 [entrez]', '2014/07/30 06:00 [pubmed]', '2015/07/17 06:00 [medline]']",['10.1007/s00430-014-0346-1 [doi]'],ppublish,Med Microbiol Immunol. 2014 Dec;203(6):365-71. doi: 10.1007/s00430-014-0346-1. Epub 2014 Jul 27.,,,,,,,,,,,,,,,,,
36193748,NLM,MEDLINE,20221108,20230320,1708-8305 (Electronic) 1195-1982 (Linking),29,7,2022 Nov 4,Improving screening and treatment for infectious diseases in migrant populations.,,taac115 [pii] 10.1093/jtm/taac115 [doi],,,"['Greenaway, Christina', 'Hargreaves, Sally']","['Greenaway C', 'Hargreaves S']","['Division of Infectious Disease, Jewish General Hospital, Montreal, H3T1E2 Quebec, Canada.', 'Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, H3T 1E2 Quebec, Canada.', 'Department of Medicine, McGill University, Montreal, H3G Quebec, Canada.', ""Centre for Global Health, Institute for Infection and Immunity, St George's University of London, UK.""]",['eng'],['Editorial'],,England,J Travel Med,Journal of travel medicine,9434456,IM,"['Humans', '*Transients and Migrants', '*Communicable Diseases/diagnosis/epidemiology', 'Mass Screening']",,['NOTNLM'],"['Migrant health', 'health disparities', 'infectious diseases', 'screening']",2022/10/05 06:00,2022/11/09 06:00,['2022/10/04 05:03'],"['2022/09/22 00:00 [received]', '2022/09/23 00:00 [accepted]', '2022/10/05 06:00 [pubmed]', '2022/11/09 06:00 [medline]', '2022/10/04 05:03 [entrez]']","['6747787 [pii]', '10.1093/jtm/taac115 [doi]']",ppublish,J Travel Med. 2022 Nov 4;29(7):taac115. doi: 10.1093/jtm/taac115.,,,,,,,,,,,,,,,,,
35810069,NLM,MEDLINE,20220920,20220923,2212-1692 (Electronic) 1875-9572 (Linking),63,5,2022 Sep,Progress in the application of metagenomic next-generation sequencing in pediatric infectious diseases.,445-451,S1875-9572(22)00108-5 [pii] 10.1016/j.pedneo.2022.03.014 [doi],"Infectious diseases are the major cause of children's deaths all over the world. With the development of evidence-based medicine, etiological diagnosis becomes more and more important. Since traditional methods have been unable to meet the needs of diagnosis and treatment, metagenomic next-generation sequencing (mNGS) gradually shows its unique advantages for pathogen diagnosis. This article aimed to introduce the application of mNGS technology in the diagnosis and treatment of neonatal and puerile infectious diseases by providing some examples.","['Copyright (c) 2022 Taiwan Pediatric Association. Published by Elsevier B.V. All', 'rights reserved.']","['Li, Chi', 'Wang, Yajuan']","['Li C', 'Wang Y']","[""Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China."", ""Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China. Electronic address: cxswyj@vip.sina.com.""]",['eng'],"['Journal Article', 'Review']",20220527,Singapore,Pediatr Neonatol,Pediatrics and neonatology,101484755,IM,"['Child', '*Communicable Diseases/diagnosis/genetics/therapy', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Infant, Newborn', '*Metagenomics', 'Sensitivity and Specificity']",,['NOTNLM'],"['Infectious disease', 'Pediatric', 'mNGS']",2022/07/10 06:00,2022/09/21 06:00,['2022/07/09 22:05'],"['2021/08/04 00:00 [received]', '2022/02/25 00:00 [revised]', '2022/03/10 00:00 [accepted]', '2022/07/10 06:00 [pubmed]', '2022/09/21 06:00 [medline]', '2022/07/09 22:05 [entrez]']","['S1875-9572(22)00108-5 [pii]', '10.1016/j.pedneo.2022.03.014 [doi]']",ppublish,Pediatr Neonatol. 2022 Sep;63(5):445-451. doi: 10.1016/j.pedneo.2022.03.014. Epub 2022 May 27.,['Declaration of competing interest The authors declare no conflicts of interest.'],,,,,,,,,,,,,,,,
21619464,NLM,MEDLINE,20120120,20161018,1437-4331 (Electronic) 1434-6621 (Linking),49,9,2011 Sep,Genetics of infectious diseases: hidden etiologies and common pathways.,1427-37,10.1515/CCLM.2011.620 [doi],"Since the completion of the human genome sequence, the study of common genetic polymorphisms in complex human diseases has become a main activity of human genetics. Employing genome-wide association studies, hundreds of modest genetic risk factors have been identified. In infectious diseases the identification of common risk factors has been varied and as in other common diseases it seems likely that important genetic risk factors remain to be discovered. Nevertheless, the identification of disease-specific genetic risk factors revealed an unexpected overlap in susceptibility genes of diverse inflammatory and infectious diseases. Analysis of the multi-disease susceptibility genes has allowed the definition of shared key pathways of inflammatory dysregulation and suggested unexpected infectious etiologies for other ""non-infectious"" common diseases.",,"['Orlova, Marianna', 'Di Pietrantonio, Tania', 'Schurr, Erwin']","['Orlova M', 'Di Pietrantonio T', 'Schurr E']","['McGill Centre for the Study of Host Resistance, The Research Institute of the McGill University Health Centre, Montreal, PQ, Canada.']",['eng'],"['Journal Article', 'Review']",20110527,Germany,Clin Chem Lab Med,Clinical chemistry and laboratory medicine,9806306,IM,"['Alleles', 'Animals', 'Communicable Diseases/*etiology/*genetics/microbiology/virology', 'Genome-Wide Association Study', 'Humans', 'Species Specificity']",,,,2011/05/31 06:00,2012/01/21 06:00,['2011/05/31 06:00'],"['2011/05/31 06:00 [entrez]', '2011/05/31 06:00 [pubmed]', '2012/01/21 06:00 [medline]']",['10.1515/CCLM.2011.620 [doi]'],ppublish,Clin Chem Lab Med. 2011 Sep;49(9):1427-37. doi: 10.1515/CCLM.2011.620. Epub 2011 May 27.,,,,,,,,,,,,,,,,,
31833314,NLM,MEDLINE,20200612,20200612,1082-6742 (Print) 1082-6742 (Linking),33,4,2019 Dec 9,Infectious Diseases in Avian Medicine.,440-442,10.1647/1082-6742-33.4.440 [doi],,,,,,['eng'],['Interview'],,United States,J Avian Med Surg,Journal of avian medicine and surgery,9512497,IM,"['Animals', 'Bird Diseases/*epidemiology/microbiology/parasitology', 'Communicable Diseases/epidemiology/microbiology/parasitology/*veterinary', 'United States/epidemiology']",,,,2019/12/14 06:00,2020/06/13 06:00,['2019/12/14 06:00'],"['2019/12/14 06:00 [entrez]', '2019/12/14 06:00 [pubmed]', '2020/06/13 06:00 [medline]']",['10.1647/1082-6742-33.4.440 [doi]'],ppublish,J Avian Med Surg. 2019 Dec 9;33(4):440-442. doi: 10.1647/1082-6742-33.4.440.,,,,,,,,,,,,,,,,,
32248926,NLM,MEDLINE,20210106,20210106,1532-8228 (Electronic) 0883-9417 (Print) 0883-9417 (Linking),34,2,2020 Apr,The emotional toll of global infectious diseases.,1,S0883-9417(20)30089-3 [pii] 10.1016/j.apnu.2020.02.011 [doi],,,,,,['eng'],['Editorial'],20200225,United States,Arch Psychiatr Nurs,Archives of psychiatric nursing,8708534,IM,"['COVID-19/psychology/*transmission', 'China', '*Communicable Diseases/psychology/transmission/virology', '*Emotions', '*Global Health', 'Health Personnel/psychology', 'Humans', '*Mental Health']",PMC7136941,,,2020/04/07 06:00,2021/01/07 06:00,['2020/04/07 06:00'],"['2020/04/07 06:00 [entrez]', '2020/04/07 06:00 [pubmed]', '2021/01/07 06:00 [medline]']","['S0883-9417(20)30089-3 [pii]', '10.1016/j.apnu.2020.02.011 [doi]']",ppublish,Arch Psychiatr Nurs. 2020 Apr;34(2):1. doi: 10.1016/j.apnu.2020.02.011. Epub 2020 Feb 25.,,,,,,,,,,,,,,,,,
20109040,NLM,MEDLINE,20100630,20100129,1744-8336 (Electronic) 1478-7210 (Linking),8,2,2010 Feb,Pediatric infectious diseases. Foreword.,111-2,10.1586/eri.09.86 [doi],,,"['Schaad, Urs B', 'Shulman, Stanford T']","['Schaad UB', 'Shulman ST']","[""Department of Pediatrics, University Children's Hospital, PO Box CH-4005 Basel, Switzerland. urs-b.schaad@unibas.ch""]",['eng'],['Introductory Journal Article'],,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/immunology/therapy', 'Humans', 'Pediatrics/trends']",,,,2010/01/30 06:00,2010/07/01 06:00,['2010/01/30 06:00'],"['2010/01/30 06:00 [entrez]', '2010/01/30 06:00 [pubmed]', '2010/07/01 06:00 [medline]']",['10.1586/eri.09.86 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2010 Feb;8(2):111-2. doi: 10.1586/eri.09.86.,,,,,,,,,,,,,,,,,
18428383,NLM,MEDLINE,20080808,20161021,1934-8258 (Electronic) 1934-8258 (Linking),Chapter 9,,2005 Nov,Infectious diseases testing.,Unit 9.18,10.1002/0471142905.hg0918s47 [doi],"Molecular methods have been applied widely for the diagnosis of infectious diseases. Beginning with solution hybridization in the early 1990s, multiple methods for nucleic acid hybridization and amplification have been introduced into the laboratory for the identification and characterization of microbial pathogens. This unit contains examples of several basic approaches for microbial detection or characterization in the laboratory. Methods in this chapter include automated nucleic acid extraction, direct detection of microbial pathogens, and characterization of pathogens by DNA sequencing or typing. Any of these methods could be customized for the characterization of bacteria, fungi, parasites, or viruses.",,"['Blakey, Gregory L', 'Luna, Ruth Ann', 'Versalovic, James']","['Blakey GL', 'Luna RA', 'Versalovic J']","['Baylor College of Medicine, Houston, Texas, USA.']",['eng'],['Journal Article'],,United States,Curr Protoc Hum Genet,Current protocols in human genetics,101287858,IM,"['Communicable Diseases/*diagnosis/genetics', 'Humans', 'Nucleic Acid Hybridization', 'Reverse Transcriptase Polymerase Chain Reaction']",,,,2008/04/23 09:00,2008/08/09 09:00,['2008/04/23 09:00'],"['2008/04/23 09:00 [pubmed]', '2008/08/09 09:00 [medline]', '2008/04/23 09:00 [entrez]']",['10.1002/0471142905.hg0918s47 [doi]'],ppublish,Curr Protoc Hum Genet. 2005 Nov;Chapter 9:Unit 9.18. doi: 10.1002/0471142905.hg0918s47.,,,,,,,,,,,,,,,,,
31005358,NLM,MEDLINE,20191224,20191224,0740-2570 (Print) 0740-2570 (Linking),36,3,2019 May,Introduction: One health and emerging infectious diseases.,143-145,S0740-2570(19)30036-X [pii] 10.1053/j.semdp.2019.04.004 [doi],"Those infectious diseases that have increased in the past two decades or that threaten to emerge are considered emerging infectious diseases. Many of these diseases are acquired through contact with plants, insects and animals. ""One health"" acknowledges the interconnectedness of environment, plant, animal and human health. The introduction to this issue of Seminars in Diagnostic Pathology gives the definition of emerging and reemerging infectious diseases, explores the concept of ""One Health"", explains the evolution of testing for infectious agents as it relates to emerging infections, and considers the difficulties in predicting which and where the next emerging infection will occur.",['Copyright (c) 2019. Published by Elsevier Inc.'],"['Guarner, Jeannette']",['Guarner J'],"['Department of Pathology and Laboratory Medicine, Emory University, 1364 Clifton Rd, Atlanta, GA 30322, United States. Electronic address: jguarne@emory.edu.']",['eng'],['Editorial'],20190416,United States,Semin Diagn Pathol,Seminars in diagnostic pathology,8502262,IM,"['Communicable Diseases, Emerging/*diagnosis/pathology', 'Humans', '*One Health']",,,,2019/04/22 06:00,2019/12/25 06:00,['2019/04/22 06:00'],"['2019/04/22 06:00 [pubmed]', '2019/12/25 06:00 [medline]', '2019/04/22 06:00 [entrez]']","['S0740-2570(19)30036-X [pii]', '10.1053/j.semdp.2019.04.004 [doi]']",ppublish,Semin Diagn Pathol. 2019 May;36(3):143-145. doi: 10.1053/j.semdp.2019.04.004. Epub 2019 Apr 16.,,,,,,,,,,,,,,,,,
23022814,NLM,MEDLINE,20130205,20121001,2008-6520 (Print) 2008-6520 (Linking),2,1,2011 Jan,Global climate change and infectious diseases.,11-9,,"Climate change is occurring as a result of warming of the earth's atmosphere due to human activity generating excess amounts of greenhouse gases. Because of its potential impact on the hydrologic cycle and severe weather events, climate change is expected to have an enormous effect on human health, including on the burden and distribution of many infectious diseases. The infectious diseases that will be most affected by climate change include those that are spread by insect vectors and by contaminated water. The burden of adverse health effects due to these infectious diseases will fall primarily on developing countries, while it is the developed countries that are primarily responsible for climate change. It is up to governments and individuals to take the lead in halting climate change, and we must increase our understanding of the ecology of infectious diseases in order to protect vulnerable populations.",,"['Shuman, E K']",['Shuman EK'],"['Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, USA. emilyks@umich.edu']",['eng'],"['Journal Article', 'Review']",,Iran,Int J Occup Environ Med,The international journal of occupational and environmental medicine,101535763,IM,"['Animals', 'Communicable Diseases/*etiology/transmission', 'Disease Vectors', 'Geography, Medical', '*Global Warming', '*Greenhouse Effect', 'Humans']",,,,2011/01/01 00:00,2013/02/06 06:00,['2012/10/02 06:00'],"['2012/10/02 06:00 [entrez]', '2011/01/01 00:00 [pubmed]', '2013/02/06 06:00 [medline]']",['65 [pii]'],ppublish,Int J Occup Environ Med. 2011 Jan;2(1):11-9.,,,,,,,,,,,,,,,,,
25516192,NLM,MEDLINE,20160106,20220330,1537-6591 (Electronic) 1058-4838 (Linking),60,7,2015 Apr 1,Use of telemedicine technologies in the management of infectious diseases: a review.,1084-94,10.1093/cid/ciu1143 [doi],"Telemedicine technologies are rapidly being integrated into infectious diseases programs with the aim of increasing access to infectious diseases specialty care for isolated populations and reducing costs. We summarize the utility and effectiveness of telemedicine in the evaluation and treatment of infectious diseases patients. The use of telemedicine in the management of acute infectious diseases, chronic hepatitis C, human immunodeficiency virus, and active pulmonary tuberculosis is considered. We recapitulate and evaluate the advantages of telemedicine described in other studies, present challenges to adopting telemedicine, and identify future opportunities for the use of telemedicine within the realm of clinical infectious diseases.","['(c) The Author 2014. Published by Oxford University Press on behalf of the', 'Infectious Diseases Society of America. All rights reserved. For Permissions,', 'please e-mail: journals.permissions@oup.com.']","['Parmar, Parmvir', 'Mackie, David', 'Varghese, Sunil', 'Cooper, Curtis']","['Parmar P', 'Mackie D', 'Varghese S', 'Cooper C']","['Faculty of Medicine, University of Ottawa.', 'Ottawa Hospital and Regional Viral Hepatitis Telemedicine Program.', 'Ottawa Hospital and Regional Viral Hepatitis Telemedicine Program.', 'Faculty of Medicine, University of Ottawa Ottawa Hospital and Regional Viral Hepatitis Telemedicine Program Division of Infectious Diseases, Department of Medicine, University of Ottawa, Ontario, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20141216,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Humans', 'Telemedicine/*methods']",,['NOTNLM'],"['HIV', 'hepatitis C virus', 'infectious diseases', 'telemedicine', 'tuberculosis']",2014/12/18 06:00,2016/01/07 06:00,['2014/12/18 06:00'],"['2014/12/18 06:00 [entrez]', '2014/12/18 06:00 [pubmed]', '2016/01/07 06:00 [medline]']","['ciu1143 [pii]', '10.1093/cid/ciu1143 [doi]']",ppublish,Clin Infect Dis. 2015 Apr 1;60(7):1084-94. doi: 10.1093/cid/ciu1143. Epub 2014 Dec 16.,,,,,,,,,,,,,,,,,
16389254,NLM,MEDLINE,20060111,20190619,1539-3704 (Electronic) 0003-4819 (Linking),144,1,2006 Jan 3,Update in infectious diseases.,49-56,,,,"['Bartlett, John G']",['Bartlett JG'],"['Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205-2191, USA. jb@jhmi.edu']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Communicable Disease Control', '*Communicable Diseases/diagnosis/drug therapy/transmission', 'Humans']",,,,2006/01/04 09:00,2006/01/13 09:00,['2006/01/04 09:00'],"['2006/01/04 09:00 [pubmed]', '2006/01/13 09:00 [medline]', '2006/01/04 09:00 [entrez]']","['144/1/49 [pii]', '10.7326/0003-4819-144-1-200601030-00009 [doi]']",ppublish,Ann Intern Med. 2006 Jan 3;144(1):49-56. doi: 10.7326/0003-4819-144-1-200601030-00009.,,,,['Ann Intern Med. 2006 May 2;144(9):704'],,10,,,,,,,,,,,
12484713,NLM,MEDLINE,20021226,20190619,1539-3704 (Electronic) 0003-4819 (Linking),137,12,2002 Dec 17,Update in infectious diseases.,974-80,,,,"['Lorber, Bennett']",['Lorber B'],"['Section of Infectious Diseases, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA. lorberb@tuhs.temple.edu']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Bioterrorism', 'Communicable Disease Control', '*Communicable Diseases/diagnosis/drug therapy/epidemiology', 'Humans', 'Public Health', 'United States/epidemiology']",,,,2002/12/18 04:00,2002/12/27 04:00,['2002/12/18 04:00'],"['2002/12/18 04:00 [pubmed]', '2002/12/27 04:00 [medline]', '2002/12/18 04:00 [entrez]']","['200212170-00011 [pii]', '10.7326/0003-4819-137-12-200212170-00011 [doi]']",ppublish,Ann Intern Med. 2002 Dec 17;137(12):974-80. doi: 10.7326/0003-4819-137-12-200212170-00011.,,,,,,7,,,,,,,,,,,
15583230,NLM,MEDLINE,20041221,20190619,1539-3704 (Electronic) 0003-4819 (Linking),141,11,2004 Dec 7,Update in infectious diseases.,875-81,,,,"['Lorber, Bennett']",['Lorber B'],"['Department of Medicine, Temple University School of Medicine and Temple University Hospital, Philadelphia, Pennsylvania 19140, USA. lorberb@tuhs.temple.edu']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['*Communicable Diseases/epidemiology/therapy/transmission', 'Humans']",,,,2004/12/08 09:00,2004/12/22 09:00,['2004/12/08 09:00'],"['2004/12/08 09:00 [pubmed]', '2004/12/22 09:00 [medline]', '2004/12/08 09:00 [entrez]']","['141/11/875 [pii]', '10.7326/0003-4819-141-11-200412070-00012 [doi]']",ppublish,Ann Intern Med. 2004 Dec 7;141(11):875-81. doi: 10.7326/0003-4819-141-11-200412070-00012.,,,,,,0,,,,,,,,,,,
23327385,NLM,MEDLINE,20160329,20181023,2219-0635 (Electronic) 0030-2465 (Linking),79,2,2012 Jul 19,'One Health' infectious diseases surveillance in Tanzania: are we all on board the same flight?,500,10.4102/ojvr.v79i2.500 [doi],"Infectious diseases account for nearly 40% of the burden of human mortality and morbidity in low-income countries, of which 7% is attributable to zoonoses and 13% to recently emerging diseases from animals. One of the strategic approaches for effective surveillance, monitoring and control of infectious diseases compromising health in both humans and animals could be through a combination of multiple disciplines. The approach can be achieved through a joint effort from stakeholders comprising health professionals (medical and veterinary), social, economic, agricultural, environmental and other interested parties. With resource scarcity in terms of number of staff, skills and facility in low-income countries, participatory multi- sectoral and multidisciplinary approaches in limiting the burden of zoonotic diseases could be worthwhile. We review challenging issues that may limit the 'One Health' approach for infectious diseases surveillance in Tanzania with a focus on Health Policy and how best the human and animal health systems could be complemented or linked to suit the community in need for disease control under the theme's context.",,"['Mbugi, Erasto V', 'Kayunze, Kim A', 'Katale, Bugwesa Z', 'Kendall, Sharon', 'Good, Liam', 'Kibik, Gibson S', 'Keyyu, Julius D', 'Godfrey-Faussett, Peter', 'Van Helden, Paul', 'Matee, Mecky I']","['Mbugi EV', 'Kayunze KA', 'Katale BZ', 'Kendall S', 'Good L', 'Kibik GS', 'Keyyu JD', 'Godfrey-Faussett P', 'Van Helden P', 'Matee MI']","['Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences. erasto.mbugi@sacids.org.']",['eng'],"['Journal Article', 'Review']",20120719,South Africa,Onderstepoort J Vet Res,The Onderstepoort journal of veterinary research,0401107,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/epidemiology/transmission/veterinary', 'Communicable Diseases, Emerging/epidemiology/*prevention & control/transmission/veterinary', 'Humans', '*Sentinel Surveillance/veterinary', 'Tanzania', '*Zoonoses']",,,,2013/01/19 06:00,2016/03/30 06:00,['2013/01/19 06:00'],"['2012/07/01 00:00 [received]', '2012/07/01 00:00 [accepted]', '2013/01/19 06:00 [entrez]', '2013/01/19 06:00 [pubmed]', '2016/03/30 06:00 [medline]']",['10.4102/ojvr.v79i2.500 [doi]'],epublish,Onderstepoort J Vet Res. 2012 Jul 19;79(2):500. doi: 10.4102/ojvr.v79i2.500.,,,,,,,,,,,,,,,,,
37496807,NLM,MEDLINE,20230728,20230728,2235-2988 (Electronic) 2235-2988 (Linking),13,,2023,Editorial: Livestock and poultry infectious diseases: pathogenesis and immune mechanisms.,1249034,10.3389/fcimb.2023.1249034 [doi] 1249034,,,"['Wu, Jiaqiang', 'Ding, Jiabo', 'Wang, Leyi']","['Wu J', 'Ding J', 'Wang L']","['Shandong Key Laboratory of Animal Disease Control and Breeding, Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, China.', 'Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.', 'Veterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL, United States.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",20230711,Switzerland,Front Cell Infect Microbiol,Frontiers in cellular and infection microbiology,101585359,IM,"['Animals', 'Humans', '*Poultry', 'Livestock', '*Communicable Diseases/etiology/veterinary']",PMC10368184,['NOTNLM'],"['immune mechanisms', 'infectious diseases', 'livestock', 'pathogenesis', 'poultry']",2023/07/27 06:43,2023/07/28 06:42,['2023/07/27 04:08'],"['2023/06/28 00:00 [received]', '2023/07/03 00:00 [accepted]', '2023/07/28 06:42 [medline]', '2023/07/27 06:43 [pubmed]', '2023/07/27 04:08 [entrez]']",['10.3389/fcimb.2023.1249034 [doi]'],epublish,Front Cell Infect Microbiol. 2023 Jul 11;13:1249034. doi: 10.3389/fcimb.2023.1249034. eCollection 2023.,"['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",,,,,,,"['Editorial on the Research Topic Livestock and poultry infectious diseases:', 'pathogenesis and immune mechanisms']",,,,,,,,,
15385008,NLM,MEDLINE,20050119,20040923,1155-5645 (Print) 1155-5645 (Linking),14,10,2004 Oct,Infectious diseases of childhood and their anesthetic implications.,810-9,,,,"['van der Walt, J H', 'Jacob, R', 'Zoanetti, D C']","['van der Walt JH', 'Jacob R', 'Zoanetti DC']","[""Department of Paediatric Anaesthesia, Women's and Children's Hospital, Adelaide, South Australia, Australia.""]",['eng'],"['Journal Article', 'Review']",,France,Paediatr Anaesth,Paediatric anaesthesia,9206575,IM,"['*Anesthesia', 'Child', 'Communicable Diseases/*complications/physiopathology/therapy', 'Humans', 'Immunization', 'Personnel Staffing and Scheduling', 'Respiratory Mechanics']",,,,2004/09/24 05:00,2005/01/20 09:00,['2004/09/24 05:00'],"['2004/09/24 05:00 [pubmed]', '2005/01/20 09:00 [medline]', '2004/09/24 05:00 [entrez]']","['PAN1378 [pii]', '10.1111/j.1460-9592.2004.01378.x [doi]']",ppublish,Paediatr Anaesth. 2004 Oct;14(10):810-9. doi: 10.1111/j.1460-9592.2004.01378.x.,,,,,,35,,,,,,,,,,,
8871997,NLM,MEDLINE,19970121,20191101,0029-6554 (Print) 0029-6554 (Linking),44,4,1996 Jul-Aug,Emerging infectious diseases: nursing responses.,164-8,,,,"['Cohen, F L', 'Larson, E']","['Cohen FL', 'Larson E']","['School of Nursing, Southern Illinois University at Edwardsville, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Nurs Outlook,Nursing outlook,0401075,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/epidemiology/etiology/*nursing', 'Disease Outbreaks/prevention & control/statistics & numerical data', 'Humans']",,,,1996/07/01 00:00,1996/07/01 00:01,['1996/07/01 00:00'],"['1996/07/01 00:00 [pubmed]', '1996/07/01 00:01 [medline]', '1996/07/01 00:00 [entrez]']","['S0029-6554(96)80036-4 [pii]', '10.1016/s0029-6554(96)80036-4 [doi]']",ppublish,Nurs Outlook. 1996 Jul-Aug;44(4):164-8. doi: 10.1016/s0029-6554(96)80036-4.,,,,,,21,,,,,,,,,,,
30297012,NLM,MEDLINE,20190517,20190517,1558-0539 (Electronic) 0733-8627 (Linking),36,4,2018 Nov,Here to Stay: Infectious Diseases in Emergency Medicine.,xvii-xviii,S0733-8627(18)30073-7 [pii] 10.1016/j.emc.2018.08.001 [doi],,,"['Liang, Stephen Y', 'Chin, Rachel L']","['Liang SY', 'Chin RL']","['Divisions of Emergency Medicine and Infectious Diseases, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8051, St. Louis, MO 63110, USA. Electronic address: syliang@wustl.edu.', 'Department of Emergency Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco School of Medicine, 1001 Potrero Avenue, Suite 6A, San Francisco, CA 94110-1377, USA. Electronic address: rachel.chin@ucsf.edu.']",['eng'],['Editorial'],,United States,Emerg Med Clin North Am,Emergency medicine clinics of North America,8219565,IM,"['*Communicable Diseases/diagnosis/therapy', '*Emergency Service, Hospital', 'Humans']",,,,2018/10/10 06:00,2019/05/18 06:00,['2018/10/10 06:00'],"['2018/10/10 06:00 [entrez]', '2018/10/10 06:00 [pubmed]', '2019/05/18 06:00 [medline]']","['S0733-8627(18)30073-7 [pii]', '10.1016/j.emc.2018.08.001 [doi]']",ppublish,Emerg Med Clin North Am. 2018 Nov;36(4):xvii-xviii. doi: 10.1016/j.emc.2018.08.001.,,,,,,,,,,,,,,,,,
28192575,NLM,MEDLINE,20170713,20170713,1938-2359 (Electronic) 0090-4481 (Linking),46,2,2017 Feb 1,Less Common Pediatric Infectious Diseases Revisited.,e40-e41,10.3928/19382359-20170119-03 [doi],,,"['Rosebush, Julia', 'Yogev, Ram']","['Rosebush J', 'Yogev R']",,['eng'],['Editorial'],,United States,Pediatr Ann,Pediatric annals,0356657,IM,"['Child', 'Communicable Diseases/*diagnosis/therapy', 'Humans', '*Pediatrics']",,,,2017/02/14 06:00,2017/07/14 06:00,['2017/02/14 06:00'],"['2017/02/14 06:00 [entrez]', '2017/02/14 06:00 [pubmed]', '2017/07/14 06:00 [medline]']",['10.3928/19382359-20170119-03 [doi]'],ppublish,Pediatr Ann. 2017 Feb 1;46(2):e40-e41. doi: 10.3928/19382359-20170119-03.,,,,,,,,,,,,,,,,,
19729848,NLM,MEDLINE,20091002,20211020,1558-8238 (Electronic) 0021-9738 (Print) 0021-9738 (Linking),119,9,2009 Sep,Human genetics of infectious diseases: between proof of principle and paradigm.,2506-14,38111 [pii] 10.1172/JCI38111 [doi],"The observation that only a fraction of individuals infected by infectious agents develop clinical disease raises fundamental questions about the actual pathogenesis of infectious diseases. Epidemiological and experimental evidence is accumulating to suggest that human genetics plays a major role in this process. As we discuss here, human predisposition to infectious diseases seems to cover a continuous spectrum from monogenic to polygenic inheritance. Although many studies have provided proof of principle that infectious diseases may result from various types of inborn errors of immunity, the genetic determinism of most infectious diseases in most patients remains unclear. However, in the future, studies in human genetics are likely to establish a new paradigm for infectious diseases.",,"['Alcais, Alexandre', 'Abel, Laurent', 'Casanova, Jean-Laurent']","['Alcais A', 'Abel L', 'Casanova JL']","['Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U550, Paris, France.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,J Clin Invest,The Journal of clinical investigation,7802877,IM,"['Communicable Diseases/*genetics/history/immunology', 'Female', 'Genetic Predisposition to Disease', 'Genetics, Medical/history', 'Genome, Human', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Immunologic Deficiency Syndromes/genetics/immunology', 'Male', 'Models, Genetic', 'Pedigree']",PMC2735901,,,2009/09/05 06:00,2009/10/03 06:00,['2009/09/05 06:00'],"['2009/09/05 06:00 [entrez]', '2009/09/05 06:00 [pubmed]', '2009/10/03 06:00 [medline]']","['38111 [pii]', '10.1172/JCI38111 [doi]']",ppublish,J Clin Invest. 2009 Sep;119(9):2506-14. doi: 10.1172/JCI38111.,,,,,,,['Howard Hughes Medical Institute/United States'],,,,,,,,,,
15744742,NLM,MEDLINE,20050607,20061115,0893-6692 (Print) 0893-6692 (Linking),45,2-3,2005 Mar-Apr,Role of infectious diseases in human carcinogenesis.,284-303,,"The burden of human infectious diseases remains a public health problem worldwide. At least 2 billion people are affected by viral infections, and a similar number by bacteria or helminths. The long-term effects of these maladies have raised particular concern since some infectious agents have been associated with chronic human diseases, especially cancer. It is estimated that 13-20% of the world cancer cases are associated with some virus, bacteria, or helminth, e.g., human papillomavirus, Helicobacter pylori, and Schistosoma haematobium that cause cervical, stomach, and urinary bladder cancer, respectively. Certain associations between infection and malignancy are strong and irrefutable; others are still speculative. This article reviews the infectious agents that have been associated with cancer and current knowledge about the mechanisms underlying these associations.",,"['Herrera, Luis A', 'Benitez-Bribiesca, Luis', 'Mohar, Alejandro', 'Ostrosky-Wegman, Patricia']","['Herrera LA', 'Benitez-Bribiesca L', 'Mohar A', 'Ostrosky-Wegman P']","['Unidad de Investigacion Biomedica en Cancer, Instituto de Investigaciones Biomedicas-Instituto Nacional de Cancerologia, Mexico City, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Environ Mol Mutagen,Environmental and molecular mutagenesis,8800109,IM,"['Animals', 'Cell Communication/physiology', 'Cell Proliferation', 'Communicable Diseases/*complications/microbiology/parasitology/virology', 'Genomic Instability/physiology', '*Helicobacter pylori', '*Helminths', 'Humans', 'Immunologic Surveillance/physiology', 'Models, Biological', 'Neoplasms/*etiology/microbiology/parasitology/*physiopathology/virology', '*Oncogenic Viruses']",,,,2005/03/04 09:00,2005/06/09 09:00,['2005/03/04 09:00'],"['2005/03/04 09:00 [pubmed]', '2005/06/09 09:00 [medline]', '2005/03/04 09:00 [entrez]']",['10.1002/em.20122 [doi]'],ppublish,Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):284-303. doi: 10.1002/em.20122.,,,,,,178,,,,,,,,,,,
25418021,NLM,MEDLINE,20150714,20231104,1474-760X (Electronic) 1465-6906 (Print) 1474-7596 (Linking),15,11,2014 Nov 22,Human infectious diseases in the genomics era: where do we go from here?,529,10.1186/s13059-014-0529-5 [doi] 529,"Ripudaman K Bains is the editor of the Genome Biology special issue content on the 'genomics of infectious diseases', and introduces the collection in this editorial.",,"['Bains, Ripudaman K']",['Bains RK'],,['eng'],['Editorial'],20141122,England,Genome Biol,Genome biology,100960660,IM,"['Bacteria/*genetics/pathogenicity', 'Communicable Diseases/*genetics/microbiology', '*Genome, Bacterial', 'Genomics', 'Humans']",PMC4283784,,,2014/11/25 06:00,2015/07/15 06:00,['2014/11/25 06:00'],"['2014/11/25 06:00 [entrez]', '2014/11/25 06:00 [pubmed]', '2015/07/15 06:00 [medline]']","['s13059-014-0529-5 [pii]', '529 [pii]', '10.1186/s13059-014-0529-5 [doi]']",epublish,Genome Biol. 2014 Nov 22;15(11):529. doi: 10.1186/s13059-014-0529-5.,,,,,,,,,,,,,,,,,
18217543,NLM,MEDLINE,20080325,20230917,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),13,11,2007 Nov,Conflict and emerging infectious diseases.,1625-31,10.3201/eid1311.061093 [doi],"Detection and control of emerging infectious diseases in conflict situations are major challenges due to multiple risk factors known to enhance emergence and transmission of infectious diseases. These include inadequate surveillance and response systems, destroyed infrastructure, collapsed health systems and disruption of disease control programs, and infection control practices even more inadequate than those in resource-poor settings, as well as ongoing insecurity and poor coordination among humanitarian agencies. This article outlines factors that potentiate emergence and transmission of infectious diseases in conflict situations and highlights several priority actions for their containment and control.",,"['Gayer, Michelle', 'Legros, Dominique', 'Formenty, Pierre', 'Connolly, Maire A']","['Gayer M', 'Legros D', 'Formenty P', 'Connolly MA']","['Disease Control in Humanitarian Emerfencies, Health Security and Environmental Cluster, World Health Organization, Geneva, Switzerland. gayerm@who.int']",['eng'],"['Journal Article', 'Review']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases, Emerging/*etiology/prevention & control/transmission', 'Dissent and Disputes', 'Humans', 'Violence', '*Warfare']",PMC3375795,,,2008/01/26 09:00,2008/03/26 09:00,['2008/01/26 09:00'],"['2008/01/26 09:00 [pubmed]', '2008/03/26 09:00 [medline]', '2008/01/26 09:00 [entrez]']","['06-1093 [pii]', '10.3201/eid1311.061093 [doi]']",ppublish,Emerg Infect Dis. 2007 Nov;13(11):1625-31. doi: 10.3201/eid1311.061093.,,,,,['Emerg Infect Dis. 2008 Jun;14(6):1004-5; author reply 1005. PMID: 18507934'],,,,,,,,,,,,
23669075,NLM,MEDLINE,20140401,20220318,2150-5608 (Electronic) 2150-5594 (Print) 2150-5594 (Linking),4,6,2013 Aug 15,Biomarkers of endothelial activation/dysfunction in infectious diseases.,507-16,10.4161/viru.24530 [doi],"Endothelial dysfunction contributes to the pathogenesis of a variety of potentially serious infectious diseases and syndromes, including sepsis and septic shock, hemolytic-uremic syndrome, severe malaria, and dengue hemorrhagic fever. Because endothelial activation often precedes overt endothelial dysfunction, biomarkers of the activated endothelium in serum and/or plasma may be detectable before classically recognized markers of disease, and therefore, may be clinically useful as biomarkers of disease severity or prognosis in systemic infectious diseases. In this review, the current status of mediators of endothelial cell function (angiopoietins-1 and -2), components of the coagulation pathway (von Willebrand Factor, ADAMTS13, and thrombomodulin), soluble cell-surface adhesion molecules (soluble E-selectin, sICAM-1, and sVCAM-1), and regulators of vascular tone and permeability (VEGF and sFlt-1) as biomarkers in severe infectious diseases is discussed in the context of sepsis, E. coli O157:H7 infection, malaria, and dengue virus infection.",,"['Page, Andrea V', 'Liles, W Conrad']","['Page AV', 'Liles WC']","['Mount Sinai Hospital-University Health Network, Toronto, ON, Canada. APage@mtsinai.on.ca']",['eng'],"['Journal Article', 'Review']",20130419,United States,Virulence,Virulence,101531386,IM,"['Animals', 'Biomarkers/*blood', 'Communicable Diseases/*blood/genetics/metabolism/physiopathology', 'Endothelium, Vascular/metabolism/*physiopathology', 'Humans']",PMC5359744,['NOTNLM'],"['ADAMTS13', 'E-selectin', 'ICAM-1', 'VEGF', 'angiopoietin-1', 'angiopoietin-2', 'endothelium', 'malaria', 'sepsis', 'von Willebrand Factor']",2013/05/15 06:00,2014/04/02 06:00,['2013/05/15 06:00'],"['2013/05/15 06:00 [entrez]', '2013/05/15 06:00 [pubmed]', '2014/04/02 06:00 [medline]']","['24530 [pii]', '10924530 [pii]', '10.4161/viru.24530 [doi]']",ppublish,Virulence. 2013 Aug 15;4(6):507-16. doi: 10.4161/viru.24530. Epub 2013 Apr 19.,,,['0 (Biomarkers)'],,,,,,,,,,,,,,
22153753,NLM,MEDLINE,20120502,20220318,1878-4380 (Electronic) 0966-842X (Print) 0966-842X (Linking),20,1,2012 Jan,The pig: a model for human infectious diseases.,50-7,10.1016/j.tim.2011.11.002 [doi],"An animal model to study human infectious diseases should accurately reproduce the various aspects of disease. Domestic pigs (Sus scrofa domesticus) are closely related to humans in terms of anatomy, genetics and physiology, and represent an excellent animal model to study various microbial infectious diseases. Indeed, experiments in pigs are much more likely to be predictive of therapeutic treatments in humans than experiments in rodents. In this review, we highlight the numerous advantages of the pig model for infectious disease research and vaccine development and document a few examples of human microbial infectious diseases for which the use of pigs as animal models has contributed to the acquisition of new knowledge to improve both animal and human health.",['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],"['Meurens, Francois', 'Summerfield, Artur', 'Nauwynck, Hans', 'Saif, Linda', 'Gerdts, Volker']","['Meurens F', 'Summerfield A', 'Nauwynck H', 'Saif L', 'Gerdts V']","['Institut National de la Recherche Agronomique, Unite de Recherche 1282, Infectiologie Animale et Sante Publique, 37380, Nouzilly (Tours), France. meurens@tours.inra.fr']",['eng'],"['Journal Article', 'Review']",20111205,England,Trends Microbiol,Trends in microbiology,9310916,IM,"['Animals', 'Anti-Infective Agents/therapeutic use', 'Communicable Diseases/drug therapy/immunology/*pathology', '*Disease Models, Animal', 'Humans', '*Sus scrofa', 'Vaccination/methods', 'Vaccines/administration & dosage/immunology']",PMC7173122,,,2011/12/14 06:00,2012/05/04 06:00,['2011/12/14 06:00'],"['2011/07/29 00:00 [received]', '2011/10/21 00:00 [revised]', '2011/11/02 00:00 [accepted]', '2011/12/14 06:00 [entrez]', '2011/12/14 06:00 [pubmed]', '2012/05/04 06:00 [medline]']","['S0966-842X(11)00195-8 [pii]', '10.1016/j.tim.2011.11.002 [doi]']",ppublish,Trends Microbiol. 2012 Jan;20(1):50-7. doi: 10.1016/j.tim.2011.11.002. Epub 2011 Dec 5.,,,"['0 (Anti-Infective Agents)', '0 (Vaccines)']",,,,,,,,,,,,,,
23751490,NLM,MEDLINE,20131223,20211203,1879-0372 (Electronic) 0952-7915 (Print) 0952-7915 (Linking),25,4,2013 Aug,Humanized mice for the study of infectious diseases.,428-35,S0952-7915(13)00082-4 [pii] 10.1016/j.coi.2013.05.012 [doi],"Many of the pathogens that cause human infectious diseases do not infect rodents or other mammalian species. Small animal models that allow studies of the pathogenesis of these agents and evaluation of drug efficacy are critical for identifying ways to prevent and treat human infectious diseases. Immunodeficient mice engrafted with functional human cells and tissues, termed 'humanized' mice, represent a critical pre-clinical bridge for in vivo studies of human pathogens. Recent advances in the development of humanized mice have allowed in vivo studies of multiple human infectious agents providing novel insights into their pathogenesis that was otherwise not possible.",['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],"['Brehm, Michael A', 'Jouvet, Nathalie', 'Greiner, Dale L', 'Shultz, Leonard D']","['Brehm MA', 'Jouvet N', 'Greiner DL', 'Shultz LD']","['Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, United States.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",20130608,England,Curr Opin Immunol,Current opinion in immunology,8900118,IM,"['Animals', 'Communicable Diseases/*immunology/microbiology/parasitology', 'Disease Models, Animal', 'Humans', 'Mice', 'Translational Research, Biomedical']",PMC3775881,,,2013/06/12 06:00,2013/12/24 06:00,['2013/06/12 06:00'],"['2013/03/19 00:00 [received]', '2013/05/15 00:00 [revised]', '2013/05/17 00:00 [accepted]', '2013/06/12 06:00 [entrez]', '2013/06/12 06:00 [pubmed]', '2013/12/24 06:00 [medline]']","['S0952-7915(13)00082-4 [pii]', '10.1016/j.coi.2013.05.012 [doi]']",ppublish,Curr Opin Immunol. 2013 Aug;25(4):428-35. doi: 10.1016/j.coi.2013.05.012. Epub 2013 Jun 8.,,,,,,,"['P30 DK032520/DK/NIDDK NIH HHS/United States', 'DK32520/DK/NIDDK NIH HHS/United States', 'CA034196/CA/NCI NIH HHS/United States', 'P01 AI046629/AI/NIAID NIH HHS/United States', 'AI046629/AI/NIAID NIH HHS/United States', 'P30 AI042845/AI/NIAID NIH HHS/United States', 'P30 CA034196/CA/NCI NIH HHS/United States']",,,['NIHMS485505'],,,,,,,
11322751,NLM,MEDLINE,20010607,20220801,0094-5145 (Print) 0094-5145 (Linking),26,2,2001 Apr,Revisiting emerging infectious diseases: the unfinished agenda.,113-22,,"Infectious diseases present a formidable threat to the world today. Not only are new infectious diseases emerging, but those presumed to be contained or eradicated are re-emerging. Developing nations, with the least resources to respond, bear the greatest burden of this threat. However, with the potential to spread rapidly and ubiquitously, infectious diseases present a significant risk to the health and development of all nations. No country or population is immune, and geographic and political barriers offer little protection. Many factors facilitate the spread of infectious diseases, including globalization of travel and trade, weakening of national and international public health infrastructure, deterioration of socioeconomic conditions, and heightened political and civil strife in some developing nations. These conditions render populations more vulnerable to infections and provide an environment conducive to the transmission of infectious diseases. Compounding these risk factors is the emergence of another threat: antimicrobial resistance. Antimicrobial drugs are rapidly losing their effectiveness because of their misuse. As a result, the global health community is confronted with the daunting task of combating more offenders with fewer defenses.",,"['Kombe, G C', 'Darrow, D M']","['Kombe GC', 'Darrow DM']","['Department of International Public Health, School of Public Health and Health Services, The George Washington University, Washington, DC 20037, USA.']",['eng'],"['Journal Article', 'Review']",,Netherlands,J Community Health,Journal of community health,7600747,IM,"['*Communicable Disease Control', '*Communicable Diseases, Emerging/classification/epidemiology/prevention & control/transmission', 'Drug Resistance, Microbial', '*Global Health', 'Humans', 'Public Health Practice', 'Socioeconomic Factors']",,,,2001/04/27 10:00,2001/06/08 10:01,['2001/04/27 10:00'],"['2001/04/27 10:00 [pubmed]', '2001/06/08 10:01 [medline]', '2001/04/27 10:00 [entrez]']",['10.1023/a:1005277213366 [doi]'],ppublish,J Community Health. 2001 Apr;26(2):113-22. doi: 10.1023/a:1005277213366.,,,,,,19,,,,,,,,,,,
9457428,NLM,MEDLINE,19980317,20210526,0893-8512 (Print) 1098-6618 (Electronic) 0893-8512 (Linking),11,1,1998 Jan,Gene therapy for infectious diseases.,42-56,,"Gene therapy is being investigated as an alternative treatment for a wide range of infectious diseases that are not amenable to standard clinical management. Approaches to gene therapy for infectious diseases can be divided into three broad categories: (i) gene therapies based on nucleic acid moieties, including antisense DNA or RNA, RNA decoys, and catalytic RNA moieties (ribozymes); (ii) protein approaches such as transdominant negative proteins and single-chain antibodies; and (iii) immunotherapeutic approaches involving genetic vaccines or pathogen-specific lymphocytes. It is further possible that combinations of the aforementioned approaches will be used simultaneously to inhibit multiple stages of the life cycle of the infectious agent.",,"['Bunnell, B A', 'Morgan, R A']","['Bunnell BA', 'Morgan RA']","['Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-1851, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,IM,"['Clinical Trials as Topic', 'Communicable Diseases/genetics/*therapy/virology', '*Genetic Therapy', 'Humans']",PMC121375,,,1998/02/11 00:00,1998/02/11 00:01,['1998/02/11 00:00'],"['1998/02/11 00:00 [pubmed]', '1998/02/11 00:01 [medline]', '1998/02/11 00:00 [entrez]']","['0006 [pii]', '10.1128/CMR.11.1.42 [doi]']",ppublish,Clin Microbiol Rev. 1998 Jan;11(1):42-56. doi: 10.1128/CMR.11.1.42.,,,,,,,,,,,,,,,,,
35544188,NLM,MEDLINE,20220517,20220608,2666-5247 (Electronic) 2666-5247 (Linking),2,4,2021 Apr,Re-emergence of infectious diseases associated with the past.,e140,S2666-5247(21)00066-5 [pii] 10.1016/S2666-5247(21)00066-5 [doi],,,"['Venkatesan, Priya']",['Venkatesan P'],,['eng'],['News'],,England,Lancet Microbe,The Lancet. Microbe,101769019,IM,"['*Communicable Diseases/epidemiology', '*Communicable Diseases, Emerging/epidemiology', 'Humans']",,,,2022/05/12 06:00,2022/05/18 06:00,['2022/05/11 11:43'],"['2022/05/11 11:43 [entrez]', '2022/05/12 06:00 [pubmed]', '2022/05/18 06:00 [medline]']","['S2666-5247(21)00066-5 [pii]', '10.1016/S2666-5247(21)00066-5 [doi]']",ppublish,Lancet Microbe. 2021 Apr;2(4):e140. doi: 10.1016/S2666-5247(21)00066-5.,,,,,,,,,,,,,,,,,
31518573,NLM,MEDLINE,20210322,20210322,1873-6254 (Electronic) 0001-706X (Linking),213,,2021 Jan,"Impact of environmental changes on infectious diseases: Key findings from an international conference in Trieste, Italy in May 2017.",105165,S0001-706X(19)31225-2 [pii] 10.1016/j.actatropica.2019.105165 [doi],"Elsevier's 2nd conference on ""Impact of Environmental Changes on Infectious Diseases"" (IECID), convened in May 2017 in Trieste, Italy, brought together some 120 researchers from more than 20 countries. They presented the latest findings and discussed the impact of current and predicted future environmental changes on infectious disease dynamics in humans, livestock and wildlife in different parts of the world. Particular emphasis was placed on food-, vector- and water-borne diseases within the general theme of infectious diseases of poverty and emerging and re-emerging diseases. The potential impact of mobility, travel, population growth, trade and globalization on infectious disease dynamics against the background of a changing climate, land use, air quality and urbanization on individual, population, ecosystem and planetary health were addressed. Speakers at the conference were encouraged to put forth their talks into stand-alone manuscripts, which resulted in a unique collection of 13 articles, now brought together into a thematic issue of Acta Tropica. In this umbrella piece, we synthesize key findings from the published articles and highlight potential actions that might be taken forward to prevent and mitigate the impact of environmental change on infectious diseases. The work presented is salient in the current era of the Sustainable Development Goals.",['Copyright (c) 2019. Published by Elsevier B.V.'],"['Brattig, Norbert W', 'Tanner, Marcel', 'Bergquist, Robert', 'Utzinger, Jurg']","['Brattig NW', 'Tanner M', 'Bergquist R', 'Utzinger J']","['Epidemiology and Diagnostics Section, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359 Hamburg, Germany. Electronic address: nbrattig@bnitm.de.', 'Ingerod, Brastad, Sweden; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland.', 'University of Basel, P.O. Box, CH-4003 Basel, Switzerland.', 'Ingerod, Brastad, Sweden; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland.']",['eng'],['Editorial'],20190910,Netherlands,Acta Trop,Acta tropica,0370374,IM,"['Animals', 'Climate Change', 'Communicable Diseases/*epidemiology/transmission/veterinary', 'Disease Vectors', '*Ecological and Environmental Phenomena', 'Ecosystem', 'Humans', 'Population Growth', 'Sustainable Development', 'Travel', 'Urbanization']",,['NOTNLM'],"['Climate change', 'Environmental change', 'Food and water systems', 'Globalization', 'Infectious diseases', 'Sustainable development goals']",2019/09/14 06:00,2021/03/23 06:00,['2019/09/14 06:00'],"['2019/09/14 06:00 [pubmed]', '2021/03/23 06:00 [medline]', '2019/09/14 06:00 [entrez]']","['S0001-706X(19)31225-2 [pii]', '10.1016/j.actatropica.2019.105165 [doi]']",ppublish,Acta Trop. 2021 Jan;213:105165. doi: 10.1016/j.actatropica.2019.105165. Epub 2019 Sep 10.,,,,,,,,,,,,,,,,,
21635726,NLM,MEDLINE,20140630,20231104,1297-9716 (Electronic) 0928-4249 (Print) 0928-4249 (Linking),42,1,2011 Jun 2,A survey of the transmission of infectious diseases/infections between wild and domestic ungulates in Europe.,70,10.1186/1297-9716-42-70 [doi],"The domestic animals/wildlife interface is becoming a global issue of growing interest. However, despite studies on wildlife diseases being in expansion, the epidemiological role of wild animals in the transmission of infectious diseases remains unclear most of the time. Multiple diseases affecting livestock have already been identified in wildlife, especially in wild ungulates. The first objective of this paper was to establish a list of infections already reported in European wild ungulates. For each disease/infection, three additional materials develop examples already published, specifying the epidemiological role of the species as assigned by the authors. Furthermore, risk factors associated with interactions between wild and domestic animals and regarding emerging infectious diseases are summarized. Finally, the wildlife surveillance measures implemented in different European countries are presented. New research areas are proposed in order to provide efficient tools to prevent the transmission of diseases between wild ungulates and livestock.",,"['Martin, Claire', 'Pastoret, Paul-Pierre', 'Brochier, Bernard', 'Humblet, Marie-France', 'Saegerman, Claude']","['Martin C', 'Pastoret PP', 'Brochier B', 'Humblet MF', 'Saegerman C']","['Research Unit in Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR), Department of Infectious and Parasitic diseases, Faculty of Veterinary Medicine, University of Liege, Boulevard de Colonster, 20, B42, B-4000 Liege, Belgium. claude.saegerman@ulg.ac.be.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20110602,England,Vet Res,Veterinary research,9309551,IM,"['Animals', '*Animals, Wild', '*Artiodactyla', 'Communicable Disease Control/legislation & jurisprudence/methods', 'Communicable Diseases/classification/epidemiology/etiology/*veterinary', 'Communicable Diseases, Emerging/classification/epidemiology/etiology/veterinary', 'Epidemiological Monitoring/*veterinary', 'Europe/epidemiology', '*Livestock', 'Risk Factors']",PMC3152899,,,2011/06/04 06:00,2014/07/01 06:00,['2011/06/04 06:00'],"['2010/08/22 00:00 [received]', '2011/06/02 00:00 [accepted]', '2011/06/04 06:00 [entrez]', '2011/06/04 06:00 [pubmed]', '2014/07/01 06:00 [medline]']","['1297-9716-42-70 [pii]', '10.1186/1297-9716-42-70 [doi]']",epublish,Vet Res. 2011 Jun 2;42(1):70. doi: 10.1186/1297-9716-42-70.,,,,,,,,,,,,,,,,,
35107892,NLM,MEDLINE,20220204,20220204,1660-9379 (Print) 1660-9379 (Linking),18,767,2022 Feb 2,"[Infectious diseases: Achievements, new Developments and Perspectives in 2021].",173-181,10.53738/REVMED.2022.18.767.173 [doi],"The substantial progresses during the last decades in the field of infectious diseases have significantly improved their prevention, diagnosis and treatment. Basic and medical sciences have efficiently dealt with the challenges of emerging infections, infectious complications related to the increasing complexity of medical practices and marked slow-down in the development of new antimicrobial agents. During the worldwide crisis related to the COVID-19 pandemic, the << medical normality >> has been put in stand-by, but medical advances have fortunately continued. In the present article we present new knowledge in the field of bacterial, viral and fungal infections, which may modify hospital and ambulatory practices. Significant achievements in the field of COVID-19 will be presented in a future article.",,"['Blondet, Fanny', 'Aebischer, Oriane', 'Tusgul, Selin', 'Monsalve Arteaga, Lia', 'Schaad, Nicolas', 'Challet, Corinne', 'Doser, Nicole', 'Sedda, Aline', 'Urbano, Luis', 'Marchetti, Oscar']","['Blondet F', 'Aebischer O', 'Tusgul S', 'Monsalve Arteaga L', 'Schaad N', 'Challet C', 'Doser N', 'Sedda A', 'Urbano L', 'Marchetti O']","['Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Pharmacie interhospitaliere de la Cote, Ensemble hospitalier de la Cote, 1110 Morges.', 'Pharmacie interhospitaliere de la Cote, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.', 'Departement de medecine, Ensemble hospitalier de la Cote, 1110 Morges.']",['fre'],['Journal Article'],,Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,IM,"['*COVID-19', '*Communicable Diseases/diagnosis/epidemiology/therapy', 'Forecasting', 'Humans', 'Pandemics', 'SARS-CoV-2']",,,,2022/02/03 06:00,2022/02/05 06:00,['2022/02/02 12:16'],"['2022/02/02 12:16 [entrez]', '2022/02/03 06:00 [pubmed]', '2022/02/05 06:00 [medline]']","['RMS0767-008 [pii]', '10.53738/REVMED.2022.18.767.173 [doi]']",ppublish,Rev Med Suisse. 2022 Feb 2;18(767):173-181. doi: 10.53738/REVMED.2022.18.767.173.,"[""Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.""]",,,,,,,,"Maladies infectieuses - Acquis, nouveautes et perspectives en 2021.",,,,,,,,
30560778,NLM,MEDLINE,20190411,20200309,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),25,1,2018 Jan,"Epidemiology of Imported Infectious Diseases, China, 2005-2016.",33-41,10.3201/eid2501.180178 [doi],"Imported infectious diseases are becoming a serious public health threat in China. However, limited information concerning the epidemiologic characteristics of imported infectious diseases is available. In this study, we collected data related to imported infectious diseases in mainland China from the National Information Reporting System of Infectious Diseases and analyzed demographic, temporal, and spatial distributions. The number of types of imported infectious diseases reported increased from 2 in 2005 to 11 in 2016. A total of 31,740 cases of infectious disease were imported to mainland China during 2005-2016; most of them were found in Yunnan Province. The cases were imported mainly from Africa and Asia. As a key and effective measure, pretravel education should be strengthened for all migrant workers and tourists in China, and border screening, cross-border international cooperation, and early warning should be further improved.",,"['Wang, Yali', 'Wang, Xuan', 'Liu, Xiaobo', 'Ren, Ruiqi', 'Zhou, Lei', 'Li, Chao', 'Tu, Wenxiao', 'Ni, Daxin', 'Li, Qun', 'Feng, Zijian', 'Zhang, Yanping']","['Wang Y', 'Wang X', 'Liu X', 'Ren R', 'Zhou L', 'Li C', 'Tu W', 'Ni D', 'Li Q', 'Feng Z', 'Zhang Y']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['China/epidemiology', 'Communicable Diseases, Imported/*epidemiology/etiology/prevention & control', 'Epidemiological Monitoring', 'Female', 'Humans', 'Male']",PMC6302593,['NOTNLM'],"['China', 'MERS', 'Zika', 'acute flaccid paralysis', 'chikungunya', 'communicable diseases', 'dengue', 'epidemiology', 'imported infectious disease', 'influenza', 'malaria', 'poliomyelitis', 'prevention and control', 'vector-borne infections', 'viruses', 'yellow fever']",2018/12/19 06:00,2019/04/12 06:00,['2018/12/19 06:00'],"['2018/12/19 06:00 [entrez]', '2018/12/19 06:00 [pubmed]', '2019/04/12 06:00 [medline]']","['18-0178 [pii]', '10.3201/eid2501.180178 [doi]']",ppublish,Emerg Infect Dis. 2018 Jan;25(1):33-41. doi: 10.3201/eid2501.180178.,,,,,,,,,,,,,,,,,
27434370,NLM,MEDLINE,20170720,20200422,1749-6632 (Electronic) 0077-8923 (Print) 0077-8923 (Linking),1382,1,2016 Oct,Observed and projected drivers of emerging infectious diseases in Europe.,73-83,10.1111/nyas.13132 [doi],"Emerging infectious diseases are of international concern because of the potential for, and impact of, pandemics; however, they are difficult to predict. To identify the drivers of disease emergence, we analyzed infectious disease threat events (IDTEs) detected through epidemic intelligence collected at the European Centre for Disease Prevention and Control (ECDC) between 2008 and 2013, and compared the observed results with a 2008 ECDC foresight study of projected drivers of future IDTEs in Europe. Among 10 categories of IDTEs, foodborne and waterborne IDTEs were the most common, vaccine-preventable IDTEs caused the highest number of cases, and airborne IDTEs caused the most deaths. Observed drivers for each IDTE were sorted into three main groups: globalization and environmental drivers contributed to 61% of all IDTEs, public health system drivers contributed to 21%, and social and demographic drivers to 18%. A multiple logistic regression analysis showed that four of the top five drivers for observed IDTEs were in the globalization and environment group. In the observational study, the globalization and environment group was related to all IDTE categories, but only to five of eight categories in the foresight study. Directly targeting these drivers with public health interventions may diminish the chances of IDTE occurrence from the outset.",['(c) 2016 New York Academy of Sciences.'],"['Semenza, Jan C', 'Rocklov, Joacim', 'Penttinen, Pasi', 'Lindgren, Elisabet']","['Semenza JC', 'Rocklov J', 'Penttinen P', 'Lindgren E']","['European Centre for Disease Prevention and Control, Stockholm, Sweden.', 'Umea University, Umea, Sweden.', 'European Centre for Disease Prevention and Control, Stockholm, Sweden.', 'Stockholm Resilience Centre, Stockholm University, Stockholm, Sweden.']",['eng'],"['Journal Article', 'Review']",20160719,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,IM,"['Animals', 'Communicable Diseases/diagnosis/*epidemiology/transmission', 'Communicable Diseases, Emerging/diagnosis/*epidemiology/transmission', 'Disease Outbreaks/prevention & control/statistics & numerical data', '*Environmental Exposure/prevention & control/statistics & numerical data', 'Europe/epidemiology', 'Forecasting', 'Humans', '*Internationality', 'Pandemics/prevention & control/statistics & numerical data', 'Public Health/statistics & numerical data/*trends']",PMC7167773,['NOTNLM'],"['drivers', 'epidemic', 'infectious diseases', 'pandemic', 'threat']",2016/07/20 06:00,2017/07/21 06:00,['2016/07/20 06:00'],"['2016/03/07 00:00 [received]', '2016/05/16 00:00 [revised]', '2016/05/17 00:00 [accepted]', '2016/07/20 06:00 [pubmed]', '2017/07/21 06:00 [medline]', '2016/07/20 06:00 [entrez]']","['NYAS13132 [pii]', '10.1111/nyas.13132 [doi]']",ppublish,Ann N Y Acad Sci. 2016 Oct;1382(1):73-83. doi: 10.1111/nyas.13132. Epub 2016 Jul 19.,['The authors declare no conflicts of interest.'],,,,,,,,,,,,,,,,
27353433,NLM,MEDLINE,20171026,20171121,1461-0248 (Electronic) 1461-023X (Linking),19,9,2016 Sep,The macroecology of infectious diseases: a new perspective on global-scale drivers of pathogen distributions and impacts.,1159-71,10.1111/ele.12644 [doi],"Identifying drivers of infectious disease patterns and impacts at the broadest scales of organisation is one of the most crucial challenges for modern science, yet answers to many fundamental questions remain elusive. These include what factors commonly facilitate transmission of pathogens to novel host species, what drives variation in immune investment among host species, and more generally what drives global patterns of parasite diversity and distribution? Here we consider how the perspectives and tools of macroecology, a field that investigates patterns and processes at broad spatial, temporal and taxonomic scales, are expanding scientific understanding of global infectious disease ecology. In particular, emerging approaches are providing new insights about scaling properties across all living taxa, and new strategies for mapping pathogen biodiversity and infection risk. Ultimately, macroecology is establishing a framework to more accurately predict global patterns of infectious disease distribution and emergence.",['(c) 2016 John Wiley & Sons Ltd/CNRS.'],"['Stephens, Patrick R', 'Altizer, Sonia', 'Smith, Katherine F', 'Alonso Aguirre, A', 'Brown, James H', 'Budischak, Sarah A', 'Byers, James E', 'Dallas, Tad A', 'Jonathan Davies, T', 'Drake, John M', 'Ezenwa, Vanessa O', 'Farrell, Maxwell J', 'Gittleman, John L', 'Han, Barbara A', 'Huang, Shan', 'Hutchinson, Rebecca A', 'Johnson, Pieter', 'Nunn, Charles L', 'Onstad, David', 'Park, Andrew', 'Vazquez-Prokopec, Gonzalo M', 'Schmidt, John P', 'Poulin, Robert']","['Stephens PR', 'Altizer S', 'Smith KF', 'Alonso Aguirre A', 'Brown JH', 'Budischak SA', 'Byers JE', 'Dallas TA', 'Jonathan Davies T', 'Drake JM', 'Ezenwa VO', 'Farrell MJ', 'Gittleman JL', 'Han BA', 'Huang S', 'Hutchinson RA', 'Johnson P', 'Nunn CL', 'Onstad D', 'Park A', 'Vazquez-Prokopec GM', 'Schmidt JP', 'Poulin R']","['Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Department of Ecology and Evolutionary Biology, Brown University, Providence, RI, 0291, USA.', 'Department of Environmental Science and Policy, George Mason University, Fairfax, VA, 22030, USA.', 'Department of Biology, University of New Mexico, Albuquerque, NM, 87131, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Department of Biology, McGill University, Montreal, Quebec, H3A 0G4, Canada.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Department of Biology, McGill University, Montreal, Quebec, H3A 0G4, Canada.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Cary Institute of Ecosystem Studies, Millbrook, New York, 12545, USA.', 'Senckenberg Biodiversity and Climate Research Centre (BiK-F), Senckenberg Gesellschaft fur Naturforschung, Senckenberganlage 25, 60325, Frankfurt, Germany.', 'School of Electrical Engineering and Computer Science, Oregon State University, Corvallis, OR, 97331, USA.', 'Department of Ecology and Evolutionary Biology, University of Colorado, Boulder, CO, 80309, USA.', 'Biological Sciences, Duke University, Durham, NC, 27708, USA.', 'ITD Data Analysis and Modelling, DuPont Agricultural Biotechnology, Experimental Station E353/317, Wilmington, DE, 19803, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Department of Environmental Sciences, Emory University, Atlanta, GA, 30322, USA.', 'Odum School of Ecology, University of Georgia, Athens, GA, 30602, USA.', 'Department of Zoology, University of Otago, Dunedin, 9054, New Zealand.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",20160628,England,Ecol Lett,Ecology letters,101121949,IM,"['Biodiversity', '*Communicable Diseases/epidemiology/etiology/transmission/veterinary', 'Ecology/methods', '*Host-Pathogen Interactions']",,['NOTNLM'],"['Biodiversity', 'conservation', 'disease ecology', 'infectious diseases', 'macroecology', 'pathogens']",2016/06/30 06:00,2017/10/27 06:00,['2016/06/30 06:00'],"['2016/03/03 00:00 [received]', '2016/04/12 00:00 [revised]', '2016/05/31 00:00 [accepted]', '2016/06/30 06:00 [entrez]', '2016/06/30 06:00 [pubmed]', '2017/10/27 06:00 [medline]']",['10.1111/ele.12644 [doi]'],ppublish,Ecol Lett. 2016 Sep;19(9):1159-71. doi: 10.1111/ele.12644. Epub 2016 Jun 28.,,,,,,,,,,,,,,,,,
26130786,NLM,MEDLINE,20160406,20150701,1791-7549 (Electronic) 0258-851X (Linking),29,4,2015 Jul-Aug,"The Spectrum of Infectious Diseases in Kidney Transplantation: A Review of the Classification, Pathogens and Clinical Manifestations.",415-22,,"Kidney transplantation is the treatment-of-choice for a significant number of patients with end-stage renal disease. Renal transplant recipients (RTRs) benefit from a longer life expectancy, with a better quality of life. Despite, recent accomplishments in the field of kidney transplantation, both short- and long-term, surgical and medical complications still exist. Among these complications, cardiovascular disease, carcinogenesis and infections are the most important. Infectious diseases constitute the most common complications after renal transplantation and the second most common cause of death among RTRs with a functioning graft. Theoretically, all infectious pathogens could cause disease in immunocompromised RTRs, yet among these, one could identify more important ones, such as the Enterobacteriaceae, causing urinary tract infections; pneumonia due to Pneumocystis jirovecii; Candida species which cause invasive fungal infections; herpes viruses; hepatitis viruses and parasites. Early diagnosis and effective treatment are key elements in salvaging both the allograft and the patient. However, clinical manifestations and diagnosis of such infectious diseases are not easily identified due to the altered state of immune response of the RTR. Thus, apart from possessing a deep knowledge of the etiology and the treatment options in each case, transplant physicians should also always remain alert when dealing with RTRs.","['Copyright (c) 2015 International Institute of Anticancer Research (Dr. John G.', 'Delinassios), All rights reserved.']","['Anastasopoulos, Nikolaos-Andreas', 'Duni, Anila', 'Peschos, Dimitrios', 'Agnantis, Niki', 'Dounousi, Evangelia']","['Anastasopoulos NA', 'Duni A', 'Peschos D', 'Agnantis N', 'Dounousi E']","['Department of Surgery, Medical School, University of Ioannina, Ioannina, Greece.', 'Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece.', 'Laboratory of Physiology, Medical School, University of Ioannina, Ioannina, Greece.', 'Laboratory of Pathology, Medical School, University of Ioannina, Ioannina, Greece.', 'Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece evangeldou@gmail.com.']",['eng'],"['Journal Article', 'Review']",,Greece,In Vivo,"In vivo (Athens, Greece)",8806809,IM,"['Central Nervous System Infections/diagnosis/etiology', 'Communicable Diseases/*diagnosis/*etiology/microbiology/parasitology/virology', 'Cross Infection', 'Gastroenteritis/diagnosis/etiology', 'Humans', 'Kidney Failure, Chronic/complications/therapy', 'Kidney Transplantation/*adverse effects', 'Respiratory Tract Infections/diagnosis/etiology', 'Time Factors', 'Transplantation, Homologous']",,['NOTNLM'],"['Kidney transplantation', 'classification', 'etiology', 'immunosuppression', 'infectious diseases', 'review']",2015/07/02 06:00,2016/04/07 06:00,['2015/07/02 06:00'],"['2015/07/02 06:00 [entrez]', '2015/07/02 06:00 [pubmed]', '2016/04/07 06:00 [medline]']",['29/4/415 [pii]'],ppublish,In Vivo. 2015 Jul-Aug;29(4):415-22.,,,,,,,,,,,,,,,,,
28345226,NLM,MEDLINE,20180312,20180312,1537-2995 (Electronic) 0041-1132 (Linking),57,3pt2,2017 Mar,Decision making in the face of uncertainty: the challenge of emerging infectious diseases.,723-728,10.1111/trf.14037 [doi],,,"['Marks, Peter W', 'Petersen, Lyle R']","['Marks PW', 'Petersen LR']","['Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Transfusion,Transfusion,0417360,IM,"['Communicable Diseases/epidemiology/virology', 'Communicable Diseases, Emerging/epidemiology/virology', '*Decision Making', 'Humans', 'Uncertainty']",,,,2017/03/28 06:00,2018/03/13 06:00,['2017/03/28 06:00'],"['2017/03/28 06:00 [entrez]', '2017/03/28 06:00 [pubmed]', '2018/03/13 06:00 [medline]']",['10.1111/trf.14037 [doi]'],ppublish,Transfusion. 2017 Mar;57(3pt2):723-728. doi: 10.1111/trf.14037.,,,,,,,,,,,,,,,,,
8443330,NLM,MEDLINE,19930406,20210209,1058-4838 (Print) 1058-4838 (Linking),16 Suppl 3,,1993 Mar,The endemic infectious diseases of Somalia.,S132-57,,,,"['Oldfield, E C 3rd', 'Rodier, G R', 'Gray, G C']","['Oldfield EC 3rd', 'Rodier GR', 'Gray GC']","['Department of Internal Medicine (Infectious Disease Division), Naval Hospital, San Diego, California 92134-5000.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Diseases/*epidemiology/etiology/therapy', 'Humans', 'Somalia/epidemiology']",,,,1993/03/01 00:00,1993/03/01 00:01,['1993/03/01 00:00'],"['1993/03/01 00:00 [pubmed]', '1993/03/01 00:01 [medline]', '1993/03/01 00:00 [entrez]']",['10.1093/clinids/16.supplement_3.s132 [doi]'],ppublish,Clin Infect Dis. 1993 Mar;16 Suppl 3:S132-57. doi: 10.1093/clinids/16.supplement_3.s132.,,,,,['Clin Infect Dis. 1993 Sep;17(3):510-1. PMID: 8218699'],229,,,,,,,,,,,
26360954,NLM,MEDLINE,20151215,20150912,1439-4413 (Electronic) 0012-0472 (Linking),140,18,2015 Sep,[Sex differences in infectious diseases and their clinical consequences].,1385-90,10.1055/s-0041-104246 [doi],"Differences between women and men range from their anatomy, their natural social behavior to their susceptibility and response to different pathologies, including infectious diseases. The underlying mechanisms of sex differences in infectious diseases are manifold, including differences in exposure to common pathogens, genetic factors that modulate immune responses against pathogens and hormonal factors that may alter susceptibility or disease progression, and responsiveness to treatment. On one hand, these mechanisms lead to higher innate and adaptive immune responses in females, which result in faster clearance of acute infections and higher antibody responses to several vaccines, on the other hand this contributes to an increased susceptibility to chronic inflammatory diseases. In this review we summarize the underlying causes of sex differences in prevalence, clinical course of disease and treatment outcome of infectious diseases. In order to develop individualized treatment concepts, a fair balance between the sexes should be maintained in basic science, preclinical and clinical studies.",['(c) Georg Thieme Verlag KG Stuttgart . New York.'],"['Beisel, Claudia', 'van Lunzen, Jan', 'Lohse, Ansgar W', 'Addo, Marylyn M', 'Altfeld, Marcus']","['Beisel C', 'van Lunzen J', 'Lohse AW', 'Addo MM', 'Altfeld M']","['I. Medizinische Klinik und Poliklinik, Universitatsklinikum Hamburg-Eppendorf.', 'I. Medizinische Klinik und Poliklinik, Universitatsklinikum Hamburg-Eppendorf.', 'I. Medizinische Klinik und Poliklinik, Universitatsklinikum Hamburg-Eppendorf.', 'I. Medizinische Klinik und Poliklinik, Universitatsklinikum Hamburg-Eppendorf.', 'Deutsches Zentrum fur Infektionsforschung (DZIF) Standort Hamburg - Lubeck - Borstel.']",['ger'],"['English Abstract', 'Journal Article', 'Review']",20150911,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adolescent', 'Adult', '*Communicable Diseases/epidemiology/immunology/physiopathology/therapy', 'Female', 'Humans', 'Male', 'Prevalence', 'Sex Factors', 'Treatment Outcome', 'Young Adult']",,,,2015/09/12 06:00,2015/12/17 06:00,['2015/09/12 06:00'],"['2015/09/12 06:00 [entrez]', '2015/09/12 06:00 [pubmed]', '2015/12/17 06:00 [medline]']",['10.1055/s-0041-104246 [doi]'],ppublish,Dtsch Med Wochenschr. 2015 Sep;140(18):1385-90. doi: 10.1055/s-0041-104246. Epub 2015 Sep 11.,,,,,,,,,Geschlechtsunterschiede bei Infektionserkrankungen.,,,,,,,,
31960965,NLM,MEDLINE,20201022,20201022,1532-6535 (Electronic) 0009-9236 (Linking),107,2,2020 Feb,Finding New Drugs for Infectious Diseases: Development Times and Success Rates.,305-307,10.1002/cpt.1728 [doi],,,"['van der Graaf, Piet H']",['van der Graaf PH'],"['Certara, Canterbury, UK.', 'University of Leiden, Leiden, The Netherlands.']",['eng'],"['Comment', 'Editorial']",,United States,Clin Pharmacol Ther,Clinical pharmacology and therapeutics,0372741,IM,"['*Communicable Diseases/drug therapy/epidemiology', 'Humans']",,,,2020/01/22 06:00,2020/10/23 06:00,['2020/01/22 06:00'],"['2019/11/22 00:00 [received]', '2019/11/22 00:00 [accepted]', '2020/01/22 06:00 [entrez]', '2020/01/22 06:00 [pubmed]', '2020/10/23 06:00 [medline]']",['10.1002/cpt.1728 [doi]'],ppublish,Clin Pharmacol Ther. 2020 Feb;107(2):305-307. doi: 10.1002/cpt.1728.,,,,,,,,['Clin Pharmacol Ther. 2020 Feb;107(2):324-332. PMID: 31502248'],,,,,,,,,
17100620,NLM,MEDLINE,20070116,20190728,1873-4286 (Electronic) 1381-6128 (Linking),12,32,2006,Toll-like receptors in human infectious diseases.,4173-84,,"Toll-like receptors (TLRs) have emerged as critical players in immunity. They are capable of sensing organisms ranging from protozoa to bacteria, fungi or viruses upon detection of the pathogen as well as recognizing endogenous ligands, and triggering transduction pathways. Following activation of the innate immune system, strong inflammatory signals are generated inducing inflammation and activation of the adaptive immune response. However, the deregulation of TLRs signaling pathways may be conducive to the pathogenesis of many infectious diseases. Therefore, innate and adaptive immunity are not simply sequential and complementary mechanisms of resistance to pathogen, they regulate each other through cellular contacts and the secretion of soluble mediators. Herein, we summarize recent findings on TLRs signaling in infectious diseases and how pathogens have developed strategies to evade these pathways. In this context, a potential modulation of the innate immune response could have therapeutic benefit through the development of new drugs as well as vaccination strategies to be employed in infectious diseases.",,"['de la Barrera, S', 'Aleman, M', 'Sasiain, M del C']","['de la Barrera S', 'Aleman M', 'Sasiain Mdel C']","['Departamento de Inmunologia, Instituto de Investigaciones Hematologicas (IIHema), Academia Nacional de Medicina, Buenos Aires, Argentina.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United Arab Emirates,Curr Pharm Des,Current pharmaceutical design,9602487,IM,"['Communicable Diseases/*immunology/microbiology/*therapy/virology', 'Humans', 'Immunity, Innate', 'Signal Transduction', 'Toll-Like Receptors/*immunology']",,,,2006/11/15 09:00,2007/01/17 09:00,['2006/11/15 09:00'],"['2006/11/15 09:00 [pubmed]', '2007/01/17 09:00 [medline]', '2006/11/15 09:00 [entrez]']",['10.2174/138161206778743493 [doi]'],ppublish,Curr Pharm Des. 2006;12(32):4173-84. doi: 10.2174/138161206778743493.,,,['0 (Toll-Like Receptors)'],,,147,,,,,,,,,,,
2275457,NLM,MEDLINE,19910226,20191022,0160-3450 (Print) 0160-3450 (Linking),NS30,12,1990 Dec,"Overview of infectious diseases, Part 3.",64-8,,,,"['Acuncius, L J', 'Henderson, R P']","['Acuncius LJ', 'Henderson RP']",,['eng'],"['Journal Article', 'Review']",,United States,Am Pharm,American pharmacy,7801164,IM,"['Communicable Diseases/complications/diagnosis/*drug therapy', 'Drug Resistance, Microbial', 'Humans']",,,,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",['10.1016/s0160-3450(15)31399-4 [doi]'],ppublish,Am Pharm. 1990 Dec;NS30(12):64-8. doi: 10.1016/s0160-3450(15)31399-4.,,,,,,10,,,,,,,,,,,
12018470,NLM,MEDLINE,20021114,20190901,0300-8126 (Print) 0300-8126 (Linking),30,2,2002 Apr,Cost of infectious diseases.,59-60,,,,"['Ruef, C']",['Ruef C'],,['eng'],['Editorial'],,Germany,Infection,Infection,0365307,IM,"['Communicable Diseases/diagnosis/*economics/therapy', '*Cost of Illness', 'Cost-Benefit Analysis', 'Humans']",,,,2002/05/23 10:00,2002/11/26 04:00,['2002/05/23 10:00'],"['2002/05/23 10:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/05/23 10:00 [entrez]']",['10.1007/s15010-002-7202-8 [doi]'],ppublish,Infection. 2002 Apr;30(2):59-60. doi: 10.1007/s15010-002-7202-8.,,,,,,,,,,,,,,,,,
22432652,NLM,MEDLINE,20120727,20190902,1326-5377 (Electronic) 0025-729X (Linking),196,5,2012 Mar 19,Infectious diseases in Australia - the next decade.,292-3,,,,"['Gottlieb, Thomas', 'Currie, Bart J', 'Looke, David F M']","['Gottlieb T', 'Currie BJ', 'Looke DF']",,['eng'],['Editorial'],,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Anti-Infective Agents/therapeutic use', 'Australia', 'Communicable Disease Control/*methods/organization & administration', '*Communicable Diseases/drug therapy/microbiology/transmission', 'Drug Resistance, Microbial', 'Drug Utilization', 'Humans', 'Inappropriate Prescribing', ""Practice Patterns, Physicians'""]",,,,2012/03/22 06:00,2012/07/28 06:00,['2012/03/22 06:00'],"['2012/01/19 00:00 [received]', '2012/02/20 00:00 [accepted]', '2012/03/22 06:00 [entrez]', '2012/03/22 06:00 [pubmed]', '2012/07/28 06:00 [medline]']","['got10116_fm [pii]', '10.5694/mja12.10116 [doi]']",ppublish,Med J Aust. 2012 Mar 19;196(5):292-3. doi: 10.5694/mja12.10116.,,,['0 (Anti-Infective Agents)'],,,,,,,,['Executive Council of the Australasian Society for Infectious Diseases'],,,,,,
15641949,NLM,MEDLINE,20050519,20101118,0309-2402 (Print) 0309-2402 (Linking),49,2,2005 Jan,Evolutionary nursing: the case of infectious diseases.,164-72,,"AIM: The aim of this paper is to examine the effect of evolution on infectious diseases nursing, and propose a model that may help to increase understanding of how hosts and microorganisms co-exist and how humans can alter the delicate balance between them. BACKGROUND AND RATIONALE: Infectious diseases occur as the result of interactions between hosts and microorganisms. There is an increasing acceptance that the evolution of host and parasite is important in the development of infectious diseases. However, such views have made little impact in nursing, and the use of evolutionary interventions remains controversial. METHOD: The Medline database was searched from 1966 to present using the terms pathogen$, virulen$, evolution, bacteria, and all combinations of these. Additionally reference lists of text books and papers were hand searched for relevant papers. Papers were selected from a variety of disciplines, including infectious diseases, microbiology, evolutionary biology, and ecology. Recurrent themes from these papers were identified and a model of evolutionary nursing constructed. RESULTS: Microorganisms are plentiful, ubiquitous, and rapidly evolving by comparison with humans and other animals. As a result of this, attempts to 'outwit' them have been, and are, doomed to failure. However, through careful management of public and personal health, a balance encouraging co-existence may be possible. A number of specific interventions is proposed. CONCLUSIONS: There are a number of key interventions that may reduce the virulence of microorganisms. With an increasing world population, antibiotic resistance and international travel, such an approach may be one way of reducing the morbidity associated with infectious diseases.",,"['Purssell, Edward']",['Purssell E'],"[""King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK. edward.purssell@kcl.ac.uk <edward.purssell@kcl.ac.uk>""]",['eng'],"['Journal Article', 'Review']",,England,J Adv Nurs,Journal of advanced nursing,7609811,IM,"['Biological Evolution', 'Communicable Disease Control', 'Communicable Diseases/microbiology/*nursing/transmission', 'Humans', 'Models, Biological', 'Selection, Genetic', 'Virulence']",,,,2005/01/12 09:00,2005/05/20 09:00,['2005/01/12 09:00'],"['2005/01/12 09:00 [pubmed]', '2005/05/20 09:00 [medline]', '2005/01/12 09:00 [entrez]']","['JAN3276 [pii]', '10.1111/j.1365-2648.2004.03276.x [doi]']",ppublish,J Adv Nurs. 2005 Jan;49(2):164-72. doi: 10.1111/j.1365-2648.2004.03276.x.,,,,,,38,,,,,,,,,,,
25441118,NLM,MEDLINE,20150410,20200409,1558-4224 (Electronic) 0749-0739 (Print) 0749-0739 (Linking),30,3,2014 Dec,New perspectives in infectious diseases.,xv-xvi,S0749-0739(14)00072-8 [pii] 10.1016/j.cveq.2014.10.001 [doi],,,"['Mealey, Robert H']",['Mealey RH'],"['Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-7040, USA. Electronic address: rhm@vetmed.wsu.edu.']",['eng'],['Introductory Journal Article'],20141106,United States,Vet Clin North Am Equine Pract,The Veterinary clinics of North America. Equine practice,8511904,IM,"['Animals', 'Communicable Diseases/diagnosis/therapy/*veterinary', 'Communicable Diseases, Emerging/diagnosis/therapy/veterinary', 'Horse Diseases/*diagnosis/*therapy', 'Horses']",PMC7127353,,,2014/12/03 06:00,2015/04/11 06:00,['2014/12/03 06:00'],"['2014/12/03 06:00 [entrez]', '2014/12/03 06:00 [pubmed]', '2015/04/11 06:00 [medline]']","['S0749-0739(14)00072-8 [pii]', '10.1016/j.cveq.2014.10.001 [doi]']",ppublish,Vet Clin North Am Equine Pract. 2014 Dec;30(3):xv-xvi. doi: 10.1016/j.cveq.2014.10.001. Epub 2014 Nov 6.,,,,,,,,,,,,,,,,,
29079162,NLM,MEDLINE,20180921,20191008,1557-9824 (Electronic) 0891-5520 (Print) 0891-5520 (Linking),31,4,2017 Dec,"Aging Has Unique Effects on the Risks, Presentation, Diagnosis, Treatment, and Prognosis of Infectious Diseases.",xiii-xv,S0891-5520(17)30077-6 [pii] 10.1016/j.idc.2017.08.001 [doi],,,"['Jump, Robin L P', 'Canaday, David H']","['Jump RLP', 'Canaday DH']","['Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University, Geriatric Research Education and Clinical Center (GRECC), Specialty Care Center of Innovation, Louis Stokes Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA. Electronic address: robin.jump@va.gov.', 'Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University, Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA. Electronic address: David.Canaday@case.edu.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,IM,"['Age Factors', 'Aged', 'Aged, 80 and over', '*Aging', '*Communicable Diseases/diagnosis/epidemiology/physiopathology/therapy', 'Geriatrics', 'Humans', 'Prognosis', 'Risk Factors', 'United States/epidemiology']",PMC5839877,,,2017/10/29 06:00,2018/09/22 06:00,['2017/10/29 06:00'],"['2017/10/29 06:00 [entrez]', '2017/10/29 06:00 [pubmed]', '2018/09/22 06:00 [medline]']","['S0891-5520(17)30077-6 [pii]', '10.1016/j.idc.2017.08.001 [doi]']",ppublish,Infect Dis Clin North Am. 2017 Dec;31(4):xiii-xv. doi: 10.1016/j.idc.2017.08.001.,,,,,,,['VA999999/VA/United States'],,,['NIHMS946795'],,,,,,,
12377560,NLM,MEDLINE,20021121,20190922,0966-842X (Print) 0966-842X (Linking),10,10 Suppl,2002,Infectious diseases: back to the future?,S1-2,,,,"['Hagan, Paul', 'Projan, Steve', 'Rosamond, John']","['Hagan P', 'Projan S', 'Rosamond J']",,['eng'],['Editorial'],,England,Trends Microbiol,Trends in microbiology,9310916,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Diseases/drug therapy/genetics/immunology/microbiology/*therapy', 'Disease Outbreaks/prevention & control', 'Drug Resistance, Microbial', 'Forecasting', 'Global Health', 'Humans', 'Infection Control/methods', 'World Health Organization']",,,,2002/10/16 04:00,2002/11/26 04:00,['2002/10/16 04:00'],"['2002/10/16 04:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/10/16 04:00 [entrez]']","['S0966842X02024502 [pii]', '10.1016/s0966-842x(02)02450-2 [doi]']",ppublish,Trends Microbiol. 2002;10(10 Suppl):S1-2. doi: 10.1016/s0966-842x(02)02450-2.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
37426883,NLM,MEDLINE,20230711,20230831,1612-3174 (Electronic) 1612-3174 (Linking),21,,2023,[The specialty of infectious diseases in German hospitals: position paper of the German Society for Infectiology (DGI)].,Doc05,10.3205/000319 [doi] Doc05,Clinical expertise in infectious diseases is crucial in treating patients with infectious complications. The new board certification in infectious diseases will establish this expertise in Germany. The role of the specialty of infectious diseases in German hospitals and the definition for clinical services in hospitals (levels 2 and 3) are outlined here.,,"['Fatkenheuer, Gerd', 'Sander, Leif Erik', 'Slevogt, Hortense', 'Salzberger, Bernd']","['Fatkenheuer G', 'Sander LE', 'Slevogt H', 'Salzberger B']","['Infektiologie, Medizinische Klinik I, Universitatsklinikum Koln, Deutschland.', 'Klinik fur Infektiologie und Intensivmedizin, Charite - Universitatsmedizin Berlin, Deutschland.', 'Klinische Infektiologie, Klinik fur Pneumologie, MH Hannover, Deutschland.', 'Krankenhaushygiene und Infektiologie, Universitatsklinikum Regensburg, Deutschland.']",['ger'],"['Journal Article', 'Review']",20230526,Germany,Ger Med Sci,German medical science : GMS e-journal,101227686,IM,"['Humans', '*Communicable Diseases/therapy/drug therapy', 'Anti-Bacterial Agents/therapeutic use', '*Medicine', 'Hospitals', 'Germany']",PMC10326742,,,2023/07/10 06:42,2023/07/11 06:42,['2023/07/10 05:16'],"['2023/05/06 00:00 [received]', '2023/07/11 06:42 [medline]', '2023/07/10 06:42 [pubmed]', '2023/07/10 05:16 [entrez]']","['000319 [pii]', 'Doc05 [pii]', '10.3205/000319 [doi]']",epublish,Ger Med Sci. 2023 May 26;21:Doc05. doi: 10.3205/000319. eCollection 2023.,,,['0 (Anti-Bacterial Agents)'],,,,,,Infektiologie in der stationaren Versorgung in Deutschland: Positionspapier der Deutschen Gesellschaft fur Infektiologie (DGI).,,['Deutsche Gesellschaft fur Infektiologie'],,,,,,
11885953,NLM,MEDLINE,20020927,20190910,0168-1702 (Print) 0168-1702 (Linking),82,1-2,2002 Jan 30,DNA-chip technology and infectious diseases.,65-71,,,,"['Vernet, Gary']",['Vernet G'],"[""Molecular Biology Department, BioMerieux, Marcy-l'etoile, France.""]",['eng'],"['Journal Article', 'Review']",,Netherlands,Virus Res,Virus research,8410979,IM,"['Bacterial Infections/*diagnosis/microbiology', 'Communicable Diseases/*diagnosis/microbiology/virology', 'Humans', '*Oligonucleotide Array Sequence Analysis/methods', '*Reagent Kits, Diagnostic', 'Virus Diseases/*diagnosis/microbiology']",,,,2002/03/12 10:00,2002/09/28 04:00,['2002/03/12 10:00'],"['2002/03/12 10:00 [pubmed]', '2002/09/28 04:00 [medline]', '2002/03/12 10:00 [entrez]']","['S0168-1702(01)00435-X [pii]', '10.1016/s0168-1702(01)00435-x [doi]']",ppublish,Virus Res. 2002 Jan 30;82(1-2):65-71. doi: 10.1016/s0168-1702(01)00435-x.,,,"['0 (Reagent Kits, Diagnostic)']",,,8,,,,,,,,,,,
25577481,NLM,MEDLINE,20150518,20150112,1419-8711 (Print) 1419-8711 (Linking),16,4,2014 Dec,[Psychiatric aspects of infectious diseases -- a literature review].,181-7,,It is essential for the psychiatrist working in the consultation-liaison field or with comorbid patients to be familiar with the psychiatric aspects of central nervous infectious diseases or infectious diseases with psychiatric symptoms. Authors have reviewed the most important psychiatric aspects of common infectious diseases. Essential knowledge for setting up a diagnosis and starting appropriate treatment has been summarized. The most important interactions of infectological and psychiatric treatments have also been discussed.,,"['Gazdag, Gabor', 'Szabo, Zsuzsa', 'Szlavik, Janos']","['Gazdag G', 'Szabo Z', 'Szlavik J']","['Egyesitett Szent Istvan es Szent Laszlo Korhaz, Addiktologiai es Pszichiatriai Ambulancia, Budapest, Hungary. gazdag@lamb.hu.']",['hun'],"['English Abstract', 'Journal Article', 'Review']",,Hungary,Neuropsychopharmacol Hung,Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology,100961631,IM,"['Central Nervous System Infections/*diagnosis/*psychology/therapy', 'Communicable Diseases/*diagnosis/*psychology/therapy', 'Creutzfeldt-Jakob Syndrome/diagnosis/psychology', 'Drug Interactions', 'Encephalitis/diagnosis/psychology', 'HIV Infections/diagnosis/psychology', 'Hepatitis B/diagnosis/psychology', 'Hepatitis C/diagnosis/psychology', 'Humans', 'Lyme Disease/diagnosis/psychology', 'Mental Disorders/*diagnosis/*etiology/therapy', 'Sexually Transmitted Diseases/*diagnosis/*psychology/therapy', 'Syphilis/diagnosis/psychology']",,,,2015/01/13 06:00,2015/05/20 06:00,['2015/01/12 06:00'],"['2015/01/12 06:00 [entrez]', '2015/01/13 06:00 [pubmed]', '2015/05/20 06:00 [medline]']",,ppublish,Neuropsychopharmacol Hung. 2014 Dec;16(4):181-7.,,,,,,,,,A fertozo betegsegek pszichiatriai vonatkozasai -- irodalmi attekintes.,,,,,,,,
24921244,NLM,MEDLINE,20150116,20211021,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),8,6,2014 Jun,Social sciences research on infectious diseases of poverty: too little and too late?,e2803,10.1371/journal.pntd.0002803 [doi] e2803,,,"['Azoh Barry, Jose']",['Azoh Barry J'],"['Investigacion & Accion, A.C., General Escobedo, Nuevo Leon, Mexico.']",['eng'],"['Journal Article', 'Review']",20140612,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,IM,"['Communicable Disease Control/methods', 'Communicable Diseases/drug therapy/*epidemiology/*transmission', 'Humans', '*Poverty', 'Social Sciences/*trends', 'Socioeconomic Factors']",PMC4055465,,,2014/06/13 06:00,2015/01/17 06:00,['2014/06/13 06:00'],"['2014/06/13 06:00 [entrez]', '2014/06/13 06:00 [pubmed]', '2015/01/17 06:00 [medline]']","['PNTD-D-13-01137 [pii]', '10.1371/journal.pntd.0002803 [doi]']",epublish,PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2803. doi: 10.1371/journal.pntd.0002803. eCollection 2014 Jun.,['The author has declared that no competing interests exist.'],,,,,,,,,,,,,,,,
19060533,NLM,MEDLINE,20090226,20081208,1531-7013 (Electronic) 1087-2418 (Linking),13,5,2008 Oct,Update on infectious diseases in pediatric solid organ transplantation.,500-5,10.1097/MOT.0b013e328310b0a4 [doi],"PURPOSE OF REVIEW: Numerous recent advances have been made in the field of infectious diseases and pediatric solid organ transplant. RECENT FINDINGS: Although many studies contain somewhat small cohorts of individuals, when summarized together they contribute significantly to our knowledge about pediatric solid organ transplant, especially regarding risk factors for infection, management of BK virus nephropathy, the use of live viral vaccines, and consideration for rare infections as well as donor-derived infections. SUMMARY: In sum, these recent advances in infection in the field of pediatric solid organ transplant will help decrease infection, thus improving morbidity and mortality, as well as transplant outcomes, especially by decreasing direct (graft injury) and indirect (immune upregulation) effects on organ transplantation. This review will focus on recent advances in the field of infectious diseases in pediatric solid organ transplant by highlighting some of the most important and interesting articles in the field within the past few years.",,"['Kotton, Camille Nelson']",['Kotton CN'],"['Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. ckotton@partners.org']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Organ Transplant,Current opinion in organ transplantation,9717388,IM,"['Anti-Infective Agents/*therapeutic use', 'Bacterial Vaccines', 'Child', 'Child, Preschool', 'Communicable Diseases/*etiology/microbiology/parasitology/virology', 'Fungal Vaccines', 'Humans', 'Incidence', 'Infant', '*Infection Control', 'Organ Transplantation/*adverse effects', 'Protozoan Vaccines', 'Risk Factors', '*Vaccination']",,,,2008/12/09 09:00,2009/02/27 09:00,['2008/12/09 09:00'],"['2008/12/09 09:00 [pubmed]', '2009/02/27 09:00 [medline]', '2008/12/09 09:00 [entrez]']","['00075200-200810000-00006 [pii]', '10.1097/MOT.0b013e328310b0a4 [doi]']",ppublish,Curr Opin Organ Transplant. 2008 Oct;13(5):500-5. doi: 10.1097/MOT.0b013e328310b0a4.,,,"['0 (Anti-Infective Agents)', '0 (Bacterial Vaccines)', '0 (Fungal Vaccines)', '0 (Protozoan Vaccines)']",,,41,,,,,,,,,,,
33667294,NLM,MEDLINE,20211001,20231107,1537-6613 (Electronic) 0022-1899 (Print) 0022-1899 (Linking),223,12 Suppl 2,2021 Jun 16,The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.,S187-S193,10.1093/infdis/jiab020 [doi],"Along with the rise in modern chronic diseases, ranging from diabetes to asthma, there are challenges posed by increasing antibiotic resistance, which results in difficult-to-treat infections, as well as sepsis. An emerging and unifying theme in the pathogenesis of these diverse public health threats is changes in the microbial communities that inhabit multiple body sites. Although there is great promise in exploring the role of these microbial communities in chronic disease pathogenesis, the shorter timeframe of most infectious disease pathogenesis may allow early translation of our basic scientific understanding of microbial ecology and host-microbiota-pathogen interactions. Likely translation avenues include development of preventive strategies, diagnostics, and therapeutics. For example, as basic research related to microbial pathogenesis continues to progress, Clostridioides difficile infection is already being addressed clinically through at least 2 of these 3 avenues: targeted antibiotic stewardship and treatment of recurrent disease through fecal microbiota transplantation.","['Published by Oxford University Press for the Infectious Diseases Society of', 'America 2021.']","['Ranallo, Ryan T', 'McDonald, L Clifford', 'Halpin, Alison Laufer', 'Hiltke, Thomas', 'Young, Vincent B']","['Ranallo RT', 'McDonald LC', 'Halpin AL', 'Hiltke T', 'Young VB']","['Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.', 'Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.', 'Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.', 'Department of Internal Medicine, Division of Infectious Diseases, The University of Michigan Medical School, Ann Arbor, Michigan, USA.']",['eng'],['Introductory Journal Article'],,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Anti-Bacterial Agents/pharmacology/therapeutic use', 'Antimicrobial Stewardship', 'Communicable Diseases/diagnosis/immunology/*microbiology/therapy', '*Drug Resistance, Microbial', 'Fecal Microbiota Transplantation', 'Homeostasis', 'Host-Pathogen Interactions', 'Humans', 'Immunity', '*Microbiota/drug effects']",PMC8206797,['NOTNLM'],"['Microbiota', 'antimicrobial resistance', 'host', 'infectious disease', 'pathogen']",2021/03/06 06:00,2021/10/02 06:00,['2021/03/05 17:08'],"['2021/03/06 06:00 [pubmed]', '2021/10/02 06:00 [medline]', '2021/03/05 17:08 [entrez]']","['6154668 [pii]', 'jiab020 [pii]', '10.1093/infdis/jiab020 [doi]']",ppublish,J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S187-S193. doi: 10.1093/infdis/jiab020.,,,['0 (Anti-Bacterial Agents)'],,,,"['U01 AI124255/AI/NIAID NIH HHS/United States', 'U54 CK000481/CK/NCEZID CDC HHS/United States', 'U54 CK000607/CK/NCEZID CDC HHS/United States']",,,,,,,,,,
19486075,NLM,MEDLINE,20091105,20211020,1469-0691 (Electronic) 1198-743X (Print) 1198-743X (Linking),15,8,2009 Aug,Facing highly infectious diseases: new trends and current concepts.,700-5,10.1111/j.1469-0691.2009.02873.x [doi],"A highly infectious disease (HID) that is transmissible from person to person causes life-threatening illness and presents a serious hazard in the healthcare setting and in the community that requires specific control measures. Due to environmental factors, changes in lifestyle and many other unknown factors, the emergence of such HIDs is becoming more and more likely. As has already been demonstrated during the SARS outbreak, healthcare facilities are likely to be the origin of future HID outbreaks. Preparedness planning will be essential in helping facilities manage future outbreaks of emerging or resurgent infectious diseases. Guidelines have been developed by national and international institutions. To avoid contamination of healthcare workers, the care of HID patients should follow the same infection control rules that are applied to laboratory workers exposed to similar agents. Here, the current knowledge concerning the clinical care of patients with HIDs is reviewed, and specific aspects of the management of such diseases are introduced.",,"['Brouqui, P']",['Brouqui P'],"['BSL3 infectious diseases isolation unit, URMITE UMR 6236 CNRS/IRD, Infectious Disease and Tropical Medicine Service, AP-HM, Marseille, France. Philippe.Brouqui@medecine.univ-mrs.fr']",['eng'],"['Journal Article', 'Review']",20090528,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['*Case Management', 'Civil Defense/methods', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/*epidemiology/therapy/transmission', 'Disease Transmission, Infectious/*prevention & control', 'Health Planning Guidelines', 'Humans', 'Occupational Diseases/prevention & control']",PMC7129674,,,2009/06/03 09:00,2009/11/06 06:00,['2009/06/03 09:00'],"['2009/06/03 09:00 [entrez]', '2009/06/03 09:00 [pubmed]', '2009/11/06 06:00 [medline]']","['S1198-743X(14)60454-7 [pii]', 'CLM2873 [pii]', '10.1111/j.1469-0691.2009.02873.x [doi]']",ppublish,Clin Microbiol Infect. 2009 Aug;15(8):700-5. doi: 10.1111/j.1469-0691.2009.02873.x. Epub 2009 May 28.,,,,,,,,,,,,,,,,,
14871635,NLM,MEDLINE,20040305,20140815,1473-3099 (Print) 1473-3099 (Linking),4,2,2004 Feb,Chips with everything: DNA microarrays in infectious diseases.,100-11,,"Two developments are set to revolutionise research in and clinical management of infectious diseases. First, the completion of the human genome project together with the sequencing of many pathogen genomes, and second, the development of microarray technology. This review explains the principles underlying DNA microarrays and highlights the uses to which they are being put to investigate the molecular basis of infectious diseases. Pathogen studies enable identification of both known and novel organisms, understanding of genetic evolution, and investigation of determinants of pathogenicity. Host studies show the complexities of development and activation of both innate and adaptive immunity. Host-pathogen studies allow global analysis of gene expression during pathogenesis. Microarray technology will accelerate our understanding of the complex genetic processes underlying the interaction between microorganisms and the host, with consequent improvements in the diagnosis, treatment, and prevention of infectious diseases.",,"['Bryant, Penelope A', 'Venter, Deon', 'Robins-Browne, Roy', 'Curtis, Nigel']","['Bryant PA', 'Venter D', 'Robins-Browne R', 'Curtis N']","[""Department of Paediatrics, University of Melbourne, Murdoch Children's Research Institute, Victoria, Australia.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Animals', 'Bacteria/drug effects/*genetics/pathogenicity', 'Communicable Diseases/drug therapy/*etiology/genetics/transmission', 'Evolution, Molecular', 'Gene Expression Profiling', 'Humans', 'Immunity, Active/genetics', 'Immunity, Innate/genetics', '*Oligonucleotide Array Sequence Analysis', 'Virulence', 'Viruses/drug effects/*genetics/pathogenicity']",,,,2004/02/12 05:00,2004/03/06 05:00,['2004/02/12 05:00'],"['2004/02/12 05:00 [pubmed]', '2004/03/06 05:00 [medline]', '2004/02/12 05:00 [entrez]']","['S1473309904009302 [pii]', '10.1016/S1473-3099(04)00930-2 [doi]']",ppublish,Lancet Infect Dis. 2004 Feb;4(2):100-11. doi: 10.1016/S1473-3099(04)00930-2.,,,,,,83,,,,,,,,,,,
16020687,NLM,MEDLINE,20050826,20181113,0893-8512 (Print) 1098-6618 (Electronic) 0893-8512 (Linking),18,3,2005 Jul,Epidemiology and management of infectious diseases in international adoptees.,510-20,,"International adoptees represent a group of children with unique health care needs. Data from published studies, along with the recent experience of the Yale International Adoption Clinic, suggest that the risk of serious infections in adoptees is low, although infections associated with institutionalization still occur commonly. Interpretation of these data must be undertaken with caution, however, since many, if not most, international adoptees are not evaluated in specialty clinics. Thus, prospective studies designed to minimize selection and referral bias are needed in order to accurately define the risk of infectious and noninfectious diseases in all international adoptees.",,"['Murray, Thomas S', 'Groth, M Elizabeth', 'Weitzman, Carol', 'Cappello, Michael']","['Murray TS', 'Groth ME', 'Weitzman C', 'Cappello M']","['Yale International Adoption Clinic, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,IM,"['*Adoption', 'Child', 'Child, Preschool', '*Communicable Disease Control/methods/standards', 'Communicable Diseases/*epidemiology/microbiology/parasitology/virology', 'Humans', 'Infant', '*International Cooperation', 'United States']",PMC1195971,,,2005/07/16 09:00,2005/08/27 09:00,['2005/07/16 09:00'],"['2005/07/16 09:00 [pubmed]', '2005/08/27 09:00 [medline]', '2005/07/16 09:00 [entrez]']","['18/3/510 [pii]', '0054-05 [pii]', '10.1128/CMR.18.3.510-520.2005 [doi]']",ppublish,Clin Microbiol Rev. 2005 Jul;18(3):510-20. doi: 10.1128/CMR.18.3.510-520.2005.,,,,,,,,,,,,,,,,,
15780893,NLM,MEDLINE,20050725,20230328,0399-077X (Print) 1769-6690 (Electronic) 0399-077X (Linking),35,2,2005 Feb,"[Emergent infectious diseases: importance for public health, epidemiology, promoting factors, and prevention].",49-61,,"At the end of the 70s, it was said that eradicating infectious diseases was possible. With the occurrence of AIDS and the discovery of new pathogens the come-back of infectious diseases was noted, 15 to 20 years later, and the concept of emerging infections was defined. An emerging infection is the appearance of a new infection or the increase of its incidence if not new. It also includes infections for which the incidence could increase because of favorable conditions. Several scenarios can be proposed: 1) the appearance of a new infection (AIDS or SARS); 2) the appearance of a known infection where it did not exist previously (West Nile virus infection in the USA); 3) an infection that existed but that was not diagnosed or could not be linked precisely to a particular infectious agent (hepatitis C before the discovery of the hepatitis C virus; 4) a known infection that increases its usual incidence (outbreaks...); 5) infectious diseases for which current conditions may facilitate transmission (decrease of immunization coverage...). The deliberate release of a biological agent is one of the possible scenarios of emergence. Qualitative changes of infectious agents such as the resistance to anti-infectious agents may also contribute, through a selection mechanism, to the emergence of new infectious threat. Emerging infections result from the interaction between the agent, the host, and environment evolving according to human activity. Surveillance, research, laboratory capacity, and an effective public health system are key factors for their control.",,"['Desenclos, J-C', 'De Valk, H']","['Desenclos JC', 'De Valk H']","[""Departement des maladies infectieuses, institut de veille sanitaire, 12, rue du Val-d'Osne, 94415 Saint-Maurice, France. jc.desenclos@invs.sante.fr""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Med Mal Infect,Medecine et maladies infectieuses,0311416,IM,"['Communicable Diseases, Emerging/*epidemiology/*prevention & control/transmission', 'Humans', 'Public Health']",PMC7127485,,,2005/03/23 09:00,2005/07/26 09:00,['2005/03/23 09:00'],"['2004/09/06 00:00 [received]', '2004/09/06 00:00 [accepted]', '2005/03/23 09:00 [pubmed]', '2005/07/26 09:00 [medline]', '2005/03/23 09:00 [entrez]']","['S0399-077X(04)00286-0 [pii]', '10.1016/j.medmal.2004.09.005 [doi]']",ppublish,Med Mal Infect. 2005 Feb;35(2):49-61. doi: 10.1016/j.medmal.2004.09.005.,,,,,,,,,"Les maladies infectieuses emergentes: importance en sante publique, aspects epidemiologiques, determinants et prevention.",,,,,,,,
21124449,NLM,MEDLINE,20110111,20221207,1476-4687 (Electronic) 0028-0836 (Print) 0028-0836 (Linking),468,7324,2010 Dec 2,Impacts of biodiversity on the emergence and transmission of infectious diseases.,647-52,10.1038/nature09575 [doi],"Current unprecedented declines in biodiversity reduce the ability of ecological communities to provide many fundamental ecosystem services. Here we evaluate evidence that reduced biodiversity affects the transmission of infectious diseases of humans, other animals and plants. In principle, loss of biodiversity could either increase or decrease disease transmission. However, mounting evidence indicates that biodiversity loss frequently increases disease transmission. In contrast, areas of naturally high biodiversity may serve as a source pool for new pathogens. Overall, despite many remaining questions, current evidence indicates that preserving intact ecosystems and their endemic biodiversity should generally reduce the prevalence of infectious diseases.",,"['Keesing, Felicia', 'Belden, Lisa K', 'Daszak, Peter', 'Dobson, Andrew', 'Harvell, C Drew', 'Holt, Robert D', 'Hudson, Peter', 'Jolles, Anna', 'Jones, Kate E', 'Mitchell, Charles E', 'Myers, Samuel S', 'Bogich, Tiffany', 'Ostfeld, Richard S']","['Keesing F', 'Belden LK', 'Daszak P', 'Dobson A', 'Harvell CD', 'Holt RD', 'Hudson P', 'Jolles A', 'Jones KE', 'Mitchell CE', 'Myers SS', 'Bogich T', 'Ostfeld RS']","['Department of Biology, Bard College, Annandale, New York 12504, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",,England,Nature,Nature,0410462,IM,"['Animals', '*Biodiversity', 'Communicable Diseases/epidemiology/microbiology/*transmission/virology', 'Communicable Diseases, Emerging/epidemiology/microbiology/transmission/virology', 'Orthohantavirus/physiology', 'Humans', 'Lyme Disease/microbiology/transmission', 'Species Specificity', 'Zoonoses/epidemiology/transmission']",PMC7094913,,,2010/12/03 06:00,2011/01/12 06:00,['2010/12/03 06:00'],"['2010/12/03 06:00 [entrez]', '2010/12/03 06:00 [pubmed]', '2011/01/12 06:00 [medline]']","['nature09575 [pii]', 'BFnature09575 [pii]', '10.1038/nature09575 [doi]']",ppublish,Nature. 2010 Dec 2;468(7324):647-52. doi: 10.1038/nature09575.,['The authors declare no competing financial interests.'],,,,,,,,,,,,,,,,
30712766,NLM,MEDLINE,20191107,20191107,1557-9824 (Electronic) 0891-5520 (Linking),33,1,2019 Mar,Migration Medicine.,265-287,S0891-5520(18)30101-6 [pii] 10.1016/j.idc.2018.10.014 [doi],"Migration is increasing and practitioners need to be aware of the unique health needs of this population. The prevalence of infectious diseases among migrants varies and generally mirrors that of their countries of origin, but is modified by the circumstance of migration, the presence of pre-arrival screening programs and post arrival access to health care. To optimize the health of migrants practitioners; (1) should take all opportunities to screen migrants at risk for latent infections such as tuberculosis, chronic hepatitis B and C, HIV, strongyloidiasis, schistosomiasis and Chagas disease, (2) update routine vaccines in all age groups and, (3) be aware of ""rare and tropical infections"" related to migration and return travel.",['Copyright (c) 2018 Elsevier Inc. All rights reserved.'],"['Greenaway, Christina', 'Castelli, Francesco']","['Greenaway C', 'Castelli F']","['Division of Infectious Diseases, Jewish General Hospital, Room E0057, 3755 Cote Ste-Catherine Road, Montreal, Quebec H3T 1E2, Canada; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, 3755 Cote Ste-Catherine Road, Montreal, Quebec H3T 1E2, Canada; J.D. MacLean Center for Tropical Diseases at McGill, McGill University Health Centre, Glen Site, 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada. Electronic address: ca.greenaway@mcgill.ca.', 'University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Piazza del Mercato, 15, Lombardy, Brescia 25121, Italy; UNESCO Chair ""Training and Empowering Human Resources for Health Development in Resource-Limited Countries"", University of Brescia, Brescia, Italy.']",['eng'],"['Journal Article', 'Review']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,IM,"['*Communicable Disease Control', 'Communicable Diseases/*diagnosis', 'Communicable Diseases, Imported/*diagnosis/drug therapy', 'Humans', '*Mass Screening', '*Transients and Migrants', 'Travel']",,['NOTNLM'],"['Health promotion', 'Infectious diseases', 'Migration', 'Screening']",2019/02/05 06:00,2019/11/08 06:00,['2019/02/05 06:00'],"['2019/02/05 06:00 [entrez]', '2019/02/05 06:00 [pubmed]', '2019/11/08 06:00 [medline]']","['S0891-5520(18)30101-6 [pii]', '10.1016/j.idc.2018.10.014 [doi]']",ppublish,Infect Dis Clin North Am. 2019 Mar;33(1):265-287. doi: 10.1016/j.idc.2018.10.014.,,,,,,,,,,,,,,,,,
37328129,NLM,MEDLINE,20231030,20231112,1953-8022 (Electronic) 1246-7820 (Linking),30,4,2023 Nov,Infectious diseases and the impact on transfusion medicine: A historical review and lessons for the future.,376-381,S1246-7820(23)00068-X [pii] 10.1016/j.tracli.2023.06.004 [doi],"Blood transfusion saves millions of lives each year. It is a well-established treatment, and many procedures are applied to avoid transmitted infections. However, throughout the history of transfusion medicine, many infectious diseases arose or were recognised, bringing up an impact on the blood supply, as the difficulties in diagnosing new diseases, the decrease in blood donors, the challenges for the medical team, the risks for the receptor and the related costs. This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.","['Copyright (c) 2023 Societe francaise de transfusion sanguine (SFTS). Published by', 'Elsevier Masson SAS. All rights reserved.']","['Dutra, Valeria de Freitas', 'Bonet-Bub, Carolina', 'Sakashita, Araci Massami', 'Kutner, Jose Mauro']","['Dutra VF', 'Bonet-Bub C', 'Sakashita AM', 'Kutner JM']","['Hospital Israelita Albert Einstein, Brazil. Electronic address: valeria.dutra@einstein.br.', 'Hospital Israelita Albert Einstein, Brazil.', 'Hospital Israelita Albert Einstein, Brazil.', 'Hospital Israelita Albert Einstein, Brazil.']",['eng'],['Journal Article'],20230614,France,Transfus Clin Biol,Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,9423846,IM,"['Humans', '*Transfusion Medicine', 'Pandemics', '*Communicable Diseases/epidemiology/etiology/therapy', 'Blood Transfusion', 'Blood Safety/methods', 'Blood Donors']",,['NOTNLM'],"['Blood bank', 'Epidemics', 'Infectious disease', 'Transfusion-transmitted infection']",2023/06/17 05:11,2023/10/30 06:47,['2023/06/16 19:19'],"['2023/03/29 00:00 [received]', '2023/06/01 00:00 [revised]', '2023/06/09 00:00 [accepted]', '2023/10/30 06:47 [medline]', '2023/06/17 05:11 [pubmed]', '2023/06/16 19:19 [entrez]']","['S1246-7820(23)00068-X [pii]', '10.1016/j.tracli.2023.06.004 [doi]']",ppublish,Transfus Clin Biol. 2023 Nov;30(4):376-381. doi: 10.1016/j.tracli.2023.06.004. Epub 2023 Jun 14.,"['Declaration of Competing Interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",,,,,,,,,,,,,,,,
31899335,NLM,MEDLINE,20200410,20200410,1469-0691 (Electronic) 1198-743X (Linking),26,4,2020 Apr,Mobile microbiology: an evolving concept in diagnosis of infectious diseases.,409-410,S1198-743X(19)30673-1 [pii] 10.1016/j.cmi.2019.12.016 [doi],,,"['Sanguinetti, M', 'Seme, K', 'Poljak, M']","['Sanguinetti M', 'Seme K', 'Poljak M']","['Istituto di Microbiologia, Universita Cattolica del Sacro Cuore, Rome, Italy; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.', 'Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia.', 'Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia. Electronic address: mario.poljak@mf.uni-lj.si.']",['eng'],['Editorial'],20191231,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Animals', 'Communicable Diseases/*diagnosis/transmission', 'Humans']",,,,2020/01/04 06:00,2020/04/11 06:00,['2020/01/04 06:00'],"['2019/12/09 00:00 [received]', '2019/12/22 00:00 [accepted]', '2020/01/04 06:00 [pubmed]', '2020/04/11 06:00 [medline]', '2020/01/04 06:00 [entrez]']","['S1198-743X(19)30673-1 [pii]', '10.1016/j.cmi.2019.12.016 [doi]']",ppublish,Clin Microbiol Infect. 2020 Apr;26(4):409-410. doi: 10.1016/j.cmi.2019.12.016. Epub 2019 Dec 31.,,,,,,,,,,,,,,,,,
8191952,NLM,MEDLINE,19940623,20191101,0065-3527 (Print) 0065-3527 (Linking),43,,1994,"New, emerging, and reemerging infectious diseases.",1-52,,,,"['Murphy, F A']",['Murphy FA'],"['School of Veterinary Medicine, University of California, Davis 95616.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Virus Res,Advances in virus research,0370441,IM,"['Animal Husbandry', 'Animals', 'Behavior', 'Communicable Disease Control', 'Communicable Diseases/epidemiology/*etiology/microbiology', 'Disease Outbreaks/prevention & control', 'Ecology', 'Humans', 'Zoonoses']",,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",['10.1016/s0065-3527(08)60046-9 [doi]'],ppublish,Adv Virus Res. 1994;43:1-52. doi: 10.1016/s0065-3527(08)60046-9.,,,,,,55,,,,,,,,,,,
12860171,NLM,MEDLINE,20040329,20051116,1567-5769 (Print) 1567-5769 (Linking),3,8,2003 Aug,Combinatorial immunotherapies for infectious diseases.,1159-67,,"Combating pathogenic organisms by combinatorial approaches involving appropriate immune response molecules and antimicrobial drugs represents a progessively more apparent and successful therapeutic paradigm for the treatment of acute and chronic persistent infectious diseases. This review explores areas of current innovation and provides an update of the present state of knowledge concerning combination of chemotherapy with several immune-based interventions in infections. In the future, a better understanding of microbial immune modulation and evasion may continue to open new avenues of inquiry and carefully targeted application of adjunctive immunotherapies.",,"['Hengel, Hartmut', 'Masihi, K Noel']","['Hengel H', 'Masihi KN']","['Robert Koch Institute, Nordufer 20, D-13353 Berlin, Germany.']",['eng'],"['Journal Article', 'Review']",,Netherlands,Int Immunopharmacol,International immunopharmacology,100965259,IM,"['Animals', 'Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*immunology/microbiology/*therapy/virology', 'Cytokines/*therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Immunotherapy/*methods']",,,,2003/07/16 05:00,2004/03/30 05:00,['2003/07/16 05:00'],"['2003/07/16 05:00 [pubmed]', '2004/03/30 05:00 [medline]', '2003/07/16 05:00 [entrez]']","['S1567-5769(03)00028-6 [pii]', '10.1016/S1567-5769(03)00028-6 [doi]']",ppublish,Int Immunopharmacol. 2003 Aug;3(8):1159-67. doi: 10.1016/S1567-5769(03)00028-6.,,,"['0 (Anti-Infective Agents)', '0 (Cytokines)']",,,50,,,,,,,,,,,
36083054,NLM,MEDLINE,20220913,20221007,2042-7670 (Electronic) 0042-4900 (Linking),191,5,2022 Sep,Reflecting on the 11th International Equine Infectious Diseases Conference.,e2208,10.1002/vetr.2208 [doi],"Julia Kydd, Martin Nielsen and Andrew Waller highlight some of the key presentations given at last year's 11th International Equine Infectious Diseases Conference, which was held virtually.",['(c) 2022 British Veterinary Association.'],"['Kydd, Julia', 'Nielsen, Martin', 'Waller, Andrew']","['Kydd J', 'Nielsen M', 'Waller A']","['School of Veterinary Medicine and Science, University of Nottingham, UK.', 'Gluck Equine Research Center, University of Kentucky, USA.', 'Intervacc, Sweden.']",['eng'],['Journal Article'],,England,Vet Rec,The Veterinary record,0031164,IM,"['Animals', '*Communicable Diseases/epidemiology/veterinary', '*Horse Diseases/epidemiology/therapy', 'Horses']",,,,2022/09/10 06:00,2022/09/14 06:00,['2022/09/09 09:12'],"['2022/09/09 09:12 [entrez]', '2022/09/10 06:00 [pubmed]', '2022/09/14 06:00 [medline]']",['10.1002/vetr.2208 [doi]'],ppublish,Vet Rec. 2022 Sep;191(5):e2208. doi: 10.1002/vetr.2208.,,,,,,,,,,,,,,,,,
7618977,NLM,MEDLINE,19950824,20190812,0003-9926 (Print) 0003-9926 (Linking),155,15,1995 Aug 7-21,Infectious diseases. Old diseases return and new agents emerge.,1571-2,,,,"['Peterson, E A', 'Mandel, R M']","['Peterson EA', 'Mandel RM']",,['eng'],"['Editorial', 'Historical Article']",,United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Communicable Disease Control', 'Communicable Diseases/history/*microbiology/therapy', 'History, 19th Century', 'History, 20th Century', 'History, Ancient', 'Humans']",,,,1995/08/07 00:00,1995/08/07 00:01,['1995/08/07 00:00'],"['1995/08/07 00:00 [pubmed]', '1995/08/07 00:01 [medline]', '1995/08/07 00:00 [entrez]']",['10.1001/archinte.155.15.1571 [doi]'],ppublish,Arch Intern Med. 1995 Aug 7-21;155(15):1571-2. doi: 10.1001/archinte.155.15.1571.,,,,,,,,,,,,,,,,,
19945083,NLM,MEDLINE,20100308,20160518,1946-9837 (Electronic) 1946-9837 (Linking),24,4,2009 Nov,Introduction: infectious diseases in clinical practice.,163,10.1053/j.tcam.2009.07.003 [doi],,,"['Mani, Indu']",['Mani I'],,['eng'],['Introductory Journal Article'],,United States,Top Companion Anim Med,Topics in companion animal medicine,101465592,IM,"['Animals', 'Communicable Diseases/diagnosis/*veterinary', 'Nervous System Diseases/veterinary', 'Tick-Borne Diseases/veterinary', 'Zoonoses']",,,,2009/12/01 06:00,2010/03/10 06:00,['2009/12/01 06:00'],"['2009/07/01 00:00 [received]', '2009/07/01 00:00 [accepted]', '2009/12/01 06:00 [entrez]', '2009/12/01 06:00 [pubmed]', '2010/03/10 06:00 [medline]']","['S1938-9736(09)00070-1 [pii]', '10.1053/j.tcam.2009.07.003 [doi]']",ppublish,Top Companion Anim Med. 2009 Nov;24(4):163. doi: 10.1053/j.tcam.2009.07.003.,,,,,,,,,,,,,,,,,
27184876,NLM,MEDLINE,20170222,20170222,1469-0691 (Electronic) 1198-743X (Linking),23,3,2017 Mar,Observational studies examining patient management in infectious diseases.,127-128,S1198-743X(16)30129-X [pii] 10.1016/j.cmi.2016.05.005 [doi],,,"['Paul, M', 'Leibovici, L']","['Paul M', 'Leibovici L']","['Infectious Diseases Institute, Rambam Health Care Campus and Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: paulm@post.tau.ac.il.', 'Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva and Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Israel.']",['eng'],['Editorial'],20160513,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Cohort Studies', 'Communicable Diseases/*diagnosis/*therapy', 'Disease Management', 'Humans', '*Observational Studies as Topic']",,,,2016/10/30 06:00,2017/02/23 06:00,['2016/05/18 06:00'],"['2016/04/23 00:00 [received]', '2016/05/03 00:00 [accepted]', '2016/10/30 06:00 [pubmed]', '2017/02/23 06:00 [medline]', '2016/05/18 06:00 [entrez]']","['S1198-743X(16)30129-X [pii]', '10.1016/j.cmi.2016.05.005 [doi]']",ppublish,Clin Microbiol Infect. 2017 Mar;23(3):127-128. doi: 10.1016/j.cmi.2016.05.005. Epub 2016 May 13.,,,,,,,,,,,,,,,,,
36190370,NLM,MEDLINE,20221222,20221222,1121-7138 (Print) 1121-7138 (Linking),45,4,2022 Dec,The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey.,260-268,,"Diagnosis and management of infectious diseases (ID) at the emergency department (ED) are challenging due to the peculiar setting and the available diagnostic tools. The involvement of an ID consultant has been described to improve clinical outcomes and antimicrobial stewardship (AMS) programs. An online survey was sent to 100 Italian Departments of Infectious Diseases affiliated with the Italian Society of Infectious Diseases and Tropical Medicine (SIMIT). The primary objective of our study was to describe the characteristics of ID services in Italian EDs to identify possible challenges and shortcomings and provide tips to improve the management of patients. Secondary objectives included the evaluation of diagnostic capability and the management of patients with suspected or confirmed ID. Seventy-six out of the 100 SIMIT centers, 32 (42.1%) of which were teaching hospitals, answered the survey. In 62 (82.7%) centers, consultations were performed by the IDs specialist on call. In 29 (38.2%) centers, there was a formal AMS program, and 32 (42.7%) had protocols for antibiotic use in the ED. Microbiological tests to be performed before starting antibiotic treatment in the ED were clearly defined in 44 (57.9%) hospitals. This survey highlighted several challenges in the current organization of ID consultations in Italian EDs.",,"['Riccardi, Niccolo', 'Antonello, Roberta Maria', 'Giacomelli, Andrea', 'Saderi, Laura', 'Canetti, Diana', 'Pallotto, Carlo', 'Mazzaferri, Fulvia', 'Degli Antoni, Anna Maria', 'Cardellino, Chiara', 'Motta, Ilaria', 'Calcagno, Andrea', 'Falcone, Marco', 'Trezzi, Michele', 'Comelli, Agnese', 'Pascale, Renato', 'Merli, Marco', 'Binda, Francesca', 'Angheben, Andrea', 'Sotgiu, Giovanni', 'Gobbi, Federico', 'Nozza, Silvia']","['Riccardi N', 'Antonello RM', 'Giacomelli A', 'Saderi L', 'Canetti D', 'Pallotto C', 'Mazzaferri F', 'Degli Antoni AM', 'Cardellino C', 'Motta I', 'Calcagno A', 'Falcone M', 'Trezzi M', 'Comelli A', 'Pascale R', 'Merli M', 'Binda F', 'Angheben A', 'Sotgiu G', 'Gobbi F', 'Nozza S']","['Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.', 'StopTB Italia Onlus, Milan, Italy.', 'StopTB Italia Onlus, Milan, Italy.', 'StopTB Italia Onlus, Milan, Italy.', 'Department of Biomedical and Clinical Sciences DIBIC L. Sacco, University of Milan, 20157 Milan, Italy.', 'Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.', 'StopTB Italia Onlus, Milan, Italy.', 'Department of Infectious and Tropical Diseases San Raffaele Hospital, 20132 Milan, Italy.', 'Infectious Diseases Unit, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, 50012 Bagno a Ripoli, Florence, Italy.', 'Infectious Diseases Section, Department of Diagnostic and Public Health, University of Verona, 37129 Verona, Italy.', 'Department of Infectious Diseases and Hepatology, Azienda Ospedaliera di Parma, 34126 Parma, Italy.', 'Department of Infectious - Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Valpolicella di Negrar, Verona, Italy.', 'University of Turin, AO ""Amedeo di Savoia"", Department of Medical Sciences, Infectious Diseases, 10149 Turin, Italy.', 'University of Turin, AO ""Amedeo di Savoia"", Department of Medical Sciences, Infectious Diseases, 10149 Turin, Italy.', 'Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.', 'Division of Infectious Diseases, Azienda USL Toscana Centro, Hospital of Pistoia, 51100 Pistoia, Italy.', 'Department of Infectious & Tropical Diseases, Spedali Civili, 25123 Brescia, Italy.', 'Infectious Diseases Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.', 'Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.', 'Division of Infectious Diseases, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.', 'Department of Infectious - Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Valpolicella di Negrar, Verona, Italy.', 'StopTB Italia Onlus, Milan, Italy.', 'Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.', 'Department of Infectious - Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Valpolicella di Negrar, Verona, Italy.', 'Department of Infectious and Tropical Diseases San Raffaele Hospital, 20132 Milan, Italy.']",['eng'],['Journal Article'],20221003,Italy,New Microbiol,The new microbiologica,9516291,IM,"['Humans', '*Communicable Diseases/diagnosis/drug therapy/epidemiology', 'Emergency Service, Hospital', 'Anti-Bacterial Agents/therapeutic use', 'Referral and Consultation', 'Italy/epidemiology', 'Hospitals, Teaching']",,['NOTNLM'],"['Antimicrobial stewardship', 'Consultant', 'Diagnostic', 'Emergency Room', 'Infectious Diseases']",2022/10/04 06:00,2022/12/23 06:00,['2022/10/03 09:43'],"['2022/12/20 00:00 [received]', '2022/12/20 00:00 [accepted]', '2022/10/04 06:00 [pubmed]', '2022/12/23 06:00 [medline]', '2022/10/03 09:43 [entrez]']",['496N292 [pii]'],ppublish,New Microbiol. 2022 Dec;45(4):260-268. Epub 2022 Oct 3.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
31635582,NLM,MEDLINE,20200225,20200225,2078-5135 (Electronic),109,9,2019 Aug 28,The infectious diseases specialty in South Africa is in crisis.,620-621,10.7196/SAMJ.2019.v109i9.14297 [doi],,,"['Boyles, T', 'Mendelson, M', 'Govender, N', 'Du Plessis, N']","['Boyles T', 'Mendelson M', 'Govender N', 'Du Plessis N']","['President, Infectious Diseases Society of Southern Africa (IDSSA). tomboyles@yahoo.com.']",['eng'],['Letter'],20190828,South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,IM,"['Communicable Diseases/epidemiology/*therapy', 'Humans', 'Infectious Disease Medicine/*organization & administration', 'South Africa/epidemiology', '*Specialization']",,,,2019/10/23 06:00,2020/02/26 06:00,['2019/10/23 06:00'],"['2019/08/28 00:00 [received]', '2019/10/23 06:00 [entrez]', '2019/10/23 06:00 [pubmed]', '2020/02/26 06:00 [medline]']",['10.7196/SAMJ.2019.v109i9.14297 [doi]'],epublish,S Afr Med J. 2019 Aug 28;109(9):620-621. doi: 10.7196/SAMJ.2019.v109i9.14297.,,,,,,,,,,,,,,,,,
26055413,NLM,MEDLINE,20160804,20200409,1469-0691 (Electronic) 1198-743X (Print) 1198-743X (Linking),21,9,2015 Sep,What is hot in infectious diseases?,803-4,S1198-743X(15)00569-8 [pii] 10.1016/j.cmi.2015.05.037 [doi],,,"['Raoult, Didier']",['Raoult D'],"['Unite de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculte de Medecine, Universite de la Mediterranee, Marseille, France. Electronic address: didier.raoult@gmail.com.']",['eng'],['Journal Article'],20150606,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['*Bibliometrics', 'Communicable Diseases/diagnosis/*epidemiology/therapy/transmission', 'Global Health', 'Humans']",PMC7129506,['NOTNLM'],"['Clinical microbiology and infection', 'highly cited papers', 'hot topics', 'infectious diseases journals', 'microbiota']",2015/06/10 06:00,2016/08/05 06:00,['2015/06/10 06:00'],"['2015/05/22 00:00 [received]', '2015/05/22 00:00 [accepted]', '2015/06/10 06:00 [entrez]', '2015/06/10 06:00 [pubmed]', '2016/08/05 06:00 [medline]']","['S1198-743X(15)00569-8 [pii]', '10.1016/j.cmi.2015.05.037 [doi]']",ppublish,Clin Microbiol Infect. 2015 Sep;21(9):803-4. doi: 10.1016/j.cmi.2015.05.037. Epub 2015 Jun 6.,,,,,,,,,,,,,,,,,
19080750,NLM,MEDLINE,20090203,20220801,1534-6293 (Electronic) 1528-4042 (Linking),9,1,2009 Jan,The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke.,28-34,,"It is well established that several infectious diseases can directly lead to ischemic or hemorrhagic stroke during their course. It appears possible that common viral and bacterial infections can increase the susceptibility to stroke by promoting atherosclerosis, inflammation, and local thrombosis. Stroke commonly leads to disruption of protective mechanisms against infection and induces a cascade of anti-inflammatory and immunosuppressive reactions, which greatly increases the risk of infection. The social and economic costs of post-stroke infections and their impact on stroke morbidity and outcome are dramatic. Understanding the pathophysiologic links between stroke and infection is therefore of paramount importance, and effective preventive strategies to reduce the risk of infection are needed. This article summarizes current clinical and experimental data regarding the interactions between stroke and infection and outlines possible targets for therapeutic intervention.",,"['Manousakis, Georgios', 'Jensen, Matthew B', 'Chacon, Marcus R', 'Sattin, Justin A', 'Levine, Ross L']","['Manousakis G', 'Jensen MB', 'Chacon MR', 'Sattin JA', 'Levine RL']","['Department of Neurology, University of Wisconsin School of Medicine and Public Health, H6/574 Clinical Sciences Center, 600 Highland Avenue, Madison, WI 53792, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Curr Neurol Neurosci Rep,Current neurology and neuroscience reports,100931790,IM,"['Animals', 'Communicable Diseases/*complications/*etiology/therapy', 'Humans', '*Stroke/complications/etiology']",,,,2008/12/17 09:00,2009/02/04 09:00,['2008/12/17 09:00'],"['2008/12/17 09:00 [entrez]', '2008/12/17 09:00 [pubmed]', '2009/02/04 09:00 [medline]']",['10.1007/s11910-009-0005-x [doi]'],ppublish,Curr Neurol Neurosci Rep. 2009 Jan;9(1):28-34. doi: 10.1007/s11910-009-0005-x.,,,,,,50,,,,,,,,,,,
35857175,NLM,MEDLINE,20221202,20221202,1573-4978 (Electronic) 0301-4851 (Print) 0301-4851 (Linking),49,12,2022 Dec,The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.,11301-11311,10.1007/s11033-022-07752-z [doi],"Emerging and relapsing infectious diseases pose a huge health threat to human health and a new challenge to global public health. Rapid, sensitive and simple diagnostic tools are keys to successful management of infectious patients and containment of disease transmission. In recent years, international research on Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-related proteins (Cas) has revolutionized our understanding of biology. The CRISPR-Cas system has the advantages of high specificity, high sensitivity, simple, rapid, low cost, and has begun to be used for molecular diagnosis and treatment of infectious diseases. In this paper, we described the biological principles, application fields and prospects of CRISPR-Cas system in the molecular diagnosis and treatment of infectious diseases, and compared it with existing molecular diagnosis methods, the advantages and disadvantages were summarized.","['(c) 2022. The Author(s), under exclusive licence to Springer Nature B.V.']","['Lou, Juan', 'Wang, Bin', 'Li, Junwei', 'Ni, Peng', 'Jin, Yuefei', 'Chen, Shuaiyin', 'Xi, Yuanlin', 'Zhang, Rongguang', 'Duan, Guangcai']","['Lou J', 'Wang B', 'Li J', 'Ni P', 'Jin Y', 'Chen S', 'Xi Y', 'Zhang R', 'Duan G']","['Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China. zrg@zzu.edu.cn.', 'International School of Public Health and One Health, The First Affiliated Hospital, Hainan Medical University, Haikou, China. zrg@zzu.edu.cn.', 'Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.']",['eng'],['Journal Article'],20220720,Netherlands,Mol Biol Rep,Molecular biology reports,0403234,IM,"['Humans', '*CRISPR-Cas Systems/genetics', '*Communicable Diseases/diagnosis/genetics/therapy']",PMC9297709,['NOTNLM'],"['Application', 'COVID-19', 'CRISPR-Cas', 'Infectious diseases']",2022/07/21 06:00,2022/12/03 06:00,['2022/07/20 11:20'],"['2022/04/16 00:00 [received]', '2022/06/28 00:00 [accepted]', '2022/06/12 00:00 [revised]', '2022/07/21 06:00 [pubmed]', '2022/12/03 06:00 [medline]', '2022/07/20 11:20 [entrez]']","['10.1007/s11033-022-07752-z [pii]', '7752 [pii]', '10.1007/s11033-022-07752-z [doi]']",ppublish,Mol Biol Rep. 2022 Dec;49(12):11301-11311. doi: 10.1007/s11033-022-07752-z. Epub 2022 Jul 20.,['The authors have declared that no competing interests exist.'],['ORCID: 0000-0001-9961-2434'],,,,,"['81773495/81773495/', 'No.820CXTD438/No.820CXTD438/']",,,,,,,,,,
9333166,NLM,MEDLINE,19971106,20220427,0022-1899 (Print) 0022-1899 (Linking),176,4,1997 Oct,"Perspective: aging and infectious diseases: past, present, and future.",1053-7,,"As we enter into the 21st century, infectious disease specialists will be managing a greater number and proportion of patients with infections who are > or = 65 years old. Much has been learned about aging, host resistance, and infections over the past 15 years. However, if we are to meet the challenge of the complex issues of geriatric infectious diseases, infectious disease clinicians, teachers, and researchers must assume a more proactive role in clinical care, training, education, and research on problems and issues confronting the aging population.",,"['Yoshikawa, T T']",['Yoshikawa TT'],"['Department of Internal Medicine, Charles R. Drew University of Medicine and Science, King-Drew Medical Center, Los Angeles, California 90059, USA.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['*Aging', 'Communicable Diseases/history/immunology/*therapy', 'Geriatrics/*education', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Immunity, Innate', ""Physician's Role"", 'Research Personnel', 'Teaching']",,,,1997/10/23 00:00,1997/10/23 00:01,['1997/10/23 00:00'],"['1997/10/23 00:00 [pubmed]', '1997/10/23 00:01 [medline]', '1997/10/23 00:00 [entrez]']",['10.1086/516547 [doi]'],ppublish,J Infect Dis. 1997 Oct;176(4):1053-7. doi: 10.1086/516547.,,,,,,65,,,,,,,,,,,
11340531,NLM,MEDLINE,20010712,20041117,1058-4838 (Print) 1058-4838 (Linking),32,11,2001 Jun 1,Infectious disease pathology.,1589-601,,"The anatomic pathologist performs an important role in the diagnosis or exclusion of infectious diseases. The morphologic interpretation of biopsies and cytologic preparations allows for the definitive establishment or exclusion of a wide variety of diseases. Once the pathologist has determined that a disease is likely to be due to an infection and has characterized the inflammatory response, associated microorganisms or viral-associated cytopathic effects should be recorded. Although some microorganisms or their cytopathic effects may be clearly visible on routine hematoxylin and eosin-stained sections, additional histochemical stains are often needed for their complete characterization. Highly specific molecular techniques, such as immunohistochemistry, in situ hybridization, and nucleic acid amplification, may be needed in certain instances to establish the diagnosis of infection. Through appropriate morphologic diagnoses and interlaboratory communication and collaboration, the anatomic pathologist contributes greatly to the diagnosis and treatment of infectious diseases.",,"['Procop, G W', 'Wilson, M']","['Procop GW', 'Wilson M']","['Division of Pathology and Laboratory Medicine, Department of Clinical Pathology, Section of Clinical Microbiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. procopg@ccf.org']",['eng'],"['Journal Article', 'Review']",20010430,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Animals', 'Communicable Diseases/diagnosis/immunology/*pathology', 'Humans', 'Immunohistochemistry', 'In Situ Hybridization', 'Polymerase Chain Reaction', 'Staining and Labeling']",,,,2001/05/08 10:00,2001/07/13 10:01,['2001/05/08 10:00'],"['2000/12/26 00:00 [received]', '2001/05/08 10:00 [pubmed]', '2001/07/13 10:01 [medline]', '2001/05/08 10:00 [entrez]']","['CID001737 [pii]', '10.1086/320537 [doi]']",ppublish,Clin Infect Dis. 2001 Jun 1;32(11):1589-601. doi: 10.1086/320537. Epub 2001 Apr 30.,,,,,['Clin Infect Dis. 2002 Jan 1;34(1):130-1. PMID: 11731960'],116,,,,,,,,,,,
32123000,NLM,MEDLINE,20231003,20231003,2633-3775 (Electronic) 2633-3767 (Linking),168,6,2022 Dec,Communicable diseases in humanitarian operations and disasters.,457-461,10.1136/bmjmilitary-2020-001415 [doi],"Military organisations have battled communicable disease for millennia. They have pioneered disease prevention from the Crusades to the World Wars and continue to do so today. Predeployment vaccinations and chemoprophylaxis are effective in preventing communicable disease, as is reliable vector destruction and bite prevention, especially in the era of multidrug resistant organisms. These measures are unlikely to be fully possible in disasters, but reactive vaccination and efforts to reduce exposure to communicable disease should be a priority. Communicable diseases can be challenging to diagnose-the UK Defence Medical Services have become familiar with tools such as multiplex PCR and mass spectrometry. These have the potential to accurately identify organisms and sensitivity patterns in austere environments. Management of communicable diseases depends on accurate diagnosis and has a largely well-established evidence base but can be limited by a lack of resources and skills in an austere setting, therefore telemedicine can assist diagnosis and treatment of infections by projecting specialist skill. Systems such as EpiNATO2 are useful in monitoring diseases and identifying trends in order to establish control measures. Many of these tools and techniques are effective in austere environments and offer learning opportunities for those providing care in similar settings. Further research is ongoing into diagnostic tools as well as remote management.","['(c) Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and', 'permissions. Published by BMJ.']","['Murphy, Ronan James']",['Murphy RJ'],"['General Duties Medical Officer, 3 Medical Regiment, Preston PR2 8AA, UK ronan.murphy@doctors.org.uk.']",['eng'],"['Journal Article', 'Review']",20200302,England,BMJ Mil Health,BMJ military health,101761581,IM,"['Humans', '*Disasters', '*Communicable Diseases/diagnosis/epidemiology/therapy', '*Telemedicine', 'Chemoprevention', '*Military Medicine/methods']",,['NOTNLM'],"['infectious diseases', 'molecular diagnostics', 'tropical medicine']",2020/03/04 06:00,2023/10/03 06:46,['2020/03/04 06:00'],"['2020/01/23 00:00 [received]', '2020/01/29 00:00 [revised]', '2020/01/31 00:00 [accepted]', '2023/10/03 06:46 [medline]', '2020/03/04 06:00 [pubmed]', '2020/03/04 06:00 [entrez]']","['bmjmilitary-2020-001415 [pii]', '10.1136/bmjmilitary-2020-001415 [doi]']",ppublish,BMJ Mil Health. 2022 Dec;168(6):457-461. doi: 10.1136/bmjmilitary-2020-001415. Epub 2020 Mar 2.,['Competing interests: None declared.'],['ORCID: 0000-0002-0263-5152'],,,,,,,,,,,,,,,
23859196,NLM,MEDLINE,20140213,20130717,1756-8927 (Electronic) 1756-8919 (Linking),5,11,2013 Jul,Forward: combating resistance: infectious diseases.,1175-6,10.4155/fmc.13.105 [doi],,,"['Gold, Barry']",['Gold B'],"['Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA. goldbi@pitt.edu']",['eng'],['Introductory Journal Article'],,England,Future Med Chem,Future medicinal chemistry,101511162,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*drug therapy/pathology', 'Drug Resistance', 'Humans']",,,,2013/07/19 06:00,2014/02/14 06:00,['2013/07/18 06:00'],"['2013/07/18 06:00 [entrez]', '2013/07/19 06:00 [pubmed]', '2014/02/14 06:00 [medline]']",['10.4155/fmc.13.105 [doi]'],ppublish,Future Med Chem. 2013 Jul;5(11):1175-6. doi: 10.4155/fmc.13.105.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
12806052,NLM,MEDLINE,20040805,20180705,1537-744X (Electronic) 2356-6140 (Print) 1537-744X (Linking),2,,2002 Jan 23,Structural predestination of individual diversity in the course and severity of infectious diseases.,205-16,,"Infectious diseases can be manifested by a spectrum of clinical signs and resultant clinical courses that range from acute to chronic and possible persistence in the victim in a latent form. Until recently, the origins of this kind of biodiversity were poorly understood, but advances in immunology--especially in identifying the constitutional mechanisms of immunity--have contributed to our understanding of the origins of biodiversity in infectious diseases. Infectious diseases affect only focal areas in the affected organisms, and the amounts and distribution of infectious lesions vary from patient to patient. In a population attacked by an infectious agent, individuals can be conveniently divided into three categories: totally resistant organisms which contain no susceptible structures and are not affected; mildly susceptible organisms in which a few foci appear and in which the infection runs a benign course; organisms in which the number of constitutionally susceptible structures is high and the infectious process develops in a severe form. The diversity is determined by the differences in susceptibility of various parts of the organism under consideration.",,"['Rumyantsev, Sergey N']",['Rumyantsev SN'],"['Institute of Vaccines and Sera, Saint Petersburg, Russia. rumyan1@yahoo.com']",['eng'],"['Journal Article', 'Review']",20020123,United States,ScientificWorldJournal,TheScientificWorldJournal,101131163,IM,"['Aging/immunology', 'Animals', 'Communicable Diseases/genetics/*immunology/microbiology/*pathology', '*Disease Susceptibility', 'Humans', 'Mosaicism/genetics', 'Selection, Genetic']",PMC6009238,,,2003/06/14 05:00,2004/08/06 05:00,['2003/06/14 05:00'],"['2003/06/14 05:00 [pubmed]', '2004/08/06 05:00 [medline]', '2003/06/14 05:00 [entrez]']","['289140 [pii]', '10.1100/tsw.2002.94 [doi]']",epublish,ScientificWorldJournal. 2002 Jan 23;2:205-16. doi: 10.1100/tsw.2002.94.,,,,,,,,,,,,,,,,,
10944477,NLM,MEDLINE,20001017,20051116,0022-1899 (Print) 0022-1899 (Linking),182 Suppl 1,,2000 Sep,Micronutrients and infectious diseases: thoughts on integration of mechanistic approaches into micronutrient research.,S1-4,,"Results of field and laboratory studies provide convincing evidence that micronutrient deficiencies contribute to the mortality and morbidity of infectious diseases. Despite encouraging results in large trials, understanding the mechanisms by which micronutrients contribute to the outcome of the encounter between an individual and an infectious agent requires additional hypothesis-driven research. Presumably, such understanding should lead to translational studies with targeted nutritional therapy. Although these mechanistic studies are varied and complex, they must be done systematically and should include examination of the mechanisms by which micronutrients affect host-pathogen interactions, development of appropriate animal models and reliable methods for the assessment of micronutrient levels, and translation of the results of basic research findings into clinical studies. Moving the frontiers of micronutrient research from the laboratory to the field will be challenging. However, sound scientific research should lead toward better human health.",,"['Taylor, C E', 'Higgs, E S']","['Taylor CE', 'Higgs ES']","['Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID, Bethesda, MD 20892-7630, USA. ct18m@nih.gov']",['eng'],"['Journal Article', 'Review']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Communicable Diseases/epidemiology/mortality/*physiopathology', 'Humans', '*Micronutrients']",,,,2000/08/17 11:00,2000/10/21 11:01,['2000/08/17 11:00'],"['2000/08/17 11:00 [pubmed]', '2000/10/21 11:01 [medline]', '2000/08/17 11:00 [entrez]']","['JID000034 [pii]', '10.1086/315904 [doi]']",ppublish,J Infect Dis. 2000 Sep;182 Suppl 1:S1-4. doi: 10.1086/315904.,,,['0 (Micronutrients)'],,,33,,,,,,,,,,,
27592742,NLM,MEDLINE,20190311,20190311,1578-1852 (Electronic) 0213-005X (Linking),35,4,2017 Apr,The challenge of infectious diseases in the emergency department: Presentation of 3 cases.,205-207,S0213-005X(16)30240-3 [pii] 10.1016/j.eimc.2016.07.010 [doi],,,"['Miro, Oscar']",['Miro O'],"['Area de Urgencias, Hospital Clinic, Universitat de Barcelona, Barcelona, Espana. Electronic address: omiro@clinic.cat.']","['eng', 'spa']",['Editorial'],20160901,Spain,Enferm Infecc Microbiol Clin,Enfermedades infecciosas y microbiologia clinica,9104081,IM,"['*Communicable Diseases/diagnosis/drug therapy', '*Emergency Service, Hospital', 'Humans']",,,,2016/09/07 06:00,2019/03/12 06:00,['2016/09/06 06:00'],"['2016/07/25 00:00 [received]', '2016/07/25 00:00 [accepted]', '2016/09/07 06:00 [pubmed]', '2019/03/12 06:00 [medline]', '2016/09/06 06:00 [entrez]']","['S0213-005X(16)30240-3 [pii]', '10.1016/j.eimc.2016.07.010 [doi]']",ppublish,Enferm Infecc Microbiol Clin. 2017 Apr;35(4):205-207. doi: 10.1016/j.eimc.2016.07.010. Epub 2016 Sep 1.,,,,,,,,,El reto de la enfermedad infecciosa en los servicios de urgencias: a proposito de 3 estudios.,,,,,,,,
35632689,NLM,MEDLINE,20220531,20220716,1999-4915 (Electronic) 1999-4915 (Linking),14,5,2022 Apr 30,Mitigating the Impact of Emerging Animal Infectious Disease Threats: First Emerging Animal Infectious Diseases Conference (EAIDC) Report.,,10.3390/v14050947 [doi] 947,"From 29 November to 1 December 2021, an ""emerging animal infectious disease conference (EAIDC)"" was held at the Pennsylvania State University. This conference brought together distinguished thought leaders in animal health, veterinary diagnostics, epidemiology and disease surveillance, and agricultural economics. The conference's primary objective was to review the lessons learned from past experiences in dealing with high-consequence animal infectious diseases to inform an action plan to prepare for future epizootics and panzootics. Invited speakers and panel members comprised world-leading experts in animal infectious diseases from federal state agencies, academia, professional societies, and the private sector. The conference concluded that the biosecurity of livestock operations is critical for minimizing the devastating impact of emerging animal infectious diseases. The panel also highlighted the need to develop and benchmark cutting-edge diagnostics for rapidly detecting pathogens in clinical samples and the environment. Developing next-generation pathogen agnostic diagnostics will help detect variants of known pathogens and unknown novel pathogens. The conference also highlighted the importance of the One Health approach in dealing with emerging animal and human infectious diseases. The recommendations of the conference may be used to inform policy discussions focused on developing strategies for monitoring and preventing emerging infectious disease threats to the livestock industry.",,"['Kuchipudi, Suresh V', 'Behring, Deanna', 'Nissly, Ruth', 'Chothe, Shubhada K', 'Gontu, Abhinay', 'Ravichandran, Abirami', 'Butler, Ty']","['Kuchipudi SV', 'Behring D', 'Nissly R', 'Chothe SK', 'Gontu A', 'Ravichandran A', 'Butler T']","['Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'The Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'College of Agricultural Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'The Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'The Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'The Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'Animal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'The Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.', 'College of Agricultural Sciences, The Pennsylvania State University, University Park, PA 16802, USA.']",['eng'],"['Congress', ""Research Support, Non-U.S. Gov't""]",20220430,Switzerland,Viruses,Viruses,101509722,IM,"['Agriculture', 'Animals', '*Communicable Diseases/diagnosis/epidemiology/veterinary', '*Communicable Diseases, Emerging/epidemiology/prevention & control/veterinary', 'Humans']",PMC9147003,['NOTNLM'],"['African swine fever', 'EAIDC', 'avian influenza', 'emerging infectious diseases', 'foot and mouth disease']",2022/05/29 06:00,2022/06/01 06:00,['2022/05/28 01:45'],"['2022/04/11 00:00 [received]', '2022/04/20 00:00 [accepted]', '2022/05/28 01:45 [entrez]', '2022/05/29 06:00 [pubmed]', '2022/06/01 06:00 [medline]']","['v14050947 [pii]', 'viruses-14-00947 [pii]', '10.3390/v14050947 [doi]']",epublish,Viruses. 2022 Apr 30;14(5):947. doi: 10.3390/v14050947.,['The authors declare no conflict of interest.'],"['ORCID: 0000-0002-8640-254X', 'ORCID: 0000-0002-3102-7447', 'ORCID: 0000-0002-7109-7810', 'ORCID: 0000-0001-6260-7092']",,,,,,,,,,,,,,,
18711428,NLM,MEDLINE,20081031,20081016,1740-1534 (Electronic) 1740-1526 (Linking),6,11,2008 Nov,Post-genomic challenges for collaborative research in infectious diseases.,858-64,10.1038/nrmicro1989 [doi],"Although high-burden pathogens have been prioritized for sequencing, genomic research has yet to yield effective vaccines, diagnostics or therapeutics for the infectious diseases that burden developing countries. International research partnerships are needed more today than ever before, and we propose that increased participation by scientists in endemic areas would overcome current roadblocks and is an essential path towards translational research outcomes.",,"['Okeke, Iruka N', 'Wain, John']","['Okeke IN', 'Wain J']","['Department of Biology, Haverford College, Haverford, Pennsylvania 19041, USA. iokeke@haverford.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20080819,England,Nat Rev Microbiol,Nature reviews. Microbiology,101190261,IM,"['Biomedical Research/*trends', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/drug therapy/*epidemiology', '*Cooperative Behavior', 'Developing Countries', '*Endemic Diseases', 'Humans']",,,,2008/08/20 09:00,2008/11/01 09:00,['2008/08/20 09:00'],"['2008/08/20 09:00 [pubmed]', '2008/11/01 09:00 [medline]', '2008/08/20 09:00 [entrez]']","['nrmicro1989 [pii]', '10.1038/nrmicro1989 [doi]']",ppublish,Nat Rev Microbiol. 2008 Nov;6(11):858-64. doi: 10.1038/nrmicro1989. Epub 2008 Aug 19.,,,,,,45,['Wellcome Trust/United Kingdom'],,,,,,,,,,
26350325,NLM,MEDLINE,20160414,20180810,2165-0497 (Electronic) 2165-0497 (Linking),3,4,2015 Aug,Infectious Risks of Traveling Abroad.,,10.1128/microbiolspec.IOL5-0005-2015 [doi],"A popular leisure activity, international travel can be associated with some infections. The most common travel-related illnesses appear to be gastrointestinal, dermatologic, respiratory, and systemic febrile syndromes. The pretravel medical consultation includes immunizations, malaria chemoprophylaxis, self-treatment for traveler's diarrhea, and advice on the prevention of a myriad of other infectious causes including dengue, chikungunya, rickettsiosis, leptospirosis, schistosomiasis, and strongyloidiasis. Travel to locations experiencing outbreaks such as Ebola virus disease, Middle East respiratory syndrome, avian influenza, and chikungunya call for specific alerts on preventive strategies. After travel, evaluation of an ill traveler must explore details of exposure, including destinations visited; activities; ingestion of contaminated food or drinks; contact with vectors, animals, fresh water, or blood and body fluids; and other potential exposures. Knowledge of the geographic distribution of infectious diseases is important in generating the differential diagnoses and testing accordingly. Empiric treatment is sometimes necessary when suspicion of a certain diagnosis is strong and confirmatory tests are delayed or lacking, particularly for infections that are rapidly progressive (for example, malaria) or for which timing of testing is prolonged (such as leptospirosis).",,"['Chen, Lin H', 'Blair, Barbra M']","['Chen LH', 'Blair BM']","['Mount Auburn Hospital, Cambridge, MA 02138.', 'Mount Auburn Hospital, Cambridge, MA 02138.']",['eng'],"['Journal Article', 'Review']",,United States,Microbiol Spectr,Microbiology spectrum,101634614,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology/transmission/virology', 'Humans', 'Risk', 'Travel/*statistics & numerical data']",,,,2015/09/10 06:00,2016/04/15 06:00,['2015/09/10 06:00'],"['2015/09/10 06:00 [entrez]', '2015/09/10 06:00 [pubmed]', '2016/04/15 06:00 [medline]']",['10.1128/microbiolspec.IOL5-0005-2015 [doi]'],ppublish,Microbiol Spectr. 2015 Aug;3(4). doi: 10.1128/microbiolspec.IOL5-0005-2015.,,,,,,,,,,,,,,,,,
20040917,NLM,MEDLINE,20100204,20231113,1740-1534 (Electronic) 1740-1526 (Print) 1740-1526 (Linking),8,2,2010 Feb,Model or meal? Farm animal populations as models for infectious diseases of humans.,139-48,10.1038/nrmicro2268 [doi],"In recent decades, theory addressing the processes that underlie the dynamics of infectious diseases has progressed considerably. Unfortunately, the availability of empirical data to evaluate these theories has not grown at the same pace. Although laboratory animals have been widely used as models at the organism level, they have been less appropriate for addressing issues at the population level. However, farm animal populations can provide empirical models to study infectious diseases at the population level.",,"['Lanzas, Cristina', 'Ayscue, Patrick', 'Ivanek, Renata', 'Grohn, Yrjo T']","['Lanzas C', 'Ayscue P', 'Ivanek R', 'Grohn YT']","['Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA. cl272@cornell.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",20091230,England,Nat Rev Microbiol,Nature reviews. Microbiology,101190261,IM,"['Animals', 'Animals, Domestic/*microbiology/virology', 'Communicable Diseases/*microbiology/*transmission/virology', '*Disease Models, Animal', '*Host-Pathogen Interactions', 'Humans', 'Models, Biological', 'Population']",PMC7097165,,,2009/12/31 06:00,2010/02/05 06:00,['2009/12/31 06:00'],"['2009/12/31 06:00 [entrez]', '2009/12/31 06:00 [pubmed]', '2010/02/05 06:00 [medline]']","['nrmicro2268 [pii]', 'BFnrmicro2268 [pii]', '10.1038/nrmicro2268 [doi]']",ppublish,Nat Rev Microbiol. 2010 Feb;8(2):139-48. doi: 10.1038/nrmicro2268. Epub 2009 Dec 30.,['The authors declare no competing financial interests.'],,,,,,"['N01AI30054/AI/NIAID NIH HHS/United States', 'N01-AI-30054/AI/NIAID NIH HHS/United States']",,,,,,,,,,
11795078,NLM,MEDLINE,20020610,20051116,0065-2822 (Print) 0065-2822 (Linking),47,,2001,Infectious diseases of international travel.,265-92,,,,"['Klion, A D', 'Nutman, T B']","['Klion AD', 'Nutman TB']","['Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Intern Med,Advances in internal medicine,0370427,IM,"['Communicable Diseases/*complications/diagnosis', 'Diarrhea/*etiology', 'Eosinophilia/*etiology', 'Fever/*etiology', 'Humans', 'Skin Diseases/*etiology', '*Travel']",,,,2002/01/25 10:00,2002/06/11 10:01,['2002/01/25 10:00'],"['2002/01/25 10:00 [pubmed]', '2002/06/11 10:01 [medline]', '2002/01/25 10:00 [entrez]']",,ppublish,Adv Intern Med. 2001;47:265-92.,,,,,,114,,,,,,,,,,,
11181125,NLM,MEDLINE,20010809,20180213,1058-4838 (Print) 1058-4838 (Linking),32,4,2001 Feb 15,Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care.,605-11,,"Modern medicine has led to dramatic changes in infectious diseases practice. Vaccination and antibiotic therapy have benefited millions of persons. However, constrained resources now threaten our ability to adequately manage threats of infectious diseases by placing clinical microbiology services and expertise distant from the patient and their infectious diseases physician. Continuing in such a direction threatens quality of laboratory results, timeliness of diagnosis, appropriateness of treatment, effective communication, reduction of health care-associated infections, advances in infectious diseases practice, and training of future practitioners. Microbiology laboratories are the first lines of defense for detection of new antibiotic resistance, outbreaks of foodborne infection, and a possible bioterrorism event. Maintaining high-quality clinical microbiology laboratories on the site of the institution that they serve is the current best approach for managing today's problems of emerging infectious diseases and antimicrobial agent resistance by providing good patient care outcomes that actually save money.",,"['Peterson, L R', 'Hamilton, J D', 'Baron, E J', 'Tompkins, L S', 'Miller, J M', 'Wilfert, C M', 'Tenover, F C', 'Thomson, R B Jr']","['Peterson LR', 'Hamilton JD', 'Baron EJ', 'Tompkins LS', 'Miller JM', 'Wilfert CM', 'Tenover FC', 'Thomson RB Jr']","['Northwestern University Medical School, Evanston, IL, USA. lancer@northwestern.edu']",['eng'],"['Journal Article', 'Review']",20010207,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Disease Control', '*Communicable Diseases/diagnosis/microbiology/therapy', '*Delivery of Health Care', 'Humans', 'Laboratories/organization & administration/*standards/trends', '*Microbiology']",,,,2001/02/22 11:00,2001/08/10 10:01,['2001/02/22 11:00'],"['2000/08/24 00:00 [received]', '2001/02/22 11:00 [pubmed]', '2001/08/10 10:01 [medline]', '2001/02/22 11:00 [entrez]']","['CID001164 [pii]', '10.1086/318725 [doi]']",ppublish,Clin Infect Dis. 2001 Feb 15;32(4):605-11. doi: 10.1086/318725. Epub 2001 Feb 7.,,,,,['Clin Infect Dis. 2001 Feb 15;32(4):604. PMID: 11181124'],28,,,,,,,,,,,
12067614,NLM,MEDLINE,20021219,20191106,1471-4914 (Print) 1471-4914 (Linking),8,6,2002 Jun,Molecular diagnostics in infectious diseases and public health microbiology: cottage industry to postgenomics.,280-7,,"Molecular methods have been used increasingly over the past ten years to improve the sensitivity and speed of diagnosis in infectious diseases. Although their routine use is still limited to the detection of pathogens that are difficult to culture in vitro,'real-time' methods, commercial kits, quantification and automation will increase potential applications. Molecular methods are now widely used for epidemiological fingerprinting of isolates of public health importance. Sequence-based identification and strain typing, together with the development of tools that can probe for thousands of markers, will allow detailed strain fingerprinting to assist in disease management and control.",,"['Gilbert, Gwendolyn L']",['Gilbert GL'],"['Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW 2145, Australia. lyng@icpmr.wsahs.nsw.gov.au']",['eng'],"['Journal Article', 'Review']",,England,Trends Mol Med,Trends in molecular medicine,100966035,IM,"['Animals', 'Communicable Diseases/*diagnosis/epidemiology/microbiology/virology', 'Disease Outbreaks', '*Genomics', 'Humans', 'Molecular Diagnostic Techniques/*methods/standards', 'Oligonucleotide Array Sequence Analysis', 'Population Surveillance', 'Public Health/*methods', 'Sensitivity and Specificity']",,,,2002/06/18 10:00,2002/12/20 04:00,['2002/06/18 10:00'],"['2002/06/18 10:00 [pubmed]', '2002/12/20 04:00 [medline]', '2002/06/18 10:00 [entrez]']","['S1471491402023493 [pii]', '10.1016/s1471-4914(02)02349-3 [doi]']",ppublish,Trends Mol Med. 2002 Jun;8(6):280-7. doi: 10.1016/s1471-4914(02)02349-3.,,,,,,51,,,,,,,,,,,
28859342,NLM,MEDLINE,20180423,20180423,1537-6591 (Electronic) 1058-4838 (Linking),65,suppl_1,2017 Aug 15,Developing Research in Infectious and Tropical Diseases in Africa: The Paradigm of Senegal.,S64-S69,10.1093/cid/cix347 [doi],"Infectious diseases represent one of the greatest potential barriers to achievement of the third Sustainable Development Goals in African countries and around the world because they continue to pose major public health challenges. The surveillance of infectious diseases has recently assumed greater importance in most African countries, both because of the emergence of infectious diseases and because strains of pathogens that cause tuberculosis, malaria, cholera, dysentery, and pneumonia have developed resistance to common and inexpensive antimicrobial drugs. However, data on the pathogen-specific causes of infectious diseases are limited. Developing research in infectious and tropical diseases in Africa is urgently needed to better describe the distribution of pathogen-borne diseases and to know which pathogens actually cause fever. This research is critical for guiding treatment and policies in Africa. More effective diagnostics are also needed for these diseases, which often are misdiagnosed or diagnosed too late. A comprehensive review of this type of research is presented here.","['(c) The Author 2017. Published by Oxford University Press for the Infectious', 'Diseases Society of America. All rights reserved. For permissions, e-mail:', 'journals.permissions@oup.com.']","['Sokhna, Cheikh', 'Gaye, Oumar', 'Doumbo, Ogobara']","['Sokhna C', 'Gaye O', 'Doumbo O']","['Aix-Marseille Univ, Unite de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut Hospitlao-Universitaire (IHU)Mediterranee-Infection.', 'Service Parasitologie, Universite Cheikh Anta Diop, Dakar, Senegal.', 'Department of Epidemiology of Infectious Diseases, Faculty of Medicine, Pharmacy and Dentistry, University of Techniques and Technologies of Bamako, Mali.']",['eng'],['Journal Article'],,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*Biomedical Research', '*Communicable Diseases/diagnosis/epidemiology', 'Communicable Diseases, Emerging/epidemiology/microbiology/parasitology/virology', 'Global Health', 'Humans', 'Malaria/epidemiology', 'Point-of-Care Systems', '*Public Health', 'Rural Population', 'Senegal/epidemiology', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization', '*Tropical Medicine', 'Tuberculosis/epidemiology']",,['NOTNLM'],"['MALDI-TOF', 'Senegal', 'emerging pathogens', 'point of care', 'rural dispensaries']",2017/09/02 06:00,2018/04/24 06:00,['2017/09/02 06:00'],"['2017/09/02 06:00 [entrez]', '2017/09/02 06:00 [pubmed]', '2018/04/24 06:00 [medline]']","['4057569 [pii]', '10.1093/cid/cix347 [doi]']",ppublish,Clin Infect Dis. 2017 Aug 15;65(suppl_1):S64-S69. doi: 10.1093/cid/cix347.,,,,,,,,,,,,,,,,,
6926595,NLM,MEDLINE,19831021,20041117,0142-0372 (Print) 0142-0372 (Linking),2,7,1982 Nov,Infectious diseases.,195-202,,,,"['Bannister, B A']",['Bannister BA'],,['eng'],['Journal Article'],,England,Nursing (Lond),Nursing,8009575,,"['Adult', 'Child', 'Communicable Diseases/diagnosis/*nursing/therapy', 'Humans', 'Infant']",,,,1982/11/01 00:00,1982/11/01 00:01,['1982/11/01 00:00'],"['1982/11/01 00:00 [pubmed]', '1982/11/01 00:01 [medline]', '1982/11/01 00:00 [entrez]']",,ppublish,Nursing (Lond). 1982 Nov;2(7):195-202.,,,,,,,,,,,,,,,,,
6999483,NLM,MEDLINE,19801216,20041117,0032-6518 (Print) 0032-6518 (Linking),224,1343,1980 May,Infectious diseases.,523-6,,,,"['Ramsay, A M']",['Ramsay AM'],,['eng'],"['Historical Article', 'Journal Article']",,England,Practitioner,The Practitioner,0404245,IM,"['Adult', 'Animals', 'Communicable Diseases/history/*therapy', 'Female', 'History, 20th Century', 'Humans', 'Male']",,,,1980/05/01 00:00,1980/05/01 00:01,['1980/05/01 00:00'],"['1980/05/01 00:00 [pubmed]', '1980/05/01 00:01 [medline]', '1980/05/01 00:00 [entrez]']",,ppublish,Practitioner. 1980 May;224(1343):523-6.,,,,,,,,,,,,,,,,,
34475606,NLM,MEDLINE,20211021,20211021,1564-0604 (Electronic) 0042-9686 (Print) 0042-9686 (Linking),99,9,2021 Sep 1,Improvements to a framework for gender and emerging infectious diseases.,682-684,10.2471/BLT.20.275636 [doi],,,"['Lawry, Lynn Lieberman', 'Lugo-Robles, Roberta', 'McIver, Vicki']","['Lawry LL', 'Lugo-Robles R', 'McIver V']","['Uniformed Services University of the Health Sciences, Preventive Medicine and Biostatistics Department, 4301 Jones Bridge Rd, Bethesda, MD 20814-4799, United States of America (USA).', 'Uniformed Services University of the Health Sciences, Preventive Medicine and Biostatistics Department, 4301 Jones Bridge Rd, Bethesda, MD 20814-4799, United States of America (USA).', '11032 Peach Ct, Belle Center, Logan, USA.']",['eng'],['Journal Article'],20210702,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,IM,"['*Communicable Diseases/epidemiology', '*Communicable Diseases, Emerging/epidemiology/prevention & control', 'Disease Outbreaks', 'Humans']",PMC8381096,,,2021/09/04 06:00,2023/02/25 06:00,['2021/09/03 06:45'],"['2020/08/03 00:00 [received]', '2021/03/31 00:00 [revised]', '2021/06/08 00:00 [accepted]', '2021/09/03 06:45 [entrez]', '2021/09/04 06:00 [pubmed]', '2023/02/25 06:00 [medline]']","['BLT.20.275636 [pii]', '10.2471/BLT.20.275636 [doi]']",ppublish,Bull World Health Organ. 2021 Sep 1;99(9):682-684. doi: 10.2471/BLT.20.275636. Epub 2021 Jul 2.,,,,,,,,,,,,,,,,,
15127331,NLM,MEDLINE,20040520,20060330,1537-6591 (Electronic) 1058-4838 (Linking),38,9,2004 May 1,"Infectious diseases consultative recommendations: if heard, they can be listened to.",1219-21,,,,"['Tenenbaum, Marvin J']",['Tenenbaum MJ'],,['eng'],"['Comment', 'Editorial']",20040414,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Diseases/diagnosis/*psychology/therapy', 'Guideline Adherence', '*Health Planning Guidelines', 'Humans', '*Patient Compliance', 'Referral and Consultation']",,,,2004/05/06 05:00,2004/05/21 05:00,['2004/05/06 05:00'],"['2004/01/21 00:00 [accepted]', '2004/05/06 05:00 [pubmed]', '2004/05/21 05:00 [medline]', '2004/05/06 05:00 [entrez]']","['CID33173 [pii]', '10.1086/383327 [doi]']",ppublish,Clin Infect Dis. 2004 May 1;38(9):1219-21. doi: 10.1086/383327. Epub 2004 Apr 14.,,,,,['Clin Infect Dis. 2005 Feb 15;40(4):636-7. PMID: 15712097'],,,['Clin Infect Dis. 2004 May 1;38(9):1212-8. PMID: 15127330'],,,,,,,,,
25557805,NLM,MEDLINE,20150922,20150114,1440-1754 (Electronic) 1034-4810 (Linking),51,1,2015 Jan,Paediatric infectious diseases: the last 50 years.,12-5,10.1111/jpc.12795 [doi],"Many advances and challenges have occurred in the field of paediatric infectious diseases during the past 50 years. It is impossible to cover all of these in a short review, but a few highlights and lowlights will be covered. These include virtual disappearance of some infectious diseases, emergence of new ones, infections in the immunocompromised, antimicrobial resistance, development of new and improved antimicrobials, improved diagnostic tests and the Human Microbiome Project.","['(c) 2015 The Author. Journal of Paediatrics and Child Health (c) 2015 Paediatrics and', 'Child Health Division (Royal Australasian College of Physicians).']","['Starr, Mike']",['Starr M'],"[""Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.""]",['eng'],"['Historical Article', 'Journal Article']",20150105,Australia,J Paediatr Child Health,Journal of paediatrics and child health,9005421,IM,"['Anti-Bacterial Agents/therapeutic use', 'Australia', 'Child', 'Communicable Disease Control/*history', 'Communicable Diseases/diagnosis/drug therapy/epidemiology/*history', 'Drug Resistance, Bacterial', 'Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Pediatrics/*history']",,['NOTNLM'],"['HIV', 'infectious diseases', 'microbiome']",2015/01/06 06:00,2015/09/24 06:00,['2015/01/06 06:00'],"['2014/10/08 00:00 [accepted]', '2015/01/06 06:00 [entrez]', '2015/01/06 06:00 [pubmed]', '2015/09/24 06:00 [medline]']",['10.1111/jpc.12795 [doi]'],ppublish,J Paediatr Child Health. 2015 Jan;51(1):12-5. doi: 10.1111/jpc.12795. Epub 2015 Jan 5.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
33121623,NLM,MEDLINE,20210907,20210907,1557-9832 (Electronic) 0272-2712 (Linking),40,4,2020 Dec,Update in Infectious Disease Diagnosis in Anatomic Pathology.,565-585,S0272-2712(20)30066-4 [pii] 10.1016/j.cll.2020.08.012 [doi],"Anatomic pathology is an important resource for detection and exclusion of infectious diseases in tissue specimens. Detection of a microorganism (i.e. bacteria, fungi, parasite) in tissue sections is frequently the beginning of a work-up and occasionally sufficient for definitive microbiologic identification. Close correlation with cultures and ancillary testing in the microbiology laboratory is of paramount importance in arriving at a diagnosis and identify with certitude causative pathogen(s). This review will discuss the adequacy and limitations of histopathology in the diagnosis of infectious diseases, describe potential pitfalls, and discuss the appropriate use of molecular diagnostics in formalin-fixed, paraffin embedded tissues.",['Copyright (c) 2020 Elsevier Inc. All rights reserved.'],"['Laga, Alvaro C']",['Laga AC'],"[""Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Amory-3, Boston, MA 02115, USA. Electronic address: alagacanales@bwh.harvard.edu.""]",['eng'],"['Journal Article', 'Review']",20201006,United States,Clin Lab Med,Clinics in laboratory medicine,8100174,IM,"['*Communicable Diseases/diagnosis/microbiology/pathology', '*Histological Techniques', 'Humans', '*Microbiological Techniques']",,['NOTNLM'],"['Detection', 'Infectious', 'Inflammatory pattern', 'Pathology', 'Pitfalls', 'Special stains']",2020/10/31 06:00,2021/09/08 06:00,['2020/10/30 05:33'],"['2020/10/30 05:33 [entrez]', '2020/10/31 06:00 [pubmed]', '2021/09/08 06:00 [medline]']","['S0272-2712(20)30066-4 [pii]', '10.1016/j.cll.2020.08.012 [doi]']",ppublish,Clin Lab Med. 2020 Dec;40(4):565-585. doi: 10.1016/j.cll.2020.08.012. Epub 2020 Oct 6.,['Disclosure The author has nothing to disclose.'],,,,,,,,,,,,,,,,
10880303,NLM,MEDLINE,20000912,20220317,1058-4838 (Print) 1058-4838 (Linking),30,6,2000 Jun,Epidemiology and unique aspects of aging and infectious diseases.,931-3,,The elderly population will grow rapidly over the next 25 years. The majority of patients with serious or life-threatening infections will be old. It is imperative that primary care physicians and infectious diseases specialists become aware of and knowledgeable about the special and unique aspects of infections in the geriatric population.,,"['Yoshikawa, T T']",['Yoshikawa TT'],"['Department of Internal Medicine, Charles R. Drew University of Medicine and Science and Martin Luther King, Jr.-Charles R. Drew Medical Center, Los Angeles, CA 90059, USA. toyoshik@cdrewu.edu']",['eng'],"['Journal Article', 'Review']",20000630,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Aged', 'Aged, 80 and over', 'Aging/*physiology', 'Anti-Bacterial Agents/adverse effects', 'Communicable Diseases/drug therapy/*epidemiology/physiopathology', 'Female', 'Humans', 'Male']",,,,2000/07/06 11:00,2000/09/19 11:01,['2000/07/06 11:00'],"['2000/07/06 11:00 [pubmed]', '2000/09/19 11:01 [medline]', '2000/07/06 11:00 [entrez]']","['CID000033 [pii]', '10.1086/313792 [doi]']",ppublish,Clin Infect Dis. 2000 Jun;30(6):931-3. doi: 10.1086/313792. Epub 2000 Jun 30.,,,['0 (Anti-Bacterial Agents)'],,,33,,,,,,,,,,,
29498313,NLM,MEDLINE,20190205,20190215,1464-5157 (Electronic) 0265-6736 (Linking),34,2,2018 Mar,Introduction to the special issue on thermal therapy and infectious diseases.,133-134,10.1080/02656736.2018.1424947 [doi],,,"['Chopra, Rajiv', 'Levi-Polyachenko, Nicole', 'Smeltzer, Mark S']","['Chopra R', 'Levi-Polyachenko N', 'Smeltzer MS']","['a Radiology , University of Texas Southwestern Medical Center , Dallas , TX , USA.', 'b Advanced Imaging Research Center , University of Texas Southwestern Medical Center , Dallas , TX , USA.', 'c Plastic and Reconstructive Surgery , Wake Forest University Health Sciences , Winston Salem , NC , USA.', 'd Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.']",['eng'],['Editorial'],,England,Int J Hyperthermia,"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group",8508395,IM,"['Communicable Diseases/pathology/*therapy', 'Humans']",,,,2018/03/03 06:00,2019/02/06 06:00,['2018/03/03 06:00'],"['2018/03/03 06:00 [entrez]', '2018/03/03 06:00 [pubmed]', '2019/02/06 06:00 [medline]']",['10.1080/02656736.2018.1424947 [doi]'],ppublish,Int J Hyperthermia. 2018 Mar;34(2):133-134. doi: 10.1080/02656736.2018.1424947.,,,,,,,,,,,,,,,,,
31216079,NLM,MEDLINE,20200818,20200818,1399-0012 (Electronic) 0902-0063 (Linking),33,9,2019 Sep,Foreword: 4th edition of the American Society of Transplantation Infectious Diseases Guidelines.,e13642,10.1111/ctr.13642 [doi],,,"['Green, Michael', 'Blumberg, Emily A', 'Danziger-Isakov, Lara', 'Huprikar, Shirish', 'Kotton, Camille Nelson', 'Kumar, Deepali']","['Green M', 'Blumberg EA', 'Danziger-Isakov L', 'Huprikar S', 'Kotton CN', 'Kumar D']","[""Division of Infectious Diseases, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania."", 'Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.', ""Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio."", 'Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.', 'Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.', 'Medicine, Transplant Infectious Diseases, University Health Network, Toronto, Ontario.']",['eng'],['Introductory Journal Article'],20190704,Denmark,Clin Transplant,Clinical transplantation,8710240,IM,"['Communicable Diseases/diagnosis/etiology/*therapy', 'Humans', 'Organ Transplantation/*adverse effects', 'Practice Guidelines as Topic/*standards', 'Societies, Medical']",,['NOTNLM'],"['Guidelines', 'infectious complications', 'transplant infections']",2019/06/20 06:00,2020/08/19 06:00,['2019/06/20 06:00'],"['2019/06/06 00:00 [received]', '2019/06/10 00:00 [accepted]', '2019/06/20 06:00 [pubmed]', '2020/08/19 06:00 [medline]', '2019/06/20 06:00 [entrez]']",['10.1111/ctr.13642 [doi]'],ppublish,Clin Transplant. 2019 Sep;33(9):e13642. doi: 10.1111/ctr.13642. Epub 2019 Jul 4.,,"['ORCID: 0000-0002-6011-2894', 'ORCID: 0000-0002-5691-5221', 'ORCID: 0000-0003-1961-0477']",,,,,,,,,,,,,,,
9713885,NLM,MEDLINE,19980914,20051116,0253-1933 (Print) 0253-1933 (Linking),17,2,1998 Aug,The role and importance of veterinary laboratories in the prevention and control of infectious diseases of animals.,405-10,,"Veterinary laboratories which deal with infectious diseases form three groups according to the tasks for which they are responsible. The first group includes central or national veterinary laboratories, national or international reference laboratories, high-security laboratories, district regional or state veterinary diagnostic laboratories. The major role of these laboratories is to assist national Veterinary Services in diagnosing infectious animal diseases. The second group comprises laboratories that produce veterinary diagnostic kits and those that produce veterinary vaccines. The third group is composed of veterinary research laboratories, which generally concentrate on basic research and do not contribute directly to the diagnosis and control of infectious animal diseases. The author describes the objectives of each of the three groups of laboratories.",,"['Truszczynski, M J']",['Truszczynski MJ'],"['National Veterinary Institute, Pulawy, Poland.']",['eng'],"['Journal Article', 'Review']",,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/diagnosis/*veterinary', '*Laboratories', '*Research', '*Veterinary Medicine']",,,,1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']",,ppublish,Rev Sci Tech. 1998 Aug;17(2):405-10.,,,,,,6,,,,,,,,,,,
20117538,NLM,MEDLINE,20100504,20100201,1558-4240 (Electronic) 0749-0720 (Linking),26,1,2010 Mar,Preface. The leaders in the field of bovine infectious diseases.,xiii-xiv,10.1016/j.cvfa.2009.11.001 [doi],,,"['Kapil, Sanjay', 'McVey, D Scott']","['Kapil S', 'McVey DS']",,['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Vet Clin North Am Food Anim Pract,The Veterinary clinics of North America. Food animal practice,8511905,IM,"['Animals', 'Cattle', 'Cattle Diseases/*epidemiology/microbiology/virology', 'Communicable Diseases/microbiology/*veterinary/virology']",,,,2010/02/02 06:00,2010/05/05 06:00,['2010/02/02 06:00'],"['2010/02/02 06:00 [entrez]', '2010/02/02 06:00 [pubmed]', '2010/05/05 06:00 [medline]']","['S0749-0720(09)00111-X [pii]', '10.1016/j.cvfa.2009.11.001 [doi]']",ppublish,Vet Clin North Am Food Anim Pract. 2010 Mar;26(1):xiii-xiv. doi: 10.1016/j.cvfa.2009.11.001.,,,,,,,,,,,,,,,,,
32942503,NLM,MEDLINE,20210701,20210701,2470-0053 (Electronic) 2470-0045 (Linking),102,2-1,2020 Aug,Wealth distribution under the spread of infectious diseases.,022303,10.1103/PhysRevE.102.022303 [doi],"We develop a mathematical framework to study the economic impact of infectious diseases by integrating epidemiological dynamics with a kinetic model of wealth exchange. The multiagent description leads to the study of the evolution over time of a system of kinetic equations for the wealth densities of susceptible, infectious, and recovered individuals, whose proportions are driven by a classical compartmental model in epidemiology. Explicit calculations show that the spread of the disease seriously affects the distribution of wealth, which, unlike the situation in the absence of epidemics, can converge toward a stationary state with a bimodal form. Furthermore, simulations confirm the ability of the model to describe different phenomenon characteristics of economic trends in situations compromised by the rapid spread of an epidemic, such as the unequal impact on the various wealth classes and the risk of a shrinking middle class.",,"['Dimarco, Giacomo', 'Pareschi, Lorenzo', 'Toscani, Giuseppe', 'Zanella, Mattia']","['Dimarco G', 'Pareschi L', 'Toscani G', 'Zanella M']","['Department of Mathematics and Computer Science, University of Ferrara, Via N. Machiavelli 35, 44121 Ferrara, Italy.', 'Department of Mathematics and Computer Science, University of Ferrara, Via N. Machiavelli 35, 44121 Ferrara, Italy.', 'Department of Mathematics ""F. Casorati"", University of Pavia, Via A. Ferrata 5, 27100 Pavia, Italy.', 'Department of Mathematics ""F. Casorati"", University of Pavia, Via A. Ferrata 5, 27100 Pavia, Italy.']",['eng'],['Journal Article'],,United States,Phys Rev E,Physical review. E,101676019,IM,"['Communicable Diseases/*economics/epidemiology/*transmission', 'Disease Susceptibility', 'Humans', 'Kinetics', '*Models, Theoretical', '*Socioeconomic Factors']",,,,2020/09/19 06:00,2021/07/02 06:00,['2020/09/18 01:00'],"['2020/04/29 00:00 [received]', '2020/07/13 00:00 [accepted]', '2020/09/18 01:00 [entrez]', '2020/09/19 06:00 [pubmed]', '2021/07/02 06:00 [medline]']",['10.1103/PhysRevE.102.022303 [doi]'],ppublish,Phys Rev E. 2020 Aug;102(2-1):022303. doi: 10.1103/PhysRevE.102.022303.,,,,,,,,,,,,,,,,,
11294731,NLM,MEDLINE,20010712,20190607,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),7,2,2001 Mar-Apr,Molecular approaches to diagnosing and managing infectious diseases: practicality and costs.,312-8,,"As molecular techniques for identifying and detecting microorganisms in the clinical microbiology laboratory have become routine, questions about the cost of these techniques and their contribution to patient care need to be addressed. Molecular diagnosis is most appropriate for infectious agents that are difficult to detect, identify, or test for susceptibility in a timely fashion with conventional methods.",,"['Pfaller, M A']",['Pfaller MA'],"['University of Iowa College of Medicine, Iowa City, Iowa 52242, USA. michael-pfaller@uiowa.edu']",['eng'],"['Journal Article', 'Review']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Clinical Laboratory Techniques', 'Communicable Diseases/*diagnosis/*therapy', 'Disease Management', 'Health Care Costs']",PMC2631730,,,2001/04/11 10:00,2001/07/13 10:01,['2001/04/11 10:00'],"['2001/04/11 10:00 [pubmed]', '2001/07/13 10:01 [medline]', '2001/04/11 10:00 [entrez]']",['10.3201/eid0702.010234 [doi]'],ppublish,Emerg Infect Dis. 2001 Mar-Apr;7(2):312-8. doi: 10.3201/eid0702.010234.,,,,,,,,,,,,,,,,,
16697238,NLM,MEDLINE,20060921,20161020,1286-4579 (Print) 1286-4579 (Linking),8,6,2006 May,Introduction: genomic approaches in infectious diseases.,1611-2,,,,"['Schnappinger, Dirk', 'Ehrt, Sabine']","['Schnappinger D', 'Ehrt S']",,['eng'],['Editorial'],20060127,France,Microbes Infect,Microbes and infection,100883508,IM,"['Communicable Diseases/*genetics/microbiology/parasitology', '*Genomics', 'Humans']",,,,2006/05/16 09:00,2006/09/22 09:00,['2006/05/16 09:00'],"['2005/11/08 00:00 [received]', '2005/11/30 00:00 [accepted]', '2006/05/16 09:00 [pubmed]', '2006/09/22 09:00 [medline]', '2006/05/16 09:00 [entrez]']","['S1286-4579(06)00005-0 [pii]', '10.1016/j.micinf.2005.11.021 [doi]']",ppublish,Microbes Infect. 2006 May;8(6):1611-2. doi: 10.1016/j.micinf.2005.11.021. Epub 2006 Jan 27.,,,,,,,,,,,,,,,,,
10596983,NLM,MEDLINE,19991230,20111117,1684-1182 (Print) 1684-1182 (Linking),31,2,1998 Jun,Current outlook of infectious diseases in Taiwan.,73-83,,"The ""emerging"" infectious diseases have received global attention. Taiwan is a country which is going through the process of becoming ""developed"" from being ""developing"". If we compare five leading causes of death in 1952 and in 1993, three were infectious diseases in 1952 and there was none in 1993. And yet today, infectious diseases remain a major problem in this country as well in every country in the world, whether developing or developed. Some of the problems Taiwan faces are old problems with old faces. They have never been adequately solved because the societal and environmental sanitary infrastructure does not ensure proper sewage disposal, safe potable water and freedom from dangerous vectors. Examples are the diarrheal diseases, parasitic diseases, scrub typhus and Japanese encephalitis. Some of the Taiwan's problems are caused by old agents which present a new face. Mortality from tuberculosis took a dramatic and gratifying plunge in the last fifty years. Yet tuberculosis is ever present and a constant public health threat. Dengue has become a problem again because of a world breakdown in the control of the mosquito, Aedes egypti, and it is partly contributed to by increased urbanization and world travel. The problem of antibiotic resistant bacteria causing hospital acquired and community acquired infections is probably the most serious ""new"" problem. The most important cause is excessive and indiscriminate use of antibiotics in the community and in hospitals. We propose the establishment of ""Bacterial Infections Reference Laboratory"" at the National Health Research Institutes to be a national facility to study the epidemiology and control of antibiotic resistance. All infectious diseases require a rigorous system of surveillance, and precise etiological diagnosis before they can be treated or prevented. This should be kept clearly in mind when one considers the changing role of the infectious disease physician in Taiwan in the face of unsolved disease problems and a new health care system. There is inadequate attention to precise microbiological definition of most infectious diseases in Taiwan. The community of infectious disease specialists may well redirect its attention to improving the competence and utilization of microbiological laboratory diagnosis.",,"['Ho, M']",['Ho M'],"['Division of Clinical Research, National Health Research Institutes, Taipei, Taiwan, ROC.']",['eng'],"['Journal Article', 'Review']",,England,J Microbiol Immunol Infect,"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi",100956211,IM,"['Clinical Laboratory Techniques', 'Communicable Diseases/drug therapy/*epidemiology/etiology', 'Cross Infection', 'Drug Resistance, Microbial', 'Humans', 'Taiwan/epidemiology']",,,,1999/12/22 00:00,1999/12/22 00:01,['1999/12/22 00:00'],"['1999/12/22 00:00 [pubmed]', '1999/12/22 00:01 [medline]', '1999/12/22 00:00 [entrez]']",,ppublish,J Microbiol Immunol Infect. 1998 Jun;31(2):73-83.,,,,,,39,,,,,,,,,,,
10214108,NLM,MEDLINE,19990506,20181113,0093-0415 (Print) 0093-0415 (Linking),170,3,1999 Mar,"Identifying infectious diseases in prisons: surveillance, protection, and intervention.",177,,,,"['White, M C']",['White MC'],,['eng'],['Editorial'],,United States,West J Med,The Western journal of medicine,0410504,IM,"['*Communicable Diseases/diagnosis/epidemiology/therapy', 'Humans', 'Population Surveillance', '*Prisoners']",PMC1305539,,,1999/04/24 00:00,1999/04/24 00:01,['1999/04/24 00:00'],"['1999/04/24 00:00 [pubmed]', '1999/04/24 00:01 [medline]', '1999/04/24 00:00 [entrez]']",,ppublish,West J Med. 1999 Mar;170(3):177.,,,,,,,,,,,,,,,,,
37958882,NLM,MEDLINE,20231115,20231117,1422-0067 (Electronic) 1422-0067 (Linking),24,21,2023 Nov 2,"Editorial of the Special Issue ""Molecular Medicine Applications in Infectious Diseases: Latest Innovations"".",,10.3390/ijms242115899 [doi] 15899,"The integration of molecular approaches in medicine allows for a more precise understanding of the mechanisms underlying infectious diseases, paving the way for targeted therapies, personalized medicine, and the development of new diagnostic tools [...].",,"['Hassan, Sherif T S']",['Hassan STS'],"['Department of Applied Ecology, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Kamycka 129, 16500 Prague, Czech Republic.']",['eng'],['Editorial'],20231102,Switzerland,Int J Mol Sci,International journal of molecular sciences,101092791,IM,"['Humans', '*Molecular Medicine', 'Precision Medicine', '*Communicable Diseases/diagnosis/drug therapy']",PMC10647289,,,2023/11/14 06:43,2023/11/15 06:42,['2023/11/14 02:10'],"['2023/10/15 00:00 [received]', '2023/10/26 00:00 [revised]', '2023/10/31 00:00 [accepted]', '2023/11/15 06:42 [medline]', '2023/11/14 06:43 [pubmed]', '2023/11/14 02:10 [entrez]']","['ijms242115899 [pii]', 'ijms-24-15899 [pii]', '10.3390/ijms242115899 [doi]']",epublish,Int J Mol Sci. 2023 Nov 2;24(21):15899. doi: 10.3390/ijms242115899.,['The author declares no conflict of interest.'],['ORCID: 0000-0003-3922-2738'],,,,,,,,,,,,,,,
23817896,NLM,MEDLINE,20140310,20130731,1432-1289 (Electronic) 0020-9554 (Linking),54,8,2013 Aug,[Clinical infectious diseases : interdisciplinary and unique].,909-10,10.1007/s00108-012-3138-y [doi],,,"['Battegay, M', 'Fatkenheuer, G', 'Kern, W V']","['Battegay M', 'Fatkenheuer G', 'Kern WV']","['Klinik fur Infektiologie & Spitalhygiene, Universitatsspital Basel, Petersgraben 4, 4031, Basel, Schweiz, manuel.battegay@usb.ch.']",['ger'],['Introductory Journal Article'],,Germany,Internist (Berl),Der Internist,0264620,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Europe', 'Internal Medicine/*trends', 'Patient Care Team/*trends', 'United States']",,,,2013/07/03 06:00,2014/03/13 06:00,['2013/07/03 06:00'],"['2013/07/03 06:00 [entrez]', '2013/07/03 06:00 [pubmed]', '2014/03/13 06:00 [medline]']",['10.1007/s00108-012-3138-y [doi]'],ppublish,Internist (Berl). 2013 Aug;54(8):909-10. doi: 10.1007/s00108-012-3138-y.,,,,,,,,,Klinische Infektiologie : Interdisziplinar und einzigartig.,,,,,,,,
17952041,NLM,MEDLINE,20080122,20101118,1529-2908 (Print) 1529-2908 (Linking),8,11,2007 Nov,"Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases.",1165-71,,"The field of human genetics of infectious diseases defines the genes and alleles rendering individuals (clinical genetics) and populations (epidemiological genetics) vulnerable to infection, and studies those selected by previous infections (evolutionary genetics). These disciplines--clinical, epidemiological and evolutionary genetics-delineate the redundant and nonredundant functions of host defense genes for past and present survival in natura--in natural ecosystems governed by natural selection. These disciplines, in other words, assess the ecologically relevant and evolutionarily selected roles of human genes and alleles in protective immunity to diverse and evolving microorganisms. The genetic dissection of human immunity to infection in natura provides unique immunological insight, making it an indispensable complement to experimental immunology in vitro and in vivo in plants and animals.",,"['Quintana-Murci, Lluis', 'Alcais, Alexandre', 'Abel, Laurent', 'Casanova, Jean-Laurent']","['Quintana-Murci L', 'Alcais A', 'Abel L', 'Casanova JL']","['Human Evolutionary Genetics Unit, Centre National de la Recherche Scientifique URA3012, Pasteur Institute, 75015 Paris, France.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Nat Immunol,Nature immunology,100941354,IM,"['Aged', '*Biological Evolution', 'Communicable Diseases/*epidemiology/*genetics/*immunology', 'Humans']",,,,2007/10/24 09:00,2008/01/23 09:00,['2007/10/24 09:00'],"['2007/10/24 09:00 [pubmed]', '2008/01/23 09:00 [medline]', '2007/10/24 09:00 [entrez]']","['ni1535 [pii]', '10.1038/ni1535 [doi]']",ppublish,Nat Immunol. 2007 Nov;8(11):1165-71. doi: 10.1038/ni1535.,,,,,,100,,,,,,,,,,,
31753764,NLM,MEDLINE,20200625,20200625,1474-4457 (Electronic) 1473-3099 (Linking),20,2,2020 Feb,Rethinking the population attributable fraction for infectious diseases.,155-157,S1473-3099(19)30618-8 [pii] 10.1016/S1473-3099(19)30618-8 [doi],,,"['Mishra, Sharmistha', 'Baral, Stefan D']","['Mishra S', 'Baral SD']","[""Division of Infectious Diseases, Department of Medicine, Institute of Medical Sciences and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, ON M5B 1T8, Canada. Electronic address: sharmistha.mishra@utoronto.ca."", 'Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.']",['eng'],['Journal Article'],20191118,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Communicable Diseases/*epidemiology/*pathology', 'Female', 'Humans', 'Male', 'Risk Factors']",,,,2019/11/23 06:00,2020/06/26 06:00,['2019/11/23 06:00'],"['2019/10/15 00:00 [received]', '2019/10/18 00:00 [accepted]', '2019/11/23 06:00 [pubmed]', '2020/06/26 06:00 [medline]', '2019/11/23 06:00 [entrez]']","['S1473-3099(19)30618-8 [pii]', '10.1016/S1473-3099(19)30618-8 [doi]']",ppublish,Lancet Infect Dis. 2020 Feb;20(2):155-157. doi: 10.1016/S1473-3099(19)30618-8. Epub 2019 Nov 18.,,,,,,,,,,,,,,,,,
18323583,NLM,MEDLINE,20080721,20211020,1084-2020 (Print) 1930-6180 (Electronic) 1084-2020 (Linking),49,2,2008,Macaque models of human infectious disease.,220-55,,"Macaques have served as models for more than 70 human infectious diseases of diverse etiologies, including a multitude of agents-bacteria, viruses, fungi, parasites, prions. The remarkable diversity of human infectious diseases that have been modeled in the macaque includes global, childhood, and tropical diseases as well as newly emergent, sexually transmitted, oncogenic, degenerative neurologic, potential bioterrorism, and miscellaneous other diseases. Historically, macaques played a major role in establishing the etiology of yellow fever, polio, and prion diseases. With rare exceptions (Chagas disease, bartonellosis), all of the infectious diseases in this review are of Old World origin. Perhaps most surprising is the large number of tropical (16), newly emergent (7), and bioterrorism diseases (9) that have been modeled in macaques. Many of these human diseases (e.g., AIDS, hepatitis E, bartonellosis) are a consequence of zoonotic infection. However, infectious agents of certain diseases, including measles and tuberculosis, can sometimes go both ways, and thus several human pathogens are threats to nonhuman primates including macaques. Through experimental studies in macaques, researchers have gained insight into pathogenic mechanisms and novel treatment and vaccine approaches for many human infectious diseases, most notably acquired immunodeficiency syndrome (AIDS), which is caused by infection with human immunodeficiency virus (HIV). Other infectious agents for which macaques have been a uniquely valuable resource for biomedical research, and particularly vaccinology, include influenza virus, paramyxoviruses, flaviviruses, arenaviruses, hepatitis E virus, papillomavirus, smallpox virus, Mycobacteria, Bacillus anthracis, Helicobacter pylori, Yersinia pestis, and Plasmodium species. This review summarizes the extensive past and present research on macaque models of human infectious disease.",,"['Gardner, Murray B', 'Luciw, Paul A']","['Gardner MB', 'Luciw PA']","['Center for Comparative Medicine, University of California, Davis, CA 95616, USA. mbgardner@ucdavis.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",,England,ILAR J,ILAR journal,9516416,IM,"['Animals', 'Communicable Diseases/*microbiology/pathology/*virology', '*Disease Models, Animal', 'Humans', 'Macaca']",PMC7108592,,,2008/03/08 09:00,2008/07/22 09:00,['2008/03/08 09:00'],"['2008/03/08 09:00 [pubmed]', '2008/07/22 09:00 [medline]', '2008/03/08 09:00 [entrez]']",['10.1093/ilar.49.2.220 [doi]'],ppublish,ILAR J. 2008;49(2):220-55. doi: 10.1093/ilar.49.2.220.,,,,,,,"['R24 RR022907/RR/NCRR NIH HHS/United States', 'RR022907/RR/NCRR NIH HHS/United States', 'RR00169/RR/NCRR NIH HHS/United States', 'P51 RR000169/RR/NCRR NIH HHS/United States', 'U54-AI065359/AI/NIAID NIH HHS/United States', 'U54 AI065359/AI/NIAID NIH HHS/United States']",,,,,,,,,,
23204016,NLM,MEDLINE,20130528,20121203,1399-3003 (Electronic) 0903-1936 (Linking),40,6,2012 Dec,Emerging and re-emerging infectious diseases: a continuous challenge for Europe.,1312-4,10.1183/09031936.00111712 [doi],,,"['Quaglio, Gianluca', 'Demotes-Mainard, Jacques', 'Loddenkemper, Robert']","['Quaglio G', 'Demotes-Mainard J', 'Loddenkemper R']",,['eng'],['Editorial'],,England,Eur Respir J,The European respiratory journal,8803460,IM,"['Bacterial Infections/diagnosis/prevention & control', '*Communicable Disease Control', 'Communicable Diseases/*diagnosis/epidemiology', 'Communicable Diseases, Emerging/*diagnosis/epidemiology/prevention & control', 'Drug Resistance, Microbial', 'Europe', 'Health Care Costs', 'Health Policy', 'Humans', 'Tuberculosis/diagnosis/prevention & control']",,,,2012/12/04 06:00,2013/05/29 06:00,['2012/12/04 06:00'],"['2012/12/04 06:00 [entrez]', '2012/12/04 06:00 [pubmed]', '2013/05/29 06:00 [medline]']","['40/6/1312 [pii]', '10.1183/09031936.00111712 [doi]']",ppublish,Eur Respir J. 2012 Dec;40(6):1312-4. doi: 10.1183/09031936.00111712.,,,,,,,,,,,,,,,,,
15325056,NLM,MEDLINE,20041207,20210119,0272-2712 (Print) 1557-9832 (Electronic) 0272-2712 (Linking),24,3,2004 Sep,Major factors affecting the emergence and re-emergence of infectious diseases.,"559-86, v",,"The diversity of infectious disease threats currently facing humanity is unprecedented because of the remarkable emergence and reemergence of pathogens worldwide. Because of population mobility, globalization of commerce and the food supply, and the effects of the HIV/AIDS pandemic, infections in the developing world must be addressed to prevent infections in industrialized countries. Because pathogens do not recognize national boundaries, the rapidity with which individuals can circumnavigate the globe incubating infections makes the control of communicable diseases an enormous challenge for governments as well as for the public and primary health care systems. A global strategy for dealing with infectious disease threats must be developed and implemented as soon as possible.",,"['Church, Deirdre L']",['Church DL'],"['Department of Pathology and Laboratory Medicine, University of Calgary, Faculty of Medicine, Health Sciences Centre, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. deirdre.church@cls.ab.ca']",['eng'],"['Journal Article', 'Review']",,United States,Clin Lab Med,Clinics in laboratory medicine,8100174,IM,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/*transmission', 'Communicable Diseases, Emerging/*epidemiology/*transmission', 'Global Health', 'Humans']",PMC7119055,,,2004/08/25 05:00,2004/12/16 09:00,['2004/08/25 05:00'],"['2004/08/25 05:00 [pubmed]', '2004/12/16 09:00 [medline]', '2004/08/25 05:00 [entrez]']","['S0272271204000642 [pii]', '10.1016/j.cll.2004.05.008 [doi]']",ppublish,"Clin Lab Med. 2004 Sep;24(3):559-86, v. doi: 10.1016/j.cll.2004.05.008.",,,,,,,,,,,,,,,,,
11229834,NLM,MEDLINE,20010802,20220408,1058-4838 (Print) 1058-4838 (Linking),32,5,2001 Mar 1,Infectious diseases: considerations for the 21st century.,675-85,,"The discipline of infectious diseases will assume added prominence in the 21st century in both developed and developing nations. To an unprecedented extent, issues related to infectious diseases in the context of global health are on the agendas of world leaders, health policymakers, and philanthropies. This attention has focused both on scientific challenges such as vaccine development and on the deleterious effects of infectious diseases on economic development and political stability. Interest in global health has led to increasing levels of financial support, which, combined with recent technological advances, provide extraordinary opportunities for infectious disease research in the 21st century. The sequencing of human and microbial genomes and advances in functional genomics will underpin significant progress in many areas, including understanding human predisposition and susceptibility to disease, microbial pathogenesis, and the development new diagnostics, vaccines, and therapies. Increasingly, infectious disease research will be linked to the development of the medical infrastructure and training needed in developing countries to translate scientific advances into operational reality.",,"['Fauci, A S']",['Fauci AS'],"['National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. af10r@nih.gov']",['eng'],['Lecture'],20010223,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Bioterrorism', 'Communicable Disease Control/economics', '*Communicable Diseases/economics/epidemiology', 'Forecasting', '*Global Health', 'Humans', 'Politics', 'Research']",,,,2001/03/07 10:00,2001/08/03 10:01,['2001/03/07 10:00'],"['2000/11/17 00:00 [received]', '2001/03/07 10:00 [pubmed]', '2001/08/03 10:01 [medline]', '2001/03/07 10:00 [entrez]']","['CID001539 [pii]', '10.1086/319235 [doi]']",ppublish,Clin Infect Dis. 2001 Mar 1;32(5):675-85. doi: 10.1086/319235. Epub 2001 Feb 23.,,,,,,,,,,,,,,,,,
25791932,NLM,MEDLINE,20160408,20211203,1567-7257 (Electronic) 1567-1348 (Linking),32,,2015 Jun,Montpellier Infectious Diseases - Pole Rabelais (MID) 3rd annual meeting (2014).,161-4,S1567-1348(15)00091-X [pii] 10.1016/j.meegid.2015.03.007 [doi],"For the third time, teams belonging to the ""Montpellier Infectious Diseases"" network in the Rabelais BioHealth Cluster held their annual meeting on the 27th and 28th of November in Montpellier, France. While the 2012 meeting was focused on the cooperation between the local force tasks in biomedical and medical chemistry and presented the interdisciplinary research programs designed to fight against virus, bacteria and parasites, the 2014 edition of the meeting was focused on the translational research in infectious diseases and highlighted the bench-to-clinic strategies designed by academic and private research groups in the Montpellier area.",['Copyright (c) 2015 Elsevier B.V.'],"['Besteiro, Sebastien', 'Blanc-Potard, Anne', 'Bonazzi, Matteo', 'Briant, Laurence', 'Chazal, Nathalie', 'Cornillot, Emmanuel', 'Lentini, Gaelle', 'Matkovic, Roy', 'Sanosyan, Armen', 'Tuaillon, Edouard', 'Van de Perre, Philippe']","['Besteiro S', 'Blanc-Potard A', 'Bonazzi M', 'Briant L', 'Chazal N', 'Cornillot E', 'Lentini G', 'Matkovic R', 'Sanosyan A', 'Tuaillon E', 'Van de Perre P']","['Dynamique des Interactions Membranaires Normales et Pathologiques (DIMNP) UMR 5235 CNRS - Universite de Montpellier, Montpellier, France.', 'Dynamique des Interactions Membranaires Normales et Pathologiques (DIMNP) UMR 5235 CNRS - Universite de Montpellier, Montpellier, France.', ""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), FRE 3689 CNRS - Universite de Montpellier, Montpellier, France."", ""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), FRE 3689 CNRS - Universite de Montpellier, Montpellier, France."", ""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), FRE 3689 CNRS - Universite de Montpellier, Montpellier, France. Electronic address: nathalie.chazal@cpbs.cnrs.fr."", ""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), FRE 3689 CNRS - Universite de Montpellier, Montpellier, France."", 'Dynamique des Interactions Membranaires Normales et Pathologiques (DIMNP) UMR 5235 CNRS - Universite de Montpellier, Montpellier, France.', ""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), FRE 3689 CNRS - Universite de Montpellier, Montpellier, France."", 'Inserm U1058, Universite Montpellier & CHRU de Montpellier, Departement de Bacteriologie-Virologie & Institut de Recherche en Biotherapie, Montpellier, France.', 'Inserm U1058, Universite Montpellier & CHRU de Montpellier, Departement de Bacteriologie-Virologie & Institut de Recherche en Biotherapie, Montpellier, France.', 'Inserm U1058, Universite Montpellier & CHRU de Montpellier, Departement de Bacteriologie-Virologie & Institut de Recherche en Biotherapie, Montpellier, France.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20150316,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Bacterial Infections/epidemiology/genetics/microbiology', 'Communicable Diseases/drug therapy/epidemiology/*genetics', 'Communicable Diseases, Emerging/epidemiology', 'Congresses as Topic', 'Drug Design', 'Humans', 'Parasitic Diseases/epidemiology/genetics/parasitology', 'Translational Research, Biomedical', 'Virus Diseases/epidemiology/genetics/virology']",,['NOTNLM'],"['Infectious diseases', 'Multidisciplinary approaches', 'Translational research']",2015/03/21 06:00,2016/04/09 06:00,['2015/03/21 06:00'],"['2015/02/18 00:00 [received]', '2015/03/05 00:00 [revised]', '2015/03/07 00:00 [accepted]', '2015/03/21 06:00 [entrez]', '2015/03/21 06:00 [pubmed]', '2016/04/09 06:00 [medline]']","['S1567-1348(15)00091-X [pii]', '10.1016/j.meegid.2015.03.007 [doi]']",ppublish,Infect Genet Evol. 2015 Jun;32:161-4. doi: 10.1016/j.meegid.2015.03.007. Epub 2015 Mar 16.,,,,,,,,,,,,,,,,,
22568709,NLM,MEDLINE,20120830,20120509,1746-0921 (Electronic) 1746-0913 (Linking),7,5,2012 May,Mass gatherings and the implications for the spread of infectious diseases.,551-3,10.2217/fmb.12.35 [doi],,,"['Kok, Jen', 'Blyth, Christopher C', 'Dwyer, Dominic E']","['Kok J', 'Blyth CC', 'Dwyer DE']",,['eng'],['Editorial'],,England,Future Microbiol,Future microbiology,101278120,IM,"['Communicable Diseases/*epidemiology/*transmission', '*Crowding', '*Disease Transmission, Infectious', 'Humans']",,,,2012/05/10 06:00,2012/08/31 06:00,['2012/05/10 06:00'],"['2012/05/10 06:00 [entrez]', '2012/05/10 06:00 [pubmed]', '2012/08/31 06:00 [medline]']",['10.2217/fmb.12.35 [doi]'],ppublish,Future Microbiol. 2012 May;7(5):551-3. doi: 10.2217/fmb.12.35.,,,,,,,,,,,,,,,,,
37287815,NLM,MEDLINE,20230609,20230613,2296-2565 (Electronic) 2296-2565 (Linking),11,,2023,"Editorial: Advances in the diagnosis and genomic research of surveillance-response activities in emerging, re-emerging, and unidentified infectious diseases.",1182918,10.3389/fpubh.2023.1182918 [doi] 1182918,,,"['Wang, Chenxi', 'Feng, Xinyu', 'Feng, Jun', 'Chen, Hui', 'Chen, Tianmu', 'Yin, Kun']","['Wang C', 'Feng X', 'Feng J', 'Chen H', 'Chen T', 'Yin K']","['School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.', 'One Health Center, Shanghai Jiao Tong University-The University of Edinburgh, Shanghai, China.', 'School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.', 'National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), Shanghai, China.', 'NHC Key Laboratory of Parasite and Vector Biology, Shanghai, China.', 'World Health Organization Collaborating Centre for Tropical Diseases, Shanghai, China.', 'National Center for International Research on Tropical Diseases, Shanghai, China.', 'Department of Biology, College of Life Sciences, Inner Mongolia University, Hohhot, China.', 'Shanghai Municipal Center for Diseases Control and Prevention, Shanghai, China.', ""Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States."", 'State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, Fujian, China.', 'School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.', 'One Health Center, Shanghai Jiao Tong University-The University of Edinburgh, Shanghai, China.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",20230523,Switzerland,Front Public Health,Frontiers in public health,101616579,IM,"['Humans', '*Communicable Diseases/diagnosis', '*Communicable Diseases, Emerging/diagnosis', 'Genomics']",PMC10242166,['NOTNLM'],"['diagnosis', 'genomic research', 'infectious diseases', 'public health', 'surveillance']",2023/06/08 06:42,2023/06/09 06:42,['2023/06/08 04:24'],"['2023/03/09 00:00 [received]', '2023/05/12 00:00 [accepted]', '2023/06/09 06:42 [medline]', '2023/06/08 06:42 [pubmed]', '2023/06/08 04:24 [entrez]']",['10.3389/fpubh.2023.1182918 [doi]'],epublish,Front Public Health. 2023 May 23;11:1182918. doi: 10.3389/fpubh.2023.1182918. eCollection 2023.,"['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",,,,,,,"['Editorial on the Research Topic Advances in the diagnosis and genomic research of', 'surveillance-response activities in emerging, re-emerging, and unidentified', 'infectious diseases']",,,,,,,,,
10879634,NLM,MEDLINE,20001101,20190831,0300-8126 (Print) 0300-8126 (Linking),28,3,2000 May-Jun,Unusual presentations of infectious diseases.,129-31,,,,"['Ruef, C']",['Ruef C'],,['eng'],"['Editorial', 'Review']",,Germany,Infection,Infection,0365307,IM,"['Communicable Diseases/*diagnosis/etiology', '*Education, Medical', 'Education, Medical, Continuing', 'Humans', '*Specialization']",,,,2000/07/06 11:00,2001/02/28 10:01,['2000/07/06 11:00'],"['2000/07/06 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/07/06 11:00 [entrez]']",['10.1007/s150100050064 [doi]'],ppublish,Infection. 2000 May-Jun;28(3):129-31. doi: 10.1007/s150100050064.,,,,,,25,,,,,,,,,,,
30666925,NLM,MEDLINE,20190729,20200309,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),25,2,2019 Feb,International Biological Reference Preparations for Epidemic Infectious Diseases.,205-211,10.3201/eid2502.180798 [doi],"Recent years have seen unprecedented investment in research and development for countermeasures for high-threat pathogens, including specific and ambitious objectives for development of diagnostics, therapeutics, and vaccines. The inadequate availability of biological reference materials for these pathogens poses a genuine obstacle in pursuit of these objectives, and the lack of a comprehensive and equitable framework for developing reference materials is a weakness. We outline the need for internationally standardized biological materials for high-threat pathogens as a core element of global health security. We also outline the key components of a framework for addressing this deficiency.",,"['Rampling, Tommy', 'Page, Mark', 'Horby, Peter']","['Rampling T', 'Page M', 'Horby P']",,['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,"['Animals', 'Biological Specimen Banks/*standards', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/*epidemiology/etiology/therapy', 'Epidemics', 'Global Health', 'Humans', 'Informed Consent', 'Research', 'Vaccines', 'World Health Organization']",PMC6346470,['NOTNLM'],"['Ebola virus disease', 'Middle East respiratory syndrome coronavirus', 'World Health Organization', 'biological standardization', 'bioterrorism and preparedness', 'emerging infectious diseases', 'epidemic preparedness', 'global health security', 'infectious diseases', 'reference preparations', 'research and development', 'vaccines', 'viruses', 'zoonoses']",2019/01/23 06:00,2019/07/30 06:00,['2019/01/23 06:00'],"['2019/01/23 06:00 [entrez]', '2019/01/23 06:00 [pubmed]', '2019/07/30 06:00 [medline]']","['18-0798 [pii]', '10.3201/eid2502.180798 [doi]']",ppublish,Emerg Infect Dis. 2019 Feb;25(2):205-211. doi: 10.3201/eid2502.180798.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
33734349,NLM,MEDLINE,20210922,20210922,1943-2631 (Electronic) 0016-6731 (Print) 0016-6731 (Linking),217,4,2021 Apr 15,Why genetic selection to reduce the prevalence of infectious diseases is way more promising than currently believed.,,10.1093/genetics/iyab024 [doi] iyab024,"Genetic selection for improved disease resistance is an important part of strategies to combat infectious diseases in agriculture. Quantitative genetic analyses of binary disease status, however, indicate low heritability for most diseases, which restricts the rate of genetic reduction in disease prevalence. Moreover, the common liability threshold model suggests that eradication of an infectious disease via genetic selection is impossible because the observed-scale heritability goes to zero when the prevalence approaches zero. From infectious disease epidemiology, however, we know that eradication of infectious diseases is possible, both in theory and practice, because of positive feedback mechanisms leading to the phenomenon known as herd immunity. The common quantitative genetic models, however, ignore these feedback mechanisms. Here, we integrate quantitative genetic analysis of binary disease status with epidemiological models of transmission, aiming to identify the potential response to selection for reducing the prevalence of endemic infectious diseases. The results show that typical heritability values of binary disease status correspond to a very substantial genetic variation in disease susceptibility among individuals. Moreover, our results show that eradication of infectious diseases by genetic selection is possible in principle. These findings strongly disagree with predictions based on common quantitative genetic models, which ignore the positive feedback effects that occur when reducing the transmission of infectious diseases. Those feedback effects are a specific kind of Indirect Genetic Effects; they contribute substantially to the response to selection and the development of herd immunity (i.e., an effective reproduction ratio less than one).","['(c) The Author(s) 2021. Published by Oxford University Press on behalf of Genetics', 'Society of America.']","['Hulst, Andries D', 'de Jong, Mart C M', 'Bijma, Piter']","['Hulst AD', 'de Jong MCM', 'Bijma P']","['Quantitative Veterinary Epidemiology, Wageningen University & Research, 6700AH, Wageningen, The Netherlands.', 'Animal Breeding and Genomics Group, Wageningen University & Research, 6700AH, Wageningen, The Netherlands.', 'Quantitative Veterinary Epidemiology, Wageningen University & Research, 6700AH, Wageningen, The Netherlands.', 'Animal Breeding and Genomics Group, Wageningen University & Research, 6700AH, Wageningen, The Netherlands.']",['eng'],['Journal Article'],,United States,Genetics,Genetics,0374636,IM,"['Animals', 'Communicable Diseases/*genetics/immunology/veterinary', '*Disease Resistance', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Immunity, Herd', 'Livestock/*genetics', '*Models, Genetic', 'Prevalence', 'Quantitative Trait, Heritable', '*Selection, Genetic']",PMC8049556,['NOTNLM'],"['epidemiology', 'heritability', 'indirect genetic effect', 'infectious disease', 'quantitative genetics', 'response to selection']",2021/03/19 06:00,2021/09/23 06:00,['2021/03/18 12:46'],"['2020/12/23 00:00 [received]', '2021/02/05 00:00 [accepted]', '2021/03/19 06:00 [pubmed]', '2021/09/23 06:00 [medline]', '2021/03/18 12:46 [entrez]']","['6137839 [pii]', 'iyab024 [pii]', '10.1093/genetics/iyab024 [doi]']",ppublish,Genetics. 2021 Apr 15;217(4):iyab024. doi: 10.1093/genetics/iyab024.,,,,,,,,,,,,,,,,,
27681053,NLM,MEDLINE,20170720,20180424,1749-6632 (Electronic) 0077-8923 (Linking),1382,1,2016 Oct,Climate forcing and infectious disease transmission in urban landscapes: integrating demographic and socioeconomic heterogeneity.,44-55,10.1111/nyas.13229 [doi],"Urbanization and climate change are the two major environmental challenges of the 21st century. The dramatic expansion of cities around the world creates new conditions for the spread, surveillance, and control of infectious diseases. In particular, urban growth generates pronounced spatial heterogeneity within cities, which can modulate the effect of climate factors at local spatial scales in large urban environments. Importantly, the interaction between environmental forcing and socioeconomic heterogeneity at local scales remains an open area in infectious disease dynamics, especially for urban landscapes of the developing world. A quantitative and conceptual framework on urban health with a focus on infectious diseases would benefit from integrating aspects of climate forcing, population density, and level of wealth. In this paper, we review what is known about these drivers acting independently and jointly on urban infectious diseases; we then outline elements that are missing and would contribute to building such a framework.",['(c) 2016 New York Academy of Sciences.'],"['Santos-Vega, Mauricio', 'Martinez, Pamela P', 'Pascual, Mercedes']","['Santos-Vega M', 'Martinez PP', 'Pascual M']","['Ecology and Evolution Department, University of Chicago, Chicago, Illinois.', 'Ecology and Evolution Department, University of Chicago, Chicago, Illinois.', 'Ecology and Evolution Department, University of Chicago, Chicago, Illinois.']",['eng'],"['Journal Article', 'Review']",20160928,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,IM,"['Climate Change/*economics', 'Communicable Diseases/*economics/epidemiology/*transmission', 'Demography/economics/trends', 'Humans', '*Population Density', '*Socioeconomic Factors', 'Urban Population/trends', 'Urbanization/*trends']",,['NOTNLM'],"['climate', 'heterogeneity', 'infectious diseases', 'transmission models', 'urbanization']",2016/09/30 06:00,2017/07/21 06:00,['2016/09/30 06:00'],"['2016/06/13 00:00 [received]', '2016/08/15 00:00 [revised]', '2016/08/18 00:00 [accepted]', '2016/09/30 06:00 [pubmed]', '2017/07/21 06:00 [medline]', '2016/09/30 06:00 [entrez]']",['10.1111/nyas.13229 [doi]'],ppublish,Ann N Y Acad Sci. 2016 Oct;1382(1):44-55. doi: 10.1111/nyas.13229. Epub 2016 Sep 28.,,,,,,,,,,,,,,,,,
26026478,NLM,MEDLINE,20160201,20200403,1873-0442 (Electronic) 1477-8939 (Print) 1477-8939 (Linking),13,4,2015 Jul-Aug,Chinese travellers visiting friends and relatives--A review of infectious risks.,285-94,S1477-8939(15)00083-6 [pii] 10.1016/j.tmaid.2015.05.004 [doi],"BACKGROUND: Travellers are potential vectors in the transmission of infectious diseases across international borders. Travellers visiting friends and relatives (VFR) have a particularly high risk of acquiring certain infections during travel. Chinese VFR travellers account for a substantial proportion of all travel in Western countries with high migrant populations. METHODS: A literature review was undertaken regarding major infectious disease risks for VFR travellers visiting China. This included an examination of the previous pandemics arising in China, the likelihood of future outbreaks in China from H5N1 and H7N9 avian influenza viruses, the potential role of travellers in disease transmission, and the special risks for VFR travellers. RESULTS: China has been the origin of several influenza pandemics in past few decades, and the origin of several emerging infectious diseases with pandemic potential, including SARS. Travel to and from China has the potential for global spread of emergent infectious diseases, as seen in the SARS outbreak in 2003. For VFR travellers, the risk of other infectious diseases may also be greater in China compared to their countries of migration, including hepatitis A and B, dengue fever, typhoid, and other diseases. CONCLUSIONS: VFR travel to China may be associated with increased risk of acquiring a range of infectious diseases, and also poses a potential risk for importation of future pandemics to other countries. Chinese VFR travellers need to be cognisant of these risks and health professionals should consider educational interventions to minimise these risks.",['Copyright (c) 2015 Elsevier Ltd. All rights reserved.'],"['Ma, Tara', 'Heywood, Anita', 'MacIntyre, C Raina']","['Ma T', 'Heywood A', 'MacIntyre CR']","['School of Public Health and Community Medicine, UNSW Australia, Kensington, NSW, Australia. Electronic address: c.h.ma@student.unsw.edu.au.', 'School of Public Health and Community Medicine, UNSW Australia, Kensington, NSW, Australia. Electronic address: a.heywood@unsw.edu.au.', ""School of Public Health and Community Medicine, UNSW Australia, Kensington, NSW, Australia; National Centre for Immunisation Research and Surveillance (NCIRS), The Children's Hospital at Westmead, Westmead, Australia. Electronic address: r.macintyre@unsw.edu.au.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20150514,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,IM,"['China/epidemiology', '*Communicable Diseases/epidemiology/transmission', 'Communicable Diseases, Emerging', '*Disease Outbreaks', 'Humans', '*Risk', '*Travel']",PMC7110956,['NOTNLM'],"['China', 'Emerging infectious diseases', 'Hong Kong', 'Infectious diseases', 'Travel medicine']",2015/06/01 06:00,2016/02/02 06:00,['2015/06/01 06:00'],"['2014/05/13 00:00 [received]', '2015/03/31 00:00 [revised]', '2015/05/04 00:00 [accepted]', '2015/06/01 06:00 [entrez]', '2015/06/01 06:00 [pubmed]', '2016/02/02 06:00 [medline]']","['S1477-8939(15)00083-6 [pii]', '10.1016/j.tmaid.2015.05.004 [doi]']",ppublish,Travel Med Infect Dis. 2015 Jul-Aug;13(4):285-94. doi: 10.1016/j.tmaid.2015.05.004. Epub 2015 May 14.,,,,,"['Travel Med Infect Dis. 2015 Sep-Oct;13(5):422-4. PMID: 26253048', 'Travel Med Infect Dis. 2016 Mar-Apr;14(2):165-6. PMID: 26778519']",,,,,,,,,,,,
30416526,NLM,MEDLINE,20190124,20190124,1687-9813 (Electronic) 1687-9805 (Print) 1687-9805 (Linking),2018,,2018,Relationship between Flooding and Out Break of Infectious Diseasesin Kenya: A Review of the Literature.,5452938,10.1155/2018/5452938 [doi] 5452938,"Flooding can potentially increase the spread of infectious diseases. To enhance good understanding of the health consequences of flooding and facilitate planning for mitigation strategies, deeper consideration of the relationship between flooding and out-break of infectious diseases is required. This paper examines the relationship between occurrence of floods in Kenya and outbreak of infectious diseases and possible interventions. This review intended to build up the quality and comprehensiveness of evidence on infectious diseases arising after flooding incidence in Kenya. An extensive literature review was conducted in 2017, and published literature from 2000 to 2017 was retrieved. This review suggests that infectious disease outbreaks such as waterborne, rodent-borne, and vector-borne diseases have been associated with flooding in Kenya. But there is need for more good quality epidemiological data to cement the evidence. Comprehensive surveillance and risk assessment, early warning systems, emergency planning, and well-coordinated collaborations are essential in reducing future vulnerability to infectious diseases following flooding.",,"['Okaka, Fredrick Okoth', 'Odhiambo, Beneah D O']","['Okaka FO', 'Odhiambo BDO']","['Department of Geography and GISc, University of Venda, Private Bag X5050 Thohoyandou 0950, South Africa.', 'Department of Geography and GISc, University of Venda, Private Bag X5050 Thohoyandou 0950, South Africa.']",['eng'],"['Journal Article', 'Review']",20181017,United States,J Environ Public Health,Journal of environmental and public health,101516361,IM,"['Communicable Diseases/classification/*epidemiology/etiology', 'Disease Outbreaks/*statistics & numerical data', '*Floods', 'Humans', 'Kenya/epidemiology']",PMC6207902,,,2018/11/13 06:00,2019/01/25 06:00,['2018/11/13 06:00'],"['2018/02/14 00:00 [received]', '2018/09/06 00:00 [accepted]', '2018/11/13 06:00 [entrez]', '2018/11/13 06:00 [pubmed]', '2019/01/25 06:00 [medline]']",['10.1155/2018/5452938 [doi]'],epublish,J Environ Public Health. 2018 Oct 17;2018:5452938. doi: 10.1155/2018/5452938. eCollection 2018.,,['ORCID: 0000-0002-7140-0306'],,,,,,,,,,,,,,,
21964841,NLM,MEDLINE,20120130,20170123,1098-9021 (Electronic) 0271-8235 (Linking),31,3,2011 Jul,Emerging and controversial issues in neurology: infectious diseases. Preface.,229-30,10.1055/s-0031-1287649 [doi],,,"['Cho, Tracey A']",['Cho TA'],"['Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. tcho@partners.org']",['eng'],['Introductory Journal Article'],20110930,United States,Semin Neurol,Seminars in neurology,8111343,IM,"['Communicable Diseases/*complications/therapy', 'Humans', 'Nervous System Diseases/*etiology/immunology/*therapy']",,,,2011/10/04 06:00,2012/01/31 06:00,['2011/10/04 06:00'],"['2011/10/04 06:00 [entrez]', '2011/10/04 06:00 [pubmed]', '2012/01/31 06:00 [medline]']",['10.1055/s-0031-1287649 [doi]'],ppublish,Semin Neurol. 2011 Jul;31(3):229-30. doi: 10.1055/s-0031-1287649. Epub 2011 Sep 30.,,,,,,,,,,,,,,,,,
32075479,NLM,MEDLINE,20201109,20201109,1945-7243 (Electronic) 0046-9580 (Print) 0046-9580 (Linking),57,,2020 Jan-Dec,Success of Big Infectious Disease Reimbursement Policy in China.,46958020907788,10.1177/0046958020907788 [doi] 0046958020907788,"Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases.",,"['Nie, Kun-Xi', 'Wang, Chan', 'Li, Xin-Wu']","['Nie KX', 'Wang C', 'Li XW']","['Shihezi University, Guangzhou, P.R. China.', 'Guangdong University of Finance & Economics, Guangzhou, P.R. China.', 'Guangdong University of Finance & Economics, Guangzhou, P.R. China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Inquiry,"Inquiry : a journal of medical care organization, provision and financing",0171671,IM,"['China', '*Communicable Diseases/diagnosis/therapy/transmission', 'Health Care Costs', 'Health Expenditures/*statistics & numerical data', 'Humans', '*Infection Control', 'Models, Statistical', '*Reimbursement Mechanisms']",PMC7036499,['NOTNLM'],"['China', 'efficiency', 'infectious disease', 'reimbursement policy', 'treatment costs']",2020/02/23 06:00,2020/11/11 06:00,['2020/02/21 06:00'],"['2020/02/21 06:00 [entrez]', '2020/02/23 06:00 [pubmed]', '2020/11/11 06:00 [medline]']","['10.1177_0046958020907788 [pii]', '10.1177/0046958020907788 [doi]']",ppublish,Inquiry. 2020 Jan-Dec;57:46958020907788. doi: 10.1177/0046958020907788.,"['Declaration of Conflicting Interests: The author(s) declared no potential', 'conflicts of interest with respect to the research, authorship, and/or', 'publication of this article.']",['ORCID: 0000-0002-4599-4411'],,,,,,,,,,,,,,,
21054472,NLM,MEDLINE,20110311,20161020,1939-165X (Electronic) 0275-6382 (Linking),39,3,2010 Sep,The polymerase chain reaction in the diagnosis of infectious diseases.,261-2,10.1111/j.1939-165X.2010.00254.x [doi],,,"['Tasker, Severine']",['Tasker S'],,['eng'],['Editorial'],,United States,Vet Clin Pathol,Veterinary clinical pathology,9880575,IM,"['Animals', 'Communicable Diseases/diagnosis/genetics/*veterinary', 'Dog Diseases/diagnosis/microbiology', 'Dogs', 'Nocardia/genetics', 'Nocardia Infections/diagnosis/veterinary', 'Polymerase Chain Reaction/*veterinary']",,,,2010/11/09 06:00,2011/03/12 06:00,['2010/11/09 06:00'],"['2010/11/09 06:00 [entrez]', '2010/11/09 06:00 [pubmed]', '2011/03/12 06:00 [medline]']",['10.1111/j.1939-165X.2010.00254.x [doi]'],ppublish,Vet Clin Pathol. 2010 Sep;39(3):261-2. doi: 10.1111/j.1939-165X.2010.00254.x.,,,,,,,,,,,,,,,,,
13419951,NLM,MEDLINE,20020501,20181201,0032-745X (Print) 0032-745X (Linking),43,44,1956 Nov 2,[Infectious diseases].,3284-302,,,,"['DREYER, M S']",['DREYER MS'],,['spa'],['Journal Article'],,Argentina,Prensa Med Argent,Prensa medica argentina,0204056,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1956/11/02 00:00,1956/11/02 00:01,['1956/11/02 00:00'],"['1956/11/02 00:00 [pubmed]', '1956/11/02 00:01 [medline]', '1956/11/02 00:00 [entrez]']",,ppublish,Prensa Med Argent. 1956 Nov 2;43(44):3284-302.,,,,,,,,,Enfermedades infecciosas.,,,['CLML: 5732:17886'],,,,,
16920363,NLM,MEDLINE,20061228,20061011,1044-5323 (Print) 1044-5323 (Linking),18,6,2006 Dec,Human genetics of infectious diseases: Fundamental insights from clinical studies.,327-9,,,,"['Abel, Laurent', 'Casanova, Jean-Laurent']","['Abel L', 'Casanova JL']",,['eng'],['Editorial'],20060822,England,Semin Immunol,Seminars in immunology,9009458,IM,"['Animals', 'Communicable Diseases/*genetics/immunology', '*Genetic Predisposition to Disease', 'Humans']",,,,2006/08/22 09:00,2006/12/29 09:00,['2006/08/22 09:00'],"['2006/07/06 00:00 [received]', '2006/07/06 00:00 [accepted]', '2006/08/22 09:00 [pubmed]', '2006/12/29 09:00 [medline]', '2006/08/22 09:00 [entrez]']","['S1044-5323(06)00080-7 [pii]', '10.1016/j.smim.2006.07.002 [doi]']",ppublish,Semin Immunol. 2006 Dec;18(6):327-9. doi: 10.1016/j.smim.2006.07.002. Epub 2006 Aug 22.,,,,,,,,,,,,,,,,,
11712880,NLM,MEDLINE,20011228,20190619,0003-4819 (Print) 0003-4819 (Linking),135,10,2001 Nov 20,Update in infectious diseases.,897-905,,,,"['Mandell, G L', 'Gillock, M R', 'Cramer, D A', 'Kefalides, P T']","['Mandell GL', 'Gillock MR', 'Cramer DA', 'Kefalides PT']","['University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['*Communicable Diseases/drug therapy/microbiology/transmission', 'Drug Resistance', 'Humans', 'Infection Control']",,,,2001/11/20 10:00,2002/01/05 10:01,['2001/11/20 10:00'],"['2001/11/20 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/11/20 10:00 [entrez]']","['200111200-00010 [pii]', '10.7326/0003-4819-135-10-200111200-00010 [doi]']",ppublish,Ann Intern Med. 2001 Nov 20;135(10):897-905. doi: 10.7326/0003-4819-135-10-200111200-00010.,,,,['Ann Intern Med 2002 Jun 4;136(11):855'],,9,,,,,,,,,,,
14869726,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4734,1951 Sep 29,INFECTIOUS diseases and vital statistics.,801-2,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2069844,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/09/29 00:00,1951/09/29 00:01,['1951/09/29 00:00'],"['1951/09/29 00:00 [pubmed]', '1951/09/29 00:01 [medline]', '1951/09/29 00:00 [entrez]']",,ppublish,Br Med J. 1951 Sep 29;2(4734):801-2.,,,,,,,,,,,,['CLML: 5221:1944:90:407'],,,,,
23305469,NLM,MEDLINE,20131119,20211021,1742-1241 (Electronic) 1368-5031 (Print) 1368-5031 (Linking),67,2,2013 Feb,Infectious diseases: a call for manuscripts in an interdisciplinary era.,99-103,10.1111/ijcp.12057 [doi],,,"['Stein, R A']",['Stein RA'],,['eng'],['Editorial'],,India,Int J Clin Pract,International journal of clinical practice,9712381,IM,"['Communicable Disease Control/*organization & administration', 'Communicable Diseases/*epidemiology', 'Communicable Diseases, Emerging/epidemiology', 'Humans', '*Interprofessional Relations']",PMC7165497,,,2013/01/12 06:00,2013/11/20 06:00,['2013/01/12 06:00'],"['2013/01/12 06:00 [entrez]', '2013/01/12 06:00 [pubmed]', '2013/11/20 06:00 [medline]']","['IJCP12057 [pii]', '10.1111/ijcp.12057 [doi]']",ppublish,Int J Clin Pract. 2013 Feb;67(2):99-103. doi: 10.1111/ijcp.12057.,,,,,,,,,,,,,,,,,
21090057,NLM,MEDLINE,20110104,20101122,0580-7247 (Print) 0580-7247 (Linking),42,10,2010 Oct,Tracking infectious diseases.,"36, 38",,,,"['Lynn, Karen']",['Lynn K'],,['eng'],['Journal Article'],,United States,MLO Med Lab Obs,MLO: medical laboratory observer,0225602,,"['Communicable Diseases/epidemiology/transmission', 'Contact Tracing/*methods', '*Diagnostic Services', 'Humans']",,,,2010/11/26 06:00,2011/01/05 06:00,['2010/11/25 06:00'],"['2010/11/25 06:00 [entrez]', '2010/11/26 06:00 [pubmed]', '2011/01/05 06:00 [medline]']",,ppublish,"MLO Med Lab Obs. 2010 Oct;42(10):36, 38.",,,,,,,,,,,,,,,,,
30124977,NLM,MEDLINE,20190916,20230121,1537-6613 (Electronic) 0022-1899 (Print) 0022-1899 (Linking),218,suppl_1,2018 Aug 14,The Damage-Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases.,S7-S11,10.1093/infdis/jiy083 [doi],"The Damage-Response Framework (DRF) is a powerful tool to inform research in infectious diseases. It can integrate clinical observation with microbiology and immunology to incorporate the role of the host response into the outcome of microbial pathogenesis. Although the role that microbial factors may play in the pathogenesis of infectious diseases is well recognized, the DRF brings the indispensable role of the host response to the fore. For example, inflammation may induce microbial control, but it can also produce host damage. On the other hand, insufficient inflammation may fail to induce sufficient microbial control. Each scenario may lead to the diagnosis of an infectious disease. Given the central role that the host response plays in the pathogenesis of infectious diseases, new strategies for treatment need to consider the nature of the host response as well as microbial factors.",,"['Pirofski, Liise-Anne', 'Casadevall, Arturo']","['Pirofski LA', 'Casadevall A']","['Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.', 'Department of Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Allergy and Immunology', 'Communicable Diseases/*etiology/immunology/microbiology/pathology', '*Host-Pathogen Interactions', 'Humans', 'Inflammation', 'Microbiology', '*Physicians', '*Research Personnel']",PMC6093430,,,2018/08/21 06:00,2019/09/17 06:00,['2018/08/21 06:00'],"['2018/08/21 06:00 [entrez]', '2018/08/21 06:00 [pubmed]', '2019/09/17 06:00 [medline]']","['5073083 [pii]', 'jiy083 [pii]', '10.1093/infdis/jiy083 [doi]']",ppublish,J Infect Dis. 2018 Aug 14;218(suppl_1):S7-S11. doi: 10.1093/infdis/jiy083.,,,,,,,"['R01 AI123654/AI/NIAID NIH HHS/United States', 'R01 AI097096/AI/NIAID NIH HHS/United States', 'R01 HL059842/HL/NHLBI NIH HHS/United States', 'R01 AG045044/AG/NIA NIH HHS/United States', 'R01 AI033774/AI/NIAID NIH HHS/United States', 'P30 AI060354/AI/NIAID NIH HHS/United States', 'R37 AI033142/AI/NIAID NIH HHS/United States', 'R01 AI052733/AI/NIAID NIH HHS/United States']",,,,,,,,,,
32157610,NLM,MEDLINE,20201006,20201017,1439-0973 (Electronic) 0300-8126 (Print) 0300-8126 (Linking),48,3,2020 Jun,"Update on the ""Choosing Wisely"" initiative in infectious diseases in Germany.",317-321,10.1007/s15010-020-01400-z [doi],"PURPOSE: The Choosing Wisely((R)) initiative is an international campaign addressing over- and underuse of diagnostic and therapeutic measures in infectious diseases among others. Since 2016, the German Society for Infectious Diseases (DGI) has constantly designed new items in this regard. Here we report the most recent recommendations. METHODS: The recommendations of the DGI are part of the ""Klug entscheiden"" initiative of the German Society of Internal Medicine (DGIM). Topics for the new items were suggested by members of the DGI, checked for scientific evidence and consented within the DGI and the DGIM before publication. RESULTS: The new recommendations are: (1) individuals with immune-suppression, advanced liver cirrhosis or renal insufficiency should receive a dual pneumococcal vaccination. (2) In case of positive blood cultures with Candida spp. thorough diagnostics and treatment should be initiated. (3) In case of suspected meningitis, adult patients should receive dexamethasone and antibiotics immediately after venipuncture for blood cultures and before potential imaging. (4) In case of suspected meningitis a CT scan before lumbar puncture should not be ordered-except for symptoms indicating high CSF pressure or focal brain pathology or in cases of severe immune-suppression. (5) In patients with suspected severe infections, a minimum of two pairs of blood cultures should be drawn using separate venipunctures prior to antibiotic therapy-regardless of body temperature. There is no need of a minimum time interval in between the blood draws. CONCLUSION: Applying these new Choosing Wisely((R)) recommendations will increase patient safety and the value of health care.",,"['Draenert, Rika', 'Jung, Norma']","['Draenert R', 'Jung N']","['LMU Klinikum, Stabsstelle Antibiotic Stewardship, Ludwig-Maximilians-University, Munich, Germany. rika.draenert@med.uni-muenchen.de.', 'Division of Infectious Diseases, Department of Internal Medicine, University of Cologne, Cologne, Germany.']",['eng'],['Journal Article'],20200310,Germany,Infection,Infection,0365307,IM,"['Communicable Diseases/*diagnosis/diagnostic imaging/*therapy', '*Delivery of Health Care', 'Germany', 'Humans', '*Practice Guidelines as Topic', '*Societies, Medical']",PMC7256090,['NOTNLM'],"['Blood cultures', 'Choosing Wisely', 'Infectious diseases', 'Meningitis', 'Vaccination']",2020/03/12 06:00,2020/10/07 06:00,['2020/03/12 06:00'],"['2020/02/03 00:00 [received]', '2020/02/06 00:00 [accepted]', '2020/03/12 06:00 [pubmed]', '2020/10/07 06:00 [medline]', '2020/03/12 06:00 [entrez]']","['10.1007/s15010-020-01400-z [pii]', '1400 [pii]', '10.1007/s15010-020-01400-z [doi]']",ppublish,Infection. 2020 Jun;48(3):317-321. doi: 10.1007/s15010-020-01400-z. Epub 2020 Mar 10.,"['In the last 3 years RD has received lecture fees from MSD and advisory fees from', 'Eumedica and NJ has received lecture fees from Gilead, Infectopharm and MSD and', 'travel grants from Gilead, Basilea, Correvio and Pfizer.']",['ORCID: 0000-0001-6049-3626'],,,,,,,,,['Choosing Wisely (Klug entscheiden) DGI Working Group'],,"['Addo, Marylyn M', 'Berner, Reinhard', 'Bickel, Markus', 'Bogner, Johannes', 'Cornely, Oliver', 'de With, Katja', 'Fatkenheuer, Gerd', 'Hagel, Stefan', 'Hanses, Frank', 'Harrer, Thomas', 'Hartmann, Pia', 'Herold, Susanne', 'Hippenstiel, Stefan', 'Kern, Winfried', 'Klauke, Stephan', 'Klinker, Hartwig', 'Lehmann, Clara', 'Lemmen, Sebastian', 'Lubbert, Christoph', 'Pletz, Mathias W R', 'Rieg, Siegbert', 'Ruf, Bernhard R', 'Rupp, Jan', 'Salzberger, Bernd', 'Slevogt, Hortense', 'Stellbrink, Hans-Jurgen', 'Stephan, Christoph', 'Suttorp, Norbert', 'Ullmann, Andrew', 'Witzenrath, Martin', 'Witzke, Oliver']","['Addo MM', 'Berner R', 'Bickel M', 'Bogner J', 'Cornely O', 'de With K', 'Fatkenheuer G', 'Hagel S', 'Hanses F', 'Harrer T', 'Hartmann P', 'Herold S', 'Hippenstiel S', 'Kern W', 'Klauke S', 'Klinker H', 'Lehmann C', 'Lemmen S', 'Lubbert C', 'Pletz MWR', 'Rieg S', 'Ruf BR', 'Rupp J', 'Salzberger B', 'Slevogt H', 'Stellbrink HJ', 'Stephan C', 'Suttorp N', 'Ullmann A', 'Witzenrath M', 'Witzke O']",,,
10963605,NLM,MEDLINE,20000914,20220409,0028-0836 (Print) 0028-0836 (Linking),406,6797,2000 Aug 17,Changing patterns of infectious disease.,762-7,,"Despite a century of often successful prevention and control efforts, infectious diseases remain an important global problem in public health, causing over 13 million deaths each year. Changes in society, technology and the microorganisms themselves are contributing to the emergence of new diseases, the re-emergence of diseases once controlled, and to the development of antimicrobial resistance. Two areas of special concern in the twenty-first century are food-borne disease and antimicrobial resistance. The effective control of infectious diseases in the new millennium will require effective public health infrastructures that will rapidly recognize and respond to them and will prevent emerging problems.",,"['Cohen, M L']",['Cohen ML'],"['Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,England,Nature,Nature,0410462,IM,"['Animals', 'Anti-Infective Agents/therapeutic use', 'Behavior', '*Communicable Diseases/epidemiology/history/transmission', 'Demography', 'Drug Resistance, Microbial', 'Environment', 'Food Microbiology', 'Forecasting', 'Global Health', 'History, 20th Century', 'Humans', 'Industry', 'Public Health/trends', 'Technology']",,,,2000/08/30 11:00,2000/09/19 11:01,['2000/08/30 11:00'],"['2000/08/30 11:00 [pubmed]', '2000/09/19 11:01 [medline]', '2000/08/30 11:00 [entrez]']",['10.1038/35021206 [doi]'],ppublish,Nature. 2000 Aug 17;406(6797):762-7. doi: 10.1038/35021206.,,,['0 (Anti-Infective Agents)'],,,45,,,,,,,,,,,
29807118,NLM,MEDLINE,20181105,20181105,1469-0691 (Electronic) 1198-743X (Linking),24,8,2018 Aug,CMI and 'primary-care' infections.,797-798,S1198-743X(18)30447-6 [pii] 10.1016/j.cmi.2018.05.014 [doi],,,"['Huttner, A', 'Pulcini, C']","['Huttner A', 'Pulcini C']","['Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland; Clinical Microbiology and Infection Editorial Board, Israel. Electronic address: angela.huttner@hcuge.ch.', 'Universite de Lorraine, APEMAC, Nancy, France; Universite de Lorraine, CHRU-Nancy, Infectious Diseases Department, Nancy, France; Clinical Microbiology and Infection Editorial Board, Israel.']",['eng'],"['Editorial', 'Introductory Journal Article']",20180525,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Diseases/*diagnosis/epidemiology/etiology/*therapy', 'Disease Management', 'Humans', '*Primary Health Care']",,,,2018/05/29 06:00,2018/11/06 06:00,['2018/05/29 06:00'],"['2018/05/22 00:00 [received]', '2018/05/22 00:00 [accepted]', '2018/05/29 06:00 [pubmed]', '2018/11/06 06:00 [medline]', '2018/05/29 06:00 [entrez]']","['S1198-743X(18)30447-6 [pii]', '10.1016/j.cmi.2018.05.014 [doi]']",ppublish,Clin Microbiol Infect. 2018 Aug;24(8):797-798. doi: 10.1016/j.cmi.2018.05.014. Epub 2018 May 25.,,,,,,,,,,,,,,,,,
2239692,NLM,MEDLINE,19901214,20191022,0160-3450 (Print) 0160-3450 (Linking),NS30,10,1990 Oct,"Overview of infectious diseases, Part 1.",51-5,,"Microbiologic characteristics include virulence, inoculum size, and the interplay between normal flora and pathogenic organisms. These characteristics, as well as relevant host factors, are an important part of the infectious disease process. Parts 2 and 3 of this series will review the use of drug therapy and the general manifestations of infectious diseases.",,"['Acuncius, L J', 'Henderson, R P']","['Acuncius LJ', 'Henderson RP']",,['eng'],"['Journal Article', 'Review']",,United States,Am Pharm,American pharmacy,7801164,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Diseases/*diagnosis/drug therapy/microbiology', 'Humans', 'Microbial Sensitivity Tests']",,,,1990/10/01 00:00,1990/10/01 00:01,['1990/10/01 00:00'],"['1990/10/01 00:00 [pubmed]', '1990/10/01 00:01 [medline]', '1990/10/01 00:00 [entrez]']",['10.1016/s0160-3450(16)33612-1 [doi]'],ppublish,Am Pharm. 1990 Oct;NS30(10):51-5. doi: 10.1016/s0160-3450(16)33612-1.,,,['0 (Anti-Bacterial Agents)'],,,12,,,,,,,,,,,
35104785,NLM,MEDLINE,20220331,20220401,2352-3964 (Electronic) 2352-3964 (Linking),76,,2022 Feb,Paediatric big data and analytics to improve the management of infectious diseases in children.,103854,S2352-3964(22)00038-X [pii] 10.1016/j.ebiom.2022.103854 [doi] 103854,,,"['Okomo, Uduak']",['Okomo U'],"['Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, P.O. Box 273, Banjul, Gambia. Electronic address: uokomo@mrc.gm.']",['eng'],['Journal Article'],20220129,Netherlands,EBioMedicine,EBioMedicine,101647039,IM,"['*Big Data', 'Child', '*Communicable Diseases/diagnosis/etiology/therapy', 'Delivery of Health Care', 'Humans']",PMC8803947,,,2022/02/02 06:00,2022/04/01 06:00,['2022/02/01 20:12'],"['2022/01/17 00:00 [received]', '2022/01/17 00:00 [accepted]', '2022/02/02 06:00 [pubmed]', '2022/04/01 06:00 [medline]', '2022/02/01 20:12 [entrez]']","['S2352-3964(22)00038-X [pii]', '103854 [pii]', '10.1016/j.ebiom.2022.103854 [doi]']",ppublish,EBioMedicine. 2022 Feb;76:103854. doi: 10.1016/j.ebiom.2022.103854. Epub 2022 Jan 29.,['Declaration of interests None to declare.'],,,,,,,,,,,,,,,,
11249522,NLM,MEDLINE,20010405,20190915,1465-6566 (Print) 1465-6566 (Linking),1,3,2000 Mar,Emerging infectious diseases--a therapeutic challenge.,363-5,,,,"['Snell, N J']",['Snell NJ'],,['eng'],['Editorial'],,England,Expert Opin Pharmacother,Expert opinion on pharmacotherapy,100897346,IM,"['Communicable Diseases/*drug therapy/microbiology', 'Humans', 'Infection Control/*trends']",,,,2001/03/16 10:00,2001/04/06 10:01,['2001/03/16 10:00'],"['2001/03/16 10:00 [pubmed]', '2001/04/06 10:01 [medline]', '2001/03/16 10:00 [entrez]']",['10.1517/14656566.1.3.363 [doi]'],ppublish,Expert Opin Pharmacother. 2000 Mar;1(3):363-5. doi: 10.1517/14656566.1.3.363.,,,,,,,,,,,,,,,,,
12717992,NLM,MEDLINE,20030718,20110727,0047-1852 (Print) 0047-1852 (Linking),61 Suppl 3,,2003 Mar,[Infectious diseases in travellers overseas].,325-30,,,,"['Kano, Shigeyuki']",['Kano S'],"['Department of Appropriate Technology Development and Transfer, Research Institute, International Medical Center of Japan.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/epidemiology/*transmission', 'Humans', '*Travel', 'Vaccines']",,,,2003/04/30 05:00,2003/07/19 05:00,['2003/04/30 05:00'],"['2003/04/30 05:00 [pubmed]', '2003/07/19 05:00 [medline]', '2003/04/30 05:00 [entrez]']",,ppublish,Nihon Rinsho. 2003 Mar;61 Suppl 3:325-30.,,,['0 (Vaccines)'],,,12,,,,,,,,,,,
24378949,NLM,MEDLINE,20150330,20140317,1532-0987 (Electronic) 0891-3668 (Linking),33,4,2014 Apr,Formal infectious diseases consultations at a tertiary pediatric hospital: a 14-year review.,411-3,10.1097/INF.0000000000000113 [doi],We analyzed the formal consultations seen by the infectious diseases service over a 14-year period at one of the largest pediatric hospitals in Australia. We highlight the increasing demand for pediatric infectious diseases expertise and the reasons for which consultations are sought. Our findings will help in planning and resource allocation in an era of increasingly complex patients.,,"['Gwee, Amanda', 'Carapetis, Jonathan R', 'Buttery, Jim', 'Starr, Mike', 'Connell, Tom G', 'Steer, Andrew', 'Bryant, Penelope A', 'Curtis, Nigel']","['Gwee A', 'Carapetis JR', 'Buttery J', 'Starr M', 'Connell TG', 'Steer A', 'Bryant PA', 'Curtis N']","[""From the *Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital Melbourne ; daggerMurdoch Children's Research Institute, Victoria; double daggerTelethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Western Australia;  section signDepartment of Infectious Diseases and Monash Immunization, Monash Children's Hospital, Monash Health;  paragraph signMonash University; and  ||Department of Paediatrics, The University of Melbourne, Victoria, Australia.""]",['eng'],['Journal Article'],,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,IM,"['Anti-Bacterial Agents/therapeutic use', 'Australia/epidemiology', 'Child', 'Communicable Diseases/*diagnosis/drug therapy/*epidemiology', 'Hospitals, Pediatric/*statistics & numerical data', 'Humans', 'Referral and Consultation/*statistics & numerical data', 'Retrospective Studies', 'Tertiary Care Centers/*statistics & numerical data']",,,,2014/01/01 06:00,2015/03/31 06:00,['2014/01/01 06:00'],"['2014/01/01 06:00 [entrez]', '2014/01/01 06:00 [pubmed]', '2015/03/31 06:00 [medline]']",['10.1097/INF.0000000000000113 [doi]'],ppublish,Pediatr Infect Dis J. 2014 Apr;33(4):411-3. doi: 10.1097/INF.0000000000000113.,,,['0 (Anti-Bacterial Agents)'],,['Pediatr Infect Dis J. 2014 Jun;33(6):669-71. PMID: 24830521'],,,,,,,,,,,,
30609454,NLM,MEDLINE,20190405,20190405,0047-1860 (Print) 0047-1860 (Linking),64,9,2016 Sep,[Recent Trends in Infection and Related Examinations: Infectious Diseases and Their Control in Other Countries (General Remarks)].,1016-1024,,"In a borderless era, infectious diseases that are prevalent in other countries may also spread to Japan at any time. Among such diseases, attention should particularly be paid to emerging, re-emerging, and zoonosis, arthropod-borne infectious diseases, as well as those occurring after major disasters. Important emerging infectious diseases include SARS, swine influenza, MERS, and infection by antimicrobial-resistant bacteria, while zoonosis is represented by rabies. Rabies is a vaccine-preventable, but vaccination is insufficient due to high costs in some areas. Arthropod-borne infectious diseases, such as malaria, dengue fever, Chikungu- nya fever, Zika fever, and yellow fever, are also important. Learning various lessens from the management of these diseases in other countries, human resource development is currently being promoted in Japan. [Review].",,"['Kaku, Koki']",['Kaku K'],,['jpn'],"['Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['Animals', '*Communicable Diseases, Emerging/diagnosis/prevention & control/transmission', 'Humans', 'Risk Assessment', 'World Health Organization']",,,,2016/09/01 00:00,2016/09/01 00:01,['2019/01/05 06:00'],"['2019/01/05 06:00 [entrez]', '2016/09/01 00:00 [pubmed]', '2016/09/01 00:01 [medline]']",,ppublish,Rinsho Byori. 2016 Sep;64(9):1016-1024.,,,,,,,,,,,,,,,,,
20974283,NLM,MEDLINE,20110428,20211020,1878-5832 (Electronic) 1359-6446 (Print) 1359-6446 (Linking),16,1-2,2011 Jan,Understanding infectious agents from an in silico perspective.,42-9,10.1016/j.drudis.2010.10.007 [doi],"Knowledge of infectious diseases now emerging from genomic, proteomic, epidemiological and clinical data can provide insights into the mechanisms of immune function, disease pathogenesis and epidemiology. Here, we describe how considerable advances in computational methods of data mining, mathematical modeling in epidemiology and simulation have been used to enhance our understanding of infectious agents and discuss their impact on the discovery of new therapeutics and controlling their spread.",['Copyright (c) 2010. Published by Elsevier Ltd.'],"['Tong, Joo Chuan', 'Ng, Lisa F P']","['Tong JC', 'Ng LF']","['Data Mining Department, Institute for Infocomm Research, 1 Fusionopolis Way, 21-01 Connexis South Tower, Singapore 138632, Singapore. victor@bic.nus.edu.sg']",['eng'],"['Journal Article', 'Review']",20101023,England,Drug Discov Today,Drug discovery today,9604391,IM,"['Communicable Diseases/*epidemiology/genetics/*microbiology', 'Data Mining/*methods', '*Epidemics', 'Epidemiologic Methods', 'Humans', '*Models, Biological']",PMC7185741,,,2010/10/27 06:00,2011/04/29 06:00,['2010/10/27 06:00'],"['2010/06/21 00:00 [received]', '2010/10/01 00:00 [revised]', '2010/10/18 00:00 [accepted]', '2010/10/27 06:00 [entrez]', '2010/10/27 06:00 [pubmed]', '2011/04/29 06:00 [medline]']","['S1359-6446(10)00777-4 [pii]', '10.1016/j.drudis.2010.10.007 [doi]']",ppublish,Drug Discov Today. 2011 Jan;16(1-2):42-9. doi: 10.1016/j.drudis.2010.10.007. Epub 2010 Oct 23.,,,,,,,,,,,,,,,,,
9487892,NLM,MEDLINE,19980421,20081121,0029-2915 (Print) 0029-2915 (Linking),76,3,1997 May-Jun,Emerging infectious diseases and dentistry. Part Two.,17-24,,,,"['Rhodus, N L']",['Rhodus NL'],"['Oral Medicine and Diagnosis, University of Minnesota School of Dentistry, Minneapolis 55455, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Northwest Dent,Northwest dentistry,0401073,,"['Communicable Diseases/diagnosis/epidemiology/*etiology/transmission', 'Humans', 'Incidence', 'Infection Control, Dental/*methods', 'Infectious Disease Transmission, Patient-to-Professional/*prevention & control', 'Prevalence', 'United States/epidemiology']",,,,1997/05/01 00:00,1998/03/06 00:01,['1997/05/01 00:00'],"['1997/05/01 00:00 [pubmed]', '1998/03/06 00:01 [medline]', '1997/05/01 00:00 [entrez]']",,ppublish,Northwest Dent. 1997 May-Jun;76(3):17-24.,,,,,,40,,,,,,,,,,,
31251367,NLM,MEDLINE,20210625,20210625,1741-3850 (Electronic) 1741-3842 (Linking),43,1,2021 Apr 12,Public health professionals' perceptions of the capacity of China's CDCs to address emerging and re-emerging infectious diseases.,209-216,10.1093/pubmed/fdz070 [doi],"BACKGROUND: China's capacity to control and prevent emerging and re-emerging infectious diseases is critical to the nation's population health. This study aimed to explore the capacity of Centers for Disease Control and Prevention (CDCs) in China to deal with infectious diseases now and in the future. METHODS: A survey was conducted in 2015 among 973 public health professionals at CDCs in Beijing and four provinces, to assess their capacity to deal with emerging and re-emerging infectious diseases. RESULTS: Although most professionals were confident with the current capacity of CDCs to cope with outbreaks, nearly all indicated more funding was required to meet future challenges. Responses indicated that Yunnan Province faced more challenges than Anhui, Henan and Liaoning Provinces in being completely prepared and able to deal with outbreaks. Participants aged 20-39 years were more likely than those aged 40 and over to believe strategies such as interdisciplinary and international collaborations for disease surveillance and control, would assist capacity building. CONCLUSION: The capacity of China's CDCs to deal with infectious diseases was excellent. However, findings suggest it is imperative to increase the number of skilled CDC staff, financial support, and strengthen county level staff training and health education programs.","['(c) The Author(s) 2019. Published by Oxford University Press on behalf of Faculty', 'of Public Health. All rights reserved. For permissions, please e-mail:', 'journals.permissions@oup.com.']","['Tong, Michael Xiaoliang', 'Hansen, Alana', 'Hanson-Easey, Scott', 'Xiang, Jianjun', 'Cameron, Scott', 'Liu, Qiyong', 'Liu, Xiaobo', 'Sun, Yehuan', 'Weinstein, Philip', 'Han, Gil-Soo', 'Mahmood, Afzal', 'Bi, Peng']","['Tong MX', 'Hansen A', 'Hanson-Easey S', 'Xiang J', 'Cameron S', 'Liu Q', 'Liu X', 'Sun Y', 'Weinstein P', 'Han GS', 'Mahmood A', 'Bi P']","['School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.', 'State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.', 'Department of Epidemiology, Anhui Medical University, Hefei, Anhui, China.', 'School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.', 'Communications & Media Studies, School of Media, Film and Journalism, Monash University, Clayton, Victoria, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.', 'School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Public Health (Oxf),"Journal of public health (Oxford, England)",101188638,IM,"['Adult', 'China/epidemiology', '*Communicable Diseases/epidemiology', '*Communicable Diseases, Emerging/epidemiology/prevention & control', 'Humans', 'Middle Aged', 'Perception', 'Public Health']",,['NOTNLM'],"['China', 'capacity', 'centers for disease control', 'infectious diseases', 'public health professionals']",2019/06/30 06:00,2021/06/29 06:00,['2019/06/29 06:00'],"['2019/01/20 00:00 [received]', '2019/05/13 00:00 [revised]', '2019/06/30 06:00 [pubmed]', '2021/06/29 06:00 [medline]', '2019/06/29 06:00 [entrez]']","['5524750 [pii]', '10.1093/pubmed/fdz070 [doi]']",ppublish,J Public Health (Oxf). 2021 Apr 12;43(1):209-216. doi: 10.1093/pubmed/fdz070.,,,,,,,,,,,,,,,,,
37156487,NLM,MEDLINE,20230607,20230612,1943-5681 (Electronic) 0002-9645 (Linking),84,6,2023 May 12,Center for Vector-borne and Emerging Infectious Diseases researchers tackle arthropod-transmitted pathogens.,,ajvr.23.04.0074 [pii] 10.2460/ajvr.23.04.0074 [doi],,,"['Berry, Tracey G']",['Berry TG'],,['eng'],['Journal Article'],20230512,United States,Am J Vet Res,American journal of veterinary research,0375011,IM,"['Animals', '*Communicable Diseases, Emerging/epidemiology/prevention & control/veterinary', '*Arthropods']",,,,2023/05/09 00:42,2023/06/07 06:42,['2023/05/08 19:25'],"['2023/06/07 06:42 [medline]', '2023/05/09 00:42 [pubmed]', '2023/05/08 19:25 [entrez]']","['ajvr.23.04.0074 [pii]', '10.2460/ajvr.23.04.0074 [doi]']",epublish,Am J Vet Res. 2023 May 12;84(6):ajvr.23.04.0074. doi: 10.2460/ajvr.23.04.0074.,,,,,,,,,,,,,,,,,
13496378,NLM,MEDLINE,20000701,20181201,0041-6959 (Print) 0041-6959 (Linking),86,11,1957 Nov,[Infectious diseases].,1232-5,,,,"['CHARBONNEAU, J H']",['CHARBONNEAU JH'],,['fre'],['Journal Article'],,Canada,Union Med Can,L'union medicale du Canada,0030444,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1957/11/01 00:00,1957/11/01 00:01,['1957/11/01 00:00'],"['1957/11/01 00:00 [pubmed]', '1957/11/01 00:01 [medline]', '1957/11/01 00:00 [entrez]']",,ppublish,Union Med Can. 1957 Nov;86(11):1232-5.,,,,,,,,,Les maladies infectieuses.,,,['CLML: 5833:39436:135'],,,,,
15086371,KIE,MEDLINE,20040831,20221207,1471-8731 (Print) 1471-8731 (Linking),4,1,2004 May,Are there characteristics of infectious diseases that raise special ethical issues?,1-16,,"This paper examines the characteristics of infectious diseases that raise special medical and social ethical issues, and explores ways of integrating both current bioethical and classical public health ethics concerns. Many of the ethical issues raised by infectious diseases are related to these diseases' powerful ability to engender fear in individuals and panic in populations. We address the association of some infectious diseases with high morbidity and mortality rates, the sense that infectious diseases are caused by invasion or attack on humans by foreign micro-organisms, the acute onset and rapid course of many infectious diseases, and, in particular, the communicability of infectious diseases. The individual fear and community panic associated with infectious diseases often leads to rapid, emotionally driven decision making about public health policies needed to protect the community that may be in conflict with current bioethical principles regarding the care of individual patients. The discussion includes recent examples where dialogue between public health practitioners and medical-ethicists has helped resolve ethical issues that require us to consider the infected patient as both a victim with individual needs and rights and as a potential vector of disease that is of concern to the community.",,"['Smith, Charles B', 'Battin, Margaret P', 'Jacobson, Jay A', 'Francis, Leslie P', 'Botkin, Jeffrey R', 'Asplund, Emily P', 'Domek, Gretchen J', 'Hawkins, Beverly']","['Smith CB', 'Battin MP', 'Jacobson JA', 'Francis LP', 'Botkin JR', 'Asplund EP', 'Domek GJ', 'Hawkins B']","['Division of Medical Ethics, University of Utah, Salt Lake City, Utah 84112 USA. battin@utah.edu']",['eng'],['Journal Article'],,England,Dev World Bioeth,Developing world bioethics,101120122,,"['Acquired Immunodeficiency Syndrome', 'Anti-Infective Agents/economics/therapeutic use', 'Attitude', 'Biological Warfare', 'Communicable Disease Control', '*Communicable Diseases/mortality/therapy/transmission', 'Developing Countries', '*Health Policy', 'Humans', 'Public Health/*ethics', 'Severe acute respiratory syndrome-related coronavirus', 'Socioeconomic Factors', 'Tuberculosis']",,['KIE'],['Health Care and Public Health'],2004/04/17 05:00,2004/09/01 05:00,['2004/04/17 05:00'],"['2004/04/17 05:00 [pubmed]', '2004/09/01 05:00 [medline]', '2004/04/17 05:00 [entrez]']","['DEWB64 [pii]', '10.1111/j.1471-8731.2004.00064.x [doi]']",ppublish,Dev World Bioeth. 2004 May;4(1):1-16. doi: 10.1111/j.1471-8731.2004.00064.x.,,,['0 (Anti-Infective Agents)'],,,,,,,,,['KIE: 115290'],,,"['KIE: 32 fn.', 'KIE: KIE Bib: public health']",,
26407351,NLM,MEDLINE,20170109,20170110,2048-7207 (Electronic) 2048-7193 (Linking),4,1,2015 Mar,Recommended Curriculum for Training in Pediatric Transplant Infectious Diseases.,4-10,10.1093/jpids/pit079 [doi],"A working group representing the American Society of Transplantation, Pediatric Infectious Diseases Society, and International Pediatric Transplant Association has developed a collaborative effort to identify and develop core knowledge in pediatric transplant infectious diseases. Guidance for patient care environments for training and core competencies is included to help facilitate training directed at improving the experience for pediatric infectious diseases trainees and practitioners in the area of pediatric transplant infectious diseases.","['(c) The Author 2013. Published by Oxford University Press on behalf of the', 'Pediatric Infectious Diseases Society. All rights reserved. For Permissions,', 'please e-mail: journals.permissions@oup.com.']","['Danziger-Isakov, Lara', 'Allen, Upton', 'Englund, Janet', 'Herold, Betsy', 'Hoffman, Jill', 'Green, Michael', 'Gantt, Soren', 'Kumar, Deepali', 'Michaels, Marian G']","['Danziger-Isakov L', 'Allen U', 'Englund J', 'Herold B', 'Hoffman J', 'Green M', 'Gantt S', 'Kumar D', 'Michaels MG']","[""Cincinnati Children's Hospital Medical Center, Ohio."", 'Hospital for Sick Children, University of Toronto, Ontario, Canada.', ""Seattle Children's Hospital, University of Washington."", ""Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York."", ""University of Southern California, Children's Hospital Los Angeles."", ""University of Pittsburgh School of Medicine, Children's Hospital Pittsburgh of UPMC, Pennsylvania."", ""British Columbia's Children's Hospital, University of British Columbia, Vancouver."", 'University of Alberta, Edmonton, Canada.', ""University of Pittsburgh School of Medicine, Children's Hospital Pittsburgh of UPMC, Pennsylvania.""]",['eng'],['Journal Article'],20131206,England,J Pediatric Infect Dis Soc,Journal of the Pediatric Infectious Diseases Society,101586049,IM,"['Biomedical Research/education', 'Child', 'Child Advocacy/education', 'Communicable Diseases/diagnosis/*etiology/therapy', 'Communication', '*Curriculum', 'Humans', 'Infectious Disease Medicine/*education', 'Patient Advocacy/education', 'Pediatrics/*education', 'Physician-Patient Relations', 'Postoperative Complications', 'Social Skills', 'Transplantation/*adverse effects/*education']",,['NOTNLM'],"['curriculum', 'fellowship', 'pediatric infectious disease', 'transplantation.']",2015/09/26 06:00,2017/01/10 06:00,['2015/09/26 06:00'],"['2013/08/30 00:00 [received]', '2013/10/06 00:00 [accepted]', '2015/09/26 06:00 [entrez]', '2015/09/26 06:00 [pubmed]', '2017/01/10 06:00 [medline]']","['pit079 [pii]', '10.1093/jpids/pit079 [doi]']",ppublish,J Pediatric Infect Dis Soc. 2015 Mar;4(1):4-10. doi: 10.1093/jpids/pit079. Epub 2013 Dec 6.,,,,,,,,,,,"['American Society of Transplantation, Pediatric Infectious Diseases Society, and', 'International Pediatric Transplant Association']",,,,,,
18930534,NLM,MEDLINE,20081110,20231113,1474-547X (Electronic) 0140-6736 (Print) 0140-6736 (Linking),372,9649,2008 Nov 1,Emergence and control of infectious diseases in China.,1598-605,10.1016/S0140-6736(08)61365-3 [doi],"Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.",,"['Wang, Longde', 'Wang, Yu', 'Jin, Shuigao', 'Wu, Zunyou', 'Chin, Daniel P', 'Koplan, Jeffrey P', 'Wilson, Mary Elizabeth']","['Wang L', 'Wang Y', 'Jin S', 'Wu Z', 'Chin DP', 'Koplan JP', 'Wilson ME']","[""Ministry of Health, People's Republic of China, Beijing, China.""]",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20081017,England,Lancet,"Lancet (London, England)",2985213R,IM,"['China/epidemiology', 'Communicable Diseases/*classification/diagnosis/transmission', 'Communicable Diseases, Emerging/*epidemiology/mortality/*prevention & control', 'Disease Notification', 'Disease Outbreaks/*prevention & control', 'Health Services Accessibility/*economics', 'Humans', 'Incidence', '*Public Health']",PMC7138027,,,2008/10/22 09:00,2008/11/11 09:00,['2008/10/22 09:00'],"['2008/10/22 09:00 [pubmed]', '2008/11/11 09:00 [medline]', '2008/10/22 09:00 [entrez]']","['S0140-6736(08)61365-3 [pii]', '10.1016/S0140-6736(08)61365-3 [doi]']",ppublish,Lancet. 2008 Nov 1;372(9649):1598-605. doi: 10.1016/S0140-6736(08)61365-3. Epub 2008 Oct 17.,,,,,['Lancet. 2009 Jan 3;373(9657):30. PMID: 19121722'],,"['U2R TW006918/TW/FIC NIH HHS/United States', 'U2R TW006918-04/TW/FIC NIH HHS/United States', 'U2R TW006918-05/TW/FIC NIH HHS/United States', 'U2R TW06918/TW/FIC NIH HHS/United States']",,,,,,,,,,
1441636,NLM,MEDLINE,19921223,20051116,0044-2178 (Print) 0044-2178 (Linking),86,20,1992 Oct 26,[Infectious diseases in the elderly].,1001-5,,,,"['Baumgarten, R']",['Baumgarten R'],"['II. Medizinische Abteilung, Krankenhauses Prenzlauer Berg.']",['ger'],"['Journal Article', 'Review']",,Germany,Z Arztl Fortbild (Jena),Zeitschrift fur arztliche Fortbildung,0414004,IM,"['Aged', '*Cause of Death', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/immunology/*mortality', 'Humans', 'Immune Tolerance/immunology', 'Risk Factors']",,,,1992/10/26 00:00,1992/10/26 00:01,['1992/10/26 00:00'],"['1992/10/26 00:00 [pubmed]', '1992/10/26 00:01 [medline]', '1992/10/26 00:00 [entrez]']",,ppublish,Z Arztl Fortbild (Jena). 1992 Oct 26;86(20):1001-5.,,,,,,10,,,Infektionskrankheiten im Alter.,,,,,,,,
9928226,NLM,MEDLINE,19990216,20190616,0077-8923 (Print) 0077-8923 (Linking),862,,1998 Dec 30,Monitoring infectious diseases.,205-10,,,,"['Meslin, F X', 'Heymann, D L', 'Witt, C']","['Meslin FX', 'Heymann DL', 'Witt C']","['Zoonoses Unit, World Health Organization, Geneva, Switzerland.']",['eng'],['Journal Article'],,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/transmission', 'Humans', 'Transplantation, Heterologous/adverse effects']",,,,1999/02/03 00:00,1999/02/03 00:01,['1999/02/03 00:00'],"['1999/02/03 00:00 [pubmed]', '1999/02/03 00:01 [medline]', '1999/02/03 00:00 [entrez]']",['10.1111/j.1749-6632.1998.tb09137.x [doi]'],ppublish,Ann N Y Acad Sci. 1998 Dec 30;862:205-10. doi: 10.1111/j.1749-6632.1998.tb09137.x.,,,,,,,,,,,,,,,,,
12710029,NLM,MEDLINE,20030618,20151119,0047-1860 (Print) 0047-1860 (Linking),Suppl 124,,2003 Feb,[Serologic tests and detection of microbial antigens for diagnosis of infectious diseases].,32-8,,,,"['Yoneyama, Akiko']",['Yoneyama A'],"['Clinical Laboratory, Tokyo University Hospital.']",['jpn'],"['Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['Antigens/*blood', 'Biomarkers/blood', 'Communicable Diseases/*diagnosis/immunology/microbiology/virology', 'Humans', 'Immunity, Cellular', 'Immunocompromised Host/immunology', '*Serologic Tests']",,,,2003/04/25 05:00,2003/06/19 05:00,['2003/04/25 05:00'],"['2003/04/25 05:00 [pubmed]', '2003/06/19 05:00 [medline]', '2003/04/25 05:00 [entrez]']",,ppublish,Rinsho Byori. 2003 Feb;Suppl 124:32-8.,,,"['0 (Antigens)', '0 (Biomarkers)']",,,8,,,,,,,,,,,
26701858,NLM,MEDLINE,20160919,20151224,1873-0442 (Electronic) 1477-8939 (Linking),13,6,2015 Nov-Dec,Syrian refugees and infectious disease challenges.,443-4,S1477-8939(15)00181-7 [pii] 10.1016/j.tmaid.2015.11.007 [doi],,,"['Leblebicioglu, Hakan', 'Ozaras, Resat']","['Leblebicioglu H', 'Ozaras R']","['Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey. Electronic address: hakanomu@yahoo.com.', 'Department of Infectious Diseases and Clinical Microbiology, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey.']",['eng'],['Editorial'],,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,IM,"['Communicable Diseases/*epidemiology/*ethnology', '*Delivery of Health Care', 'Humans', '*Refugees', 'Syria']",,,,2015/12/25 06:00,2016/09/20 06:00,['2015/12/25 06:00'],"['2015/11/12 00:00 [received]', '2015/11/12 00:00 [accepted]', '2015/12/25 06:00 [entrez]', '2015/12/25 06:00 [pubmed]', '2016/09/20 06:00 [medline]']","['S1477-8939(15)00181-7 [pii]', '10.1016/j.tmaid.2015.11.007 [doi]']",ppublish,Travel Med Infect Dis. 2015 Nov-Dec;13(6):443-4. doi: 10.1016/j.tmaid.2015.11.007.,,,,,,,,,,,,,,,,,
25257182,NLM,MEDLINE,20150921,20220321,2042-3306 (Electronic) 0425-1644 (Linking),47,1,2015 Jan,"Science in brief: Report on the first Havemeyer workshop on infectious diseases in working equids, Addis Ababa, Ethiopia, November 2013.",6-9,10.1111/evj.12359 [doi],,,"['Stringer, A', 'Lunn, D P', 'Reid, S']","['Stringer A', 'Lunn DP', 'Reid S']","['Society for the Protection of Animals Abroad (SPANA), London, UK.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,United States,Equine Vet J,Equine veterinary journal,0173320,IM,"['Animals', 'Communicable Disease Control/methods/standards', 'Communicable Diseases/economics/epidemiology/*veterinary', '*Developing Countries', '*Equidae', 'Ethiopia']",,,,2014/09/27 06:00,2015/09/22 06:00,['2014/09/27 06:00'],"['2014/09/27 06:00 [entrez]', '2014/09/27 06:00 [pubmed]', '2015/09/22 06:00 [medline]']",['10.1111/evj.12359 [doi]'],ppublish,Equine Vet J. 2015 Jan;47(1):6-9. doi: 10.1111/evj.12359.,,,,,,,,,,,,,,,,,
13130406,NLM,MEDLINE,20031103,20171116,1537-6591 (Electronic) 1058-4838 (Linking),37,7,2003 Oct 1,Infectious diseases in cinema: virus hunters and killer microbes.,939-42,,"The world of infectious diseases has been rarely presented in the cinema with accuracy. Apart from random biographies of scientists and retellings of stories about great epidemics from the past, most films focus on the dangers presented by outbreaks of unknown agents that originate from acts of bioterrorism, from laboratory accidents, or even from space. We review these films and underline the possible effect that they have on the public's perception of infection--a perception that, when misguided, could prove to be problematic in times of epidemics.",,"['Pappas, Georgios', 'Seitaridis, Savvas', 'Akritidis, Nikolaos', 'Tsianos, Epaminondas']","['Pappas G', 'Seitaridis S', 'Akritidis N', 'Tsianos E']","['Internal Medicine Department, University Hospital of Ioannina, Ioannina, Greece. gpele@otenet.gr']",['eng'],['Journal Article'],20030905,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Bioterrorism', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology/virology', '*Disease Outbreaks', 'Humans', '*Motion Pictures', 'Perception', 'Population Surveillance', 'Vaccination']",,,,2003/09/18 05:00,2003/11/05 05:00,['2003/09/18 05:00'],"['2003/04/15 00:00 [received]', '2003/06/18 00:00 [accepted]', '2003/09/18 05:00 [pubmed]', '2003/11/05 05:00 [medline]', '2003/09/18 05:00 [entrez]']","['CID31360 [pii]', '10.1086/377740 [doi]']",ppublish,Clin Infect Dis. 2003 Oct 1;37(7):939-42. doi: 10.1086/377740. Epub 2003 Sep 5.,,,,,,,,,,,,,,,,,
37232312,NLM,MEDLINE,20230529,20230613,0253-1933 (Print) 0253-1933 (Linking),42,,2023 May,Surveillance and risk assessment for early detection of emerging infectious diseases in livestock.,120-127,10.20506/rst.42.3355 [doi],"Those who work in the area of surveillance and prevention of emerging infectious diseases (EIDs) face a challenge in accurately predicting where infection will occur and who (or what) it will affect. Establishing surveillance and control programmes for EIDs requires substantial and long-term commitment of resources that are limited in nature. This contrasts with the unquantifiable number of possible zoonotic and non-zoonotic infectious diseases that may emerge, even when the focus is restricted to diseases involving livestock. Such diseases may emerge from many combinations of, and changes in, host species, production systems, environments/habitats and pathogen types. Given these multiple elements, risk prioritisation frameworks should be used more widely to support decision-making and resource allocation for surveillance. In this paper, the authors use recent examples of EID events in livestock to review surveillance approaches for the early detection of EIDs, and highlight the need for surveillance programmes to be informed and prioritised by regularly updated risk assessment frameworks. They conclude by discussing some unmet needs in risk assessment practices for EIDs, and the need for improved coordination in global infectious disease surveillance.",,"['Drewe, J A', 'Snary, E L', 'Crotta, M', 'Alarcon, P', 'Guitian, J']","['Drewe JA', 'Snary EL', 'Crotta M', 'Alarcon P', 'Guitian J']",,['eng'],['Journal Article'],,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', '*Communicable Diseases, Emerging/diagnosis/prevention & control/veterinary', 'Livestock', 'Risk Assessment', 'Ecosystem']",,['NOTNLM'],"['Control', 'Early detection', 'Emerging infectious disease', 'Epidemiology', 'Hazard', 'Livestock', 'Maladie emergente', 'Prevention', 'Production systems', 'Risk assessment']",2023/05/26 13:09,2023/05/29 06:42,['2023/05/26 06:03'],"['2023/05/29 06:42 [medline]', '2023/05/26 13:09 [pubmed]', '2023/05/26 06:03 [entrez]']",['10.20506/rst.42.3355 [doi]'],ppublish,Rev Sci Tech. 2023 May;42:120-127. doi: 10.20506/rst.42.3355.,,,,,,,,,Surveillance and risk assessment for early detection of emerging infectious diseases in livestock.,,,,,,,,
23416259,NLM,MEDLINE,20140403,20181202,1567-7257 (Electronic) 1567-1348 (Linking),16,,2013 Jun,"Montpellier Infectious Diseases (MID), 2nd annual meeting (2012).",450-4,S1567-1348(13)00040-3 [pii] 10.1016/j.meegid.2013.01.019 [doi],"For the second consecutive year, teams of the network ""Montpellier Infectious Diseases"" held their annual meeting. Whereas the 2011 meeting was focused on host-pathogen interaction and pathophysiology, the 2012 meeting was focused on the cooperation between medical and chemical sciences interdisciplinary approaches to fight against virus, bacteria and parasites. Several approaches aimed at designing new bioactive compounds were described during this meeting.",['Copyright (c) 2013 Elsevier B.V. All rights reserved.'],"['Bastien, Patrick', 'Braun-Breton, Catherine', 'Chazal, Nathalie', 'Devaux, Christian', 'Foulongne, Vincent', 'Frank, Marie', 'Hernandez, Jean-Francois', 'Kremer, Laurent', 'Lebrun, Maryse', 'Le Moing, Vincent', 'Leonetti, Jean-Paul', 'Lionne, Corinne', 'Peyrottes, Suzanne']","['Bastien P', 'Braun-Breton C', 'Chazal N', 'Devaux C', 'Foulongne V', 'Frank M', 'Hernandez JF', 'Kremer L', 'Lebrun M', 'Le Moing V', 'Leonetti JP', 'Lionne C', 'Peyrottes S']","['MIVEGEC, UMR5290, CNRS, IRD, UM1, UM2, France.']",['eng'],['Congress'],20130214,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Animals', 'Anti-Infective Agents/therapeutic use', 'Communicable Diseases/*drug therapy/microbiology/parasitology', 'Host-Pathogen Interactions', 'Humans', 'Occupational Health', 'Virulence']",,,,2013/02/19 06:00,2014/04/04 06:00,['2013/02/19 06:00'],"['2013/01/25 00:00 [received]', '2013/01/29 00:00 [accepted]', '2013/02/19 06:00 [entrez]', '2013/02/19 06:00 [pubmed]', '2014/04/04 06:00 [medline]']","['S1567-1348(13)00040-3 [pii]', '10.1016/j.meegid.2013.01.019 [doi]']",ppublish,Infect Genet Evol. 2013 Jun;16:450-4. doi: 10.1016/j.meegid.2013.01.019. Epub 2013 Feb 14.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
21584994,NLM,MEDLINE,20110519,20110420,0047-1860 (Print) 0047-1860 (Linking),Suppl 146,,2010 Oct,[Working despite having diseases: Infectious diseases].,147-57,,,,"['Koga, Toshihiro']",['Koga T'],,['jpn'],"['Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['*Communicable Diseases/diagnosis/transmission', 'Humans', '*Occupational Health Services', 'Severity of Illness Index', 'Sick Leave', 'Workplace']",,,,2011/05/19 06:00,2011/05/20 06:00,['2011/05/19 06:00'],"['2011/05/19 06:00 [entrez]', '2011/05/19 06:00 [pubmed]', '2011/05/20 06:00 [medline]']",,ppublish,Rinsho Byori. 2010 Oct;Suppl 146:147-57.,,,,,,,,,,,,,,,,,
27604999,NLM,MEDLINE,20170327,20181023,1756-1833 (Electronic) 0959-8138 (Linking),354,,2016 Sep 7,Commentary: How to encourage more diagnostics for infectious diseases.,i4744,10.1136/bmj.i4744 [doi],,,"['Powers, John H']",['Powers JH'],"['George Washington University School of Medicine, Washington, DC, USA.']",['eng'],['Journal Article'],20160907,England,BMJ,BMJ (Clinical research ed.),8900488,IM,"['Anti-Bacterial Agents/economics/therapeutic use', 'Clinical Decision-Making', 'Communicable Diseases/*diagnosis/drug therapy/economics', 'Drug Discovery/economics', 'Drug Industry/economics', 'Health Care Sector', 'Humans', 'Motivation']",,,,2016/09/09 06:00,2017/03/28 06:00,['2016/09/09 06:00'],"['2016/09/09 06:00 [entrez]', '2016/09/09 06:00 [pubmed]', '2017/03/28 06:00 [medline]']",['10.1136/bmj.i4744 [doi]'],epublish,BMJ. 2016 Sep 7;354:i4744. doi: 10.1136/bmj.i4744.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
17455609,NLM,MEDLINE,20070629,20111117,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[Diagnosis of infectious diseases].,155-7,,,,"['Saito, Takashi', 'Ichiyama, Satoshi']","['Saito T', 'Ichiyama S']","['Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Communicable Diseases/*diagnosis/microbiology/parasitology/virology', 'Humans', 'Interdisciplinary Communication', 'Medical Laboratory Personnel', 'Physicians', 'Specimen Handling']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:155-7.,,,,,,4,,,,,,,,,,,
8799000,NLM,MEDLINE,19961204,20200825,0304-4602 (Print) 0304-4602 (Linking),25,2,1996 Mar,Emerging infectious diseases: the old and the new.,177-8,,,,"['Ang, B']",['Ang B'],,['eng'],['Editorial'],,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,IM,"['*Communicable Diseases/epidemiology/microbiology/therapy', 'Humans']",,,,1996/03/01 00:00,1996/03/01 00:01,['1996/03/01 00:00'],"['1996/03/01 00:00 [pubmed]', '1996/03/01 00:01 [medline]', '1996/03/01 00:00 [entrez]']",,ppublish,Ann Acad Med Singap. 1996 Mar;25(2):177-8.,,,,,,,,,,,,,,,,,
22296079,NLM,MEDLINE,20120208,20120705,1533-4406 (Electronic) 0028-4793 (Linking),366,5,2012 Feb 2,The perpetual challenge of infectious diseases.,454-61,10.1056/NEJMra1108296 [doi],,,"['Fauci, Anthony S', 'Morens, David M']","['Fauci AS', 'Morens DM']","['National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. afauci@niaid.nih.gov']",['eng'],"['Historical Article', 'Journal Article']",,United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Bacteria/pathogenicity', 'Communicable Disease Control/*history', 'Communicable Diseases/drug therapy/*history/microbiology', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Vaccines/*history', 'Viruses/pathogenicity']",,,,2012/02/03 06:00,2012/02/09 06:00,['2012/02/03 06:00'],"['2012/02/03 06:00 [entrez]', '2012/02/03 06:00 [pubmed]', '2012/02/09 06:00 [medline]']",['10.1056/NEJMra1108296 [doi]'],ppublish,N Engl J Med. 2012 Feb 2;366(5):454-61. doi: 10.1056/NEJMra1108296.,,,['0 (Vaccines)'],['N Engl J Med. 2012 Mar 1;366(9):868'],"['N Engl J Med. 2012 Jul 5;367(1):89; author reply 90. PMID: 22762338', 'N Engl J Med. 2012 Jul 5;367(1):90; author reply 90. PMID: 22762339']",,,,,,,,,,,,
18672081,NLM,MEDLINE,20090210,20231113,1286-4579 (Print) 1769-714X (Electronic) 1286-4579 (Linking),10,9,2008 Jul,The book reopened on infectious diseases.,942-7,10.1016/j.micinf.2008.07.012 [doi],"Emerging infectious diseases represent a major challenge to human health worldwide. The risk of evolving new infectious pathogens has been intensifying due to urbanization, demographic changes, air travel, inappropriate use of antibiotics, and climate change. These pathogens can affect humans from urban centers to the remotest corners of the globe. Far from being a scourge of the past, infectious diseases are relevant for the world today.",,"['Avila, Maria', 'Said, Najwane', 'Ojcius, David M']","['Avila M', 'Said N', 'Ojcius DM']","['School of Natural Sciences, University of California, Merced, CA 95344, USA.']",['eng'],"['Historical Article', 'Journal Article']",20080710,France,Microbes Infect,Microbes and infection,100883508,IM,"['Chronic Disease/epidemiology', 'Communicable Disease Control', '*Communicable Diseases/epidemiology/history', '*Communicable Diseases, Emerging/epidemiology', 'Disease Outbreaks', 'Global Health', 'History, 20th Century', 'History, Ancient', 'Humans', 'Public Health', 'Vaccination']",PMC7110887,,,2008/08/02 09:00,2009/02/12 09:00,['2008/08/02 09:00'],"['2008/08/02 09:00 [pubmed]', '2009/02/12 09:00 [medline]', '2008/08/02 09:00 [entrez]']","['S1286-4579(08)00189-5 [pii]', '10.1016/j.micinf.2008.07.012 [doi]']",ppublish,Microbes Infect. 2008 Jul;10(9):942-7. doi: 10.1016/j.micinf.2008.07.012. Epub 2008 Jul 10.,,,,,,,,,,,,,,,,,
15158688,NLM,MEDLINE,20040831,20200403,0001-706X (Print) 1873-6254 (Electronic) 0001-706X (Linking),91,1,2004 Jun,Surveillance of imported infectious diseases in Europe: report from the 4th TropNetEurop workshop.,47-51,,,,"['Jelinek, Tomas', 'Myrvang, Bjorn']","['Jelinek T', 'Myrvang B']","['Institute of Tropical Medicine, Spandauer Damm 130, Berlin 14050, Germany. tomas.jelinek@charite.de']",['eng'],"['Journal Article', 'Review']",,Netherlands,Acta Trop,Acta tropica,0370374,IM,"['Animals', 'Communicable Diseases/*epidemiology/*etiology', 'Europe', 'Humans', '*Sentinel Surveillance', '*Travel']",PMC7110220,,,2004/05/26 05:00,2004/09/01 05:00,['2004/05/26 05:00'],"['2004/01/20 00:00 [received]', '2004/02/03 00:00 [accepted]', '2004/05/26 05:00 [pubmed]', '2004/09/01 05:00 [medline]', '2004/05/26 05:00 [entrez]']","['S0001706X04000403 [pii]', 'S0001-706X(04)00040-3 [pii]', '10.1016/j.actatropica.2004.02.007 [doi]']",ppublish,Acta Trop. 2004 Jun;91(1):47-51. doi: 10.1016/j.actatropica.2004.02.007.,,,,,,,,,,,,,,,,,
16959992,NLM,MEDLINE,20060920,20141120,1095-9203 (Electronic) 0036-8075 (Linking),313,5792,2006 Sep 8,Epidemiology. Infectious diseases: preparing for the future.,1392-3,,,,"['King, D A', 'Peckham, C', 'Waage, J K', 'Brownlie, J', 'Woolhouse, M E J']","['King DA', 'Peckham C', 'Waage JK', 'Brownlie J', 'Woolhouse ME']","['Office of Science and Innovation, Department of Trade and Industry, London SW1H 0ET, UK.']",['eng'],['Journal Article'],,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Animals', '*Communicable Diseases/diagnosis/epidemiology/transmission/veterinary', 'Communicable Diseases, Emerging/diagnosis/epidemiology', 'Forecasting', '*Global Health', 'Health Policy/*trends', 'Humans', 'International Cooperation', 'Plant Diseases', 'Public Policy', 'Risk Assessment', 'Zoonoses']",,,,2006/09/09 09:00,2006/09/21 09:00,['2006/09/09 09:00'],"['2006/09/09 09:00 [pubmed]', '2006/09/21 09:00 [medline]', '2006/09/09 09:00 [entrez]']","['313/5792/1392 [pii]', '10.1126/science.1129134 [doi]']",ppublish,Science. 2006 Sep 8;313(5792):1392-3. doi: 10.1126/science.1129134.,,,,,,,,,,,,,,,,,
34140736,NLM,MEDLINE,20210621,20210621,0253-1933 (Print) 0253-1933 (Linking),40,1,2021 Jun,Emerging and endemic zoonotic diseases: surveillance and diagnostics.,119-129,10.20506/rst.40.1.3212 [doi],"In this paper, the authors: (a) list methods used to diagnose zoonotic diseases in humans and animals; (b) identify between-species differences in diagnostic approaches, providing commentary on the benefits that might arise from simultaneous interpretation of data from human and animal health surveillance systems; and (c) reiterate the importance of using species-specific, validated diagnostic tests for surveillance and disease outbreak investigations. Emerging and endemic zoonotic diseases are likely to provide a continued threat to global health in the short- to medium-term future. A good deal of knowledge about the drivers of infectious disease emergence has been developed based on numerous examples from the recent past. Sharing of diagnostic resources across human and animal health sectors, sharing of human and animal health surveillance data, development of skills in the interpretation of that data and awareness of issues related to the validation and interpretation of diagnostic test data are necessary prerequisites for an effective endemic disease surveillance system. A good understanding of the epidemiological patterns of endemic disease will allow human and animal health professionals be able to more quickly detect the presence of emerging disease threats.",,"['Stevenson, M', 'Halpin, K']","['Stevenson M', 'Halpin K']",,['eng'],['Journal Article'],,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', '*Communicable Diseases/veterinary', '*Communicable Diseases, Emerging/diagnosis/epidemiology/veterinary', 'Disease Outbreaks/veterinary', 'Endemic Diseases/veterinary', 'Global Health', 'Zoonoses/epidemiology']",,['NOTNLM'],"['Diagnostic tests', 'Emerging infectious diseases', 'One Health', 'Surveillance', 'Zoonoses']",2021/06/19 06:00,2021/06/22 06:00,['2021/06/18 06:39'],"['2021/06/18 06:39 [entrez]', '2021/06/19 06:00 [pubmed]', '2021/06/22 06:00 [medline]']",['10.20506/rst.40.1.3212 [doi]'],ppublish,Rev Sci Tech. 2021 Jun;40(1):119-129. doi: 10.20506/rst.40.1.3212.,,,,,,,,,,,,,,,,,
37963966,NLM,MEDLINE,20231116,20231124,2045-2322 (Electronic) 2045-2322 (Linking),13,1,2023 Nov 13,Emerging infectious disease surveillance using a hierarchical diagnosis model and the Knox algorithm.,19836,10.1038/s41598-023-47010-1 [doi] 19836,"Emerging infectious diseases are a critical public health challenge in the twenty-first century. The recent proliferation of such diseases has raised major social and economic concerns. Therefore, early detection of emerging infectious diseases is essential. Subjects from five medical institutions in Beijing, China, which met the spatial-specific requirements, were analyzed. A quality control process was used to select 37,422 medical records of infectious diseases and 56,133 cases of non-infectious diseases. An emerging infectious disease detection model (EIDDM), a two-layer model that divides the problem into two sub-problems, i.e., whether a case is an infectious disease, and if so, whether it is a known infectious disease, was proposed. The first layer model adopts the binary classification model TextCNN-Attention. The second layer is a multi-classification model of LightGBM based on the one-vs-rest strategy. Based on the experimental results, a threshold of 0.5 is selected. The model results were compared with those of other models such as XGBoost and Random Forest using the following evaluation indicators: accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. The prediction performance of the first-layer TextCNN is better than that of other comparison models. Its average specificity for non-infectious diseases is 97.57%, with an average negative predictive value of 82.63%, indicating a low risk of misdiagnosing non-infectious diseases as infectious (i.e., a low false positive rate). Its average positive predictive value for eight selected infectious diseases is 95.07%, demonstrating the model's ability to avoid misdiagnoses. The overall average accuracy of the model is 86.11%. The average prediction accuracy of the second-layer LightGBM model for emerging infectious diseases reaches 90.44%. Furthermore, the response time of a single online reasoning using the LightGBM model is approximately 27 ms, which makes it suitable for analyzing clinical records in real time. Using the Knox method, we found that all the infectious diseases were within 2000 m in our case, and a clustering feature of spatiotemporal interactions (P < 0.05) was observed as well. Performance testing and model comparison results indicated that the EIDDM is fast and accurate and can be used to monitor the onset/outbreak of emerging infectious diseases in real-world hospitals.",['(c) 2023. The Author(s).'],"['Wang, Mengying', 'Yang, Bingqing', 'Liu, Yunpeng', 'Yang, Yingyun', 'Ji, Hong', 'Yang, Cheng']","['Wang M', 'Yang B', 'Liu Y', 'Yang Y', 'Ji H', 'Yang C']","['State Key Laboratory of Media Convergence and Communication, Communication University of China, No. 1, Dingfuzhuang East Street, Chaoyang District, Beijing, China.', 'Information Management and Big Data Center, Peking University Third Hospital, No. 49, Huayuan North Road, Beijing, China.', 'Goodwill Hessian Health Technology Co. Ltd, Beijing, China.', 'Goodwill Hessian Health Technology Co. Ltd, Beijing, China.', 'State Key Laboratory of Media Convergence and Communication, Communication University of China, No. 1, Dingfuzhuang East Street, Chaoyang District, Beijing, China.', 'Information Management and Big Data Center, Peking University Third Hospital, No. 49, Huayuan North Road, Beijing, China. my15611908807@126.com.', 'State Key Laboratory of Media Convergence and Communication, Communication University of China, No. 1, Dingfuzhuang East Street, Chaoyang District, Beijing, China. chy@cuc.edu.cn.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20231113,England,Sci Rep,Scientific reports,101563288,IM,"['Humans', '*Communicable Diseases, Emerging/diagnosis/epidemiology', '*Noncommunicable Diseases', '*Communicable Diseases/diagnosis/epidemiology', 'Disease Outbreaks', 'Algorithms']",PMC10645817,,,2023/11/15 00:41,2023/11/16 06:45,['2023/11/14 23:30'],"['2023/04/03 00:00 [received]', '2023/11/07 00:00 [accepted]', '2023/11/16 06:45 [medline]', '2023/11/15 00:41 [pubmed]', '2023/11/14 23:30 [entrez]']","['10.1038/s41598-023-47010-1 [pii]', '47010 [pii]', '10.1038/s41598-023-47010-1 [doi]']",epublish,Sci Rep. 2023 Nov 13;13(1):19836. doi: 10.1038/s41598-023-47010-1.,['The authors declare no competing interests.'],,,,,,,,,,,,,,,,
36621250,NLM,MEDLINE,20230110,20230412,2529-993X (Electronic) 2529-993X (Linking),41,1,2023 Jan,The infectious diseases challenges facing Spain in 2040 require the specialty: A national and international survey.,60-61,S2529-993X(22)00282-9 [pii] 10.1016/j.eimce.2022.08.008 [doi],,,"['Miro, Jose M', 'Moreno, Asuncion']","['Miro JM', 'Moreno A']","['Infectious Diseases Service, Hospital Clinic - IDIBAPS, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jmmiro@ub.edu.', 'Infectious Diseases Service, Hospital Clinic - IDIBAPS, University of Barcelona, Barcelona, Spain.']",['eng'],"['Case Reports', 'Journal Article']",,Spain,Enferm Infecc Microbiol Clin (Engl Ed),Enfermedades infecciosas y microbiologia clinica (English ed.),101777541,IM,"['Humans', 'Spain', '*Communicable Diseases/epidemiology/therapy']",,,,2023/01/10 06:00,2023/01/11 06:00,['2023/01/09 04:43'],"['2022/08/16 00:00 [received]', '2022/08/16 00:00 [accepted]', '2023/01/09 04:43 [entrez]', '2023/01/10 06:00 [pubmed]', '2023/01/11 06:00 [medline]']","['S2529-993X(22)00282-9 [pii]', '10.1016/j.eimce.2022.08.008 [doi]']",ppublish,Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan;41(1):60-61. doi: 10.1016/j.eimce.2022.08.008.,,,,,,,,,,,,,,,,,
29557320,NLM,MEDLINE,20190103,20220716,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),146,6,2018 Apr,Updating the epidemiological transition model.,680-687,10.1017/S0950268818000572 [doi],"The main feature of the epidemiological transition is a shift in the recorded causes of death from infectious diseases to other morbid conditions. This paper outlines modifications made to Omran's original model and stages of transition, and suggests that without a focus on aetiology and morbidity, these have been basically descriptive rather than explanatory, and potentially misleading because infections have been confirmed as causes of various chronic diseases. Common infections and related immune responses or inflammatory processes contribute to the multifactorial aetiology of morbid conditions that together make a substantial contribution to overall mortality, and infectious causation is suspected for many others because of strong evidence of association. Investigation into possible infectious causes of conditions frequently recorded as the underlying cause of death can be integrated into a framework for comparative research on patterns of disease and mortality in support of public health and prevention. A theory of epidemiological transition aimed at understanding changes in disease patterns can encompass the role in different conditions and chronic diseases of infections contracted over the life course, and their contribution to disability, morbidity and mortality relative to other causes and determinants.",,"['Mercer, A J']",['Mercer AJ'],"['Independent Researcher,38 Wren Walk, Eynesbury, St Neots, Cambridgeshire PE19 2GE,UK.']",['eng'],['Journal Article'],20180320,England,Epidemiol Infect,Epidemiology and infection,8703737,IM,"['Communicable Diseases/*epidemiology/*mortality/transmission', '*Disease Transmission, Infectious', 'Humans', '*Models, Biological']",PMC9134371,['NOTNLM'],"['Aetiology', 'chronic disease', 'epidemiological transition', 'infectious disease', 'mortality']",2018/03/21 06:00,2019/01/04 06:00,['2018/03/21 06:00'],"['2018/03/21 06:00 [pubmed]', '2019/01/04 06:00 [medline]', '2018/03/21 06:00 [entrez]']","['S0950268818000572 [pii]', '00057 [pii]', '10.1017/S0950268818000572 [doi]']",ppublish,Epidemiol Infect. 2018 Apr;146(6):680-687. doi: 10.1017/S0950268818000572. Epub 2018 Mar 20.,['None.'],,,,,,,,,,,,,,,,
25475887,NLM,MEDLINE,20150724,20230705,2046-9055 (Electronic) 2046-9047 (Print) 2046-9047 (Linking),34 Suppl 1,Suppl 1,2014 Dec,Severe acute malnutrition and infection.,S1-S29,10.1179/2046904714Z.000000000218 [doi],"Severe acute malnutrition (SAM) is associated with increased severity of common infectious diseases, and death amongst children with SAM is almost always as a result of infection. The diagnosis and management of infection are often different in malnourished versus well-nourished children. The objectives of this brief are to outline the evidence underpinning important practical questions relating to the management of infectious diseases in children with SAM and to highlight research gaps. Overall, the evidence base for many aspects covered in this brief is very poor. The brief addresses antimicrobials; antipyretics; tuberculosis; HIV; malaria; pneumonia; diarrhoea; sepsis; measles; urinary tract infection; nosocomial Infections; soil transmitted helminths; skin infections and pharmacology in the context of SAM. The brief is structured into sets of clinical questions, which we hope will maximise the relevance to contemporary practice.",,"['Jones, Kelsey D J', 'Berkley, James A']","['Jones KD', 'Berkley JA']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Paediatr Int Child Health,Paediatrics and international child health,101582666,IM,"['Adolescent', 'Biomedical Research/trends', 'Child', 'Child, Preschool', 'Communicable Diseases/diagnosis/*mortality/*pathology/therapy', 'Humans', 'Infant', 'Malnutrition/*complications']",PMC4266374,['NOTNLM'],"['Antibiotics,', 'Children,', 'Diarrhoea,', 'HIV,', 'Infection,', 'Malaria', 'Malnutrition,', 'Measles,', 'Pneumonia,', 'Sepsis,', 'Tuberculosis,', 'Urinary tract infection,']",2014/12/06 06:00,2015/07/25 06:00,['2014/12/06 06:00'],"['2014/12/06 06:00 [entrez]', '2014/12/06 06:00 [pubmed]', '2015/07/25 06:00 [medline]']","['201410 [pii]', '10.1179/2046904714Z.000000000218 [doi]']",ppublish,Paediatr Int Child Health. 2014 Dec;34 Suppl 1(Suppl 1):S1-S29. doi: 10.1179/2046904714Z.000000000218.,,,,,,,"['WT_/Wellcome Trust/United Kingdom', '092654/WT_/Wellcome Trust/United Kingdom', '092088/WT_/Wellcome Trust/United Kingdom', '083579/WT_/Wellcome Trust/United Kingdom']",,,,,,,,,,
22242158,NLM,MEDLINE,20120508,20211021,1932-6203 (Electronic) 1932-6203 (Linking),7,1,2012,Evolutionary determinants of genetic variation in susceptibility to infectious diseases in humans.,e29089,10.1371/journal.pone.0029089 [doi] e29089,"Although genetic variation among humans in their susceptibility to infectious diseases has long been appreciated, little focus has been devoted to identifying patterns in levels of variation in susceptibility to different diseases. Levels of genetic variation in susceptibility associated with 40 human infectious diseases were assessed by a survey of studies on both pedigree-based quantitative variation, as well as studies on different classes of marker alleles. These estimates were correlated with pathogen traits, epidemiological characteristics, and effectiveness of the human immune response. The strongest predictors of levels of genetic variation in susceptibility were disease characteristics negatively associated with immune effectiveness. High levels of genetic variation were associated with diseases with long infectious periods and for which vaccine development attempts have been unsuccessful. These findings are consistent with predictions based on theoretical models incorporating fitness costs associated with the different types of resistance mechanisms. An appreciation of these observed patterns will be a valuable tool in directing future research given that genetic variation in disease susceptibility has large implications for vaccine development and epidemiology.",,"['Baker, Christi', 'Antonovics, Janis']","['Baker C', 'Antonovics J']","['Department of Biology, University of Virginia, Charlottesville, VA 22904, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20120105,United States,PLoS One,PloS one,101285081,IM,"['Communicable Diseases/*genetics/microbiology/parasitology/virology', '*Evolution, Molecular', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Multivariate Analysis', 'Quantitative Trait, Heritable', 'Treatment Outcome', 'Vaccines/immunology']",PMC3252296,,,2012/01/14 06:00,2012/05/09 06:00,['2012/01/14 06:00'],"['2011/06/08 00:00 [received]', '2011/11/21 00:00 [accepted]', '2012/01/14 06:00 [entrez]', '2012/01/14 06:00 [pubmed]', '2012/05/09 06:00 [medline]']","['PONE-D-11-10087 [pii]', '10.1371/journal.pone.0029089 [doi]']",ppublish,PLoS One. 2012;7(1):e29089. doi: 10.1371/journal.pone.0029089. Epub 2012 Jan 5.,['Competing Interests: The authors have declared that no competing interests exist.'],,['0 (Vaccines)'],,,,,,,,,,,,,,
17188223,NLM,MEDLINE,20070424,20061225,1201-9712 (Print) 1201-9712 (Linking),11,1,2007 Jan,"Internationalism, infectious diseases and international development: there is an elephant in the living room.",3,,,,"['Cameron, D W']",['Cameron DW'],,['eng'],['Editorial'],,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,IM,"['Communicable Diseases/*economics/*epidemiology', 'Developing Countries', 'Disease Outbreaks/*economics', 'Humans', 'Internationality']",,,,2006/12/26 09:00,2007/04/25 09:00,['2006/12/26 09:00'],"['2006/12/26 09:00 [pubmed]', '2007/04/25 09:00 [medline]', '2006/12/26 09:00 [entrez]']","['S1201-9712(06)00204-9 [pii]', '10.1016/j.ijid.2006.12.002 [doi]']",ppublish,Int J Infect Dis. 2007 Jan;11(1):3. doi: 10.1016/j.ijid.2006.12.002.,,,,,,,,,,,,,,,,,
26548640,NLM,MEDLINE,20160915,20151209,1744-8352 (Electronic) 1473-7159 (Linking),15,12,2015,The potential of whole genome NGS for infectious disease diagnosis.,1517-9,10.1586/14737159.2015.1111140 [doi],"Non-targeted identification of microbes is now possible directly in biological samples, based on whole-genome-NGS (WG-NGS) techniques that allow deep sequencing of nucleic acids, data mining and sorting out of sequences of pathogens without any a priori hypothesis. WG-NGS was first only used as a research tool due to its cost, complexity and lack of standardization. Recent improvements in sample preparation and bioinformatics pipelines and decrease in cost now allow actionable diagnostics in patients. The potency and limits of WG-NGS and possible future indications are discussed here. WG-NGS will likely soon become a standard procedure in microbiological diagnosis.",,"['Lecuit, Marc', 'Eloit, Marc']","['Lecuit M', 'Eloit M']","['Institut Pasteur, Inserm Unit 1117, Biology of Infection Unit, Paris, France.', 'b Biology of Infection Unit , Institut Pasteur, Inserm U1117, Pathogen Discovery Laboratory , Paris , France.', 'c Pathoquest , Paris , France.']",['eng'],['Editorial'],20151107,England,Expert Rev Mol Diagn,Expert review of molecular diagnostics,101120777,IM,"['Communicable Diseases/*diagnosis/microbiology/virology', 'Genome, Bacterial', 'Genome, Fungal', '*Genome, Microbial', 'Genome, Viral', '*High-Throughput Nucleotide Sequencing/methods', 'Humans']",,['NOTNLM'],"['NGS', 'bacteria', 'diagnostic', 'fungus', 'infectious diseases', 'virus']",2015/11/10 06:00,2016/09/16 06:00,['2015/11/10 06:00'],"['2015/11/10 06:00 [entrez]', '2015/11/10 06:00 [pubmed]', '2016/09/16 06:00 [medline]']",['10.1586/14737159.2015.1111140 [doi]'],ppublish,Expert Rev Mol Diagn. 2015;15(12):1517-9. doi: 10.1586/14737159.2015.1111140. Epub 2015 Nov 7.,,,,['Expert Rev Mol Diagn. 2016;16(3):v. PMID: 26694253'],,,,,,,,,,,,,
6848575,NLM,MEDLINE,19830214,20190709,0002-8614 (Print) 0002-8614 (Linking),31,1,1983 Jan,Geriatric infectious diseases: an emerging problem.,34-9,,,,"['Yoshikawa, T T']",['Yoshikawa TT'],,['eng'],['Journal Article'],,United States,J Am Geriatr Soc,Journal of the American Geriatrics Society,7503062,IM,"['Aged', 'Aging', 'Anti-Bacterial Agents/therapeutic use', 'Communicable Disease Control', 'Communicable Diseases/drug therapy/*epidemiology/etiology/mortality', 'Hospitalization', 'Humans', 'United States', 'Vaccination']",,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",['10.1111/j.1532-5415.1983.tb06285.x [doi]'],ppublish,J Am Geriatr Soc. 1983 Jan;31(1):34-9. doi: 10.1111/j.1532-5415.1983.tb06285.x.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
10163653,NLM,MEDLINE,19970117,20051116,1041-3235 (Print) 1041-3235 (Linking),15,9,1996 Oct,Addressing emerging infectious diseases. The critical role of the laboratory.,8,,,,"['Hughes, J M']",['Hughes JM'],"['National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA 30333, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Am Clin Lab,American clinical laboratory,8903666,,"['Communicable Diseases/*diagnosis/microbiology', 'Humans', '*Laboratories']",,,,1996/09/04 00:00,1996/09/04 00:01,['1996/09/04 00:00'],"['1996/09/04 00:00 [pubmed]', '1996/09/04 00:01 [medline]', '1996/09/04 00:00 [entrez]']",,ppublish,Am Clin Lab. 1996 Oct;15(9):8.,,,,,,18,,,,,,,,,,,
22777091,NLM,MEDLINE,20130312,20141009,2164-554X (Electronic) 2164-5515 (Linking),8,7,2012 Jul,Accelerated vaccine development against emerging infectious diseases.,1010-2,10.4161/hv.20805 [doi],"Emerging and re-emerging infectious diseases represent a major challenge to vaccine development since it involves two seemingly contradictory requirements. Rapid and flexible vaccine generation while using technologies and processes that can facilitate accelerated regulatory review. Development in the ""-omics"" in combination with advances in vaccinology offer novel opportunities to meet these requirements. Here we describe how a consortium of five different organizations from academia and industry is addressing these challenges. This novel approach has the potential to become the new standard in vaccine development allowing timely deployment to avert potential pandemics.",,"['Leblanc, Pierre R', 'Yuan, Jianping', 'Brauns, Tim', 'Gelfand, Jeffrey A', 'Poznansky, Mark C']","['Leblanc PR', 'Yuan J', 'Brauns T', 'Gelfand JA', 'Poznansky MC']","['Vaccine and Immunotherapy Center, Infectious Diseases Medicine, Massachusetts General Hospital, Charlestown, MA, USA.']",['eng'],['Journal Article'],20120701,United States,Hum Vaccin Immunother,Human vaccines & immunotherapeutics,101572652,IM,"['Communicable Diseases, Emerging/*epidemiology/prevention & control/transmission/*veterinary', '*Drug Approval', 'Drug Discovery/*trends', 'Humans', 'Vaccines/*immunology']",,,,2012/07/11 06:00,2013/03/13 06:00,['2012/07/11 06:00'],"['2012/07/11 06:00 [entrez]', '2012/07/11 06:00 [pubmed]', '2013/03/13 06:00 [medline]']","['20805 [pii]', '10.4161/hv.20805 [doi]']",ppublish,Hum Vaccin Immunother. 2012 Jul;8(7):1010-2. doi: 10.4161/hv.20805. Epub 2012 Jul 1.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
31751454,NLM,MEDLINE,20210201,20210328,1537-6613 (Electronic) 0022-1899 (Print) 0022-1899 (Linking),221,Suppl 3,2020 Mar 28,Precision Medicine and Precision Public Health in the Era of Pathogen Next-Generation Sequencing.,S289-S291,10.1093/infdis/jiz424 [doi],"This brief report serves as an introduction to a supplement of the Journal of Infectious Diseases entitled ""Next-Generation Sequencing (NGS) Technologies to Advance Global Infectious Disease Research."" We briefly discuss the history of NGS technologies and describe how the techniques developed during the past 40 years have impacted our understanding of infectious diseases. Our focus is on the application of NGS in the context of pathogen genomics. Beyond obvious clinical and public health applications, we also discuss the challenges that still remain within this rapidly evolving field.","['(c) The Author(s) 2019. Published by Oxford University Press for the Infectious', 'Diseases Society of America. All rights reserved. For permissions, e-mail:', 'journals.permissions@oup.com.']","['Leguia, Mariana', 'Vila-Sanjurjo, Anton', 'Chain, Patrick S G', 'Berry, Irina Maljkovic', 'Jarman, Richard G', 'Pollett, Simon']","['Leguia M', 'Vila-Sanjurjo A', 'Chain PSG', 'Berry IM', 'Jarman RG', 'Pollett S']","['Laboratorio de Genomica, Pontificia Universidad Catolica del Peru, Lima.', 'Departamento de Bioloxia Celular e Molecular, Facultade de Ciencias, Universidade de A Coruna, Spain.', 'Bioscience Division, Los Alamos National Laboratory, New Mexico.', 'Walter Reed Army Institute of Research, Silver Spring, Maryland.', 'Walter Reed Army Institute of Research, Silver Spring, Maryland.', 'Walter Reed Army Institute of Research, Silver Spring, Maryland.', 'Department of Preventive Medicine and Biostatistics (Uniformed Services University of the Health Sciences), Bethesda, Maryland.']",['eng'],"['Introductory Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Communicable Diseases/*microbiology/parasitology/virology', '*Genomics', '*High-Throughput Nucleotide Sequencing', 'Humans', '*Precision Medicine', '*Public Health']",PMC7101274,['NOTNLM'],"['infectious diseases', 'next-generation sequencing', 'pathogen genomics']",2019/11/22 06:00,2021/02/02 06:00,['2019/11/22 06:00'],"['2019/11/22 06:00 [pubmed]', '2021/02/02 06:00 [medline]', '2019/11/22 06:00 [entrez]']","['5637477 [pii]', 'jiz424 [pii]', '10.1093/infdis/jiz424 [doi]']",ppublish,J Infect Dis. 2020 Mar 28;221(Suppl 3):S289-S291. doi: 10.1093/infdis/jiz424.,,,,,,,,,,,,,,,,,
34558712,NLM,MEDLINE,20220113,20220113,2042-7670 (Electronic) 0042-4900 (Linking),189,6,2021 Sep,From molecular surveillance to electronic health data and back: creating virtual biobanks for infectious diseases of companion animals.,241-243,10.1002/vetr.998 [doi],,,"['Mira, Francesco']",['Mira F'],"[""Istituto Zooprofilattico Sperimentale della Sicilia 'A Mirri', Palermo, Italy.""]",['eng'],"['Comment', 'Journal Article']",,England,Vet Rec,The Veterinary record,0031164,IM,"['Animals', '*Biological Specimen Banks', '*Communicable Diseases/epidemiology/veterinary', 'Electronic Health Records', 'Pets']",,,,2021/09/25 06:00,2022/01/14 06:00,['2021/09/24 08:52'],"['2021/09/24 08:52 [entrez]', '2021/09/25 06:00 [pubmed]', '2022/01/14 06:00 [medline]']",['10.1002/vetr.998 [doi]'],ppublish,Vet Rec. 2021 Sep;189(6):241-243. doi: 10.1002/vetr.998.,,,,,,,,['Vet Rec. 2021 Sep;189(6):e556. PMID: 34101190'],,,,,,,,,
17455626,NLM,MEDLINE,20070629,20110727,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[Management of infectious diseases--principles and challenges].,253-7,,,,"['Kimura, Satoshi']",['Kimura S'],['Tokyo Teishin Hospital.'],['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Anti-Bacterial Agents/*administration & dosage', 'Communicable Diseases/*diagnosis/*drug therapy/microbiology', 'Diagnosis, Differential', 'Drug Administration Schedule', 'Drug Monitoring', 'Humans', 'Practice Guidelines as Topic']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:253-7.,,,['0 (Anti-Bacterial Agents)'],,,15,,,,,,,,,,,
15803325,NLM,MEDLINE,20050927,20151119,0020-9554 (Print) 0020-9554 (Linking),46,6,2005 Jun,[Clinical study of infectious diseases. An interdisciplinary challenge in medicine].,621-2,,,,"['Fluckiger, U', 'Battegay, M']","['Fluckiger U', 'Battegay M']",,['ger'],['Editorial'],,Germany,Internist (Berl),Der Internist,0264620,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*therapy', 'Humans', '*Patient Care Team', 'Practice Guidelines as Topic', ""Practice Patterns, Physicians'""]",,,,2005/04/02 09:00,2005/09/28 09:00,['2005/04/02 09:00'],"['2005/04/02 09:00 [pubmed]', '2005/09/28 09:00 [medline]', '2005/04/02 09:00 [entrez]']",['10.1007/s00108-005-1398-5 [doi]'],ppublish,Internist (Berl). 2005 Jun;46(6):621-2. doi: 10.1007/s00108-005-1398-5.,,,,,,,,,Klinische Infektiologie. Eine interdisziplinare Herausforderung in der Medizin.,,,,,,,,
9700890,NLM,MEDLINE,19980917,20200716,0372-9311 (Print) 0372-9311 (Linking),,3,1998 May-Jun,[Genodiagnosis of infectious diseases].,86-95,,,,"['Gintsburg, A L']",['Gintsburg AL'],"['Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia.']",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/*diagnosis/genetics/immunology', 'Genes, Bacterial', 'Genes, Viral', 'Genetic Complementation Test', '*Genetic Techniques', 'Humans', '*Immunologic Tests', '*Microbiological Techniques', 'Polymerase Chain Reaction']",,,,1998/08/13 00:00,1998/08/13 00:01,['1998/08/13 00:00'],"['1998/08/13 00:00 [pubmed]', '1998/08/13 00:01 [medline]', '1998/08/13 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1998 May-Jun;(3):86-95.,,,,,,32,,,Genodiagnostika infektsionnykh zabolevanii.,,,,,,,,
20049719,NLM,MEDLINE,20100310,20211203,1757-4684 (Electronic) 1757-4676 (Print) 1757-4676 (Linking),1,4,2009 Jul,Framing a concept and an agenda for infectious diseases in EMBO Molecular Medicine.,193-4,10.1002/emmm.200900031 [doi],,,"['Sansonetti, Philippe J']",['Sansonetti PJ'],,['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,England,EMBO Mol Med,EMBO molecular medicine,101487380,IM,"['Communicable Diseases/diagnosis/epidemiology/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Periodicals as Topic', 'Translational Research, Biomedical']",PMC3378131,,,2010/01/06 06:00,2010/03/11 06:00,['2010/01/06 06:00'],"['2010/01/06 06:00 [entrez]', '2010/01/06 06:00 [pubmed]', '2010/03/11 06:00 [medline]']",['10.1002/emmm.200900031 [doi]'],ppublish,EMBO Mol Med. 2009 Jul;1(4):193-4. doi: 10.1002/emmm.200900031.,,,,,,,['Howard Hughes Medical Institute/United States'],,,,,,,,,,
10334978,NLM,MEDLINE,19990618,20190619,0036-8075 (Print) 0036-8075 (Linking),284,5418,1999 May 21,Emerging infectious diseases: public health issues for the 21st century.,1311-3,,"Infectious diseases are the third leading cause of death in the United States and the leading cause worldwide. As the new millennium approaches, the public health community must replenish capacity depleted during years of inadequate funding while simultaneously incorporating new technologies and planning for the longer term. Among the challenges facing the public health community is the need for coordinated, global, multisectoral approaches to preventing and controlling complex infectious disease problems.",,"['Binder, S', 'Levitt, A M', 'Sacks, J J', 'Hughes, J M']","['Binder S', 'Levitt AM', 'Sacks JJ', 'Hughes JM']","['Division of Parasitic Diseases, National Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC), F-22, 4770 Buford Highway, NE, Atlanta, GA 30341, USA. scb1@cdc.gov']",['eng'],['Journal Article'],,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['*Communicable Disease Control/trends', '*Communicable Diseases/diagnosis/epidemiology/mortality', 'Drug Resistance, Microbial', 'Environmental Health', 'Global Health', 'Humans', 'Population Surveillance', '*Public Health Practice', 'Socioeconomic Factors', 'United States/epidemiology', 'Vaccination']",,,,1999/05/21 00:00,1999/05/21 00:01,['1999/05/21 00:00'],"['1999/05/21 00:00 [pubmed]', '1999/05/21 00:01 [medline]', '1999/05/21 00:00 [entrez]']",['10.1126/science.284.5418.1311 [doi]'],ppublish,Science. 1999 May 21;284(5418):1311-3. doi: 10.1126/science.284.5418.1311.,,,,,,,,,,,,,,,,,
25291576,NLM,MEDLINE,20141023,20161017,1538-3598 (Electronic) 0098-7484 (Linking),312,14,2014 Oct 8,Contemporary challenges to human health: infectious disease theme issue.,1407-8,10.1001/jama.2014.12673 [doi],,,"['Malani, Preeti N']",['Malani PN'],"['Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor2Associate Editor, JAMA.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,JAMA,JAMA,7501160,IM,"['*Communicable Diseases/diagnosis/drug therapy/epidemiology', 'Global Health/trends', 'Humans', 'Public Health/trends']",,,,2014/10/08 06:00,2014/10/24 06:00,['2014/10/08 06:00'],"['2014/10/08 06:00 [entrez]', '2014/10/08 06:00 [pubmed]', '2014/10/24 06:00 [medline]']","['1911310 [pii]', '10.1001/jama.2014.12673 [doi]']",ppublish,JAMA. 2014 Oct 8;312(14):1407-8. doi: 10.1001/jama.2014.12673.,,,,,,,,,,,,,,,,,
13029255,NLM,MEDLINE,20030501,20181201,0041-5782 (Print) 0041-5782 (Linking),114,44,1952 Oct 30,[Imported infectious diseases].,1549-54,,,,"['S|OTTRUP, T']",['S|OTTRUP T'],,['und'],['Journal Article'],,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,OM,"['Communicable Diseases/*epidemiology/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/10/30 00:00,1952/10/30 00:01,['1952/10/30 00:00'],"['1952/10/30 00:00 [pubmed]', '1952/10/30 00:01 [medline]', '1952/10/30 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1952 Oct 30;114(44):1549-54.,,,,,,,,,Importerede infektionssygdomme.,,,['CLML: 5323:54234:131'],,,,,
22164636,NLM,MEDLINE,20120109,20111209,1005-6661 (Print) 1005-6661 (Linking),23,2,2011 Apr,[Application of spatial statistical analysis methods and related analytic softwares in research of infectious diseases].,217-20,,"This paper summarizes the application of several spatial statistical analysis methods, and their related softwares in the research of infectious diseases, in order to improve the prevention and control of infectious diseases.",,"['Feng, Jun', 'Wu, Xiao-Hua', 'Li, Shi-Zhu', 'Zhou, Xiao-Nong']","['Feng J', 'Wu XH', 'Li SZ', 'Zhou XN']","['National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China.']",['chi'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,China,Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi,Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control,101144973,IM,"['Communicable Disease Control/*instrumentation', 'Communicable Diseases/*epidemiology/transmission', '*Data Interpretation, Statistical', 'Humans', '*Software']",,,,2011/12/15 06:00,2012/01/10 06:00,['2011/12/15 06:00'],"['2011/12/15 06:00 [entrez]', '2011/12/15 06:00 [pubmed]', '2012/01/10 06:00 [medline]']",,ppublish,Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011 Apr;23(2):217-20.,,,,,,,,,,,,,,,,,
15614701,NLM,MEDLINE,20051017,20060725,1537-6591 (Electronic) 1058-4838 (Linking),40,1,2005 Jan 1,Global Infectious Diseases and Epidemiology Network (GIDEON): a world wide Web-based program for diagnosis and informatics in infectious diseases.,123-6,,"The Global Infectious Diseases and Epidemiology Network (GIDEON) (http://www.gideononline.com) consists of 4 modules. The first is designed to generate a ranked differential diagnosis list for any infectious diseases scenario in any of 220 countries. The second follows the country-specific epidemiology of 337 individual diseases. The third presents a comprehensive encyclopedia of 308 generic anti-infective drugs and vaccines, including a listing of >9500 trade names. The fourth generates a ranked identification list based on the phenotype of bacteria, mycobacteria, and yeasts. The program performs well and serves as a useful paradigm for World Wide Web-based informatics. GIDEON is an eclectic program that can serve the needs of clinicians, epidemiologists, and microbiologists working in the fields of infectious diseases and geographic medicine.",,"['Edberg, Stephen C']",['Edberg SC'],"['Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. Stephen.Edberg@Yale.edu']",['eng'],['Journal Article'],20041206,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*Communicable Diseases/diagnosis/epidemiology/microbiology/therapy', 'Diagnosis, Differential', 'Humans', 'Informatics', '*Information Systems', '*Internet', '*Software']",,,,2004/12/23 09:00,2005/10/18 09:00,['2004/12/23 09:00'],"['2004/08/24 00:00 [received]', '2004/08/25 00:00 [accepted]', '2004/12/23 09:00 [pubmed]', '2005/10/18 09:00 [medline]', '2004/12/23 09:00 [entrez]']","['CID34810 [pii]', '10.1086/426549 [doi]']",ppublish,Clin Infect Dis. 2005 Jan 1;40(1):123-6. doi: 10.1086/426549. Epub 2004 Dec 6.,,,,,['Clin Infect Dis. 2006 Jan 1;42(1):157-8. PMID: 16323112'],,,,,,,,,,,,
25047768,NLM,MEDLINE,20140904,20211021,1326-5377 (Electronic) 0025-729X (Print) 0025-729X (Linking),201,1 Suppl,2014 Jul 7,"The rise and fall of infectious diseases: Australian perspectives, 1914-2014.",S11-4,,"Australia has been fortunate in its experience with infectious diseases over the past century. By the 1960s, many communicable diseases were controlled through a combination of high living standards, progressive adoption of vaccines and antimicrobial treatment. Australian medical scientists have made substantial contributions to the understanding of many historically significant communicable diseases and global initiatives for control. New challenges have emerged as previously unrecognised viral infections have emerged, and microbial resistance to antibiotics has developed in many old pathogens. Ongoing evolutionary forces, both environmental and social, change the balance between humans and microbes. The effects of these forces are most sorely felt in poor countries and communities.",,"['Cossart, Yvonne E']",['Cossart YE'],"['Infectious Diseases and Immunology, University of Sydney, Sydney, NSW, Australia. ycossart@sydney.edu.au.']",['eng'],"['Historical Article', 'Journal Article']",,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Australia/epidemiology', 'Communicable Diseases/epidemiology/*history', 'History, 20th Century', 'History, 21st Century', 'Humans']",PMC7168456,,,2014/07/23 06:00,2014/09/05 06:00,['2014/07/23 06:00'],"['2014/01/24 00:00 [received]', '2014/05/14 00:00 [accepted]', '2014/07/23 06:00 [entrez]', '2014/07/23 06:00 [pubmed]', '2014/09/05 06:00 [medline]']","['10.5694/mja14.00112 [pii]', 'MJA2S11 [pii]', '10.5694/mja14.00112 [doi]']",ppublish,Med J Aust. 2014 Jul 7;201(1 Suppl):S11-4. doi: 10.5694/mja14.00112.,,,,,,,,,,,,,,,,,
15516917,NLM,MEDLINE,20050204,20200327,1078-8956 (Print) 1546-170X (Electronic) 1078-8956 (Linking),10,11,2004 Nov,From Pasteur to genomics: progress and challenges in infectious diseases.,1177-85,,"Over the past decade, microbiology and infectious disease research have undergone the most profound revolution since the times of Pasteur. Genomic sequencing has revealed the much-awaited blueprint of most pathogens. Screening blood for the nucleic acids of infectious agents has blunted the spread of pathogens by transfusion, the field of antiviral therapeutics has exploded and technologies for the development of novel and safer vaccines have become available. The quantum jump in our ability to detect, prevent and treat infectious diseases resulting from improved technologies and genomics was moderated during this period by the greatest emergence of new infectious agents ever recorded and a worrisome increase in resistance to existing therapies. Dozens of new infectious diseases are expected to emerge in the coming decades. Controlling these diseases will require a better understanding of the worldwide threat and economic burden of infectious diseases and a global agenda.",,"['Rappuoli, Rino']",['Rappuoli R'],"['Rino Rappuoli is at Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy. rino_rappuoli@chiron.com']",['eng'],"['Historical Article', 'Journal Article']",,United States,Nat Med,Nature medicine,9502015,IM,"['Antiviral Agents/therapeutic use', 'Communicable Disease Control/*trends', 'Communicable Diseases/diagnosis/*history', 'Communicable Diseases, Emerging/diagnosis/*epidemiology', '*Genomics', 'Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Vaccines/*therapeutic use']",PMC7096024,,,2004/11/02 09:00,2005/02/05 09:00,['2004/11/02 09:00'],"['2004/11/02 09:00 [pubmed]', '2005/02/05 09:00 [medline]', '2004/11/02 09:00 [entrez]']","['nm1129 [pii]', 'BFnm1129 [pii]', '10.1038/nm1129 [doi]']",ppublish,Nat Med. 2004 Nov;10(11):1177-85. doi: 10.1038/nm1129.,['The author is an employee of Chiron Corporation.'],,"['0 (Antiviral Agents)', '0 (Vaccines)']",,,,,,,,,,,,,,
19861073,NLM,MEDLINE,20100120,20211020,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),15,10,2009 Oct,"Surveillance system for infectious diseases of pets, Santiago, Chile.",1674-6,10.3201/eid1510.081596 [doi],"Pet diseases may pose risks to human health but are rarely included in surveillance systems. A pilot surveillance system of pet infectious diseases in Santiago, Chile, found that 4 canine and 3 feline diseases accounted for 90.1% and 98.4% of notifications, respectively. Data also suggested association between poverty and pet diseases.",,"['Lopez, Javier', 'Abarca, Katia', 'Cerda, Jaime', 'Valenzuela, Berta', 'Lorca, Lilia', 'Olea, Andrea', 'Aguilera, Ximena']","['Lopez J', 'Abarca K', 'Cerda J', 'Valenzuela B', 'Lorca L', 'Olea A', 'Aguilera X']","['Chilean Society of Veterinary Infectious Diseases, Santiago, Chile.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Animals', 'Animals, Domestic', 'Cat Diseases/*transmission', 'Cats', 'Chile/epidemiology', 'Communicable Diseases/epidemiology/transmission/*veterinary', 'Dog Diseases/*transmission', 'Dogs', 'Female', 'Humans', 'Male', 'Population Surveillance', 'Poverty', 'Zoonoses']",PMC2866383,,,2009/10/29 06:00,2010/01/21 06:00,['2009/10/29 06:00'],"['2009/10/29 06:00 [entrez]', '2009/10/29 06:00 [pubmed]', '2010/01/21 06:00 [medline]']","['08-1596 [pii]', '10.3201/eid1510.081596 [doi]']",ppublish,Emerg Infect Dis. 2009 Oct;15(10):1674-6. doi: 10.3201/eid1510.081596.,,,,,,,,,,,,,,,,,
12992155,NLM,MEDLINE,20030501,20201218,0025-729X (Print) 0025-729X (Linking),2,6,1952 Aug 9,INFECTIOUS diseases in Victoria.,209-10,,,,,,,['eng'],['Journal Article'],,Australia,Med J Aust,The Medical journal of Australia,0400714,OM,"['Communicable Diseases/*epidemiology/*statistics & numerical data', 'Victoria']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/08/09 00:00,1952/08/09 00:01,['1952/08/09 00:00'],"['1952/08/09 00:00 [pubmed]', '1952/08/09 00:01 [medline]', '1952/08/09 00:00 [entrez]']",['10.5694/j.1326-5377.1916.tb17713.x [doi]'],ppublish,Med J Aust. 1952 Aug 9;2(6):209-10. doi: 10.5694/j.1326-5377.1916.tb17713.x.,,,,,,,,,,,,['CLML: 5323:16472:131'],,,,,
7719633,NLM,MEDLINE,19950519,20190920,0966-842X (Print) 0966-842X (Linking),3,1,1995 Jan,Molecular ecology of infectious diseases.,1-2,,,,"['Gibson, W']",['Gibson W'],"['School of Veterinary Science, University of Bristol, Langford, UK.']",['eng'],['Congress'],,England,Trends Microbiol,Trends in microbiology,9310916,IM,"['Animals', '*Communicable Diseases/genetics/microbiology/parasitology/virology', 'Disease Vectors', 'Ecology', 'Humans', 'Molecular Biology', 'Plants/microbiology']",,,,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']","['S0966-842X(00)88859-9 [pii]', '10.1016/s0966-842x(00)88859-9 [doi]']",ppublish,Trends Microbiol. 1995 Jan;3(1):1-2. doi: 10.1016/s0966-842x(00)88859-9.,,,,,,,,,,,,,,,,,
9821368,NLM,MEDLINE,19981211,20051116,0023-2149 (Print) 0023-2149 (Linking),76,9,1998,[Locomotor disorders in infectious diseases].,20-4,,,,"['Bogomolov, B P']",['Bogomolov BP'],,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Communicable Diseases/*complications/diagnosis', 'Humans', 'Musculoskeletal Diseases/diagnosis/*etiology', 'Prognosis']",,,,1998/11/20 00:00,1998/11/20 00:01,['1998/11/20 00:00'],"['1998/11/20 00:00 [pubmed]', '1998/11/20 00:01 [medline]', '1998/11/20 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1998;76(9):20-4.,,,,,,0,,,Porazhenie oporno-dvigatel'nogo apparata pri infektsionnykh bolezniakh.,,,,,,,,
14999633,NLM,MEDLINE,20040331,20220408,1537-6591 (Electronic) 1058-4838 (Linking),38,6,2004 Mar 15,Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project.,871-8,,"Infectious diseases are responsible for >25% of the global disease toll. The new Disease Control Priorities in Developing Countries Project (DCPP) aims to decrease the burden of these diseases by producing science-based analyses from demographic, epidemiologic, disease intervention, and economic evidence for the purpose of defining disease priorities and implementing control measures. The DCPP recently reviewed selected tropical infectious diseases, examined successful control experiences, and defined unsettled patient treatment, prevention, and research issues. Disease elimination programs against American trypanosomiasis (Chagas disease), onchocerciasis, lymphatic filariasis, leprosy, trachoma, and measles are succeeding. Dengue, leishmaniasis, African trypanosomiasis, malaria, diarrheal diseases, helminthic infections, and tuberculosis have reemerged because of inadequate interventions and control strategies and the breakdown of health delivery systems. Application of technologies must be cost-effective and intensified research is essential if these and other scourges are to be controlled or eliminated in the 21st century.",,"['Hotez, Peter J', 'Remme, Jan H F', 'Buss, Paulo', 'Alleyne, George', 'Morel, Carlos', 'Breman, Joel G']","['Hotez PJ', 'Remme JH', 'Buss P', 'Alleyne G', 'Morel C', 'Breman JG']","['George Washington University, Washington, DC, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",20040226,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Biomedical Research', 'Communicable Disease Control/*methods', 'Communicable Diseases/*drug therapy/epidemiology/transmission', 'Delivery of Health Care', 'Demography', '*Developing Countries', 'Economics', 'Global Health', 'Health Priorities', 'Humans', 'Politics', 'Tropical Medicine']",,,,2004/03/05 05:00,2004/04/01 05:00,['2004/03/05 05:00'],"['2003/08/27 00:00 [received]', '2003/10/18 00:00 [accepted]', '2004/03/05 05:00 [pubmed]', '2004/04/01 05:00 [medline]', '2004/03/05 05:00 [entrez]']","['CID32199 [pii]', '10.1086/382077 [doi]']",ppublish,Clin Infect Dis. 2004 Mar 15;38(6):871-8. doi: 10.1086/382077. Epub 2004 Feb 26.,,,,,['Clin Infect Dis. 2004 Mar 15;38(6):879-80. PMID: 14999634'],,,,,,,,,,,,
22895200,NLM,MEDLINE,20121015,20141120,1539-0683 (Electronic) 0361-929X (Linking),37,5,2012 Sep,Are emerging infectious diseases the most significant global health concern for nurses? Pro.,288,10.1097/NMC.0b013e31825ecd0f [doi],,,"['Capitulo, Kathleen Leask', 'Korniewicz, Denise M', 'Baldwin, Carol M']","['Capitulo KL', 'Korniewicz DM', 'Baldwin CM']","['University of North Dakota College of Nursing, Grand Forks, ND, USA. Denise.Korniewicz@und.edu']",['eng'],['Journal Article'],,United States,MCN Am J Matern Child Nurs,MCN. The American journal of maternal child nursing,7605941,IM,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/nursing', 'Communicable Diseases, Emerging/*epidemiology/nursing', '*Global Health', 'Humans', 'Nursing/*trends']",,,,2012/08/17 06:00,2012/10/16 06:00,['2012/08/17 06:00'],"['2012/08/17 06:00 [entrez]', '2012/08/17 06:00 [pubmed]', '2012/10/16 06:00 [medline]']","['00005721-201209000-00002 [pii]', '10.1097/NMC.0b013e31825ecd0f [doi]']",ppublish,MCN Am J Matern Child Nurs. 2012 Sep;37(5):288. doi: 10.1097/NMC.0b013e31825ecd0f.,,,,,['MCN Am J Matern Child Nurs. 2012 Sep;37(5):289. PMID: 23066542'],,,,,,,,,,,,
12748262,NLM,MEDLINE,20030715,20200310,0022-2615 (Print) 0022-2615 (Linking),52,Pt 6,2003 Jun,Five postulates for resolving outbreaks of infectious disease.,447-451,10.1099/jmm.0.05121-0 [doi],"Outbreaks of infection challenge the surveillance of infectious disease, but they also offer opportunities to improve and refine it. An outbreak may be the first sign of an emerging pathogen or it may draw attention to a new risk group or route of infection. Postulates analogous to those used a century ago by Robert Koch to prove the microbial aetiology of infectious diseases can be employed to verify the existence of an outbreak, demonstrate its cause and pinpoint its origins. In doing this, high-resolution molecular finger printing of micro-organisms has now assumed a crucial role. Without formal analysis based on postulates, the existence, extent and source of outbreaks may be overlooked and public health interventions misapplied or lost.",,"['Mortimer, Philip P']",['Mortimer PP'],"['Virus Reference Division, Central Public Health Laboratory, London NW9 5HT, UK.']",['eng'],"['Journal Article', 'Review']",,England,J Med Microbiol,Journal of medical microbiology,0224131,IM,"['Animals', 'Communicable Diseases/diagnosis/*epidemiology/microbiology', '*Disease Outbreaks', 'Humans']",,,,2003/05/16 05:00,2003/07/16 05:00,['2003/05/16 05:00'],"['2003/05/16 05:00 [pubmed]', '2003/07/16 05:00 [medline]', '2003/05/16 05:00 [entrez]']",['10.1099/jmm.0.05121-0 [doi]'],ppublish,J Med Microbiol. 2003 Jun;52(Pt 6):447-451. doi: 10.1099/jmm.0.05121-0.,,,,,,17,,,,,,,,,,,
35589564,NLM,MEDLINE,20220523,20220523,0254-6450 (Print) 0254-6450 (Linking),43,5,2022 May 10,[Strategy and measures in response to highly uncertain emerging infectious disease].,627-633,10.3760/cma.j.cn112338-20220210-00106 [doi],"The incidence and spread of emerging infectious diseases are highly uncertain. This paper summarizes the uncertainty and complexity of emerging infectious disease, and suggests that for the response to the varied emerging infectious diseases in the future, it is still necessary for human to take the strategy of constantly strengthening the prevention and control capability and improving various preparedness protocols. For the better response to emerging infectious diseases and protection of people's health and life, the following measures can be taken, paying more attention to the layout of the infectious disease surveillance network, establishing and maintaining the laboratory surveillance network of infectious diseases, establishing and improving a ""wartime-peacetime"" transition mechanism or system of medical treatment and response, developing and improving the prevention and control plan for emerging infectious diseases, strengthening the training and rehearsal of emerging infectious disease treatment and response, establishing and improving the system for the grading, classification and stockpile of medical supplies for public health emergency response and establishing and maintaining the system of early warning of emerging infectious diseases and technical platform regulations.",,"['Yang, W Z', 'Zhang, T']","['Yang WZ', 'Zhang T']","['School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.', 'School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.']",['chi'],['Journal Article'],,China,Zhonghua Liu Xing Bing Xue Za Zhi,Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,8208604,IM,"['*Communicable Diseases/epidemiology', '*Communicable Diseases, Emerging/epidemiology/prevention & control', 'Disease Outbreaks/prevention & control', 'Humans', 'Public Health', 'Uncertainty']",,,,2022/05/20 06:00,2022/05/24 06:00,['2022/05/19 22:13'],"['2022/05/19 22:13 [entrez]', '2022/05/20 06:00 [pubmed]', '2022/05/24 06:00 [medline]']",['10.3760/cma.j.cn112338-20220210-00106 [doi]'],ppublish,Zhonghua Liu Xing Bing Xue Za Zhi. 2022 May 10;43(5):627-633. doi: 10.3760/cma.j.cn112338-20220210-00106.,,,,,,,"['2021-I2M-1-044/Chinese Academy of Medical Sciences Innovation Fund for Health', 'Technology and Sciences/', '2021P062QG008/Peking Union Medical College Fund for Scientific Research/']",,,,,,,,,,
7950151,NLM,MEDLINE,19941206,20191101,0941-0198 (Print) 0941-0198 (Linking),72,6,1994 Jun,Molecular diagnostics for infectious diseases: where do we stand?,415-6,,,,"['Telenti, A']",['Telenti A'],,['eng'],['Editorial'],,Germany,Clin Investig,The Clinical investigator,9207154,IM,"['Communicable Diseases/*diagnosis/genetics', 'Humans', 'Polymerase Chain Reaction']",,,,1994/06/01 00:00,1994/06/01 00:01,['1994/06/01 00:00'],"['1994/06/01 00:00 [pubmed]', '1994/06/01 00:01 [medline]', '1994/06/01 00:00 [entrez]']",['10.1007/BF00180513 [doi]'],ppublish,Clin Investig. 1994 Jun;72(6):415-6. doi: 10.1007/BF00180513.,,,,,,,,,,,,,,,,,
21073306,NLM,MEDLINE,20110225,20181201,1746-0921 (Electronic) 1746-0913 (Linking),5,10,2010 Oct,The Australasian Society for Infectious Diseases Annual Scientific Meeting 2010.,1465-7,10.2217/fmb.10.118 [doi],"The 2010 Australasian Society for Infectious Diseases Annual Scientific Meeting took place in May in the Northern Territory (Australia) and focussed on infections in the region. The meeting highlights included the changing spectrum of malaria and dengue in endemic regions, the latest on influenza epidemiology, multidrug-resistant organisms and infectious diseases in the Australian indigenous population. This was complemented by subspeciality interest group research encompassing mycobacterial disease, infection control, mycology and virology.",,"['Senanayake, Sanjaya N', 'Daveson, Kathryn L']","['Senanayake SN', 'Daveson KL']","['Australian National University Medical School, ACT, Australia. sanjaya.senanayake@act.gov.au']",['eng'],['Congress'],,England,Future Microbiol,Future microbiology,101278120,IM,"['Australasia/epidemiology', 'Communicable Disease Control/*methods/*trends', 'Communicable Diseases/diagnosis/drug therapy/*epidemiology', 'Drug Resistance, Multiple', 'Humans', 'Incidence']",,,,2010/11/16 06:00,2011/02/26 06:00,['2010/11/16 06:00'],"['2010/11/16 06:00 [entrez]', '2010/11/16 06:00 [pubmed]', '2011/02/26 06:00 [medline]']",['10.2217/fmb.10.118 [doi]'],ppublish,Future Microbiol. 2010 Oct;5(10):1465-7. doi: 10.2217/fmb.10.118.,,,,,,,,,,,,,,,,,
12297411,NLM,MEDLINE,20021112,20191106,1471-4906 (Print) 1471-4906 (Linking),23,10,2002 Oct,Forward genetics of infectious diseases: immunological impact.,469-72,,,,"['Casanova, Jean-Laurent', 'Schurr, Erwin', 'Abel, Laurent', 'Skamene, Emil']","['Casanova JL', 'Schurr E', 'Abel L', 'Skamene E']","['Laboratory of Human Genetics of Infectious Diseases, University of Paris Rene Descartes-INSERM U550, Necker Medical School, Paris, France, EU. casanova@necker.fr']",['eng'],['Congress'],,England,Trends Immunol,Trends in immunology,100966032,IM,"['Animals', 'Communicable Diseases/*genetics/*immunology', 'Germ-Line Mutation', 'Humans', 'Mice', 'Phenotype']",,,,2002/09/26 06:00,2002/11/26 04:00,['2002/09/26 06:00'],"['2002/09/26 06:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/09/26 06:00 [entrez]']","['S1471490602022895 [pii]', '10.1016/s1471-4906(02)02289-5 [doi]']",ppublish,Trends Immunol. 2002 Oct;23(10):469-72. doi: 10.1016/s1471-4906(02)02289-5.,,,,,,,,,,,,,,,,,
19189466,NLM,MEDLINE,20090406,20200716,0372-9311 (Print) 0372-9311 (Linking),,6,2008 Nov-Dec,"[Legal and theoretical premises of use of nanotechnology and nanomaterials in diagnostics, prevention and treatment of quarantine infectious diseases].",93-7,,"AIM: Analysis of legal acts designed for progress of nanotechnologies in Russia and in basic works on use of nanotechnologies and nanomaterials for development of methods for diagnostics, prevention and treatment of especially dangerous infections in Russia. MATERIALS AND METHODS: Nanoparticles, nanostructural materials, atomic-force microscopy. RESULTS: In 2007 set of normative documents regulating conduction of works in area of nanotechnology was adopted. Now in research and scientific institutes of Federal Service for Surveillance for Protection of Consumers Rights and Human Welfare, Russian Academy of Medical Sciences and other agencies works are conducted in order to develop methods for diagnostics, prevention and treatment of especially dangerous infectious diseases with applying nanotechnologies and nanomaterials. CONCLUSION: Incorporation of nanotechnologies in health care practice will provide qualitatively new level of struggle with especially dangerous infectious diseases.",,"['Onishchenko, G G', 'Kutyrev, V V', 'Utkin, D V']","['Onishchenko GG', 'Kutyrev VV', 'Utkin DV']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Animals', 'Communicable Diseases/*diagnosis/epidemiology/*therapy', 'Humans', 'Nanostructures/*statistics & numerical data', 'Nanotechnology/*legislation & jurisprudence/*methods', 'Russia/epidemiology']",,,,2009/02/04 09:00,2009/04/07 09:00,['2009/02/04 09:00'],"['2009/02/04 09:00 [entrez]', '2009/02/04 09:00 [pubmed]', '2009/04/07 09:00 [medline]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2008 Nov-Dec;(6):93-7.,,,,,,18,,,,,,,,,,,
27600934,NLM,MEDLINE,20170620,20170620,0303-4240 (Print) 0303-4240 (Linking),172,,2016,Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities.,39-75,,"Since their first description in the 1980s, exosomes, small endosomal-derived extracellular vesicles, have been involved in innate and adaptive immunity through modulating immune responses and mediating antigen presentation. Increasing evidence has reported the role of exosomes in host-pathogen interactions and particularly in the activation of antimicrobial immune responses. The growing interest concerning exosomes in infectious diseases, their accessibility in various body fluids, and their capacity to convey a rich content (e.g., proteins, lipids, and nucleic acids) to distant recipient cells led the scientific community to consider the use of exosomes as potential new diagnostic and therapeutic tools. In this review, we summarize current understandings of exosome biogenesis and their composition and highlight the function of exosomes as immunomodulators in pathological states such as in infectious disorders. The potential of using exosomes as diagnostic and therapeutic tools is also discussed.",,"['Carriere, Jessica', 'Barnich, Nicolas', 'Nguyen, Hang Thi Thu']","['Carriere J', 'Barnich N', 'Nguyen HT']","['University of Clermont Auvergne, M2iSH, UMR 1071 INSERM/University of Auvergne, Clermont-Ferrand, 63001, France.', 'INRA USC 2018, Clermont-Ferrand, 63001, France.', 'University of Clermont Auvergne, M2iSH, UMR 1071 INSERM/University of Auvergne, Clermont-Ferrand, 63001, France.', 'INRA USC 2018, Clermont-Ferrand, 63001, France.', 'University of Clermont Auvergne, M2iSH, UMR 1071 INSERM/University of Auvergne, Clermont-Ferrand, 63001, France. hang.nguyen@udamail.fr.', 'INRA USC 2018, Clermont-Ferrand, 63001, France. hang.nguyen@udamail.fr.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,Germany,Rev Physiol Biochem Pharmacol,"Reviews of physiology, biochemistry and pharmacology",0434624,IM,"['Communicable Diseases/diagnosis/*metabolism/therapy', 'Exosomes/*metabolism', '*Host-Pathogen Interactions', 'Humans']",,['NOTNLM'],"['Exosomes', 'Host-pathogen interactions', 'Immune responses', 'Infectious diseases']",2016/09/08 06:00,2017/06/21 06:00,['2016/09/08 06:00'],"['2016/09/08 06:00 [pubmed]', '2017/06/21 06:00 [medline]', '2016/09/08 06:00 [entrez]']",['10.1007/112_2016_7 [doi]'],ppublish,Rev Physiol Biochem Pharmacol. 2016;172:39-75. doi: 10.1007/112_2016_7.,,,,,,,,,,,,,,,,,
9569896,NLM,MEDLINE,19980506,20161209,0755-4982 (Print) 0755-4982 (Linking),26,37,1997 Nov 29,[Infectious diseases: almost 60 years of antibiotic use].,1766-7,,,,"['Bergogne-Berezin, E']",['Bergogne-Berezin E'],,['fre'],"['Editorial', 'Historical Article']",,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,IM,"['Anti-Bacterial Agents/history/*therapeutic use', 'Communicable Diseases/*drug therapy/history/microbiology', 'History, 20th Century', 'Humans', 'Male']",,,,1998/05/07 00:00,1998/05/07 00:01,['1998/05/07 00:00'],"['1998/05/07 00:00 [pubmed]', '1998/05/07 00:01 [medline]', '1998/05/07 00:00 [entrez]']",,ppublish,Presse Med. 1997 Nov 29;26(37):1766-7.,,,['0 (Anti-Bacterial Agents)'],,,,,,Infectiologie: presque 60 ans d'usage des antibiotiques.,,,,,,,,
17824419,NLM,MEDLINE,20071010,20190902,0012-9658 (Print) 0012-9658 (Linking),88,8,2007 Aug,Globalization of human infectious disease.,1903-10,,"Globalization has facilitated the spread of numerous infectious agents to all corners of the planet. Analysis of the Global Infectious Disease and Epidemiology Network (GIDEON) database quantitatively illustrates that the globalization of human infectious agents depends significantly on the range of hosts used. Infectious agents specific to humans are broadly and uniformly distributed, whereas zoonotic infectious agents are far more localized in their geographical distribution. Moreover, these patterns vary depending on transmission mode and infectious agent taxonomy. This dichotomy is unlikely to persist if certain aspects of globalization (for example, exotic species introductions) continue unabated. This raises a serious concern for public health and leaves nations with the task of determining the infectious agents that have the greatest potential to establish within their borders. At the advent of a century characterized by an apparent increase in emerging infectious diseases, these results have critical implications for public-health policy and future research pathways of infectious disease ecology.",,"['Smith, Katherine F', 'Sax, Dov F', 'Gaines, Steven D', 'Guernier, Vanina', 'Guegan, Jean-Francois']","['Smith KF', 'Sax DF', 'Gaines SD', 'Guernier V', 'Guegan JF']","['University of Georgia Institute of Ecology, Ecology Building Way, Athens, Georgia 30602, USA. smithk@uga.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",,United States,Ecology,Ecology,0043541,IM,"['Animals', 'Communicable Diseases/*epidemiology/*transmission/veterinary', 'Communicable Diseases, Emerging/epidemiology/transmission/veterinary', 'Demography', 'Disease Susceptibility', 'Disease Transmission, Infectious', 'Humans', '*Public Health', 'Species Specificity', 'Travel', '*Zoonoses']",,,,2007/09/11 09:00,2007/10/11 09:00,['2007/09/11 09:00'],"['2007/09/11 09:00 [pubmed]', '2007/10/11 09:00 [medline]', '2007/09/11 09:00 [entrez]']",['10.1890/06-1052.1 [doi]'],ppublish,Ecology. 2007 Aug;88(8):1903-10. doi: 10.1890/06-1052.1.,,,,,,,,,,,,,,,,,
10490352,NLM,MEDLINE,19990915,20191103,1369-5274 (Print) 1369-5274 (Linking),2,4,1999 Aug,"New challenges, new tools: the impact of climate change on infectious diseases.",445-51,,,,"['Patz, J A', 'Lindsay, S W']","['Patz JA', 'Lindsay SW']","['Environmental Health Sciences, Johns Hopkins School of Public Health, Baltimore, MD 21205-2179, USA. jpatz@jhsph.edu']",['eng'],"['Journal Article', 'Review']",,England,Curr Opin Microbiol,Current opinion in microbiology,9815056,IM,"['Animals', 'Climate', 'Communicable Diseases/microbiology/parasitology/*transmission', 'Geography', 'Humans', 'Malaria/parasitology/transmission', 'Weather']",,,,1999/09/18 00:00,1999/09/18 00:01,['1999/09/18 00:00'],"['1999/09/18 00:00 [pubmed]', '1999/09/18 00:01 [medline]', '1999/09/18 00:00 [entrez]']","['S1369527499800782 [pii]', '10.1016/s1369-5274(99)80078-2 [doi]']",ppublish,Curr Opin Microbiol. 1999 Aug;2(4):445-51. doi: 10.1016/s1369-5274(99)80078-2.,,,,,,67,,,,,,,,,,,
27855269,NLM,MEDLINE,20170607,20170607,2326-5108 (Electronic) 2326-5094 (Linking),14,6,2016 Nov/Dec,"Enhancing the Diagnosis, Treatment, Surveillance, and Control of Infectious Diseases in the ACA Era.",397-408,,"As US public health faces increasing threats from outbreaks, impending changes to the healthcare landscape in the United States may alter the way that health departments are able to detect and control some of the most common infectious diseases. The Patient Protection and Affordable Care Act (ACA) has made significant changes in the way health care is provided in the United States. While many of the clinical, economic, and policy implications of the ACA are well described, there has been limited analysis of changes, if any, in the surveillance and control of infectious diseases of public health importance-such as tuberculosis, sexually transmitted infections, and HIV-that are anticipated or occurring as the ACA is implemented across the United States. To address these questions, we reviewed the literature for evidence of changing trends and conducted 66 semi-structured, not-for-attribution interviews with 82 participants from healthcare systems; academia; federal, state, and local public health agencies; and professional and nongovernmental organizations across the United States. This analysis identifies several ways in which ACA implementation has not fully addressed the public health needs associated with diagnosis, treatment, surveillance, and control of infectious diseases of public health importance.",,"['Nuzzo, Jennifer B', 'Watson, Matthew', 'Shearer, Matthew P']","['Nuzzo JB', 'Watson M', 'Shearer MP']",,['eng'],['Journal Article'],20161117,United States,Health Secur,Health security,101654694,IM,"['Communicable Disease Control/*trends', 'Communicable Diseases/*diagnosis/*epidemiology/*therapy', 'Disease Outbreaks/prevention & control', 'Humans', '*Patient Protection and Affordable Care Act', '*Public Health Administration', 'United States']",,['NOTNLM'],"['Electronic health records', 'Infectious diseases', 'National strategy/policy', 'Public health preparedness/response', 'Surveillance']",2016/11/18 06:00,2017/06/08 06:00,['2016/11/18 06:00'],"['2016/11/18 06:00 [pubmed]', '2017/06/08 06:00 [medline]', '2016/11/18 06:00 [entrez]']",['10.1089/hs.2016.0053 [doi]'],ppublish,Health Secur. 2016 Nov/Dec;14(6):397-408. doi: 10.1089/hs.2016.0053. Epub 2016 Nov 17.,,,,,,,,,,,,,,,,,
25418281,NLM,MEDLINE,20150714,20220129,1474-760X (Electronic) 1465-6906 (Print) 1474-7596 (Linking),15,11,2014 Nov 22,"Genomic analysis of emerging pathogens: methods, application and future trends.",541,10.1186/s13059-014-0541-9 [doi] 541,"The number of emerging infectious diseases is increasing. Characterizing novel or re-emerging infections is aided by the availability of pathogen genomes. In this review, we evaluate methods that exploit pathogen sequences and the contribution of genomic analysis to understand the epidemiology of recently emerged infectious diseases.",,"['Li, Lucy M', 'Grassly, Nicholas C', 'Fraser, Christophe']","['Li LM', 'Grassly NC', 'Fraser C']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20141122,England,Genome Biol,Genome biology,100960660,IM,"['Bacteria/*genetics/pathogenicity', 'Communicable Diseases/*genetics/microbiology/virology', 'Communicable Diseases, Emerging/*genetics/microbiology/virology', 'Genome, Bacterial', 'Genome, Viral', 'Genomics', 'Humans', 'Viruses/*genetics/pathogenicity']",PMC4283782,,,2014/11/25 06:00,2015/07/15 06:00,['2014/11/25 06:00'],"['2014/11/25 06:00 [entrez]', '2014/11/25 06:00 [pubmed]', '2015/07/15 06:00 [medline]']","['s13059-014-0541-9 [pii]', '541 [pii]', '10.1186/s13059-014-0541-9 [doi]']",epublish,Genome Biol. 2014 Nov 22;15(11):541. doi: 10.1186/s13059-014-0541-9.,,,,,,,"['G0800596/MRC_/Medical Research Council/United Kingdom', 'MR/K010174/1/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,
23958370,NLM,MEDLINE,20140415,20130820,1558-299X (Electronic) 0095-4543 (Linking),40,3,2013 Sep,Primary care: clinics in office practice devoted to the topic of infectious diseases.,xiii,S0095-4543(13)00069-9 [pii] 10.1016/j.pop.2013.07.002 [doi],,,"['Malone, Michael A']",['Malone MA'],,['eng'],['Editorial'],,United States,Prim Care,Primary care,0430463,IM,"['Communicable Diseases/*diagnosis/*drug therapy/epidemiology', 'Humans', 'Practice Guidelines as Topic', 'Primary Health Care/*organization & administration']",,,,2013/08/21 06:00,2014/04/16 06:00,['2013/08/21 06:00'],"['2013/08/21 06:00 [entrez]', '2013/08/21 06:00 [pubmed]', '2014/04/16 06:00 [medline]']","['S0095-4543(13)00069-9 [pii]', '10.1016/j.pop.2013.07.002 [doi]']",ppublish,Prim Care. 2013 Sep;40(3):xiii. doi: 10.1016/j.pop.2013.07.002.,,,,,,,,,,,,,,,,,
15360152,NLM,MEDLINE,20041202,20161209,0755-4982 (Print) 0755-4982 (Linking),33 Spec No,,2004 Jun 15,[Regarding infectious diseases].,Sp67-9,,,,"['Bricaire, Francois']",['Bricaire F'],"[""Service des maladies infectieuses et tropicales, GH Pitie-Salpetriere, 47 boulevard de l'Hopital, 75013 Paris.""]",['fre'],['Journal Article'],,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,IM,"['*Communicable Diseases/microbiology/therapy', 'Humans', 'Microbiology/trends']",,,,2004/09/14 05:00,2004/12/16 09:00,['2004/09/14 05:00'],"['2004/09/14 05:00 [pubmed]', '2004/12/16 09:00 [medline]', '2004/09/14 05:00 [entrez]']",,ppublish,Presse Med. 2004 Jun 15;33 Spec No:Sp67-9.,,,,,,,,,A propos des maladies infectieuses.,,,,,,,,
10574011,NLM,MEDLINE,19991202,20190607,1020-4989 (Print) 1020-4989 (Linking),6,2,1999 Aug,[Infectious and parasitic diseases in Brazil: a decade of transition].,99-109,,"Brazil has been undergoing a period of epidemiological and demographic transition, which has included an improvement in the quality of death certificate registrations and major changes in the patterns of mortality from infectious and parasitic diseases. This article outlines the changes in the mortality patterns that were observed in the country and in its states during the decade of the 1980s. We used data from the Ministry of Health Mortality Information System, classified according to the International Classification of Diseases, 9th Revision. Our analysis showed important changes in mortality patterns in Brazil. Mortality from infectious diseases decreased by 41% among men and by 44% among women. While these types of changes were especially noticeable in the states of the North and Northeast, these states still have the highest mortality rates in the country. The changes particularly affected the extreme limits of the age continuum, most especially children under 1 year of age. Within the group of infectious and parasitic diseases, we also assessed the mortality due to intestinal infectious diseases, tuberculosis, and septicemia. We found that in the 1980s there was a major decrease in the rates of mortality due to intestinal infectious diseases and to tuberculosis. However, there was an increase in the risk of death from septicemia during the decade. In conclusion, we find that the rate of mortality caused by infectious and parasitic diseases remains high in Brazil. Therefore, Brazilian health authorities still need to give priority attention to this cause of death.",,"['Paes, N A', 'Silva, L A']","['Paes NA', 'Silva LA']","['Universidade Federal da Paraiba, Departamento de Estatistica, Joao Pessoa, PB, Brasil. antunes@de.ufpb.br']",['por'],"['English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,IM,"['Brazil/epidemiology', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology/parasitology', 'Epidemiologic Methods', 'Female', 'Humans', 'Male', 'Parasitic Diseases/*epidemiology']",,,,1999/11/26 00:00,1999/11/26 00:01,['1999/11/26 00:00'],"['1999/11/26 00:00 [pubmed]', '1999/11/26 00:01 [medline]', '1999/11/26 00:00 [entrez]']","['S1020-49891999000700004 [pii]', '10.1590/s1020-49891999000700004 [doi]']",ppublish,Rev Panam Salud Publica. 1999 Aug;6(2):99-109. doi: 10.1590/s1020-49891999000700004.,,,,,,,,,Doencas infecciosas e parasitarias no Brasil: uma decada de transicao.,,,,,,,,
12717997,NLM,MEDLINE,20030718,20131121,0047-1852 (Print) 0047-1852 (Linking),61 Suppl 3,,2003 Mar,[Rapid diagnosis for infectious diseases].,363-7,,,,"['Okada, Jun']",['Okada J'],"['Clinical Laboratory, Kanto Medical Center NTT EC.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Communicable Diseases/*diagnosis/etiology', 'Gentian Violet', 'Humans', 'Immunologic Tests/methods', 'Phenazines']",,,,2003/04/30 05:00,2003/07/19 05:00,['2003/04/30 05:00'],"['2003/04/30 05:00 [pubmed]', '2003/07/19 05:00 [medline]', '2003/04/30 05:00 [entrez]']",,ppublish,Nihon Rinsho. 2003 Mar;61 Suppl 3:363-7.,,,"[""0 (Gram's stain)"", '0 (Phenazines)', 'J4Z741D6O5 (Gentian Violet)']",,,5,,,,,,,,,,,
12462808,NLM,MEDLINE,20030107,20141120,0012-7183 (Print) 0012-7183 (Linking),118,19,2002,[New and newly reappearing infectious diseases--the moving goal of infection epidemiology].,2027-30,,,,"['Lyytikainen, Outi', 'Nuorti, Pekka']","['Lyytikainen O', 'Nuorti P']","['Kansanterveyslaitos Infektioepidemiologian osasto, Mannerheimintie 166 00300 Helsinki. outi.lyytikainen@ktl.fi']",['fin'],"['Journal Article', 'Review']",,Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,IM,"['Communicable Disease Control/organization & administration/*standards/trends', 'Communicable Diseases/*epidemiology/transmission', 'Communicable Diseases, Emerging/epidemiology/transmission', 'Global Health', 'Humans', 'Organizational Objectives', 'Risk Factors']",,,,2002/12/05 04:00,2003/01/08 04:00,['2002/12/05 04:00'],"['2002/12/05 04:00 [pubmed]', '2003/01/08 04:00 [medline]', '2002/12/05 04:00 [entrez]']",,ppublish,Duodecim. 2002;118(19):2027-30.,,,,,,14,,,Uudet ja uudelleen ilmaantuvat tartuntataudit--infektioepidemiologian liikkuva maali.,,,,,,,,
10218388,NLM,MEDLINE,19990601,20081121,0035-2640 (Print) 0035-2640 (Linking),49,6,1999 Mar 15,[Microbiology of emerging infectious diseases].,577-9,,,,"['Drancourt, M']",['Drancourt M'],"['Unite des rickettsies CNRS UPRES-A 6020, Faculte de medecine, Universite de la Mediterranee, Marseille.']",['fre'],"['Journal Article', 'Review']",,France,Rev Prat,La Revue du praticien,0404334,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Diseases/drug therapy/*microbiology/transmission', 'Diagnosis, Differential', 'Disease Transmission, Infectious', 'Humans']",,,,1999/04/28 00:00,1999/04/28 00:01,['1999/04/28 00:00'],"['1999/04/28 00:00 [pubmed]', '1999/04/28 00:01 [medline]', '1999/04/28 00:00 [entrez]']",,ppublish,Rev Prat. 1999 Mar 15;49(6):577-9.,,,['0 (Anti-Bacterial Agents)'],,,15,,,Pathogenes emergents et veille microbiologique.,,,,,,,,
2282446,NLM,MEDLINE,19910315,20181113,0028-7091 (Print) 0028-7091 (Linking),66,6,1990 Nov-Dec,Transatlantic transmission of infectious diseases; the applicability of paleopathology.,660-3,,,,"['Jarcho, S']",['Jarcho S'],,['eng'],"['Historical Article', 'Journal Article']",,United States,Bull N Y Acad Med,Bulletin of the New York Academy of Medicine,7505398,IM,"['Communicable Diseases/epidemiology/*history/transmission', 'Disease Outbreaks/*history', 'Global Health', 'History, 15th Century', 'History, 16th Century', 'History, 17th Century', 'History, 18th Century', 'History, 20th Century', 'Humans', '*Paleopathology', 'Travel']",PMC1809789,,,1990/11/01 00:00,1990/11/01 00:01,['1990/11/01 00:00'],"['1990/11/01 00:00 [pubmed]', '1990/11/01 00:01 [medline]', '1990/11/01 00:00 [entrez]']",,ppublish,Bull N Y Acad Med. 1990 Nov-Dec;66(6):660-3.,,,,,,,,,,,,,,,,,
9490345,NLM,MEDLINE,19980227,20051116,0023-2149 (Print) 0023-2149 (Linking),75,10,1997,[Hepatosplenic syndrome in differential diagnosis of infectious diseases].,63-6,,,,"['Bogomolov, B P']",['Bogomolov BP'],"[""Central Clinic Hospital, Medical Center of President's Affair, Moscow.""]",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Communicable Diseases/complications/*diagnosis', 'Diagnosis, Differential', 'Hepatomegaly/*etiology', 'Humans', 'Splenomegaly/*etiology', 'Syndrome']",,,,1997/01/01 00:00,1998/03/07 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1998/03/07 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1997;75(10):63-6.,,,,,,0,,,Gepatolienal'nyi sindrom v differentsial'noi diagnostike infektsionnykh boleznei.,,,,,,,,
12861707,NLM,MEDLINE,20030926,20161020,0869-6047 (Print) 0869-6047 (Linking),,6,2003,[Current understanding of the pathogenesis of infectious diseases].,3-9,,"New experimental data in such research fields as molecular biology, biochemistry, genomics and others as well as the changes occurring in the medical-and-epidemiological situation in respect to a number of infectious diseases dictate the necessity to systemize and to revise the appropriate knowledge for the purpose of ensuring a more profound understanding of the processes providing a foundation for the relations within the system of ""host--parasite"". The article deals with modern aspects of investigating the pathogenesis of infectious diseases, i.e. issues of the genetic and of structural-and-functional organization as well as of regulation of the pathogenetic potential of microorganisms; and mechanism of antimicrobial protection of microorganisms including from the standpoint of evolutionary biology.",,"['Pimenov, E V', 'Totolian, A A', 'Byvalov, A A', 'Darmov, I V', 'Roshchevskii, M P']","['Pimenov EV', 'Totolian AA', 'Byvalov AA', 'Darmov IV', 'Roshchevskii MP']",,['rus'],"['English Abstract', 'Journal Article', 'Review']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Communicable Diseases/*etiology/genetics/microbiology', 'Humans']",,,,2003/07/17 05:00,2003/09/27 05:00,['2003/07/17 05:00'],"['2003/07/17 05:00 [pubmed]', '2003/09/27 05:00 [medline]', '2003/07/17 05:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2003;(6):3-9.,,,,,,47,,,Sovremennye predstableniia o patogeneze infektsionnykh zabolevanii.,,,,,,,,
24719972,NLM,MEDLINE,20140725,20140410,0039-1735 (Print) 0039-1735 (Linking),93,1,2014,[Oral infections].,64-71,,"In the survey the basic aspects of the infectious pathology are analyzed, that are to be met in the work of stomatologist. There is in detail described the intra-hospital infection, caused by conditionally pathogenic flora. There is given the clinical characteristics of the oral manifestations of the basic of <<traditional>> infectious diseases.",,"['Shestakova, I V', 'Iushchuk, N D', 'Balmasova, I P']","['Shestakova IV', 'Iushchuk ND', 'Balmasova IP']",,['rus'],"['English Abstract', 'Journal Article', 'Review']",,Russia (Federation),Stomatologiia (Mosk),Stomatologiia,0412072,IM,"['Communicable Diseases/*diagnosis/epidemiology/*microbiology', 'Cross Infection/*diagnosis/epidemiology/*microbiology', 'Humans', 'Stomatognathic Diseases/*diagnosis/epidemiology/*microbiology']",,,,2014/04/12 06:00,2014/07/26 06:00,['2014/04/12 06:00'],"['2014/04/12 06:00 [entrez]', '2014/04/12 06:00 [pubmed]', '2014/07/26 06:00 [medline]']",,ppublish,Stomatologiia (Mosk). 2014;93(1):64-71.,,,,,,,,,,,,,,,,,
14923244,NLM,MEDLINE,20040215,20181201,,11,2-3,1952 Feb-Mar,Infectious diseases in Israel in the last quarter and during the whole year of 1951.,51-6,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/02/01 00:00,1952/02/01 00:01,['1952/02/01 00:00'],"['1952/02/01 00:00 [pubmed]', '1952/02/01 00:01 [medline]', '1952/02/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1952 Feb-Mar;11(2-3):51-6.,,,,,,,,,,,,['CLML: 5222:9224:113'],,,,,
22591975,NLM,MEDLINE,20140512,20220716,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),141,3,2013 Mar,Unhealthy behaviour is contagious: an invitation to exploit models for infectious diseases.,667-9,10.1017/S0950268812000891 [doi],"We argue that the spread of unhealthy behaviour shows marked similarities with infectious diseases. It is therefore interesting and challenging to use infectious disease methodologies for studying the spread and control of unhealthy behaviour. This would be a great addition to current methods, because it allows taking into account the dynamics of individual interactions and the social environment at large. In particular, the application of individual-based modelling holds great promise to address some major public health questions.",,"['Blok, D J', 'VAN Empelen, P', 'VAN Lenthe, F J', 'Richardus, J H', 'DE Vlas, S J']","['Blok DJ', 'VAN Empelen P', 'VAN Lenthe FJ', 'Richardus JH', 'DE Vlas SJ']","['Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.', 'Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.', 'Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.', 'Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.', 'Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands.']",['eng'],['Journal Article'],20120517,England,Epidemiol Infect,Epidemiology and infection,8703737,IM,"['Communicable Diseases/epidemiology/*transmission', '*Health Behavior', 'Humans', '*Models, Biological', 'Risk Reduction Behavior']",PMC9151862,,,2012/05/18 06:00,2014/05/13 06:00,['2012/05/18 06:00'],"['2012/05/18 06:00 [entrez]', '2012/05/18 06:00 [pubmed]', '2014/05/13 06:00 [medline]']","['S0950268812000891 [pii]', '00089 [pii]', '10.1017/S0950268812000891 [doi]']",ppublish,Epidemiol Infect. 2013 Mar;141(3):667-9. doi: 10.1017/S0950268812000891. Epub 2012 May 17.,,,,,,,,,,,,,,,,,
10885030,NLM,MEDLINE,20000811,20061115,0042-8809 (Print) 0042-8809 (Linking),46,2,2000 Mar-Apr,[Role of free radical oxidation processes in the pathogenesis of infectious diseases].,110-6,,Recent literature data on the mechanisms responsible for oxidative stress at infectious diseases and methods of their correction are reviewed.,,"['Shepelev, A P', 'Kornienko, I V', 'Shestopalov, A V', 'Antipov, A Iu']","['Shepelev AP', 'Kornienko IV', 'Shestopalov AV', 'Antipov AIu']","['Rostov Research Institute of Microbiology and Parasitology, Rostov-on-Don, Russia.']",['rus'],"['English Abstract', 'Journal Article', 'Review']",,Russia (Federation),Vopr Med Khim,Voprosy meditsinskoi khimii,0416601,IM,"['Communicable Diseases/etiology/*metabolism', 'Free Radicals', 'Humans', 'Oxidation-Reduction']",,,,2000/07/08 11:00,2000/08/19 11:00,['2000/07/08 11:00'],"['2000/07/08 11:00 [pubmed]', '2000/08/19 11:00 [medline]', '2000/07/08 11:00 [entrez]']",,ppublish,Vopr Med Khim. 2000 Mar-Apr;46(2):110-6.,,,['0 (Free Radicals)'],,,49,,,Rol' protsessov svobodnoradikal'nogo okisleniia v patogenez infektsionnykh boleznei.,,,,,,,,
20015230,NLM,MEDLINE,20100426,20211203,1574-695X (Electronic) 0928-8244 (Linking),58,1,2010 Feb,Highlights from the first meeting of the Europe-Africa frontier research conference series infectious diseases: from basic to translational research.,1-2,10.1111/j.1574-695X.2009.00638.x [doi],,,"['Capron, Monique', 'Mizrahi, Valerie']","['Capron M', 'Mizrahi V']",,['eng'],['Editorial'],20091201,England,FEMS Immunol Med Microbiol,FEMS immunology and medical microbiology,9315554,IM,"['Africa', 'Animals', '*Communicable Diseases/microbiology/parasitology/virology', '*Congresses as Topic', 'Europe', 'Humans', '*Research', '*Translational Research, Biomedical']",,,,2009/12/18 06:00,2010/04/27 06:00,['2009/12/18 06:00'],"['2009/12/18 06:00 [entrez]', '2009/12/18 06:00 [pubmed]', '2010/04/27 06:00 [medline]']","['FIM638 [pii]', '10.1111/j.1574-695X.2009.00638.x [doi]']",ppublish,FEMS Immunol Med Microbiol. 2010 Feb;58(1):1-2. doi: 10.1111/j.1574-695X.2009.00638.x. Epub 2009 Dec 1.,,,,,,,,,,,,,,,,,
22044389,NLM,MEDLINE,20120330,20220331,1365-2567 (Electronic) 0019-2805 (Print) 0019-2805 (Linking),135,2,2012 Feb,Do multiple concurrent infections in African children cause irreversible immunological damage?,125-32,10.1111/j.1365-2567.2011.03523.x [doi],"Much of the developing world, particularly sub-Saharan Africa, has high levels of morbidity and mortality associated with infectious diseases. The greatest risk of invasive disease is in the young, the malnourished and HIV-infected individuals. In many regions in Africa these vulnerable groups and the wider general population are under constant immune pressure from a range of environmental factors, under-nutrition and multiple concurrent infections from birth through to adulthood. Intermittent microbial exposure during childhood is required for the generation of naturally acquired immunity capable of protection against a range of infectious diseases in adult life. However, in the context of a resource-poor setting, the heavy burden of malarial, diarrhoeal and respiratory infections in childhood may subvert or suppress immune responses rather than protect, resulting in sub-optimal immunity. This review will explore how poor maternal health, HIV exposure, socio-economic and seasonal factors conspire to weaken childhood immune defences to disease and discuss the hypothesis that recurrent infections may drive immune dysregulation, leading to relative immune senescence and premature immunological aging.",['(c) 2011 The Authors. Immunology (c) 2011 Blackwell Publishing Ltd.'],"['Glennie, Sarah J', 'Nyirenda, Moffat', 'Williams, Neil A', 'Heyderman, Robert S']","['Glennie SJ', 'Nyirenda M', 'Williams NA', 'Heyderman RS']","['Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. sarah.glennie@liverpool.ac.uk']",['eng'],"['Journal Article', 'Review']",,England,Immunology,Immunology,0374672,IM,"['Africa/epidemiology', 'Child', 'Child, Preschool', 'Communicable Diseases/complications/epidemiology/*immunology/*pathology', 'Humans']",PMC3277714,,,2011/11/03 06:00,2012/03/31 06:00,['2011/11/03 06:00'],"['2011/11/03 06:00 [entrez]', '2011/11/03 06:00 [pubmed]', '2012/03/31 06:00 [medline]']",['10.1111/j.1365-2567.2011.03523.x [doi]'],ppublish,Immunology. 2012 Feb;135(2):125-32. doi: 10.1111/j.1365-2567.2011.03523.x.,,,,,,,['G0501934/MRC_/Medical Research Council/United Kingdom'],,,,,,,,,,
7688622,NLM,MEDLINE,19930916,20161020,0869-6047 (Print) 0869-6047 (Linking),,2,1993,[The study of the molecular mechanisms of the development of infectious diseases--a basis for improving pathogenetic therapy].,54-6,,,,"['Iurkiv, V A', 'Iushchuk, N D', 'Maleev, V V']","['Iurkiv VA', 'Iushchuk ND', 'Maleev VV']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Anti-Infective Agents/therapeutic use', 'Combined Modality Therapy', 'Communicable Diseases/*etiology/metabolism/*therapy', 'Fluid Therapy', 'Humans']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 1993;(2):54-6.,,,['0 (Anti-Infective Agents)'],,,28,,,Issledovanie molekuliarnykh mekhanizmov razvitiia infektsionnykh zabolevanii--osnova sovershenstvovaniia patogeneticheskoi terapii.,,,,,,,,
2683519,NLM,MEDLINE,19891212,20200716,0372-9311 (Print) 0372-9311 (Linking),,7,1989 Jul,[Ecologico-epidemiologic principles of the classification of human infectious diseases].,109-14,,,,"['Shliakhov, E N', 'Litvin, V Iu']","['Shliakhov EN', 'Litvin VIu']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Animals', 'Communicable Diseases/*classification/epidemiology/etiology/transmission', 'Disease Vectors', 'Ecology', 'Environmental Health', 'Humans', 'Zoonoses/classification/transmission']",,,,1989/07/01 00:00,1989/07/01 00:01,['1989/07/01 00:00'],"['1989/07/01 00:00 [pubmed]', '1989/07/01 00:01 [medline]', '1989/07/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1989 Jul;(7):109-14.,,,,,,24,,,Ekologo-epidemiologicheskie printsipy klassifikatsii infektsionnykh boleznei cheloveka.,,,,,,,,
11838598,NLM,MEDLINE,20021021,20190605,0918-2918 (Print) 0918-2918 (Linking),41,1,2002 Jan,"5. Infectious disease surveillance designated by the Infectious Disease Control Law, and the situation of emerging/re-emerging infectious diseases in Japan.",61-2,,,,"['Okabe, Nobuhiko']",['Okabe N'],"['Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo.']",['eng'],['Journal Article'],,Japan,Intern Med,"Internal medicine (Tokyo, Japan)",9204241,IM,"['Communicable Disease Control/*legislation & jurisprudence', 'Communicable Diseases/epidemiology', 'Communicable Diseases, Emerging/*epidemiology/*prevention & control', 'Humans', 'Japan/epidemiology', 'Population Surveillance']",,,,2002/02/13 10:00,2002/10/22 04:00,['2002/02/13 10:00'],"['2002/02/13 10:00 [pubmed]', '2002/10/22 04:00 [medline]', '2002/02/13 10:00 [entrez]']",['10.2169/internalmedicine.41.61 [doi]'],ppublish,Intern Med. 2002 Jan;41(1):61-2. doi: 10.2169/internalmedicine.41.61.,,,,,,,,,,,,,,,,,
26555388,NLM,MEDLINE,20161013,20181202,1532-0987 (Electronic) 0891-3668 (Linking),35,2,2016 Feb,"33rd Annual Meeting of the European Society for Paediatric Infectious Diseases in Leipzig, Germany.",209-10,10.1097/INF.0000000000000985 [doi],,,"['Borte, Michael', 'Schuster, Volker']","['Borte M', 'Schuster V']","['From the *Hospital for Children and Adolescents, St. Georg Hospital; and daggerUniversity of Leipzig, Leipzig, Germany.']",['eng'],['Congress'],,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/*epidemiology/therapy', 'Germany', 'Global Health', 'Humans', 'Infectious Disease Medicine/*methods/trends', 'Pediatrics/*methods/trends', 'Societies, Medical']",,,,2015/11/12 06:00,2016/10/14 06:00,['2015/11/12 06:00'],"['2015/11/12 06:00 [entrez]', '2015/11/12 06:00 [pubmed]', '2016/10/14 06:00 [medline]']",['10.1097/INF.0000000000000985 [doi]'],ppublish,Pediatr Infect Dis J. 2016 Feb;35(2):209-10. doi: 10.1097/INF.0000000000000985.,,,,,,,,,,,,,,,,,
27915000,NLM,MEDLINE,20170502,20180507,1873-0442 (Electronic) 1477-8939 (Linking),14,6,2016 Nov-Dec,Drug resistant pathogens and travel: No road map but a new initiative from Travel Medicine and Infectious Disease.,543-545,S1477-8939(16)30199-5 [pii] 10.1016/j.tmaid.2016.11.018 [doi],,,"['Schlagenhauf, Patricia', 'Gautret, Philippe', 'Rodriguez-Morales, Alfonso J', 'Jones, Michael E', 'Toovey, Stephen', 'Petersen, Eskild', 'Chen, Lin H']","['Schlagenhauf P', 'Gautret P', 'Rodriguez-Morales AJ', 'Jones ME', 'Toovey S', 'Petersen E', 'Chen LH']","['University of Zurich Centre for Travel Medicine, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001 Zurich, Switzerland. Electronic address: patricia.schlagenhauf@uzh.ch.', 'University Hospital Institute for Infectious and Tropical Diseases, Aix-Marseille University, Marseille, France.', 'Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia.', 'Spire Shawfair Park Hospital, 10 Easter Shawfair, Edinburgh, Scotland, UK.', 'Pegasus Research, 4103 Bottmingen, Switzerland.', 'Department of Infectious Diseases, The Royal Hospital, Muscat, Oman and the Institute of Clinical Medicine, University of Aarhus, Denmark.', 'Travel Medicine Center, Mount Auburn Hospital, Cambridge, MA; Harvard Medical School, Boston, MA, USA.']",['eng'],"['Editorial', 'Introductory Journal Article']",20161130,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,IM,"['Bacteria/pathogenicity', 'Communicable Diseases/microbiology/parasitology/*transmission/virology', '*Drug Resistance', 'Humans', '*Travel']",,,,2016/12/05 06:00,2017/05/04 06:00,['2016/12/05 06:00'],"['2016/11/26 00:00 [received]', '2016/11/29 00:00 [accepted]', '2016/12/05 06:00 [pubmed]', '2017/05/04 06:00 [medline]', '2016/12/05 06:00 [entrez]']","['S1477-8939(16)30199-5 [pii]', '10.1016/j.tmaid.2016.11.018 [doi]']",ppublish,Travel Med Infect Dis. 2016 Nov-Dec;14(6):543-545. doi: 10.1016/j.tmaid.2016.11.018. Epub 2016 Nov 30.,,,,,,,,,,,,,,,,,
18800937,NLM,MEDLINE,20081023,20080919,1537-6591 (Electronic) 1058-4838 (Linking),47,8,2008 Oct 15,On the greatly exaggerated reports of the death of infectious diseases.,1113-4,10.1086/592123 [doi],,,"['Pier, Gerald B']",['Pier GB'],,['eng'],"['Comment', 'Historical Article', 'Letter']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Diseases/*epidemiology/*history', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Incidence']",,,,2008/09/20 09:00,2008/10/24 09:00,['2008/09/20 09:00'],"['2008/09/20 09:00 [pubmed]', '2008/10/24 09:00 [medline]', '2008/09/20 09:00 [entrez]']",['10.1086/592123 [doi]'],ppublish,Clin Infect Dis. 2008 Oct 15;47(8):1113-4. doi: 10.1086/592123.,,,,,,,,['Clin Infect Dis. 2008 Jul 15;47(2):294. PMID: 18564938'],,,,,,,,,
18874031,NLM,MEDLINE,20081016,20201005,0369-8300 (Print) 0369-8300 (Linking),38,25,1948 Jul 3,[Infectious diseases in 1948].,309-17,,,,"['DOPTER, C']",['DOPTER C'],,['fre'],['Journal Article'],,France,Paris Med,Paris medical,19520510R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Public Health']",,['NLM'],"['*INFECTIOUS DISEASES/epidemiology and statistics', '*PUBLIC HEALTH']",1948/07/03 00:00,2008/11/01 09:00,['1948/07/03 00:00'],"['1948/07/03 00:00 [pubmed]', '2008/11/01 09:00 [medline]', '1948/07/03 00:00 [entrez]']",,ppublish,Paris Med. 1948 Jul 3;38(25):309-17.,,,,,,,,,Les maladies infectieuses en 1948.,,,['CLML: 4815:764b'],,,,,
14692555,NLM,MEDLINE,20040123,20071115,0022-4510 (Print) 0022-4510 (Linking),44,12,2003 Dec,Congress 2004: geriatric cats and feline infectious diseases.,569-70,,,,"['Wilson, Jackie']",['Wilson J'],,['eng'],['News'],,England,J Small Anim Pract,The Journal of small animal practice,0165053,IM,"['*Aging', 'Animals', 'Cat Diseases/*diagnosis/*therapy', 'Cats', 'Communicable Diseases/diagnosis/therapy/*veterinary', 'Congresses as Topic']",,,,2003/12/25 05:00,2004/01/24 05:00,['2003/12/25 05:00'],"['2003/12/25 05:00 [pubmed]', '2004/01/24 05:00 [medline]', '2003/12/25 05:00 [entrez]']",,ppublish,J Small Anim Pract. 2003 Dec;44(12):569-70.,,,,,,,,,,,,,,,,,
8371724,NLM,MEDLINE,19931014,20051116,0208-0613 (Print) 0208-0613 (Linking),,4,1993 Jul-Aug,[Diagnosis of infectious diseases using the polymerase chain reaction].,3-8,,,,"['Aksenov, M Iu', 'Gintsburg, A L']","['Aksenov MIu', 'Gintsburg AL']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Mol Gen Mikrobiol Virusol,"Molekuliarnaia genetika, mikrobiologiia i virusologiia",9315607,IM,"['Communicable Diseases/*diagnosis/genetics/metabolism', 'Genes, Bacterial', 'Genes, Viral', 'Humans', '*Polymerase Chain Reaction']",,,,1993/07/01 00:00,1993/07/01 00:01,['1993/07/01 00:00'],"['1993/07/01 00:00 [pubmed]', '1993/07/01 00:01 [medline]', '1993/07/01 00:00 [entrez]']",,ppublish,Mol Gen Mikrobiol Virusol. 1993 Jul-Aug;(4):3-8.,,,,,,56,,,Diagnostika infektsionnykh zabolevanii s pomoshch'iu metoda polimeraznoi tsepnoi reaktsii.,,,,,,,,
11434536,NLM,MEDLINE,20011204,20191105,1120-009X (Print) 1120-009X (Linking),13 Suppl 1,,2001 Apr,Infectious diseases on the 21st century doorstep.,7-10,,"Accelerating change can be expected to occur in the fields of Clinical Microbiology and Infectious Diseases. New pathogens, new diseases, new technologies, new vaccines and new treatment modalities will descend on us with increasing frequency in the decade ahead. In order to cope with and even appreciate change, we need to increase our commitment to training, recruiting and retaining health professionals in these disciplines, enhance our research programs, and remain enthusiastic about the benefits offered by skilled, knowledgeable practitioners to our patients. Infectious disease deaths have been increasing during the '90's in most societies. We must reverse this!",,"['Ronald, A']",['Ronald A'],"['Medical Microbiology, University of Manitoba, Winnipeg, Canada. maronald@escape.ca']",['eng'],['Journal Article'],,England,J Chemother,"Journal of chemotherapy (Florence, Italy)",8907348,IM,"['Communicable Diseases/drug therapy/*epidemiology', 'Education, Medical/trends', 'Forecasting', 'Humans', '*Public Health']",,,,2001/07/04 10:00,2002/01/05 10:01,['2001/07/04 10:00'],"['2001/07/04 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/07/04 10:00 [entrez]']",['10.1080/1120009x.2001.11782321 [doi]'],ppublish,J Chemother. 2001 Apr;13 Suppl 1:7-10. doi: 10.1080/1120009x.2001.11782321.,,,,,,,,,,,,,,,,,
12141049,NLM,MEDLINE,20020913,20200716,0372-9311 (Print) 0372-9311 (Linking),,3,2002 May-Jun,[Identification (definition) of outbreaks of infectious diseases].,92-7,,,,"['Cherkasskii, V L']",['Cherkasskii VL'],"['Central Research Institute of Epidemiology, Moscow.']",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/*epidemiology/etiology', '*Disease Outbreaks', 'Humans', 'Russia/epidemiology']",,,,2002/07/27 10:00,2002/09/14 10:01,['2002/07/27 10:00'],"['2002/07/27 10:00 [pubmed]', '2002/09/14 10:01 [medline]', '2002/07/27 10:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2002 May-Jun;(3):92-7.,,,,,,7,,,Identifikatsiia (definitsiia) vspyshek infektsionnykh boleznei.,,,,,,,,
12717998,NLM,MEDLINE,20030718,20111117,0047-1852 (Print) 0047-1852 (Linking),61 Suppl 3,,2003 Mar,[Immunoassay for rapid diagnosis of infectious diseases].,368-72,,,,"['Mitsuda, Toshihiro']",['Mitsuda T'],"['Division of Clinical Laboratory Medicine, School of Medicine, Yokohama City University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Chromatography/*methods', 'Communicable Diseases/*diagnosis/etiology', 'Humans', 'Immunoassay/*methods', 'Immunoenzyme Techniques/*methods', 'Luminescent Measurements']",,,,2003/04/30 05:00,2003/07/19 05:00,['2003/04/30 05:00'],"['2003/04/30 05:00 [pubmed]', '2003/07/19 05:00 [medline]', '2003/04/30 05:00 [entrez]']",,ppublish,Nihon Rinsho. 2003 Mar;61 Suppl 3:368-72.,,,,,,8,,,,,,,,,,,
10615653,NLM,MEDLINE,20000309,20041117,0935-8943 (Print) 0935-8943 (Linking),78,11,1999 Nov,[Infectious diseases in childhood].,612,,,,"['Luckhaupt, H']",['Luckhaupt H'],"['HNO-Klinik der Ruhr-Universitat St. Elisabeth-Hospital, Bochum.']",['ger'],['Journal Article'],,Germany,Laryngorhinootologie,Laryngo- rhino- otologie,8912371,IM,"['Age Factors', 'Child', 'Communicable Diseases/*diagnosis/epidemiology/microbiology', 'Germany/epidemiology', 'Humans', 'Otorhinolaryngologic Diseases/*diagnosis/epidemiology/microbiology']",,,,2000/01/01 09:00,2000/03/11 09:00,['2000/01/01 09:00'],"['2000/01/01 09:00 [pubmed]', '2000/03/11 09:00 [medline]', '2000/01/01 09:00 [entrez]']",,ppublish,Laryngorhinootologie. 1999 Nov;78(11):612.,,,,,,,,,Infektiologie im Kindesalter.,,,,,,,,
13019154,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4810,1953 Mar 14,INFECTIOUS diseases and vital statistics.,627-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2015576,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1953/03/14 00:00,1953/03/14 00:01,['1953/03/14 00:00'],"['1953/03/14 00:00 [pubmed]', '1953/03/14 00:01 [medline]', '1953/03/14 00:00 [entrez]']",,ppublish,Br Med J. 1953 Mar 14;1(4810):627-9.,,,,,,,,,,,,['CLML: 5323:44057:131:592'],,,,,
13019128,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4809,1953 Mar 7,INFECTIOUS diseases and vital statistics.,571-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2015543,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1953/03/07 00:00,1953/03/07 00:01,['1953/03/07 00:00'],"['1953/03/07 00:00 [pubmed]', '1953/03/07 00:01 [medline]', '1953/03/07 00:00 [entrez]']",,ppublish,Br Med J. 1953 Mar 7;1(4809):571-3.,,,,,,,,,,,,['CLML: 5323:44031:131:592'],,,,,
12978373,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4789,1952 Oct 18,INFECTIOUS diseases and vital statistics.,885-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021716,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/10/18 00:00,1952/10/18 00:01,['1952/10/18 00:00'],"['1952/10/18 00:00 [pubmed]', '1952/10/18 00:01 [medline]', '1952/10/18 00:00 [entrez]']",,ppublish,Br Med J. 1952 Oct 18;2(4789):885-6.,,,,,,,,,,,,['CLML: 5323:2604:131:592'],,,,,
12978352,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4788,1952 Oct 11,INFECTIOUS diseases and vital statistics.,838,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021504,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/10/11 00:00,1952/10/11 00:01,['1952/10/11 00:00'],"['1952/10/11 00:00 [pubmed]', '1952/10/11 00:01 [medline]', '1952/10/11 00:00 [entrez]']",,ppublish,Br Med J. 1952 Oct 11;2(4788):838.,,,,,,,,,,,,['CLML: 5323:2583:131:592'],,,,,
14935357,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4776,1952 Jul 19,INFECTIOUS diseases and vital statistics.,170-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021315,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/07/19 00:00,1952/07/19 00:01,['1952/07/19 00:00'],"['1952/07/19 00:00 [pubmed]', '1952/07/19 00:01 [medline]', '1952/07/19 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jul 19;2(4776):170-1.,,,,,,,,,,,,['CLML: 5222:21495:113:495'],,,,,
14935316,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4774,1952 Jul 5,INFECTIOUS diseases and vital statistics.,48-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2020893,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/07/05 00:00,1952/07/05 00:01,['1952/07/05 00:00'],"['1952/07/05 00:00 [pubmed]', '1952/07/05 00:01 [medline]', '1952/07/05 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jul 5;2(4774):48-9.,,,,,,,,,,,,['CLML: 5222:21454:113:495'],,,,,
14935291,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4773,1952 Jun 28,INFECTIOUS diseases and vital statistics.,1414-5,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023834,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/06/28 00:00,1952/06/28 00:01,['1952/06/28 00:00'],"['1952/06/28 00:00 [pubmed]', '1952/06/28 00:01 [medline]', '1952/06/28 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jun 28;1(4773):1414-5.,,,,,,,,,,,,['CLML: 5222:21429:113:495'],,,,,
14925443,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4770,1952 Jun 7,INFECTIOUS diseases and vital statistics.,1257,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023620,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/06/07 00:00,1952/06/07 00:01,['1952/06/07 00:00'],"['1952/06/07 00:00 [pubmed]', '1952/06/07 00:01 [medline]', '1952/06/07 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jun 7;1(4770):1257.,,,,,,,,,,,,['CLML: 5222:11431:113'],,,,,
14916162,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4762,1952 Apr 12,INFECTIOUS diseases and vital statistics.,826-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023008,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/04/12 00:00,1952/04/12 00:01,['1952/04/12 00:00'],"['1952/04/12 00:00 [pubmed]', '1952/04/12 00:01 [medline]', '1952/04/12 00:00 [entrez]']",,ppublish,Br Med J. 1952 Apr 12;1(4762):826-7.,,,,,,,,,,,,['CLML: 5222:2016:113:495'],,,,,
14896159,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4754,1952 Feb 16,INFECTIOUS diseases and vital statistics.,391-2,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022559,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/02/16 00:00,1952/02/16 00:01,['1952/02/16 00:00'],"['1952/02/16 00:00 [pubmed]', '1952/02/16 00:01 [medline]', '1952/02/16 00:00 [entrez]']",,ppublish,Br Med J. 1952 Feb 16;1(4754):391-2.,,,,,,,,,,,,['CLML: 5221:26612:90'],,,,,
14896119,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4752,1952 Feb 2,INFECTIOUS diseases and vital statistics.,281-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022626,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/02/02 00:00,1952/02/02 00:01,['1952/02/02 00:00'],"['1952/02/02 00:00 [pubmed]', '1952/02/02 00:01 [medline]', '1952/02/02 00:00 [entrez]']",,ppublish,Br Med J. 1952 Feb 2;1(4752):281-3.,,,,,,,,,,,,['CLML: 5221:26572:90:407'],,,,,
14896052,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4749,1952 Jan 12,INFECTIOUS diseases and vital statistics.,113-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022488,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/01/12 00:00,1952/01/12 00:01,['1952/01/12 00:00'],"['1952/01/12 00:00 [pubmed]', '1952/01/12 00:01 [medline]', '1952/01/12 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jan 12;1(4749):113-4.,,,,,,,,,,,,['CLML: 5221:26505:90:407'],,,,,
14886652,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4746,1951 Dec 22,INFECTIOUS diseases and vital statistics.,1530-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/12/22 00:00,1951/12/22 00:01,['1951/12/22 00:00'],"['1951/12/22 00:00 [pubmed]', '1951/12/22 00:01 [medline]', '1951/12/22 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 22;2(4746):1530-1.,,,,,,,,,,,,['CLML: 5221:17021:90:407'],,,,,
14879144,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4745,1951 Dec 15,INFECTIOUS diseases and vital statistics.,1470-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/12/15 00:00,1951/12/15 00:01,['1951/12/15 00:00'],"['1951/12/15 00:00 [pubmed]', '1951/12/15 00:01 [medline]', '1951/12/15 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 15;2(4745):1470-1.,,,,,,,,,,,,['CLML: 5221:9415:90:407'],,,,,
14879096,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4743,1951 Dec 1,INFECTIOUS diseases and vital statistics.,1353-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070408,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/12/01 00:00,1951/12/01 00:01,['1951/12/01 00:00'],"['1951/12/01 00:00 [pubmed]', '1951/12/01 00:01 [medline]', '1951/12/01 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 1;2(4743):1353-4.,,,,,,,,,,,,['CLML: 5221:9367:90:407'],,,,,
14869745,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4735,1951 Oct 6,INFECTIOUS diseases and vital statistics.,857-8,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070045,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/10/06 00:00,1951/10/06 00:01,['1951/10/06 00:00'],"['1951/10/06 00:00 [pubmed]', '1951/10/06 00:01 [medline]', '1951/10/06 00:00 [entrez]']",,ppublish,Br Med J. 1951 Oct 6;2(4735):857-8.,,,,,,,,,,,,['CLML: 5221:1963:90:407'],,,,,
13009272,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4808,1953 Feb 28,INFECTIOUS diseases and vital statistics.,515-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2015404,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1953/02/28 00:00,1953/02/28 00:01,['1953/02/28 00:00'],"['1953/02/28 00:00 [pubmed]', '1953/02/28 00:01 [medline]', '1953/02/28 00:00 [entrez]']",,ppublish,Br Med J. 1953 Feb 28;1(4808):515-7.,,,,,,,,,,,,['CLML: 5323:33993:131:592'],,,,,
12997787,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4798,1952 Dec 20,INFECTIOUS diseases and vital statistics.,1365-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022187,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/12/20 00:00,1952/12/20 00:01,['1952/12/20 00:00'],"['1952/12/20 00:00 [pubmed]', '1952/12/20 00:01 [medline]', '1952/12/20 00:00 [entrez]']",,ppublish,Br Med J. 1952 Dec 20;2(4798):1365-7.,,,,,,,,,,,,['CLML: 5323:22334:131:592'],,,,,
12987745,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4792,1952 Nov 8,INFECTIOUS diseases and vital statistics.,1053-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022009,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/11/08 00:00,1952/11/08 00:01,['1952/11/08 00:00'],"['1952/11/08 00:00 [pubmed]', '1952/11/08 00:01 [medline]', '1952/11/08 00:00 [entrez]']",,ppublish,Br Med J. 1952 Nov 8;2(4792):1053-4.,,,,,,,,,,,,['CLML: 5323:12053:131:592'],,,,,
14944839,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4780,1952 Aug 16,INFECTIOUS diseases and vital statistics.,398-400,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021059,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/08/16 00:00,1952/08/16 00:01,['1952/08/16 00:00'],"['1952/08/16 00:00 [pubmed]', '1952/08/16 00:01 [medline]', '1952/08/16 00:00 [entrez]']",,ppublish,Br Med J. 1952 Aug 16;2(4780):398-400.,,,,,,,,,,,,['CLML: 5222:31175:113:495'],,,,,
14935424,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4779,1952 Aug 9,INFECTIOUS diseases and vital statistics.,346-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2020953,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/08/09 00:00,1952/08/09 00:01,['1952/08/09 00:00'],"['1952/08/09 00:00 [pubmed]', '1952/08/09 00:01 [medline]', '1952/08/09 00:00 [entrez]']",,ppublish,Br Med J. 1952 Aug 9;2(4779):346-7.,,,,,,,,,,,,['CLML: 5222:21562:113:495'],,,,,
14935337,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4775,1952 Jul 12,INFECTIOUS diseases and vital statistics.,102-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021262,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/07/12 00:00,1952/07/12 00:01,['1952/07/12 00:00'],"['1952/07/12 00:00 [pubmed]', '1952/07/12 00:01 [medline]', '1952/07/12 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jul 12;2(4775):102-3.,,,,,,,,,,,,['CLML: 5222:21475:113:495'],,,,,
14925463,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4771,1952 Jun 14,INFECTIOUS diseases and vital statistics.,1308-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023708,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/06/14 00:00,1952/06/14 00:01,['1952/06/14 00:00'],"['1952/06/14 00:00 [pubmed]', '1952/06/14 00:01 [medline]', '1952/06/14 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jun 14;1(4771):1308-9.,,,,,,,,,,,,['CLML: 5222:11451:113:495'],,,,,
14925404,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4768,1952 May 24,INFECTIOUS diseases and vital statistics.,1140-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023529,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/05/24 00:00,1952/05/24 00:01,['1952/05/24 00:00'],"['1952/05/24 00:00 [pubmed]', '1952/05/24 00:01 [medline]', '1952/05/24 00:00 [entrez]']",,ppublish,Br Med J. 1952 May 24;1(4768):1140-1.,,,,,,,,,,,,['CLML: 5222:11392:113:495'],,,,,
14916227,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4765,1952 May 3,INFECTIOUS diseases and vital statistics.,980-2,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023401,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/05/03 00:00,1952/05/03 00:01,['1952/05/03 00:00'],"['1952/05/03 00:00 [pubmed]', '1952/05/03 00:01 [medline]', '1952/05/03 00:00 [entrez]']",,ppublish,Br Med J. 1952 May 3;1(4765):980-2.,,,,,,,,,,,,['CLML: 5222:2081:113:495'],,,,,
14869852,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4740,1951 Nov 10,INFECTIOUS diseases and vital statistics.,1161-2,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2069894,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/11/10 00:00,1951/11/10 00:01,['1951/11/10 00:00'],"['1951/11/10 00:00 [pubmed]', '1951/11/10 00:01 [medline]', '1951/11/10 00:00 [entrez]']",,ppublish,Br Med J. 1951 Nov 10;2(4740):1161-2.,,,,,,,,,,,,['CLML: 5221:2070:90:407'],,,,,
14869828,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4739,1951 Nov 3,INFECTIOUS diseases and vital statistics.,1097-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070605,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/11/03 00:00,1951/11/03 00:01,['1951/11/03 00:00'],"['1951/11/03 00:00 [pubmed]', '1951/11/03 00:01 [medline]', '1951/11/03 00:00 [entrez]']",,ppublish,Br Med J. 1951 Nov 3;2(4739):1097-9.,,,,,,,,,,,,['CLML: 5221:2046:90:407'],,,,,
14869806,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4738,1951 Oct 27,INFECTIOUS diseases and vital statistics.,1035-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070293,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/10/27 00:00,1951/10/27 00:01,['1951/10/27 00:00'],"['1951/10/27 00:00 [pubmed]', '1951/10/27 00:01 [medline]', '1951/10/27 00:00 [entrez]']",,ppublish,Br Med J. 1951 Oct 27;2(4738):1035-7.,,,,,,,,,,,,['CLML: 5221:2024:90:407'],,,,,
14869788,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4737,1951 Oct 20,INFECTIOUS diseases and vital statistics.,980-2,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070547,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/10/20 00:00,1951/10/20 00:01,['1951/10/20 00:00'],"['1951/10/20 00:00 [pubmed]', '1951/10/20 00:01 [medline]', '1951/10/20 00:00 [entrez]']",,ppublish,Br Med J. 1951 Oct 20;2(4737):980-2.,,,,,,,,,,,,['CLML: 5221:2006:90:407'],,,,,
14869764,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4736,1951 Oct 13,INFECTIOUS diseases and vital statistics.,915-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070201,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/10/13 00:00,1951/10/13 00:01,['1951/10/13 00:00'],"['1951/10/13 00:00 [pubmed]', '1951/10/13 00:01 [medline]', '1951/10/13 00:00 [entrez]']",,ppublish,Br Med J. 1951 Oct 13;2(4736):915-6.,,,,,,,,,,,,['CLML: 5221:1982:90:407'],,,,,
14869711,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4733,1951 Sep 22,INFECTIOUS diseases and vital statistics.,742-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2069792,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/09/22 00:00,1951/09/22 00:01,['1951/09/22 00:00'],"['1951/09/22 00:00 [pubmed]', '1951/09/22 00:01 [medline]', '1951/09/22 00:00 [entrez]']",,ppublish,Br Med J. 1951 Sep 22;2(4733):742-3.,,,,,,,,,,,,['CLML: 5221:1929:90:407'],,,,,
14869692,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4732,1951 Sep 15,INFECTIOUS diseases and vital statistics.,684-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2069983,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/09/15 00:00,1951/09/15 00:01,['1951/09/15 00:00'],"['1951/09/15 00:00 [pubmed]', '1951/09/15 00:01 [medline]', '1951/09/15 00:00 [entrez]']",,ppublish,Br Med J. 1951 Sep 15;2(4732):684-6.,,,,,,,,,,,,['CLML: 5221:1910:90:407'],,,,,
12997840,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4800,1953 Jan 3,INFECTIOUS diseases and vital statistics.,50-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2015106,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1953/01/03 00:00,1953/01/03 00:01,['1953/01/03 00:00'],"['1953/01/03 00:00 [pubmed]', '1953/01/03 00:01 [medline]', '1953/01/03 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jan 3;1(4800):50-1.,,,,,,,,,,,,['CLML: 5323:22387:131:592'],,,,,
12987724,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4791,1952 Nov 1,INFECTIOUS diseases and vital statistics.,1002-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021776,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/11/01 00:00,1952/11/01 00:01,['1952/11/01 00:00'],"['1952/11/01 00:00 [pubmed]', '1952/11/01 00:01 [medline]', '1952/11/01 00:00 [entrez]']",,ppublish,Br Med J. 1952 Nov 1;2(4791):1002-3.,,,,,,,,,,,,['CLML: 5323:12032:131:592'],,,,,
12978332,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4787,1952 Oct 4,INFECTIOUS diseases and vital statistics.,785-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021643,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/10/04 00:00,1952/10/04 00:01,['1952/10/04 00:00'],"['1952/10/04 00:00 [pubmed]', '1952/10/04 00:01 [medline]', '1952/10/04 00:00 [entrez]']",,ppublish,Br Med J. 1952 Oct 4;2(4787):785-6.,,,,,,,,,,,,['CLML: 5323:2563:131:592'],,,,,
12978308,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4786,1952 Sep 27,INFECTIOUS diseases and vital statistics.,729-30,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021582,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/09/27 00:00,1952/09/27 00:01,['1952/09/27 00:00'],"['1952/09/27 00:00 [pubmed]', '1952/09/27 00:01 [medline]', '1952/09/27 00:00 [entrez]']",,ppublish,Br Med J. 1952 Sep 27;2(4786):729-30.,,,,,,,,,,,,['CLML: 5323:2539:131:592'],,,,,
14954189,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4784,1952 Sep 13,INFECTIOUS diseases and vital statistics.,620-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021472,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/09/13 00:00,1952/09/13 00:01,['1952/09/13 00:00'],"['1952/09/13 00:00 [pubmed]', '1952/09/13 00:01 [medline]', '1952/09/13 00:00 [entrez]']",,ppublish,Br Med J. 1952 Sep 13;2(4784):620-1.,,,,,,,,,,,,['CLML: 5222:40647:113:495'],,,,,
14944902,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4782,1952 Aug 30,INFECTIOUS diseases and vital statistics.,520-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021385,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/08/30 00:00,1952/08/30 00:01,['1952/08/30 00:00'],"['1952/08/30 00:00 [pubmed]', '1952/08/30 00:01 [medline]', '1952/08/30 00:00 [entrez]']",,ppublish,Br Med J. 1952 Aug 30;2(4782):520-1.,,,,,,,,,,,,['CLML: 5222:31238:113'],,,,,
14944861,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4781,1952 Aug 23,INFECTIOUS diseases and vital statistics.,449-51,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021143,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/08/23 00:00,1952/08/23 00:01,['1952/08/23 00:00'],"['1952/08/23 00:00 [pubmed]', '1952/08/23 00:01 [medline]', '1952/08/23 00:00 [entrez]']",,ppublish,Br Med J. 1952 Aug 23;2(4781):449-51.,,,,,,,,,,,,['CLML: 5222:31197:113:495'],,,,,
14935402,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4778,1952 Aug 2,INFECTIOUS diseases and vital statistics.,293-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2020978,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/08/02 00:00,1952/08/02 00:01,['1952/08/02 00:00'],"['1952/08/02 00:00 [pubmed]', '1952/08/02 00:01 [medline]', '1952/08/02 00:00 [entrez]']",,ppublish,Br Med J. 1952 Aug 2;2(4778):293-4.,,,,,,,,,,,,['CLML: 5222:21540:113:495'],,,,,
14935382,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4777,1952 Jul 26,INFECTIOUS diseases and vital statistics.,240-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021129,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/07/26 00:00,1952/07/26 00:01,['1952/07/26 00:00'],"['1952/07/26 00:00 [pubmed]', '1952/07/26 00:01 [medline]', '1952/07/26 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jul 26;2(4777):240-1.,,,,,,,,,,,,['CLML: 5222:21520:113:495'],,,,,
14925378,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4767,1952 May 17,INFECTIOUS diseases and vital statistics.,1088-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023295,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/05/17 00:00,1952/05/17 00:01,['1952/05/17 00:00'],"['1952/05/17 00:00 [pubmed]', '1952/05/17 00:01 [medline]', '1952/05/17 00:00 [entrez]']",,ppublish,Br Med J. 1952 May 17;1(4767):1088-9.,,,,,,,,,,,,['CLML: 5222:11366:113:495'],,,,,
14925360,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4766,1952 May 10,INFECTIOUS diseases and vital statistics.,1037-8,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/05/10 00:00,1952/05/10 00:01,['1952/05/10 00:00'],"['1952/05/10 00:00 [pubmed]', '1952/05/10 00:01 [medline]', '1952/05/10 00:00 [entrez]']",,ppublish,Br Med J. 1952 May 10;1(4766):1037-8.,,,,,,,,,,,,['CLML: 5222:11348:113:495'],,,,,
14916203,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4764,1952 Apr 26,INFECTIOUS diseases and vital statistics.,927-8,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023362,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/04/26 00:00,1952/04/26 00:01,['1952/04/26 00:00'],"['1952/04/26 00:00 [pubmed]', '1952/04/26 00:01 [medline]', '1952/04/26 00:00 [entrez]']",,ppublish,Br Med J. 1952 Apr 26;1(4764):927-8.,,,,,,,,,,,,['CLML: 5222:2057:113:495'],,,,,
14896099,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4751,1952 Jan 26,INFECTIOUS diseases and vital statistics.,226-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022382,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/01/26 00:00,1952/01/26 00:01,['1952/01/26 00:00'],"['1952/01/26 00:00 [pubmed]', '1952/01/26 00:01 [medline]', '1952/01/26 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jan 26;1(4751):226-7.,,,,,,,,,,,,['CLML: 5221:26552:90:407'],,,,,
14896076,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4750,1952 Jan 19,INFECTIOUS diseases and vital statistics.,169-71,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022282,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/01/19 00:00,1952/01/19 00:01,['1952/01/19 00:00'],"['1952/01/19 00:00 [pubmed]', '1952/01/19 00:01 [medline]', '1952/01/19 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jan 19;1(4750):169-71.,,,,,,,,,,,,['CLML: 5221:26529:90:407'],,,,,
14896029,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4748,1952 Jan 5,INFECTIOUS diseases and vital statistics.,53-5,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022227,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/01/05 00:00,1952/01/05 00:01,['1952/01/05 00:00'],"['1952/01/05 00:00 [pubmed]', '1952/01/05 00:01 [medline]', '1952/01/05 00:00 [entrez]']",,ppublish,Br Med J. 1952 Jan 5;1(4748):53-5.,,,,,,,,,,,,['CLML: 5221:26482:90:407'],,,,,
12997761,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4797,1952 Dec 13,INFECTIOUS diseases and vital statistics.,1315-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022469,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/12/13 00:00,1952/12/13 00:01,['1952/12/13 00:00'],"['1952/12/13 00:00 [pubmed]', '1952/12/13 00:01 [medline]', '1952/12/13 00:00 [entrez]']",,ppublish,Br Med J. 1952 Dec 13;2(4797):1315-6.,,,,,,,,,,,,['CLML: 5323:22308:131:592'],,,,,
12978400,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4790,1952 Oct 25,INFECTIOUS diseases and vital statistics.,948-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021820,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/10/25 00:00,1952/10/25 00:01,['1952/10/25 00:00'],"['1952/10/25 00:00 [pubmed]', '1952/10/25 00:01 [medline]', '1952/10/25 00:00 [entrez]']",,ppublish,Br Med J. 1952 Oct 25;2(4790):948-9.,,,,,,,,,,,,['CLML: 5323:2631:131:592'],,,,,
14954210,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4785,1952 Sep 20,INFECTIOUS diseases and vital statistics.,673-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021653,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/09/20 00:00,1952/09/20 00:01,['1952/09/20 00:00'],"['1952/09/20 00:00 [pubmed]', '1952/09/20 00:01 [medline]', '1952/09/20 00:00 [entrez]']",,ppublish,Br Med J. 1952 Sep 20;2(4785):673-4.,,,,,,,,,,,,['CLML: 5222:40668:113:495'],,,,,
14954169,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4783,1952 Sep 6,INFECTIOUS diseases and vital statistics.,570-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2021227,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/09/06 00:00,1952/09/06 00:01,['1952/09/06 00:00'],"['1952/09/06 00:00 [pubmed]', '1952/09/06 00:01 [medline]', '1952/09/06 00:00 [entrez]']",,ppublish,Br Med J. 1952 Sep 6;2(4783):570-1.,,,,,,,,,,,,['CLML: 5222:40627:113:495'],,,,,
14925422,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4769,1952 May 31,INFECTIOUS diseases and vital statistics.,1202-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2023656,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/05/31 00:00,1952/05/31 00:01,['1952/05/31 00:00'],"['1952/05/31 00:00 [pubmed]', '1952/05/31 00:01 [medline]', '1952/05/31 00:00 [entrez]']",,ppublish,Br Med J. 1952 May 31;1(4769):1202-3.,,,,,,,,,,,,['CLML: 5222:11410:113:495'],,,,,
14916180,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4763,1952 Apr 19,INFECTIOUS diseases and vital statistics.,875-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Smallpox', '*Variola virus', '*Vital Statistics']",PMC2023250,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX', '*VITAL STATISTICS']",1952/04/19 00:00,1952/04/19 00:01,['1952/04/19 00:00'],"['1952/04/19 00:00 [pubmed]', '1952/04/19 00:01 [medline]', '1952/04/19 00:00 [entrez]']",,ppublish,Br Med J. 1952 Apr 19;1(4763):875-7.,,,,,,,,,,,,['CLML: 5222:2034:113:423:495'],,,,,
14916139,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4761,1952 Apr 5,INFECTIOUS diseases and vital statistics.,774-5,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Smallpox', '*Variola virus', '*Vital Statistics']",PMC2022836,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX', '*VITAL STATISTICS']",1952/04/05 00:00,1952/04/05 00:01,['1952/04/05 00:00'],"['1952/04/05 00:00 [pubmed]', '1952/04/05 00:01 [medline]', '1952/04/05 00:00 [entrez]']",,ppublish,Br Med J. 1952 Apr 5;1(4761):774-5.,,,,,,,,,,,,['CLML: 5222:1993:113:423:495'],,,,,
14879162,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4747,1951 Dec 29,INFECTIOUS diseases and vital statistics.,1589-90,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070484,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/12/29 00:00,1951/12/29 00:01,['1951/12/29 00:00'],"['1951/12/29 00:00 [pubmed]', '1951/12/29 00:01 [medline]', '1951/12/29 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 29;2(4747):1589-90.,,,,,,,,,,,,['CLML: 5221:9433:90:407'],,,,,
14879120,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4744,1951 Dec 8,INFECTIOUS diseases and vital statistics.,1409-11,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/12/08 00:00,1951/12/08 00:01,['1951/12/08 00:00'],"['1951/12/08 00:00 [pubmed]', '1951/12/08 00:01 [medline]', '1951/12/08 00:00 [entrez]']",,ppublish,Br Med J. 1951 Dec 8;2(4744):1409-11.,,,,,,,,,,,,['CLML: 5221:9391:90:407'],,,,,
14879069,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4742,1951 Nov 24,INFECTIOUS diseases and vital statistics.,1289-90,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['Anti-Bacterial Agents/*pharmacology', '*Antibiotics, Antitubercular', '*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070813,['NLM'],"['*ANTIBIOTICS/effects', '*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/11/24 00:00,1951/11/24 00:01,['1951/11/24 00:00'],"['1951/11/24 00:00 [pubmed]', '1951/11/24 00:01 [medline]', '1951/11/24 00:00 [entrez]']",,ppublish,Br Med J. 1951 Nov 24;2(4742):1289-90.,,,"['0 (Anti-Bacterial Agents)', '0 (Antibiotics, Antitubercular)']",,,,,,,,,['CLML: 5221:9340:27:90:407'],,,,,
14879054,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4741,1951 Nov 17,INFECTIOUS diseases and vital statistics.,1227-8,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070728,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/11/17 00:00,1951/11/17 00:01,['1951/11/17 00:00'],"['1951/11/17 00:00 [pubmed]', '1951/11/17 00:01 [medline]', '1951/11/17 00:00 [entrez]']",,ppublish,Br Med J. 1951 Nov 17;2(4741):1227-8.,,,,,,,,,,,,['CLML: 5221:9325:90:407'],,,,,
14869669,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4731,1951 Sep 8,INFECTIOUS diseases and vital statistics.,617-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2070072,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1951/09/08 00:00,1951/09/08 00:01,['1951/09/08 00:00'],"['1951/09/08 00:00 [pubmed]', '1951/09/08 00:01 [medline]', '1951/09/08 00:00 [entrez]']",,ppublish,Br Med J. 1951 Sep 8;2(4731):617-9.,,,,,,,,,,,,['CLML: 5221:1887:90:407'],,,,,
11685776,NLM,MEDLINE,20011217,20061115,0047-1860 (Print) 0047-1860 (Linking),49,9,2001 Sep,[Effective clinical information system closely connected with clinical laboratory data for infectious diseases].,887-93,,"Nowadays, information on clinical laboratory tests for infectious disease is almost supported by information on such as clinical, identical and susceptible microbiological tests. However, information support necessary for clinical diagnosis and therapy with clinically valuable data remains unsatisfactory. To offer more useful microbiological information to support clinics from clinical laboratory division, exchange of clinical information between clinical divisions, integrated systems of clinical information in the district and establishment of domestic and international information network et al are required. Establishment of these advanced total information network systems for clinical microbiological tests for infectious diseases may exceedingly contribute to earlier diagnosis, control and prevention of various infectious diseases.",,"['Tanimoto, A', 'Ikawa, S']","['Tanimoto A', 'Ikawa S']","['Division of Clinical Laboratory, Tottori University Hospital, Yonago 683-8504.']",['jpn'],"['English Abstract', 'Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['*Clinical Laboratory Information Systems', 'Communicable Disease Control', '*Communicable Diseases/diagnosis/microbiology', 'Computer Communication Networks', 'Databases, Factual', 'Humans', 'Microbiological Techniques']",,,,2001/11/01 10:00,2002/01/05 10:01,['2001/11/01 10:00'],"['2001/11/01 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/11/01 10:00 [entrez]']",,ppublish,Rinsho Byori. 2001 Sep;49(9):887-93.,,,,,,7,,,,,,,,,,,
12144316,NLM,MEDLINE,20020813,20190916,0363-3624 (Print) 0363-3624 (Linking),26,3,2001 May-Jun,Teaching undergraduate nursing students about infectious diseases.,110,,,,"['Jennings-Sanders, A']",['Jennings-Sanders A'],,['eng'],['News'],,United States,Nurse Educ,Nurse educator,7701902,,"['*Communicable Diseases/diagnosis/epidemiology/therapy', 'Community Health Nursing/education', '*Curriculum', 'Education, Nursing, Baccalaureate/*methods', 'Focus Groups', 'Games, Experimental', 'Humans', 'Students, Nursing', 'Teaching/*methods']",,,,2002/07/30 10:00,2002/08/14 10:01,['2002/07/30 10:00'],"['2002/07/30 10:00 [pubmed]', '2002/08/14 10:01 [medline]', '2002/07/30 10:00 [entrez]']",['10.1097/00006223-200105000-00003 [doi]'],ppublish,Nurse Educ. 2001 May-Jun;26(3):110. doi: 10.1097/00006223-200105000-00003.,,,,,,,,,,,,,,,,,
19374613,NLM,MEDLINE,20090729,20201219,0025-729X (Print) 0025-729X (Linking),190,8,2009 Apr 20,"The Australasian Society for Infectious Diseases guidelines for the diagnosis, management and prevention of infections in recently arrived refugees: an abridged outline.",421-5,,"About 13,000 refugees are currently accepted for migration into Australia each year, many of whom have spent protracted periods living in extremely disadvantaged circumstances. As a result, medical practitioners are increasingly managing recently arrived refugees with acute and chronic infectious diseases. The Australasian Society for Infectious Diseases has formulated guidelines for the diagnosis, management and prevention of infection in newly arrived refugees. This article is an abridged version of the guidelines, which are available in full at <http://www.asid.net.au>. All refugees should be offered a comprehensive health assessment, ideally within 1 month of arrival in Australia, that includes screening for and treatment of tuberculosis, malaria, blood-borne viral infections, schistosomiasis, helminth infection, sexually transmitted infections, and other infections (eg, Helicobacter pylori) as indicated by clinical assessment; and assessment of immunisation status, and catch-up immunisations where appropriate. The assessment can be undertaken by a general practitioner or within a multidisciplinary refugee health clinic, with use of an appropriate interpreter when required. The initial assessment should take place over at least two visits: the first for initial assessment and investigation and the second for review of results and treatment or referral.",,"['Murray, Ronan J', 'Davis, Joshua S', 'Burgner, David P', 'Hansen-Knarhoi, Meredith', 'Krause, Vicki', 'Biggs, Beverley-Ann', 'Lemoh, Christopher', 'Benson, Jill', 'Cherian, Sarah', 'Buttery, Jim', 'Paxton, Georgia']","['Murray RJ', 'Davis JS', 'Burgner DP', 'Hansen-Knarhoi M', 'Krause V', 'Biggs BA', 'Lemoh C', 'Benson J', 'Cherian S', 'Buttery J', 'Paxton G']","['Royal Perth Hospital and PathWest Laboratory Medicine WA, Perth, WA. ronan.murray@health.wa.gov.au']",['eng'],"['Journal Article', 'Practice Guideline']",,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Australia', 'Communicable Disease Control/*organization & administration', 'Communicable Diseases/*diagnosis/*therapy/transmission', 'Humans', '*Refugees']",,,,2009/04/21 09:00,2009/07/30 09:00,['2009/04/21 09:00'],"['2008/06/15 00:00 [received]', '2008/09/03 00:00 [accepted]', '2009/04/21 09:00 [entrez]', '2009/04/21 09:00 [pubmed]', '2009/07/30 09:00 [medline]']","['mur10728_fm [pii]', '10.5694/j.1326-5377.2009.tb02489.x [doi]']",ppublish,Med J Aust. 2009 Apr 20;190(8):421-5. doi: 10.5694/j.1326-5377.2009.tb02489.x.,,,,,,,,,,,"['Australasian Society for Infectious Diseases Refugee Health Guidelines Writing', 'Group']",,,,,,
21767666,NLM,MEDLINE,20120224,20181201,1567-7257 (Electronic) 1567-1348 (Linking),11,7,2011 Oct,Montpellier infectious diseases (MID): 1st annual meeting (2011).,1493-8,10.1016/j.meegid.2011.07.001 [doi],,,"['Sitbon, Marc', 'Biard-Piechaczyk, Martine', 'Robert, Vincent', 'Briant, Laurence', 'Kohler, Stephan', 'Labesse, Gilles', 'Devaux, Christian']","['Sitbon M', 'Biard-Piechaczyk M', 'Robert V', 'Briant L', 'Kohler S', 'Labesse G', 'Devaux C']","[""Centre d'etudes d'agents Pathogenes et Biotechnologies pour la Sante (CPBS), UMR5236, CNRS-UM1-UM2, Montpellier Cedex 5, France.""]",['eng'],['Congress'],20110713,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Animals', '*Communicable Diseases/immunology/therapy/transmission', 'Disease Reservoirs', 'Disease Vectors', 'Drug Design', 'Drug Resistance, Microbial', 'France', 'Host-Pathogen Interactions', 'Humans']",,,,2011/07/20 06:00,2012/03/01 06:00,['2011/07/20 06:00'],"['2011/06/30 00:00 [received]', '2011/07/01 00:00 [accepted]', '2011/07/20 06:00 [entrez]', '2011/07/20 06:00 [pubmed]', '2012/03/01 06:00 [medline]']","['S1567-1348(11)00235-8 [pii]', '10.1016/j.meegid.2011.07.001 [doi]']",ppublish,Infect Genet Evol. 2011 Oct;11(7):1493-8. doi: 10.1016/j.meegid.2011.07.001. Epub 2011 Jul 13.,,,,,,,,,,,,,,,,,
19855125,NLM,MEDLINE,20110222,20161125,1529-8795 (Electronic) 0031-5982 (Linking),52,4,2009 Autumn,"Richard Bradley: a unified, living agent theory of the cause of infectious diseases of plants, animals, and humans in the first decades of the 18th century.",566-78,10.1353/pbm.0.0124 [doi],"During the years 1714 to 1721, Richard Bradley, who was later to become the first Professor of Botany at Cambridge University, proposed a unified, unique, living agent theory of the cause of infectious diseases of plants and animals and the plague of humans. Bradley's agents included microscopic organisms, revealed by the studies of Robert Hooke and Antony van Leeuwenhoek. His theory derived from his experimental studies of plants and their diseases and from microscopic observation of animalcules in different naturally occurring and artificial environments. He concluded that there was a microscopic world of ""insects"" that lived and reproduced under the appropriate conditions, and that infectious diseases of plants were caused by such ""insects."" Since there are structural and functional similarities between plants and animals, Bradley concluded that microscopic organisms caused human and animal infectious diseases as well. However, his living agent cause of infectious diseases was not accepted by the contemporary scientific society.",,"['Santer, Melvin']",['Santer M'],"['Department of Biology, Haverford College, Haverford, PA 19041, USA. msanter@haverford.edu']",['eng'],"['Biography', 'Historical Article', 'Journal Article']",,United States,Perspect Biol Med,Perspectives in biology and medicine,0401132,IM,"['Animals', 'Communicable Diseases/etiology/*history/transmission', 'History, 18th Century', 'Humans', 'Microscopy/history', 'Philosophy, Medical/*history', 'Plant Diseases/etiology/*history', 'United Kingdom']",,,,2009/10/27 06:00,2011/02/23 06:00,['2009/10/27 06:00'],"['2009/10/27 06:00 [entrez]', '2009/10/27 06:00 [pubmed]', '2011/02/23 06:00 [medline]']","['S1529879509400061 [pii]', '10.1353/pbm.0.0124 [doi]']",ppublish,Perspect Biol Med. 2009 Autumn;52(4):566-78. doi: 10.1353/pbm.0.0124.,,,,,,,,,,,,,,,,['Bradley R'],"['Bradley, Richard']"
8374857,NLM,MEDLINE,19931021,20051116,0749-0690 (Print) 0749-0690 (Linking),9,3,1993 Aug,Infectious disease emergencies in the geriatric population.,559-75,,"Infectious diseases continue to be a common cause for emergency department visits among the elderly population. This phenomenon may be due to the existence of comorbid diseases as well as alterations in immune function with senescence. Diagnosis and acute management of specific infections are discussed in this article, including meningitis, endocarditis, urinary tract and skin infections, septic shock, and fever of unknown origin.",,"['Jacobs, L G']",['Jacobs LG'],"['Albert Einstein College of Medicine, Bronx, New York.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Geriatr Med,Clinics in geriatric medicine,8603766,IM,"['Aged', '*Communicable Diseases/immunology/microbiology/therapy', 'Emergencies', 'Humans', 'Immunization']",,,,1993/08/01 00:00,1993/08/01 00:01,['1993/08/01 00:00'],"['1993/08/01 00:00 [pubmed]', '1993/08/01 00:01 [medline]', '1993/08/01 00:00 [entrez]']",,ppublish,Clin Geriatr Med. 1993 Aug;9(3):559-75.,,,,,,78,,,,,,,,,,,
10959652,NLM,MEDLINE,20001213,20190826,0036-5548 (Print) 0036-5548 (Linking),32,4,2000,Hospital-treated infectious diseases in Western Pomeranian region in a 5-year surveillance: importance for travellers.,417-8,,"Retrospective analysis of the incidence of infectious diseases in the five-year period 1994-1998 as recorded by the Department of Infectious Diseases of the Pomeranian Medical School, has been presented. In this period contagious diseases were diagnosed in 3,863 adults with mean age of 42.8 +/- 33.5 y. Most patients still had viral liver diseases, but we observe some major changes in the epidemiology of infectious diseases in our region. There is an increased number of hospitalisations due to chronic hepatitis and liver cirrhosis as well as due to symptomatic HIV infections, whereas some acute diseases namely acute hepatitis B and infectious intoxication show decreasing tendency.",,"['Karpinska, E', 'Leonciuk, A', 'Wawrzynowicz-Syczewska, M', 'Boron-Kaczmarska, A']","['Karpinska E', 'Leonciuk A', 'Wawrzynowicz-Syczewska M', 'Boron-Kaczmarska A']","['Department of Infectious Diseases, Pomeranian Medical School, Szczecin, Poland.']",['eng'],['Journal Article'],,England,Scand J Infect Dis,Scandinavian journal of infectious diseases,0215333,IM,"['Adult', 'Aged', 'Communicable Diseases/*epidemiology/therapy', 'Hospitals', 'Humans', 'Middle Aged', 'Poland/epidemiology', 'Retrospective Studies', '*Travel']",,,,2000/08/26 11:00,2001/02/28 10:01,['2000/08/26 11:00'],"['2000/08/26 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/08/26 11:00 [entrez]']",['10.1080/003655400750045015 [doi]'],ppublish,Scand J Infect Dis. 2000;32(4):417-8. doi: 10.1080/003655400750045015.,,,,,,,,,,,,,,,,,
14887959,NLM,MEDLINE,20040215,20181201,0367-4800 (Print) 0367-4800 (Linking),32,10,1951 Oct,"INFECTIOUS diseases and epidemiological notes; vital statistics for 5 weeks ending 29th September, 1951.",313-4,,,,,,,['eng'],['Journal Article'],,Scotland,Glasgow Med J,Glasgow medical journal,17140140R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Pressure Ulcer', '*Vital Statistics']",PMC5973078,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*DECUBITUS ULCER']",1951/10/01 00:00,1951/10/01 00:01,['1951/10/01 00:00'],"['1951/10/01 00:00 [pubmed]', '1951/10/01 00:01 [medline]', '1951/10/01 00:00 [entrez]']",,ppublish,Glasgow Med J. 1951 Oct;32(10):313-4.,,,,,,,,,,,,['CLML: 5221:18328:90:103'],,,,,
30103157,NLM,MEDLINE,20190129,20200409,1873-4235 (Electronic) 0956-5663 (Print) 0956-5663 (Linking),119,,2018 Nov 15,Arch-shaped multiple-target sensing for rapid diagnosis and identification of emerging infectious pathogens.,79-85,S0956-5663(18)30595-5 [pii] 10.1016/j.bios.2018.08.007 [doi],"Rapid identification of emerging infectious pathogens is crucial for preventing public health threats. Various pathogen detection techniques have been introduced; however, most techniques are time-consuming and lack multiple-target detection specificity. Although multiple-target detection techniques can distinguish emerging infectious pathogens from related pathogens, direct amplification methods have not been widely examined. Here, we present a novel arch-shaped multiple-target sensor capable of rapid pathogen identification using direct amplification in clinical samples. In this study, an arch-shaped amplification containing primer sequences was designed to rapidly amplify multiple targets. Further, the sensing platform allowed for sensitive and specific detection of human coronavirus, Middle East respiratory syndrome, Zika virus, and Ebola virus down to several copies. This platform also simultaneously distinguished between Middle East respiratory syndrome and human coronavirus in clinical specimens within 20min. This arch-shaped multiple-target sensing assay can provide rapid, sensitive, and accurate diagnoses of emerging infectious diseases in clinical applications.",['Copyright (c) 2018 Elsevier B.V. All rights reserved.'],"['Koo, Bonhan', 'Hong, Ki Ho', 'Jin, Choong Eun', 'Kim, Ji Yeun', 'Kim, Sung-Han', 'Shin, Yong']","['Koo B', 'Hong KH', 'Jin CE', 'Kim JY', 'Kim SH', 'Shin Y']","['Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Biomedical Engineering Research Center, Asan Institute of Life Sciences, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea.', 'Department of Laboratory Medicine, Seoul Medical Center, Seoul, Republic of Korea.', 'Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Biomedical Engineering Research Center, Asan Institute of Life Sciences, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea.', 'Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.', 'Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: kimsunghanmd@hotmail.com.', 'Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Biomedical Engineering Research Center, Asan Institute of Life Sciences, Asan Medical Center, 88 Olympicro-43gil, Songpa-gu, Seoul, Republic of Korea. Electronic address: shinyongno1@gmail.com.']",['eng'],['Journal Article'],20180808,England,Biosens Bioelectron,Biosensors & bioelectronics,9001289,IM,"['Biosensing Techniques/*methods', 'Communicable Diseases/*diagnosis/virology', 'Communicable Diseases, Emerging/*diagnosis/virology', 'Humans', 'Nucleic Acid Amplification Techniques', 'Sensitivity and Specificity', 'Viruses/genetics']",PMC7126750,['NOTNLM'],"['Diagnosis', 'Ebola', 'Emerging infectious pathogen', 'Middle East respiratory syndrome', 'Pathogens identification', 'Zika']",2018/08/14 06:00,2019/01/30 06:00,['2018/08/14 06:00'],"['2018/05/21 00:00 [received]', '2018/07/24 00:00 [revised]', '2018/08/07 00:00 [accepted]', '2018/08/14 06:00 [pubmed]', '2019/01/30 06:00 [medline]', '2018/08/14 06:00 [entrez]']","['S0956-5663(18)30595-5 [pii]', '10.1016/j.bios.2018.08.007 [doi]']",ppublish,Biosens Bioelectron. 2018 Nov 15;119:79-85. doi: 10.1016/j.bios.2018.08.007. Epub 2018 Aug 8.,,,,,,,,,,,,,,,,,
20063396,NLM,MEDLINE,20100413,20151119,1553-5606 (Electronic) 1553-5592 (Linking),5,1,2010 Jan,The top 10 infectious disease pitfalls that hospitalists can avoid.,42-5,10.1002/jhm.515 [doi],"Infectious diseases are commonly encountered by hospitalists in their day-to-day care of patients. Challenges involved in caring for patients with infectious diseases include choosing the correct antibiotic, treating patients with a penicillin allergy, interpreting blood cultures, and caring for patients with human immunodeficiency virus (HIV). The evidence-based pearls in this article will help hospitalists avoid common pitfalls in the recognition and treatment of such disorders and guide their decision about when to consult an infectious diseases specialist.",['(c) 2010 Society of Hospital Medicine.'],"['Paige, Neil M', 'Vazirani, Sondra S', 'Graber, Christopher J']","['Paige NM', 'Vazirani SS', 'Graber CJ']","['Division of General Internal Medicine, Veterans Affairs (VA) Greater Los Angeles Healthcare System, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California 90073, USA. neil.paige@va.gov']",['eng'],['Journal Article'],,United States,J Hosp Med,Journal of hospital medicine,101271025,IM,"['Anti-Infective Agents/therapeutic use', 'Catheters, Indwelling', 'Communicable Disease Control/*methods', 'Communicable Diseases/blood/diagnosis/*drug therapy/physiopathology', 'Device Removal', 'Diagnosis, Differential', 'Drug Interactions', 'Female', 'Guidelines as Topic', 'HIV Infections', '*Hospitalists', 'Humans', 'Male', ""Practice Patterns, Physicians'"", 'Pregnancy']",,,,2010/01/12 06:00,2010/04/14 06:00,['2010/01/12 06:00'],"['2010/01/12 06:00 [entrez]', '2010/01/12 06:00 [pubmed]', '2010/04/14 06:00 [medline]']",['10.1002/jhm.515 [doi]'],ppublish,J Hosp Med. 2010 Jan;5(1):42-5. doi: 10.1002/jhm.515.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
1669768,NLM,MEDLINE,19940315,20041117,0144-1108 (Print) 0144-1108 (Linking),1,3,1991 Mar 1,Infectious diseases in the eastern province of Saudi Arabia.,R31-2,,,,"['Hawker, J I', 'Blair, I']","['Hawker JI', 'Blair I']",['East Birmingham Health Authority.'],['eng'],['Journal Article'],,England,CDR (Lond Engl Rev),"CDR (London, England : Review)",9316754,IM,"['*Communicable Disease Control', 'Communicable Diseases/epidemiology/etiology/*transmission', 'Humans', 'Risk Factors', 'Saudi Arabia/epidemiology', '*Travel']",,,,1991/03/01 00:00,1991/03/01 00:01,['1991/03/01 00:00'],"['1991/03/01 00:00 [pubmed]', '1991/03/01 00:01 [medline]', '1991/03/01 00:00 [entrez]']",,ppublish,CDR (Lond Engl Rev). 1991 Mar 1;1(3):R31-2.,,,,,,,,,,,,,,,,,
26581564,NLM,MEDLINE,20160706,20220129,1474-760X (Electronic) 1474-7596 (Print) 1474-7596 (Linking),16,,2015 Nov 19,Using genomics to combat infectious diseases on a global scale.,250,10.1186/s13059-015-0822-y [doi] 250,"A report on the seventh annual Infectious Disease Genomics Conference, held in Hinxton, Cambridge, UK, 14-16 October 2015.",,"['Cain, Amy K', 'Lees, John A']","['Cain AK', 'Lees JA']","['Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. ac19@sanger.ac.uk.', 'Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.']",['eng'],['Congress'],20151119,England,Genome Biol,Genome biology,100960660,IM,"['Communicable Diseases/*genetics/microbiology/*therapy', '*Genomics', 'Humans']",PMC4652341,,,2015/11/20 06:00,2016/07/07 06:00,['2015/11/20 06:00'],"['2015/11/20 06:00 [entrez]', '2015/11/20 06:00 [pubmed]', '2016/07/07 06:00 [medline]']","['10.1186/s13059-015-0822-y [pii]', '822 [pii]', '10.1186/s13059-015-0822-y [doi]']",epublish,Genome Biol. 2015 Nov 19;16:250. doi: 10.1186/s13059-015-0822-y.,,,,,,,['G1100100/MRC_/Medical Research Council/United Kingdom'],,,,,,,,,,
28859351,NLM,MEDLINE,20180423,20180423,1537-6591 (Electronic) 1058-4838 (Linking),65,suppl_1,2017 Aug 15,New Laboratory Tools for Emerging Bacterial Challenges.,S39-S49,10.1093/cid/cix405 [doi],"Since its creation, the Mediterranee-Infection foundation has aimed at optimizing the management of infectious diseases and surveying the local and global epidemiology. This pivotal role was permitted by the development of rational sampling, point-of-care tests, and extended automation as well as new technologies, including mass spectrometry for colony identification, real-time genomics for isolate characterization, and the development of versatile and permissive culture systems. By identifying and characterizing emerging microbial pathogens, these developments provided significant breakthroughs in infectious diseases.","['(c) The Author 2017. Published by Oxford University Press for the Infectious', 'Diseases Society of America. All rights reserved. For permissions, e-mail:', 'journals.permissions@oup.com.']","['Fournier, Pierre-Edouard', 'Drancourt, Michel', 'Raoult, Didier']","['Fournier PE', 'Drancourt M', 'Raoult D']","['URMITE, UM63, CNRS7278, IRD198, Inserm 1095, Institut Hospitalo-Universitaire Mediterranee-Infection, Aix-Marseille Universite, Faculte de Medecine, Marseille, France.', 'URMITE, UM63, CNRS7278, IRD198, Inserm 1095, Institut Hospitalo-Universitaire Mediterranee-Infection, Aix-Marseille Universite, Faculte de Medecine, Marseille, France.', 'URMITE, UM63, CNRS7278, IRD198, Inserm 1095, Institut Hospitalo-Universitaire Mediterranee-Infection, Aix-Marseille Universite, Faculte de Medecine, Marseille, France.']",['eng'],['Journal Article'],,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Automation, Laboratory', 'Bacteria/*isolation & purification/pathogenicity', 'Bacterial Infections/diagnosis/*microbiology/prevention & control/therapy', 'Bacteriological Techniques', 'Communicable Diseases/*diagnosis/microbiology', 'Communicable Diseases, Emerging/diagnosis/*microbiology/prevention & control/therapy', 'Genomics/methods', 'Humans', 'Laboratories', 'Mass Spectrometry', 'Point-of-Care Systems']",,['NOTNLM'],"['clinical microbiology', 'mass spectrometry', 'point-of-care', 'real-time genomics', 'syndrome-based sampling']",2017/09/02 06:00,2018/04/24 06:00,['2017/09/02 06:00'],"['2017/09/02 06:00 [entrez]', '2017/09/02 06:00 [pubmed]', '2018/04/24 06:00 [medline]']","['4057578 [pii]', '10.1093/cid/cix405 [doi]']",ppublish,Clin Infect Dis. 2017 Aug 15;65(suppl_1):S39-S49. doi: 10.1093/cid/cix405.,,,,['Clin Infect Dis. 2019 Jan 7;68(2):354. PMID: 30496356'],,,,,,,,,,,,,
27055290,NLM,MEDLINE,20160919,20190609,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),22,1,2016 Jan,"Flatboats, Travelers, Infectious Diseases, and Other River Thoughts.",162-3,,,,"['Breedlove, Byron']",['Breedlove B'],,['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/*etiology/*transmission', 'Humans', 'Rivers', 'Travel']",PMC4696723,,,2016/04/09 06:00,2016/09/20 06:00,['2016/04/09 06:00'],"['2016/04/09 06:00 [entrez]', '2016/04/09 06:00 [pubmed]', '2016/09/20 06:00 [medline]']","['AC-2201 [pii]', '10.3201/eid2201.ac2201 [doi]']",ppublish,Emerg Infect Dis. 2016 Jan;22(1):162-3. doi: 10.3201/eid2201.ac2201.,,,,,,,,,,,,,,,,,
13592355,NLM,MEDLINE,20000701,20181201,0370-9590 (Print) 0370-9590 (Linking),112,Suppl 11,1958 Jul 10,Treatment of infectious diseases.,278-82 passim concl,,,,"['INK, J']",['INK J'],,['eng'],['Journal Article'],,Argentina,Sem Med,La Semana medica,0404403,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1958/07/10 00:00,1958/07/10 00:01,['1958/07/10 00:00'],"['1958/07/10 00:00 [pubmed]', '1958/07/10 00:01 [medline]', '1958/07/10 00:00 [entrez]']",,ppublish,Sem Med. 1958 Jul 10;112(Suppl 11):278-82 passim concl.,,,,,,,,,Tratamiento de las enfermedades infecciosas.,,,['CLML: 5935:21768:151'],,,,,
7088138,NLM,MEDLINE,19820807,20190617,0028-0836 (Print) 0028-0836 (Linking),297,5867,1982 Jun 17,"The impact, transmission and evolution of infectious diseases.",539-40,,,,"['May, R M']",['May RM'],,['eng'],['News'],,England,Nature,Nature,0410462,IM,"['Bacteria/genetics', '*Biological Evolution', 'Communicable Diseases/microbiology/*transmission', 'Host-Parasite Interactions', 'Humans', 'Viruses/genetics']",,,,1982/06/17 00:00,1982/06/17 00:01,['1982/06/17 00:00'],"['1982/06/17 00:00 [pubmed]', '1982/06/17 00:01 [medline]', '1982/06/17 00:00 [entrez]']",['10.1038/297539a0 [doi]'],ppublish,Nature. 1982 Jun 17;297(5867):539-40. doi: 10.1038/297539a0.,,,,,,,,,,,,,,,,,
19748461,NLM,MEDLINE,20091109,20200930,1934-6069 (Electronic) 1931-3128 (Linking),6,3,2009 Sep 17,Shifting the paradigm: host gene signatures for diagnosis of infectious diseases.,199-200,10.1016/j.chom.2009.08.007 [doi],"Instead of focusing on the pathogen, in a paradigm shift, Zaas et al. (2009) identified host gene profiles as a strategy for diagnosis of respiratory infections. Application of host gene profiles offers tremendous possibilities for identification of diagnostic signatures, markers of disease severity, and eventually, prognostic indicators in the clinical setting.",,"['Ramilo, Octavio', 'Mejias, Asuncion']","['Ramilo O', 'Mejias A']","[""Division of Pediatric Infectious Diseases, Nationwide Children's Hospital and the Ohio State University College of Medicine, Columbus, OH 43205, USA. octavio.ramilo@nationwidechildrens.org""]",['eng'],"['Comment', 'Journal Article']",,United States,Cell Host Microbe,Cell host & microbe,101302316,IM,"['Communicable Diseases/*diagnosis/*genetics/virology', '*Gene Expression Profiling', 'Humans', 'Prognosis']",,,,2009/09/15 06:00,2009/11/10 06:00,['2009/09/15 06:00'],"['2009/09/15 06:00 [entrez]', '2009/09/15 06:00 [pubmed]', '2009/11/10 06:00 [medline]']","['S1931-3128(09)00286-8 [pii]', '10.1016/j.chom.2009.08.007 [doi]']",ppublish,Cell Host Microbe. 2009 Sep 17;6(3):199-200. doi: 10.1016/j.chom.2009.08.007.,,,,,,,,['Cell Host Microbe. 2009 Sep 17;6(3):207-17. PMID: 19664979'],,,,,,,,,
11930395,NLM,MEDLINE,20020430,20191025,1041-2972 (Print) 1041-2972 (Linking),13,1,2001 Jan,Infectious diseases of refugees and immigrants.,7-9,,,,"['Roberts, A', 'Kemp, C']","['Roberts A', 'Kemp C']","['International Family Nurse Practitioner Program, Louise Herrington School of Nursing, Baylor University, USA. amy_roberts@baylor.edu']",['eng'],['Journal Article'],,United States,J Am Acad Nurse Pract,Journal of the American Academy of Nurse Practitioners,8916634,,"['Communicable Diseases/nursing/*transmission', 'Disease Outbreaks', 'Disease Transmission, Infectious', '*Emigration and Immigration', 'Global Health', 'Humans', '*Refugees', 'Travel']",,,,2002/04/05 10:00,2002/05/01 10:01,['2002/04/05 10:00'],"['2002/04/05 10:00 [pubmed]', '2002/05/01 10:01 [medline]', '2002/04/05 10:00 [entrez]']",['10.1111/j.1745-7599.2001.tb00207.x [doi]'],ppublish,J Am Acad Nurse Pract. 2001 Jan;13(1):7-9. doi: 10.1111/j.1745-7599.2001.tb00207.x.,,,,,,,,,,,,,,,,,
12219739,NLM,MEDLINE,20021125,20181130,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),8,9,2002 Sep,Fifth annual conference on new and re-emerging infectious diseases.,1008-10,,"The fifth annual Conference on New and Re-Emerging Infectious Diseases was hosted on April 18-19, 2002, by the College of Veterinary Medicine, University of Illinois at Urbana-Champaign (UIUC). The conference featured 8 speakers and 35 poster presentations.",,"['Docampo, Roberto']",['Docampo R'],"['University of Illinois at Urbana-Champaign, USA.']",['eng'],['Congress'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Antitubercular Agents/pharmacology', 'Biological Warfare/trends', 'Cholera/microbiology', '*Communicable Diseases/epidemiology/microbiology/parasitology', '*Communicable Diseases, Emerging/epidemiology/microbiology/parasitology', 'Drug Resistance, Bacterial', 'Humans', 'Mycobacterium tuberculosis/drug effects', 'Parasitic Diseases/epidemiology', 'Tuberculosis/epidemiology/microbiology']",PMC2732540,,,2002/09/11 10:00,2002/11/26 04:00,['2002/09/11 10:00'],"['2002/09/11 10:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/09/11 10:00 [entrez]']","['02-0279 [pii]', '10.3201/eid0809.020279 [doi]']",ppublish,Emerg Infect Dis. 2002 Sep;8(9):1008-10. doi: 10.3201/eid0809.020279.,,,['0 (Antitubercular Agents)'],,,,,,,,,,,,,,
1808889,NLM,MEDLINE,19920521,20151119,0070-4067 (Print) 0070-4067 (Linking),97,,1991,[DNA probes instead of culture methods in diagnosis of infectious diseases?].,212-21,,,,"['Gobel, U B']",['Gobel UB'],"['Institut fur Medizinische Mikrobiologie und Hygiene, Universitat Freiburg.']",['ger'],"['Journal Article', 'Review']",,Germany,Verh Dtsch Ges Inn Med,Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,7503702,IM,"['Communicable Diseases/*diagnosis/genetics', '*DNA Probes', 'Humans', '*Microbiological Techniques', 'Polymerase Chain Reaction']",,,,1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Inn Med. 1991;97:212-21.,,,['0 (DNA Probes)'],,,35,,,DNS-Sonden anstelle von Kulturmethoden in der Diagnostik von Infektionskrankheiten?,,,,,,,,
12712530,NLM,MEDLINE,20030811,20200716,0372-9311 (Print) 0372-9311 (Linking),,4 Suppl,2000 Jul-Aug,[Classification of human diseases and prophylaxis of morbidity among the population].,106-9,,"The existing approaches to the classification of diseases, based on the determination of their nosological forms, are mainly oriented on the clinical requirements. Within the only approach to the classification of diseases, it is difficult to combine the requirements of diagnostics and those of the epidemiological generalization of the data on morbidity for the development of the prophylactic system for the prevention of the mass spread of diseases, which is of particular importance for infectious diseases. It is necessary to form the specialized classification of epidemiological situations, based on the International Classification of Diseases and capable of ensuring the assessment of the epidemic spread of infectious diseases and the development of adequate measures for decreasing mass morbidity among the population.",,"['Drynov, I D', 'Sergiev, V P', 'Malyshev, N A']","['Drynov ID', 'Sergiev VP', 'Malyshev NA']","['Gamaleya Research Institute of Epidemiology and Microbiology, Institute of Parasitology and Tropical Medicine, Clinical Infectious Hospital No. 1, Moscow, Russia.']",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Disease Control/methods/trends', 'Communicable Diseases/classification/diagnosis/*epidemiology/microbiology/mortality', 'Cross Infection/microbiology', 'Diagnosis, Differential', 'Disease Outbreaks/prevention & control', 'Humans', 'Infections/epidemiology', 'International Cooperation', 'Morbidity/trends', 'Population Surveillance', 'Prevalence', 'Russia/epidemiology', 'Systems Analysis', 'USSR/epidemiology']",,,,2003/04/26 05:00,2003/08/12 05:00,['2003/04/26 05:00'],"['2003/04/26 05:00 [pubmed]', '2003/08/12 05:00 [medline]', '2003/04/26 05:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2000 Jul-Aug;(4 Suppl):106-9.,,,,,,8,,,Klassifikatsiia boleznei cheloveka i profilaktika zabolevaemosti naseleniia.,,,,,,,,
13685037,NLM,MEDLINE,19981101,20181130,0368-3001 (Print) 0368-3001 (Linking),137,,1960 Oct,[Infectious diseases in 1960].,984-1018,,,,"['AUBERTIN, E']",['AUBERTIN E'],,['fre'],['Journal Article'],,France,J Med Bord,Journal de medecine de Bordeaux et du Sud-Ouest,0161067,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1960/10/01 00:00,1960/10/01 00:01,['1960/10/01 00:00'],"['1960/10/01 00:00 [pubmed]', '1960/10/01 00:01 [medline]', '1960/10/01 00:00 [entrez]']",,ppublish,J Med Bord. 1960 Oct;137:984-1018.,,,,,,,,,,,,,,,,,
14948339,NLM,MEDLINE,20040215,20181201,,7,3,1952 May-Jun,[Infectious diseases in adolescents].,150-3,,,,"['PROCHAZKA, J', 'CERVENY, R', 'DANKOVA, M', 'GRUNBERG, J']","['PROCHAZKA J', 'CERVENY R', 'DANKOVA M', 'GRUNBERG J']",,['und'],['Journal Article'],,Czech Republic,Pediatr Listy,Pediatricke listy,0204303,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/05/01 00:00,1952/05/01 00:01,['1952/05/01 00:00'],"['1952/05/01 00:00 [pubmed]', '1952/05/01 00:01 [medline]', '1952/05/01 00:00 [entrez]']",,ppublish,Pediatr Listy. 1952 May-Jun;7(3):150-3.,,,,,,,,,Infek6cni nemoci u mladistvych.,,,['CLML: 5222:34677:113'],,,,,
13186599,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),4,21,1954 Jul 21,[Infectious diseases in 1954].,1897-1918,,,,"['MORIN, M', 'PEROL, R']","['MORIN M', 'PEROL R']",,['und'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1954/07/21 00:00,1954/07/21 00:01,['1954/07/21 00:00'],"['1954/07/21 00:00 [pubmed]', '1954/07/21 00:01 [medline]', '1954/07/21 00:00 [entrez]']",,ppublish,Rev Prat. 1954 Jul 21;4(21):1897-1918.,,,,,,,,,Les maladies infectieuses en 1954.,,,['CLML: 5426:49552:118'],,,,,
24541953,NLM,MEDLINE,20140218,20211021,0367-1038 (Print) 0367-1038 (Linking),14,131,1951-1952,A review of infectious diseases during the first half of this century. The incidence of infectious diseases 1900-1950.,15-21,,,,"['JOE, A']",['JOE A'],,['eng'],['Journal Article'],,Scotland,Edinb Med J,Edinburgh medical journal,0007305,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Incidence']",PMC5270831,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1951/01/01 00:00,2014/08/13 06:00,['2014/02/19 06:00'],"['2014/02/19 06:00 [entrez]', '1951/01/01 00:00 [pubmed]', '2014/08/13 06:00 [medline]']",,ppublish,Edinb Med J. 1951-1952;14(131):15-21.,,,,,,,,,,,,['CLML: 5222:29135:114'],,,,,
9386552,NLM,MEDLINE,19971211,20141120,1293-8505 (Print) 1293-8505 (Linking),,30,1997 Sep,[Infectious diseases are tenacious].,18-24,,,,"['Trabacchi, G', 'Burrus, O']","['Trabacchi G', 'Burrus O']",,['fre'],['Journal Article'],,France,Rev Infirm,Revue de l'infirmiere,1267175,,"['Communicable Diseases/*epidemiology/*microbiology', '*Drug Resistance, Microbial', '*Global Health', 'Humans']",,,,1997/12/05 00:00,1997/12/05 00:01,['1997/12/05 00:00'],"['1997/12/05 00:00 [pubmed]', '1997/12/05 00:01 [medline]', '1997/12/05 00:00 [entrez]']",,ppublish,Rev Infirm. 1997 Sep;(30):18-24.,,,,,,,,,Les maladies infectieuses ont la peau dure!,,,,,,,,
13007395,NLM,MEDLINE,20030501,20181201,,11,10,1952 Oct,Infectious diseases in Israel in the second quarter of 1952.,208-10,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/10/01 00:00,1952/10/01 00:01,['1952/10/01 00:00'],"['1952/10/01 00:00 [pubmed]', '1952/10/01 00:01 [medline]', '1952/10/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1952 Oct;11(10):208-10.,,,,,,,,,,,,['CLML: 5323:32113:131'],,,,,
12975993,NLM,MEDLINE,20030501,20181201,,11,5,1952 May,Infectious diseases in Israel in the first quarter of 1952.,114-6,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/05/01 00:00,1952/05/01 00:01,['1952/05/01 00:00'],"['1952/05/01 00:00 [pubmed]', '1952/05/01 00:01 [medline]', '1952/05/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1952 May;11(5):114-6.,,,,,,,,,,,,['CLML: 5323:173:131'],,,,,
14894162,NLM,MEDLINE,20040215,20181201,,10,10,1951 Oct,Infectious diseases in Israel in June-September 1951.,234-7,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Female', 'Humans', 'Israel', 'Uterus/*surgery']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*UTERUS/surgery']",1951/10/01 00:00,1951/10/01 00:01,['1951/10/01 00:00'],"['1951/10/01 00:00 [pubmed]', '1951/10/01 00:01 [medline]', '1951/10/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1951 Oct;10(10):234-7.,,,,,,,,,,,,['CLML: 5221:24603:90:401'],,,,,
25144802,NLM,MEDLINE,20151028,20181202,1532-0987 (Electronic) 0891-3668 (Linking),33,11,2014 Nov,"32nd annual meeting of the European Society for Pediatric Infectious Diseases in Dublin, Ireland.",1180-2,10.1097/INF.0000000000000515 [doi],,,"['Butler, Karina']",['Butler K'],"[""From the Department of Infectious Diseases and Immunology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.""]",['eng'],['Congress'],,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,IM,"['Bacterial Infections/drug therapy/prevention & control', '*Communicable Disease Control', '*Communicable Diseases/drug therapy/epidemiology/immunology/metabolism', 'Communicable Diseases, Emerging', 'Drug Resistance, Microbial', 'Europe', 'Humans', 'Infection Control', 'Inflammation/metabolism/microbiology', '*Societies, Medical', '*Vaccination', 'Vaccines', 'Virus Diseases/drug therapy/prevention & control']",,,,2014/08/22 06:00,2015/10/29 06:00,['2014/08/22 06:00'],"['2014/08/22 06:00 [entrez]', '2014/08/22 06:00 [pubmed]', '2015/10/29 06:00 [medline]']",['10.1097/INF.0000000000000515 [doi]'],ppublish,Pediatr Infect Dis J. 2014 Nov;33(11):1180-2. doi: 10.1097/INF.0000000000000515.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
9480302,NLM,MEDLINE,19980225,20110728,0021-5384 (Print) 0021-5384 (Linking),86,11,1997 Nov 10,[Various problems of recent infectious diseases and the countermeasures( editorial)].,2011-5,,,,"['Shimada, J']",['Shimada J'],,['jpn'],['Editorial'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Animals', '*Communicable Diseases/drug therapy/epidemiology', 'Disease Outbreaks', 'Drug Administration Schedule', 'Drug Resistance, Multiple', 'Humans']",,,,1998/02/28 00:00,1998/02/28 00:01,['1998/02/28 00:00'],"['1998/02/28 00:00 [pubmed]', '1998/02/28 00:01 [medline]', '1998/02/28 00:00 [entrez]']",,ppublish,Nihon Naika Gakkai Zasshi. 1997 Nov 10;86(11):2011-5.,,,,,,,,,,,,,,,,,
12997814,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4799,1952 Dec 27,INFECTIOUS diseases and vital statistics. Summary for British Isles for week ending December 6 (No. 49) and corresponding week 1951.,1427-8,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC2022311,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1952/12/27 00:00,1952/12/27 00:01,['1952/12/27 00:00'],"['1952/12/27 00:00 [pubmed]', '1952/12/27 00:01 [medline]', '1952/12/27 00:00 [entrez]']",,ppublish,Br Med J. 1952 Dec 27;2(4799):1427-8.,,,,,,,,,,,,['CLML: 5323:22361:131:592'],,,,,
9415152,NLM,MEDLINE,19980115,20191102,1357-4310 (Print) 1357-4310 (Linking),1,4,1995 Jul,Infectious diseases in the year of Louis Pasteur.,160-1,,,,"['Digoutte, J P', 'Hoosen, A A']","['Digoutte JP', 'Hoosen AA']","['Institut Pasteur de Dakar, Senegal.']",['eng'],"['Biography', 'Congress', 'Historical Article', 'Portrait']",,England,Mol Med Today,Molecular medicine today,9508560,IM,"['Acquired Immunodeficiency Syndrome/epidemiology', 'Africa/epidemiology', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/*history/mortality', 'France', 'History, 19th Century', 'Humans', 'Sexually Transmitted Diseases/epidemiology/mortality/prevention & control']",,,,1995/07/01 00:00,1998/02/12 00:01,['1995/07/01 00:00'],"['1995/07/01 00:00 [pubmed]', '1998/02/12 00:01 [medline]', '1995/07/01 00:00 [entrez]']","['S1357-4310(95)91699-7 [pii]', '10.1016/s1357-4310(95)91699-7 [doi]']",ppublish,Mol Med Today. 1995 Jul;1(4):160-1. doi: 10.1016/s1357-4310(95)91699-7.,,,,,,,,,,,,,,,,['Pasteur L'],"['Pasteur, L']"
27522818,NLM,MEDLINE,20161213,20190724,0021-5384 (Print) 0021-5384 (Linking),103,11,2014 Nov 10,[Progress in Diagnostic Technology and Management of Infectious Diseases. Topics: IV. Measures for Infection Control; 5. Preparedness and response to pandemic infectious disease].,2761-9,,,,"['Tanabe, Masaki']",['Tanabe M'],,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['*Communicable Diseases/diagnosis/epidemiology', 'Community Health Planning', 'Guidelines as Topic', 'Humans', '*Infection Control', 'Pandemics']",,,,2014/11/10 00:00,2016/12/15 06:00,['2016/08/16 06:00'],"['2016/08/16 06:00 [entrez]', '2014/11/10 00:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.2169/naika.103.2761 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2014 Nov 10;103(11):2761-9. doi: 10.2169/naika.103.2761.,,,,,,,,,,,,,,,,,
11468579,NLM,MEDLINE,20010920,20061115,0003-4509 (Print) 0003-4509 (Linking),59,4,2001 Jul,"[The worldwide challenges of ""new"" or reemerging communicable diseases at the dawn of the 21st century].",246-77,,"In the first part of this review, AIDS, prion diseases, Hantavirus and arbovirus infections, Ebola hemorrhagic fever, legionellosis, hepatitis C, enterotoxigenic Escherichia coli infections, Lyme disease, tuberculosis have provided alarming examples of emerging or reemerging infectious diseases. In this second part, the stress is placed on the reemergence of diphtheria and of serious streptococcal infections, on bartonelloses, Chlamydia infections, fungal infections, while malaria and cholera are still prevalent in several areas. The increasing resistance of too many pathogens to antimicrobial agents is a major source of concern, directly related to the challenge of nosocomial infections. An infectious cause has been demonstrated (or strongly suspected) for various diseases and the scope of infectiology keeps widening, while the threat of bioterrorism cannot be neglected. The causes of the emergence or reemergence of infectious diseases are multiple and diverse, often in direct relation with human activities (population migrations, changes in husbandry or farming practices, worldwide exchanges of goods and foods, inadequate uses of antibiotics) but also with climatic variations in several areas. The challenge represented by this unexpected comeback of infections to the forefront of human and animal pathology can only be met with a significant improvement of hygienic practices, cessation of certain dangerous behaviors and also, of course, with the development of novel antimicrobial molecules (acting on original targets) as well as of a whole series of new specific vaccines.",,"['Werner, G H']",['Werner GH'],"[""Membre Associe Libre de l'Academie nationale de Pharmacie.""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Ann Pharm Fr,Annales pharmaceutiques francaises,2985176R,IM,"['Anti-Bacterial Agents/therapeutic use', 'Bioterrorism', '*Communicable Disease Control', '*Communicable Diseases/drug therapy/microbiology/virology', 'Humans']",,,,2001/07/27 10:00,2001/09/21 10:01,['2001/07/27 10:00'],"['2001/07/27 10:00 [pubmed]', '2001/09/21 10:01 [medline]', '2001/07/27 10:00 [entrez]']",['MDOI-APF-07-2001-59-4-0003-4509-101019-ART6 [pii]'],ppublish,Ann Pharm Fr. 2001 Jul;59(4):246-77.,,,['0 (Anti-Bacterial Agents)'],,,199,,,"Les defis mondiaux des maladies infectieuses ""nouvelles"" ou resurgentes en ce debut de XXIe siecle. Deuxieme partie.",,,,,,,,
14387323,NLM,MEDLINE,20030501,20190916,0888-2479 (Print) 0888-2479 (Linking),96,1,1955 Jul,Infectious diseases; twentieth annual review of significant publications.,90-125,,,,"['REIMANN, H A']",['REIMANN HA'],,['eng'],['Journal Article'],,United States,AMA Arch Intern Med,A.M.A. archives of internal medicine,14470100R,OM,"['Communicable Diseases/*therapy', '*Publications']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1955/07/01 00:00,1955/07/01 00:01,['1955/07/01 00:00'],"['1955/07/01 00:00 [pubmed]', '1955/07/01 00:01 [medline]', '1955/07/01 00:00 [entrez]']",['10.1001/archinte.1955.04430010104010 [doi]'],ppublish,AMA Arch Intern Med. 1955 Jul;96(1):90-125. doi: 10.1001/archinte.1955.04430010104010.,,,,,,,,,,,,['CLML: 5528:38467:151'],,,,,
13021570,NLM,MEDLINE,20030501,20181201,0367-4800 (Print) 0367-4800 (Linking),34,1,1953 Jan,"INFECTIOUS diseases and epidemiological notes; vital statistics for 4 weeks ending 27th December, 1952.",33-4,,,,,,,['eng'],['Journal Article'],,Scotland,Glasgow Med J,Glasgow medical journal,17140140R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC5981791,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*VITAL STATISTICS']",1953/01/01 00:00,1953/01/01 00:01,['1953/01/01 00:00'],"['1953/01/01 00:00 [pubmed]', '1953/01/01 00:01 [medline]', '1953/01/01 00:00 [entrez]']",,ppublish,Glasgow Med J. 1953 Jan;34(1):33-4.,,,,,,,,,,,,['CLML: 5323:46478:131:592'],,,,,
12980377,NLM,MEDLINE,20030501,20181201,0367-4800 (Print) 0367-4800 (Linking),33,8,1952 Aug,INFECTIOUS diseases and epidemiological notes; vital statistics for 5 weeks ending 2nd August 1952.,347,,,,,,,['eng'],['Journal Article'],,Scotland,Glasgow Med J,Glasgow medical journal,17140140R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC5979722,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/08/01 00:00,1952/08/01 00:01,['1952/08/01 00:00'],"['1952/08/01 00:00 [pubmed]', '1952/08/01 00:01 [medline]', '1952/08/01 00:00 [entrez]']",,ppublish,Glasgow Med J. 1952 Aug;33(8):347.,,,,,,,,,,,,['CLML: 5323:4613:131'],,,,,
14955163,NLM,MEDLINE,20040215,20181201,0367-4800 (Print) 0367-4800 (Linking),33,6,1952 Jun,"INFECTIOUS diseases and epidemiological notes; vital statistics for 5 weeks ending 31st May, 1952.",261-2,,,,,,,['eng'],['Journal Article'],,Scotland,Glasgow Med J,Glasgow medical journal,17140140R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Vital Statistics']",PMC5979738,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,Glasgow Med J. 1952 Jun;33(6):261-2.,,,,,,,,,,,,['CLML: 5222:41621:114'],,,,,
26821524,NLM,MEDLINE,20160222,20190823,0387-5911 (Print) 0387-5911 (Linking),89,6,2015 Nov,[The Value of Infectious Diseases Specialists in the Outpatient Setting at a Comprehensive Cancer Center in Japan: What do Oncology Specialists Request?].,745-7,,,,"['Kawamura, Ichiro', 'Kurai, Hanako']","['Kawamura I', 'Kurai H']",,['jpn'],['Journal Article'],,Japan,Kansenshogaku Zasshi,Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,0236671,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cancer Care Facilities', 'Communicable Diseases/complications/*diagnosis/*therapy', 'Female', 'Humans', 'Japan', 'Male', 'Middle Aged', 'Outpatients', ""*Physician's Role"", 'Young Adult']",,,,2016/01/30 06:00,2016/02/24 06:00,['2016/01/30 06:00'],"['2016/01/30 06:00 [entrez]', '2016/01/30 06:00 [pubmed]', '2016/02/24 06:00 [medline]']",['10.11150/kansenshogakuzasshi.89.745 [doi]'],ppublish,Kansenshogaku Zasshi. 2015 Nov;89(6):745-7. doi: 10.11150/kansenshogakuzasshi.89.745.,,,,,,,,,,,,,,,,,
18462117,NLM,MEDLINE,20080721,20080508,1537-6591 (Electronic) 1058-4838 (Linking),46,11,2008 Jun 1,Why did it take the Infectious Diseases Society of America so long to address the problem of antibiotic resistance?,1791-2; author reply 1792-3; discussion 1793-4,10.1086/588057 [doi],,,"['Kunin, Calvin M']",['Kunin CM'],,['eng'],"['Comment', 'Letter']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Disease Control/methods/*organization & administration', 'Communicable Diseases/*drug therapy/*microbiology/transmission', 'Disease Outbreaks', '*Drug Resistance, Microbial', 'Humans', 'Public Health', '*Societies']",,,,2008/05/09 09:00,2008/07/22 09:00,['2008/05/09 09:00'],"['2008/05/09 09:00 [pubmed]', '2008/07/22 09:00 [medline]', '2008/05/09 09:00 [entrez]']",['10.1086/588057 [doi]'],ppublish,Clin Infect Dis. 2008 Jun 1;46(11):1791-2; author reply 1792-3; discussion 1793-4. doi: 10.1086/588057.,,,,,,,,['Clin Infect Dis. 2008 Jan 15;46(2):155-64. PMID: 18171244'],,,,,,,,,
4459486,NLM,MEDLINE,19750808,20041117,0023-1495 (Print) 0023-1495 (Linking),42,10,1974 Oct,[Infectious diseases and our children].,439-48,,,,"['Von Ocklitz, H W']",['Von Ocklitz HW'],,['ger'],['Journal Article'],,Germany,Kinderarztl Prax,Kinderarztliche Praxis,0376356,IM,"['Age Factors', 'Child', 'Child, Preschool', '*Communicable Diseases/epidemiology/mortality', 'Germany, East', 'Humans', 'Infant']",,,,1974/10/01 00:00,1974/10/01 00:01,['1974/10/01 00:00'],"['1974/10/01 00:00 [pubmed]', '1974/10/01 00:01 [medline]', '1974/10/01 00:00 [entrez]']",,ppublish,Kinderarztl Prax. 1974 Oct;42(10):439-48.,,,,,,,,,Infektionskrankheiten und unsere Kinder.,,,,,,,,
20997543,NLM,MEDLINE,20101028,20181201,0042-6644 (Print) 0042-6644 (Linking),73,,1946 Sep,Historical aspects of infectious diseases.,398-402,,,,"['NELSON, K']",['NELSON K'],,['eng'],['Journal Article'],,United States,Va Med Mon (1918),Virginia medical monthly,0407231,OM,"['Communicable Diseases/*history', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/history'],1946/09/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/09/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",,ppublish,Va Med Mon (1918). 1946 Sep;73:398-402.,,,,,,,,,,,,['CLML: 4611:720l'],,,,,
23350286,NLM,MEDLINE,20130215,20130128,0017-7768 (Print) 0017-7768 (Linking),151,8,2012 Aug,[Pediatric infectious diseases--an ongoing battle].,"447-9, 499",,"Eleven articles are included in this special issue of Harefuah dedicated to pediatric infectious diseases. Herein, they present the problems and dilemmas pediatricians, as well as general practitioners, face in current practice. In spite of tremendous achievements in prevention, diagnosis and treatment, infectious diseases remain a major concern in pediatrics. Additional efforts are urgently needed including judicious use of antibiotics to reduce resistance, development of modern vaccines and antibiotics and public health measures in order to overcome the battle against infections. This can be possible only with robust governmental support.",,"['Spirer, Zvi', 'Barzilai, Asher']","['Spirer Z', 'Barzilai A']","[""The Edmond and LiLy Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan. spirer@post.tau.ac.il""]",['heb'],"['English Abstract', 'Journal Article']",,Israel,Harefuah,Harefuah,0034351,IM,"['Anti-Infective Agents/administration & dosage/*pharmacology', 'Child', 'Communicable Diseases/*drug therapy/epidemiology/microbiology', 'Drug Resistance, Microbial', 'General Practitioners/organization & administration', 'Humans', '*Public Health Practice', 'Vaccines/administration & dosage']",,,,2013/01/29 06:00,2013/02/16 06:00,['2013/01/29 06:00'],"['2013/01/29 06:00 [entrez]', '2013/01/29 06:00 [pubmed]', '2013/02/16 06:00 [medline]']",,ppublish,"Harefuah. 2012 Aug;151(8):447-9, 499.",,,"['0 (Anti-Infective Agents)', '0 (Vaccines)']",,,,,,,,,,,,,,
12584921,NLM,MEDLINE,20030515,20061115,0035-3639 (Print) 0035-3639 (Linking),23 Suppl 2,,2002,[The infective diseases clinic].,93-6,,"The Clinic of Infectious Diseases was created at Erasme Hospital in 1980. Its main activity consists in taking care of patients with infectious complications in various hospital departments. Its main scientific contributions concern the evaluation of new treatments, pharmacokinetics of antimicrobial agents and physiopathology of sepsis. The evaluation of the impact of infectious diseases on the appropriateness of antimicrobial therapy and the control of infection is a major contribution of the clinic. Several works concern the study of the immune response in case of infection due to an intracellular pathogen and in response to vaccination.",,"['Jacobs, F', 'Byl, B']","['Jacobs F', 'Byl B']",['fjacobs@ulb.ac.be'],['fre'],"['English Abstract', 'Journal Article', 'Review']",,Belgium,Rev Med Brux,Revue medicale de Bruxelles,8003474,IM,"['Belgium', '*Communicable Diseases/*drug therapy/physiopathology', '*Hospital Departments', 'Hospitals, University', 'Humans']",,,,2003/02/15 04:00,2003/05/16 05:00,['2003/02/15 04:00'],"['2003/02/15 04:00 [pubmed]', '2003/05/16 05:00 [medline]', '2003/02/15 04:00 [entrez]']",,ppublish,Rev Med Brux. 2002;23 Suppl 2:93-6.,,,,,,38,,,La Clinique des Maladies Infectieuses.,,,,,,,,
9200368,NLM,MEDLINE,19970721,20190516,1098-4275 (Electronic) 0031-4005 (Linking),100,1,1997 Jul,Summary of major changes in the 1997 Red Book: Report of the Committee on Infectious Diseases.,109-11,,,,"['Peter, G']",['Peter G'],"['Division of Pediatric Infectious Diseases, Rhode Island Hospital, Providence, RI 02903, USA.']",['eng'],"['Guideline', 'Journal Article', 'Practice Guideline']",,United States,Pediatrics,Pediatrics,0376422,IM,"['Adolescent', 'Age Factors', 'Child', '*Communicable Diseases/diagnosis/therapy', 'Humans', 'Infant', 'Infant, Newborn']",,,,1997/07/01 00:00,1997/07/01 00:01,['1997/07/01 00:00'],"['1997/07/01 00:00 [pubmed]', '1997/07/01 00:01 [medline]', '1997/07/01 00:00 [entrez]']",['10.1542/peds.100.1.109 [doi]'],ppublish,Pediatrics. 1997 Jul;100(1):109-11. doi: 10.1542/peds.100.1.109.,,,,,,,,,,,,,,,,,
9772514,NLM,MEDLINE,19990427,20041117,0376-2491 (Print) 0376-2491 (Linking),77,10,1997 Oct,[Clinical uses of polymerase chain reaction in infectious diseases].,725-6,,,,"['Liu, J']",['Liu J'],,['chi'],['Editorial'],,China,Zhonghua Yi Xue Za Zhi,Zhonghua yi xue za zhi,7511141,IM,"['Communicable Diseases/diagnosis/*microbiology', 'Humans', '*Polymerase Chain Reaction/methods', 'Quality Control', 'Sensitivity and Specificity']",,,,1998/10/17 00:00,1998/10/17 00:01,['1998/10/17 00:00'],"['1998/10/17 00:00 [pubmed]', '1998/10/17 00:01 [medline]', '1998/10/17 00:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi. 1997 Oct;77(10):725-6.,,,,,,,,,,,,,,,,,
58429,NLM,MEDLINE,19760802,20061101,0033-2100 (Print) 0033-2100 (Linking),30,1,1976,[Infectious diseases in Poland against the background of their incidence in the world].,75-82,,,,"['Kostrzewski, J']",['Kostrzewski J'],,['pol'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Africa', 'Americas', 'Asia', 'Australia', 'Communicable Diseases/*epidemiology/mortality', 'Europe', 'Humans', 'Poland']",,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1976;30(1):75-82.,,,,,,,,,Choroby zakazne w Polsce w 1974 r. na tle sytuacji w swiecie.,,,,,,,,
11680036,NLM,MEDLINE,20011204,20191025,1078-4659 (Print) 1078-4659 (Linking),7,5,2001 Sep,Evolution of the Control of Communicable Diseases Manual: 1917 to 2000.,97-104,,"For 84 years, The Control of Communicable Diseases Manual has provided public health practitioners with relevant and timely information on infectious diseases. An examination of the contents of the Manual's 17 editions provides insight into the changes in medical understanding of infectious diseases. This article provides an evolution of the manual and examines the diseases described in each edition.",,"['Malloy, C D', 'Marr, J S']","['Malloy CD', 'Marr JS']","['Washington Institute, University of Washington School of Medicine, Division of Psychiatry and Behavioral Sciences, Tacoma, Washington, USA.']",['eng'],"['Historical Article', 'Journal Article']",,United States,J Public Health Manag Pract,Journal of public health management and practice : JPHMP,9505213,,"['Communicable Disease Control/*history', 'Communicable Diseases/epidemiology/*history', 'History, 20th Century', 'Humans', '*Manuals as Topic', 'United States/epidemiology']",,,,2001/10/30 10:00,2002/01/05 10:01,['2001/10/30 10:00'],"['2001/10/30 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/10/30 10:00 [entrez]']",['10.1097/00124784-200107050-00013 [doi]'],ppublish,J Public Health Manag Pract. 2001 Sep;7(5):97-104. doi: 10.1097/00124784-200107050-00013.,,,,,,,,,,,,,,,,,
7840440,NLM,MEDLINE,19950224,20181130,0077-8923 (Print) 0077-8923 (Linking),740,,1994 Dec 15,"Disease in Evolution: Global Changes and Emergence of Infectious Diseases. Proceedings of a conference. Woods Hole, Massachusetts, November 7-10, 1993.",1-503,,,,,,,['eng'],"['Congress', 'Overall', ""Research Support, Non-U.S. Gov't""]",,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,IM,"['Animals', 'Biological Evolution', '*Communicable Diseases/epidemiology/etiology/transmission', 'Disease Outbreaks', 'Disease Susceptibility', '*Global Health', 'Humans', 'Population Dynamics']",,,,1994/12/15 00:00,1994/12/15 00:01,['1994/12/15 00:00'],"['1994/12/15 00:00 [pubmed]', '1994/12/15 00:01 [medline]', '1994/12/15 00:00 [entrez]']",,ppublish,Ann N Y Acad Sci. 1994 Dec 15;740:1-503.,,,,,,,,,,,,,,,,,
4230970,NLM,MEDLINE,19680610,20181130,0044-197X (Print) 0044-197X (Linking),10,8,1966 Aug,[The volume of necessary bacteriological laboratory studies connected with infectious diseases and diseases suspected of being infectious in extra-hospital service of the urban population].,7-12,,,,"[""Rozenfel'd, D B""]","[""Rozenfel'd DB""]",,['rus'],['Journal Article'],,Russia (Federation),Zdravookhr Ross Fed,Zdravookhranenie Rossiiskoi Federatsii,8707911,IM,"['Ambulatory Care', 'Clinical Laboratory Techniques/*statistics & numerical data', 'Communicable Diseases/*diagnosis/epidemiology', 'Humans', 'Russia']",,,,1966/08/01 00:00,1966/08/01 00:01,['1966/08/01 00:00'],"['1966/08/01 00:00 [pubmed]', '1966/08/01 00:01 [medline]', '1966/08/01 00:00 [entrez]']",,ppublish,Zdravookhr Ross Fed. 1966 Aug;10(8):7-12.,,,,,,,,,"Ob'em neobkhodimykh laboratornykh bakteriologicheskikh issledovanii, sviazannykh s infektsionnymi i podozritel'nymi na infektsionnye bolezniami, pri vnebol'nichnom obsluzhivanii gorodskogo naseleniia.",,,,,,,,
16010728,NLM,MEDLINE,20050804,20190608,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),10,11,2004 Nov,"Proceedings of the First International Conference on Women and Infectious Diseases. February 27-28, 2004. Atlanta, Georgia, USA.",1963-2036,,,,"['McDonald, Marian', 'Anker, Martha', 'Deal, Carolyn', 'Mawle, Alison', ""O'Connor, Siobhan"", 'Slaughter, Larisa']","['McDonald M', 'Anker M', 'Deal C', 'Mawle A', ""O'Connor S"", 'Slaughter L']","['Centers for Disease Control and Prevention, Atlanta, Georgia, USA;', 'World Health Organization, Geneva, Switzerland;', 'National Institutes of Health, Bethesda, Maryland, USA', 'Centers for Disease Control and Prevention, Atlanta, Georgia, USA;', 'Centers for Disease Control and Prevention, Atlanta, Georgia, USA;', 'Centers for Disease Control and Prevention, Atlanta, Georgia, USA;']",['eng'],"['Congress', 'Overall']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Disease Control/*methods', '*Communicable Diseases/epidemiology/etiology/transmission', 'Female', 'Humans', 'Risk Factors', ""*Women's Health""]",PMC3329007,,,2005/07/14 09:00,2005/08/05 09:00,['2005/07/14 09:00'],"['2005/07/14 09:00 [pubmed]', '2005/08/05 09:00 [medline]', '2005/07/14 09:00 [entrez]']","['04-0612 [pii]', '10.3201/eid1011.040612 [doi]']",ppublish,Emerg Infect Dis. 2004 Nov;10(11):1963-2036. doi: 10.3201/eid1011.040612.,,,,,,,,,,,,,,,,,
15813004,NLM,MEDLINE,20050825,20200409,1198-743X (Print) 1469-0691 (Electronic) 1198-743X (Linking),11 Suppl 1,,2005 Apr,Introduction: progress towards meeting the challenges in clinical microbiology and infectious diseases.,1-2,,,,"['Struelens, M J', 'Van Eldere, J']","['Struelens MJ', 'Van Eldere J']","['Department of Microbiology, Universite Libre de Bruxelles, Hopital Erasme, Brussels, Belgium. marc.struelens@ulb.ac.be']",['eng'],['Journal Article'],,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Bioterrorism', '*Communicable Disease Control', '*Communicable Diseases/diagnosis/economics/epidemiology/therapy', 'Communicable Diseases, Emerging/therapy', 'Community-Acquired Infections/diagnosis/economics/epidemiology/therapy', 'Cross Infection/diagnosis/economics/epidemiology/therapy', 'Delivery of Health Care', 'Drug Resistance, Multiple, Bacterial', 'Education, Medical', 'Health Policy', 'Humans']",PMC7129899,,,2005/04/09 09:00,2005/08/27 09:00,['2005/04/09 09:00'],"['2005/04/09 09:00 [pubmed]', '2005/08/27 09:00 [medline]', '2005/04/09 09:00 [entrez]']","['S1198-743X(15)30014-8 [pii]', '10.1111/j.1469-0691.2005.01080.x [doi]']",ppublish,Clin Microbiol Infect. 2005 Apr;11 Suppl 1:1-2. doi: 10.1111/j.1469-0691.2005.01080.x.,,,,,,,,,,,,,,,,,
37232315,NLM,MEDLINE,20230529,20230613,0253-1933 (Print) 0253-1933 (Linking),42,,2023 May,Assessing the quality of data for drivers of disease emergence.,90-102,10.20506/rst.42.3352 [doi],"Drivers are factors that have the potential to directly or indirectly influence the likelihood of infectious diseases emerging or re-emerging. It is likely that an emerging infectious disease (EID) rarely occurs as the result of only one driver; rather, a network of sub-drivers (factors that can influence a driver) are likely to provide conditions that allow a pathogen to (re-)emerge and become established. Data on sub-drivers have therefore been used by modellers to identify hotspots where EIDs may next occur, or to estimate which sub-drivers have the greatest influence on the likelihood of their occurrence. To minimise error and bias when modelling how sub-drivers interact, and thus aid in predicting the likelihood of infectious disease emergence, researchers need good-quality data to describe these sub-drivers. This study assesses the quality of the available data on sub-drivers of West Nile virus against various criteria as a case study. The data were found to be of varying quality with regard to fulfilling the criteria. The characteristic with the lowest score was completeness, i.e. where sufficient data are available to fulfil all the requirements for the model. This is an important characteristic as an incomplete data set could lead to erroneous conclusions being drawn from modelling studies. Thus, the availability of good-quality data is essential to reduce uncertainty when estimating the likelihood of where EID outbreaks may occur and identifying the points on the risk pathway where preventive measures may be taken.",,"['Horigan, V', 'Kelly, L', 'Papa, A', 'Koopmans, M P G', 'Sikkema, R S', 'Koren, L G H', 'Snary, E L']","['Horigan V', 'Kelly L', 'Papa A', 'Koopmans MPG', 'Sikkema RS', 'Koren LGH', 'Snary EL']",,['eng'],['Journal Article'],,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', '*Communicable Diseases, Emerging/prevention & control/veterinary', '*Communicable Diseases/epidemiology/veterinary', 'Disease Outbreaks/prevention & control']",,['NOTNLM'],"['Data quality', 'Drivers', 'Emerging infectious disease', 'Modellinge', 'Predicting disease outbreaks', 'Prevention', 'West Nile virus']",2023/05/26 13:09,2023/05/29 06:42,['2023/05/26 06:03'],"['2023/05/29 06:42 [medline]', '2023/05/26 13:09 [pubmed]', '2023/05/26 06:03 [entrez]']",['10.20506/rst.42.3352 [doi]'],ppublish,Rev Sci Tech. 2023 May;42:90-102. doi: 10.20506/rst.42.3352.,,,,,,,,,Assessing the quality of data for drivers of disease emergence.,,,,,,,,
8903747,NLM,MEDLINE,19970312,20071115,0885-114X (Print) 0885-114X (Linking),10,4,1995 Oct-Dec,Communicable disease and firefighters.,747-62,,"As firefighters are increasing working in emergency medical response roles, their exposure to infectious diseases has also increased. This article discusses the various pathogens to which firefighters are particularly exposed and outlines measures to reduce their incidence. Legislation and resources specific to the fire service also are identified.",,"['Weaver, V M', 'Arndt, S D']","['Weaver VM', 'Arndt SD']","['Division of Occupational Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Occup Med,"Occupational medicine (Philadelphia, Pa.)",8605629,IM,"['*Communicable Disease Control/methods', '*Communicable Diseases/diagnosis/epidemiology/physiopathology/therapy', '*Fires', 'Guidelines as Topic', 'Humans', 'Incidence', 'Prognosis', 'Risk Factors']",,,,1995/10/01 00:00,1995/10/01 00:01,['1995/10/01 00:00'],"['1995/10/01 00:00 [pubmed]', '1995/10/01 00:01 [medline]', '1995/10/01 00:00 [entrez]']",,ppublish,Occup Med. 1995 Oct-Dec;10(4):747-62.,,,,,,59,,,,,,,,,,,
20256635,NLM,MEDLINE,20100318,20181201,0035-9238 (Print) 0035-9238 (Linking),109,Pt 2,1946,The statistical study of infectious diseases.,85-110,,,,"['GREENWOOD, M']",['GREENWOOD M'],,['eng'],['Journal Article'],,England,J R Stat Soc Ser A,Journal of the Royal Statistical Society. Series A (General),7503112,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1946/01/01 00:00,2011/01/06 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '1946/01/01 00:00 [pubmed]', '2011/01/06 06:00 [medline]']",,ppublish,J R Stat Soc Ser A. 1946;109(Pt 2):85-110.,,,,,,,,,,,,['CLML: 4713:867q'],,,,,
24741949,NLM,MEDLINE,20140513,20161020,0869-6047 (Print) 0869-6047 (Linking),,12,2013,[The concept of infectious diseases pathogenesis].,89-92,,"In this article a concept of infectious disease pathogenesis as consisted with clinical symptoms is provided. The course of disease, immediate and long-term consequences depend on the mode of entry. If the infection comes via oropharynx, airway, gastrointestinal tract or via skin, the immune system provides adequate immune response. This leads to typical symptoms, cyclical clinic progression and usually to the recovery with the formation of full sterile immunity. In case of parenteral way of infection, which includes perinatal way, there is no full mode of entry, the disease takes chronic course involving visceral organs because of different mechanisms of affinity and new tropic organ involving. For the full sanogenesis germ or its mediators should persist in the primary focus of infection. It is suggested, that HIV, HCV, hepatitis B virus, tetanus, rabies and other infectious diseases with inner organs involvement, as well as all slow infections, should be treated as infectious diseases with the parental way of infection, proceeding with affinity changings, which lead to the appearance of new tropic sites in visceral organs. The theory of the mode of entry, affinity, appearance of tropic sites in visceral organs should form the basis of modern infectology.",,"['Uchaikin, V F', 'Shamsheva, O V']","['Uchaikin VF', 'Shamsheva OV']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Chronic Disease', '*Communicable Diseases/classification/diagnosis/physiopathology', '*Disease Progression', 'Humans', '*Organs at Risk', 'Patient Acuity', 'Symptom Assessment']",,,,2013/01/01 00:00,2014/05/14 06:00,['2014/04/19 06:00'],"['2014/04/19 06:00 [entrez]', '2013/01/01 00:00 [pubmed]', '2014/05/14 06:00 [medline]']",,ppublish,Vestn Ross Akad Med Nauk. 2013;(12):89-92.,,,,,,,,,,,,,,,,,
19127845,NLM,MEDLINE,20090130,20090108,0255-7053 (Print) 0255-7053 (Linking),37,4,2007 Oct,[A type analysis of the statutory infectious diseases in the Republican period].,215-7,,"In the current academic circle, there are different opinions about the types of the statutory infectious diseases in the Republican period, including the nine-, ten-, eleven- and thirteen-type hypotheses being the most popular. They are different not only on the diseases types, but also about the time of its announcement. This article argues that there were eight kinds of statutory infectious diseases in 1916, i.e. cholera, dysentery, typhoid, smallpox, diphtheria, scarlatina,plague, and typhus; nine in 1928, with cerebrospinal meningitis being added; ten in 1944, with relapsing fever being added; after that, there were no changes. The appointed infectious diseases were initially relapsing fever and malaria; when the relapsing fever became the statutory one, then the appointed ones were the malaria and kala-azar. The establishment of the statutory and the appointed infectious diseases signified that the government of the Republican period had intervened in the administration of infectious diseases.",,"['Zhang, Tai-shan']",['Zhang TS'],"['Department of History, Hubei Normal University, Huangshi 435002, China.']",['chi'],"['English Abstract', 'Historical Article', 'Journal Article']",,China,Zhonghua Yi Shi Za Zhi,"Zhonghua yi shi za zhi (Beijing, China : 1980)",8303081,,"['China', 'Communicable Diseases/classification/*history', 'History, 20th Century', 'Humans']",,,,2007/10/01 00:00,2009/01/31 09:00,['2009/01/09 09:00'],"['2009/01/09 09:00 [entrez]', '2007/10/01 00:00 [pubmed]', '2009/01/31 09:00 [medline]']",,ppublish,Zhonghua Yi Shi Za Zhi. 2007 Oct;37(4):215-7.,,,,,,,,,,,,,,,,,
15760445,NLM,MEDLINE,20050825,20061115,1198-743X (Print) 1198-743X (Linking),11 Suppl 1,,2005 Apr,Conclusion: ESCMID declaration on meeting the challenges in clinical microbiology and infectious diseases.,50-1,,,,"['Struelens, M J', 'Van Eldere, J']","['Struelens MJ', 'Van Eldere J']","['Department of Microbiology, Universite Libre de Bruxelles, Hopital Erasme, Brussels, Belgium. marc.struelens@ulb.ac.be']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Bioterrorism', '*Communicable Disease Control', 'Communicable Diseases/diagnosis/economics/*epidemiology/therapy', 'Communicable Diseases, Emerging/therapy', 'Community-Acquired Infections/*prevention & control', 'Cross Infection/*prevention & control', 'Drug Resistance, Multiple, Bacterial', 'Europe', '*Health Policy', 'Humans', 'Infection Control Practitioners/*education']",,,,2005/03/12 09:00,2005/08/27 09:00,['2005/03/12 09:00'],"['2005/03/12 09:00 [pubmed]', '2005/08/27 09:00 [medline]', '2005/03/12 09:00 [entrez]']","['CLM1092 [pii]', '10.1111/j.1469-0691.2005.01092.x [doi]']",ppublish,Clin Microbiol Infect. 2005 Apr;11 Suppl 1:50-1. doi: 10.1111/j.1469-0691.2005.01092.x.,,,,,,,,,,,,,,,,,
11203366,NLM,MEDLINE,20001219,20161020,0256-2855 (Print) 0256-2855 (Linking),110,10,2000,[Infectious diseases in the dental office].,"1095-8, 1121-3",,,,"['Vetter, C']",['Vetter C'],,"['fre', 'ger']",['News'],,Switzerland,Schweiz Monatsschr Zahnmed,Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia,8709597,IM,"['*Communicable Disease Control', 'Communicable Diseases/microbiology/*transmission/virology', 'Dental Care/*methods', 'Humans']",,,,2001/02/24 12:00,2001/02/28 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/02/28 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,"Schweiz Monatsschr Zahnmed. 2000;110(10):1095-8, 1121-3.",,,,,,,,,Les maladies infectieuses au cabinet dentaire.,,,,,,,,
26960840,NLM,MEDLINE,20160512,20160310,1438-3276 (Print) 1438-3276 (Linking),157,21-22,2015 Dec 14,[Currently your infectious diseases knowledge is required].,"10-2, 14",10.1007/s15006-015-7578-x [doi],,,"['Oberhofer, Elke']",['Oberhofer E'],['.'],['ger'],['News'],,Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,IM,"['Communicable Diseases/*diagnosis/epidemiology/*transmission', 'Cross-Sectional Studies', '*General Practice', 'Germany', 'Humans', 'Rare Diseases', '*Refugees', '*Transients and Migrants', '*Travel Medicine']",,,,2016/03/11 06:00,2016/05/14 06:00,['2016/03/11 06:00'],"['2016/03/11 06:00 [entrez]', '2016/03/11 06:00 [pubmed]', '2016/05/14 06:00 [medline]']","['10.1007/s15006-015-7578-x [pii]', '10.1007/s15006-015-7578-x [doi]']",ppublish,"MMW Fortschr Med. 2015 Dec 14;157(21-22):10-2, 14. doi: 10.1007/s15006-015-7578-x.",,,,,,,,,Jetzt ist Ihr infektiologisches Wissen gefragt!,,,,,,,,
6922534,NLM,MEDLINE,19821203,20161123,0029-6511 (Print) 0029-6511 (Linking),155,9,1982 Sep 1,Notifiable infectious diseases. 1. Always a menace.,24-5,,,,"['Thomson, W']",['Thomson W'],,['eng'],['Journal Article'],,England,Nurs Mirror,Nursing mirror,7708429,,"['*Communicable Disease Control', 'Communicable Diseases/diagnosis/*epidemiology', 'Humans', 'United Kingdom']",,,,1982/09/01 00:00,1982/09/01 00:01,['1982/09/01 00:00'],"['1982/09/01 00:00 [pubmed]', '1982/09/01 00:01 [medline]', '1982/09/01 00:00 [entrez]']",,ppublish,Nurs Mirror. 1982 Sep 1;155(9):24-5.,,,,,,,,,,,,,,,,,
7879783,NLM,MEDLINE,19950404,20190512,0002-9262 (Print) 0002-9262 (Linking),141,5,1995 Mar 1,The distribution of incubation periods of infectious disease. 1949.,386-94; discussion 385,,"1. Characteristics of the distribution of incubation periods of a number of infectious diseases, as reported in the literature, have been reviewed. 2. The usual frequency curve of incubation time takes the form of a logarithmic normal curve. This appears to be equally true of diseases with very short and very long incubation periods. 3. The measure of variation in incubation periods used in this study, termed the dispersion factor, is the antilogarithm of the logarithmic standard deviation. Dispersion factors for most of the diseases studied range from 1.2 to 1.5 and are independent of mean length of incubation. 4. Some epidemiological uses for a knowledge of the distribution of incubation time are discussed.",,"['Sartwell, P E']",['Sartwell PE'],,['eng'],"['Biography', 'Classical Article', 'Historical Article', 'Journal Article']",,United States,Am J Epidemiol,American journal of epidemiology,7910653,IM,"['Communicable Diseases/epidemiology/*history/physiopathology', 'History, 20th Century', 'Humans', 'Normal Distribution', 'Time Factors']",,,,1995/03/01 00:00,1995/03/01 00:01,['1995/03/01 00:00'],"['1995/03/01 00:00 [pubmed]', '1995/03/01 00:01 [medline]', '1995/03/01 00:00 [entrez]']",['10.1093/oxfordjournals.aje.a117440 [doi]'],ppublish,Am J Epidemiol. 1995 Mar 1;141(5):386-94; discussion 385. doi: 10.1093/oxfordjournals.aje.a117440.,,,,,,,,,,,,,,,,['Sartwell PE'],"['Sartwell, P E']"
24046397,NLM,MEDLINE,20141023,20141120,1743-0593 (Electronic) 1743-0585 (Linking),99,1,2014 Feb,Fifteen-minute consultation: The infant with frequent infections.,8-12,10.1136/archdischild-2013-303971 [doi],"Children with frequent or recurrent infections commonly present to medical practitioners in both primary and secondary care. Here we provide a structured approach to the consultation of the infant under 2 years of age with frequent infections. The key is a focused history and examination to elicit red flags to an underlying diagnosis, while at the same time seeking benign explanations for the frequency of infections, which account for the majority of children, thereby avoiding unnecessary investigations.",,"['Bryant, Penelope A', 'South, Mike']","['Bryant PA', 'South M']","[""Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital, Parkville, Australia.""]",['eng'],['Journal Article'],20130917,England,Arch Dis Child Educ Pract Ed,Archives of disease in childhood. Education and practice edition,101220684,IM,"['Cohort Studies', 'Communicable Diseases/*diagnosis/immunology/microbiology/*therapy', 'Female', 'Humans', 'Immune System Diseases/*diagnosis/*therapy', 'Infant', 'Male', 'Practice Guidelines as Topic', 'Primary Health Care/*methods', 'Risk Factors', 'Secondary Prevention']",,['NOTNLM'],"['Allergy', 'Immunology', 'Infectious Diseases', 'Respiratory']",2013/09/21 06:00,2014/10/24 06:00,['2013/09/19 06:00'],"['2013/09/19 06:00 [entrez]', '2013/09/21 06:00 [pubmed]', '2014/10/24 06:00 [medline]']","['archdischild-2013-303971 [pii]', '10.1136/archdischild-2013-303971 [doi]']",ppublish,Arch Dis Child Educ Pract Ed. 2014 Feb;99(1):8-12. doi: 10.1136/archdischild-2013-303971. Epub 2013 Sep 17.,,,,,,,,,,,,,,,,,
9762642,NLM,MEDLINE,19981209,20190515,1099-3460 (Print) 1468-2869 (Electronic) 1099-3460 (Linking),75,3,1998 Sep,Emerging infectious diseases': meeting the challenge. Introduction.,459-62,,,,"['Gold, J']",['Gold J'],,['eng'],['Journal Article'],,United States,J Urban Health,Journal of urban health : bulletin of the New York Academy of Medicine,9809909,IM,"['Communicable Disease Control', '*Communicable Diseases/diagnosis/epidemiology/transmission', 'Disease Outbreaks/prevention & control', 'Drug Resistance, Microbial', 'Forecasting', 'Humans']",PMC5587425,,,1998/10/08 00:00,1998/10/08 00:01,['1998/10/08 00:00'],"['1998/10/08 00:00 [pubmed]', '1998/10/08 00:01 [medline]', '1998/10/08 00:00 [entrez]']","['BF02427683 [pii]', '10.1007/BF02427683 [doi]']",ppublish,J Urban Health. 1998 Sep;75(3):459-62. doi: 10.1007/BF02427683.,,,,,,,,,,,,,,,,,
6535401,NLM,MEDLINE,19850628,20061115,0302-4342 (Print) 0302-4342 (Linking),21,4,1984 Sep 30,[Emergencies in infectious diseases].,321-9,,,,"['Molina, J A', 'Loscertales, M', 'Bayes, R', 'del Moral, E', 'Giron, F', 'Maldonado, J', 'Narbona, E']","['Molina JA', 'Loscertales M', 'Bayes R', 'del Moral E', 'Giron F', 'Maldonado J', 'Narbona E']",,['spa'],['Journal Article'],,Spain,An Esp Pediatr,Anales espanoles de pediatria,0420463,IM,"['Child, Preschool', 'Communicable Diseases/diagnosis/etiology/*therapy', 'Emergencies', 'Humans', 'Infant', 'Sepsis/diagnosis/etiology/therapy']",,,,1984/09/30 00:00,1984/09/30 00:01,['1984/09/30 00:00'],"['1984/09/30 00:00 [pubmed]', '1984/09/30 00:01 [medline]', '1984/09/30 00:00 [entrez]']",,ppublish,An Esp Pediatr. 1984 Sep 30;21(4):321-9.,,,,,,,,,Urgencias en enfermedades infecciosas.,,,,,,,,
27522811,NLM,MEDLINE,20161213,20190724,0021-5384 (Print) 0021-5384 (Linking),103,11,2014 Nov 10,[Progress in Diagnostic Technology and Management of Infectious Diseases. Topics: III. Progress in Treatment of Infectious Diseases; 1. Antimicrobial use--up to date].,2714-20,,,,"['Aoki, Yosuke']",['Aoki Y'],,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/complications/*drug therapy', 'Fever/etiology', 'Humans']",,,,2014/11/10 00:00,2016/12/15 06:00,['2016/08/16 06:00'],"['2016/08/16 06:00 [entrez]', '2014/11/10 00:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.2169/naika.103.2714 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2014 Nov 10;103(11):2714-20. doi: 10.2169/naika.103.2714.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
27522813,NLM,MEDLINE,20161213,20190724,0021-5384 (Print) 0021-5384 (Linking),103,11,2014 Nov 10,[Progress in Diagnostic Technology and Management of Infectious Diseases. Topics: III. Progress in Treatment of Infectious Diseases: 3. Multidisciplinary therapy for severe infection].,2728-34,,,,"['Ishii, Yoshiki']",['Ishii Y'],,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Acute Disease', '*Combined Modality Therapy', 'Communicable Diseases/complications/*therapy', 'Humans', 'Sepsis/microbiology/therapy']",,,,2014/11/10 00:00,2016/12/15 06:00,['2016/08/16 06:00'],"['2016/08/16 06:00 [entrez]', '2014/11/10 00:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.2169/naika.103.2728 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2014 Nov 10;103(11):2728-34. doi: 10.2169/naika.103.2728.,,,,,,,,,,,,,,,,,
10422420,NLM,MEDLINE,19990812,20150901,1607-551X (Print) 1607-551X (Linking),15 Suppl,,1999,Emerging problems in infectious diseases.,S36-41,,,,"['Henderson, D A']",['Henderson DA'],"['Johns Hopkins University, Baltimore, MD, USA.']",['eng'],['Journal Article'],,China (Republic : 1949- ),Kaohsiung J Med Sci,The Kaohsiung journal of medical sciences,100960562,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/etiology', 'Humans', 'Recurrence']",,,,1999/07/28 00:00,1999/07/28 00:01,['1999/07/28 00:00'],"['1999/07/28 00:00 [pubmed]', '1999/07/28 00:01 [medline]', '1999/07/28 00:00 [entrez]']",,ppublish,Kaohsiung J Med Sci. 1999;15 Suppl:S36-41.,,,,,,,,,,,,,,,,,
3911133,NLM,MEDLINE,19860305,20041117,0030-2465 (Print) 0030-2465 (Linking),52,3,1985 Sep,The epidemiology of infectious diseases of livestock.,195-200,,"From the time of the first modern studies of infectious diseases, by Koch, Pasteur, Theiler and their colleagues, it has been clear that laboratory investigation must be complemented by epidemiologic investigation. The measurement of all aspects of the natural history of a disease in naturally affected populations is necessary if we are to rationally design control regimens. Building upon a historic perspective, this paper presents a view of the present status of epidemiology as it pertains to animal disease control, and presents a view of the merits of expanding the use of this science in future animal disease control programs, internationally, in developed and developing countries. The basis for this view lies in adaptation of principles employed in human infectious disease epidemiology, and principles which guide the organization of international disease control agencies.",,"['Murphy, F A']",['Murphy FA'],,['eng'],"['Historical Article', 'Journal Article']",,South Africa,Onderstepoort J Vet Res,The Onderstepoort journal of veterinary research,0401107,IM,"['Animals', 'Animals, Domestic', 'Communicable Disease Control', 'Communicable Diseases/epidemiology/history/*veterinary', 'Disease Outbreaks/veterinary', 'Epidemiologic Methods/veterinary', 'History, 20th Century', 'Humans', 'Veterinary Medicine']",,,,1985/09/01 00:00,1985/09/01 00:01,['1985/09/01 00:00'],"['1985/09/01 00:00 [pubmed]', '1985/09/01 00:01 [medline]', '1985/09/01 00:00 [entrez]']",,ppublish,Onderstepoort J Vet Res. 1985 Sep;52(3):195-200.,,,,,,,,,,,,,,,,,
15461204,NLM,MEDLINE,20041221,20190906,0393-2990 (Print) 0393-2990 (Linking),19,7,2004,The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades.,707-10,,,,"['Dvorakova, Alena', 'Poledne, Rudolf']","['Dvorakova A', 'Poledne R']",,['eng'],['Letter'],,Netherlands,Eur J Epidemiol,European journal of epidemiology,8508062,IM,"['Arteriosclerosis/complications/*mortality', 'Bacterial Infections/classification/epidemiology', 'Communicable Diseases/classification/*epidemiology/microbiology/virology', 'Czech Republic/epidemiology', 'Humans', 'Incidence', 'Population Surveillance', 'Virus Diseases/classification/epidemiology']",,,,2004/10/06 09:00,2004/12/22 09:00,['2004/10/06 09:00'],"['2004/10/06 09:00 [pubmed]', '2004/12/22 09:00 [medline]', '2004/10/06 09:00 [entrez]']",['10.1023/b:ejep.0000036769.77566.06 [doi]'],ppublish,Eur J Epidemiol. 2004;19(7):707-10. doi: 10.1023/b:ejep.0000036769.77566.06.,,,,,,,,,,,,,,,,,
8549110,NLM,MEDLINE,19960220,20191023,0147-9571 (Print) 0147-9571 (Linking),18,4,1995 Sep,"The 13th International Symposium of the World Association of Veterinary Microbiologists, Immunologists and Specialists in Infectious Diseases Perugia, Mantova, Italy 2-7 October 1994.",223-6,,,,"['Martin, W B']",['Martin WB'],,['eng'],['Congress'],,England,Comp Immunol Microbiol Infect Dis,"Comparative immunology, microbiology and infectious diseases",7808924,IM,"['Allergy and Immunology', 'Animals', 'Communicable Diseases/immunology/microbiology/*veterinary', 'Humans', 'Italy', 'Microbiology', '*Veterinary Medicine']",,,,1995/09/01 00:00,1995/09/01 00:01,['1995/09/01 00:00'],"['1995/09/01 00:00 [pubmed]', '1995/09/01 00:01 [medline]', '1995/09/01 00:00 [entrez]']","['014795719599035N [pii]', '10.1016/0147-9571(95)99035-n [doi]']",ppublish,Comp Immunol Microbiol Infect Dis. 1995 Sep;18(4):223-6. doi: 10.1016/0147-9571(95)99035-n.,,,,,,,,,,,,,,,,,
9718927,NLM,MEDLINE,19980918,20191102,0300-2977 (Print) 0300-2977 (Linking),52,6,1998 Jun,The challenge of infectious diseases; the European perspective. Surveillance.,267-70,,,,"['Bartlett, C L']",['Bartlett CL'],"['PHLS Communicable Disease Surveillance Centre, London, UK.']",['eng'],['Journal Article'],,Netherlands,Neth J Med,The Netherlands journal of medicine,0356133,IM,"['Communicable Diseases/diagnosis/*epidemiology', 'Humans', '*Population Surveillance']",,,,1998/08/27 00:00,1998/08/27 00:01,['1998/08/27 00:00'],"['1998/08/27 00:00 [pubmed]', '1998/08/27 00:01 [medline]', '1998/08/27 00:00 [entrez]']","['S0300297798000424 [pii]', '10.1016/s0300-2977(98)00042-4 [doi]']",ppublish,Neth J Med. 1998 Jun;52(6):267-70. doi: 10.1016/s0300-2977(98)00042-4.,,,,,,,,,,,,,,,,,
11427818,NLM,MEDLINE,20010823,20061115,0003-4509 (Print) 0003-4509 (Linking),59,3,2001 May,"[The worldwide challenges of ""new"" or reemerging communicable diseases at the dawn of the 21st century].",147-75,,"In spite of the very significant advances made during the 20 th century in the prevention and the treatment of communicable diseases, infections are still today, even in developed countries, a major cause of morbidity and mortality. New infectious diseases have emerged (AIDS, legionellosis, exterotoxigenic E. coli, Ebola fever), others have significantly reemerged (tuberculosis, diphtheria, Bartonella infections) or have seen their geographic distribution widen considerably (dengue, Hantavirus, West Nile Virus, Lyme disease). New and widespread hepatotropic viruses (mainly hepatitis C) have been identified, while the bacterial cause (Helicobacter pylori) of gastric ulcer was demonstrated. The second part of this review will deal with other examples of emerging or reemerging infections and with the problem of the increasing resistance of pathogens to antimicrobial agents. It will analyse the multiple causes of these various phenomena and describe the diverse strategies which should become available for the prevention and/or treatment of these numerous infectious diseases.",,"['Werner, G H']",['Werner GH'],"[""Membre Associe Libre de l'Academie nationale de Pharmacie.""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Ann Pharm Fr,Annales pharmaceutiques francaises,2985176R,IM,"['Animals', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/transmission', 'Humans']",,,,2001/06/28 10:00,2001/08/24 10:01,['2001/06/28 10:00'],"['2001/06/28 10:00 [pubmed]', '2001/08/24 10:01 [medline]', '2001/06/28 10:00 [entrez]']",['61374 [pii]'],ppublish,Ann Pharm Fr. 2001 May;59(3):147-75.,,,,,,0,,,"Les defis mondiaux des maladies infectieuses ""nouvelles"" ou resurgentes en ce debut de XXIe siecle.",,,,,,,,
16044855,NLM,MEDLINE,20050926,20200409,1438-4221 (Print) 1618-0607 (Electronic) 1438-4221 (Linking),295,3,2005 Jun,"Threat of infection: microbes of high pathogenic potential--strategies for detection, control and eradication.",141-51,,"Infectious diseases due to microbes of high pathogenic potential remain a constant and variable threat for human and animal health. The emergence of new diseases or the re-emergence of diseases that were previously under control complicates the situation to date. Infectious disease research, which has undergone a dramatic progress in understanding disease mechanisms such as host-pathogen interactions, is now focusing increasingly on new strategies for prevention and therapy. Significant progress has been achieved in the development of delivery systems for protective heterologous protein antigens and in veterinary vaccinology. A landmark of infectious diseases research is the chemical synthesis of genomes, a major new field of research referred to as ""synthetic biology"", that to date has resulted in the chemical synthesis of the poliovirus and of phage phiX174 genomes and their expression as infectious viruses. On the molecular level the evolution of pathogens and mechanisms of genome flexibility, which account for several pathogenic properties of infectious agents, have received increased attention. Bacterial toxins are an additional threat to human health and their interference with host cells and cellular functions is receiving more attention.",,"['Hammerschmidt, Sven', 'Hacker, Jorg', 'Klenk, Hans-Dieter']","['Hammerschmidt S', 'Hacker J', 'Klenk HD']","['Research Center for Infectious Diseases, University of Wurzburg, Germany. s.hammerschmidt@mail.uni-wuerzburg.de']",['eng'],['Congress'],,Germany,Int J Med Microbiol,International journal of medical microbiology : IJMM,100898849,IM,"['Animals', 'Bacterial Toxins/metabolism/toxicity', '*Communicable Disease Control', 'Communicable Diseases/*microbiology', '*Communicable Diseases, Emerging/microbiology/prevention & control/virology', 'Humans', 'Vaccines']",PMC7129083,,,2005/07/28 09:00,2005/09/27 09:00,['2005/07/28 09:00'],"['2005/07/28 09:00 [pubmed]', '2005/09/27 09:00 [medline]', '2005/07/28 09:00 [entrez]']","['S1438-4221(05)00045-7 [pii]', '10.1016/j.ijmm.2005.03.004 [doi]']",ppublish,Int J Med Microbiol. 2005 Jun;295(3):141-51. doi: 10.1016/j.ijmm.2005.03.004.,,,"['0 (Bacterial Toxins)', '0 (Vaccines)']",,,,,,,,,,,,,,
13425919,NLM,MEDLINE,20020501,20181201,0004-1955 (Print) 0004-1955 (Linking),19,2,1957,[Relation between non-infectious and infectious diseases].,75-8,,,,"['SOSOV, R F']",['SOSOV RF'],,['rus'],['Journal Article'],,Russia (Federation),Arkh Patol,Arkhiv patologii,0370604,OM,"['Communicable Diseases/*physiology', '*Nervous System']",,['NLM'],"['*COMMUNICABLE DISEASES/physiology', '*NERVOUS SYSTEM']",1957/01/01 00:00,1957/01/01 00:01,['1957/01/01 00:00'],"['1957/01/01 00:00 [pubmed]', '1957/01/01 00:01 [medline]', '1957/01/01 00:00 [entrez]']",,ppublish,Arkh Patol. 1957;19(2):75-8.,,,,,,,,,O sviazi mezhdu neinfektsionnymi i infektsionnymi bolezniami.,,,['CLML: 5732:24096'],,,,,
8073142,NLM,MEDLINE,19940923,20061101,0033-2100 (Print) 0033-2100 (Linking),48,1-2,1994,[Infectious diseases in Poland in 1992].,45-8,,,,"['Magdzik, W', 'Czarkowski, M P']","['Magdzik W', 'Czarkowski MP']",,['pol'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Communicable Diseases/classification/*epidemiology', 'Disease Outbreaks', 'Humans', 'Poland/epidemiology']",,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1994;48(1-2):45-8.,,,,,,,,,Choroby zakazne w Polsce w 1992 roku.,,,,,,,,
15254816,NLM,MEDLINE,20040907,20200324,1436-9990 (Print) 1437-1588 (Electronic) 1436-9990 (Linking),47,7,2004 Jul,[The emergence of old and new epidemics as a consequence of human actions].,611-21,,"In the era of antibiotics and vaccines and prior to the appearance of AIDS, well-known infectious diseases received decreasing clinical attention. Occasionally, the opinion was also expressed that new types of infectious diseases could no longer be expected. However, a more detailed analysis of the state of infectious diseases yields quite a different picture. A variety of new infectious diseases has clinically been defined over the last few decades. New viruses, bacteria, and parasites with pathogenic potential for humans have been detected and well-known microorganisms have spread beyond their original geographic areas. Infectious agents, in particular viruses, permanently alter their genomes and may thus gain new clinical relevance. This article demonstrates that primarily the behavior of man influenced the nature and distribution of infectious diseases in the past and will affect the spread of infectious diseases in the future.",,"['Kurth, R']",['Kurth R'],"['Robert Koch-Institut, Berlin. kurthr@rki.de']",['ger'],"['English Abstract', 'Journal Article', 'Review']",,Germany,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz",101181368,IM,"['Acquired Immunodeficiency Syndrome/epidemiology/prevention & control', 'Communicable Diseases, Emerging/classification/*epidemiology/*etiology', '*Health Behavior', '*Life Style', '*Population Dynamics', 'Risk Assessment/trends']",PMC7079979,,,2004/07/16 05:00,2004/09/08 05:00,['2004/07/16 05:00'],"['2004/07/16 05:00 [pubmed]', '2004/09/08 05:00 [medline]', '2004/07/16 05:00 [entrez]']","['857 [pii]', '10.1007/s00103-004-0857-9 [doi]']",ppublish,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Jul;47(7):611-21. doi: 10.1007/s00103-004-0857-9.,,,,,,,,,Das Auftreten alter und neuer Seuchen als Konsequenz menschlichen Handelns.,,,,,,,,
6372054,NLM,MEDLINE,19840601,20041117,0210-5020 (Print) 0210-5020 (Linking),7,67,1984 Mar,[Infectious diseases. Specimen collection for diagnosis].,14-7,,,,"['Eguiluz, M C']",['Eguiluz MC'],,['spa'],['Journal Article'],,Spain,Rev Enferm,"Revista de enfermeria (Barcelona, Spain)",8309920,,"['Bacteriological Techniques', 'Communicable Diseases/*diagnosis/microbiology', 'Humans', 'Specimen Handling/*methods']",,,,1984/03/01 00:00,1984/03/01 00:01,['1984/03/01 00:00'],"['1984/03/01 00:00 [pubmed]', '1984/03/01 00:01 [medline]', '1984/03/01 00:00 [entrez]']",,ppublish,Rev Enferm. 1984 Mar;7(67):14-7.,,,,,,,,,Enfermedades infecciosas. Recoleccion de muestras para el diagnostico.,,,,,,,,
18133954,NLM,MEDLINE,20071227,20201005,0369-8300 (Print) 0369-8300 (Linking),39,23,1949 Jun 18,[Electrophoresis in infectious diseases].,277-81,,,,"['BENHAMOU, E', 'PUGLIESE, J']","['BENHAMOU E', 'PUGLIESE J']",,['fre'],['Journal Article'],,France,Paris Med,Paris medical,19520510R,OM,"['Communicable Diseases/*therapy', '*Ion Exchange']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*ION TRANSFER']",1949/06/18 00:00,2008/01/17 09:00,['1949/06/18 00:00'],"['1949/06/18 00:00 [pubmed]', '2008/01/17 09:00 [medline]', '1949/06/18 00:00 [entrez]']",,ppublish,Paris Med. 1949 Jun 18;39(23):277-81.,,,,,,,,,L'electrophorese dans les maladies infectieuses.,,,['CLML: 4917:644m'],,,,,
13592353,NLM,MEDLINE,20000701,20181201,0370-9590 (Print) 0370-9590 (Linking),112,Suppl 9,1958 Jun 20,[Treatment of infectious diseases].,242-8 passim contd,,,,"['INK, J']",['INK J'],,['spa'],['Journal Article'],,Argentina,Sem Med,La Semana medica,0404403,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1958/06/20 00:00,1958/06/20 00:01,['1958/06/20 00:00'],"['1958/06/20 00:00 [pubmed]', '1958/06/20 00:01 [medline]', '1958/06/20 00:00 [entrez]']",,ppublish,Sem Med. 1958 Jun 20;112(Suppl 9):242-8 passim contd.,,,,,,,,,Tratamiento de las enfermedades infecciosas.,,,['CLML: 5935:21766:151'],,,,,
14948348,NLM,MEDLINE,20040215,20181201,,7,3,1952 May-Jun,[Cosmopolitism and infectious diseases].,176-7,,,,['ONDRACEK'],['ONDRACEK'],,['und'],['Journal Article'],,Czech Republic,Pediatr Listy,Pediatricke listy,0204303,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/05/01 00:00,1952/05/01 00:01,['1952/05/01 00:00'],"['1952/05/01 00:00 [pubmed]', '1952/05/01 00:01 [medline]', '1952/05/01 00:00 [entrez]']",,ppublish,Pediatr Listy. 1952 May-Jun;7(3):176-7.,,,,,,,,,Kosmopolitismus a infek6cni choroby.,,,['CLML: 5222:34686:114'],,,,,
23548359,NLM,MEDLINE,20130627,20130403,0177-5103 (Print) 0177-5103 (Linking),103,2,2013 Mar 26,Pathology and causes of death of stranded cetaceans in the Canary Islands (1999-2005).,87-99,10.3354/dao02558 [doi],"Between 1999 and 2005, 233 stranded cetaceans (comprising 19 species) were reported in the waters of the Canary Islands. Of these, 138/233 (59.2%) were subjected to a complete or partial standardized necropsy, including 4 Balaenopteridae, 9 Physeteridae, 8 Kogiidae, 27 Ziphiidae and 90 Delphinidae. Of these, 46/138 (33.3%) cetaceans were diagnosed with anthropogenic pathological categories (i.e. the cause of death was anthropogenic). These included fishing interaction (bycatch) (19 individuals), 'atypical' mass stranding events linked to naval exercises (13), ship collisions (8) and other anthropogenic-related pathology (6). 'Natural' (i.e. non-anthropogenic) causes of death accounted for another 82/138 (59.4%) cases, including infectious and non-infectious diseases (63), neonatal pathology (8), intra- and interspecific interactions (6) and mass strandings (5). The cause(s) of death could not be determined in 10/138 (7.3%) necropsied animals. The most common causes of death were ship collisions in 6/9 (66.6%) Physeteridae, 'atypical' mass stranding linked to naval exercises in 13/27 (48.1%) Ziphiidae, and 'natural' infectious and non-infectious diseases in 55/90 (61.1%) Delphinidae. Interaction with fishing activities was established as cause of death in 15/90 (16.7%) Delphinidae. These data show that a range of anthropogenic and natural single and mass mortality events occur in multiple cetacean species stranded in the Canary Islands.",,"['Arbelo, Manuel', 'Los Monteros, Antonio Espinosa de', 'Herraez, Pedro', 'Andrada, Marisa', 'Sierra, Eva', 'Rodriguez, Francisco', 'Jepson, Paul D', 'Fernandez, Antonio']","['Arbelo M', 'Los Monteros AE', 'Herraez P', 'Andrada M', 'Sierra E', 'Rodriguez F', 'Jepson PD', 'Fernandez A']","['Institute of Animal Health, University of Las Palmas de Gran Canaria, Canary Islands, Spain. marbelo@dmor.ulpgc.es']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Germany,Dis Aquat Organ,Diseases of aquatic organisms,8807037,IM,"['Animals', '*Cetacea', 'Communicable Diseases/epidemiology/mortality/pathology/*veterinary', 'Human Activities', 'Ships', 'Spain/epidemiology', 'Time Factors', 'Wounds and Injuries/epidemiology/mortality/*veterinary']",,,,2013/04/04 06:00,2013/06/29 06:00,['2013/04/04 06:00'],"['2013/04/04 06:00 [entrez]', '2013/04/04 06:00 [pubmed]', '2013/06/29 06:00 [medline]']",['10.3354/dao02558 [doi]'],ppublish,Dis Aquat Organ. 2013 Mar 26;103(2):87-99. doi: 10.3354/dao02558.,,,,,,,,,,,,,,,,,
13842236,NLM,MEDLINE,19981101,20200716,0372-9311 (Print) 0372-9311 (Linking),31,,1960 Jun,"[National literature on the problems of microbiology, immunology, infectious diseases and epidemiology published during the first quarter of 1959. 4. Infectious diseases].",142-9 concl,,,,"[""VIL'SHANSKAIA, M L""]","[""VIL'SHANSKAIA ML""]",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,['Communicable Diseases/*epidemiology'],,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1960/06/01 00:00,1960/06/01 00:01,['1960/06/01 00:00'],"['1960/06/01 00:00 [pubmed]', '1960/06/01 00:01 [medline]', '1960/06/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1960 Jun;31:142-9 concl.,,,,,,,,,,,,,,,,,
19722833,NLM,MEDLINE,20091022,20181201,1746-0921 (Electronic) 1746-0913 (Linking),4,7,2009 Sep,Report from the European Congress of Clinical Microbiology and Infectious Diseases.,783-7,10.2217/fmb.09.50 [doi],"With its cool climate, Finland has a lower prevalence of fungal infections than many other European countries that have hosted the annual congress of the European Society of Clinical Microbiology and Infectious Diseases. However, changing patterns of infection and drug resistance, and their impact on treatment decisions, are as important to Nordic infectious disease specialists as to their colleagues in warmer countries. Similarly, developments in diagnostic techniques that enable fungal invasion to be identified before there is clinical evidence of infection will be a major step forward for physicians wherever they practise. It should therefore come as no surprise that this year's European Congress of Clinical Microbiology and Infectious Diseases was as well attended as previous meetings, with over 8000 participants arriving from all parts of Europe.",,"['Anttila, Veli-Jukka', 'Bryan, Jenny']","['Anttila VJ', 'Bryan J']","['Infection Epidemiological Unit, Helsinki University Hospital, Finland. veli-jukka.anttila@hus.fi']",['eng'],['Congress'],,England,Future Microbiol,Future microbiology,101278120,IM,"['Biomedical Research/*trends', 'Clinical Laboratory Techniques/*methods', 'Communicable Diseases/drug therapy/*epidemiology/*microbiology', 'Diagnostic Techniques and Procedures', 'Finland', 'Humans', 'Mycoses/drug therapy/*epidemiology/*microbiology']",,,,2009/09/03 06:00,2009/10/23 06:00,['2009/09/03 09:00'],"['2009/09/03 09:00 [entrez]', '2009/09/03 06:00 [pubmed]', '2009/10/23 06:00 [medline]']",['10.2217/fmb.09.50 [doi]'],ppublish,Future Microbiol. 2009 Sep;4(7):783-7. doi: 10.2217/fmb.09.50.,,,,,,,,,,,,,,,,,
20278722,NLM,MEDLINE,20100329,20201005,0025-8458 (Print) 0025-8458 (Linking),41,16,1946 Aug,[Infectious diseases. In the light of the war experience].,341-6,,,,"['STOERMER, A']",['STOERMER A'],,['ger'],['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Disease', '*Warfare']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*WAR/diseases']",1946/08/01 00:00,2014/08/13 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '1946/08/01 00:00 [pubmed]', '2014/08/13 06:00 [medline]']",,ppublish,Med Klin. 1946 Aug;41(16):341-6.,,,,,,,,,Infektionskrankheiten. im Lichte der Kriegserfahrungen.,,,['CLML: 4712:263v'],,,,,
19679031,NLM,MEDLINE,20091207,20130501,1560-7917 (Electronic) 1025-496X (Linking),14,32,2009 Aug 13,EMCDDA publishes updated version of the drug-related infectious diseases testing guidelines in July 2009.,,19305 [pii],,,,,,['eng'],['News'],20090813,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,IM,"['Communicable Diseases/diagnosis/*epidemiology/transmission', 'Europe/epidemiology', '*Guidelines as Topic', 'Humans', '*Population Surveillance', '*Substance Abuse, Intravenous']",,,,2009/08/15 09:00,2009/12/16 06:00,['2009/08/15 09:00'],"['2009/08/15 09:00 [entrez]', '2009/08/15 09:00 [pubmed]', '2009/12/16 06:00 [medline]']",['19305 [pii]'],epublish,Euro Surveill. 2009 Aug 13;14(32):19305.,,,,,,,,,,,['Editorial team'],,,,,,
25842963,NLM,MEDLINE,20150811,20200716,0372-9311 (Print) 0372-9311 (Linking),,1,2015 Jan-Feb,[Epidemiological risk of introduction of dangerous and exotic infectious diseases on the territory of the XXII Olympic Winter Games and XI Paralympic Winter Games 2014 in Sochi].,115-21,,"To assess the epidemiological risk of introduction of serious infectious diseases in the pre-Olympic period defined list of dangerous and exotic infections and held assessment of potential danger threatening. Initial external information to assess the potential risk of skidding were reports, forecasts, posted on the official websites. The risk of skidding and epidemiological complications conditionally designated as high, moderate and minimal risk importation of measles virus-Rate was considered as high. In confirmation of the forecast for the period of the Olympic Games in Sochi have been registered about 100 cases of measles. Moderate risk of importation was determined for poliomyelitis due to wild poliovirus, Lassa fever, cholera, plague, and the minimal--for Dengue fever, yellow fever, the Middle East and respiratory syndrome, diseases caused by viruses Marburg and Ebola. Based on of analysis of previous Olympic Games and subsequent co-events related to the activity of the infectious diseases in the world, mate-cluded that even a slight risk of importation of infectious diseases requires maximum alertness and readiness to conduct adequate epidemiological issues incorporated.",,"[""Kuz'kin, B P"", 'Ezhlova, E B', 'Kulichenko, A N', 'Maletskaia, O V', 'Demina, Iu V', 'Taran, T V', 'Pakskina, N D', 'Kharchenko, T V', 'Grizhebovskii, G M', ""Savel'ev, V N"", 'Orobei, V G', 'Klindukhov, V P', 'Grechanaia, T V', 'Tesheva, S Ch', 'Brukhanova, G D']","[""Kuz'kin BP"", 'Ezhlova EB', 'Kulichenko AN', 'Maletskaia OV', 'Demina IuV', 'Taran TV', 'Pakskina ND', 'Kharchenko TV', 'Grizhebovskii GM', ""Savel'ev VN"", 'Orobei VG', 'Klindukhov VP', 'Grechanaia TV', 'Tesheva SCh', 'Brukhanova GD']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Anniversaries and Special Events', 'Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*epidemiology/microbiology', 'Humans', 'Risk']",,,,2015/04/07 06:00,2015/08/12 06:00,['2015/04/07 06:00'],"['2015/04/07 06:00 [entrez]', '2015/04/07 06:00 [pubmed]', '2015/08/12 06:00 [medline]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2015 Jan-Feb;(1):115-21.,,,,,,,,,,,,,,,,,
1035016,NLM,MEDLINE,19770315,20140603,,163,1-4,1976,[New topics in infectious medicine (author's transl)].,81-95,,"After the eradication and control of the old classical epidemics, the situation in the sector of infectious diseases has changed. These days 3 groups of infectious diseases have gained importance than they had in the past and thus have changed the scene: I. Infectious diseases which earlier were either not known on such a scale or completely unknown Under this group fall mainly the ""infectious factor diseases"" caused by so-called ""opportunistic"" germs, mixed infections, old and new zoonoses, iatrogenic infections, ""explosion epidemics"" and epidemics caused by germ mutations. II. Therapy-resistant infectious diseases Here a distinction is made between infectious diseases caused by chemotherapy-resistant germs and the diseases whose increased rate of incidence is due to the fact that the arthropod vectors became resistant to insecticides. III. Infectious diseases to which the classical Henle-Koch postulates no longer apply These are chronic diseases and persistent infections, immunopathogenic consequences of infections and viral tumours. The diseases are discussed separately with respect to the cause/effect relationship with the emphasis on the following subjects: Opportunistic problem germs, infectious factor diseases with hospitalism, mixed infections, salmonellosis and new viral zoonoses, chronic diseases, ""slow viruses"", immunopathogenic consequences of infections and viral tumours.",,"['Mayr, A']",['Mayr A'],,['ger'],"['English Abstract', 'Journal Article']",,Germany,Zentralbl Bakteriol Orig B,"Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, praventive Medizin",1306477,IM,"['Animals', 'Cell Transformation, Neoplastic', 'Chronic Disease', '*Communicable Diseases/drug therapy/epidemiology/etiology', 'Cross Infection', 'Disease Outbreaks', 'Humans', 'Neoplasms/etiology', 'Virus Diseases', 'Zoonoses']",,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Zentralbl Bakteriol Orig B. 1976;163(1-4):81-95.,,,,,,,,,Neue Schwerpunkte in der Infektionsmedizin.,,,,,,,,
21936598,NLM,MEDLINE,20120123,20181023,1551-0018 (Electronic) 1547-1063 (Linking),8,4,2011 Oct 1,Global asymptotic properties of staged models with multiple progression pathways for infectious diseases.,1019-34,10.3934/mbe.2011.8.1019 [doi],"We consider global asymptotic properties of compartment staged-progression models for infectious diseases with long infectious period, where there are multiple alternative disease progression pathways and branching. For example, these models reflect cases when there is considerable difference in virulence, or when only a part of the infected individuals undergoes a treatment whereas the rest remains untreated. Using the direct Lyapunov method, we establish sufficient and necessary conditions for the existence and global stability of a unique endemic equilibrium state, and for the stability of an infection-free equilibrium state.",,"['Melnik, Andrey V', 'Korobeinikov, Andrei']","['Melnik AV', 'Korobeinikov A']","['Department of Applied Mathematics and Computer Science, Samara Nayanova Academia, Molodogvardeyskaya 196, Samara, Russian Federation. andrey.v.melnik@gmail.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Math Biosci Eng,Mathematical biosciences and engineering : MBE,101197794,IM,"['Basic Reproduction Number', 'Communicable Diseases/epidemiology/*immunology/pathology/transmission', '*Disease Outbreaks', 'Disease Progression', 'Humans', '*Models, Immunological']",,,,2011/09/23 06:00,2012/01/24 06:00,['2011/09/23 06:00'],"['2011/09/23 06:00 [entrez]', '2011/09/23 06:00 [pubmed]', '2012/01/24 06:00 [medline]']",['10.3934/mbe.2011.8.1019 [doi]'],ppublish,Math Biosci Eng. 2011 Oct 1;8(4):1019-34. doi: 10.3934/mbe.2011.8.1019.,,,,,,,,,,,,,,,,,
20282602,NLM,MEDLINE,20100318,20181201,,2,17,1946 Sep 15,CASES of infectious diseases notified among displaced persons in Germany.,715-8,,,,,,,['eng'],['Journal Article'],,Singapore,Wkly Bull Epidemiol Inf Receiv,"Weekly bulletin; epidemiological information received. Interim Commission of the World Health Organization. Epidemiological Intelligence Station, Singapore",23480060R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Disease', 'Germany', '*Warfare']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*WAR/diseases']",1946/09/15 00:00,2014/08/13 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '1946/09/15 00:00 [pubmed]', '2014/08/13 06:00 [medline]']",,ppublish,Wkly Bull Epidemiol Inf Receiv. 1946 Sep 15;2(17):715-8.,,,,,,,,,,,,['CLML: 4712:465c'],,,,,
3689556,NLM,MEDLINE,19880209,20041117,0539-6115 (Print) 0539-6115 (Linking),44,11,1987 Nov,[Infectious diseases of man: the 2 faces of Janus].,645-9,,,,"['Kumate, J']",['Kumate J'],,['spa'],['Journal Article'],,Mexico,Bol Med Hosp Infant Mex,Boletin medico del Hospital Infantil de Mexico,0414106,IM,"['Animals', '*Communicable Diseases/etiology/therapy', 'Disease Vectors', 'Drug Resistance, Microbial', 'Humans']",,,,1987/11/01 00:00,1987/11/01 00:01,['1987/11/01 00:00'],"['1987/11/01 00:00 [pubmed]', '1987/11/01 00:01 [medline]', '1987/11/01 00:00 [entrez]']",,ppublish,Bol Med Hosp Infant Mex. 1987 Nov;44(11):645-9.,,,,,,,,,Las enfermedades infecciosas del hombre: las dos caras de Jano.,,,,,,,,
9419162,NLM,MEDLINE,19980123,20190512,0022-1899 (Print) 0022-1899 (Linking),177,1,1998 Jan,"Summary of the International Conference on Emerging Infectious Diseases US-Japan Cooperative Medical Science Program, Bangkok, 1997.",3-4,,,,"['Mahmoud, A A', 'La Montagne, J', 'Takeda, Y']","['Mahmoud AA', 'La Montagne J', 'Takeda Y']","['Case Western Reserve University and University Hospitals of Cleveland, Ohio 44106-5029, USA.']",['eng'],['Congress'],,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Asia/epidemiology', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/*epidemiology/etiology', 'Global Health', 'Pacific Ocean', 'Population Surveillance', 'Public Health Administration', 'World Health Organization']",,,,1998/01/07 00:00,1998/01/07 00:01,['1998/01/07 00:00'],"['1998/01/07 00:00 [pubmed]', '1998/01/07 00:01 [medline]', '1998/01/07 00:00 [entrez]']",['10.1086/513828 [doi]'],ppublish,J Infect Dis. 1998 Jan;177(1):3-4. doi: 10.1086/513828.,,,,,,,,,,,,,,,,,
11693425,NLM,MEDLINE,20020319,20041117,0393-974X (Print) 0393-974X (Linking),15,3,2001 Jul-Sep,"The National Institute for Infectious Diseases ""Lazzaro Spallanzani"": a sense of mission.",201-11,,,,"['Ippolito, G']",['Ippolito G'],"['National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.']",['eng'],['Journal Article'],,Italy,J Biol Regul Homeost Agents,Journal of biological regulators and homeostatic agents,8809253,IM,"['Academic Medical Centers', '*Academies and Institutes', '*Communicable Diseases/diagnosis/therapy', 'Humans']",,,,2001/11/06 10:00,2002/03/20 10:01,['2001/11/06 10:00'],"['2001/11/06 10:00 [pubmed]', '2002/03/20 10:01 [medline]', '2001/11/06 10:00 [entrez]']",,ppublish,J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):201-11.,,,,,,,,,,,,,,,,,
9633297,NLM,MEDLINE,19980702,20141120,1096-6293 (Print) 1096-6293 (Linking),6,5,1998 May,Back from the dead. Emerging and re-emerging infectious diseases.,67-8,,,,"['Cornell, S']",['Cornell S'],,['eng'],['Journal Article'],,United States,Adv Nurse Pract,Advance for nurse practitioners,9892010,,"['Anti-Bacterial Agents/*therapeutic use', 'Communicable Diseases/*drug therapy/*epidemiology/microbiology', '*Drug Resistance, Microbial', '*Global Health', 'Humans']",,,,1998/06/20 00:00,1998/06/20 00:01,['1998/06/20 00:00'],"['1998/06/20 00:00 [pubmed]', '1998/06/20 00:01 [medline]', '1998/06/20 00:00 [entrez]']",,ppublish,Adv Nurse Pract. 1998 May;6(5):67-8.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
27405923,NLM,MEDLINE,20171211,20171211,1873-3468 (Electronic) 0014-5793 (Linking),590,13,2016 Jul,Integrative analysis of pathogen replication and spread: zooming into increasing complexity.,1855-7,10.1002/1873-3468.12253 [doi],,,"['Fackler, Oliver T', 'Krausslich, Hans-Georg']","['Fackler OT', 'Krausslich HG']","['Department of Infectious Diseases, Integrative Virology, University Hospital Heidelberg, Germany.', 'Department of Infectious Diseases, Virology, University Hospital Heidelberg, Germany.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,FEBS Lett,FEBS letters,0155157,IM,"['Animals', 'Communicable Diseases/*immunology/parasitology/virology', 'Host-Pathogen Interactions', 'Humans', 'Parasites/*physiology', '*Virus Physiological Phenomena', 'Virus Replication']",,,,2016/07/14 06:00,2017/12/12 06:00,['2016/07/14 06:00'],"['2016/07/14 06:00 [entrez]', '2016/07/14 06:00 [pubmed]', '2017/12/12 06:00 [medline]']",['10.1002/1873-3468.12253 [doi]'],ppublish,FEBS Lett. 2016 Jul;590(13):1855-7. doi: 10.1002/1873-3468.12253.,,,,,,,,,,,,,,,,,
20108477,NLM,MEDLINE,20100308,20211020,1844-122X (Print) 1844-3117 (Electronic) 1844-122X (Linking),1,1,2008 Jan-Mar,Mathematical functions for modeling the variation of specific medical criteria in some infectious diseases.,34-9,,"The paper presents the definition of rules for the medical algorithms in some infectious diseases and also the mathematical functions for modeling: interrogation rules to elaborate specific concepts and work methods in HIV/AIDS infection, interrogation rules to elaborate specifically concepts and work methods in SEPSIS, initial conditions regarding the introduction of the notion of stochastic correlation coefficient, determination of the the stochastic correlation coefficient through the method of reciprocal comparison of the variables, determination of the influential ponders through reciprocal comparison of the characteristics. models for the study of the variation of the specific medical criteria of some infectious diseases in the case of adopting the analysis method of reciprocal non comparison.",,"['Streinu-Cercel, Adrian', 'Costoiu, Sergiu', 'Marza, Maria', 'Arama, Victoria', 'Streinu-Cercel, Anca', 'Marza, Monica']","['Streinu-Cercel A', 'Costoiu S', 'Marza M', 'Arama V', 'Streinu-Cercel A', 'Marza M']","['Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. secretariat@mateibals.ro']",['eng'],['Journal Article'],,Romania,J Med Life,Journal of medicine and life,101477617,IM,"['*Biomedical Engineering', '*Biotechnology', 'Communicable Diseases/*diagnosis/*therapy', 'Humans', '*Models, Theoretical', 'Stochastic Processes']",PMC5607785,,,2008/01/01 00:00,2010/03/10 06:00,['2010/01/30 06:00'],"['2010/01/30 06:00 [entrez]', '2008/01/01 00:00 [pubmed]', '2010/03/10 06:00 [medline]']",['JMedLife-1-34 [pii]'],ppublish,J Med Life. 2008 Jan-Mar;1(1):34-9.,,,,,,,,,,,,,,,,,
10887525,NLM,MEDLINE,20000807,20111117,0023-9852 (Print) 0023-9852 (Linking),47,5,1999 Sep-Oct,The impact of new technology on infectious diseases.,276-80,,,,"['Kanj, S S', 'Araj, G F']","['Kanj SS', 'Araj GF']","['Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Lebanon. sk11@aub.edu.lb']",['eng'],['Journal Article'],,Lebanon,J Med Liban,Le Journal medical libanais. The Lebanese medical journal,0375352,IM,"['Communicable Disease Control/trends', 'Communicable Diseases/diagnosis/therapy/*transmission', 'Forecasting', 'Humans', 'Lebanon', 'Medical Laboratory Science/*trends', 'Risk Factors']",,,,2000/07/11 11:00,2000/08/12 11:00,['2000/07/11 11:00'],"['2000/07/11 11:00 [pubmed]', '2000/08/12 11:00 [medline]', '2000/07/11 11:00 [entrez]']",,ppublish,J Med Liban. 1999 Sep-Oct;47(5):276-80.,,,,,,,,,,,,,,,,,
17845288,NLM,MEDLINE,20070925,20101118,1461-0248 (Electronic) 1461-023X (Linking),10,10,2007 Oct,Applying population-genetic models in theoretical evolutionary epidemiology.,876-88,,"Much of the existing theory for the evolutionary biology of infectious diseases uses an invasion analysis approach. In this Ideas and Perspectives article, we suggest that techniques from theoretical population genetics can also be profitably used to study the evolutionary epidemiology of infectious diseases. We highlight four ways in which population-genetic models provide benefits beyond those provided by most invasion analyses: (i) they can make predictions about the rate of pathogen evolution; (ii) they explicitly draw out the mechanistic way in which the epidemiological dynamics feed into evolutionary change, and thereby provide new insights into pathogen evolution; (iii) they can make predictions about the evolutionary consequences of non-equilibrium epidemiological dynamics; (iv) they can readily incorporate the effects of multiple host dynamics, and thereby account for phenomena such as immunological history and/or host co-evolution.",,"['Day, Troy', 'Gandon, Sylvain']","['Day T', 'Gandon S']","[""Department of Mathematics, Jeffery Hall, Queen's University, Kingston, ON K7L 3N6, Canada. tday@mast.queensu.ca""]",['eng'],['Journal Article'],,England,Ecol Lett,Ecology letters,101121949,IM,"['Biological Evolution', 'Communicable Diseases/*epidemiology/*genetics/transmission', 'Genetics, Population', 'Humans', '*Models, Genetic']",,,,2007/09/12 09:00,2007/09/26 09:00,['2007/09/12 09:00'],"['2007/09/12 09:00 [pubmed]', '2007/09/26 09:00 [medline]', '2007/09/12 09:00 [entrez]']","['ELE1091 [pii]', '10.1111/j.1461-0248.2007.01091.x [doi]']",ppublish,Ecol Lett. 2007 Oct;10(10):876-88. doi: 10.1111/j.1461-0248.2007.01091.x.,,,,,,,,,,,,,,,,,
8665656,NLM,MEDLINE,19960808,20190905,0891-1150 (Print) 0891-1150 (Linking),63,3,1996 May-Jun,Recognizing and treating new and emerging infections encountered in everyday practice.,172-8,,"Although infectious diseases were once considered a diminishing threat, new pathogens are constantly challenging the health care system. This article reviews the clinical presentation, diagnosis, and treatment of seven emerging infections that primary care physicians are likely to encounter.",,"['Gordon, S M']",['Gordon SM'],"['Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Cleve Clin J Med,Cleveland Clinic journal of medicine,8703441,IM,"['Communicable Diseases/*diagnosis/epidemiology/microbiology/*therapy', 'Diagnosis, Differential', 'Humans', 'Primary Health Care', 'Risk Factors']",,,,1996/05/01 00:00,1996/05/01 00:01,['1996/05/01 00:00'],"['1996/05/01 00:00 [pubmed]', '1996/05/01 00:01 [medline]', '1996/05/01 00:00 [entrez]']",['10.3949/ccjm.63.3.172 [doi]'],ppublish,Cleve Clin J Med. 1996 May-Jun;63(3):172-8. doi: 10.3949/ccjm.63.3.172.,,,,,,24,,,,,,,,,,,
2096496,NLM,MEDLINE,19910717,20190510,0035-9203 (Print) 0035-9203 (Linking),84,6,1990 Nov-Dec,The polymerase chain reaction and infectious diseases: hopes and realities.,"755-6, 758",,,,"['Stoker, N G']",['Stoker NG'],"['Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, UK.']",['eng'],['Journal Article'],,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,IM,"['Communicable Diseases/*diagnosis/genetics', 'Developing Countries', 'Humans', '*Polymerase Chain Reaction']",,,,1990/11/01 00:00,1990/11/01 00:01,['1990/11/01 00:00'],"['1990/11/01 00:00 [pubmed]', '1990/11/01 00:01 [medline]', '1990/11/01 00:00 [entrez]']",['10.1016/0035-9203(90)90064-l [doi]'],ppublish,"Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):755-6, 758. doi: 10.1016/0035-9203(90)90064-l.",,,,,,,,,,,,,,,,,
887816,NLM,MEDLINE,19770922,20061101,0033-2100 (Print) 0033-2100 (Linking),31,1,1977,[Various infectious diseases in the period 1971-1975 in Poland according to the new administrative division. The general epidemiological situation in 1975].,41-5,,,,"['Kostrzewski, J', 'Piatkowski, J']","['Kostrzewski J', 'Piatkowski J']",,['pol'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Communicable Diseases/*epidemiology/mortality', 'Disease Outbreaks', 'Female', 'Humans', 'Male', 'Poland']",,,,1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1977;31(1):41-5.,,,,,,,,,Niektore choroby zakazne w Polsce w latach 1971--1975 wedlud nowego podzialu administracyjnego kraju i ogolna sytuacja epidemiologiczna w 1975 r.,,,,,,,,
34365428,NLM,MEDLINE,20210810,20220531,1512-0112 (Print) 1512-0112 (Linking),,315,2021 Jun,[SEVERE INFECTIOUS DISEASE AS A PREDICTOR OF CRITICAL ILLNESS ENCEPHALOPATHY IN CHILDREN (CLINICAL CASE)].,66-73,,"In childhood, infectious diseases, as a rule, are generalized in nature with the development of urgent or critical conditions that require the transfer of the child to mechanical ventilation. A child's stay on mechanical ventilation, on the one hand, is vital, on the other hand, it is a factor that threatens the development of acute encephalopathy, mechanical ventilation associated pneumonia, polyneuropathy and myopathy of critical conditions. According to the authors, the incidence of critical encephalopathy in patients with generalized infectious diseases who are on mechanical ventilation is 75%, and in the long-term (after 1 year) outcome in convalescents, the frequency of neurological deficit reaches 33%. In this regard, it is extremely important to timely diagnose and predict encephalopathy, including in children, as well as early adequate therapy with the inclusion of a complex action drug Cytoflavin, which has not only an antioxidant, antiplatelet effect, but also anti-inflammatory and remyelinating. The article presents a clinical case of critical state encephalopathy, which developed against the background of a severe infectious disease after artificial ventilation with effective timely use of Cytoflavin.",,"['Skripchenko, N', 'Egorova, E', 'Vilnits, A', 'Skripchenko, E']","['Skripchenko N', 'Egorova E', 'Vilnits A', 'Skripchenko E']","['1Pediatric Research and Clinical Center for Infectious Diseases, Saint-Petersburg;2Saint-Petersburg State Pediatric Medical University, Russia.', '1Pediatric Research and Clinical Center for Infectious Diseases, Saint-Petersburg; Russia.', '1Pediatric Research and Clinical Center for Infectious Diseases, Saint-Petersburg;2Saint-Petersburg State Pediatric Medical University, Russia.', '1Pediatric Research and Clinical Center for Infectious Diseases, Saint-Petersburg;2Saint-Petersburg State Pediatric Medical University, Russia.']",['rus'],"['Case Reports', 'Journal Article']",,Georgia (Republic),Georgian Med News,Georgian medical news,101218222,IM,"['*Brain Diseases/diagnosis/epidemiology', 'Child', '*Communicable Diseases/complications/diagnosis/epidemiology', 'Critical Illness', 'Humans', '*Polyneuropathies', 'Respiration, Artificial']",,,,2021/08/09 06:00,2021/08/11 06:00,['2021/08/08 20:58'],"['2021/08/08 20:58 [entrez]', '2021/08/09 06:00 [pubmed]', '2021/08/11 06:00 [medline]']",,ppublish,Georgian Med News. 2021 Jun;(315):66-73.,,,,,,,,,,,,,,,,,
740298,NLM,MEDLINE,19790425,20041117,0026-4806 (Print) 0026-4806 (Linking),69,59,1978 Dec 1,[Mortality for some infectious diseases in Europe. Study conducted by means of univariant indicators and with the analysis of correspondence].,4017-27,,,,"['Peruzy, A D', 'Coppi, R']","['Peruzy AD', 'Coppi R']",,['ita'],['Journal Article'],,Italy,Minerva Med,Minerva medica,0400732,IM,"['Communicable Diseases/epidemiology/*mortality', 'Europe', 'Humans', 'Respiratory Tract Diseases/epidemiology/mortality']",,,,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",,ppublish,Minerva Med. 1978 Dec 1;69(59):4017-27.,,,,,,,,,La mortalita per alcune malattie infettive in Europa. Studio condotto mediante indicatori statistici univariati e con l'analisi delle corrispondenze.,,,,,,,,
11247707,NLM,MEDLINE,20010614,20071115,1058-4838 (Print) 1058-4838 (Linking),32,6,2001 Mar 15,Guide to development of practice guidelines.,851-4,,,,"['Kish, M A']",['Kish MA'],"['HealthPartners, Inc., Robbinsdale, MN, 55422, USA. Mary.A.Kish@HealthPartners.com']",['eng'],['Journal Article'],20010309,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*Communicable Diseases/diagnosis/therapy', 'Humans', '*Practice Guidelines as Topic']",,,,2001/03/15 10:00,2001/06/15 10:01,['2001/03/15 10:00'],"['2000/11/11 00:00 [received]', '2001/03/15 10:00 [pubmed]', '2001/06/15 10:01 [medline]', '2001/03/15 10:00 [entrez]']","['CID001571 [pii]', '10.1086/319366 [doi]']",ppublish,Clin Infect Dis. 2001 Mar 15;32(6):851-4. doi: 10.1086/319366. Epub 2001 Mar 9.,,,,,,,,,,,['Infectious Diseases Society of America'],,,,,,
14890413,NLM,MEDLINE,20040215,20181201,0368-931X (Print) 0368-931X (Linking),18,4,1951 Oct,[Monthly report on infectious diseases].,367-8,,,,,,,['und'],['Journal Article'],,Spain,Med Colon,La Medicina colonial,18610270R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Procaine/*therapeutic use']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*PROCAINE/therapeutic use']",1951/10/01 00:00,1951/10/01 00:01,['1951/10/01 00:00'],"['1951/10/01 00:00 [pubmed]', '1951/10/01 00:01 [medline]', '1951/10/01 00:00 [entrez]']",,ppublish,Med Colon. 1951 Oct;18(4):367-8.,,,['4Z8Y51M438 (Procaine)'],,,,,,BOLETIN mensual de enfermedades transmisibles.,,,['CLML: 5221:20782:90:304'],,,,,
13531885,NLM,MEDLINE,20000701,20200716,0372-9311 (Print) 0372-9311 (Linking),28,10,1957 Oct,[Medicinal therapy of infectious diseases].,41-7,,,,"['LAZAREV, N V']",['LAZAREV NV'],,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1957/10/01 00:00,1957/10/01 00:01,['1957/10/01 00:00'],"['1957/10/01 00:00 [pubmed]', '1957/10/01 00:01 [medline]', '1957/10/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1957 Oct;28(10):41-7.,,,,,,,,,Puti lekarstvennogo vmeshatel'stva v techenie infektsionnykh zabolevanii.,,,['CLML: 5834:24358:155'],,,,,
20992699,NLM,MEDLINE,20101112,20190717,0002-9629 (Print) 0002-9629 (Linking),211,,1946 Jun,The epidemiologic significance of amplitudes of seasonal fluctuation in infectious diseases.,709-17,,,,"['AYCOCK, W L', 'FOLEY, G E', 'HENDRIE, K H']","['AYCOCK WL', 'FOLEY GE', 'HENDRIE KH']",,['eng'],['Journal Article'],,United States,Am J Med Sci,The American journal of the medical sciences,0370506,OM,"['Communicable Diseases/*epidemiology/*statistics & numerical data', '*Epidemiology', 'Humans', '*Meteorological Concepts', '*Meteorology', '*Seasons']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*EPIDEMIOLOGY', '*METEOROLOGY', '*SEASONS']",1946/06/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/06/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",['10.1097/00000441-194606000-00011 [doi]'],ppublish,Am J Med Sci. 1946 Jun;211:709-17. doi: 10.1097/00000441-194606000-00011.,,,,,,,,,,,,['CLML: 4611:488d'],,,,,
6998435,NLM,MEDLINE,19801120,20061115,0004-1955 (Print) 0004-1955 (Linking),42,7,1980,[Pathomorphosis of infectious diseases in children].,15-9,,The general and therapeutically conditioned pathomorphosis was expressed in a significantly reduced number of autopsies predominantly due to reduced incidence of infectious diseases in children. Histological features of reactions in various organs in antibiotic therapy are examined. The necessity of continuous study of the clinical features and time course of infectious diseases in children is emphasized because the evolution of these processes continues.,,"[""Afanas'eva, V M"", 'Smirnov, Iu P']","[""Afanas'eva VM"", 'Smirnov IuP']",,['rus'],"['English Abstract', 'Historical Article', 'Journal Article']",,Russia (Federation),Arkh Patol,Arkhiv patologii,0370604,IM,"['Anti-Bacterial Agents/therapeutic use', 'Autopsy', 'Child', 'Child, Preschool', 'Communicable Diseases/drug therapy/history/*pathology', 'History, 20th Century', 'Humans', 'Infant', 'Moscow']",,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Arkh Patol. 1980;42(7):15-9.,,,['0 (Anti-Bacterial Agents)'],,,,,,Patomorfoz infektsionnykh zabolevanii u detei.,,,,,,,,
9482964,NLM,MEDLINE,19980305,20181201,0774-935X (Print) 0774-935X (Linking),,1-2,1997 Jun,[Emergent and reemergent infectious diseases].,48-51,,,,,,,['fre'],['Congress'],,Belgium,FNIB Info,FNIB info,9002951,,"['Communicable Diseases/*epidemiology/*microbiology', '*Global Health', 'Hepatitis C/epidemiology', 'Humans', 'Population Surveillance', 'Tuberculosis/epidemiology']",,,,1997/06/01 00:00,1998/03/04 00:01,['1997/06/01 00:00'],"['1997/06/01 00:00 [pubmed]', '1998/03/04 00:01 [medline]', '1997/06/01 00:00 [entrez]']",,ppublish,FNIB Info. 1997 Jun;(1-2):48-51.,,,,,,,,,Les maladies infectieuses emergentes et reemergentes.,,,,,,,,
7279531,NLM,MEDLINE,19811118,20160523,0031-403X (Print) 0031-403X (Linking),,7,1981 Jul,[Incubation period of infectious diseases].,5-9,,,,"['Nosov, S D']",['Nosov SD'],,['rus'],['Journal Article'],,Russia (Federation),Pediatriia,Pediatriia,0405563,IM,"['Animals', 'Communicable Diseases/diagnosis/*etiology/microbiology', 'Humans', 'Time Factors']",,,,1981/07/01 00:00,1981/07/01 00:01,['1981/07/01 00:00'],"['1981/07/01 00:00 [pubmed]', '1981/07/01 00:01 [medline]', '1981/07/01 00:00 [entrez]']",,ppublish,Pediatriia. 1981 Jul;(7):5-9.,,,,,,,,,Ob inkubatsionnom periode infektsionnykh boleznei.,,,,,,,,
7384901,NLM,MEDLINE,19800828,20101118,0038-5077 (Print) 0038-5077 (Linking),,5,1980,[Atypical forms of infectious diseases].,57-9,,,,"['Nosov, S D']",['Nosov SD'],,['rus'],['Journal Article'],,Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,IM,"['Biological Evolution', 'Communicable Diseases/*diagnosis/microbiology/transmission', 'Ecology', 'Humans']",,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Sov Med. 1980;(5):57-9.,,,,,,,,,Atipichnye formy infektsionnykh boleznei.,,,,,,,,
524777,NLM,MEDLINE,19800324,20061115,0042-8825 (Print) 0042-8825 (Linking),24,12,1979 Dec,[Formation of chronic infectious diseases].,8-12,,,,"['Nosov, S D']",['Nosov SD'],,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Vopr Okhr Materin Det,Voprosy okhrany materinstva i detstva,0416600,IM,"['Acute Disease', 'Child', 'Chronic Disease', 'Communicable Diseases/classification/*etiology', 'Humans', 'Research', 'USSR']",,,,1979/12/01 00:00,1979/12/01 00:01,['1979/12/01 00:00'],"['1979/12/01 00:00 [pubmed]', '1979/12/01 00:01 [medline]', '1979/12/01 00:00 [entrez]']",,ppublish,Vopr Okhr Materin Det. 1979 Dec;24(12):8-12.,,,,,,,,,O formirovanii khronicheskikh infektsionnykh boleznei.,,,,,,,,
1256701,NLM,MEDLINE,19760510,20041117,0026-4806 (Print) 0026-4806 (Linking),67,9,1976 Feb 25,"[Cultural evolution, technological development and infectious diseases].",543-8,,,,"['Tolentino, P']",['Tolentino P'],,['ita'],['Journal Article'],,Italy,Minerva Med,Minerva medica,0400732,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/genetics', '*Culture', 'Environment', 'Humans', 'Socioeconomic Factors', '*Technology']",,,,1976/02/25 00:00,1976/02/25 00:01,['1976/02/25 00:00'],"['1976/02/25 00:00 [pubmed]', '1976/02/25 00:01 [medline]', '1976/02/25 00:00 [entrez]']",,ppublish,Minerva Med. 1976 Feb 25;67(9):543-8.,,,,,,,,,"Evoluzione culturale, sviluppo tecnologico e malattie infettive.",,,,,,,,
11221009,NLM,MEDLINE,20010503,20091021,0025-8326 (Print) 0025-8326 (Linking),,4,1999 Oct-Dec,[Criteria for classification of infectious diseases and infections which require measures for sanitary protection over the territory of the Russian Federation].,7-9,,,,"['Fedorov, Iu M', 'Kokushkin, A M']","['Fedorov IuM', 'Kokushkin AM']",,['rus'],['Journal Article'],,Russia (Federation),Med Parazitol (Mosk),Meditsinskaia parazitologiia i parazitarnye bolezni,0376635,IM,"['*Communicable Disease Control', 'Communicable Diseases/*classification/microbiology', 'Humans', 'Russia']",,,,2001/02/28 10:00,2001/05/05 10:01,['2001/02/28 10:00'],"['2001/02/28 10:00 [pubmed]', '2001/05/05 10:01 [medline]', '2001/02/28 10:00 [entrez]']",,ppublish,Med Parazitol (Mosk). 1999 Oct-Dec;(4):7-9.,,,,,,,,,"Kriterii otneseniia infektsionnykh zabolevanii i kategorii infektsii, v otnoshenii kotorykh neobkhodimo provedenie meropriiatii po sanitarnoi okhrane territorii Rossiiskoi Federatsii.",,,,,,,,
8036584,NLM,MEDLINE,19940816,20041117,0040-3660 (Print) 0040-3660 (Linking),65,1,1993,[The teaching of infectious diseases in the system for training the general practice physician].,77-80,,,,"['Cherkasov, V L']",['Cherkasov VL'],,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['*Communicable Diseases/diagnosis/therapy', 'Diagnosis, Differential', 'Family Practice/*education', 'Humans', 'Moscow', 'Teaching/*methods']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1993;65(1):77-80.,,,,,,,,,Prepodavanie infektsionnykh boleznei v sisteme podgotovki vracha obshchei praktiki.,,,,,,,,
7919802,NLM,MEDLINE,19941121,20181130,0188-4409 (Print) 0188-4409 (Linking),25,2,1994 Summer,"Proceedings of the Cuban-Mexican Symposium. Immunity, vaccines and diagnosis of infectious diseases. Mexico City, October 11-15, 1993.",151-277,,,,,,,['eng'],"['Congress', 'Overall']",,United States,Arch Med Res,Archives of medical research,9312706,IM,"['Animals', 'Communicable Diseases/diagnosis/*immunology', 'Humans', '*Immunotherapy']",,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Arch Med Res. 1994 Summer;25(2):151-277.,,,,,,,,,,,,,,,,,
14959182,NLM,MEDLINE,20040215,20181201,0350-0063 (Print) 0350-0063 (Linking),21,7-8,1952,[Progress in the treatment of infectious diseases].,148-51,,,,"['RUS, S']",['RUS S'],,['und'],['Journal Article'],,Slovenia,Zdrav Vestn,Zdravstveni vestnik,21730250R,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1952/01/01 00:00,1952/01/01 00:01,['1952/01/01 00:00'],"['1952/01/01 00:00 [pubmed]', '1952/01/01 00:01 [medline]', '1952/01/01 00:00 [entrez]']",,ppublish,Zdrav Vestn. 1952;21(7-8):148-51.,,,,,,,,,Novosti v terapiji infekcijskih bolezni.,,,['CLML: 5222:45684:114'],,,,,
19514421,NLM,MEDLINE,20090821,20090611,0040-3660 (Print) 0040-3660 (Linking),81,4,2009,[Clinical diagnosis of infectious diseases: historical aspects].,44-6,,,,"['Bogomolov, B P']",['Bogomolov BP'],,['rus'],"['Historical Article', 'Journal Article']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Clinical Medicine/*history/methods', 'Communicable Diseases/classification/*diagnosis/*history', 'History, 17th Century', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'History, Medieval', 'Humans']",,,,2009/06/12 09:00,2009/08/22 09:00,['2009/06/12 09:00'],"['2009/06/12 09:00 [entrez]', '2009/06/12 09:00 [pubmed]', '2009/08/22 09:00 [medline]']",,ppublish,Ter Arkh. 2009;81(4):44-6.,,,,,,,,,,,,,,,,,
5616825,NLM,MEDLINE,19690904,20200716,0372-9311 (Print) 0372-9311 (Linking),44,6,1967 Jun,[Growth in knowledge of the geography of human infectious diseases].,3-9,,,,"['Lysenko, A Ia', ""Iashkul', V K""]","['Lysenko AIa', ""Iashkul' VK""]",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/epidemiology/etiology/*history', 'Epidemiology/*history', 'Geography', 'Humans', 'USSR']",,,,1967/06/01 00:00,1967/06/01 00:01,['1967/06/01 00:00'],"['1967/06/01 00:00 [pubmed]', '1967/06/01 00:01 [medline]', '1967/06/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1967 Jun;44(6):3-9.,,,,,,,,,Razvitie ucheniia o geografii infektsionnykh boleznei cheloveka.,,,,,,,,
7233143,NLM,MEDLINE,19810720,20101118,0036-7281 (Print) 0036-7281 (Linking),123,3,1981 Mar,[Development and disappearance of infectious diseases].,111-9,,,,"['Fey, H']",['Fey H'],,['ger'],['Journal Article'],,Switzerland,Schweiz Arch Tierheilkd,Schweizer Archiv fur Tierheilkunde,0424247,IM,"['Animals', 'Biological Evolution', '*Communicable Disease Control', '*Communicable Diseases/transmission/veterinary', 'Humans']",,,,1981/03/01 00:00,1981/03/01 00:01,['1981/03/01 00:00'],"['1981/03/01 00:00 [pubmed]', '1981/03/01 00:01 [medline]', '1981/03/01 00:00 [entrez]']",,ppublish,Schweiz Arch Tierheilkd. 1981 Mar;123(3):111-9.,,,,,,,,,Werden und Vergehen der Infektionskrankheiten.,,,,,,,,
9934275,NLM,MEDLINE,19991202,20041117,0038-0814 (Print) 0038-0814 (Linking),,629,1998 Oct,[Epidemiology of infectious diseases in France].,54-5,,,,"['Giraud, M']",['Giraud M'],,['fre'],['Journal Article'],,France,Soins,Soins; la revue de reference infirmiere,20910580R,,"['Communicable Disease Control/methods', 'Communicable Diseases/*epidemiology/etiology/transmission', 'France/epidemiology', 'Humans']",,,,1999/02/06 00:00,1999/02/06 00:01,['1999/02/06 00:00'],"['1999/02/06 00:00 [pubmed]', '1999/02/06 00:01 [medline]', '1999/02/06 00:00 [entrez]']",,ppublish,Soins. 1998 Oct;(629):54-5.,,,,,,,,,Etat des lieux des maladies infectieuses en France.,,,,,,,,
8067071,NLM,MEDLINE,19940916,20200716,0372-9311 (Print) 0372-9311 (Linking),,1,1993 Jan-Feb,[The structure of populations of the causative agents of infectious diseases and the mechanism of the development of the epidemic process].,40-5,,"The parameters of clonality and preservation capacity, characterizing the population structure of the causative agents of infectious diseases, have been worked out on the basis of the clonal concept and the concept of self-restructuring of microbial populations. Different correlations between these parameters determine the existence of 9 independent groups of infections. The mechanisms and manifestations of the epidemic process of these infections have been described and the priority directions of anti-epidemic measures formulated.",,"['Beliakov, V D', 'Kaminskii, G D']","['Beliakov VD', 'Kaminskii GD']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Adult', 'Age Distribution', 'Child', 'Child, Preschool', 'Communicable Diseases/*epidemiology/genetics/*microbiology/transmission', '*Disease Outbreaks', 'Humans', 'Molecular Epidemiology', 'Seasons']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1993 Jan-Feb;(1):40-5.,,,,,,,,,Struktura populiatsii vozbuditelei infektsionnykh boleznei i mekhanizm razvitiia epidemicheskogo protsessa.,,,,,,,,
328401,NLM,MEDLINE,19770917,20190827,0300-8126 (Print) 0300-8126 (Linking),5,2,1977,[Changes in the frequency and pathomorphosis of infectious diseases during the last thirty years on the basis of autopsy reports of the Heidelberg University Department of Pathology (author's transl)].,98-103,,,,"['Kuhn, H', 'Hopker, W W', 'Patzschke, U']","['Kuhn H', 'Hopker WW', 'Patzschke U']",,['ger'],"['English Abstract', 'Historical Article', 'Journal Article']",,Germany,Infection,Infection,0365307,IM,"['Anti-Infective Agents/*therapeutic use', 'Autopsy', 'Communicable Diseases/drug therapy/epidemiology/*history/pathology', 'Female', 'Germany, West', 'History, 20th Century', 'Hospitals, University', 'Humans', 'Male', 'Schools, Medical']",,,,1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/BF01642089 [doi]'],ppublish,Infection. 1977;5(2):98-103. doi: 10.1007/BF01642089.,,,['0 (Anti-Infective Agents)'],,,,,,Panorama- und Gestaltwandel der Infektionskrankheiten im Sektionsgut des Pathologischen Institutes der Universitat Heidelberg wahrend drei Dezennien Chemotherapie.,,,,,,,,
3359539,NLM,MEDLINE,19880602,20061115,0009-0689 (Print) 0009-0689 (Linking),36,2,1988 Feb,[The present impact of infectious diseases].,68-78,,,,"['Gopfertova, D']",['Gopfertova D'],,['cze'],"['English Abstract', 'Journal Article']",,Czech Republic,Cesk Zdrav,Ceskoslovenske zdravotnictvi,0416604,IM,"['Communicable Diseases/economics/*epidemiology/mortality', 'Czechoslovakia', 'Humans']",,,,1988/02/01 00:00,1988/02/01 00:01,['1988/02/01 00:00'],"['1988/02/01 00:00 [pubmed]', '1988/02/01 00:01 [medline]', '1988/02/01 00:00 [entrez]']",,ppublish,Cesk Zdrav. 1988 Feb;36(2):68-78.,,,,,,,,,Soucasna zavaznost infekcnich nemoci.,,,,,,,,
5694003,NLM,MEDLINE,19681230,20041117,0036-7672 (Print) 0036-7672 (Linking),98,16,1968 Apr 20,"[Future of infectious diseases: extermination, eradication].",597-602,,,,"['Gsell, O']",['Gsell O'],,['ger'],['Journal Article'],,Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality', 'Disease Vectors', 'Humans', 'Tropical Medicine', 'World Health Organization']",,,,1968/04/20 00:00,1968/04/20 00:01,['1968/04/20 00:00'],"['1968/04/20 00:00 [pubmed]', '1968/04/20 00:01 [medline]', '1968/04/20 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1968 Apr 20;98(16):597-602.,,,,,,,,,"Zukunft der Infektionskrankheiten: Ausrottung, Eradikation.",,,,,,,,
5451083,NLM,MEDLINE,19701006,20041117,0026-4806 (Print) 0026-4806 (Linking),61,63,1970 Aug 11,[On the incidence of infectious diseases in the province of Vercelli].,3355-62,,,,"['Giannuzzo, E']",['Giannuzzo E'],,['ita'],['Journal Article'],,Italy,Minerva Med,Minerva medica,0400732,IM,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality', 'Humans', 'Italy']",,,,1970/08/11 00:00,1970/08/11 00:01,['1970/08/11 00:00'],"['1970/08/11 00:00 [pubmed]', '1970/08/11 00:01 [medline]', '1970/08/11 00:00 [entrez]']",,ppublish,Minerva Med. 1970 Aug 11;61(63):3355-62.,,,,,,,,,Alcune osservazioni in merito all'andamento delle malattie infettive nella provincia di Vercelli.,,,,,,,,
2609810,NLM,MEDLINE,19900221,20200716,0372-9311 (Print) 0372-9311 (Linking),,10,1989 Oct,[The classification of infectious diseases in the light of new data on the subject of epidemiology].,40-3,,,,"['Kovaleva, E P']",['Kovaleva EP'],,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Animals', 'Communicable Diseases/*classification/epidemiology/transmission/veterinary', 'Disease Outbreaks/veterinary', 'Disease Vectors', 'Humans', 'Zoonoses/classification/transmission']",,,,1989/10/01 00:00,1989/10/01 00:01,['1989/10/01 00:00'],"['1989/10/01 00:00 [pubmed]', '1989/10/01 00:01 [medline]', '1989/10/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1989 Oct;(10):40-3.,,,,,,,,,O klassifikatsii infektsionnykh boleznei v svete novykh dannykh o predmete epidemiologii.,,,,,,,,
9400148,NLM,MEDLINE,19980102,20141120,0174-108X (Print) 0174-108X (Linking),35,9,1997 Sep,[Renaissance of infectious diseases. Which infections are of importance today?].,340-9,,,,"['Klinker, H']",['Klinker H'],['Kinikum der Universitat Wurzburg.'],['ger'],['Journal Article'],,Germany,Krankenpfl J,Krankenpflege Journal,8006304,,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/transmission', '*Global Health', '*Health Priorities', 'Humans', 'Population Surveillance']",,,,1997/12/24 00:00,1997/12/24 00:01,['1997/12/24 00:00'],"['1997/12/24 00:00 [pubmed]', '1997/12/24 00:01 [medline]', '1997/12/24 00:00 [entrez]']",,ppublish,Krankenpfl J. 1997 Sep;35(9):340-9.,,,,,,,,,Renaissance der Infektionserkrankungen. Welche Infektionen sind heute von Bedeutung?,,,,,,,,
7354608,NLM,MEDLINE,19800426,20041117,0023-1495 (Print) 0023-1495 (Linking),48,1,1980,[Changes in the course of infectious diseases in childhood].,11-4,,,,"['Koditz, H']",['Koditz H'],,['ger'],['Journal Article'],,Germany,Kinderarztl Prax,Kinderarztliche Praxis,0376356,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Communicable Diseases/*diagnosis/epidemiology', 'Germany, East', 'Humans', 'Infant']",,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Kinderarztl Prax. 1980;48(1):11-4.,,,,,,,,,Vom Wandel der Infektionskrankheiten im Kindesalter.,,,,,,,,
13001723,NLM,MEDLINE,20030501,20181201,0368-931X (Print) 0368-931X (Linking),20,4,1952 Oct,"[Monthly bulletin of infectious diseases; January, 1942].",387-8,,,,,,,['und'],['Journal Article'],,Spain,Med Colon,La Medicina colonial,18610270R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1952/10/01 00:00,1952/10/01 00:01,['1952/10/01 00:00'],"['1952/10/01 00:00 [pubmed]', '1952/10/01 00:01 [medline]', '1952/10/01 00:00 [entrez]']",,ppublish,Med Colon. 1952 Oct;20(4):387-8.,,,,,,,,,BOLETIN mensual de enfermedades transmisibles; mes de enero de 1952.,,,['CLML: 5323:26273:131'],,,,,
6012240,NLM,MEDLINE,19690328,20080116,0042-4846 (Print) 0042-4846 (Linking),43,5,1966 May,[Laboratory diagnostis of infectious diseases of bees].,100-4,,,,"['Smirnova, N I']",['Smirnova NI'],,['rus'],['Journal Article'],,Russia (Federation),Veterinariia,Veterinariia,0412751,IM,"['Animals', '*Bees', 'Communicable Diseases/diagnosis/*veterinary', 'Methods']",,,,1966/05/01 00:00,1966/05/01 00:01,['1966/05/01 00:00'],"['1966/05/01 00:00 [pubmed]', '1966/05/01 00:01 [medline]', '1966/05/01 00:00 [entrez]']",,ppublish,Veterinariia. 1966 May;43(5):100-4.,,,,,,,,,Laboratorniaia diagnostika infektsionnykh boleznei pchel.,,,,,,,,
8953834,NLM,MEDLINE,19970103,20191210,0035-2640 (Print) 0035-2640 (Linking),46,15,1996 Oct 1,[New and resurgent infectious diseases associated with poverty].,1827-38,,"The economic crisis has led to the onset of resurgence of several infectious diseases among patients with social deprivation. Health access being difficult for these patients, delay between onset of symptoms and time of diagnosis is increased and therapeutic adherence is impaired. Such conditions favour the transmission of infectious agents via either direct human interaction (sexual and blood transmission) or arthropode-borne agents. Tuberculosis remains the most frequent infection observed in this population and appears as a major public health problem. Such diseases underline the need for global approach of the patient, including a search for infected contact of sufficient duration, treatments and prevention of recurrence.",,"['Poinsignon, Y', 'Marjanovic, Z', 'Farge, D']","['Poinsignon Y', 'Marjanovic Z', 'Farge D']","['Service de medecine interne, Hopital Saint-Louis, Paris.']",['fre'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,,"['Communicable Diseases/diagnosis/epidemiology/therapy', 'Cross Infection/epidemiology', 'France/epidemiology', 'Humans', 'Infections/*diagnosis/epidemiology/*therapy', '*Poverty', 'Sexually Transmitted Diseases/diagnosis/epidemiology/therapy', 'Tuberculosis/diagnosis/epidemiology/therapy']",,,,1996/10/01 00:00,1996/10/01 00:01,['1996/10/01 00:00'],"['1996/10/01 00:00 [pubmed]', '1996/10/01 00:01 [medline]', '1996/10/01 00:00 [entrez]']",,ppublish,Rev Prat. 1996 Oct 1;46(15):1827-38.,,,,,,,,,Maladies infectieuses nouvelles et resurgentes liees a la pauvrete.,,,,,,,,
1762416,NLM,MEDLINE,19920212,20041117,0174-108X (Print) 0174-108X (Linking),29,11,1991 Nov,[The close relationship between man and his environment. Epidemics and infectious diseases].,526-30,,,,"['Vasold, M']",['Vasold M'],,['ger'],['Journal Article'],,Germany,Krankenpfl J,Krankenpflege Journal,8006304,,"['Communicable Diseases/epidemiology/*microbiology/mortality', 'Humans', 'Life Expectancy', 'Urban Health']",,,,1991/11/01 00:00,1991/11/01 00:01,['1991/11/01 00:00'],"['1991/11/01 00:00 [pubmed]', '1991/11/01 00:01 [medline]', '1991/11/01 00:00 [entrez]']",,ppublish,Krankenpfl J. 1991 Nov;29(11):526-30.,,,,,,,,,Die enge Beziehung zwischen Mensch und Umwelt. Seuchen und Infektions-krankheiten.,,,,,,,,
14699856,NLM,MEDLINE,20040305,20110728,0021-4930 (Print) 0021-4930 (Linking),58,4,2003 Nov,[Civilization and infectious diseases--historical review of their relationship].,657-62,,,,"['Oya, Akira']",['Oya A'],,['jpn'],"['Historical Article', 'Journal Article']",,Japan,Nihon Saikingaku Zasshi,Nihon saikingaku zasshi. Japanese journal of bacteriology,2984804R,IM,"['Civilization/*history', 'Communicable Diseases/epidemiology/*history/microbiology/transmission', 'Disease Outbreaks/history', 'History, 19th Century', 'History, 20th Century', 'Humans']",,,,2004/01/01 05:00,2004/03/06 05:00,['2004/01/01 05:00'],"['2004/01/01 05:00 [pubmed]', '2004/03/06 05:00 [medline]', '2004/01/01 05:00 [entrez]']",,ppublish,Nihon Saikingaku Zasshi. 2003 Nov;58(4):657-62.,,,,,,,,,,,,,,,,,
13254667,NLM,MEDLINE,20030501,20181201,0032-7867 (Print) 0032-7867 (Linking),63,57,1955 Sep 3,[The treatment of infectious diseases approaches its perfection].,1168,,,,"['RAVINA, A']",['RAVINA A'],,['fre'],['Journal Article'],,France,Presse Med (1893),La Presse medicale,0312556,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1955/09/03 00:00,1955/09/03 00:01,['1955/09/03 00:00'],"['1955/09/03 00:00 [pubmed]', '1955/09/03 00:01 [medline]', '1955/09/03 00:00 [entrez]']",,ppublish,Presse Med (1893). 1955 Sep 3;63(57):1168.,,,,,,,,,La therapeutique des maladies infectieuses approche-t-elle de sa perfection?,,,['CLML: 5629:6519'],,,,,
368428,NLM,MEDLINE,19790425,20041117,0023-2149 (Print) 0023-2149 (Linking),56,12,1978 Dec,[On the centenary of discovery of the role of microorganisms in the etiology of infectious diseases by Louis Pasteur].,116-21,,,,,,,['rus'],"['Biography', 'Historical Article', 'Journal Article']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Communicable Diseases/etiology/microbiology', 'France', 'History, 19th Century', 'Microbiology/*history']",,,,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1978 Dec;56(12):116-21.,,,,,,,,,100 let so dnia otkrytiia Lui Pasterom roli mikroorganizmov v etiologii infektsionnykh boleznei.,,,,,,,['Pasteur L'],"['Pasteur, L']"
18898299,NLM,MEDLINE,20081016,20201005,0043-5325 (Print) 0043-5325 (Linking),59,47,1947 Nov 28,[New experiences in the treatment of infectious diseases].,777-81,,,,"['HOLLER, G']",['HOLLER G'],,['ger'],['Journal Article'],,Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1947/11/28 00:00,2008/10/24 09:00,['1947/11/28 00:00'],"['1947/11/28 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1947/11/28 00:00 [entrez]']",,ppublish,Wien Klin Wochenschr. 1947 Nov 28;59(47):777-81.,,,,,,,,,Neue Erfahrungen in der Therapie der Infektionskrankheiten.,,,['CLML: 4814:339r'],,,,,
18114104,NLM,MEDLINE,20071227,20201005,0369-8394 (Print) 0369-8394 (Linking),38,2,1949 Jan 13,[Development directions In the therapy of infectious diseases].,23-8,,,,"['HORING, F O']",['HORING FO'],,['ger'],['Journal Article'],,Switzerland,Praxis,Praxis,0401230,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1949/01/13 00:00,2008/01/17 09:00,['1949/01/13 00:00'],"['1949/01/13 00:00 [pubmed]', '2008/01/17 09:00 [medline]', '1949/01/13 00:00 [entrez]']",,ppublish,Praxis. 1949 Jan 13;38(2):23-8.,,,,,,,,,Entwicklungsrichtungen in der Therapie der Infektionskrankheiten.,,,['CLML: 4916:838f'],,,,,
537903,NLM,MEDLINE,19800514,20131121,0301-1518 (Print) 0301-1518 (Linking),8,42,1979 Oct 31,[Use of amikacin in a clinic for infectious diseases].,3496-7,,,,"['Bertrand, A', 'Lepeu, G']","['Bertrand A', 'Lepeu G']",,['fre'],['Journal Article'],,France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Amikacin/*therapeutic use', 'Communicable Diseases/*drug therapy/microbiology', 'Humans', 'Kanamycin/*analogs & derivatives']",,,,1979/10/31 00:00,1979/10/31 00:01,['1979/10/31 00:00'],"['1979/10/31 00:00 [pubmed]', '1979/10/31 00:01 [medline]', '1979/10/31 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1979 Oct 31;8(42):3496-7.,,,"['59-01-8 (Kanamycin)', '84319SGC3C (Amikacin)']",,,,,,Utilisation de l'amikacine en clinique des maladies infectieuses.,,,,,,,,
130578,NLM,MEDLINE,19760510,20091111,0029-8573 (Print) 0029-8573 (Linking),37,4,1975 Apr,[Danger of infection and infectious diseases (author's transl)].,198-206,,,,"['Gartner, H']",['Gartner H'],,['ger'],"['English Abstract', 'Historical Article', 'Journal Article']",,Germany,Offentl Gesundheitswes,Das Offentliche Gesundheitswesen,0107170,IM,"['Communicable Disease Control', '*Communicable Diseases/epidemiology/history', 'Europe', 'Germany, West', 'History, 19th Century', 'History, 20th Century', 'Humans', 'India']",,,,1975/04/01 00:00,1975/04/01 00:01,['1975/04/01 00:00'],"['1975/04/01 00:00 [pubmed]', '1975/04/01 00:01 [medline]', '1975/04/01 00:00 [entrez]']",,ppublish,Offentl Gesundheitswes. 1975 Apr;37(4):198-206.,,,,,,,,,Infektionsgefahren und Infektionskrankheiten.,,,,,,,,
4467065,NLM,MEDLINE,19760102,20160523,0031-403X (Print) 0031-403X (Linking),,1,1974 Jan,[Acute cardiovascular insufficiency in infectious diseases in children].,31-2,,,,"['Libov, A L', 'Kalinova, E A', 'Kuznetsova, A T']","['Libov AL', 'Kalinova EA', 'Kuznetsova AT']",,['rus'],['Journal Article'],,Russia (Federation),Pediatriia,Pediatriia,0405563,IM,"['Acute Disease', 'Child', 'Communicable Diseases/*complications/drug therapy', 'Humans', 'Shock/*etiology']",,,,1974/01/01 00:00,1974/01/01 00:01,['1974/01/01 00:00'],"['1974/01/01 00:00 [pubmed]', '1974/01/01 00:01 [medline]', '1974/01/01 00:00 [entrez]']",,ppublish,Pediatriia. 1974 Jan;(1):31-2.,,,,,,,,,Ostraia serdechno-sosudistaia nedostatochnost' pri infektsionnykh zabolevaniiakh u detei.,,,,,,,,
979436,NLM,MEDLINE,19761223,20061115,0023-7205 (Print) 0023-7205 (Linking),73,43,1976 Oct 20,"[Range and treatment of infectious diseases at Dakar, Senegal].",3666-8,,,,"['Cronberg, S']",['Cronberg S'],,['swe'],"['English Abstract', 'Journal Article']",,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Adult', 'Child', 'Climate', 'Communicable Diseases/*epidemiology/therapy', 'Hospitals, Teaching', 'Humans', 'Senegal']",,,,1976/10/20 00:00,1976/10/20 00:01,['1976/10/20 00:00'],"['1976/10/20 00:00 [pubmed]', '1976/10/20 00:01 [medline]', '1976/10/20 00:00 [entrez]']",,ppublish,Lakartidningen. 1976 Oct 20;73(43):3666-8.,,,,,,,,,"Sjukdomspanorama och infektionssjukvard i Dakar, Senegal.",,,,,,,,
6678511,NLM,MEDLINE,19840827,20101118,0202-1447 (Print) 0202-1447 (Linking),61,,1983,[Further improvement in the classification of infectious diseases].,42-7,,,,"['Shliakhtenko, L I']",['Shliakhtenko LI'],,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Tr Inst Im Pastera,Trudy Instituta imeni Pastera,7709028,IM,"['Animals', 'Biological Evolution', 'Communicable Diseases/*classification/transmission', 'Ecology', 'Humans', 'Zoonoses/classification/transmission']",,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",,ppublish,Tr Inst Im Pastera. 1983;61:42-7.,,,,,,,,,O dal'neishem sovershenstvovanii klassifikatsii infektsionnykh boleznei.,,,,,,,,
5206841,NLM,MEDLINE,19710731,20091111,0024-3477 (Print) 0024-3477 (Linking),92,7,1970 Jul,[Changes in the clinical picture of infectious diseases].,733-46,,,,"['Mihaljevic, F']",['Mihaljevic F'],,['hrv'],['Journal Article'],,Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,IM,"['Communicable Diseases/drug therapy/*epidemiology/etiology', 'Humans', 'Yugoslavia']",,,,1970/07/01 00:00,1970/07/01 00:01,['1970/07/01 00:00'],"['1970/07/01 00:00 [pubmed]', '1970/07/01 00:01 [medline]', '1970/07/01 00:00 [entrez]']",,ppublish,Lijec Vjesn. 1970 Jul;92(7):733-46.,,,,,,,,,O preobrazaju infektologije.,,,,,,,,
6844777,NLM,MEDLINE,19830623,20150826,0370-629X (Print) 0370-629X (Linking),38,5,1983 Mar 1,[Role of the internist specializing in infectious diseases].,153-5,,,,"['Demonty, J']",['Demonty J'],,['fre'],['Journal Article'],,Belgium,Rev Med Liege,Revue medicale de Liege,0404317,IM,"['Communicable Diseases/*diagnosis/therapy', 'Humans', '*Medicine', 'Role', '*Specialization']",,,,1983/03/01 00:00,1983/03/01 00:01,['1983/03/01 00:00'],"['1983/03/01 00:00 [pubmed]', '1983/03/01 00:01 [medline]', '1983/03/01 00:00 [entrez]']",,ppublish,Rev Med Liege. 1983 Mar 1;38(5):153-5.,,,,,,,,,Role de l'interniste specialise en pathologie infectieuse.,,,,,,,,
18084844,NLM,MEDLINE,20080205,20181201,1211-264X (Print) 1211-264X (Linking),13,4,2007 Aug,[Report from the 25th International Congress of Chemotherapy and the 17th European Congress of Clinical Microbiology and Infectious Diseases].,165-7,,,,"['Holub, M', 'Beran, O']","['Holub M', 'Beran O']",,['cze'],['Congress'],,Czech Republic,Klin Mikrobiol Infekc Lek,Klinicka mikrobiologie a infekcni lekarstvi,101189112,IM,"['*Communicable Diseases/diagnosis/drug therapy', 'Humans']",,,,2007/12/19 09:00,2008/02/06 09:00,['2007/12/19 09:00'],"['2007/12/19 09:00 [pubmed]', '2008/02/06 09:00 [medline]', '2007/12/19 09:00 [entrez]']",,ppublish,Klin Mikrobiol Infekc Lek. 2007 Aug;13(4):165-7.,,,,,,,,,Zprava z kongresu 25th International Congress of Chemotherapy a 17th European Congress of Clinical Microbiology and Infectious Diseases.,,,,,,,,
452453,NLM,MEDLINE,19790816,20090225,0026-9050 (Print) 0026-9050 (Linking),,2,1979 Feb,[Procedure of the ship's physician in the appearance of infectious diseases during a long cruise].,67-9,,,,"['Ivanov, K S', 'Nosov, Iu N']","['Ivanov KS', 'Nosov IuN']",,['rus'],['Journal Article'],,Russia (Federation),Voen Med Zh,Voenno-meditsinskii zhurnal,2984871R,IM,"['Communicable Diseases/diagnosis/*epidemiology/therapy', 'Disease Outbreaks/epidemiology', 'Humans', '*Military Medicine', '*Naval Medicine', 'USSR']",,,,1979/02/01 00:00,1979/02/01 00:01,['1979/02/01 00:00'],"['1979/02/01 00:00 [pubmed]', '1979/02/01 00:01 [medline]', '1979/02/01 00:00 [entrez]']",,ppublish,Voen Med Zh. 1979 Feb;(2):67-9.,,,,,,,,,Taktika korabel'nogo vracha pri poiavlenii infektsionnykh zabolevanii v usloviiakh dlitel'nogo plavaniia.,,,,,,,,
4439687,NLM,MEDLINE,19750317,20090225,0026-9050 (Print) 0026-9050 (Linking),,10,1974 Oct,[Detection and treatment of infectious diseases on board ship during prolonged cruisses].,78-80,,,,"['Mironov, G S']",['Mironov GS'],,['rus'],['Journal Article'],,Russia (Federation),Voen Med Zh,Voenno-meditsinskii zhurnal,2984871R,IM,"['Communicable Diseases/*diagnosis/drug therapy', 'Humans', 'Military Medicine', '*Naval Medicine', 'Time Factors', 'USSR']",,,,1974/10/01 00:00,1974/10/01 00:01,['1974/10/01 00:00'],"['1974/10/01 00:00 [pubmed]', '1974/10/01 00:01 [medline]', '1974/10/01 00:00 [entrez]']",,ppublish,Voen Med Zh. 1974 Oct;(10):78-80.,,,,,,,,,Vyiavlenie i lechenie infektsionnykh bol'nykh na korabliakh v period dlitel'nogo plavaniia.,,,,,,,,
4569503,NLM,MEDLINE,19730423,20080620,0032-3756 (Print) 0032-3756 (Linking),27,51,1972 Dec 18,"[Importance of the textbook, Lectures on Acute Infectious Diseases, by W. Bieganski for the science of etiology].",2040-1,,,,"['Gawrychowski, S']",['Gawrychowski S'],,['pol'],"['Biography', 'Historical Article', 'Journal Article']",,Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Acute Disease', 'Communicable Diseases/etiology/history', 'History, 20th Century', 'Humans', 'Poland']",,,,1972/12/18 00:00,1972/12/18 00:01,['1972/12/18 00:00'],"['1972/12/18 00:00 [pubmed]', '1972/12/18 00:01 [medline]', '1972/12/18 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1972 Dec 18;27(51):2040-1.,,,,,,,,,Znaczenie podrecznika pt.: Wyklady o chorobach zakaznych ostrych W. Bieganskiego dla nauki o etiologii.,,,,,,,['Bieganski W'],"['Bieganski, W']"
12476831,NLM,MEDLINE,20030123,20041117,0016-9900 (Print) 0016-9900 (Linking),,5,2002 Sep-Oct,[Topical problems of infectious diseases in a high natural and man-made loaded area].,37-9,,,,"['Vereshchagin, N N']",['Vereshchagin NN'],,['rus'],['Journal Article'],,Russia (Federation),Gig Sanit,Gigiena i sanitariia,0412700,IM,"['Communicable Diseases/economics/*epidemiology/*microbiology', 'Humans', 'Rural Population/*statistics & numerical data', 'Russia/epidemiology', 'Urban Population/*statistics & numerical data']",,,,2002/12/13 04:00,2003/01/24 04:00,['2002/12/13 04:00'],"['2002/12/13 04:00 [pubmed]', '2003/01/24 04:00 [medline]', '2002/12/13 04:00 [entrez]']",,ppublish,Gig Sanit. 2002 Sep-Oct;(5):37-9.,,,,,,,,,Aktual'nye problemy infektsionnoi patologii v regione s vysokoi prirodno-antropogennoi nagruzkoi.,,,,,,,,
20244773,NLM,MEDLINE,20100318,20201005,,3,1,1947 Jan,[The neutrophilic coefficient of insegmentation in infectious diseases].,57-66,,,,"['MAS y MAGRO, F']",['MAS y MAGRO F'],,['spa'],['Journal Article'],,Spain,Clin. Hisp,Clinica hispanica,16230270R,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', '*Epidemiology', 'Pectins/*therapy']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*EPIDEMIOLOGY', '*PECTIN/therapy']",1947/01/01 00:00,2011/01/06 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '1947/01/01 00:00 [pubmed]', '2011/01/06 06:00 [medline]']",,ppublish,Clin. Hisp. 1947 Jan;3(1):57-66.,,,['89NA02M4RX (Pectins)'],,,,,,El coeficiente neutrofilo de insegmentacion en las enfermedades infecciosas.,,,['CLML: 4713:309d'],,,,,
18118355,NLM,MEDLINE,20071227,20231207,0040-5965 (Print) 0040-5965 (Linking),,1,1949,[Penicillin therapy and prophylaxis for acute infectious diseases].,6-9,,,,"['TIETZE, A', 'KEHREN, C']","['TIETZE A', 'KEHREN C']",,['ger'],['Journal Article'],,Germany,Ther Ggw,Therapie der Gegenwart,0413576,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1949/01/01 00:00,2008/01/17 09:00,['1949/01/01 00:00'],"['1949/01/01 00:00 [pubmed]', '2008/01/17 09:00 [medline]', '1949/01/01 00:00 [entrez]']",,ppublish,Ther Ggw. 1949;(1):6-9.,,,,,,,,,Penicillintherapie und -prophylaxe bei akuten Infektionskrankheiten.,,,['CLML: 4916:1066k'],,,,,
13467160,NLM,MEDLINE,20000701,20181201,0036-7672 (Print) 0036-7672 (Linking),87,29,1957 Jul 20,[The mutual clinical relations of the infectious diseases].,970-3,,,,"['MIKUTOWSKI, V']",['MIKUTOWSKI V'],,['ger'],['Journal Article'],,Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,OM,['Communicable Diseases/*physiology'],,['NLM'],['*COMMUNICABLE DISEASES/physiology'],1957/07/20 00:00,1957/07/20 00:01,['1957/07/20 00:00'],"['1957/07/20 00:00 [pubmed]', '1957/07/20 00:01 [medline]', '1957/07/20 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1957 Jul 20;87(29):970-3.,,,,,,,,,Uber die wechselseitigen klinischen Beziehungen der Infektionskrankheiten.,,,['CLML: 5833:9830:135'],,,,,
3321774,NLM,MEDLINE,19880224,20200716,0372-9311 (Print) 0372-9311 (Linking),,10,1987 Oct,[L.V. Gromashevskii and the classification of infectious diseases].,17-21,,,,"['Shliakhov, E N']",['Shliakhov EN'],,['rus'],"['Biography', 'Historical Article', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/*classification/history', 'Epidemiology/history', 'History, 19th Century', 'History, 20th Century', 'Humans', 'USSR']",,,,1987/10/01 00:00,1987/10/01 00:01,['1987/10/01 00:00'],"['1987/10/01 00:00 [pubmed]', '1987/10/01 00:01 [medline]', '1987/10/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1987 Oct;(10):17-21.,,,,,,,,,L.V. Gromashevskii i klassifikatsiia infektsionnykh boleznei.,,,,,,,['Gromashevskii LV'],"['Gromashevskii, L V']"
4891692,NLM,MEDLINE,19690802,20200716,0372-9311 (Print) 0372-9311 (Linking),44,8,1967 Aug,[The clinical picture of infectious diseases over the past 50 years (missions completed and future tasks)].,3-7,,,,"['Ridnev, G P']",['Ridnev GP'],,['rus'],"['Historical Article', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['*Communicable Disease Control/history', 'Communicable Diseases/*epidemiology/therapy', 'History, 20th Century', 'Humans', 'USSR']",,,,1967/08/01 00:00,1967/08/01 00:01,['1967/08/01 00:00'],"['1967/08/01 00:00 [pubmed]', '1967/08/01 00:01 [medline]', '1967/08/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1967 Aug;44(8):3-7.,,,,,,,,,Klinika infektsionnykh boleznei za 50 let (O proidennom puti i ocherednykh zadachakh).,,,,,,,,
6666010,NLM,MEDLINE,19840316,20031114,0324-1068 (Print) 0324-1068 (Linking),20,10,1983,[Trends in research work on the infectious diseases of agricultural animals].,32-9,,,,"['Ivanov, I N']",['Ivanov IN'],,['bul'],['Journal Article'],,Bulgaria,Vet Med Nauki,Veterinarno-meditsinski nauki,0414760,IM,"['*Animal Diseases/epidemiology/microbiology', 'Animals', 'Animals, Domestic', 'Bulgaria', 'Communicable Diseases/epidemiology/microbiology/*veterinary', 'Research']",,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",,ppublish,Vet Med Nauki. 1983;20(10):32-9.,,,,,,,,,Nasoki na nauchnoizsledovatelskata rabota po zarazni bolesti po selskostopanskite zhivotni.,,,,,,,,
7221946,NLM,MEDLINE,19810623,20041117,0040-3660 (Print) 0040-3660 (Linking),53,2,1981,[Diagnosis and therapy of emergency states in infectious diseases].,98-103,,,,"['Chaitsev, V G']",['Chaitsev VG'],,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Alcoholism/complications', 'Communicable Diseases/complications/*diagnosis/therapy', 'Critical Care/methods', 'Diagnostic Errors', '*Emergencies', 'Humans', 'Shock, Septic/diagnosis', 'Time Factors']",,,,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1981;53(2):98-103.,,,,,,,,,Diagnostika i lechenie neotlozhnykh sostoianii pri infektsionnykh zabolevaniiakh.,,,,,,,,
13519227,NLM,MEDLINE,20000701,20181201,0038-5077 (Print) 0038-5077 (Linking),21,9,1957 Sep,[Chemotherapy and basic principles of general therapy of infectious diseases].,3-12,,,,"['BILIBIN, A F']",['BILIBIN AF'],,['rus'],['Journal Article'],,Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,OM,['Communicable Diseases/*therapy'],,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1957/09/01 00:00,1957/09/01 00:01,['1957/09/01 00:00'],"['1957/09/01 00:00 [pubmed]', '1957/09/01 00:01 [medline]', '1957/09/01 00:00 [entrez]']",,ppublish,Sov Med. 1957 Sep;21(9):3-12.,,,,,,,,,Khimioterapiia i osnovnye polozheniia obshchei terapii infektsionnykh bol'nykh.,,,['CLML: 5834:11610:155'],,,,,
15137200,NLM,MEDLINE,20040614,20190816,0869-2084 (Print) 0869-2084 (Linking),,3,2004 Mar,[Strategy of laboratory studies of the immune system in infectious diseases].,23-34,,,,"['Kashkin, K P', 'Bekhalo, V A']","['Kashkin KP', 'Bekhalo VA']",,['rus'],['Lecture'],,Russia (Federation),Klin Lab Diagn,Klinicheskaia laboratornaia diagnostika,9432021,IM,"['*Clinical Laboratory Techniques', 'Communicable Diseases/*diagnosis/immunology/microbiology', 'Humans', 'Prognosis']",,,,2004/05/13 05:00,2004/06/15 05:00,['2004/05/13 05:00'],"['2004/05/13 05:00 [pubmed]', '2004/06/15 05:00 [medline]', '2004/05/13 05:00 [entrez]']",,ppublish,Klin Lab Diagn. 2004 Mar;(3):23-34.,,,,,,,,,Strategiia imunolaboratornykh issledovanii v klinike infektsionnykh boleznei (lektsiia).,,,,,,,,
675512,NLM,MEDLINE,19780930,20041117,0040-3660 (Print) 0040-3660 (Linking),50,5,1978,[Certain results of the study of clinical aspects of infectious diseases].,13-8,,,,"['Bilibin, A F']",['Bilibin AF'],,['rus'],['Journal Article'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['*Communicable Diseases/drug therapy/etiology', 'Humans']",,,,1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1978;50(5):13-8.,,,,,,,,,Nekotorye itogi izucheniia v klinikakh infektsionnoi patologii.,,,,,,,,
9254589,NLM,MEDLINE,19970812,20181130,0235-2990 (Print) 0235-2990 (Linking),42,5,1997,[A survey of the materials from the 7th International Congress on Infectious Diseases].,42-6,,,,"['Budanov, S V', 'Tsybanev, A A']","['Budanov SV', 'Tsybanev AA']",,['rus'],['Congress'],,Russia (Federation),Antibiot Khimioter,Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],8803688,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Disease Control', '*Communicable Diseases/diagnosis/drug therapy', 'Humans']",,,,1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Antibiot Khimioter. 1997;42(5):42-6.,,,['0 (Anti-Bacterial Agents)'],,,,,,Obzor materialov VII Mezhdunarodnogo Kongressa po infektsionnym bolezniam.,,,,,,,,
20243317,NLM,MEDLINE,20100329,20201005,0043-5341 (Print) 0043-5341 (Linking),97,16-17,1947 Apr 26,[Some remarks about the current epidemiology and clinic of acute infectious diseases].,189-92,,,,"['ZISCHINSKY, H']",['ZISCHINSKY H'],,['ger'],['Journal Article'],,Austria,Wien Med Wochenschr,Wiener medizinische Wochenschrift (1946),8708475,OM,"['Communicable Diseases/*epidemiology/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology and statistics'],1947/04/26 00:00,2011/01/06 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '1947/04/26 00:00 [pubmed]', '2011/01/06 06:00 [medline]']",,ppublish,Wien Med Wochenschr. 1947 Apr 26;97(16-17):189-92.,,,,,,,,,Einige Bemerkungen uber die gegenwartige Epidemiologie und Klinik der akuten Infektionskrankheiten.,,,['CLML: 4713:226n'],,,,,
8589956,NLM,MEDLINE,19960322,20190816,0869-2084 (Print) 0869-2084 (Linking),,6,1995 Nov-Dec,[The role of laboratory studies in the diagnosis and monitoring of infectious diseases].,28-33,,,,"['Pokrovskii, V I', 'Maleev, V V', 'Semina, N A']","['Pokrovskii VI', 'Maleev VV', 'Semina NA']",,['rus'],['Journal Article'],,Russia (Federation),Klin Lab Diagn,Klinicheskaia laboratornaia diagnostika,9432021,IM,"['Carrier State/diagnosis/epidemiology/microbiology/virology', 'Communicable Diseases/*diagnosis/epidemiology/microbiology/virology', 'Humans', 'Monitoring, Physiologic', 'Seroepidemiologic Studies']",,,,1995/11/01 00:00,1995/11/01 00:01,['1995/11/01 00:00'],"['1995/11/01 00:00 [pubmed]', '1995/11/01 00:01 [medline]', '1995/11/01 00:00 [entrez]']",,ppublish,Klin Lab Diagn. 1995 Nov-Dec;(6):28-33.,,,,,,,,,Rol' laboratornykh issledovanii v diagnostike i monitoringe infektsionnykh boleznei.,,,,,,,,
4071240,NLM,MEDLINE,19860107,20041117,0038-5077 (Print) 0038-5077 (Linking),,7,1985,[Scope and nature of the specialized outpatient care of patients with infectious diseases].,69-72,,,,"['Kobyshcha, Iu V', 'Zubko, S A', 'Gubina, T G', 'Skuliak, S G']","['Kobyshcha IuV', 'Zubko SA', 'Gubina TG', 'Skuliak SG']",,['rus'],['Journal Article'],,Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,IM,"['*Ambulatory Care', 'Communicable Diseases/diagnosis/*therapy', 'Diagnosis, Differential', 'Humans', 'USSR']",,,,1985/01/01 00:00,1985/01/01 00:01,['1985/01/01 00:00'],"['1985/01/01 00:00 [pubmed]', '1985/01/01 00:01 [medline]', '1985/01/01 00:00 [entrez]']",,ppublish,Sov Med. 1985;(7):69-72.,,,,,,,,,"Ob""em i kharakter spetsializirovannoi poliklinicheskoi pomoshchi infektsionnym bol'nym.",,,,,,,,
5792185,NLM,MEDLINE,19690822,20200716,0372-9311 (Print) 0372-9311 (Linking),46,2,1969 Feb,[Several methodological problems in the relationship of morbidity and mortality in infectious diseases].,77-81,,,,"['Shakhanina, I L', 'Argutina, T P']","['Shakhanina IL', 'Argutina TP']",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/*epidemiology/mortality', 'Humans', 'Medical Records']",,,,1969/02/01 00:00,1969/02/01 00:01,['1969/02/01 00:00'],"['1969/02/01 00:00 [pubmed]', '1969/02/01 00:01 [medline]', '1969/02/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1969 Feb;46(2):77-81.,,,,,,,,,Nekotorye metodicheskie voprosy izucheniia vzaimootnosheniia zabolevaemosti i smertnosti pri infektsionnykh bolezniakh.,,,,,,,,
4907373,NLM,MEDLINE,19700427,20041117,0034-1193 (Print) 0034-1193 (Linking),44,1,1968 Jan,"[Uses of a new technic, immunofluorescence, in diagnostic and pathogenetic problems of infectious diseases].",75-86,,,,"['Tolentino, P']",['Tolentino P'],,['ita'],['Journal Article'],,Italy,Recenti Prog Med,Recenti progressi in medicina,0401271,IM,"['Communicable Diseases/*diagnosis/immunology', '*Fluorescent Antibody Technique', 'Humans']",,,,1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,Recenti Prog Med. 1968 Jan;44(1):75-86.,,,,,,,,,"Applicazioni di una nuova tecnica, la immunofluorescenza, ai problemi diagnostici e patogenetici delle malattie infettive.",,,,,,,,
18581642,NLM,MEDLINE,20080627,20080626,1344-6304 (Print) 1344-6304 (Linking),57 Suppl,,2004,"Annual report on findings of infectious agents in Japan, 2003.",1-143,,,,,,,['eng'],['Journal Article'],,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,IM,"['Communicable Diseases/*epidemiology/*microbiology', 'Humans', 'Japan/epidemiology', '*Population Surveillance']",,,,2008/06/28 09:00,2008/06/28 09:01,['2008/06/28 09:00'],"['2008/06/28 09:00 [pubmed]', '2008/06/28 09:01 [medline]', '2008/06/28 09:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2004;57 Suppl:1-143.,,,,,,,,,,,"['Editorial Committee of Infectious Agents Surveillance Report, National Institute', 'of Infectious Diseases']",,,,,,
17378098,NLM,MEDLINE,20070323,20070322,1344-6304 (Print) 1344-6304 (Linking),56 Suppl,,2003,"Annual report on findings of infectious agents in Japan, 2002.",1-143,,,,,,,['eng'],['Journal Article'],,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,IM,"['Communicable Diseases/*epidemiology/*microbiology', 'Humans', 'Japan/epidemiology', 'Population Surveillance']",,,,2007/03/24 09:00,2007/03/24 09:01,['2007/03/24 09:00'],"['2007/03/24 09:00 [pubmed]', '2007/03/24 09:01 [medline]', '2007/03/24 09:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2003;56 Suppl:1-143.,,,,,,,,,,,"['Editorial Committee of Infectious Agents Surveillance Report, National Institute', 'of Infectious Diseases']",,,,,,
15505929,NLM,MEDLINE,20041027,20041117,1344-6304 (Print) 1344-6304 (Linking),54 Suppl,,2001,"Annual Report on Findings of Infectious Agents in Japan, 2000.",1-143,,,,,,,['eng'],['Journal Article'],,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,IM,"['Communicable Diseases/*epidemiology/*microbiology', 'Humans', 'Japan/epidemiology', '*Population Surveillance']",,,,2004/10/28 09:00,2004/10/28 09:01,['2004/10/28 09:00'],"['2004/10/28 09:00 [pubmed]', '2004/10/28 09:01 [medline]', '2004/10/28 09:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2001;54 Suppl:1-143.,,,,,,,,,,,"['Editorial Committee of Infectious Agents Surveillance Report, National Institute', 'of Infectious Diseases']",,,,,,
14565123,NLM,MEDLINE,20040423,20200716,0372-9311 (Print) 0372-9311 (Linking),,5,2003 Sep-Oct,"[Morbidity: terminology, mechanisms of formation and classification].",45-9,,"In the 70-ies of the last century the evolution of the epidemic process doctrine resulted in developing population approach to morbidity analysis, in addition to the traditional focal approach. On the one hand, this led to the discussion on the possibility of applying such notion to non-infectious diseases and, on the other hand, to the discussion on the mechanisms of the development and formation of different manifestations in infectious diseases. In both cases the discussion was centered on the phenomenon of morbidity. The present article deals with the nature of morbidity as a phenomenon and the acceptability of general scientific approaches in the interpretation of seasonal and cyclic character of morbidity from the viewpoint of the wave process in an open system. On the basis of the data presented in this work the terms used in epidemiology in considering manifestations of the epidemic process are discussed. The improved classification of morbidity by qualitative and quantitative signs for infectious diseases is proposed.",,"['Kolpakov, S L', 'Iakovlev, A A']","['Kolpakov SL', 'Iakovlev AA']","['State Medical University, Vladivostok, Russia.']",['rus'],"['English Abstract', 'Historical Article', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Bacteria/pathogenicity', 'Communicable Diseases/*epidemiology/etiology/microbiology', 'Epidemiology/history', 'History, 20th Century', '*Morbidity', 'Periodicity', 'Seasons', 'Systems Theory', '*Terminology as Topic', 'Viruses/pathogenicity']",,,,2003/10/21 05:00,2004/04/24 05:00,['2003/10/21 05:00'],"['2003/10/21 05:00 [pubmed]', '2004/04/24 05:00 [medline]', '2003/10/21 05:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2003 Sep-Oct;(5):45-9.,,,,,,,,,"Zabolevaemost': terminologiia, mekhanizmy formirovaniia i klassifikatsiia.",,,,,,,,
3321775,NLM,MEDLINE,19880224,20200716,0372-9311 (Print) 0372-9311 (Linking),,10,1987 Oct,[Biological significance of L.V. Gromashevskii's classification of infectious diseases].,21-4,,,,"['Siniak, K M']",['Siniak KM'],,['rus'],"['Biography', 'Historical Article', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Diseases/*classification/history/transmission', 'Epidemiology/history', 'History, 19th Century', 'History, 20th Century', 'Humans', 'USSR']",,,,1987/10/01 00:00,1987/10/01 00:01,['1987/10/01 00:00'],"['1987/10/01 00:00 [pubmed]', '1987/10/01 00:01 [medline]', '1987/10/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1987 Oct;(10):21-4.,,,,,,,,,Biologicheskoe znachenie klassifikatsii infektsionnykh boleznei L.V. Gromashevskogo.,,,,,,,['Gromashevskii KM'],"['Gromashevskii, K M']"
6730372,NLM,MEDLINE,19840716,20090225,0026-9050 (Print) 0026-9050 (Linking),,4,1984 Apr,[Clinico-epidemiological aspects of the diagnosis of infectious diseases].,39-41,,,,"['Ugriumov, B L']",['Ugriumov BL'],,['rus'],"['Case Reports', 'Journal Article']",,Russia (Federation),Voen Med Zh,Voenno-meditsinskii zhurnal,2984871R,IM,"['Adult', 'Communicable Diseases/diagnosis/*epidemiology/pathology', 'Diagnosis, Differential', 'Diagnostic Errors', 'Ecology', 'Epidemiologic Methods', 'Humans', 'Male']",,,,1984/04/01 00:00,1984/04/01 00:01,['1984/04/01 00:00'],"['1984/04/01 00:00 [pubmed]', '1984/04/01 00:01 [medline]', '1984/04/01 00:00 [entrez]']",,ppublish,Voen Med Zh. 1984 Apr;(4):39-41.,,,,,,,,,Kliniko-epidemiologicheskie aspekty diagnostiki infektsionnykh boleznei.,,,,,,,,
17727140,NLM,MEDLINE,20071010,20200127,0090-4481 (Print) 0090-4481 (Linking),36,6,2007 Jun,Germs on a plane--infectious issues and the pediatric international traveler: what pediatricians should know.,344-51,10.3928/0090-4481-20070601-10 [doi],,,"['Lee, Paul J', 'Krilov, Leonard R']","['Lee PJ', 'Krilov LR']","['Winthrop-University Hospital, Division of Pediatric Infectious Diseases, 120 Mineola Blvd, Suite 210, Mineola, NY 11501, USA. plee@winthrop.org']",['eng'],['Journal Article'],,United States,Pediatr Ann,Pediatric annals,0356657,IM,"['*Aircraft', '*Communicable Disease Control', 'Communicable Diseases/diagnosis/epidemiology/physiopathology', 'Humans', '*Internationality', '*Pediatrics', '*Travel', 'United States']",,,,2007/08/31 09:00,2007/10/11 09:00,['2007/08/31 09:00'],"['2007/08/31 09:00 [pubmed]', '2007/10/11 09:00 [medline]', '2007/08/31 09:00 [entrez]']",['10.3928/0090-4481-20070601-10 [doi]'],ppublish,Pediatr Ann. 2007 Jun;36(6):344-51. doi: 10.3928/0090-4481-20070601-10.,,,,,,,,,,,,,,,,,
14565121,NLM,MEDLINE,20040423,20200716,0372-9311 (Print) 0372-9311 (Linking),,5,2003 Sep-Oct,[Role of epidemiological science and practice in protecting the health of the population of the country].,34-40,,"The historical stages of the development of epidemiology as a science with a specific object of study, is summarized. One of the greatest theoretical generalizations is the doctrine on the natural focality of diseases. New principles of theoretical epidemiology, new theories and concepts are analyzed. The role of infectious pathology as one of the main criteria of the population health is emphasized as well as a wide spread of infectious (parasitic) diseases. The specific feature of the present stage of epidemiological situation is the dominating and constantly increasing role of viruses in the etiology of infectious diseases. The effectiveness of vaccinal prophylaxis to control vaccine-preventable infections is substantiated. The role of epidemiological science in revealing the epidemiological regularities of emerging and re-emerging infections is emphasized.",,"['Pokrovskii, V I']",['Pokrovskii VI'],"['Central Research Institute of Epidemiology, Moscow, Russia.']",['rus'],"['English Abstract', 'Historical Article', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Disease Control', 'Communicable Diseases/diagnosis/epidemiology/etiology/pathology', 'Communicable Diseases, Emerging/epidemiology/etiology/transmission', '*Epidemiologic Methods', 'Epidemiology/*history', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Parasitic Diseases/epidemiology', 'Population Surveillance', '*Public Health Practice', 'Russia', 'Russia (Pre-1917)', 'USSR', 'Viral Vaccines/immunology', 'Virus Diseases/epidemiology']",,,,2003/10/21 05:00,2004/04/24 05:00,['2003/10/21 05:00'],"['2003/10/21 05:00 [pubmed]', '2004/04/24 05:00 [medline]', '2003/10/21 05:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2003 Sep-Oct;(5):34-40.,,,['0 (Viral Vaccines)'],,,,,,Rol' epidemiologicheskoi nauki i praktiki v okhrane zdorov'ia naseleniia strany.,,,,,,,,
30592805,NLM,MEDLINE,20190124,20190124,0026-9050 (Print) 0026-9050 (Linking),337,10,2016 Oct,[Evacuation of contagious patients in the modern system of medical support].,4-12,,"Evacuation of contagious patients in the modern system. of medical support. The main problematic issues of organizing and conducting the evacuation of contagious patients are defined. A peculiarity of evacuation and healthcare delivery to contagious patients is the need for permanent complex of sanitary and anti-epidemic (preventive) measures aimed at preventing the spread of infectious diseases. Set out fundamental approaches to triage of infectious patients at different stages of medical evacuation, defined sorting group. The attention is focused on the clinical-and-syndrome principle infectious pathology diagnostics. The experience of the medical evacuation of infectious diseases in Afghanistan is analysed. The necessity of protecting the accompanying medical staff is showed. The possibilities, the benefits and how to use for the isolation of infectious patients and the evacuation of mobile autonomous units - the transport of insulating boxes are studied.",,"['Zhdanov, K V', 'Zakharenko, S M', 'Sidorchuk, S N', 'Yurkaev, I M']","['Zhdanov KV', 'Zakharenko SM', 'Sidorchuk SN', 'Yurkaev IM']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Voen Med Zh,Voenno-meditsinskii zhurnal,2984871R,IM,"['Communicable Diseases/*diagnosis/*epidemiology/therapy', 'Humans', 'Transportation of Patients/*methods/*standards', 'Triage/methods/standards']",,,,2016/10/01 00:00,2016/10/01 00:01,['2018/12/29 06:00'],"['2018/12/29 06:00 [entrez]', '2016/10/01 00:00 [pubmed]', '2016/10/01 00:01 [medline]']",,ppublish,Voen Med Zh. 2016 Oct;337(10):4-12.,,,,,,,,,,,,,,,,,
1035014,NLM,MEDLINE,19770315,20140603,,163,1-4,1976,[The challenge of world infectious diseases since 1945 in Middle Europe (author's transl)].,1-33,,,,"['Gsell, O']",['Gsell O'],,['ger'],"['English Abstract', 'Journal Article']",,Germany,Zentralbl Bakteriol Orig B,"Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, praventive Medizin",1306477,IM,"['Animals', 'Bacterial Infections/epidemiology', 'Communicable Disease Control', 'Communicable Diseases/drug therapy/*epidemiology/mortality', 'Disease Vectors', 'Europe', 'Germany, West', 'Humans', 'Parasitic Diseases/epidemiology', 'Pest Control', 'Vaccination', 'Virus Diseases/epidemiology']",,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Zentralbl Bakteriol Orig B. 1976;163(1-4):1-33.,,,,,,,,,Die Entwicklung der Weltseuchenlage seit 1945 und die heutige epidemiologische Situation in Mitteleuropa.,,,,,,,,
30049602,NLM,MEDLINE,20190408,20210109,1471-5007 (Electronic) 1471-4922 (Print) 1471-4922 (Linking),34,9,2018 Sep,Human Mobility and the Global Spread of Infectious Diseases: A Focus on Air Travel.,772-783,S1471-4922(18)30142-9 [pii] 10.1016/j.pt.2018.07.004 [doi],"Greater human mobility, largely driven by air travel, is leading to an increase in the frequency and reach of infectious disease epidemics. Air travel can rapidly connect any two points on the planet, and this has the potential to cause swift and broad dissemination of emerging and re-emerging infectious diseases that may pose a threat to global health security. Investments to strengthen surveillance, build robust early-warning systems, improve predictive models, and coordinate public health responses may help to prevent, detect, and respond to new infectious disease epidemics.",['Copyright (c) 2018 Elsevier Ltd. All rights reserved.'],"['Findlater, Aidan', 'Bogoch, Isaac I']","['Findlater A', 'Bogoch II']","['Department of Medicine, University of Toronto, Toronto, Canada.', 'Department of Medicine, University of Toronto, Toronto, Canada; Divisions of General Internal Medicine and Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Canada. Electronic address: isaac.bogoch@uhn.ca.']",['eng'],"['Journal Article', 'Review']",20180723,England,Trends Parasitol,Trends in parasitology,100966034,IM,"['*Air Travel', 'Communicable Diseases/epidemiology/*transmission', '*Global Health', 'Humans', 'Models, Theoretical']",PMC7106444,['NOTNLM'],"['air travel', 'arbovirus', 'flight', 'infection', 'public health', 'surveillance']",2018/07/28 06:00,2019/04/09 06:00,['2018/07/28 06:00'],"['2018/05/16 00:00 [received]', '2018/07/08 00:00 [revised]', '2018/07/09 00:00 [accepted]', '2018/07/28 06:00 [pubmed]', '2019/04/09 06:00 [medline]', '2018/07/28 06:00 [entrez]']","['S1471-4922(18)30142-9 [pii]', '10.1016/j.pt.2018.07.004 [doi]']",ppublish,Trends Parasitol. 2018 Sep;34(9):772-783. doi: 10.1016/j.pt.2018.07.004. Epub 2018 Jul 23.,,,,,,,,,,,,,,,,,
23327368,NLM,MEDLINE,20160329,20181023,2219-0635 (Electronic) 0030-2465 (Linking),79,2,2012 Jun 20,"Towards one Africa, one health: the Southern African Centre for Infectious Disease Surveillance One Health focus on infectious diseases.",449,10.4102/ojvr.v79i2.449 [doi],,,"['Rweyemamu, Mark M', 'Paweska, Janusz', 'Kambarage, Dominic', 'Namuba, Filomena']","['Rweyemamu MM', 'Paweska J', 'Kambarage D', 'Namuba F']","['Southern African Centre for infectious diseases surveillance, Sokoine University of Agriculture. mark.rweyemamu@sacids.org.']",['eng'],"['Introductory Journal Article', ""Research Support, Non-U.S. Gov't""]",20120620,South Africa,Onderstepoort J Vet Res,The Onderstepoort journal of veterinary research,0401107,IM,"['Africa/epidemiology', 'Animals', 'Communicable Diseases/*epidemiology/*veterinary', 'Humans', '*Public Health Surveillance', 'Zoonoses']",,,,2013/01/19 06:00,2016/03/30 06:00,['2013/01/19 06:00'],"['2012/06/12 00:00 [received]', '2012/06/12 00:00 [accepted]', '2013/01/19 06:00 [entrez]', '2013/01/19 06:00 [pubmed]', '2016/03/30 06:00 [medline]']",['10.4102/ojvr.v79i2.449 [doi]'],epublish,Onderstepoort J Vet Res. 2012 Jun 20;79(2):449. doi: 10.4102/ojvr.v79i2.449.,,,,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,
9460280,NLM,MEDLINE,19980326,20061115,0034-9887 (Print) 0034-9887 (Linking),125,4,1997 Apr,[Seasonal patterns of infectious disease: similarity and differences].,403-8,,"BACKGROUND: Most infectious diseases in template climates have seasonal pattern, that can be influenced by climatic, social and host factors. AIM: To study the seasonal patterns of seven human infectious diseases in Chile. MATERIAL AND METHODS: Series of monthly cases of measles, whooping cough, scarlet fever, meningitis, diphtheria, typhoid fever and poliomyelitis were obtained from yearly reports of infectious disease of the Ministry of Health. Descriptive statistical parameters and multivariate methods were used to analyze data. RESULTS: Diseases that have an enteric mode of transmission predominate in summer, independent of the type of agent (viral or bacterial) or presence of carriers. Diseases with a respiratory mode of transmission have two different patterns. Those without carriers (measles and whooping cough) predominate in spring and those with carriers (scarlet fever, diphtheria and meningitis) have a winter predominance. CONCLUSIONS: This work confirms the seasonal variation of enteric and respiratory infectious diseases and defines patterns that can be useful for future studies.",,"['Canals, M']",['Canals M'],"['Departamento de Ciecias Biologicas, Facultad de Ciencias Veternarias, Universidad de Chile, Santiago de Chile. macanals@abello.dic.uchile.cl']",['spa'],"['English Abstract', 'Journal Article']",,Chile,Rev Med Chil,Revista medica de Chile,0404312,IM,"['Chile', 'Communicable Diseases/*epidemiology/transmission', 'Humans', '*Seasons']",,,,1997/04/01 00:00,1998/02/14 00:01,['1997/04/01 00:00'],"['1997/04/01 00:00 [pubmed]', '1998/02/14 00:01 [medline]', '1997/04/01 00:00 [entrez]']",,ppublish,Rev Med Chil. 1997 Apr;125(4):403-8.,,,,,,,,,Patrones estacionales de enfermedades infecciosas: similitud y distancias.,,,,,,,,
4806120,NLM,MEDLINE,19751010,20041117,0303-6286 (Print) 0303-6286 (Linking),1,3,1973,[The clinical significance of the species within a genus in infectious diseases].,367-70,,,,"['Elkeles, G']",['Elkeles G'],,['ger'],['Journal Article'],,Germany,Tierarztl Prax,Tierarztliche Praxis,7501042,IM,"['Animals', 'Brucella/pathogenicity', 'Brucellosis/microbiology', 'Communicable Diseases/classification/etiology/*microbiology', 'Humans', 'Salmonella/pathogenicity', 'Salmonella Infections/microbiology', 'Streptococcal Infections/microbiology', 'Streptococcus/pathogenicity']",,,,1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Tierarztl Prax. 1973;1(3):367-70.,,,,,,,,,"Uber die klinische Bedeutung der 'Spezies"" innerhalb des 'Genus"" bei Infektionskrankheiten.",,,,,,,,
19520317,NLM,MEDLINE,20090804,20090612,1768-3238 (Electronic) 1631-0691 (Linking),332,6,2009 Jun,Emergence of infectious diseases: when hidden pathogens break out.,539-47,10.1016/j.crvi.2009.01.008 [doi],"Our understanding of disease emergence is largely limited by the assumption that disease emergence is the result of increased exposure to pathogenic agents. Pathogen exposure is thought to arise through an increase in the number of interactions between humans and their natural environment, changes in demography and mobility, or through genetic variation in the infectious agents which may alter virulence or ability to infect new host species. The study of new diseases (which are often revealed by unusually severe symptoms or atypical epidemiological patterns) applies the most effort to the research of new pathogens. Here, using examples, we discuss alternative but non-exclusive mechanisms that may either reveal the presence of long-term circulating pathogens or explain changes in their nosologic properties in relation to their pattern of circulation and infection conditions. A better understanding of the ecology of pathogenic organisms and their host populations should help to define more efficient health management strategies.",,"['Pontier, Dominique', 'Guiserix, Micheline', 'Fouchet, David', 'Sauvage, Frank', 'Gonzalez, Jean-Paul']","['Pontier D', 'Guiserix M', 'Fouchet D', 'Sauvage F', 'Gonzalez JP']","['UMR-CNRS, Universite de Lyon, Villeurbanne, France. dpontier@biomserv.univ-lyon1.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20090319,France,C R Biol,Comptes rendus biologies,101140040,IM,"['Animals', 'Communicable Diseases/*epidemiology/immunology/microbiology/parasitology', 'Environment', 'Human Activities', 'Humans', 'Risk Factors', 'Zoonoses/epidemiology']",,,,2009/06/13 09:00,2009/08/06 09:00,['2009/06/13 09:00'],"['2008/11/04 00:00 [received]', '2009/01/31 00:00 [accepted]', '2009/06/13 09:00 [entrez]', '2009/06/13 09:00 [pubmed]', '2009/08/06 09:00 [medline]']","['S1631-0691(09)00056-0 [pii]', '10.1016/j.crvi.2009.01.008 [doi]']",ppublish,C R Biol. 2009 Jun;332(6):539-47. doi: 10.1016/j.crvi.2009.01.008. Epub 2009 Mar 19.,,,,,,,,,,,,,,,,,
13083360,NLM,MEDLINE,20030501,20181201,0012-1320 (Print) 0012-1320 (Linking),4,9-10-11-12,1953 May 26,[Overwarming as significant curative factor in therapy of infectious diseases].,250-2,,,,"['LAMPERT, H']",['LAMPERT H'],,['und'],['Journal Article'],,Germany,Dtsch Med J,Deutsches medizinisches Journal,0420573,OM,"['Communicable Diseases/*therapy', '*Hydrotherapy']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*HYDROTHERAPY']",1953/05/26 00:00,1953/05/26 00:01,['1953/05/26 00:00'],"['1953/05/26 00:00 [pubmed]', '1953/05/26 00:01 [medline]', '1953/05/26 00:00 [entrez]']",,ppublish,Dtsch Med J. 1953 May 26;4(9-10-11-12):250-2.,,,,,,,,,Uberwarmung als wichtiger Heilfaktor in der Therapie der Infektionskrankheiten.,,,['CLML: 5425:4105:117:228'],,,,,
1035015,NLM,MEDLINE,19770315,20140603,,163,1-4,1976,[Notifiable and non-notifiable infectious diseases in the federal republic of germany (author's transl)].,34-54,,"Owing to the growing density of population, urbanization, and the use of all kinds of publicly accessible facilities, the interruption of the infection chain for air-borne diseases proves particularly inadequate if no efficient prophylactic inoculations are available to combat viral infections or if no efficient chemotherapeutical measures can be adopted against bacterial infections. Equally problematic is the struggle against salmonellosis associated with the mechanized mass production and distribution of foodstuffs as well as the forms of infectious hospitalism, especially hepatitis B, which are favoured by the technical advances in the medical field. Venereal diseases prove highly resistant because the human patterns of sexual behaviour are difficult to influence. Thus the infectious diseases caused by deficient hygiene have virtually disappeared in our country, while those diseases survive or occur which are capable of profiting from the sociological changes and the technical progress of civilisation. On the whole, the mortality rate has drastically dropped while morbidity has remained more or less the same (with, however, a change in the spectrum of the infectious diseases); this is due mainly to mass inoculation and specific therapy.",,"['Weise, H J']",['Weise HJ'],,['ger'],"['English Abstract', 'Journal Article']",,Germany,Zentralbl Bakteriol Orig B,"Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, praventive Medizin",1306477,IM,"['Adolescent', 'Adult', 'Aged', 'Air Microbiology', 'Animals', 'Child', 'Child, Preschool', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality/transmission', 'Female', 'Germany, West', 'Humans', 'Infant', 'Legislation, Medical', 'Male', 'Middle Aged', 'Population Density', 'Urbanization', 'Zoonoses']",,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Zentralbl Bakteriol Orig B. 1976;163(1-4):34-54.,,,,,,,,,Meldepflichtige und nicht meldepflichtige Infektionskrankheiten in der Bundesrepublik Deutschland.,,,,,,,,
16496917,NLM,MEDLINE,20060414,20190513,0891-6640 (Print) 0891-6640 (Linking),20,1,2006 Jan-Feb,Real-time polymerase chain reaction: a novel molecular diagnostic tool for equine infectious diseases.,3-12,,"The focus of rapid diagnosis of infectious disease of horses in the last decade has shifted from the conventional laboratory techniques of antigen detection, microscopy, and culture to molecular diagnosis of infectious agents. Equine practitioners must be able to interpret the use, limitations, and results of molecular diagnostic techniques, as they are increasingly integrated into routine microbiology laboratory protocols. Polymerase chain reaction (PCR) is the best-known and most successfully implemented diagnostic molecular technology to date. It can detect slow-growing, difficult-to-cultivate, or uncultivatable microorganisms and can be used in situations in which clinical microbiology diagnostic procedures are inadequate, time-consuming, difficult, expensive, or hazardous to laboratory staff. Inherent technical limitations of PCR are present, but they are reduced in laboratories that use standardized protocols, conduct rigid validation protocols, and adhere to appropriate quality-control procedures. Improvements in PCR, especially probe-based real-time PCR, have broadened its diagnostic capabilities in clinical infectious diseases to complement and even surpass traditional methods in some situations. Furthermore, real-time PCR is capable of quantitation, allowing discrimination of clinically relevant infections characterized by pathogen replication and high pathogen loads from chronic latent infections. Automation of all components of PCR is now possible, which will decrease the risk of generating false-positive results due to contamination. The novel real-time PCR strategy and clinical applications in equine infectious diseases will be the subject of this review.",,"['Pusterla, N', 'Madigan, J E', 'Leutenegger, C M']","['Pusterla N', 'Madigan JE', 'Leutenegger CM']","['Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA. npusterla@ucdavis.edu']",['eng'],"['Journal Article', 'Review']",,United States,J Vet Intern Med,Journal of veterinary internal medicine,8708660,IM,"['Animals', 'Communicable Diseases/diagnosis/microbiology/*veterinary', 'Horse Diseases/*diagnosis/microbiology', 'Horses/microbiology', 'Polymerase Chain Reaction/*veterinary']",,,,2006/02/25 09:00,2006/04/15 09:00,['2006/02/25 09:00'],"['2006/02/25 09:00 [pubmed]', '2006/04/15 09:00 [medline]', '2006/02/25 09:00 [entrez]']",['10.1892/0891-6640(2006)20[3:rpcran]2.0.co;2 [doi]'],ppublish,J Vet Intern Med. 2006 Jan-Feb;20(1):3-12. doi: 10.1892/0891-6640(2006)20[3:rpcran]2.0.co;2.,,,,,,63,,,,,,,,,,,
19647464,NLM,MEDLINE,20100701,20100315,1878-3511 (Electronic) 1201-9712 (Linking),14,3,2010 Mar,Transplantation and tropical infectious diseases.,e189-96,10.1016/j.ijid.2009.04.021 [doi],"The number of transplant recipients with tropical infectious diseases is growing due to increasing international travel and the rising number of transplants taking place in the tropics and subtropics. With increases in population migration, the prevalence of individuals infected with geographically restricted organisms also rises. There are three potential categories of tropical infections in transplant patients: (1) donor-related infections transmitted by the graft or through transfusion of blood products; (2) reactivation or recrudescence of latent infections in the donor recipient; and (3) de novo acquisition of infection in the post-transplant period through the traditional route of infection. We present an overall discussion of the association of parasitic (protozoa and helminths) and non-parasitic (viral, bacterial, and fungal) tropical infectious diseases and solid-organ and hematopoietic transplantation. We also suggest potential screening guidelines for some of these tropical infections.","['Copyright 2009 International Society for Infectious Diseases. Published by', 'Elsevier Ltd. All rights reserved.']","['Franco-Paredes, Carlos', 'Jacob, Jesse T', 'Hidron, Alicia', 'Rodriguez-Morales, Alfonso J', 'Kuhar, David', 'Caliendo, Angela M']","['Franco-Paredes C', 'Jacob JT', 'Hidron A', 'Rodriguez-Morales AJ', 'Kuhar D', 'Caliendo AM']","['Division of Infectious Diseases, Emory University School of Medicine, 550 Peachtree Street, MOT 7th Floor TravelWell, Atlanta, GA 30308, USA. cfranco@sph.emory.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20090803,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,IM,"['Animals', 'Communicable Diseases/diagnosis/etiology/transmission', 'Disease Transmission, Infectious', 'Hematopoietic Stem Cell Transplantation/*adverse effects', 'Humans', 'Immunization', 'Organ Transplantation/*adverse effects', '*Tissue Donors', 'Travel', '*Tropical Climate']",,,,2009/08/04 09:00,2010/07/02 06:00,['2009/08/04 09:00'],"['2008/11/12 00:00 [received]', '2009/04/03 00:00 [revised]', '2009/04/14 00:00 [accepted]', '2009/08/04 09:00 [entrez]', '2009/08/04 09:00 [pubmed]', '2010/07/02 06:00 [medline]']","['S1201-9712(09)00204-5 [pii]', '10.1016/j.ijid.2009.04.021 [doi]']",ppublish,Int J Infect Dis. 2010 Mar;14(3):e189-96. doi: 10.1016/j.ijid.2009.04.021. Epub 2009 Aug 3.,,,,,,135,,,,,,,,,,,
20128461,NLM,MEDLINE,20100223,20190923,0253-1933 (Print) 0253-1933 (Linking),28,2,2009 Aug,Essential veterinary education in infectious diseases of livestock and related scientific disciplines.,537-44,,"The World Organisation for Animal Health (commonly referred to bythe acronym of its original French name Office International des Epizooties [OIE]) was created in 1924 with the aim of controlling the international spread of infectious animal diseases. The OIE mandate has broadened since then, but the prevention and control of infectious and parasitic diseases are still at the heart of OIE activities. To plan and implement effective disease control strategies the Veterinary Services of OIE Member Countries need well-educated veterinarians who have extensive knowledge of how and why outbreaks of infectious animal diseases occur and spread and how they can be prevented and controlled. The teaching of fundamental scientific disciplines - virology, bacteriology, parasitology, epidemiology, risk analysis, immunology and vaccinology--is therefore a vital component of all veterinary education programmes.",,"['Pastoret, P P', 'Vallat, B']","['Pastoret PP', 'Vallat B']","['World Organisation for Animal Health, 12, rue de Prony, 75017 Paris, France. pp.pastoret@oie.int']",['eng'],['Journal Article'],,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', 'Communicable Disease Control/*methods', 'Communicable Diseases/epidemiology/transmission/*veterinary', 'Communicable Diseases, Emerging/prevention & control/veterinary', 'Disease Outbreaks/prevention & control/*veterinary', 'Disease Transmission, Infectious/prevention & control/veterinary', '*Education, Veterinary', 'Humans', 'Public Health', 'Risk Assessment', 'Risk Factors', 'Veterinary Medicine/*standards', 'Zoonoses']",,,,2010/02/05 06:00,2010/02/24 06:00,['2010/02/05 06:00'],"['2010/02/05 06:00 [entrez]', '2010/02/05 06:00 [pubmed]', '2010/02/24 06:00 [medline]']",['10.20506/rst.28.2.1895 [doi]'],ppublish,Rev Sci Tech. 2009 Aug;28(2):537-44. doi: 10.20506/rst.28.2.1895.,,,,,,,,,,,,,,,,,
35670110,NLM,MEDLINE,20220718,20221117,1746-0921 (Electronic) 1746-0913 (Linking),17,,2022 Jul,Diagnostic stewardship in infectious diseases: steps towards intentional diagnostic testing.,813-817,10.2217/fmb-2022-0070 [doi],,,"['Zacharioudakis, Ioannis M', 'Zervou, Fainareti N']","['Zacharioudakis IM', 'Zervou FN']","['Department of Medicine, Division of Infectious Diseases &amp; Immunology, NYU Grossman School of Medicine, New York, NY 10016, USA.', 'Department of Medicine, Division of Infectious Diseases &amp; Immunology, NYU Grossman School of Medicine, New York, NY 10016, USA.']",['eng'],['Journal Article'],20220607,England,Future Microbiol,Future microbiology,101278120,IM,"['Anti-Bacterial Agents/therapeutic use', '*Antimicrobial Stewardship', '*Communicable Diseases/diagnosis/drug therapy', 'Diagnostic Techniques and Procedures', 'Humans']",,['NOTNLM'],"['diagnostic stewardship', 'infectious disease', 'intentional diagnostic testing']",2022/06/08 06:00,2022/07/19 06:00,['2022/06/07 04:03'],"['2022/06/08 06:00 [pubmed]', '2022/07/19 06:00 [medline]', '2022/06/07 04:03 [entrez]']",['10.2217/fmb-2022-0070 [doi]'],ppublish,Future Microbiol. 2022 Jul;17:813-817. doi: 10.2217/fmb-2022-0070. Epub 2022 Jun 7.,,"['ORCID: 0000-0002-7091-8437', 'ORCID: 0000-0002-6192-7403']",['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
31002311,NLM,MEDLINE,20201222,20201222,1537-6591 (Electronic) 1058-4838 (Linking),70,5,2020 Feb 14,TeleMedicine-based Infectious Diseases: Outcomes and Impact.,771-772,10.1093/cid/ciz298 [doi],,,"['Siddiqui, Javeed']",['Siddiqui J'],"['TeleMed2U, Roseville, California.']",['eng'],"['Comment', 'Journal Article']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*Communicable Diseases/diagnosis/epidemiology', 'Hospitals', 'Humans', 'Inpatients', 'Referral and Consultation', 'Retrospective Studies', '*Telemedicine']",,,,2019/04/20 06:00,2020/12/23 06:00,['2019/04/20 06:00'],"['2019/03/24 00:00 [received]', '2019/04/16 00:00 [accepted]', '2019/04/20 06:00 [pubmed]', '2020/12/23 06:00 [medline]', '2019/04/20 06:00 [entrez]']","['5475299 [pii]', '10.1093/cid/ciz298 [doi]']",ppublish,Clin Infect Dis. 2020 Feb 14;70(5):771-772. doi: 10.1093/cid/ciz298.,,,,,,,,['Clin Infect Dis. 2020 Feb 14;70(5):763-770. PMID: 31002338'],,,,,,,,,
29199919,NLM,MEDLINE,20180426,20180605,1875-533X (Electronic) 0929-8673 (Linking),24,36,2017 Nov 24,Editorial: Molecular Scenarios Behind Infectious Diseases.,3939-3941,10.2174/092986732436171124165140 [doi],,,"['Berisio, Rita', 'Squeglia, Flavia', 'Ruggiero, Alessia']","['Berisio R', 'Squeglia F', 'Ruggiero A']","['Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples. Italy.', 'Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples. Italy.', 'Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples. Italy.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United Arab Emirates,Curr Med Chem,Current medicinal chemistry,9440157,IM,"['*Communicable Diseases/etiology/immunology', 'Humans', 'Immunity/*physiology', 'Virulence/*physiology']",,,,2017/12/05 06:00,2018/04/27 06:00,['2017/12/05 06:00'],"['2017/12/05 06:00 [entrez]', '2017/12/05 06:00 [pubmed]', '2018/04/27 06:00 [medline]']","['CMC-EPUB-87102 [pii]', '10.2174/092986732436171124165140 [doi]']",ppublish,Curr Med Chem. 2017 Nov 24;24(36):3939-3941. doi: 10.2174/092986732436171124165140.,,,,,,,,,,,,,,,,,
29068251,NLM,MEDLINE,20171212,20181202,1532-2750 (Electronic) 1098-612X (Linking),19,11,2017 Nov,Skin as a marker of general feline health: Cutaneous manifestations of infectious disease.,1149-1165,10.1177/1098612X17735764 [doi],"Practical relevance: Infectious disease in feline patients often presents a diagnostic challenge. This article reviews the most relevant viral, bacterial and protozoal diseases and their cutaneous manifestations. Many of the diseases discussed have overlapping presentations or may mimic more common noninfectious disease processes. The purpose of the article is to reinforce knowledge of common and uncommon infectious diseases, help practitioners identify possible infectious dermatoses, create a comprehensive and prioritized differential list, and provide guidance for the diagnosis of these diseases. A working knowledge of these clinical syndromes is important if what is thought to be a case of a common disease does not respond to conventional management. AUDIENCE: This review is aimed at veterinarians who treat cats and especially those with an interest in feline dermatology. Tables are included to allow the reader to formulate a concise list of differential diagnoses for clinically similar presentations. The diagnostic approach to a case of ulcerative facial dermatitis is reviewed in a Case Notes quiz. Evidence base: This article includes up-to-date information regarding dermatologic manifestations of less commonly encountered feline cutaneous infectious diseases. Information has been drawn from the published, peer-reviewed literature and the most recent textbook chapters with a particular aim of describing and differentiating clinical lesions and the diagnostic approach to cutaneous disease, especially in unusual cases.",,"['Backel, Katherine', 'Cain, Christine']","['Backel K', 'Cain C']","['Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, 3900 Spruce Street, Philadelphia, PA 19104, USA.', 'Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, 3900 Spruce Street, Philadelphia, PA 19104, USA.']",['eng'],"['Journal Article', 'Review']",,England,J Feline Med Surg,Journal of feline medicine and surgery,100897329,IM,"['Animals', 'Cat Diseases/*diagnosis/pathology', 'Cats', 'Communicable Diseases/diagnosis/pathology/*veterinary', 'Diagnosis, Differential', 'Skin Diseases/diagnosis/pathology/*veterinary']",,,,2017/10/27 06:00,2017/12/13 06:00,['2017/10/26 06:00'],"['2017/10/26 06:00 [entrez]', '2017/10/27 06:00 [pubmed]', '2017/12/13 06:00 [medline]']",['10.1177/1098612X17735764 [doi]'],ppublish,J Feline Med Surg. 2017 Nov;19(11):1149-1165. doi: 10.1177/1098612X17735764.,,,,,,,,,,,,,,,,,
22941454,NLM,MEDLINE,20140512,20211021,1432-1416 (Electronic) 0303-6812 (Linking),67,5,2013 Nov,Extending the type reproduction number to infectious disease control targeting contacts between types.,1067-82,10.1007/s00285-012-0579-9 [doi],"A new quantity called the target reproduction number is defined to measure control strategies for infectious diseases with multiple host types such as waterborne, vector-borne and zoonotic diseases. The target reproduction number includes as a special case and extends the type reproduction number to allow disease control targeting contacts between types. Relationships among the basic, type and target reproduction numbers are established. Examples of infectious disease models from the literature are given to illustrate the use of the target reproduction number.",,"['Shuai, Zhisheng', 'Heesterbeek, J A P', 'van den Driessche, P']","['Shuai Z', 'Heesterbeek JA', 'van den Driessche P']","['Department of Mathematics and Statistics, University of Victoria, Victoria, BC, V8W 3R4, Canada, zshuai@uvic.ca.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20120902,Germany,J Math Biol,Journal of mathematical biology,7502105,IM,"['*Basic Reproduction Number', 'Communicable Diseases/epidemiology/*immunology/transmission', 'Disease Outbreaks/*prevention & control', 'Humans', '*Models, Immunological']",,,,2012/09/04 06:00,2014/05/13 06:00,['2012/09/04 06:00'],"['2012/04/02 00:00 [received]', '2012/07/20 00:00 [revised]', '2012/09/04 06:00 [entrez]', '2012/09/04 06:00 [pubmed]', '2014/05/13 06:00 [medline]']",['10.1007/s00285-012-0579-9 [doi]'],ppublish,J Math Biol. 2013 Nov;67(5):1067-82. doi: 10.1007/s00285-012-0579-9. Epub 2012 Sep 2.,,,,['J Math Biol. 2015 Jul;71(1):255-7. PMID: 25800536'],,,,,,,,,,,,,
13858267,NLM,MEDLINE,19981101,20181201,0370-629X (Print) 0370-629X (Linking),14,,1959 Aug 15,[INFECTIOUS diseases in this country and abroad].,582-4,,,,,,,['fre'],['Journal Article'],,Belgium,Rev Med Liege,Revue medicale de Liege,0404317,OM,"['Communicable Diseases/*etiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/etiology'],1959/08/15 00:00,1959/08/15 00:01,['1959/08/15 00:00'],"['1959/08/15 00:00 [pubmed]', '1959/08/15 00:01 [medline]', '1959/08/15 00:00 [entrez]']",,ppublish,Rev Med Liege. 1959 Aug 15;14:582-4.,,,,,,,,,,,,,,,,,
31174594,NLM,MEDLINE,20230811,20231012,2046-4053 (Electronic) 2046-4053 (Linking),8,1,2019 Jun 7,Telemedicine infectious diseases consultations and clinical outcomes: a systematic review and meta-analysis protocol.,135,10.1186/s13643-019-1056-y [doi] 135,"BACKGROUND: Telemedicine use is increasing in many specialties, but its impact on clinical outcomes in infectious diseases has not been systematically studied and reviewed. The proposed systematic review will evaluate the current evidence regarding the effect of telemedicine infectious diseases consultation on a range of clinical outcomes, including mortality, hospital readmission, antimicrobial use, and cost. METHOD/DESIGN: Standard systematic review methodology will be used, with searches of Ovid MEDLINE 1946-, https://embase.com/ 1947-, Scopus 1823-, Cochrane Database of Systematic Reviews (CDSR), Cochrane Central Register of Controlled Trials (CENTRAL), and https://clinicaltrials.gov/ 1997-. There will be no restriction on language or year of publication. The primary outcome will be 30-day all-cause mortality and secondary outcomes will include readmission within 30 days after discharge from an initial hospitalization with an infection, patient compliance/adherence, patient satisfaction, cost or cost effectiveness, length of hospital stay, antimicrobial use, and antimicrobial stewardship. Bias will be assessed using standard Cochrane methodologies. Data will be grouped by outcome and narratively synthesized. Meta-analysis will be performed for outcomes with clinical or methodological homogeneity. The systematic review and meta-analysis will be registered through PROSPERO. Pre-planned subgroup analyses will be detailed. DISCUSSION: A number of studies have documented the feasibility of telemedicine for infectious diseases, but a synthesis of clinical outcomes data with telemedicine infectious diseases consultation has not been performed. This systematic review will analyze many clinical outcomes of telemedicine infectious diseases consultation. The findings of this study will add to established literature about feasibility of telemedicine consultation by synthesizing the evidence for clinical effectiveness. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018105225.",,"['Burnham, Jason P', 'Fritz, Stephanie A', 'Yaeger, Lauren H', 'Colditz, Graham A']","['Burnham JP', 'Fritz SA', 'Yaeger LH', 'Colditz GA']","['Division of Infectious Diseases, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8051, St. Louis, MO, 63110, USA. burnham@wustl.edu.', 'Department of Pediatrics, Washington University, St. Louis, MO, USA.', 'Bernard Becker Medical Library, Washington University, St. Louis, MO, USA.', 'Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, P.H.S.""]",20190607,England,Syst Rev,Systematic reviews,101580575,IM,"['Humans', 'Anti-Infective Agents/therapeutic use', '*Communicable Diseases/drug therapy/economics/mortality/therapy', 'Cost-Benefit Analysis', 'Patient Readmission', '*Telemedicine/methods', 'Treatment Outcome', 'Meta-Analysis as Topic', 'Systematic Reviews as Topic']",PMC6554925,['NOTNLM'],"['Antimicrobial', 'Consultation', 'Cost', 'Infectious diseases', 'Mortality', 'Systematic review', 'Telehealth', 'Telemedicine']",2019/06/09 06:00,2020/07/28 06:00,['2019/06/09 06:00'],"['2019/01/15 00:00 [received]', '2019/05/26 00:00 [accepted]', '2019/06/09 06:00 [entrez]', '2019/06/09 06:00 [pubmed]', '2020/07/28 06:00 [medline]']","['10.1186/s13643-019-1056-y [pii]', '1056 [pii]', '10.1186/s13643-019-1056-y [doi]']",epublish,Syst Rev. 2019 Jun 7;8(1):135. doi: 10.1186/s13643-019-1056-y.,['The authors declare that they have no competing interests.'],['ORCID: 0000-0002-4777-3006'],['0 (Anti-Infective Agents)'],,,,"['KL2 TR002346/TR/NCATS NIH HHS/United States', 'R01 HS024269/HS/AHRQ HHS/United States', 'UL1 TR002345/TR/NCATS NIH HHS/United States']",,,,,,,,,,
24265288,NLM,MEDLINE,20150512,20140226,1544-2217 (Electronic) 0300-9858 (Linking),51,2,2014 Mar,Common and emerging infectious diseases in the animal shelter.,478-91,10.1177/0300985813511129 [doi],"The beneficial role that animal shelters play is unquestionable. An estimated 3 to 4 million animals are cared for or placed in homes each year, and most shelters promote public health and support responsible pet ownership. It is, nonetheless, inevitable that shelters are prime examples of anthropogenic biological instability: even well-run shelters often house transient, displaced, and mixed populations of animals. Many of these animals have received minimal to no prior health care, and some have a history of scavenging or predation to survive. Overcrowding and poor shelter conditions further magnify these inherent risks to create individual, intraspecies, and interspecies stress and provide an environment conducive to exposure to numerous potentially collaborative pathogens. All of these factors can contribute to the evolution and emergence of new pathogens or to alterations in virulence of endemic pathogens. While it is not possible to effectively anticipate the timing or the pathogen type in emergence events, their sites of origin are less enigmatic, and pathologists and diagnosticians who work with sheltered animal populations have recognized several such events in the past decade. This article first considers the contribution of the shelter environment to canine and feline disease. This is followed by summaries of recent research on the pathogenesis of common shelter pathogens, as well as research that has led to the discovery of novel or emerging diseases and the methods that are used for their diagnosis and discovery. For the infectious agents that commonly affect sheltered dogs and cats, including canine distemper virus, canine influenza virus, Streptococcus spp, parvoviruses, feline herpesvirus, feline caliciviruses, and feline infectious peritonitis virus, we present familiar as well as newly recognized lesions associated with infection. Preliminary studies on recently discovered viruses like canine circovirus, canine bocavirus, and feline norovirus indicate that these pathogens can cause or contribute to canine and feline disease.",,"['Pesavento, P A', 'Murphy, B G']","['Pesavento PA', 'Murphy BG']","['School of Veterinary Medicine, UC Davis, Vet Med: PMI, 4206 VM3A, 1 Shields Ave, Davis, CA 95616, USA. Email: papesavento@ucdavis.edu.']",['eng'],"['Journal Article', 'Review']",20131121,United States,Vet Pathol,Veterinary pathology,0312020,IM,"['Animals', 'Cat Diseases/*epidemiology/microbiology', 'Cats', 'Communicable Diseases/epidemiology/microbiology/*veterinary', 'Communicable Diseases, Emerging/epidemiology/microbiology/*veterinary', 'Dog Diseases/*epidemiology/microbiology', 'Dogs', 'Housing, Animal/*standards']",,['NOTNLM'],"['canine', 'cat', 'dog', 'feline', 'infectious disease', 'intensive housing', 'shelter', 'virus']",2013/11/23 06:00,2015/05/13 06:00,['2013/11/23 06:00'],"['2013/11/23 06:00 [entrez]', '2013/11/23 06:00 [pubmed]', '2015/05/13 06:00 [medline]']","['0300985813511129 [pii]', '10.1177/0300985813511129 [doi]']",ppublish,Vet Pathol. 2014 Mar;51(2):478-91. doi: 10.1177/0300985813511129. Epub 2013 Nov 21.,,,,,,,,,,,,,,,,,
973011,NLM,MEDLINE,19761203,20061115,0014-2565 (Print) 0014-2565 (Linking),142,1,1976 Jul 15,[Contribution to the study of platelet ultrastructure in infectious diseases].,25-34,,,,"['Romero Bobillo, E', 'Coca, M C', 'Romero, E', 'Maranon, A']","['Romero Bobillo E', 'Coca MC', 'Romero E', 'Maranon A']",,['spa'],"['English Abstract', 'Journal Article']",,Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Blood Platelets/*pathology', 'Communicable Diseases/*blood/pathology', 'Humans']",,,,1976/07/15 00:00,1976/07/15 00:01,['1976/07/15 00:00'],"['1976/07/15 00:00 [pubmed]', '1976/07/15 00:01 [medline]', '1976/07/15 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1976 Jul 15;142(1):25-34.,,,,,,,,,Contribucion al estudio de la ultraestructura de la plaqueta en las enfermedades infecciosas.,,,,,,,,
15760444,NLM,MEDLINE,20050825,20091119,1198-743X (Print) 1198-743X (Linking),11 Suppl 1,,2005 Apr,Report of working group 3: specialist training and continuing medical education/professional development in the infection disciplines.,46-9,,"The European Union of Medical Specialists (UEMS) core curricula for training in infectious diseases and medical microbiology are adequate with the exception of one deficiency which is the absence of training in epidemiology, public health and infection control. Infectious disease curricula should include training in HIV, tuberculosis, hepatitis and sexually transmitted diseases. There is a need for a core curriculum in infection control. Infection control should have a basis in both medical microbiology and infectious diseases, and should become a specialty dealing with healthcare hygiene in hospitals, in outpatient clinics and also in institutions for the elderly. In the UK, a specialty training in infection is offered and includes internal medicine, clinical infectious diseases and medical microbiology for a total of 9 years. The UEMS should be contacted about the creation of a single specialty of infection, allowing for various degrees of sub-specialisation in infectious diseases or medical microbiology. It is unlikely that a European board examination validating the training of specialists will become a reality soon. Meanwhile, national systems should be created, documenting the content of the training and evaluating the quality of the training institutions. A medical specialist has a constant need for further education. This is generally a national matter, with requirements varying throughout Europe. It should be possible to accumulate continuing medical education/continuing professional development merits on a European level as well as on a national one. With the expansion of the European Union, it is important that the quality and content of specialist training can be verified and training curricula be harmonised. The UEMS should assist in this, in collaboration with scientific societies such as the ESCMID.",,"['Norrby, S Ragnar', 'Carbon, C']","['Norrby SR', 'Carbon C']","['Swedish Institute for Infectious Disease Control, Solna, Sweden. Ragnar.Norrby@smi.ki.se']",['eng'],['Journal Article'],,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Disease Control', '*Communicable Diseases/diagnosis/drug therapy/epidemiology', 'Curriculum/*standards', '*Education, Medical', '*Education, Medical, Continuing', 'Europe', 'Health Policy', 'Humans', 'Infection Control Practitioners/*education', 'Microbiology', '*Specialization']",,,,2005/03/12 09:00,2005/08/27 09:00,['2005/03/12 09:00'],"['2005/03/12 09:00 [pubmed]', '2005/08/27 09:00 [medline]', '2005/03/12 09:00 [entrez]']","['CLM1091 [pii]', '10.1111/j.1469-0691.2005.01091.x [doi]']",ppublish,Clin Microbiol Infect. 2005 Apr;11 Suppl 1:46-9. doi: 10.1111/j.1469-0691.2005.01091.x.,,,,,,,,,,,,,,,,,
12797976,NLM,MEDLINE,20030717,20181130,1567-1348 (Print) 1567-1348 (Linking),2,4,2003 Apr,"MEEGID VI: Sixth International Meeting on Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases. Paris, France, 23-27 July 2002. Abstracts.",231-321,,,,,,,['eng'],"['Congress', 'Overall']",,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Animals', 'Communicable Diseases/*epidemiology/*microbiology', '*Genetics, Microbial', 'Humans', '*Molecular Epidemiology']",,,,2003/06/12 05:00,2003/07/19 05:00,['2003/06/12 05:00'],"['2003/06/12 05:00 [pubmed]', '2003/07/19 05:00 [medline]', '2003/06/12 05:00 [entrez]']",['S1567134803000108 [pii]'],ppublish,Infect Genet Evol. 2003 Apr;2(4):231-321.,,,,,,,,,,,,,,,,,
8969256,NLM,MEDLINE,19970204,20090521,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),2,4,1996 Oct-Dec,Emerging infectious diseases and the depopulation of French Polynesia in the 19th century.,359-61,,,,"['Martin, P M', 'Combes, C']","['Martin PM', 'Combes C']",,['eng'],"['Historical Article', 'Letter']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/epidemiology/*history', 'Disease Outbreaks/history', 'History, 19th Century', 'Humans', 'Polynesia/epidemiology', '*Population Dynamics']",PMC2639926,,,1996/10/01 00:00,1996/10/01 00:01,['1996/10/01 00:00'],"['1996/10/01 00:00 [pubmed]', '1996/10/01 00:01 [medline]', '1996/10/01 00:00 [entrez]']",['10.3201/eid0204.960416 [doi]'],ppublish,Emerg Infect Dis. 1996 Oct-Dec;2(4):359-61. doi: 10.3201/eid0204.960416.,,,,,,,,,,,,,,,,,
15241422,NLM,MEDLINE,20040727,20231113,1476-4687 (Electronic) 0028-0836 (Print) 0028-0836 (Linking),430,6996,2004 Jul 8,The challenge of emerging and re-emerging infectious diseases.,242-9,,"Infectious diseases have for centuries ranked with wars and famine as major challenges to human progress and survival. They remain among the leading causes of death and disability worldwide. Against a constant background of established infections, epidemics of new and old infectious diseases periodically emerge, greatly magnifying the global burden of infections. Studies of these emerging infections reveal the evolutionary properties of pathogenic microorganisms and the dynamic relationships between microorganisms, their hosts and the environment.",,"['Morens, David M', 'Folkers, Gregory K', 'Fauci, Anthony S']","['Morens DM', 'Folkers GK', 'Fauci AS']","['National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-2520, USA.']",['eng'],"['Journal Article', 'Review']",,England,Nature,Nature,0410462,IM,"['Animals', 'Bioterrorism/prevention & control/*trends', 'Communicable Diseases, Emerging/*epidemiology/microbiology/*transmission/virology', 'Drug Resistance', 'HIV Infections/epidemiology/transmission/virology', 'Humans']",PMC7094993,,,2004/07/09 05:00,2004/07/28 05:00,['2004/07/09 05:00'],"['2004/07/09 05:00 [pubmed]', '2004/07/28 05:00 [medline]', '2004/07/09 05:00 [entrez]']","['nature02759 [pii]', 'BFnature02759 [pii]', '10.1038/nature02759 [doi]']",ppublish,Nature. 2004 Jul 8;430(6996):242-9. doi: 10.1038/nature02759.,['The authors declare that they have no competing financial interests.'],,,['Nature. 2010 Jan 7;463(7277):122'],,,,,,,,,,,,,
24314804,NLM,MEDLINE,20140204,20211021,1557-8194 (Electronic) 0011-5029 (Print) 0011-5029 (Linking),59,12,2013 Dec,Global infectious diseases - the new norm for the United States?,426-33,S0011-5029(13)00177-6 [pii] 10.1016/j.disamonth.2013.10.004 [doi],,,"['McFee, Robin B']",['McFee RB'],,['eng'],['Journal Article'],,United States,Dis Mon,Disease-a-month : DM,0370657,IM,"['*Communicable Disease Control/methods/organization & administration/trends', '*Communicable Diseases/classification/epidemiology/etiology/transmission', '*Disease Transmission, Infectious/prevention & control/statistics & numerical data', 'Ecological and Environmental Phenomena', 'Global Health', 'Human Migration/trends', 'Humans', 'Internationality', 'Public Health/methods', '*Travel', 'United States/epidemiology']",PMC7094339,,,2013/12/10 06:00,2014/02/05 06:00,['2013/12/10 06:00'],"['2013/12/10 06:00 [entrez]', '2013/12/10 06:00 [pubmed]', '2014/02/05 06:00 [medline]']","['S0011-5029(13)00177-6 [pii]', '10.1016/j.disamonth.2013.10.004 [doi]']",ppublish,Dis Mon. 2013 Dec;59(12):426-33. doi: 10.1016/j.disamonth.2013.10.004.,,,,,,,,,,,,,,,,,
8416820,NLM,MEDLINE,19930127,20220316,0011-8532 (Print) 0011-8532 (Linking),37,1,1993 Jan,The basic principles of infectious diseases as related to dental practice.,1-20,,"A variety of bacterial, viral, fungal, and protozoan microbes may present hazards to the dental team and to patients. After contamination with a microbe, three major factors determine if an infectious disease results: (1) virulence of the microbe, (2) the dose or number of microbial cells that contaminate the body, and (3) the resistance of the body to the microbe. Because nothing can be done about microbial virulence, prevention of infectious diseases involves decreasing the dose and increasing body resistance, coupled with education about disease spread and modes of prevention. The steps in the development of an infectious disease are (1) source of the microbe, (2) escape of the microbe from the source, (3) spread of the microbe to a new person, (4) entry of the microbe into the new person, and (5) infection and damage. The prevention of infectious disease can be accomplished by interfering with any of the above steps.",,"['Miller, C H', 'Cottone, J A']","['Miller CH', 'Cottone JA']","['Department of Oral Microbiology, Indiana University School of Dentistry, Indianapolis.']",['eng'],"['Journal Article', 'Review']",,United States,Dent Clin North Am,Dental clinics of North America,0217440,IM,"['*Communicable Diseases/immunology/microbiology/transmission', 'Cross Infection/prevention & control', '*Dentists', 'Humans', '*Infection Control', 'Mouth/microbiology', 'Occupational Diseases/*microbiology/prevention & control']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Dent Clin North Am. 1993 Jan;37(1):1-20.,,,,,,16,,,,,,,,,,,
18543807,NLM,MEDLINE,20080715,20080611,0031-1847 (Print) 0031-1847 (Linking),42,1,2008 Jan-Feb,[Nosogeographical estimation of the territory of Primorsky Krai based on the analysis of spatial and temporal structure of the incidence of infectious diseases].,66-74,,"Nosogeographic estimation of the territory of Primorsky Krai has been carried out on the base of the long-term data on spatial distribution of the incidence of infectious diseases. Analysis of the complex maps of the zoning allow us to say, that the territory of the region is rather clearly differentiated by the groups of infections.",,"['Bolotin, E I']",['Bolotin EI'],,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Parazitologiia,Parazitologiia,0101672,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/epidemiology/veterinary', 'Humans', 'Incidence', 'Siberia/epidemiology']",,,,2008/06/12 09:00,2008/07/17 09:00,['2008/06/12 09:00'],"['2008/06/12 09:00 [pubmed]', '2008/07/17 09:00 [medline]', '2008/06/12 09:00 [entrez]']",,ppublish,Parazitologiia. 2008 Jan-Feb;42(1):66-74.,,,,,,,,,,,,,,,,,
19766536,NLM,MEDLINE,20091211,20091005,1471-4973 (Electronic) 1471-4892 (Linking),9,5,2009 Oct,Key pathogens and emerging therapies in infectious diseases.,535-6,10.1016/j.coph.2009.09.001 [doi],,,"['Miller, Paul F', 'Mueller, John P']","['Miller PF', 'Mueller JP']",,['eng'],"['Editorial', 'Introductory Journal Article']",20090918,England,Curr Opin Pharmacol,Current opinion in pharmacology,100966133,IM,"['Animals', 'Anti-Bacterial Agents/*therapeutic use', 'Antiviral Agents/*therapeutic use', 'Communicable Diseases/*drug therapy/microbiology/virology', 'Drug Resistance, Bacterial', 'Drug Resistance, Viral', 'Humans', 'Treatment Outcome', 'Virulence']",,,,2009/09/22 06:00,2009/12/16 06:00,['2009/09/22 06:00'],"['2009/09/22 06:00 [entrez]', '2009/09/22 06:00 [pubmed]', '2009/12/16 06:00 [medline]']","['S1471-4892(09)00134-9 [pii]', '10.1016/j.coph.2009.09.001 [doi]']",ppublish,Curr Opin Pharmacol. 2009 Oct;9(5):535-6. doi: 10.1016/j.coph.2009.09.001. Epub 2009 Sep 18.,,,"['0 (Anti-Bacterial Agents)', '0 (Antiviral Agents)']",,,,,,,,,,,,,,
29052511,NLM,MEDLINE,20180514,20231112,1741-7007 (Electronic) 1741-7007 (Linking),15,1,2017 Oct 19,"Q&A: What are pathogens, and what have they done to and for us?",91,10.1186/s12915-017-0433-z [doi] 91,"Microbes are found on us, within us and around us. They inhabit virtually every environment on the planet and the bacteria carried by an average human, mostly in their gut, outnumber human cells. The vast majority of microbes are harmless to us, and many play essential roles in plant, animal and human health. Others, however, are either obligate or facultative pathogens exerting a spectrum of deleterious effects on their hosts. Infectious diseases have historically represented the most common cause of death in humans until recently, exceeding by far the toll taken by wars or famines. From the dawn of humanity and throughout history, infectious diseases have shaped human evolution, demography, migrations and history.",,"['Balloux, Francois', 'van Dorp, Lucy']","['Balloux F', 'van Dorp L']","['UCL Genetics Institute (UGI), Darwin Building, Gower Street, London, WC1E 6BT, UK. f.balloux@ucl.ac.uk.', 'UCL Genetics Institute (UGI), Darwin Building, Gower Street, London, WC1E 6BT, UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20171019,England,BMC Biol,BMC biology,101190720,IM,"['Bacteria/*genetics/*pathogenicity', 'Bacterial Physiological Phenomena', '*Biological Evolution', '*Communicable Diseases/epidemiology/microbiology/transmission', '*Genome, Bacterial', 'Host Specificity', '*Host-Pathogen Interactions', 'Humans']",PMC5648414,,,2017/10/21 06:00,2018/05/15 06:00,['2017/10/21 06:00'],"['2017/10/21 06:00 [entrez]', '2017/10/21 06:00 [pubmed]', '2018/05/15 06:00 [medline]']","['10.1186/s12915-017-0433-z [pii]', '433 [pii]', '10.1186/s12915-017-0433-z [doi]']",epublish,BMC Biol. 2017 Oct 19;15(1):91. doi: 10.1186/s12915-017-0433-z.,"[""The authors declare that they have no competing interests. PUBLISHER'S NOTE:"", 'Springer Nature remains neutral with regard to jurisdictional claims in published', 'maps and institutional affiliations.']",,,,,,"['MR/P007597/1/MRC_/Medical Research Council/United Kingdom', 'BB_/Biotechnology and Biological Sciences Research Council/United Kingdom']",,,,,,,,,,
27604081,NLM,MEDLINE,20170526,20220310,1741-7015 (Electronic) 1741-7015 (Linking),14,1,2016 Sep 7,Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).,132,10.1186/s12916-016-0686-3 [doi] 132,"Media and World Health Organization (WHO) attention on Zika virus transmission at the 2016 Rio Olympic Games and the 2015 Ebola virus outbreak in West Africa diverted the attention of global public health authorities from other lethal infectious diseases with epidemic potential. Mass gatherings such as the annual Hajj pilgrimage hosted by Kingdom of Saudi Arabia attract huge crowds from all continents, creating high-risk conditions for the rapid global spread of infectious diseases. The highly lethal Middle Eastern respiratory syndrome coronavirus (MERS-CoV) remains in the WHO list of top emerging diseases likely to cause major epidemics. The 2015 MERS-CoV outbreak in South Korea, in which 184 MERS cases including 33 deaths occurred in 2 months, that was imported from the Middle East by a South Korean businessman was a wake-up call for the global community to refocus attention on MERS-CoV and other emerging and re-emerging infectious diseases with epidemic potential. The international donor community and Middle Eastern countries should make available resources for, and make a serious commitment to, taking forward a ""One Health"" global network for proactive surveillance, rapid detection, and prevention of MERS-CoV and other epidemic infectious diseases threats.",,"['Zumla, Alimuddin', 'Alagaili, Abdulaziz N', 'Cotten, Matthew', 'Azhar, Esam I']","['Zumla A', 'Alagaili AN', 'Cotten M', 'Azhar EI']","['Division of Infection and Immunity, University College London, London, UK. a.zumla@ucl.ac.uk.', 'NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK. a.zumla@ucl.ac.uk.', 'KSU Mammals Research Chair, Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia.', 'Viroscience Department, Erasmus Medical Center, Rotterdam, Netherlands.', 'Special Infectious Agents Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.']",['eng'],['Editorial'],20160907,England,BMC Med,BMC medicine,101190723,IM,"['Attention', 'Communicable Diseases/epidemiology/transmission', 'Communicable Diseases, Emerging/epidemiology/prevention & control/transmission', 'Coronavirus Infections/*epidemiology/*prevention & control/transmission', 'Disease Outbreaks/*prevention & control', 'Epidemics/*prevention & control', '*Global Health', 'Humans', '*Middle East Respiratory Syndrome Coronavirus/isolation & purification', 'Saudi Arabia/epidemiology', 'Travel']",PMC5015245,['NOTNLM'],"['Control', 'Epidemic transmission', 'Hajj', 'Infectious diseases', 'MERS-CoV', 'Mass gathering']",2016/09/09 06:00,2017/05/27 06:00,['2016/09/09 06:00'],"['2016/09/01 00:00 [received]', '2016/09/06 00:00 [accepted]', '2016/09/09 06:00 [entrez]', '2016/09/09 06:00 [pubmed]', '2017/05/27 06:00 [medline]']","['10.1186/s12916-016-0686-3 [pii]', '686 [pii]', '10.1186/s12916-016-0686-3 [doi]']",epublish,BMC Med. 2016 Sep 7;14(1):132. doi: 10.1186/s12916-016-0686-3.,,,,,,,['MC_UU_12014/12/MRC_/Medical Research Council/United Kingdom'],,,,,,,,,,
5533147,NLM,MEDLINE,19710401,20041117,0032-6518 (Print) 0032-6518 (Linking),205,228,1970 Oct,Advances in the treatment of infectious diseases.,514-22,,,,"['Christie, A B']",['Christie AB'],,['eng'],"['Journal Article', 'Review']",,England,Practitioner,The Practitioner,0404245,IM,"['Adolescent', 'Anti-Bacterial Agents/therapeutic use', 'Child, Preschool', 'Communicable Diseases/drug therapy/*therapy', 'Hepatitis B Antigens', 'Humans']",,,,1970/10/01 00:00,1970/10/01 00:01,['1970/10/01 00:00'],"['1970/10/01 00:00 [pubmed]', '1970/10/01 00:01 [medline]', '1970/10/01 00:00 [entrez]']",,ppublish,Practitioner. 1970 Oct;205(228):514-22.,,,"['0 (Anti-Bacterial Agents)', '0 (Hepatitis B Antigens)']",,,32,,,,,,,,,,,
18877641,NLM,MEDLINE,20081021,20201005,0025-8458 (Print) 0025-8458 (Linking),43,11-12,1948 Jun,"[To carry out the reporting obligation, secretion and disinfection for infectious diseases].",336,,,,"['SAUER, W']",['SAUER W'],,['ger'],['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,OM,['Communicable Diseases/*legislation & jurisprudence'],,['NLM'],['*COMMUNICABLE DISEASES/legislation'],1948/06/01 00:00,2008/10/24 09:00,['1948/06/01 00:00'],"['1948/06/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/06/01 00:00 [entrez]']",,ppublish,Med Klin. 1948 Jun;43(11-12):336.,,,,,,,,,"Zur Durchfuhrung der Meldepflicht, Absonderung und Desinfektion bei ansteckenden Krankheiten.",,,['CLML: 4815:918r'],,,,,
18578017,NLM,MEDLINE,20080915,20220310,1469-3178 (Electronic) 1469-221X (Print) 1469-221X (Linking),9 Suppl 1,Suppl 1,2008 Jul,Pricing infectious disease. The economic and health implications of infectious diseases.,S13-7,10.1038/embor.2008.110 [doi],,,"['Fonkwo, Peter Ndeboc']",['Fonkwo PN'],['peterfonkwo@yahoo.com'],['eng'],['Journal Article'],,England,EMBO Rep,EMBO reports,100963049,IM,"['Animals', 'Communicable Disease Control/economics', 'Communicable Diseases/*economics/transmission', 'Developing Countries', 'Humans', 'Public Health/*economics', 'Sexual Behavior']",PMC3327542,,,2008/07/17 09:00,2008/09/16 09:00,['2008/07/17 09:00'],"['2008/07/17 09:00 [pubmed]', '2008/09/16 09:00 [medline]', '2008/07/17 09:00 [entrez]']","['embor2008110 [pii]', '10.1038/embor.2008.110 [doi]']",ppublish,EMBO Rep. 2008 Jul;9 Suppl 1(Suppl 1):S13-7. doi: 10.1038/embor.2008.110.,,,,,,,,,,,,,,,,,
24329938,NLM,MEDLINE,20140829,20181203,1469-0691 (Electronic) 1198-743X (Linking),20,2,2014 Feb,Systematic reviews and meta-analyses in infectious diseases: topics that merit special attention.,101-4,10.1111/1469-0691.12497 [doi],"As in other disciplines in medicine, systematic reviews (SR) and meta-analyses (MA) in infectious diseases are an important aid to clinical decision-making. In the present article we review features important to SRs in infectious diseases that should be addressed in most SRs and MAs. We stress the need to include in the SR analysis all patients that were randomized; and all studies that were performed. Authors of SRs should choose one main outcome that matters to patients, and base their conclusions mainly on this outcome. Resistance as an outcome is a topic that should be addressed in all SRs of antibiotic treatment. Ethical aspects and especially patients' safety should be addressed in SRs.","['(c) 2013 The Authors Clinical Microbiology and Infection (c) 2013 European Society of', 'Clinical Microbiology and Infectious Diseases.']","['Leibovici, L', 'Yahav, D', 'Paul, M']","['Leibovici L', 'Yahav D', 'Paul M']","['Department of Medicine E, Rabin Medical Centre, Beilinson Hospital, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.']",['eng'],"['Editorial', 'Meta-Analysis', 'Review', 'Systematic Review']",,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Decision Making', 'Drug Resistance, Bacterial', 'Humans', '*Meta-Analysis as Topic', '*Review Literature as Topic']",,['NOTNLM'],"['Ethics', 'meta-analysis', 'outcomes', 'resistance', 'systematic review']",2013/12/18 06:00,2014/08/30 06:00,['2013/12/17 06:00'],"['2013/12/17 06:00 [entrez]', '2013/12/18 06:00 [pubmed]', '2014/08/30 06:00 [medline]']","['S1198-743X(14)60042-2 [pii]', '10.1111/1469-0691.12497 [doi]']",ppublish,Clin Microbiol Infect. 2014 Feb;20(2):101-4. doi: 10.1111/1469-0691.12497.,,,,,,,,,,,,,,,,,
2673938,NLM,MEDLINE,19891026,20051116,0016-867X (Print) 0016-867X (Linking),44 Suppl A,,1989 Aug,Infectious diseases in the elderly: an overview.,4-6,,The elderly represent the fastest growing portion of the population. Aspects of the normal aging process combined with chronic diseases place the elderly at increased risk for infection. This overview will discuss the most common infectious diseases in the elderly and some approaches to the prevention and treatment of these infections.,,"['Meyers, B R']",['Meyers BR'],"['Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10029.']",['eng'],"['Journal Article', 'Review']",,United States,Geriatrics,Geriatrics,2985102R,IM,"['Aged', 'Aged, 80 and over', 'Aging/*metabolism', 'Anti-Bacterial Agents/*pharmacokinetics', '*Communicable Diseases/drug therapy/etiology/immunology', 'Cross Infection/drug therapy/etiology/immunology', 'Humans', 'Nursing Homes']",,,,1989/08/01 00:00,1989/08/01 00:01,['1989/08/01 00:00'],"['1989/08/01 00:00 [pubmed]', '1989/08/01 00:01 [medline]', '1989/08/01 00:00 [entrez]']",,ppublish,Geriatrics. 1989 Aug;44 Suppl A:4-6.,,,['0 (Anti-Bacterial Agents)'],,,16,,,,,,,,,,,
7525858,NLM,MEDLINE,19941206,20151119,0015-4148 (Print) 0015-4148 (Linking),81,8,1994 Aug,Probing for answers. Use of DNA probes in infectious diseases.,543-5,,"Diagnostic molecular biology is at the forefront in the diagnosis of infectious diseases. Through the use of deoxyribonucleic acid (DNA) probes in conjunction with other molecular techniques such as polymerase chain reaction (PCR), physicians will be able to more rapidly and accurately diagnose causative agents in a variety of infectious diseases. This article will focus on the molecular basis of these techniques, how they may aid the physician in patient diagnosis, and the shortcomings of this new and exciting technology.",,"['Sinnott, J T 4th', 'Ragsdale, R', 'Bergen, G A', 'Padios, M M']","['Sinnott JT 4th', 'Ragsdale R', 'Bergen GA', 'Padios MM']","['Division of Infectious Diseases and Tropical Medicine, University of South Florida College of Medicine, Tampa.']",['eng'],['Journal Article'],,United States,J Fla Med Assoc,The Journal of the Florida Medical Association,7505604,IM,"['Communicable Diseases/*diagnosis/genetics', 'DNA/analysis', '*DNA Probes', 'Humans', 'Molecular Biology', 'Polymerase Chain Reaction', 'RNA/analysis']",,,,1994/08/01 00:00,2001/03/28 10:01,['1994/08/01 00:00'],"['1994/08/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1994/08/01 00:00 [entrez]']",,ppublish,J Fla Med Assoc. 1994 Aug;81(8):543-5.,,,"['0 (DNA Probes)', '63231-63-0 (RNA)', '9007-49-2 (DNA)']",,,,,,,,,,,,,,
24547658,NLM,MEDLINE,20140313,20190923,0253-1933 (Print) 0253-1933 (Linking),32,2,2013 Aug,Development of improved analytical methods for use in animal health and in foodborne disease surveillance for source attribution.,549-58,,"Considering the 'One Health' principles, the links between animal and human health are very strong. Both domestic and wild animals are sources of infectious agents that cause diseases in humans. Poor animal health may also indirectly affect human health, through reduced access to food. A large number of infectious diseases of animals, the transboundary animal diseases, spread rapidly across borders. Robust and accurate diagnostic assays are needed to detect the infectious agents rapidly and to limit their spread. A large arsenal of novel assays has been developed during the last three decades, with a tremendous impact on the detection of infectious agents. The new diagnostic methods are mostly laboratory-based and expensive, requiring sophisticated equipment and special skills. However, rapid and cheap field-based assays have also been developed. Herein, the authors give several examples of the development of novel assays, with special focus on the 'One Health' principles.",,"['Widen, F', 'Leijon, M', 'Olsson Engvall, E', 'Muradrasoli, S', 'Munir, M', 'Belak, S']","['Widen F', 'Leijon M', 'Olsson Engvall E', 'Muradrasoli S', 'Munir M', 'Belak S']","['Department of Virology, Immunobiology and Parasitology, National Veterinary Institute, Trawagen 22, 75189 Uppsala, Sweden. frederik.widen@sva.se', 'Department of Virology, Immunobiology and Parasitology, National Veterinary Institute, Trawagen 22, 75189 Uppsala, Sweden.', 'Department of Bacteriology, European Union Reference Laboratory for Campylobacter, National Veterinary Institute, Trawagen 22, 75189 Uppsala, Sweden.', 'Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, P.O. Box 7036, 75007 Uppsala, Sweden.', 'Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, P.O. Box 7036, 75007 Uppsala, Sweden.', 'Department of Virology, Immunobiology and Parasitology, National Veterinary Institute, Trawagen 22, 75189 Uppsala, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animal Diseases/*epidemiology', 'Animals', 'Communicable Diseases/epidemiology/microbiology/*veterinary/virology', 'Foodborne Diseases/*epidemiology', 'Global Health', 'Humans', 'Population Surveillance']",,,,2014/02/20 06:00,2014/03/14 06:00,['2014/02/20 06:00'],"['2014/02/20 06:00 [entrez]', '2014/02/20 06:00 [pubmed]', '2014/03/14 06:00 [medline]']",['10.20506/rst.32.2.2240 [doi]'],ppublish,Rev Sci Tech. 2013 Aug;32(2):549-58. doi: 10.20506/rst.32.2.2240.,,,,,,,,,,,,,,,,,
14481884,NLM,MEDLINE,19981101,20181201,0016-5557 (Print) 0016-5557 (Linking),(Special),,1956-1961,"[Therapeutic assessment, 1956-1961. Infectious diseases].",115-28,,,,"['OLMER, J', 'CASANOVA, P']","['OLMER J', 'CASANOVA P']",,['fre'],['Journal Article'],,France,Gaz Med Fr,Gazette medicale de France,0034270,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1956/01/01 00:00,1956/01/01 00:01,['1956/01/01 00:00'],"['1956/01/01 00:00 [pubmed]', '1956/01/01 00:01 [medline]', '1956/01/01 00:00 [entrez]']",,ppublish,Gaz Med Fr. 1956-1961;(Special):115-28.,,,,,,,,,,,,,,,,,
10705794,NLM,MEDLINE,20000404,20091119,0035-3655 (Print) 0035-3655 (Linking),120,1,2000 Jan,[Is there a role for infectious disease specialists in private practice?].,59-64,,"For the last 20 years infectious diseases have gained increasing importance for hospital medicine. As a specialty, infectious diseases have been recognized only recently by the Swiss medical association. However, the precise role of infectious disease specialist operating in private practice remain to be defined. The medical community faces many challenges for which infectious disease specialist must provide answers. Knowledge in microbiology has progressed enormously and many very sophisticated and, partly, expensive diagnostic techniques are widely available. New treatment options are introduced while numerous microbial species demonstrate increasing resistance to antimicrobial agents. The intervention of infectious disease specialist could thus contribute to optimize treatment and limit the use of economic resources. Infectious disease specialist in private practice are also facing new activities such as parenteral outpatient treatment for severe infections and HIV infection, which clearly require a specialized professional approach. Infectious disease specialist in private practice will need great care to find a responsible equilibrium between clinical consultation and telephone consultation.",,"['Erard, P']",['Erard P'],,['fre'],"['English Abstract', 'Journal Article']",,Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,IM,"['*Communicable Diseases/epidemiology/therapy', 'Humans', '*Medicine', '*Private Practice', '*Specialization', 'Switzerland']",,,,2000/03/08 00:00,2000/03/08 00:01,['2000/03/08 00:00'],"['2000/03/08 00:00 [pubmed]', '2000/03/08 00:01 [medline]', '2000/03/08 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 2000 Jan;120(1):59-64.,,,,,,,,,Un role pour l'infectiologue en pratique privee?,,,,,,,,
14371201,NLM,MEDLINE,20030501,20181201,0032-5481 (Print) 0032-5481 (Linking),17,3,1955 Mar,Diagnosis of infectious diseases.,A-66-8,,,,"['SANFORD, A H']",['SANFORD AH'],,['eng'],['Journal Article'],,England,Postgrad Med,Postgraduate medicine,0401147,OM,"['Communicable Diseases/*diagnosis', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1955/03/01 00:00,1955/03/01 00:01,['1955/03/01 00:00'],"['1955/03/01 00:00 [pubmed]', '1955/03/01 00:01 [medline]', '1955/03/01 00:00 [entrez]']",,ppublish,Postgrad Med. 1955 Mar;17(3):A-66-8.,,,,,,,,,,,,['CLML: 5528:22046:151'],,,,,
21706925,NLM,MEDLINE,20111004,20110628,0125-1562 (Print) 0125-1562 (Linking),42,3,2011 May,The Armed Forces Research Institute of Medical Sciences: five decades of collaborative medical research.,477-90,,"The Armed Forces Research Institute of Medical Sciences (AFRIMS) is a 50-year-old joint institute of the US and Royal Thai Army Medical Departments located in Bangkok, Thailand. Investigators from the Institute have carried out research in Thailand and the region, in collaboration with many partners, focused on a large number of tropical infectious diseases. In celebration of the 50th anniversary, this paper summarizes highlights of this research, focusing on malaria, Japanese encephalitis, dengue, diarrhea and HIV. In addition, research done in support of the medical problems of refugees and of the health of Thai peace-keeping forces are summarized. The research carried out by AFRIMS and added to the scientific literature has contributed significantly to advancement in multiple areas of tropical infectious disease.",,"['Brown, Arthur', 'Nitayaphan, Sorachai']","['Brown A', 'Nitayaphan S']","['US Army Medical Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand. Arthur.Brown@afrims.org']",['eng'],"['Historical Article', 'Journal Article']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,IM,"['Academies and Institutes/history', 'Biomedical Research/*history', 'Communicable Diseases/diagnosis/*history/therapy/transmission', 'Cooperative Behavior', 'History, 20th Century', 'History, 21st Century', 'Humans', 'International Cooperation/history', 'Military Medicine/history', 'Thailand', 'United States']",,,,2011/06/29 06:00,2011/10/05 06:00,['2011/06/29 06:00'],"['2011/06/29 06:00 [entrez]', '2011/06/29 06:00 [pubmed]', '2011/10/05 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2011 May;42(3):477-90.,,,,,,,,,,,,,,,,,
16419905,NLM,MEDLINE,20060223,20061115,0035-2640 (Print) 0035-2640 (Linking),55,18,2005 Nov 30,[Infectious diseases risk management].,2003-13,,"Surveillance activities first target health problems for which treatment, effective prevention or control measures are available. The data produced by surveillance systems allow prioritising public health actions and defining the objectives of infectious diseases control or prevention. The surveillance of infectious diseases relies on a large number of partners grouped in a public health network in which clinicians have a prominent role. In France, the surveillance of infectious diseases is based on mandatory notification of some diseases, national reference centers, networks of voluntary health professionals and repeated surveys, alerting health authorities in case of threats and identifying the determinants of changes in the population health's status. At hospital, the infectious risk is significant and the risk of epidemic outbreaks very high. A solid system for surveillance is mandatory. An educational program is needed to define the prevention program based on the use of hand disinfection and other standard precautions, antiviral and pneumococcal vaccination. A strong cooperation between general practitioners, healthcare team and relatives is necessary.",,"['Salomon, Jerome', 'Guillemot, Didier', 'Bernard, Louis', 'Perronne, Christian']","['Salomon J', 'Guillemot D', 'Bernard L', 'Perronne C']","['Departement de medecine aigue specialisee, unite des maladies infectieuses, CHU Raymond Poincare (AP-HP), Faculte de medecine Paris lie-de-France Ouest, Universite de Versailles, Garches. jerome.salomon@rpc.aphp.fr']",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Rev Prat,La Revue du praticien,0404334,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Disease Control/*methods', 'Communicable Diseases/drug therapy/epidemiology/transmission', 'Disease Outbreaks/*prevention & control', 'Drug Utilization/statistics & numerical data', 'France/epidemiology', 'Humans', 'Population Surveillance', '*Risk Management']",,,,2006/01/20 09:00,2006/02/24 09:00,['2006/01/20 09:00'],"['2006/01/20 09:00 [pubmed]', '2006/02/24 09:00 [medline]', '2006/01/20 09:00 [entrez]']",,ppublish,Rev Prat. 2005 Nov 30;55(18):2003-13.,,,['0 (Anti-Bacterial Agents)'],,,16,,,La gestion do risque infectieux.,,,,,,,,
10762104,NLM,MEDLINE,20000712,20190905,0163-4453 (Print) 0163-4453 (Linking),40,1,2000 Jan,Introduction to the mini-review series on emerging infectious diseases.,2,,,,"['Wilkins, E']",['Wilkins E'],,['eng'],['Editorial'],,England,J Infect,The Journal of infection,7908424,IM,"['Communicable Diseases/*epidemiology/microbiology', 'Drug Resistance, Microbial', 'HIV Infections/*epidemiology/virology', 'Humans']",,,,2000/04/13 09:00,2000/07/15 11:00,['2000/04/13 09:00'],"['2000/04/13 09:00 [pubmed]', '2000/07/15 11:00 [medline]', '2000/04/13 09:00 [entrez]']","['S0163445399906230 [pii]', '10.1053/jinf.1999.0623 [doi]']",ppublish,J Infect. 2000 Jan;40(1):2. doi: 10.1053/jinf.1999.0623.,,,,,,,,,,,,,,,,,
23092558,NLM,MEDLINE,20130411,20211021,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),18,11,2012 Nov,"Infectious disease mortality rates, Thailand, 1958-2009.",1794-801,10.3201/eid1811.120637 [doi],"To better define infectious diseases of concern in Thailand, trends in the mortality rate during 1958-2009 were analyzed by using data from public health statistics reports. From 1958 to the mid-1990s, the rate of infectious disease-associated deaths declined 5-fold (from 163.4 deaths/100,000 population in 1958 to 29.5/100,000 in 1997). This average annual reduction of 3.2 deaths/100,000 population was largely attributed to declines in deaths related to malaria, tuberculosis, pneumonia, and gastrointestinal infections. However, during 1998-2003, the mortality rate increased (peak of 70.0 deaths/100,000 population in 2003), coinciding with increases in mortality rate from AIDS, tuberculosis, and pneumonia. During 2004-2009, the rate declined to 41.0 deaths/100,000 population, coinciding with a decrease in AIDS-related deaths. The emergence of AIDS and the increase in tuberculosis- and pneumonia-related deaths in the late twentieth century emphasize the need to direct resources and efforts to the control of emerging and re-emerging infectious diseases.",,"['Aungkulanon, Suchunya', 'McCarron, Margaret', 'Lertiendumrong, Jongkol', 'Olsen, Sonja J', 'Bundhamcharoen, Kanitta']","['Aungkulanon S', 'McCarron M', 'Lertiendumrong J', 'Olsen SJ', 'Bundhamcharoen K']","['International Health Policy Program (IHPP), Nonthaburi, Thailand. suchunya@ihpp.thaigov.net']",['eng'],"['Historical Article', 'Journal Article']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/epidemiology/history/*mortality', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Population Surveillance', 'Thailand/epidemiology']",PMC3559154,,,2012/10/25 06:00,2013/04/12 06:00,['2012/10/25 06:00'],"['2012/10/25 06:00 [entrez]', '2012/10/25 06:00 [pubmed]', '2013/04/12 06:00 [medline]']","['12-0637 [pii]', '10.3201/eid1811.120637 [doi]']",ppublish,Emerg Infect Dis. 2012 Nov;18(11):1794-801. doi: 10.3201/eid1811.120637.,,,,,,,,,,,,,,,,,
16532294,NLM,MEDLINE,20061130,20181113,0165-5701 (Print) 0165-5701 (Linking),25,5-6,2004 Oct-Dec,Oculo-renal disorders in infectious diseases.,299-319,,"BACKGROUND: The aim of this article is to review the potential ocular and renal disorders in infectious diseases to which humans are susceptible and to determine prevalence of these diseases. METHODS: Published cases of oculo-renal disorders associated with various infectious diseases were collected from the international literature by searching the MEDLINE database (PUBMED 1970-2004) for original reports and review articles published in English. Citations from papers retrieved were screened and retrieved papers were evaluated. RESULTS: Based on the screened data, we propose a practical, structure-oriented checklist of such lesions divided into bacterial, viral, parasital, and fugal infections. CONCLUSION: The oculorenal manifestations of infectious diseases may be flagrant or subtle. Awareness of the signs and symptoms of infections allows early recognition and prompt, appropriate management. The clinical presentation and relative frequency of those manifestations are reviewed.",,"['Izzedine, Hassane', 'Buhaescu, Irina', 'Bodaghi, Bahram', 'Martinez, Valerie', 'Caumes, Eric', 'Lehoang, Phuc', 'Deray, Gilbert']","['Izzedine H', 'Buhaescu I', 'Bodaghi B', 'Martinez V', 'Caumes E', 'Lehoang P', 'Deray G']","['Department of Nephrology, Pitie-Salpetriere Hospital, Paris, France. hassan.izzedine@psl.ap-hop-paris.fr']",['eng'],"['Journal Article', 'Review']",20060307,Netherlands,Int Ophthalmol,International ophthalmology,7904294,IM,"['Anti-Bacterial Agents/therapeutic use', 'Clinical Trials as Topic', 'Communicable Diseases/*complications/diagnosis/drug therapy', 'Eye Infections/diagnosis/drug therapy/*microbiology', 'Humans', 'Kidney Diseases/diagnosis/drug therapy/*microbiology']",,,,2006/03/15 09:00,2006/12/09 09:00,['2006/03/15 09:00'],"['2004/03/30 00:00 [received]', '2005/11/01 00:00 [accepted]', '2006/03/15 09:00 [pubmed]', '2006/12/09 09:00 [medline]', '2006/03/15 09:00 [entrez]']",['10.1007/s10792-005-4833-7 [doi]'],ppublish,Int Ophthalmol. 2004 Oct-Dec;25(5-6):299-319. doi: 10.1007/s10792-005-4833-7. Epub 2006 Mar 7.,,,['0 (Anti-Bacterial Agents)'],,,158,,,,,,,,,,,
23339016,NLM,MEDLINE,20131022,20211021,1435-4373 (Electronic) 0934-9723 (Print) 0934-9723 (Linking),32,6,2013 Jun,"Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases.",723-8,10.1007/s10096-013-1813-0 [doi],"In recent years we have observed great advances in our ability to combat infectious diseases. Through the development of novel genetic methodologies, including a better understanding of pathogen biology, pathogenic mechanisms, advances in vaccine development, designing new therapeutic drugs, and optimization of diagnostic tools, significant infectious diseases are now better controlled. Here, we briefly describe recent reports in the literature concentrating on infectious disease control. The focus of this review is to describe the molecular methods widely used in the diagnosis, prevention, and control of infectious diseases with regard to the innovation of molecular techniques. Since the list of pathogenic microorganisms is extensive, we emphasize some of the major human infectious diseases (AIDS, tuberculosis, malaria, rotavirus, herpes virus, viral hepatitis, and dengue fever). As a consequence of these developments, infectious diseases will be more accurately and effectively treated; safe and effective vaccines are being developed and rapid detection of infectious agents now permits countermeasures to avoid potential outbreaks and epidemics. But, despite considerable progress, infectious diseases remain a strong challenge to human survival.",,"['Franca, R F O', 'da Silva, C C', 'De Paula, S O']","['Franca RF', 'da Silva CC', 'De Paula SO']","['Department of Pharmacology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Avenida dos Bandeirantes 3900, Ribeirao Preto, SP, 14049-900, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130122,Germany,Eur J Clin Microbiol Infect Dis,European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,8804297,IM,"['*Communicable Disease Control', 'Communicable Diseases/*diagnosis/therapy', 'Humans', '*Molecular Diagnostic Techniques', 'Vaccines/immunology/therapeutic use']",PMC7087945,,,2013/01/23 06:00,2013/10/23 06:00,['2013/01/23 06:00'],"['2012/11/26 00:00 [received]', '2013/01/01 00:00 [accepted]', '2013/01/23 06:00 [entrez]', '2013/01/23 06:00 [pubmed]', '2013/10/23 06:00 [medline]']","['1813 [pii]', '10.1007/s10096-013-1813-0 [doi]']",ppublish,Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):723-8. doi: 10.1007/s10096-013-1813-0. Epub 2013 Jan 22.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
10929170,NLM,MEDLINE,20000811,20190619,0003-4819 (Print) 0003-4819 (Linking),133,4,2000 Aug 15,Update in infectious diseases.,285-92,,,,"['Bartlett, J G']",['Bartlett JG'],"['Division of Infectious Diseases, Baltimore, MD 21205, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Communicable Diseases/*drug therapy/microbiology', 'Community-Acquired Infections/drug therapy', 'Drug Resistance, Microbial', 'HIV Infections/drug therapy', 'Humans', 'Pneumonia, Bacterial/drug therapy']",,,,2000/08/06 00:00,2000/08/06 00:01,['2000/08/06 00:00'],"['2000/08/06 00:00 [pubmed]', '2000/08/06 00:01 [medline]', '2000/08/06 00:00 [entrez]']","['200008150-00013 [pii]', '10.7326/0003-4819-133-4-200008150-00013 [doi]']",ppublish,Ann Intern Med. 2000 Aug 15;133(4):285-92. doi: 10.7326/0003-4819-133-4-200008150-00013.,,,,,['Ann Intern Med. 2001 Jul 3;135(1):64. PMID: 11434743'],17,,,,,,,,,,,
25969964,NLM,MEDLINE,20160324,20160511,1945-0257 (Electronic) 1945-0257 (Linking),19,5,2015 May,Expanding the Scope of our Journal to Include Molecular Diagnostics for Infectious Diseases.,225,10.1089/gtmb.2015.28999.gde [doi],,,"['Ehrlich, Garth D']",['Ehrlich GD'],"['Center for Genomic Sciences and Center for Advanced Microbial Processing, Institute of Molecular Medicine and Infectious Disease, Department of Microbiology and Immunology, Drexel College of Medicine, Philadelphia, Pennsylvania.']",['eng'],['Editorial'],,United States,Genet Test Mol Biomarkers,Genetic testing and molecular biomarkers,101494210,IM,"['Communicable Diseases/*diagnosis/genetics', 'Humans', 'Pathology, Molecular', 'Periodicals as Topic']",,,,2015/05/15 06:00,2016/03/25 06:00,['2015/05/14 06:00'],"['2015/05/14 06:00 [entrez]', '2015/05/15 06:00 [pubmed]', '2016/03/25 06:00 [medline]']",['10.1089/gtmb.2015.28999.gde [doi]'],ppublish,Genet Test Mol Biomarkers. 2015 May;19(5):225. doi: 10.1089/gtmb.2015.28999.gde.,,,,,,,,,,,,,,,,,
3727384,NLM,MEDLINE,19860814,20031114,0324-1068 (Print) 0324-1068 (Linking),23,3,1986,[Problems in studying infectious diseases in animals being raised commercially].,3-8,,,,"['Zhelev, V']",['Zhelev V'],,['bul'],['Journal Article'],,Bulgaria,Vet Med Nauki,Veterinarno-meditsinski nauki,0414760,IM,"['Animal Diseases/immunology/*prevention & control', '*Animal Husbandry', 'Animals', 'Animals, Domestic', 'Bulgaria', 'Communicable Disease Control', 'Communicable Diseases/immunology/*veterinary', 'Research', 'USSR']",,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Vet Med Nauki. 1986;23(3):3-8.,,,,,,,,,Vurkhu niakoi problemi po izuchavaneto na infektsioznite zaboliavaniia po zhivotnite pri promishlenoto im otglezhdane.,,,,,,,,
19194609,NLM,MEDLINE,20091113,20141120,0716-1018 (Print) 0716-1018 (Linking),25,6,2008 Dec,[Climate change and infectious diseases. A novel epidemiological scenario].,447-52,,"For the international scientific community, it is undoubted that planetary temperature is increasing, being projected an average raise of 1.0 degrees C-3.5 degrees C by the year 2100. Forecasted consequences are diverse, most of them adverse for human health, including the establishment of favorable epidemiological scenarios for the emergence and reemergence of infectious diseases. The present article summarizes the available evidence regarding the mechanisms that promote climate change, its environmental effects and its consequences on human health. In order to accomplish this objective, demonstrated changes in the dynamics of zoonotic, vectorial, food and water-borne diseases are described. The position of Chile in the international community is commented, as well as multiple pending challenges, among which outstands the importance of incorporating professionals that work in the health sector to the national debate.",,"['Cerda L, Jaime', 'Valdivia C, Gonzalo', 'Valenzuela B, M Teresa', 'Venegas L, Jairo']","['Cerda L J', 'Valdivia C G', 'Valenzuela B MT', 'Venegas L J']",['Pontificia Universidad Catolica de Chile. Facultad de Medicina Departamento de Salud Publica. jcerda@med.puc.cl'],['spa'],"['English Abstract', 'Journal Article']",20090129,Chile,Rev Chilena Infectol,Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,9305754,IM,"['Chile', '*Climate', '*Communicable Diseases/epidemiology/etiology/transmission', 'Global Health', '*Hot Temperature', 'Humans', 'Risk Assessment']",,,,2009/02/06 09:00,2009/11/17 06:00,['2009/02/06 09:00'],"['2009/02/06 09:00 [entrez]', '2009/02/06 09:00 [pubmed]', '2009/11/17 06:00 [medline]']",['S0716-10182008000600006 [pii]'],ppublish,Rev Chilena Infectol. 2008 Dec;25(6):447-52. Epub 2009 Jan 29.,,,,,,,,,Cambio climatico y enfermedades infecciosas. Un nuevo escenario epidemiologico.,,,,,,,,
32327045,NLM,MEDLINE,20200922,20200922,1558-4232 (Electronic) 1094-9194 (Linking),23,2,2020 May,Updates on Selected Emerging Infectious Diseases of Ornamental Fish.,413-428,S1094-9194(20)30004-9 [pii] 10.1016/j.cvex.2020.01.004 [doi],"Emerging infectious diseases of ornamental fish are discussed with special focus on clinical relevance, detection, and treatment, where applicable. Important emerging infectious diseases of fish include goldfish herpesvirus, koi herpesvirus, carp edema virus, Erysipelothrix, Edwardsiella ictaluri, Edwardseilla piscicida, and Francisella. Some diseases are more species or genus specific, but many emerging diseases do not seem to have a species preference and affect a variety of species worldwide. Proper husbandry and biosecurity with a disease detection plan for ornamental fish is essential to monitor and prevent future outbreaks.",['Copyright (c) 2020 Elsevier Inc. All rights reserved.'],"['McDermott, Colin', 'Palmeiro, Brian']","['McDermott C', 'Palmeiro B']","['Zodiac Pet and Exotic Hospital, Victoria Centre, Shop 101A, 1/F, 15 Watson Road, Fortress Hill, Hong Kong. Electronic address: Cmcd.vmd@gmail.com.', 'Lehigh Valley Veterinary Dermatology & Fish Hospital, Pet Fish Doctor, 4580 Crackersport Road, Allentown, PA 18104, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Exot Anim Pract,The veterinary clinics of North America. Exotic animal practice,9815628,IM,"['Animals', 'Communicable Diseases, Emerging/epidemiology/prevention & control/*veterinary', 'Fish Diseases/*epidemiology/prevention & control', 'Fishes', 'Species Specificity']",,['NOTNLM'],"['Carp edema virus', 'Edwardsiella', 'Erysipelothrix', 'Francisella', 'Goldfish herpesvirus', 'Koi herpesvirus']",2020/04/25 06:00,2020/09/23 06:00,['2020/04/25 06:00'],"['2020/04/25 06:00 [entrez]', '2020/04/25 06:00 [pubmed]', '2020/09/23 06:00 [medline]']","['S1094-9194(20)30004-9 [pii]', '10.1016/j.cvex.2020.01.004 [doi]']",ppublish,Vet Clin North Am Exot Anim Pract. 2020 May;23(2):413-428. doi: 10.1016/j.cvex.2020.01.004.,['Disclosure The authors have nothing to disclose.'],,,,,,,,,,,,,,,,
26656834,NLM,MEDLINE,20161020,20200605,1567-7257 (Electronic) 1567-1348 (Print) 1567-1348 (Linking),38,,2016 Mar,Interaction of the role of Concentrated Animal Feeding Operations (CAFOs) in Emerging Infectious Diseases (EIDS).,44-46,S1567-1348(15)30067-8 [pii] 10.1016/j.meegid.2015.12.002 [doi],"Most significant change in the evolution of the influenza virus is the rapid growth of the Concentrated Animal Feeding Operations (CAFOs) on a global scale. These industrial agricultural operations have the potential of housing thousands of animals in a relatively small area. Emerging Infectious Diseases (EIDs) event can be considered as a shift in the pathogen-host-environment interplay characteristics described by Engering et al. (2013). These changes in the host-environment and the disease ecology are key to creating novel transmission patterns and selection of novel pathogens with a modification of genetic traits. With the development of CAFOs throughout the world, the need for training of animal caretakers to observe, identify, treat, vaccinate and cull if necessary is important to safeguard public health. The best defense against another pandemic of Emerging Infectious Diseases (EIDs) is the constant monitoring of the livestock and handlers of CAFOs and the live animal markets. These are the most likely epicenter of the next pandemic.",['Copyright (c) 2015 Elsevier B.V. All rights reserved.'],"['Hollenbeck, James E']",['Hollenbeck JE'],"['Indiana University Southeast, New Albany, IN 47150, United States. Electronic address: jehollen@ius.edu.']",['eng'],['Journal Article'],20151202,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['*Agriculture', '*Animal Feed', 'Animals', 'Communicable Diseases, Emerging/*epidemiology/*etiology/transmission', 'Environmental Exposure', '*Food Industry', 'Host-Pathogen Interactions', 'Humans']",PMC7106093,['NOTNLM'],"['Agricultural health and disease prevention', 'Airborne pathogens', 'Emerging Infectious Diseases (EIDs)', 'Environmental health']",2015/12/15 06:00,2016/10/21 06:00,['2015/12/15 06:00'],"['2015/07/12 00:00 [received]', '2015/11/30 00:00 [revised]', '2015/12/01 00:00 [accepted]', '2015/12/15 06:00 [entrez]', '2015/12/15 06:00 [pubmed]', '2016/10/21 06:00 [medline]']","['S1567-1348(15)30067-8 [pii]', '10.1016/j.meegid.2015.12.002 [doi]']",ppublish,Infect Genet Evol. 2016 Mar;38:44-46. doi: 10.1016/j.meegid.2015.12.002. Epub 2015 Dec 2.,,,,,,,,,,,,,,,,,
16092733,NLM,MEDLINE,20050929,20050811,1046-7041 (Print) 1046-7041 (Linking),16,3,2005 May-Jun,Infectious diseases of the 21st century and nursing care.,51,,,,"['Johnson, Ruth W']",['Johnson RW'],,['eng'],['Editorial'],,United States,ABNF J,"The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc",9112807,,"['Communicable Disease Control/*methods', 'Communicable Diseases/epidemiology/*nursing', 'Humans', ""*Nurse's Role"", 'Primary Prevention/*methods']",,,,2005/08/12 09:00,2005/09/30 09:00,['2005/08/12 09:00'],"['2005/08/12 09:00 [pubmed]', '2005/09/30 09:00 [medline]', '2005/08/12 09:00 [entrez]']",,ppublish,ABNF J. 2005 May-Jun;16(3):51.,,,,,,,,,,,,,,,,,
8114242,NLM,MEDLINE,19940331,20161017,0098-7484 (Print) 0098-7484 (Linking),271,11,1994 Mar 16,Infectious diseases in competitive sports.,862-7,,"OBJECTIVE: Participation in competitive sports is popular and widely encouraged throughout the United States. Reports of infectious disease outbreaks among competitive athletes and recent publicity regarding infectious disease concerns in sports underscore the need to better characterize the occurrence of these problems. DATA SOURCES: To identify reports of infectious diseases in sports, we performed a comprehensive search of the medical literature (MEDLINE) and newspaper databases in two on-line services (NEXIS and DIALOG PAPERS). STUDY SELECTION: Articles selected from the literature review included those describing cases or outbreaks of disease in which exposure to an infectious agent was likely to have occurred during training for competitive sports or during actual competition. Articles from the newspaper review included reports of outbreaks, exposures, or preventive measures that directly or indirectly involved teams or spectators. DATA SYNTHESIS: The literature review identified 38 reports of infectious disease outbreaks or other instances of transmission through person-to-person (24 reports), common-source (nine reports), or airborne (five reports) routes; the newspaper search identified 28 reports. Infectious agents included predominantly viruses but also a variety of fungi and gram-positive and gram-negative bacteria. CONCLUSIONS: Our findings indicate that strategies to prevent transmission of infectious diseases in sports must recognize risks at three levels: the individual athlete, the team, and spectators or others who may become exposed to infectious diseases as a result of sports-related activities. Team physicians and others who are responsible for the health of athletes should be especially familiar with the features of infectious diseases that occur in sports and measures for the prevention of these problems.",,"['Goodman, R A', 'Thacker, S B', 'Solomon, S L', 'Osterholm, M T', 'Hughes, J M']","['Goodman RA', 'Thacker SB', 'Solomon SL', 'Osterholm MT', 'Hughes JM']","['Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Ga 30333.']",['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology/transmission', 'Data Collection', '*Disease Outbreaks/prevention & control/statistics & numerical data', 'HIV Infections/transmission', 'Humans', 'Information Systems', 'MEDLINE', 'Newspapers as Topic', '*Sports/statistics & numerical data', 'United States']",,,,1994/03/16 00:00,1994/03/16 00:01,['1994/03/16 00:00'],"['1994/03/16 00:00 [pubmed]', '1994/03/16 00:01 [medline]', '1994/03/16 00:00 [entrez]']",,ppublish,JAMA. 1994 Mar 16;271(11):862-7.,,,,,['JAMA. 1994 Aug 10;272(6):436. PMID: 8040978'],,,,,,,,,,,,
24939908,NLM,MEDLINE,20150601,20140927,1537-6591 (Electronic) 1058-4838 (Linking),59,8,2014 Oct 15,Incorporating pathology in the practice of infectious disease: myths and reality.,1133-41,10.1093/cid/ciu469 [doi],"The role pathology plays in establishing or excluding infectious diseases has been established. However, as the practice of pathology has become subspecialized, there is not enough infectious disease specimen volume to have a pathologist dedicated full time to this crosscutting subspecialty. So, what are the myths and realities of a practicing infectious disease pathologist in the hospital setting? Infectious disease clinicians tend to consult pathologists when there are questions regarding terminology used in pathology reports; when there is the need to perform additional studies on formalin-fixed, paraffin-embedded tissues; and when there is an interest in seeing biopsies or resections obtained from patients and in obtaining photographs for presentations. Pathologists consult infectious disease pathologists when there is a need to review diverse inflammatory reactions; for identification of fungi, parasites, or unknown structures; to define the need to use special stains and other techniques in order to identify organisms in tissues that have been formalin fixed; and to help with terminology to be used in reports. This review explores in more detail why and how these consultations occur.","['(c) The Author 2014. Published by Oxford University Press on behalf of the', 'Infectious Diseases Society of America. All rights reserved. For Permissions,', 'please e-mail: journals.permissions@oup.com.']","['Guarner, Jeannette']",['Guarner J'],"['Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.']",['eng'],"['Journal Article', 'Review']",20140616,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Biopsy', 'Communicable Diseases/*diagnosis/*pathology', 'Humans', 'Pathology/*methods', 'Referral and Consultation']",,['NOTNLM'],"['infectious diseases', 'myths', 'pathology', 'practice', 'reality']",2014/06/19 06:00,2015/06/02 06:00,['2014/06/19 06:00'],"['2014/06/19 06:00 [entrez]', '2014/06/19 06:00 [pubmed]', '2015/06/02 06:00 [medline]']","['ciu469 [pii]', '10.1093/cid/ciu469 [doi]']",ppublish,Clin Infect Dis. 2014 Oct 15;59(8):1133-41. doi: 10.1093/cid/ciu469. Epub 2014 Jun 16.,,,,,['Pediatr Infect Dis J. 2015 Mar;34(3):303. PMID: 25901339'],,,,,,,,,,,,
18074063,NLM,MEDLINE,20080911,20200413,0021-7557 (Print) 0021-7557 (Linking),83,6,2007 Nov-Dec,Infectious diseases and daycare and preschool education.,574-5; author reply 575-6,10.2223/JPED.1734 [doi],,,"['Gurgel, Ricardo Queiroz', 'Correia, Jailson Barros']","['Gurgel RQ', 'Correia JB']",,['eng'],"['Comment', 'Letter']",,Brazil,J Pediatr (Rio J),Jornal de pediatria,2985188R,IM,"['*Child Day Care Centers', 'Child, Preschool', '*Communicable Diseases/epidemiology/transmission', 'Humans', 'Infant', 'Risk Factors']",,,,2007/12/13 09:00,2008/09/13 09:00,['2007/12/13 09:00'],"['2007/12/13 09:00 [pubmed]', '2008/09/13 09:00 [medline]', '2007/12/13 09:00 [entrez]']",['10.2223/JPED.1734 [doi]'],ppublish,J Pediatr (Rio J). 2007 Nov-Dec;83(6):574-5; author reply 575-6. doi: 10.2223/JPED.1734.,,,,,,,,['J Pediatr (Rio J). 2007 Jul-Aug;83(4):299-312. PMID: 17632670'],,,,,,,,,
25416751,NLM,MEDLINE,20160502,20200403,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),60,5,2015 Mar 1,The infectious diseases physician in the future of healthcare: not only about antibiotic prescribing.,773-6,10.1093/cid/ciu925 [doi],"The uncertainties of healthcare payment and delivery reform on income and care process have created a sense of foreboding, concern, and fear that a career in medicine is not what it used to be and that a career in infectious diseases in particular may no longer be viable. Fears have been raised that the need for infectious diseases consultation and management will be curtailed because we provide cognitive services that are not perceived as being needed in a health system filled with intensivists, hospitalists, and skilled nursing facility physicians. Now is the time for us to reframe our role in the health system that is evolving to a process of care focused on population health and patient safety that pays providers for value they bring to achieve those goals. Specific suggestions are made to enhance the infectious diseases physician's profile with the intent of encouraging debate, discussion, and action.","['(c) The Author 2014. Published by Oxford University Press on behalf of the', 'Infectious Diseases Society of America. All rights reserved. For Permissions,', 'please e-mail: journals.permissions@oup.com.']","['Nahass, Ronald G']",['Nahass RG'],"['ID Care, Hillsborough Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.']",['eng'],"['Case Reports', 'Journal Article']",20141120,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*drug therapy', 'Communicable Diseases, Emerging/drug therapy/prevention & control', 'Drug Prescriptions/*standards', 'Female', '*Health Facilities', 'Humans', 'Infection Control/methods', 'Male', '*Patient Safety', '*Physicians']",PMC7108033,['NOTNLM'],"['healthcare reform', 'image', 'infectious disease physician', 'value']",2014/11/25 06:00,2016/05/03 06:00,['2014/11/23 06:00'],"['2014/11/23 06:00 [entrez]', '2014/11/25 06:00 [pubmed]', '2016/05/03 06:00 [medline]']","['ciu925 [pii]', '10.1093/cid/ciu925 [doi]']",ppublish,Clin Infect Dis. 2015 Mar 1;60(5):773-6. doi: 10.1093/cid/ciu925. Epub 2014 Nov 20.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
13465553,NLM,MEDLINE,20000701,20190713,0032-5481 (Print) 0032-5481 (Linking),22,3,1957 Sep,Guides for clinical diagnosis of some infectious diseases.,240-5,,,,"['HOYNE, A L']",['HOYNE AL'],,['eng'],['Journal Article'],,England,Postgrad Med,Postgraduate medicine,0401147,OM,"['Communicable Diseases/*diagnosis', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1957/09/01 00:00,1957/09/01 00:01,['1957/09/01 00:00'],"['1957/09/01 00:00 [pubmed]', '1957/09/01 00:01 [medline]', '1957/09/01 00:00 [entrez]']",['10.1080/00325481.1957.11691901 [doi]'],ppublish,Postgrad Med. 1957 Sep;22(3):240-5. doi: 10.1080/00325481.1957.11691901.,,,,,,,,,,,,['CLML: 5833:8212:135'],,,,,
18114153,NLM,MEDLINE,20071227,20181201,0035-0362 (Print) 0035-0362 (Linking),33,6,1948 Dec,"[Directions and trends of therapy, infectious diseases].",374-8,,,,"['MEIRA, J A']",['MEIRA JA'],,['por'],['Journal Article'],,Brazil,Rev Paul Med,Revista paulista de medicina,0404326,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1948/12/01 00:00,2008/01/17 09:00,['1948/12/01 00:00'],"['1948/12/01 00:00 [pubmed]', '2008/01/17 09:00 [medline]', '1948/12/01 00:00 [entrez]']",,ppublish,Rev Paul Med. 1948 Dec;33(6):374-8.,,,,,,,,,Rumos e tendencias da terapeutica; molestias infecciosas.,,,['CLML: 4916:840s'],,,,,
14905028,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4759,1952 Mar 22,INFECTIOUS diseases and vital statistics.,666-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Smallpox/*epidemiology/*statistics & numerical data', '*Variola virus', '*Vital Statistics']",PMC2023210,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX/epidemiology and statistics', '*VITAL STATISTICS']",1952/03/22 00:00,1952/03/22 00:01,['1952/03/22 00:00'],"['1952/03/22 00:00 [pubmed]', '1952/03/22 00:01 [medline]', '1952/03/22 00:00 [entrez]']",,ppublish,Br Med J. 1952 Mar 22;1(4759):666-7.,,,,,,,,,,,,['CLML: 5221:35612:90:346:407'],,,,,
14896209,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4756,1952 Mar 1,INFECTIOUS diseases and vital statistics.,498-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Smallpox/*epidemiology/*statistics & numerical data', '*Variola virus', '*Vital Statistics']",PMC2022901,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX/epidemiology and statistics', '*VITAL STATISTICS']",1952/03/01 00:00,1952/03/01 00:01,['1952/03/01 00:00'],"['1952/03/01 00:00 [pubmed]', '1952/03/01 00:01 [medline]', '1952/03/01 00:00 [entrez]']",,ppublish,Br Med J. 1952 Mar 1;1(4756):498-9.,,,,,,,,,,,,['CLML: 5221:26662:90:346:407'],,,,,
14896187,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4755,1952 Feb 23,INFECTIOUS diseases and vital statistics.,444-5,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Smallpox/*epidemiology/*statistics & numerical data', '*Variola virus', '*Vital Statistics']",PMC2022715,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX/epidemiology and statistics', '*VITAL STATISTICS']",1952/02/23 00:00,1952/02/23 00:01,['1952/02/23 00:00'],"['1952/02/23 00:00 [pubmed]', '1952/02/23 00:01 [medline]', '1952/02/23 00:00 [entrez]']",,ppublish,Br Med J. 1952 Feb 23;1(4755):444-5.,,,,,,,,,,,,['CLML: 5221:26640:90:346:407'],,,,,
29217262,NLM,MEDLINE,20181016,20181016,1879-2499 (Electronic) 1369-8486 (Linking),67,,2018 Feb,"Universal etiology, multifactorial diseases and the constitutive model of disease classification.",8-15,S1369-8486(17)30033-X [pii] 10.1016/j.shpsc.2017.11.002 [doi],"Infectious diseases are often said to have a universal etiology, while chronic and noncommunicable diseases are said to be multifactorial in their etiology. It has been argued that the universal etiology of an infectious disease results from its classification using a monocausal disease model. In this article, I will reconstruct the monocausal model and argue that modern 'multifactorial diseases' are not monocausal by definition. 'Multifactorial diseases' are instead defined according to a constitutive disease model. On closer analysis, infectious diseases are also defined using the constitutive model rather than the monocausal model. As a result, our classification models alone cannot explain why infectious diseases have a universal etiology while chronic and noncommunicable diseases lack one. The explanation is instead provided by the Nineteenth Century germ theorists.",['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],"['Fuller, Jonathan']",['Fuller J'],"['Faculty of Medicine, University of Toronto, Canada; Research Associate, African Centre for Epistemology and Philosophy of Science, University of Johannesburg, South Africa. Electronic address: jonathan.fuller@mail.utoronto.ca.']",['eng'],"['Historical Article', 'Journal Article']",20171206,England,Stud Hist Philos Biol Biomed Sci,Studies in history and philosophy of biological and biomedical sciences,9810965,IM,"['Communicable Diseases/*classification/*etiology', 'Germ Theory of Disease/history', 'History, 19th Century', 'Humans', '*Models, Theoretical', 'Philosophy, Medical/*history']",,['NOTNLM'],"['Disease classification', 'Etiology', 'Monocausal model', 'Multifactorial', 'Philosophy of medicine']",2017/12/09 06:00,2018/10/17 06:00,['2017/12/09 06:00'],"['2017/03/06 00:00 [received]', '2017/11/01 00:00 [revised]', '2017/11/03 00:00 [accepted]', '2017/12/09 06:00 [pubmed]', '2018/10/17 06:00 [medline]', '2017/12/09 06:00 [entrez]']","['S1369-8486(17)30033-X [pii]', '10.1016/j.shpsc.2017.11.002 [doi]']",ppublish,Stud Hist Philos Biol Biomed Sci. 2018 Feb;67:8-15. doi: 10.1016/j.shpsc.2017.11.002. Epub 2017 Dec 6.,,,,,,,,,,,,,,,,,
24566353,NLM,MEDLINE,20140926,20140403,0048-7554 (Print) 0048-7554 (Linking),29,1-2,2014,"Combating infectious diseases in the Pacific Islands: sentinel surveillance, environmental health, and geospatial tools.",113-7,10.1515/reveh-2014-0028 [doi],"Infectious diseases are responsible for significant disease burden in the Pacific Islands. Environmental drivers of disease transmission and public health challenges vary between diseases, at times of emergence versus outbreaks, and also during the last stages of elimination where prevalence is low. In order to more effectively combat infectious diseases in the region, innovative approaches such as sentinel surveillance, environmental monitoring, the use of geospatial tools should be explored.",,"['Lau, Colleen']",['Lau C'],,['eng'],['Journal Article'],,Germany,Rev Environ Health,Reviews on environmental health,0425754,IM,"['Communicable Disease Control/methods', 'Communicable Diseases/*epidemiology/transmission', 'Disease Eradication/methods', 'Disease Outbreaks', '*Environment', 'Geographic Information Systems', 'Humans', 'Pacific Islands', 'Sentinel Surveillance']",,,,2014/02/26 06:00,2014/09/27 06:00,['2014/02/26 06:00'],"['2014/01/17 00:00 [received]', '2014/01/17 00:00 [accepted]', '2014/02/26 06:00 [entrez]', '2014/02/26 06:00 [pubmed]', '2014/09/27 06:00 [medline]']","['/j/reveh-ahead-of-print/reveh-2014-0028/reveh-2014-0028.xml [pii]', '10.1515/reveh-2014-0028 [doi]']",ppublish,Rev Environ Health. 2014;29(1-2):113-7. doi: 10.1515/reveh-2014-0028.,,,,,,,,,,,,,,,,,
28040271,NLM,MEDLINE,20170524,20220408,1873-1716 (Electronic) 0167-5877 (Linking),137,Pt B,2017 Feb 1,Effects of climate change on the occurrence and distribution of livestock diseases.,119-129,S0167-5877(16)30631-6 [pii] 10.1016/j.prevetmed.2016.11.019 [doi],"The planet's mean air and ocean temperatures have been rising over the last century because of increasing greenhouse gas (GHG) emissions. These changes have substantial effects on the epidemiology of infectious diseases. We describe direct and indirect processes linking climate change and infectious diseases in livestock with reference to specific case studies. Some of the studies are used to show a positive association between temperature and expansion of the geographical ranges of arthropod vectors (e.g. Culicoides imicola, which transmits bluetongue virus) while others are used to illustrate an opposite trend (e.g. tsetse flies that transmit a range of trypanosome parasites in sub-Saharan Africa). We further describe a positive association between extreme events: droughts and El Nino/southern oscillation (ENSO) weather patterns and Rift Valley fever outbreaks in East Africa and some adaptation practices used to mitigate the impacts of climate change that may increase risk of exposure to infectious pathogens. We conclude by outlining mitigation and adaptation measures that can be used specifically in the livestock sector to minimize the impacts of climate change-associated livestock diseases.",['Copyright (c) 2016 Elsevier B.V. All rights reserved.'],"['Bett, B', 'Kiunga, P', 'Gachohi, J', 'Sindato, C', 'Mbotha, D', 'Robinson, T', 'Lindahl, J', 'Grace, D']","['Bett B', 'Kiunga P', 'Gachohi J', 'Sindato C', 'Mbotha D', 'Robinson T', 'Lindahl J', 'Grace D']","['International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya. Electronic address: b.bett@cgiar.org.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya; Department of Veterinary Services, Ministry of Agriculture, Livestock and Fisheries, Private Bag, Kabete, 00625 Kangemi, Kenya.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya; College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, P. O. Box 62000, Nairobi, Kenya.', 'National Institute for Medical Research, P.O. Box - 482, Tabora, Tanzania.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya; Swedish University of Agricultural Sciences, P.O. Box 7054, SE-750 07, Uppsala, Sweden.', 'International Livestock Research Institute, P.O. Box 30709-00100, Nairobi, Kenya.']",['eng'],"['Journal Article', 'Review']",20161214,Netherlands,Prev Vet Med,Preventive veterinary medicine,8217463,IM,"['Animal Diseases/*epidemiology/etiology', 'Animals', '*Climate Change', 'Communicable Diseases/epidemiology/etiology/*veterinary', '*Livestock']",,['NOTNLM'],"['Climate change', 'Livestock diseases', 'Mitigation and adaptation measures']",2017/01/04 06:00,2017/05/26 06:00,['2017/01/02 06:00'],"['2016/05/06 00:00 [received]', '2016/11/30 00:00 [accepted]', '2017/01/04 06:00 [pubmed]', '2017/05/26 06:00 [medline]', '2017/01/02 06:00 [entrez]']","['S0167-5877(16)30631-6 [pii]', '10.1016/j.prevetmed.2016.11.019 [doi]']",ppublish,Prev Vet Med. 2017 Feb 1;137(Pt B):119-129. doi: 10.1016/j.prevetmed.2016.11.019. Epub 2016 Dec 14.,,,,,,,,,,,,,,,,,
22455675,NLM,MEDLINE,20120730,20120329,1557-850X (Electronic) 1538-7135 (Linking),10,1,2012 Mar,Public health surveillance and infectious disease detection.,6-16,10.1089/bsp.2011.0088 [doi],"Emerging infectious diseases, such as HIV/AIDS, SARS, and pandemic influenza, and the anthrax attacks of 2001, have demonstrated that we remain vulnerable to health threats caused by infectious diseases. The importance of strengthening global public health surveillance to provide early warning has been the primary recommendation of expert groups for at least the past 2 decades. However, despite improvements in the past decade, public health surveillance capabilities remain limited and fragmented, with uneven global coverage. Recent initiatives provide hope of addressing this issue, and new technological and conceptual advances could, for the first time, place capability for global surveillance within reach. Such advances include the revised International Health Regulations (IHR 2005) and the use of new data sources and methods to improve global coverage, sensitivity, and timeliness, which show promise for providing capabilities to extend and complement the existing infrastructure. One example is syndromic surveillance, using nontraditional and often automated data sources. Over the past 20 years, other initiatives, including ProMED-mail, GPHIN, and HealthMap, have demonstrated new mechanisms for acquiring surveillance data. In 2009 the U.S. Agency for International Development (USAID) began the Emerging Pandemic Threats (EPT) program, which includes the PREDICT project, to build global capacity for surveillance of novel infections that have pandemic potential (originating in wildlife and at the animal-human interface) and to develop a framework for risk assessment. Improved understanding of factors driving infectious disease emergence and new technological capabilities in modeling, diagnostics and pathogen identification, and communications, such as using the increasing global coverage of cellphones for public health surveillance, can further enhance global surveillance.",,"['Morse, Stephen S']",['Morse SS'],"['USAID Emerging Pandemic Threats-PREDICT Program, Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, USA. ssm20@columbia.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",,United States,Biosecur Bioterror,"Biosecurity and bioterrorism : biodefense strategy, practice, and science",101156085,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/epidemiology', 'Communicable Diseases, Emerging/diagnosis/epidemiology/prevention & control', 'Disease Notification', 'Humans', 'International Cooperation', 'Pandemics', 'Population Surveillance/*methods', 'Practice Guidelines as Topic', 'United States/epidemiology']",,,,2012/03/30 06:00,2012/07/31 06:00,['2012/03/30 06:00'],"['2012/03/30 06:00 [entrez]', '2012/03/30 06:00 [pubmed]', '2012/07/31 06:00 [medline]']",['10.1089/bsp.2011.0088 [doi]'],ppublish,Biosecur Bioterror. 2012 Mar;10(1):6-16. doi: 10.1089/bsp.2011.0088.,,,,,,,,,,,,,,,,,
18464545,NLM,MEDLINE,20080603,20200716,0372-9311 (Print) 0372-9311 (Linking),,2,2008 Mar-Apr,[Epidemiologic situation and measures for prevention of infectious diseases in Sverdlovsk region in 2006-2007].,69-72,,Materials characterizing the epidemiologic situation on most significant infectious diseases in Sverdlovsk region are presented. Experience on providing the epidemiologic welfare based on systematic surveillance for activity of various factors influencing the epidemic process is described.,,"['Nikonov, B I', 'Romanenko, V V', 'Iurovskikh, A I', 'Skriabina, S V', 'Semenova, L V', 'Struin, N L', 'Smirnova, S S', 'Perminova, S A', 'Paltusova, V V', 'Osipova, S N', 'Krymova, L V']","['Nikonov BI', 'Romanenko VV', 'Iurovskikh AI', 'Skriabina SV', 'Semenova LV', 'Struin NL', 'Smirnova SS', 'Perminova SA', 'Paltusova VV', 'Osipova SN', 'Krymova LV']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/veterinary', 'Disease Reservoirs', 'Environmental Monitoring', 'Epidemiological Monitoring', 'Humans', 'Russia/epidemiology']",,,,2008/05/10 09:00,2008/06/05 09:00,['2008/05/10 09:00'],"['2008/05/10 09:00 [pubmed]', '2008/06/05 09:00 [medline]', '2008/05/10 09:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2008 Mar-Apr;(2):69-72.,,,,,,,,,,,,,,,,,
23863603,NLM,MEDLINE,20140401,20211021,2150-5608 (Electronic) 2150-5594 (Print) 2150-5594 (Linking),4,6,2013 Aug 15,Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction.,572-82,10.4161/viru.25740 [doi],"Recent evidence suggests that loss of endothelial barrier function and resulting microvascular leak play important mechanistic roles in the pathogenesis of infection-related end-organ dysfunction and failure. Several distinct therapeutic strategies, designed to prevent or limit infection-related microvascular endothelial activation and permeability, thereby mitigating end-organ injury/dysfunction, have recently been investigated in pre-clinical models. In this review, these potential therapeutic strategies, namely, VEGFR2/Src antagonists, sphingosine-1-phosphate agonists, fibrinopeptide Bbeta 15-42, slit2N, secinH3, angiopoietin-1/tie-2 agonists, angiopoietin-2 antagonists, statins, atrial natriuretic peptide, and mesenchymal stromal (stem) cells, are discussed in terms of their translational potential for the management of clinical infectious diseases.",,"['Darwish, Ilyse', 'Liles, W Conrad']","['Darwish I', 'Liles WC']","['University Health Network-Toronto General Hospital, Toronto, ON, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130716,United States,Virulence,Virulence,101531386,IM,"['Animals', 'Communicable Diseases/*drug therapy/genetics/metabolism/physiopathology', 'Endothelium, Vascular/drug effects/*metabolism/physiopathology', 'Humans', 'Microvessels/drug effects/*metabolism']",PMC5359747,['NOTNLM'],"['acute lung injury', 'emerging therapeutics', 'endothelium', 'infectious diseases', 'microvascular leak', 'sepsis']",2013/07/19 06:00,2014/04/02 06:00,['2013/07/19 06:00'],"['2013/07/19 06:00 [entrez]', '2013/07/19 06:00 [pubmed]', '2014/04/02 06:00 [medline]']","['25740 [pii]', '10925740 [pii]', '10.4161/viru.25740 [doi]']",ppublish,Virulence. 2013 Aug 15;4(6):572-82. doi: 10.4161/viru.25740. Epub 2013 Jul 16.,,,,,,,['Canadian Institutes of Health Research/Canada'],,,,,,,,,,
35446391,NLM,MEDLINE,20221130,20221230,1537-6613 (Electronic) 0022-1899 (Linking),226,11,2022 Nov 28,CRISPR-Cas in Diagnostics and Therapy of Infectious Diseases.,1867-1876,10.1093/infdis/jiac145 [doi],"Infectious diseases are a major threat to the global health. The rise in antimicrobial-resistant organisms, incurable chronic infections, and an increasing demand for rapid accurate diagnostics have prompted researchers to experiment with new approaches. Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) is a naturally occurring adaptive immune system in bacteria that has been developed as a tool for performing genomic alterations in any genome of interest, including humans and microbes. Accordingly, several studies have been conducted to investigate how the technology can be utilized in infectious diseases to improve diagnostics, disrupt antimicrobial resistance, and cure chronic infections. This review provides an overview of the CRISPR-Cas system and how it has been applied in studies on infectious diseases. The review also investigates the current challenges of the technology and the improvements that are needed for the platform to be adopted for clinical use in patients.","['(c) The Author(s) 2022. Published by Oxford University Press on behalf of', 'Infectious Diseases Society of America. All rights reserved. For permissions,', 'please e-mail: journals.permissions@oup.com.']","['Gleerup, Jens Lind', 'Mogensen, Trine H']","['Gleerup JL', 'Mogensen TH']","['Department of Biomedicine, Aarhus University, Aarhus, Denmark.', 'Department of Biomedicine, Aarhus University, Aarhus, Denmark.', 'Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Humans', 'CRISPR-Cas Systems', '*Communicable Diseases/diagnosis/therapy', 'Bacteria/genetics', 'Genome', '*Anti-Infective Agents']",,['NOTNLM'],"['CRISPR/Cas9', 'antimicrobial', 'antiviral', 'diagnostics', 'infectious diseases']",2022/04/22 06:00,2022/12/01 06:00,['2022/04/21 12:15'],"['2022/01/19 00:00 [received]', '2022/04/11 00:00 [accepted]', '2022/04/22 06:00 [pubmed]', '2022/12/01 06:00 [medline]', '2022/04/21 12:15 [entrez]']","['6571946 [pii]', '10.1093/infdis/jiac145 [doi]']",ppublish,J Infect Dis. 2022 Nov 28;226(11):1867-1876. doi: 10.1093/infdis/jiac145.,"['Potential conflicts of interest. The authors: No reported conflicts of interest.', 'All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts', 'of Interest. Conflicts that the editors consider relevant to the content of the', 'manuscript have been disclosed.']",['ORCID: 0000-0002-1853-9704'],['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
30200314,NLM,MEDLINE,20181211,20181211,1420-3049 (Electronic) 1420-3049 (Linking),23,9,2018 Aug 31,Application of Dendrimers for the Treatment of Infectious Diseases.,,10.3390/molecules23092205 [doi] 2205,"Dendrimers are drug delivery systems that are characterized by a three-dimensional, star-shaped, branched macromolecular network. They possess ideal properties such as low polydispersity index, biocompatibility and good water solubility. They are made up of the interior and the exterior layers. The exterior layer consists of functional groups that are useful for conjugation of drugs and targeting moieties. The interior layer exhibits improved drug encapsulation efficiency, reduced drug toxicity, and controlled release mechanisms. These unique properties make them useful for drug delivery. Dendrimers have attracted considerable attention as drug delivery system for the treatment of infectious diseases. The treatment of infectious diseases is hampered severely by drug resistance. Several properties of dendrimers such as their ability to overcome drug resistance, toxicity and control the release mechanism of the encapsulated drugs make them ideal systems for the treatment of infectious disease. The aim of this review is to discuss the potentials of dendrimers for the treatment of viral and parasitic infections.",,"['Mhlwatika, Zandile', 'Aderibigbe, Blessing Atim']","['Mhlwatika Z', 'Aderibigbe BA']","['Department of Chemistry, University of Fort Hare, Alice Campus, Eastern Cape 5700, South Africa. 201103519@ufh.ac.za.', 'Department of Chemistry, University of Fort Hare, Alice Campus, Eastern Cape 5700, South Africa. blessingaderibigbe@gmail.com.']",['eng'],"['Journal Article', 'Review']",20180831,Switzerland,Molecules,"Molecules (Basel, Switzerland)",100964009,IM,"['Communicable Diseases/*drug therapy/parasitology/virology', 'Dendrimers/chemistry/*therapeutic use', 'Humans', 'Pharmaceutical Preparations/chemistry']",PMC6225509,['NOTNLM'],"['antivirals', 'dendrimers', 'drug delivery', 'parasites', 'polymers']",2018/09/12 06:00,2018/12/12 06:00,['2018/09/12 06:00'],"['2018/05/14 00:00 [received]', '2018/06/14 00:00 [revised]', '2018/06/15 00:00 [accepted]', '2018/09/12 06:00 [entrez]', '2018/09/12 06:00 [pubmed]', '2018/12/12 06:00 [medline]']","['molecules23092205 [pii]', 'molecules-23-02205 [pii]', '10.3390/molecules23092205 [doi]']",epublish,Molecules. 2018 Aug 31;23(9):2205. doi: 10.3390/molecules23092205.,['The authors declare no conflict of interest.'],,"['0 (Dendrimers)', '0 (Pharmaceutical Preparations)']",,,,,,,,,,,,,,
20192680,NLM,MEDLINE,20100601,20181201,1744-8336 (Electronic) 1478-7210 (Linking),8,3,2010 Mar,6th meeting of the World Society for Pediatric Infectious Diseases.,263-5,10.1586/eri.10.6 [doi],"The 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), which was recently held in Buenos Aires, Argentina, between 18 and 22 November 2009, attracted 2401 attendees from 90 countries representing six continents. The WSPID, founded in 1994 by Professor Saldana Gonzalez of the Mexican Pediatric Infectious Diseases Society, is a network of pediatric infectious diseases societies dedicated to the treatment and prevention of pediatric infectious diseases. All the regional societies from Europe, North America, Latin America, Asia, Australasia and Africa have participated in the WSPID.",,"['Falade, Adegoke Gbadegesin']",['Falade AG'],"['College of Medicine, University of Ibadan, Ibadan and University College Hospital, Ibadan, Oyo State, Nigeria. afalade33@hotmail.com']",['eng'],['Congress'],,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,IM,"['Anti-Bacterial Agents/therapeutic use', 'Argentina', 'Bacterial Vaccines/immunology', 'Biomedical Research/trends', 'Communicable Disease Control/*methods', '*Communicable Diseases/epidemiology/etiology/therapy', '*Cross Infection/drug therapy/epidemiology/prevention & control', 'Humans', 'Intensive Care, Neonatal', 'Viral Vaccines/immunology']",,,,2010/03/03 06:00,2010/06/02 06:00,['2010/03/03 06:00'],"['2010/03/03 06:00 [entrez]', '2010/03/03 06:00 [pubmed]', '2010/06/02 06:00 [medline]']",['10.1586/eri.10.6 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2010 Mar;8(3):263-5. doi: 10.1586/eri.10.6.,,,"['0 (Anti-Bacterial Agents)', '0 (Bacterial Vaccines)', '0 (Viral Vaccines)']",,,,,,,,,,,,,,
20630143,NLM,MEDLINE,20101012,20190608,1560-7917 (Electronic) 1025-496X (Linking),15,27,2010 Jul 8,Strategies to intervene on social determinants of infectious diseases.,32-9,19611 [pii],"Systematic health inequalities exist in all European countries today. Individuals with lower socio-economic status suffer disproportionally from adverse health outcomes. While this is widely accepted for chronic diseases, a literature review covering the years 1999-2010 reveals that infectious diseases are also distributed unevenly throughout society, with vulnerable groups bearing a disproportionate burden. This burden is not restricted to a few 'signature infections of social determinants' such as tuberculosis or human immunodeficiency virus (HIV) infections, but also a wide array of other infectious diseases. Tremendous advances in public health over the last century have reduced the absolute magnitude of inequalities but relative differences remain. In order to explore the underlying reasons for such persistent inequalities in Europe, I examined interventions targeting social determinants of infectious diseases: interventions on social determinants tend to focus on chronic diseases rather than infectious diseases, and interventions for these mainly focus on HIV/AIDS or other sexually transmitted infections. Thus, there seems to be a need to intervene on inequalities in infectious diseases but ideally with a comprehensive public health approach. Three intervention strategies are discussed: population-at-risk, population, and vulnerable population approaches. Strengths and weaknesses of these options are illustrated.",,"['Semenza, J C']",['Semenza JC'],"['Scientific Advice Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Jan.Semenza@ecdc.europa.eu']",['eng'],['Journal Article'],20100708,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,IM,"['Chronic Disease/prevention & control', 'Communicable Disease Control/economics/*methods', 'Communicable Diseases/economics/*epidemiology/etiology', 'Europe/epidemiology', 'Health Promotion/methods', 'Health Status Indicators', 'Humans', 'Models, Theoretical', '*Poverty', 'Public Health/*methods', '*Socioeconomic Factors', 'Vulnerable Populations']",,,,2010/07/16 06:00,2010/10/13 06:00,['2010/07/16 06:00'],"['2010/07/16 06:00 [entrez]', '2010/07/16 06:00 [pubmed]', '2010/10/13 06:00 [medline]']","['19611 [pii]', '10.2807/ese.15.27.19611-en [doi]']",epublish,Euro Surveill. 2010 Jul 8;15(27):32-9. doi: 10.2807/ese.15.27.19611-en.,,,,['Euro Surveill. 2010;15(28). pii: 19613'],,,,,,,,,,,,,
11285678,NLM,MEDLINE,20010426,20220316,0042-9686 (Print) 0042-9686 (Linking),79,3,2001,Applying DALYs to the burden of infectious diseases.,267-9,,,,"['Zou, S']",['Zou S'],,['eng'],"['Comment', 'Letter']",,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,IM,"['Communicable Diseases/*classification/epidemiology', '*Cost of Illness', 'Disabled Persons/*classification', 'Global Health', 'Humans', '*Quality-Adjusted Life Years']",PMC2566368,,,2001/04/05 10:00,2001/05/01 10:01,['2001/04/05 10:00'],"['2001/04/05 10:00 [pubmed]', '2001/05/01 10:01 [medline]', '2001/04/05 10:00 [entrez]']",,ppublish,Bull World Health Organ. 2001;79(3):267-9.,,,,,,,,['Bull World Health Organ. 2000;78(8):981-94. PMID: 10994282'],,,,,,,,,
14904982,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4757,1952 Mar 8,INFECTIOUS diseases and vital statistics.,552-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Smallpox/*epidemiology/*statistics & numerical data', '*Variola virus', '*Vital Statistics']",PMC2022947,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX/epidemiology and statistics', '*VITAL STATISTICS']",1952/03/08 00:00,1952/03/08 00:01,['1952/03/08 00:00'],"['1952/03/08 00:00 [pubmed]', '1952/03/08 00:01 [medline]', '1952/03/08 00:00 [entrez]']",,ppublish,Br Med J. 1952 Mar 8;1(4757):552-4.,,,,,,,,,,,,['CLML: 5221:35566:90:347:407'],,,,,
9019429,NLM,MEDLINE,19970210,20091111,0016-3813 (Print) 0016-3813 (Linking),132,6,1996 Nov-Dec,[Emerging infectious diseases: reemerging and new].,649-52,,,,"['Ortiz-Quesada, F', 'Mendez-Galvan, J F']","['Ortiz-Quesada F', 'Mendez-Galvan JF']","['Asociacion Fronteriza Mexicano-Estadounidense de Salud, Tijuana.']",['spa'],"['Comparative Study', 'Journal Article']",,Mexico,Gac Med Mex,Gaceta medica de Mexico,0010333,IM,"['Adult', 'Child', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality', 'Developing Countries', 'Humans', 'Latin America', 'United States']",,,,1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']",,ppublish,Gac Med Mex. 1996 Nov-Dec;132(6):649-52.,,,,,,,,,"Enfermedades infecciosas emergentes, reemergentes y nuevas.",,,,,,,,
26177788,NLM,MEDLINE,20160609,20181113,2150-5608 (Electronic) 2150-5594 (Print) 2150-5594 (Linking),6,6,2015,Climate change and adaptation of the health sector: The case of infectious diseases.,554-7,10.1080/21505594.2015.1023985 [doi],"Infectious diseases form a group of health problems highly susceptible to the influences of climate. Adaptation to protect human population health from the changes in infectious disease epidemiology expected to occur as a consequence of climate change involve actions in the health systems as well as in other non-health sectors. In the health sector strategies such as enhanced and targeted epidemiological and entomological surveillance and the development of epidemic early warning systems informed by climate scenarios are needed. Measures in other sectors such as meteorology, civil defense and environmental sanitation will also contribute to a reduction in the risk of infection under climate change.",,"['Confalonieri, Ulisses E C', 'Menezes, Julia Alves', 'Margonari de Souza, Carina']","['Confalonieri UE', 'Menezes JA', 'Margonari de Souza C']","['a Rene Rachou Research Center; Laboratorio de Educacao em Saude e Ambiente; FIOCRUZ ; Belo Horizonte , Brazil.', 'a Rene Rachou Research Center; Laboratorio de Educacao em Saude e Ambiente; FIOCRUZ ; Belo Horizonte , Brazil.']",['eng'],"['Journal Article', 'Review']",20150715,United States,Virulence,Virulence,101531386,IM,"['*Climate Change', 'Communicable Disease Control/*methods/*organization & administration', 'Communicable Diseases/*epidemiology/*transmission', '*Disease Transmission, Infectious', 'Environmental Monitoring', '*Epidemiologic Methods', 'Humans']",PMC4720270,['NOTNLM'],"['Adaptation', 'Climate Change', 'Health', 'Infectious Diseases', 'Outbreaks', 'Surveillance', 'Vulnerability']",2015/07/17 06:00,2016/06/10 06:00,['2015/07/17 06:00'],"['2015/07/17 06:00 [entrez]', '2015/07/17 06:00 [pubmed]', '2016/06/10 06:00 [medline]']","['1023985 [pii]', '10.1080/21505594.2015.1023985 [doi]']",ppublish,Virulence. 2015;6(6):554-7. doi: 10.1080/21505594.2015.1023985. Epub 2015 Jul 15.,,,,,,,,,,,,,,,,,
29973020,NLM,MEDLINE,20190301,20190301,0253-9624 (Print) 0253-9624 (Linking),52,3,2018 Mar 6,[Epidemic characteristics and prophylaxis/control measures of infectious diseases caused by hydrological disasters].,332-336,10.3760/cma.j.issn.0253-9624.2018.03.024 [doi],"Hydrological disasters are associated with infectious disease outbreaks and epidemics. Hydrological disasters will lead to water pollution, increased vulnerability to diseases, and increased density of vectors. These factors will facilitate the outbreaks of water-borne/food-borne diseases, vector-borne diseases, and air-borne/contagious diseases. Pre-event preparedness for disasters and post-event reconstruction of both disease surveillance system and water-supply system are key measures to prevent infectious disease outbreaks caused by hydrological disasters. This study reviews the domestic and overseas experiences of controlling infectious diseases after hydrologic disasters, outlines the spectrum of post-disaster infectious disease as well as their epidemiological characteristics, and provides practicable suggestions accordingly.",,"['Ma, L T', 'Cao, G W']","['Ma LT', 'Cao GW']","['Department of Epidemiology, The Second Military Medical University, Shanghai 200433, China.']",['chi'],"['Journal Article', 'Review']",,China,Zhonghua Yu Fang Yi Xue Za Zhi,Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],7904962,IM,"['China/epidemiology', 'Communicable Disease Control/*methods', 'Communicable Diseases/*epidemiology/etiology', '*Disasters', 'Disease Outbreaks/*prevention & control', '*Epidemics', 'Humans', 'Post-Exposure Prophylaxis', 'Water Supply']",,['NOTNLM'],"['Communicable diseases', 'Disaster medicine', 'Pandemics', 'Preventive medicine']",2018/07/06 06:00,2019/03/02 06:00,['2018/07/06 06:00'],"['2018/07/06 06:00 [entrez]', '2018/07/06 06:00 [pubmed]', '2019/03/02 06:00 [medline]']",['10.3760/cma.j.issn.0253-9624.2018.03.024 [doi]'],ppublish,Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):332-336. doi: 10.3760/cma.j.issn.0253-9624.2018.03.024.,,,,,,,,,,,,,,,,,
16729713,NLM,MEDLINE,20060606,20141120,0022-3395 (Print) 0022-3395 (Linking),92,2,2006 Apr,Systematics and emerging infectious diseases: from management to solution.,426-9,,"The crisis of emerging infectious disease stems from the absence of comprehensive taxonomic inventories of the world's parasites, which includes the world's pathogens. Recent technological developments raise hopes that the global inventory of species, including potential pathogens, can be accomplished in a timely and cost-effective manner. The phylogenetics revolution initiated by systematists provides a means by which information about pathogen transmission dynamics can be placed in a predictive framework. Increasingly, that information is widely available in digital form on the Internet. Systematic biology is well positioned to play a crucial role in efforts to be proactive in the arena of emerging parasitic and infectious diseases.",,"['Brooks, Daniel R', 'Hoberg, Eric P']","['Brooks DR', 'Hoberg EP']","['Department of Zoology, University of Toronto, Toronto, Ontario M5S 3G5, Canada. dbrooks@zoo.utoronto.ca']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,J Parasitol,The Journal of parasitology,7803124,IM,"['Animals', 'Biodiversity', 'Biological Evolution', 'Communicable Diseases, Emerging/*classification/epidemiology/etiology/*therapy', 'Global Health', 'Humans', 'Parasites/classification', 'Phylogeny', 'Risk Assessment']",,,,2006/05/30 09:00,2006/06/07 09:00,['2006/05/30 09:00'],"['2006/05/30 09:00 [pubmed]', '2006/06/07 09:00 [medline]', '2006/05/30 09:00 [entrez]']",['10.1645/GE-711R.1 [doi]'],ppublish,J Parasitol. 2006 Apr;92(2):426-9. doi: 10.1645/GE-711R.1.,,,,,,,,,,,,,,,,,
19043463,NLM,MEDLINE,20090223,20091111,0048-0169 (Print) 0048-0169 (Linking),56,6,2008 Dec,Disease threats to sheep associated with intensification of pastoral farming.,270-3,10.1080/00480169.2008.36846 [doi],"Sheep farming in New Zealand is based on an outdoor grazing system with various systems of grazing management utilised depending on the type of farm and the time of year. In the current grazing systems, periods of high stocking density, sometimes combined with poor husbandry, contribute to infectious diseases such as abortion and salmonellosis. Intensification such as housing or intensive stocking of ewes for lambing, or feedlot systems, are unlikely to become common in sheep production in New Zealand. However, should these be utilised on individual farms there is likely to be in an increase in diseases such as coccidiosis, bacterial diseases of lambs, cryptosporidiosis and mastitis. In any management system involving high stocking densities, careful husbandry is essential to minimise the transmission of infectious diseases.",,"['Ridler, Al']",['Ridler A'],"['Royal Veterinary College, Hawkshead Lane, Hatfi eld, Herts AL9 7TA, United Kingdom. aridler@rvc.ac.uk']",['eng'],"['Journal Article', 'Review']",,England,N Z Vet J,New Zealand veterinary journal,0021406,IM,"['Animal Husbandry/*methods', 'Animals', 'Communicable Diseases/epidemiology/transmission/*veterinary', 'Female', 'Housing, Animal/standards', 'Male', 'New Zealand/epidemiology', 'Population Density', 'Sheep/*physiology', 'Sheep Diseases/*epidemiology/*transmission']",,,,2008/12/02 09:00,2009/02/24 09:00,['2008/12/02 09:00'],"['2008/12/02 09:00 [pubmed]', '2009/02/24 09:00 [medline]', '2008/12/02 09:00 [entrez]']",['10.1080/00480169.2008.36846 [doi]'],ppublish,N Z Vet J. 2008 Dec;56(6):270-3. doi: 10.1080/00480169.2008.36846.,,,,,,47,,,,,,,,,,,
15840462,NLM,MEDLINE,20050621,20050420,1201-9712 (Print) 1201-9712 (Linking),9,3,2005 May,Don't overlook infectious diseases in ICD-9 chapters other than Chapter I.,180-1,,,,"['Lu, Tsung-Hsueh']",['Lu TH'],,['eng'],"['Comment', 'Letter']",,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,IM,"['Cause of Death', 'Communicable Diseases/classification/*mortality', 'Comorbidity', 'Humans', '*International Classification of Diseases', 'Parasitic Diseases/*mortality']",,,,2005/04/21 09:00,2005/06/23 09:00,['2005/04/21 09:00'],"['2004/04/09 00:00 [received]', '2004/06/17 00:00 [accepted]', '2005/04/21 09:00 [pubmed]', '2005/06/23 09:00 [medline]', '2005/04/21 09:00 [entrez]']","['S1201-9712(05)00008-1 [pii]', '10.1016/j.ijid.2004.06.013 [doi]']",ppublish,Int J Infect Dis. 2005 May;9(3):180-1. doi: 10.1016/j.ijid.2004.06.013.,,,,,,,,['Int J Infect Dis. 2004 Mar;8(2):121-5. PMID: 14732330'],,,,,,,,,
13221872,NLM,MEDLINE,20030501,20181201,0021-129X (Print) 0021-129X (Linking),36,211,1955 Jan,Recent advances in the treatment of infectious diseases.,14-7,,,,"['CAWLEY, P']",['CAWLEY P'],,['eng'],['Journal Article'],,Ireland,J Ir Med Assoc,Journal of the Irish Medical Association,0430304,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1955/01/01 00:00,1955/01/01 00:01,['1955/01/01 00:00'],"['1955/01/01 00:00 [pubmed]', '1955/01/01 00:01 [medline]', '1955/01/01 00:00 [entrez]']",,ppublish,J Ir Med Assoc. 1955 Jan;36(211):14-7.,,,,,,,,,,,,['CLML: 5527:33804:120'],,,,,
13116646,NLM,MEDLINE,20030501,20181201,0010-5309 (Print) 0010-5309 (Linking),75,49,1953 Dec,[Active and passive therapy of infectious diseases].,4185-6,,,,"['FISCHER, G']",['FISCHER G'],,['und'],['Journal Article'],,France,Concours Med,Concours medical,2984731R,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1953/12/01 00:00,1953/12/01 00:01,['1953/12/01 00:00'],"['1953/12/01 00:00 [pubmed]', '1953/12/01 00:01 [medline]', '1953/12/01 00:00 [entrez]']",,ppublish,Concours Med. 1953 Dec;75(49):4185-6.,,,,,,,,,Guerison active et guerison passive des maladies infectieuses.,,,['CLML: 5425:37854:117'],,,,,
34555157,NLM,MEDLINE,20211028,20211028,1460-2091 (Electronic) 0305-7453 (Print) 0305-7453 (Linking),76,Suppl 3,2021 Sep 23,Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases.,iii4-iii11,10.1093/jac/dkab245 [doi],"Advanced microbiology technologies such as multiplex molecular assays (i.e. syndromic diagnostic tests) are a novel approach to the rapid diagnosis of common infectious diseases. As the global burden of antimicrobial resistance continues to rise, the judicious use of antimicrobials is of utmost importance. Syndromic panels are now being recognized in some clinical practice guidelines as a 'game-changer' in the diagnosis of infectious diseases. These syndromic panels, if implemented thoughtfully and interpreted carefully, have the potential to improve patient outcomes through improved clinical decision making, optimized laboratory workflow, and enhanced antimicrobial stewardship. This paper reviews the potential benefits of and considerations regarding various infectious diseases syndromic panels, and highlights how to maximize impact through collaboration between clinical microbiology laboratory and antimicrobial stewardship programmes.","['(c) The Author(s) 2021. Published by Oxford University Press on behalf of the', 'British Society for Antimicrobial Chemotherapy.']","['Dumkow, Lisa E', 'Worden, Lacy J', 'Rao, Sonia N']","['Dumkow LE', 'Worden LJ', 'Rao SN']","[""Mercy Health Saint Mary's Hospital, Grand Rapids, MI, USA."", ""Mercy Health Saint Mary's Hospital, Grand Rapids, MI, USA."", 'QIAGEN LLC, Germantown, MD, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,J Antimicrob Chemother,The Journal of antimicrobial chemotherapy,7513617,IM,"['*Anti-Infective Agents', '*Antimicrobial Stewardship', '*Communicable Diseases/diagnosis/drug therapy', 'Diagnostic Tests, Routine', 'Humans', 'Patient Care']",PMC8460095,,,2021/09/24 06:00,2021/10/29 06:00,['2021/09/23 17:27'],"['2021/09/23 17:27 [entrez]', '2021/09/24 06:00 [pubmed]', '2021/10/29 06:00 [medline]']","['6374616 [pii]', 'dkab245 [pii]', '10.1093/jac/dkab245 [doi]']",ppublish,J Antimicrob Chemother. 2021 Sep 23;76(Suppl 3):iii4-iii11. doi: 10.1093/jac/dkab245.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
9684618,NLM,MEDLINE,19980804,20190516,0002-9637 (Print) 0002-9637 (Linking),59,1,1998 Jul,Why America must care about tropical medicine: threats to global health and security from tropical infectious diseases.,3-16,,,,"['Guerrant, R L']",['Guerrant RL'],"['Division of Geographic and International Medicine, University of Virginia, School of Medicine, Charlottesville 22908, USA.']",['eng'],"['Address', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,IM,"['Altruism', 'Communicable Diseases/*epidemiology/psychology/transmission', 'Disease Outbreaks', '*Global Health', 'Humans', 'Leadership', 'Population Dynamics', '*Societies, Medical', '*Tropical Medicine', 'United States']",,,,1998/07/31 00:00,1998/07/31 00:01,['1998/07/31 00:00'],"['1998/07/31 00:00 [pubmed]', '1998/07/31 00:01 [medline]', '1998/07/31 00:00 [entrez]']",['10.4269/ajtmh.1998.59.3 [doi]'],ppublish,Am J Trop Med Hyg. 1998 Jul;59(1):3-16. doi: 10.4269/ajtmh.1998.59.3.,,,,,,,['2-U01-AI26512/AI/NIAID NIH HHS/United States'],,,,,,,,,,
21712250,NLM,MEDLINE,20120209,20220311,1367-4811 (Electronic) 1367-4803 (Print) 1367-4803 (Linking),27,16,2011 Aug 15,Integration and visualization of host-pathogen data related to infectious diseases.,2279-87,10.1093/bioinformatics/btr391 [doi],"MOTIVATION: Infectious disease research is generating an increasing amount of disparate data on pathogenic systems. There is a growing need for resources that effectively integrate, analyze, deliver and visualize these data, both to improve our understanding of infectious diseases and to facilitate the development of strategies for disease control and prevention. RESULTS: We have developed Disease View, an online host-pathogen resource that enables infectious disease-centric access, analysis and visualization of host-pathogen interactions. In this resource, we associate infectious diseases with corresponding pathogens, provide information on pathogens, pathogen virulence genes and the genetic and chemical evidences for the human genes that are associated with the diseases. We also deliver the relationships between pathogens, genes and diseases in an interactive graph and provide the geolocation reports of associated diseases around the globe in real time. Unlike many other resources, we have applied an iterative, user-centered design process to the entire resource development, including data acquisition, analysis and visualization. AVAILABILITY AND IMPLEMENTATION: Freely available at http://www.patricbrc.org; all major web browsers supported. CONTACT: cmao@vbi.vt.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,"['Driscoll, Timothy', 'Gabbard, Joseph L', 'Mao, Chunhong', 'Dalay, Oral', 'Shukla, Maulik', 'Freifeld, Clark C', 'Hoen, Anne Gatewood', 'Brownstein, John S', 'Sobral, Bruno W']","['Driscoll T', 'Gabbard JL', 'Mao C', 'Dalay O', 'Shukla M', 'Freifeld CC', 'Hoen AG', 'Brownstein JS', 'Sobral BW']","['Virginia Bioinformatics Institute, Virginia Tech, Blacksburg, VA 24061, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",20110627,England,Bioinformatics,"Bioinformatics (Oxford, England)",9808944,IM,"['Bacteria/pathogenicity', 'Bacterial Infections/microbiology', 'Communicable Diseases/epidemiology/genetics/*microbiology', 'Computational Biology', 'Computer Graphics', '*Databases, Factual', '*Host-Pathogen Interactions', 'Humans', 'Software', 'Systems Integration', 'Virulence']",PMC3150046,,,2011/06/30 06:00,2012/02/10 06:00,['2011/06/30 06:00'],"['2011/06/30 06:00 [entrez]', '2011/06/30 06:00 [pubmed]', '2012/02/10 06:00 [medline]']","['btr391 [pii]', '10.1093/bioinformatics/btr391 [doi]']",ppublish,Bioinformatics. 2011 Aug 15;27(16):2279-87. doi: 10.1093/bioinformatics/btr391. Epub 2011 Jun 27.,,,,,,,['HHSN272200900040C/AI/NIAID NIH HHS/United States'],,,,,,,,,,
13758774,NLM,MEDLINE,19981101,20181130,0068-3957 (Print) 0068-3957 (Linking),2,,1961 Jun,[Therapy of infectious diseases with cortisone and its derivatives].,330-41,,,,"['LANG, W']",['LANG W'],,['ger'],['Journal Article'],,Bulgaria,Izv Mikrobiol Inst (Sofiia),Izvestiia na Mikrobiologicheskiia institut,7600108,OM,"['Communicable Diseases/*therapy', '*Cortisone']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*CORTISONE']",1961/06/01 00:00,1961/06/01 00:01,['1961/06/01 00:00'],"['1961/06/01 00:00 [pubmed]', '1961/06/01 00:01 [medline]', '1961/06/01 00:00 [entrez]']",,ppublish,Izv Mikrobiol Inst (Sofiia). 1961 Jun;2:330-41.,,,['V27W9254FZ (Cortisone)'],,,,,,,,,,,,,,
14881891,NLM,MEDLINE,20040215,20181201,,226,14,1951 Oct 3,Some notes on the modern treatment of the common infectious diseases.,336-42,,,,"['JOHNSTONE, D F']",['JOHNSTONE DF'],,['eng'],['Journal Article'],,England,Med Press,The Medical press,0017457,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1951/10/03 00:00,1951/10/03 00:01,['1951/10/03 00:00'],"['1951/10/03 00:00 [pubmed]', '1951/10/03 00:01 [medline]', '1951/10/03 00:00 [entrez]']",,ppublish,Med Press. 1951 Oct 3;226(14):336-42.,,,,,,,,,,,,['CLML: 5221:12162:90'],,,,,
18879430,NLM,MEDLINE,20081016,20201005,0026-4806 (Print) 0026-4806 (Linking),39,32,1948 Aug 11,[On the subject of therapy for infectious diseases].,113-5,,,,"['DE MATTIA, R']",['DE MATTIA R'],,['ita'],['Journal Article'],,Italy,Minerva Med,Minerva medica,0400732,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1948/08/11 00:00,2008/10/24 09:00,['1948/08/11 00:00'],"['1948/08/11 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/08/11 00:00 [entrez]']",,ppublish,Minerva Med. 1948 Aug 11;39(32):113-5.,,,,,,,,,In tema di terapia delle malattie infettive.,,,['CLML: 4815:997a'],,,,,
13361072,NLM,MEDLINE,20020501,20181201,0041-6959 (Print) 0041-6959 (Linking),85,7,1956 Jul,[What's new in infectious diseases?].,796-8,,,,"['CHARBONNEAU, H']",['CHARBONNEAU H'],,['fre'],['Journal Article'],,Canada,Union Med Can,L'union medicale du Canada,0030444,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1956/07/01 00:00,1956/07/01 00:01,['1956/07/01 00:00'],"['1956/07/01 00:00 [pubmed]', '1956/07/01 00:01 [medline]', '1956/07/01 00:00 [entrez]']",,ppublish,Union Med Can. 1956 Jul;85(7):796-8.,,,,,,,,,Quoi de neuf en maladies infectieuses?,,,['CLML: 5731:7133'],,,,,
14905003,NLM,MEDLINE,20040215,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4758,1952 Mar 15,INFECTIOUS diseases and vital statistics.,610-1,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*epidemiology/*statistics & numerical data', 'Smallpox/*epidemiology/*statistics & numerical data', '*Variola virus', '*Vital Statistics']",PMC2023034,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology and statistics', '*SMALLPOX/epidemiology and statistics', '*VITAL STATISTICS']",1952/03/15 00:00,1952/03/15 00:01,['1952/03/15 00:00'],"['1952/03/15 00:00 [pubmed]', '1952/03/15 00:01 [medline]', '1952/03/15 00:00 [entrez]']",,ppublish,Br Med J. 1952 Mar 15;1(4758):610-1.,,,,,,,,,,,,['CLML: 5221:35587:90:346:407'],,,,,
21047022,NLM,MEDLINE,20101210,20101104,1934-4287 (Print) 1934-4287 (Linking),21,2,2010 Aug,Infectious diseases and immunizations. Preface.,xii,,,,"['Braverman, Paula K', 'Frenck, Robert W Jr', 'Holland-Hall, Cynthia']","['Braverman PK', 'Frenck RW Jr', 'Holland-Hall C']","[""Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.""]",['eng'],['Introductory Journal Article'],,United States,Adolesc Med State Art Rev,Adolescent medicine: state of the art reviews,101314248,IM,"['Adolescent', '*Adolescent Medicine', 'Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*therapy', 'Humans', '*Immunization']",,,,2010/11/05 06:00,2010/12/14 06:00,['2010/11/05 06:00'],"['2010/11/05 06:00 [entrez]', '2010/11/05 06:00 [pubmed]', '2010/12/14 06:00 [medline]']",,ppublish,Adolesc Med State Art Rev. 2010 Aug;21(2):xii.,,,,,,,,,,,,,,,,,
18860858,NLM,MEDLINE,20081020,20201005,0369-8394 (Print) 0369-8394 (Linking),37,13,1948 Apr 1,[Some cases of infectious diseases treated with ferricillin (penicillineretard)].,231,,,,"['GUILLERMIN, R']",['GUILLERMIN R'],,['fre'],['Journal Article'],,Switzerland,Praxis,Praxis,0401230,OM,"['Communicable Diseases/*therapy', '*Penicillins']",,['NLM'],"['*INFECTIOUS DISEASES/therapy', '*PENICILLIN/depot']",1948/04/01 00:00,1948/04/01 00:01,['1948/04/01 00:00'],"['1948/04/01 00:00 [pubmed]', '1948/04/01 00:01 [medline]', '1948/04/01 00:00 [entrez]']",,ppublish,Praxis. 1948 Apr 1;37(13):231.,,,['0 (Penicillins)'],,,,,,Quelques cas de maladies infectieuses traitees par la ferricilline (penicillineretard).,,,['CLML: 4815:203h'],,,,,
30178972,NLM,MEDLINE,20190429,20190429,0021-5384 (Print) 0021-5384 (Linking),105,11,2016 Nov,[Up-to-date imported infectious disease. Travel Medicine and Infectious Diseases from Foreign Countries].,2113-6,,,,"['Hamada, Atsuo']",['Hamada A'],,['jpn'],['Editorial'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['*Communicable Diseases', '*Communicable Diseases, Imported', 'Humans', 'Internationality', '*Travel Medicine']",,,,2016/11/01 00:00,2019/04/30 06:00,['2018/09/05 06:00'],"['2018/09/05 06:00 [entrez]', '2016/11/01 00:00 [pubmed]', '2019/04/30 06:00 [medline]']",,ppublish,Nihon Naika Gakkai Zasshi. 2016 Nov;105(11):2113-6.,,,,,,,,,,,,,,,,,
7663187,NLM,MEDLINE,19951011,20161020,0869-6047 (Print) 0869-6047 (Linking),,8,1995,[Scientific bases of the prevention of infectious diseases].,40-4,,,,"[""Vorob'ev, A A"", 'Andzhaparidze, O G', 'Drozdov, S G', ""L'vov, D K"", 'Prozorovskii, S V', 'Semenov, B F', 'Totolian, A A', 'Shuvalova, E P']","[""Vorob'ev AA"", 'Andzhaparidze OG', 'Drozdov SG', ""L'vov DK"", 'Prozorovskii SV', 'Semenov BF', 'Totolian AA', 'Shuvalova EP']",,['rus'],['Journal Article'],,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Communicable Diseases/*epidemiology/microbiology/mortality', 'Humans', '*Infection Control/methods', 'Research', 'Russia/epidemiology', 'USSR/epidemiology', 'United States/epidemiology', 'Vaccination']",,,,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 1995;(8):40-4.,,,,,,,,,Nauchnye osnovy bor'by s infektsionnymi zabolevaniiami.,,,,,,,,
4048500,NLM,MEDLINE,19851104,20061115,0033-2100 (Print) 0033-2100 (Linking),39,1,1985,[Infectious diseases in Poland 1983].,27-34,,,,"['Kostrzewski, J', 'Piatkowski, J']","['Kostrzewski J', 'Piatkowski J']",,['pol'],"['Comparative Study', 'English Abstract', 'Journal Article']",,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', 'Child, Preschool', 'Communicable Diseases/*epidemiology/etiology', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Poland']",,,,1985/01/01 00:00,1985/01/01 00:01,['1985/01/01 00:00'],"['1985/01/01 00:00 [pubmed]', '1985/01/01 00:01 [medline]', '1985/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1985;39(1):27-34.,,,,,,,,,Choroby zakazne w Polsce w roku 1983.,,,,,,,,
17201304,NLM,MEDLINE,20070524,20181201,0025-682X (Print) 0025-682X (Linking),66,5,2006 Oct,[Emerging infectious diseases: which threats?].,517-9,,,,"['Cot, S', 'Thill, M', 'Gillet, A M']","['Cot S', 'Thill M', 'Gillet AM']","[""L'Institut de medecine tropicale du Service de sante des armees.""]",['fre'],['Congress'],,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,IM,"['*Communicable Diseases, Emerging/epidemiology/etiology/prevention & control', 'Humans']",,,,2007/01/05 09:00,2007/05/26 09:00,['2007/01/05 09:00'],"['2007/01/05 09:00 [pubmed]', '2007/05/26 09:00 [medline]', '2007/01/05 09:00 [entrez]']",,ppublish,Med Trop (Mars). 2006 Oct;66(5):517-9.,,,,,,,,,Infections emergentes: quelles menaces?,,,,,,,,
19393904,NLM,MEDLINE,20090522,20090427,1557-9824 (Electronic) 0891-5520 (Linking),23,2,2009 Jun,Systematic reviews and meta-analyses in infectious diseases: how are they done and what are their strengths and limitations?,181-94,10.1016/j.idc.2009.01.002 [doi],"In infectious diseases, as in other domains, systematic reviews and meta-analyses are the type of research most easily translated into clinical practice. Practitioners should familiarize themselves with the methodology of systematic reviews and meta-analyses, their interpretation, and their limitations.",,"['Leibovici, Leonard', 'Falagas, Matthew E']","['Leibovici L', 'Falagas ME']","['Department of Medicine E, Rabin Medical Center, Petah-Tiqva, Israel. leibovic@post.tau.ac.il']",['eng'],['Journal Article'],,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,IM,"['Case Management', 'Communicable Diseases/*diagnosis/*therapy', 'Humans', '*Meta-Analysis as Topic', '*Randomized Controlled Trials as Topic', 'Treatment Outcome']",,,,2009/04/28 09:00,2009/05/23 09:00,['2009/04/28 09:00'],"['2009/04/28 09:00 [entrez]', '2009/04/28 09:00 [pubmed]', '2009/05/23 09:00 [medline]']","['S0891-5520(09)00004-X [pii]', '10.1016/j.idc.2009.01.002 [doi]']",ppublish,Infect Dis Clin North Am. 2009 Jun;23(2):181-94. doi: 10.1016/j.idc.2009.01.002.,,,,,,,,,,,,,,,,,
15494798,NLM,MEDLINE,20041210,20080623,0379-5284 (Print) 0379-5284 (Linking),25,10,2004 Oct,Isolation versus quarantine and alternative measures to control emerging infectious diseases.,1337-46,,"In the past 25 years, the world has witnessed the emergence and re-emergence of many infectious diseases. In the early stages of their emergence, isolation and quarantine may be the only and last resort to effectively control infectious diseases when we are confronted with limited or no knowledge of a newly identified and previously unknown contagious disease, which causes a serious public health threat either locally or internationally. The article traces back the origins of isolation and quarantine; defines precisely the terms isolation and quarantine as they are currently used in the modern era; compare and contrast these terms; identifies some of the harmful consequences of applying quarantine measures; highlights considerations for the use of isolation and quarantine; and identifies alternative measures adopted by the world health community to respond to emerging and re-emerging health threats.",,"['Al-Ateeg, Fahad A']",['Al-Ateeg FA'],"['Health Programs Sector, Institute of Public Administration, Riyadh, Kingdom of Saudi Arabia. ateegf@ipa.edu.sa']",['eng'],"['Comparative Study', 'Journal Article', 'Review']",,Saudi Arabia,Saudi Med J,Saudi medical journal,7909441,IM,"['Communicable Disease Control/*standards/trends', 'Communicable Diseases/diagnosis/*epidemiology', 'Communicable Diseases, Emerging/diagnosis/*prevention & control', 'Developing Countries', '*Disease Outbreaks', 'Female', 'Humans', 'Incidence', 'Male', 'Patient Isolation/*organization & administration', 'Program Evaluation', 'Quarantine/*organization & administration', 'Risk Assessment', 'Saudi Arabia/epidemiology']",,,,2004/10/21 09:00,2004/12/16 09:00,['2004/10/21 09:00'],"['2004/10/21 09:00 [pubmed]', '2004/12/16 09:00 [medline]', '2004/10/21 09:00 [entrez]']","[""20030564' [pii]""]",ppublish,Saudi Med J. 2004 Oct;25(10):1337-46.,,,,,,27,,,,,,,,,,,
21906695,NLM,MEDLINE,20120326,20220311,1567-7257 (Electronic) 1567-1348 (Print) 1567-1348 (Linking),11,8,2011 Dec,Phylogenetic and epidemic modeling of rapidly evolving infectious diseases.,1825-41,10.1016/j.meegid.2011.08.005 [doi],"Epidemic modeling of infectious diseases has a long history in both theoretical and empirical research. However the recent explosion of genetic data has revealed the rapid rate of evolution that many populations of infectious agents undergo and has underscored the need to consider both evolutionary and ecological processes on the same time scale. Mathematical epidemiology has applied dynamical models to study infectious epidemics, but these models have tended not to exploit--or take into account--evolutionary changes and their effect on the ecological processes and population dynamics of the infectious agent. On the other hand, statistical phylogenetics has increasingly been applied to the study of infectious agents. This approach is based on phylogenetics, molecular clocks, genealogy-based population genetics and phylogeography. Bayesian Markov chain Monte Carlo and related computational tools have been the primary source of advances in these statistical phylogenetic approaches. Recently the first tentative steps have been taken to reconcile these two theoretical approaches. We survey the Bayesian phylogenetic approach to epidemic modeling of infection diseases and describe the contrasts it provides to mathematical epidemiology as well as emphasize the significance of the future unification of these two fields.",['Copyright (c) 2011 Elsevier B.V. All rights reserved.'],"['Kuhnert, Denise', 'Wu, Chieh-Hsi', 'Drummond, Alexei J']","['Kuhnert D', 'Wu CH', 'Drummond AJ']","['Allan Wilson Centre for Molecular Ecology and Evolution, University of Auckland, Auckland, New Zealand.']",['eng'],"['Journal Article', 'Review']",20110831,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Animals', 'Bayes Theorem', '*Biological Evolution', 'Communicable Diseases/*classification/*epidemiology/*genetics', 'Epidemics', 'Humans', 'Markov Chains', '*Models, Theoretical', 'Monte Carlo Method', 'Phylogeny']",PMC7106223,,,2011/09/13 06:00,2012/03/27 06:00,['2011/09/13 06:00'],"['2011/04/01 00:00 [received]', '2011/08/09 00:00 [revised]', '2011/08/09 00:00 [accepted]', '2011/09/13 06:00 [entrez]', '2011/09/13 06:00 [pubmed]', '2012/03/27 06:00 [medline]']","['S1567-1348(11)00284-X [pii]', '10.1016/j.meegid.2011.08.005 [doi]']",ppublish,Infect Genet Evol. 2011 Dec;11(8):1825-41. doi: 10.1016/j.meegid.2011.08.005. Epub 2011 Aug 31.,,,,,,,,,,,,,,,,,
17598991,NLM,MEDLINE,20071108,20190816,1124-9390 (Print) 1124-9390 (Linking),Suppl 1,,2007,[Infectious diseases and population assistance: general issues].,30-7,,"Actually the infectious diseases are a predominant cause of morbidity and mortality in limited resource countries and, of course, not unimportant in industrialized countries where the social phenomena of immigration and increased internal and international mobility of people may facilitate the reemergence of infectious diseases considered overcome. It is becoming more and more important to consider the actual role of assistance of people for infectious diseases: a careful consideration needing of concretes example for becoming medical practices and social languages appropriates to the local context and useful for promoting more efficacious cares and prevention of infectious diseases.",,"['Russo, G', 'Riccardo, F', 'Scaroni, E', 'Nardi, L', 'De Rosa, A G', 'Pacini, A', 'Pacifici, L E']","['Russo G', 'Riccardo F', 'Scaroni E', 'Nardi L', 'De Rosa AG', 'Pacini A', 'Pacifici LE']","['Dipartimento di Malattie Infettive e Tropicali, Universita degli Studi di Roma La Sapienza, Italy.']",['ita'],"['Comparative Study', 'English Abstract', 'Journal Article']",,Italy,Infez Med,Le infezioni in medicina,9613961,IM,"['Cameroon', '*Communicable Diseases/epidemiology/mortality/therapy', '*Delivery of Health Care', '*Disasters', '*Emigration and Immigration', 'Female', 'HIV Infections/*prevention & control/transmission', '*Helping Behavior', 'Humans', 'Infant, Newborn', 'Infectious Disease Transmission, Vertical/prevention & control', '*International Cooperation', 'Italy', 'Male', 'Pregnancy', 'Red Cross', 'Risk Factors', 'Socioeconomic Factors', 'Sri Lanka', 'Vaccination', 'World Health Organization']",,,,2007/10/06 09:00,2007/11/09 09:00,['2007/10/06 09:00'],"['2007/10/06 09:00 [pubmed]', '2007/11/09 09:00 [medline]', '2007/10/06 09:00 [entrez]']",,ppublish,Infez Med. 2007;Suppl 1:30-7.,,,,,,,,,Assistenza infettivologica alla popolazione: problemi generali.,,,,,,,,
6472510,NLM,MEDLINE,19841010,20041117,0028-2162 (Print) 0028-2162 (Linking),128,30,1984 Jul 28,[Patients with infectious diseases registered in 1983].,1432-6,,,,"['Bijkerk, H']",['Bijkerk H'],,['dut'],['Journal Article'],,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Adolescent', 'Adult', 'Aged', 'Animals', 'Child', 'Child, Preschool', 'Communicable Diseases/*epidemiology/veterinary', 'Female', 'Foxes', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Netherlands']",,,,1984/07/28 00:00,1984/07/28 00:01,['1984/07/28 00:00'],"['1984/07/28 00:00 [pubmed]', '1984/07/28 00:01 [medline]', '1984/07/28 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1984 Jul 28;128(30):1432-6.,,,,,,,,,Aangegeven patienten met infectieziekten in 1983.,,,,,,,,
31519020,NLM,MEDLINE,20200522,20200522,1537-6613 (Electronic) 0022-1899 (Linking),220,12,2019 Nov 6,The Double-Edged Sword of Military Response to Societal Disruptions: A Systematic Review of the Evidence for Military Personnel as Pathogen Transmitters.,1873-1884,10.1093/infdis/jiz400 [doi],"Given their lack of immunity and increased exposure, military personnel have the potential to serve as carriers or reservoirs for infectious diseases into or out of the deployment areas, but, to our knowledge, the historical evidence for such transmission events has not previously been reviewed. Using PubMed, we performed a systematic review of published literature between 1955 and 2018, which documented evidence for military personnel transporting infectious pathogens into or out of deployment areas. Of the 439 articles screened, 67 were included for final qualitative and quantitative review. The data extracted from these articles described numerous instances in which thousands of military service members demonstrated potential or actual transmission and transportation of multiple diverse pathogens. These data underscore the immense importance preventive medical professionals play in mitigating such risk, how their public health efforts must be supported, and the importance of surveillance in protecting both military and civilian populations.","['Published by Oxford University Press for the Infectious Diseases Society of', 'America 2019.']","['Zemke, Juliana N', 'Sanchez, Jose L', 'Pang, Junxiong', 'Gray, Gregory C']","['Zemke JN', 'Sanchez JL', 'Pang J', 'Gray GC']","['Duke Global Health Institute, Duke University, Durham, North Carolina.', 'Division of Infectious Diseases, Duke University, Durham, North Carolina.', 'Department of Defense, Defense Health Agency, Public Health Division, Armed Forces Health Surveillance Branch, Silver Spring, Maryland.', 'Duke Global Health Institute, Duke University, Durham, North Carolina.', 'Centre for Infectious Disease Epidemiology & Research, Saw Swee Hock School of Public Health, National University of Singapore.', 'Duke Global Health Institute, Duke University, Durham, North Carolina.', 'Division of Infectious Diseases, Duke University, Durham, North Carolina.', 'Emerging Infectious Disease Program, Duke-National University of Singapore Medical School, Singapore.', 'Global Health Research Center, Duke-Kunshan University, Kunshan, China.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Systematic Review']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,IM,"['Communicable Diseases/*epidemiology/etiology/history/*transmission', 'Disease Notification/statistics & numerical data', 'Geography, Medical', 'Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', '*Military Personnel', 'Risk Assessment', 'Risk Factors', 'Seroconversion']",,['NOTNLM'],"['Communicable Diseases', 'Global Health', 'Military Medicine', 'Military Personnel']",2019/09/14 06:00,2020/05/23 06:00,['2019/09/14 06:00'],"['2019/05/30 00:00 [received]', '2019/08/02 00:00 [accepted]', '2019/09/14 06:00 [pubmed]', '2020/05/23 06:00 [medline]', '2019/09/14 06:00 [entrez]']","['5550907 [pii]', '10.1093/infdis/jiz400 [doi]']",ppublish,J Infect Dis. 2019 Nov 6;220(12):1873-1884. doi: 10.1093/infdis/jiz400.,,,,,,,,,,,,,,,,,
22036487,NLM,MEDLINE,20120315,20111031,1558-0776 (Electronic) 1071-9091 (Linking),18,2,2011 Jun,Infectious diseases of the nervous system.,88-90,10.1016/j.spen.2011.05.015 [doi],The curriculum for child neurology trainees should include information regarding the many infectious and post-infectious disorders that affect the developing nervous system. This article provides recommendations regarding the nature of the educational content and suggestions how this content can be provided to trainees.,['Copyright (c) 2011 Elsevier Inc. All rights reserved.'],"['Bale, James F Jr']",['Bale JF Jr'],"['Department of Pediatrics, Division of Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, UT, USA. James.Bale@hsc.utah.edu']",['eng'],['Journal Article'],,United States,Semin Pediatr Neurol,Seminars in pediatric neurology,9441351,IM,"['Child', 'Clinical Competence/*standards', 'Communicable Disease Control', '*Communicable Diseases/diagnosis/epidemiology/therapy', 'Curriculum', 'Education, Medical, Graduate/*standards', 'Humans', '*Nervous System Diseases/diagnosis/epidemiology/therapy', 'Neurology/*education']",,,,2011/11/01 06:00,2012/03/16 06:00,['2011/11/01 06:00'],"['2011/11/01 06:00 [entrez]', '2011/11/01 06:00 [pubmed]', '2012/03/16 06:00 [medline]']","['S1071-9091(11)00045-3 [pii]', '10.1016/j.spen.2011.05.015 [doi]']",ppublish,Semin Pediatr Neurol. 2011 Jun;18(2):88-90. doi: 10.1016/j.spen.2011.05.015.,,,,,,,,,,,,,,,,,
13698203,NLM,MEDLINE,19981101,20181130,0030-6002 (Print) 0030-6002 (Linking),102,,1961 Jul 30,[Hibernation and infectious diseases].,1464-7,,,,"['FARKAS, E', 'KOMAN, E']","['FARKAS E', 'KOMAN E']",,['hun'],['Journal Article'],,Hungary,Orv Hetil,Orvosi hetilap,0376412,OM,"['Communicable Diseases/*therapy', '*Hibernation', '*Hypothermia, Induced']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*HIBERNATION, ARTIFICIAL']",1961/07/30 00:00,1961/07/30 00:01,['1961/07/30 00:00'],"['1961/07/30 00:00 [pubmed]', '1961/07/30 00:01 [medline]', '1961/07/30 00:00 [entrez]']",,ppublish,Orv Hetil. 1961 Jul 30;102:1464-7.,,,,,,,,,,,,,,,,,
16404852,NLM,MEDLINE,20060221,20141120,0040-3660 (Print) 0040-3660 (Linking),77,11,2005,[Infectious diseases: a global challenge and problem of military medicine].,5-7,,,,"['Pokrovskii, V I', 'Lobzin, Iu V']","['Pokrovskii VI', 'Lobzin IuV']",,['rus'],['Editorial'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Bacteria/isolation & purification', 'Communicable Diseases/*epidemiology/*microbiology', '*Global Health', 'Humans', 'Military Medicine/*trends', 'Viruses/isolation & purification']",,,,2006/01/13 09:00,2006/02/24 09:00,['2006/01/13 09:00'],"['2006/01/13 09:00 [pubmed]', '2006/02/24 09:00 [medline]', '2006/01/13 09:00 [entrez]']",,ppublish,Ter Arkh. 2005;77(11):5-7.,,,,,,,,,,,,,,,,,
8541756,NLM,MEDLINE,19960209,20190501,0959-8138 (Print) 1468-5833 (Electronic) 0959-8138 (Linking),311,7021,1995 Dec 23-30,Infectious diseases: an ecological perspective.,1681-4,,,,"['Wilson, M E']",['Wilson ME'],"['Department of Population and International Health, Harvard School of Public Health, Boston, MA 02115-6023, USA.']",['eng'],['Journal Article'],,England,BMJ,BMJ (Clinical research ed.),8900488,IM,"['Climate', 'Communicable Diseases/*epidemiology/etiology', 'Ecology', 'Emigration and Immigration', 'Global Health', 'Humans', 'Residence Characteristics']",PMC2539080,,,1995/12/23 00:00,1995/12/23 00:01,['1995/12/23 00:00'],"['1995/12/23 00:00 [pubmed]', '1995/12/23 00:01 [medline]', '1995/12/23 00:00 [entrez]']",['10.1136/bmj.311.7021.1681 [doi]'],ppublish,BMJ. 1995 Dec 23-30;311(7021):1681-4. doi: 10.1136/bmj.311.7021.1681.,,,,['BMJ 1996 Jan 27;312(7025):220'],['BMJ. 1996 Apr 6;312(7035):907-8. PMID: 8611890'],,,,,,,,,,,,
23777159,NLM,MEDLINE,20130904,20190724,0021-5384 (Print) 0021-5384 (Linking),102,3,2013 Mar 10,[Programs for continuing medical education: B session; 8. Use of antibiotics at clinical settings].,694-8,,,,"['Iwata, Kentaro']",['Iwata K'],"['Division of Infectious Diseases Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Japan.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Anti-Bacterial Agents/*therapeutic use', 'Communicable Diseases/diagnosis/*drug therapy', 'Education, Medical, Continuing', 'Humans']",,,,2013/06/20 06:00,2013/09/05 06:00,['2013/06/20 06:00'],"['2013/06/20 06:00 [entrez]', '2013/06/20 06:00 [pubmed]', '2013/09/05 06:00 [medline]']",['10.2169/naika.102.694 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2013 Mar 10;102(3):694-8. doi: 10.2169/naika.102.694.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
17455615,NLM,MEDLINE,20070629,20131121,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[Rapid diagnosis of infectious diseases].,188-92,,,,"['Okada, Jun']",['Okada J'],"['Department of Health Science, Daito Bunka University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Antibodies, Bacterial/analysis', 'Antigens, Bacterial/analysis', 'Communicable Diseases/*diagnosis/microbiology/virology', 'Gentian Violet', 'Humans', 'Immunoassay', 'Microbiological Techniques/*methods', 'Phenazines', 'Sensitivity and Specificity', 'Specimen Handling', 'Time Factors']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:188-92.,,,"['0 (Antibodies, Bacterial)', '0 (Antigens, Bacterial)', ""0 (Gram's stain)"", '0 (Phenazines)', 'J4Z741D6O5 (Gentian Violet)']",,,4,,,,,,,,,,,
30903670,NLM,MEDLINE,20200930,20200930,1399-0012 (Electronic) 0902-0063 (Linking),33,9,2019 Sep,Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.,e13547,10.1111/ctr.13547 [doi],"These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation will review the current state of the art of donor-derived infections. Specifically, the guideline will summarize standardized definitions and approaches to defining imputability, updated data on the epidemiology of donor-derived infections, and approaches to risk mitigation against transmission of infections. This update will additionally provide guidance on the use of HIV+ donors in HIV+ recipients, the use of HCV-viremic donors in non-viremic recipients, donors with endemic infections, and donors with bacteremia, meningitis, and encephalitis. Lastly, the guidance will summarize an approach to recipients with a suspected donor-derived infection.",['(c) 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],"['Wolfe, Cameron R', 'Ison, Michael G']","['Wolfe CR', 'Ison MG']","['Division of Infectious Diseases, Duke University, Durham, North Carolina.', 'Divisions of Infectious Diseases & Organ Transplantation, Northwestern University Feinberg School of Medicine, Northwestern University Comprehensive Transplant Center, Chicago, Illinois.']",['eng'],['Journal Article'],20190410,Denmark,Clin Transplant,Clinical transplantation,8710240,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*diagnosis/*drug therapy/etiology', 'Donor Selection/*standards', 'Humans', 'Organ Transplantation/*adverse effects', 'Practice Guidelines as Topic/*standards', 'Societies, Medical', 'Tissue Donors/*supply & distribution', 'Transplant Recipients']",,['NOTNLM'],"['complication', 'donor-derived infections', 'donors and donation', 'infectious']",2019/03/25 06:00,2020/10/02 06:00,['2019/03/24 06:00'],"['2019/03/04 00:00 [received]', '2019/03/18 00:00 [accepted]', '2019/03/25 06:00 [pubmed]', '2020/10/02 06:00 [medline]', '2019/03/24 06:00 [entrez]']",['10.1111/ctr.13547 [doi]'],ppublish,Clin Transplant. 2019 Sep;33(9):e13547. doi: 10.1111/ctr.13547. Epub 2019 Apr 10.,,,['0 (Anti-Infective Agents)'],,,,,,,,['AST Infectious Diseases Community of Practice'],,,,,,
21241521,NLM,MEDLINE,20110503,20211020,1471-2334 (Electronic) 1471-2334 (Linking),11,,2011 Jan 18,Possible impact of rising sea levels on vector-borne infectious diseases.,18,10.1186/1471-2334-11-18 [doi],"BACKGROUND: Vector-borne infectious diseases are a significant cause of human and animal mortality and morbidity. Modeling studies predict that changes in climate that accompany global warming will alter the transmission risk of many vector-borne infectious diseases in different parts of the world. Global warming will also raise sea levels, which will lead to an increase in saline and brackish water bodies in coastal areas. The potential impact of rising sea levels, as opposed to climate change, on the prevalence of vector-borne infectious diseases has hitherto been unrecognised. PRESENTATION OF THE HYPOTHESIS: Mosquito species possessing salinity-tolerant larvae and pupae, and capable of transmitting arboviruses and parasites are found in many parts of the world. An expansion of brackish and saline water bodies in coastal areas, associated with rising sea levels, can increase densities of salinity-tolerant vector mosquitoes and lead to the adaptation of freshwater vectors to breed in brackish and saline waters. The breeding of non-mosquito vectors may also be influenced by salinity changes in coastal habitats. Higher vector densities can increase transmission of vector-borne infectious diseases in coastal localities, which can then spread to other areas. TESTING THE HYPOTHESIS: The demonstration of increases in vector populations and disease prevalence that is related to an expansion of brackish/saline water bodies in coastal areas will provide the necessary supportive evidence. However the implementation of specific vector and disease control measures to counter the threat will confound the expected findings. IMPLICATIONS OF THE HYPOTHESIS: Rising sea levels can act synergistically with climate change and then interact in a complex manner with other environmental and socio-economic factors to generate a greater potential for the transmission of vector-borne infectious diseases. The resulting health impacts are likely to be particularly significant in resource-poor countries in the tropics and semi-tropics. Some measures to meet this threat are outlined.",,"['Ramasamy, Ranjan', 'Surendran, Sinnathamby N']","['Ramasamy R', 'Surendran SN']","['PAPSRB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam. ranjan.ramasamy@ubd.edu.bn']",['eng'],['Journal Article'],20110118,England,BMC Infect Dis,BMC infectious diseases,100968551,IM,"['Animals', 'Climate Change', 'Communicable Diseases/epidemiology/parasitology/*transmission/virology', '*Ecosystem', 'Fresh Water/parasitology', 'Humans', 'Insect Vectors/parasitology/*physiology/virology', '*Salt Tolerance', 'Seawater/parasitology']",PMC3035583,,,2011/01/19 06:00,2011/05/04 06:00,['2011/01/19 06:00'],"['2010/09/29 00:00 [received]', '2011/01/18 00:00 [accepted]', '2011/01/19 06:00 [entrez]', '2011/01/19 06:00 [pubmed]', '2011/05/04 06:00 [medline]']","['1471-2334-11-18 [pii]', '10.1186/1471-2334-11-18 [doi]']",epublish,BMC Infect Dis. 2011 Jan 18;11:18. doi: 10.1186/1471-2334-11-18.,,,,,,,,,,,,,,,,,
7528465,NLM,MEDLINE,19950123,20190512,0002-9173 (Print) 0002-9173 (Linking),102,6,1994 Dec,Surgical pathology and the diagnosis of infectious diseases.,711-2,,,,"['Watts, J C']",['Watts JC'],,['eng'],"['Comment', 'Comparative Study', 'Editorial']",,England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Communicable Diseases/*diagnosis/microbiology', 'Histological Techniques', 'Humans', 'Microbiological Techniques', '*Pathology, Surgical', 'Sensitivity and Specificity', 'Staining and Labeling']",,,,1994/12/01 00:00,1994/12/01 00:01,['1994/12/01 00:00'],"['1994/12/01 00:00 [pubmed]', '1994/12/01 00:01 [medline]', '1994/12/01 00:00 [entrez]']",['10.1093/ajcp/102.6.711 [doi]'],ppublish,Am J Clin Pathol. 1994 Dec;102(6):711-2. doi: 10.1093/ajcp/102.6.711.,,,,,,,,['Am J Clin Pathol. 1994 Dec;102(6):736-40. PMID: 7528466'],,,,,,,,,
24053492,NLM,MEDLINE,20140623,20211021,1471-2334 (Electronic) 1471-2334 (Linking),13,,2013 Sep 20,An easy operating pathogen microarray (EOPM) platform for rapid screening of vertebrate pathogens.,437,10.1186/1471-2334-13-437 [doi],"BACKGROUND: Infectious diseases emerge frequently in China, partly because of its large and highly mobile population. Therefore, a rapid and cost-effective pathogen screening method with broad coverage is required for prevention and control of infectious diseases. The availability of a large number of microbial genome sequences generated by conventional Sanger sequencing and next generation sequencing has enabled the development of a high-throughput high-density microarray platform for rapid large-scale screening of vertebrate pathogens. METHODS: An easy operating pathogen microarray (EOPM) was designed to detect almost all known pathogens and related species based on their genomic sequences. For effective identification of pathogens from EOPM data, a statistical enrichment algorithm has been proposed, and further implemented in a user-friendly web-based interface. RESULTS: Using multiple probes designed to specifically detect a microbial genus or species, EOPM can correctly identify known pathogens at the species or genus level in blinded testing. Despite a lower sensitivity than PCR, EOPM is sufficiently sensitive to detect the predominant pathogens causing clinical symptoms. During application in two recent clinical infectious disease outbreaks in China, EOPM successfully identified the responsible pathogens. CONCLUSIONS: EOPM is an effective surveillance platform for infectious diseases, and can play an important role in infectious disease control.",,"['Huang, Weiwei', 'Yang, Yinhui', 'Zhang, Xinlei', 'Zhao, Changan', 'Yin, Aihua', 'Zhang, Xiaozhuang', 'He, Zhengxin', 'Jiang, Yongqiang', 'Zhang, Liang']","['Huang W', 'Yang Y', 'Zhang X', 'Zhao C', 'Yin A', 'Zhang X', 'He Z', 'Jiang Y', 'Zhang L']","['BioChain (Beijing) Science & Technology Inc,, No,7A, Yongchang North Rd, Business Development Area, Beijing 100176, China. jiangyq710327@sina.com.']",['eng'],"['Evaluation Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20130920,England,BMC Infect Dis,BMC infectious diseases,100968551,IM,"['Animals', 'Bacteria/genetics/*isolation & purification', 'China', 'Communicable Diseases/*diagnosis/microbiology/parasitology/virology', 'Fungi/genetics/*isolation & purification', 'Humans', 'Microarray Analysis/instrumentation/*methods', 'Parasites/genetics/*isolation & purification', 'Vertebrates', 'Viruses/genetics/*isolation & purification']",PMC3848773,,,2013/09/24 06:00,2014/06/24 06:00,['2013/09/24 06:00'],"['2012/11/05 00:00 [received]', '2013/09/13 00:00 [accepted]', '2013/09/24 06:00 [entrez]', '2013/09/24 06:00 [pubmed]', '2014/06/24 06:00 [medline]']","['1471-2334-13-437 [pii]', '10.1186/1471-2334-13-437 [doi]']",epublish,BMC Infect Dis. 2013 Sep 20;13:437. doi: 10.1186/1471-2334-13-437.,,,,,,,,,,,,,,,,,
17427139,NLM,MEDLINE,20070719,20081121,1537-5323 (Electronic) 0003-0147 (Linking),169,5,2007 May,Predation can increase the prevalence of infectious disease.,690-9,,"Many host-pathogen interactions are embedded in a web of other interspecific interactions. Recent theoretical studies have suggested that reductions in predator abundance can indirectly lead to upsurges in infectious diseases harbored by prey populations. In this note, we use simple models to show that in some circumstances, predation can actually increase the equilibrial prevalence of infection in a host, where prevalence is defined as the fraction of host population that is infected. Our results show that there is no complete generalization possible about how shifts in predation pressure translate into shifts in infection levels, without some understanding of host population regulation and the role of acquired immunity. Our results further highlight the importance of understanding the dynamics of nonregulatory pathogens in reservoir host populations and the understudied effects of demographic costs incurred by individuals that survive infection and develop acquired immunity.",,"['Holt, Robert D', 'Roy, Manojit']","['Holt RD', 'Roy M']","['Department of Zoology, University of Florida, P.O. Box 118525, Gainesville, Florida 32611, USA. rdholt@zoo.ufl.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20070309,United States,Am Nat,The American naturalist,2984688R,IM,"['Animals', 'Communicable Diseases/epidemiology/*transmission/*veterinary', 'Computer Simulation', 'Disease Transmission, Infectious/*veterinary', '*Food Chain', '*Models, Theoretical', 'Prevalence']",,,,2007/04/12 09:00,2007/07/20 09:00,['2007/04/12 09:00'],"['2006/04/18 00:00 [received]', '2006/11/02 00:00 [accepted]', '2007/04/12 09:00 [pubmed]', '2007/07/20 09:00 [medline]', '2007/04/12 09:00 [entrez]']","['AN41777 [pii]', '10.1086/513188 [doi]']",ppublish,Am Nat. 2007 May;169(5):690-9. doi: 10.1086/513188. Epub 2007 Mar 9.,,,,,,,,,,,,,,,,,
13434106,NLM,MEDLINE,20020501,20181201,0043-3284 (Print) 0043-3284 (Linking),53,6,1957 Jun,Some current problems in the management of infectious diseases.,213-7,,,,"['KEEFER, C S']",['KEEFER CS'],,['eng'],['Journal Article'],,United States,W V Med J,The West Virginia medical journal,0413777,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1957/06/01 00:00,1957/06/01 00:01,['1957/06/01 00:00'],"['1957/06/01 00:00 [pubmed]', '1957/06/01 00:01 [medline]', '1957/06/01 00:00 [entrez]']",,ppublish,W V Med J. 1957 Jun;53(6):213-7.,,,,,,,,,,,,['CLML: 5732:32310'],,,,,
13624951,NLM,MEDLINE,20000701,20181201,0039-5560 (Print) 0039-5560 (Linking),13,33,1958 Dec 20,[Aims & arrangement of current treatment of infectious diseases].,1622-30,,,,"['FORSSELL, P']",['FORSSELL P'],,['fin'],['Journal Article'],,Finland,Suom Laakaril,Suomen laakarilehti. Finlands lakartidning,0404547,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1958/12/20 00:00,1958/12/20 00:01,['1958/12/20 00:00'],"['1958/12/20 00:00 [pubmed]', '1958/12/20 00:01 [medline]', '1958/12/20 00:00 [entrez]']",,ppublish,Suom Laakaril. 1958 Dec 20;13(33):1622-30.,,,,,,,,,"Infektiotautien hoidon paamaarat ja jarjestely nykyaikana, erikoisesti helsingin kaupungin oloja silmallapitaten.",,,['CLML: 5935:54641:151'],,,,,
25045666,NLM,MEDLINE,20150312,20211021,2314-6141 (Electronic) 2314-6133 (Print),2014,,2014,The impact of coinfections and their simultaneous transmission on antigenic diversity and epidemic cycling of infectious diseases.,375862,10.1155/2014/375862 [doi] 375862,"Epidemic cycling in human infectious diseases is common; however, its underlying mechanisms have been poorly understood. Much effort has been made to search for external mechanisms. Multiple strains of an infectious agent were usually observed and coinfections were frequent; further, empirical evidence indicates the simultaneous transmission of coinfections. To explore intrinsic mechanisms for epidemic cycling, in this study we consider a multistrain Susceptible-Infected-Recovered-Susceptible epidemic model by including coinfections and simultaneous transmission. We show that coinfections and their simultaneous transmission widen the parameter range for coexistence and coinfections become popular when strains enhance each other and the immunity wanes quickly. However, the total prevalence is nearly independent of these characteristics and approximated by that of one-strain model. With sufficient simultaneous transmission and antigenic diversity, cyclical epidemics can be generated even when strains interfere with each other by reducing infectivity. This indicates that strain interactions within coinfections and cross-immunity during subsequent infection provide a possible intrinsic mechanism for epidemic cycling.",,"['Zhang, Xu-Sheng', 'Cao, Ke-Fei']","['Zhang XS', 'Cao KF']","['Department of Statistics, Modelling and Economics, Centre for Infectious Disease Surveillance and Control, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK ; Medical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, Norfolk Place, London W2 1PG, UK.', 'Centre for Nonlinear Complex Systems, Department of Physics, Yunnan University, Kunming, Yunnan 650091, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20140622,United States,Biomed Res Int,BioMed research international,101600173,IM,"['Antigenic Variation/immunology', 'Coinfection/*epidemiology', 'Communicable Diseases/*epidemiology/pathology/transmission', 'Humans', 'Models, Immunological', '*Models, Theoretical']",PMC4090573,,,2014/07/22 06:00,2015/03/13 06:00,['2014/07/22 06:00'],"['2014/02/06 00:00 [received]', '2014/04/18 00:00 [revised]', '2014/04/18 00:00 [accepted]', '2014/07/22 06:00 [entrez]', '2014/07/22 06:00 [pubmed]', '2015/03/13 06:00 [medline]']",['10.1155/2014/375862 [doi]'],ppublish,Biomed Res Int. 2014;2014:375862. doi: 10.1155/2014/375862. Epub 2014 Jun 22.,,,,,,,,,,,,,,,,,
11999232,NLM,MEDLINE,20020524,20201219,0025-729X (Print) 0025-729X (Linking),176,5,2002 Mar 4,Management of infectious diseases.,202-3,,,,"['Grayson, M Lindsay', 'Wesselingh, Steven']","['Grayson ML', 'Wesselingh S']",,['eng'],"['Comment', 'Editorial']",,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['*Communicable Disease Control', 'Communicable Diseases/mortality/*therapy', 'Cross Infection/prevention & control', 'Drug Resistance', 'Evidence-Based Medicine', 'Global Health', 'Humans']",,,,2002/05/10 10:00,2002/05/25 10:01,['2002/05/10 10:00'],"['2002/01/24 00:00 [received]', '2002/01/25 00:00 [accepted]', '2002/05/10 10:00 [pubmed]', '2002/05/25 10:01 [medline]', '2002/05/10 10:00 [entrez]']","['gra10070 [pii]', '10.5694/j.1326-5377.2002.tb04371.x [doi]']",ppublish,Med J Aust. 2002 Mar 4;176(5):202-3. doi: 10.5694/j.1326-5377.2002.tb04371.x.,,,,,,,,['Med J Aust. 2002 Mar 4;176(5):229-36. PMID: 11999241'],,,,,,,,,
16034426,NLM,MEDLINE,20050830,20200327,1529-2908 (Print) 1529-2916 (Electronic) 1529-2908 (Linking),6,8,2005 Aug,The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research.,743-7,,"The US has entered a new period of fiscal restraint. What does this mean for basic research? Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, discusses the way forward for research scientists in the US.",,"['Fauci, Anthony S']",['Fauci AS'],"['National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-2520, USA. afauci@niaid.nih.gov']",['eng'],['Journal Article'],,United States,Nat Immunol,Nature immunology,100941354,IM,"['Biomedical Research', 'Budgets', 'Communicable Disease Control', 'Communicable Diseases/*diagnosis/*therapy', 'Financing, Government', 'Government Agencies', 'International Cooperation', 'National Institutes of Health (U.S.)', 'Research', '*Research Support as Topic', 'Time Factors', 'United States']",PMC7097332,,,2005/07/22 09:00,2005/09/01 09:00,['2005/07/22 09:00'],"['2005/07/22 09:00 [pubmed]', '2005/09/01 09:00 [medline]', '2005/07/22 09:00 [entrez]']","['ni0805-743 [pii]', 'BFni0805743 [pii]', '10.1038/ni0805-743 [doi]']",ppublish,Nat Immunol. 2005 Aug;6(8):743-7. doi: 10.1038/ni0805-743.,,,,,,,,,,,,,,,,,
16377857,NLM,MEDLINE,20060316,20061115,1344-6304 (Print) 1344-6304 (Linking),58,6,2005 Dec,Effectiveness of vaccination strategies for infectious diseases according to human contact networks.,S16-7,,"Mathematical modeling of infectious disease transmission aims to predict the spread of infection and the effectiveness of containment strategies. For the case of infectious diseases that transmit between human, one key factor becomes the modeling of contacts between individuals through which the disease is potentially transmitted. We review several formulations of such contacts with emphasis on the recently investigated scale-free network, and also discuss the effectiveness of vaccination strategies.",,"['Takeuchi, Fumihiko']",['Takeuchi F'],"['Department of Infection Control Science, Juntendo University, Tokyo 113-8421, Japan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,IM,"['*Communicable Disease Control', 'Communicable Diseases/immunology/*transmission', '*Contact Tracing', 'Humans', '*Models, Biological', '*Vaccination']",,,,2005/12/27 09:00,2006/03/17 09:00,['2005/12/27 09:00'],"['2005/12/27 09:00 [pubmed]', '2006/03/17 09:00 [medline]', '2005/12/27 09:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2005 Dec;58(6):S16-7.,,,,,,,,,,,,,,,,,
24750997,NLM,MEDLINE,20141208,20211021,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),20,5,2014 May,"Trends in infectious disease mortality rates, Spain, 1980-2011.",782-9,10.3201/eid2005.131528 [doi],"Using mortality data from National Institute of Statistics in Spain, we analyzed trends of infectious disease mortality rates in Spain during 1980-2011 to provide information on surveillance and control of infectious diseases. During the study period, 628,673 infectious disease-related deaths occurred, the annual change in the mortality rate was -1.6%, and the average infectious disease mortality rate was 48.5 deaths/100,000 population. Although the beginning of HIV/AIDS epidemic led to an increased mortality rate, a decreased rate was observed by the end of the twentieth century. By codes from the International Classification of Diseases, 9th revision, the most frequent underlying cause of death was pneumonia. Emergence and reemergence of infectious diseases continue to be public health problems despite reduced mortality rates produced by various interventions. Therefore, surveillance and control systems should be reinforced with a goal of providing reliable data for useful decision making.",,"['Lopez-Cuadrado, Teresa', 'Llacer, Alicia', 'Palmera-Suarez, Rocio', 'Gomez-Barroso, Diana', 'Savulescu, Camelia', 'Gonzalez-Yuste, Paloma', 'Fernandez-Cuenca, Rafael']","['Lopez-Cuadrado T', 'Llacer A', 'Palmera-Suarez R', 'Gomez-Barroso D', 'Savulescu C', 'Gonzalez-Yuste P', 'Fernandez-Cuenca R']",,['eng'],"['Historical Article', 'Journal Article']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Communicable Diseases/*epidemiology/history/mortality', 'Female', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Mortality', 'Spain/epidemiology', 'Young Adult']",PMC4012808,['NOTNLM'],"['ICD', 'Spain', 'infectious diseases', 'international classification of diseases', 'joinpoints', 'mortality rates', 'trends']",2014/04/23 06:00,2014/12/15 06:00,['2014/04/23 06:00'],"['2014/04/23 06:00 [entrez]', '2014/04/23 06:00 [pubmed]', '2014/12/15 06:00 [medline]']","['13-1528 [pii]', '10.3201/eid2005.131528 [doi]']",ppublish,Emerg Infect Dis. 2014 May;20(5):782-9. doi: 10.3201/eid2005.131528.,,,,,,,,,,,,,,,,,
9738403,NLM,MEDLINE,19981022,20071115,0033-2100 (Print) 0033-2100 (Linking),52,1-2,1998,[Epidemiological chronicle: evidence of change in patterns of infectious diseases].,3-6,,,,"['Naruszewicz-Lesiuk, D', 'Galazka, A']","['Naruszewicz-Lesiuk D', 'Galazka A']",,['pol'],"['Editorial', 'Historical Article']",,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Communicable Diseases/epidemiology/*history', 'Epidemiology/history', 'History, 20th Century', 'Periodicals as Topic/*history', 'Poland/epidemiology', 'Publishing/*history']",,,,1998/09/17 00:00,1998/09/17 00:01,['1998/09/17 00:00'],"['1998/09/17 00:00 [pubmed]', '1998/09/17 00:01 [medline]', '1998/09/17 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1998;52(1-2):3-6.,,,,,,,,,Kronika epidemiologiczna--swiadek zmian przebiegu chorob zakaznych.,,,,,,,,
26971465,NLM,MEDLINE,20161213,20161230,1744-8387 (Electronic) 1478-9450 (Linking),13,4,2016,Clinical applications of bacterial glycoproteins.,345-53,10.1586/14789450.2016.1166054 [doi],"There is an ongoing race between bacterial evolution and medical advances. Pathogens have the advantages of short generation times and horizontal gene transfer that enable rapid adaptation to new host environments and therapeutics that currently outpaces clinical research. Antibiotic resistance, the growing impact of nosocomial infections, cancer-causing bacteria, the risk of zoonosis, and the possibility of biowarfare all emphasize the increasingly urgent need for medical research focussed on bacterial pathogens. Bacterial glycoproteins are promising targets for alternative therapeutic intervention since they are often surface exposed, involved in host-pathogen interactions, required for virulence, and contain distinctive glycan structures. The potential exists to exploit these unique structures to improve clinical prevention, diagnosis, and treatment strategies. Translation of the potential in this field to actual clinical impact is an exciting prospect for fighting infectious diseases.",,"['Fulton, Kelly M', 'Smith, Jeffrey C', 'Twine, Susan M']","['Fulton KM', 'Smith JC', 'Twine SM']","['a Human Health Therapeutics Portfolio , National Research Council Canada , Ottawa , Canada.', 'b Department of Chemistry and Institute of Biochemistry , Carleton University , Ottawa , Canada.', 'a Human Health Therapeutics Portfolio , National Research Council Canada , Ottawa , Canada.']",['eng'],"['Journal Article', 'Review']",20160328,England,Expert Rev Proteomics,Expert review of proteomics,101223548,IM,"['Animals', 'Bacterial Proteins/*metabolism', 'Biomarkers/metabolism', 'Communicable Diseases/*diagnosis/metabolism/microbiology/therapy', 'Glycoproteins/*metabolism', 'Host-Pathogen Interactions', 'Humans', 'Virulence Factors/metabolism']",,['NOTNLM'],"['Infectious disease', 'antibiotic resistance', 'bacterial pathogen', 'bacterial therapeutics', 'diagnostics', 'glycoprotein', 'host-pathogen interactions', 'pathogenesis', 'vaccines', 'virulence factor']",2016/03/15 06:00,2016/12/15 06:00,['2016/03/15 06:00'],"['2016/03/15 06:00 [entrez]', '2016/03/15 06:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.1586/14789450.2016.1166054 [doi]'],ppublish,Expert Rev Proteomics. 2016;13(4):345-53. doi: 10.1586/14789450.2016.1166054. Epub 2016 Mar 28.,,,"['0 (Bacterial Proteins)', '0 (Biomarkers)', '0 (Glycoproteins)', '0 (Virulence Factors)']",,,,,,,,,,,,,,
4168781,NLM,MEDLINE,19680127,20191210,0048-7848 (Print) 0048-7848 (Linking),71,1,1967 Jan-Mar,[Immunoglobulins and their use in prevention and treatment of infectious diseases. I. Generalities. Their use in bacterial diseases].,9-16,,,,"['Ivan, A', 'Zavate, O']","['Ivan A', 'Zavate O']",,['rum'],['Journal Article'],,Romania,Rev Med Chir Soc Med Nat Iasi,Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,0413735,IM,"['Communicable Diseases/*drug therapy/*immunology', 'Humans', 'Infections/*drug therapy', 'gamma-Globulins/*therapeutic use']",,,,1967/01/01 00:00,1967/01/01 00:01,['1967/01/01 00:00'],"['1967/01/01 00:00 [pubmed]', '1967/01/01 00:01 [medline]', '1967/01/01 00:00 [entrez]']",,ppublish,Rev Med Chir Soc Med Nat Iasi. 1967 Jan-Mar;71(1):9-16.,,,['0 (gamma-Globulins)'],,,,,,Imunoglobulinele si utilizarea lor in profilaxia si tratamentul bolilor inFEC.TIOASE. I. Generalitati. Aplicarea lor in bolile bacteriene.,,,,,,,,
33152761,NLM,MEDLINE,20210120,20210120,1708-8305 (Electronic) 1195-1982 (Print) 1195-1982 (Linking),27,8,2020 Dec 23,Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland.,,10.1093/jtm/taaa180 [doi] taaa180,"Based on notification data the impact of the COVID-19 lockdown in Switzerland was assessed. While the incidence of tick-borne encephalitis almost doubled as compared to 2016-2019, a reduction in all other infectious diseases was recorded. The lowest reduction rates (<25%) were noted for legionellosis, hepatitis A, chlamydia infection and gonorrhoea.",,"['Steffen, Robert', 'Lautenschlager, Stephan', 'Fehr, Jan']","['Steffen R', 'Lautenschlager S', 'Fehr J']","[""Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Traveller's Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland."", 'Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.', 'Dermatology and Venereology Outpatient Clinics, City Hospitals Waid and Triemli, Zurich, Switzerland.', ""Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Traveller's Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland."", 'Department of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland.']",['eng'],['Journal Article'],,England,J Travel Med,Journal of travel medicine,9434456,IM,"['Adult', 'Basic Reproduction Number/statistics & numerical data', '*COVID-19/diagnosis/epidemiology/prevention & control', '*Communicable Disease Control/organization & administration/statistics & numerical data', 'Communicable Diseases/classification/diagnosis/epidemiology', '*Communicable Diseases, Imported/diagnosis/epidemiology/prevention & control', 'Disease Notification/methods/statistics & numerical data', 'Female', 'Humans', 'Male', '*Physical Distancing', 'SARS-CoV-2/isolation & purification', '*Sexually Transmitted Diseases/diagnosis/epidemiology', 'Switzerland/epidemiology', '*Travel/statistics & numerical data/trends', 'Travel Medicine/methods/trends']",PMC7543597,['NOTNLM'],"['COVID-19', 'dengue', 'hepatitis', 'legionella', 'pneumococcal', 'sexually transmitted infections', 'transmission', 'typhoid']",2020/11/06 06:00,2021/01/21 06:00,['2020/11/05 20:20'],"['2020/08/05 00:00 [received]', '2020/09/09 00:00 [revised]', '2020/09/22 00:00 [accepted]', '2020/11/06 06:00 [pubmed]', '2021/01/21 06:00 [medline]', '2020/11/05 20:20 [entrez]']","['5912954 [pii]', 'taaa180 [pii]', '10.1093/jtm/taaa180 [doi]']",ppublish,J Travel Med. 2020 Dec 23;27(8):taaa180. doi: 10.1093/jtm/taaa180.,,,,,,,,,,,,,,,,,
13856833,NLM,MEDLINE,19981101,20181201,0007-1447 (Print) 0007-1447 (Linking),2,5203,1960 Sep 24,NOTIFICATION of infectious diseases.,954,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans']",PMC2098128,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1960/09/24 00:00,1960/09/24 00:01,['1960/09/24 00:00'],"['1960/09/24 00:00 [pubmed]', '1960/09/24 00:01 [medline]', '1960/09/24 00:00 [entrez]']",,ppublish,Br Med J. 1960 Sep 24;2(5203):954.,,,,,,,,,,,,,,,,,
6154174,NLM,MEDLINE,19800616,20041117,0023-2149 (Print) 0023-2149 (Linking),58,2,1980 Feb,[Immune system and the pathogenesis of infectious diseases].,7-11,,,,"['Bunin, K V']",['Bunin KV'],,['rus'],['Journal Article'],,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Antibody Formation', '*Antigen-Antibody Reactions', 'Communicable Diseases/*etiology/immunology', 'Enzymes/immunology', 'Epitopes', 'Humans', 'Immune Tolerance', 'Immunity', 'Immunity, Cellular']",,,,1980/02/01 00:00,1980/02/01 00:01,['1980/02/01 00:00'],"['1980/02/01 00:00 [pubmed]', '1980/02/01 00:01 [medline]', '1980/02/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1980 Feb;58(2):7-11.,,,"['0 (Enzymes)', '0 (Epitopes)']",,,,,,Immunnaia sistema i patogenez infektsionnykh boleznei.,,,,,,,,
23747356,NLM,MEDLINE,20140424,20141120,1096-0260 (Electronic) 0091-7435 (Linking),57,3,2013 Sep,Global confluence of infectious and non-communicable diseases -- the case of type 2 diabetes.,149-51,S0091-7435(13)00190-4 [pii] 10.1016/j.ypmed.2013.05.027 [doi],"Globally the prevalence and public health importance of non-communicable diseases (NCD) is increasing in high-, middle-, and low-income countries alike. Concomitant to the NCD burden, control of key infectious diseases (i.e., group B Streptococcus, hepatitis C, tuberculosis, and HIV) in most regions of the world remains elusive. With new epidemiologic trends in disease burden, the allocation of resources and expertise to simultaneously control infectious diseases and NCD becomes increasingly difficult. Using the case of diabetes and three co-occurring infectious diseases, we demonstrate the importance of generating innovative strategies to attack the old (infectious diseases) and new (NCD) disease agendas together.",['Copyright (c) 2013 Elsevier Inc. All rights reserved.'],"['Magee, M J', 'Narayan, K M Venkat']","['Magee MJ', 'Narayan KM']",,['eng'],['Journal Article'],20130606,United States,Prev Med,Preventive medicine,0322116,IM,"['Communicable Disease Control/*organization & administration', 'Communicable Diseases/*complications/*epidemiology', 'Diabetes Mellitus, Type 2/complications/*epidemiology/*prevention & control', '*Global Health', 'Humans']",,['NOTNLM'],"['Communicable diseases', 'Diabetes mellitus', 'Group B Streptococcus', 'HIV', 'Tuberculosis']",2013/06/12 06:00,2014/04/25 06:00,['2013/06/11 06:00'],"['2013/01/29 00:00 [received]', '2013/05/27 00:00 [revised]', '2013/05/29 00:00 [accepted]', '2013/06/11 06:00 [entrez]', '2013/06/12 06:00 [pubmed]', '2014/04/25 06:00 [medline]']","['S0091-7435(13)00190-4 [pii]', '10.1016/j.ypmed.2013.05.027 [doi]']",ppublish,Prev Med. 2013 Sep;57(3):149-51. doi: 10.1016/j.ypmed.2013.05.027. Epub 2013 Jun 6.,,,,,,,,,,,,,,,,,
13862446,NLM,MEDLINE,19981101,20181201,,3,,1962 Sep,[The therapy of circulatory failure in infectious diseases].,549-54,,,,"['ARNOLD, O H']",['ARNOLD OH'],,['ger'],['Journal Article'],,Bulgaria,Izv Bulg Akad Naukite Sofia Nauchnoizsledovatelski Inst protivorak antibiot,Izvestiia. Nauchnoizsledovatelski institut za protivorakovi antibiotitsi (Bulgarska akademiia na naukite),15751090R,OM,"['Communicable Diseases/*physiology', '*Convulsive Therapy', '*Shock']",,['NLM'],"['*COMMUNICABLE DISEASES/physiology', '*SHOCK/therapy']",1962/09/01 00:00,1962/09/01 00:01,['1962/09/01 00:00'],"['1962/09/01 00:00 [pubmed]', '1962/09/01 00:01 [medline]', '1962/09/01 00:00 [entrez]']",,ppublish,Izv Bulg Akad Naukite Sofia Nauchnoizsledovatelski Inst protivorak antibiot. 1962 Sep;3:549-54.,,,,,,,,,,,,,,,,,
1765188,NLM,MEDLINE,19920220,20041117,0014-9772 (Print) 0014-9772 (Linking),56,8,1991 Aug,[The economic loss caused by temporary loss of work capacity related to infectious diseases].,7-10,,,,"['Khromenkova, V P']",['Khromenkova VP'],,['rus'],['Journal Article'],,Russia (Federation),Feldsher Akush,Fel'dsher i akusherka,16930040R,,"['*Absenteeism', 'Communicable Diseases/*economics/epidemiology', 'Costs and Cost Analysis/economics', 'Humans', 'USSR/epidemiology']",,,,1991/08/01 00:00,1991/08/01 00:01,['1991/08/01 00:00'],"['1991/08/01 00:00 [pubmed]', '1991/08/01 00:01 [medline]', '1991/08/01 00:00 [entrez]']",,ppublish,Feldsher Akush. 1991 Aug;56(8):7-10.,,,,,,,,,"Ekonomicheskii ushcherb, obuslovlennyi vremennoi netrudosposobnost'ui v sviazi s infektsionnymi bolezniami.",,,,,,,,
4014274,NLM,MEDLINE,19850812,20190626,0002-9343 (Print) 0002-9343 (Linking),78,6B,1985 Jun 28,Emerging perspectives in management and prevention of infectious diseases.,1-236,,,,,,,['eng'],['Journal Article'],,United States,Am J Med,The American journal of medicine,0267200,IM,"['*Bacterial Infections/drug therapy/prevention & control/therapy', '*Communicable Disease Control', 'Communicable Diseases/drug therapy/*therapy', 'Humans']",,,,1985/06/28 00:00,1985/06/28 00:01,['1985/06/28 00:00'],"['1985/06/28 00:00 [pubmed]', '1985/06/28 00:01 [medline]', '1985/06/28 00:00 [entrez]']",['10.1016/0002-9343(85)90355-9 [doi]'],ppublish,Am J Med. 1985 Jun 28;78(6B):1-236. doi: 10.1016/0002-9343(85)90355-9.,,,,,,,,,,,,,,,,,
28426114,NLM,MEDLINE,20170831,20220330,1708-8305 (Electronic) 1195-1982 (Linking),24,4,2017 Jul 1,Infectious diseases and migrant worker health in Singapore: a receiving country's perspective.,,10.1093/jtm/tax014 [doi],"BACKGROUND: Approximately 1.4 million migrant workers reside in Singapore, presenting unique infectious disease challenges to both migrants and Singapore. METHODS: A Pubmed, MEDLINE (Ovid), EBSCO Host (Global Health) and Google Scholar search was performed for both peer, non-peer reviewed articles and reports relevant to migrant health in Singapore, published between 1 January 1989 and 1 September 2016. Additional studies were identified from citations within searched articles. We also reviewed published data and policy documents from the Ministries of Health and Manpower, Singapore. RESULTS: A significant proportion of malaria, enteric fevers, hepatitis A and E and tuberculosis diagnosed in Singapore involve migrant workers. From the 1990-2000 through 2009-11, while malaria and hepatitis A cases have decreased and remain sporadic, enteric fevers and tuberculosis cases have increased, possibly due to greater influx of migrant workers. Hepatitis E numbers remain low but migrant workers account for half of diagnosed cases. In an interplay of immune naivete, work and living conditions, migrants in the construction industry are at higher risk of arboviral infections such as dengue, Zika and chikungunya. Infections such as chikungunya were likely introduced into Singapore by travellers including migrant workers from the Indian subcontinent but autochthonous transmission continued due to the presence of competent mosquito vectors. There is less data regarding sexual health, networks and infections amongst migrant workers, an area which merits further attention. CONCLUSIONS: Migrant workers appear to be at higher risk than Singaporeans for specific infectious diseases, probably due to a complex interplay of several factors, including higher disease prevalence in their countries of origin, socio-economic factors, their living conditions in Singapore and financial, language and cultural barriers to healthcare access. Receiving countries need improved surveillance, expansion of preventive measures and decreased barriers to healthcare access for migrant workers.","['(c) International Society of Travel Medicine, 2017. Published by Oxford University', 'Press. All rights reserved. For Permissions, please e-mail:', 'journals.permissions@oup.com']","['Sadarangani, Sapna P', 'Lim, Poh Lian', 'Vasoo, Shawn']","['Sadarangani SP', 'Lim PL', 'Vasoo S']","['Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.', 'Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology, Communicable Diseases Center, Tan Tock Seng Hospital, Moulmein Road, Singapore.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.', 'Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology, Communicable Diseases Center, Tan Tock Seng Hospital, Moulmein Road, Singapore.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.', 'Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology, Communicable Diseases Center, Tan Tock Seng Hospital, Moulmein Road, Singapore.']",['eng'],"['Journal Article', 'Review']",,England,J Travel Med,Journal of travel medicine,9434456,IM,"[""Agricultural Workers' Diseases/*epidemiology/etiology"", 'Animals', 'Communicable Diseases/*epidemiology/etiology/transmission', 'Disease Vectors', 'Female', 'Foodborne Diseases/epidemiology/etiology', 'Humans', 'Male', 'Rodentia', 'Sexually Transmitted Diseases/epidemiology/etiology/transmission', 'Singapore/epidemiology', '*Transients and Migrants/statistics & numerical data', '*Travel Medicine']",,['NOTNLM'],"['Migrant worker', 'Singapore', 'domestic worker', 'foreign worker', 'health', 'infectious diseases']",2017/04/21 06:00,2017/09/01 06:00,['2017/04/21 06:00'],"['2017/02/15 00:00 [accepted]', '2017/04/21 06:00 [entrez]', '2017/04/21 06:00 [pubmed]', '2017/09/01 06:00 [medline]']","['3095986 [pii]', '10.1093/jtm/tax014 [doi]']",ppublish,J Travel Med. 2017 Jul 1;24(4). doi: 10.1093/jtm/tax014.,,,,,,,,,,,,,,,,,
13084065,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),45,1,1953 Jul 1,"[MINISTRY of Health statistics on infectious diseases during May, 1953].",24,,,,,,,['und'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/07/01 00:00,1953/07/01 00:01,['1953/07/01 00:00'],"['1953/07/01 00:00 [pubmed]', '1953/07/01 00:01 [medline]', '1953/07/01 00:00 [entrez]']",,ppublish,Harefuah. 1953 Jul 1;45(1):24.,,,,,,,,,,,,['CLML: 5425:4816:117'],,,,,
27032175,NLM,MEDLINE,20160502,20161201,0387-5911 (Print) 0387-5911 (Linking),90,1,2016 Jan,[The JAID/JSC Guidelines to Clinical Management of Infectious Diseases (Intestinal infection)].,31-65,,,,"['Ohnishi, Kenji', 'Ainoda, Yusuke', 'Imamura, Akifumi', 'Iwabuchi, Sentaro', 'Okuda, Masumi', 'Nakano, Takashi']","['Ohnishi K', 'Ainoda Y', 'Imamura A', 'Iwabuchi S', 'Okuda M', 'Nakano T']",,['jpn'],"['Journal Article', 'Practice Guideline']",,Japan,Kansenshogaku Zasshi,Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,0236671,IM,"['Communicable Diseases/diagnosis/*drug therapy', 'Humans', 'Intestinal Diseases/diagnosis/*drug therapy', 'Japan', 'Risk Factors']",,,,2016/04/02 06:00,2016/05/03 06:00,['2016/04/02 06:00'],"['2016/04/02 06:00 [entrez]', '2016/04/02 06:00 [pubmed]', '2016/05/03 06:00 [medline]']",,ppublish,Kansenshogaku Zasshi. 2016 Jan;90(1):31-65.,,,,,,,,,,,,,,,,,
21272793,NLM,MEDLINE,20110309,20220331,1474-4457 (Electronic) 1473-3099 (Print) 1473-3099 (Linking),11,2,2011 Feb,Urbanisation and infectious diseases in a globalised world.,131-41,10.1016/S1473-3099(10)70223-1 [doi],"The world is becoming urban. The UN predicts that the world's urban population will almost double from 3.3 billion in 2007 to 6.3 billion in 2050. Most of this increase will be in developing countries. Exponential urban growth is having a profound effect on global health. Because of international travel and migration, cities are becoming important hubs for the transmission of infectious diseases, as shown by recent pandemics. Physicians in urban environments in developing and developed countries need to be aware of the changes in infectious diseases associated with urbanisation. Furthermore, health should be a major consideration in town planning to ensure urbanisation works to reduce the burden of infectious diseases in the future.",['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],"['Alirol, Emilie', 'Getaz, Laurent', 'Stoll, Beat', 'Chappuis, Francois', 'Loutan, Louis']","['Alirol E', 'Getaz L', 'Stoll B', 'Chappuis F', 'Loutan L']","['Division of International and Humanitarian Medicine, Department of Community Medicine and Primary Care, Geneva University Hospitals, Geneva, Switzerland.']",['eng'],"['Journal Article', 'Review']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/*epidemiology/*transmission', 'Emigration and Immigration', 'Humans', '*Internationality', 'Population Dynamics', 'Travel', '*Urban Population', 'Urbanization/*trends']",PMC7106397,,,2011/01/29 06:00,2011/03/10 06:00,['2011/01/29 06:00'],"['2011/01/29 06:00 [entrez]', '2011/01/29 06:00 [pubmed]', '2011/03/10 06:00 [medline]']","['S1473-3099(10)70223-1 [pii]', '10.1016/S1473-3099(10)70223-1 [doi]']",ppublish,Lancet Infect Dis. 2011 Feb;11(2):131-41. doi: 10.1016/S1473-3099(10)70223-1.,,,,,,,,,,,,,,,,,
13101262,NLM,MEDLINE,20030501,20181201,0035-3655 (Print) 0035-3655 (Linking),73,6,1953 Jun,[Active and passive therapy of infectious diseases].,532-6,,,,"['MOZER, J J']",['MOZER JJ'],,['und'],['Journal Article'],,Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1953/06/01 00:00,1953/06/01 00:01,['1953/06/01 00:00'],"['1953/06/01 00:00 [pubmed]', '1953/06/01 00:01 [medline]', '1953/06/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1953 Jun;73(6):532-6.,,,,,,,,,Guerison active et guerison passive des maladies infectieuses.,,,['CLML: 5425:22238:117'],,,,,
24895702,NLM,MEDLINE,20140604,20161021,1138-3593 (Print) 1138-3593 (Linking),38,2,2012 Mar,[Study of infectious diseases in a primary care clinic with a majority immigrant population. Application of microbiological techniques in the primary care clinic].,72-8,,"INTRODUCTION: Patients are often seen in Primary Care due to infectious diseases. The aetiology of these diseases is often unclear. The application of basic microbiological techniques in the Primary Care clinic could improve the diagnosis and patient management. The purpose of this study is to introduce basic techniques and rapid diagnostics in the management of patients attending a Primary Care clinic. METHODS: The analysis of patient samples by microbiological stains or rapid tests. RESULTS: In the study of 249 samples analysed on patients in the clinic, an aetiological diagnosis of the infection was made in 23% of the cases. A microbiology result that helped in the treatment was obtained in 72% of the patients. CONCLUSION: The application of basic microbiological techniques may improve diagnosis and therefore the management of patients visiting the Primary Care clinic. The characteristics of the population served (mostly immigrant, low socio-economic level, difficulty in monitoring patients) suggest that this project could be very useful in that kind of population. It would require larger studies to assess the application on a larger scale and cost-effectiveness of these measures",,"['Regata Cuesta, C']",['Regata Cuesta C'],,['spa'],"['English Abstract', 'Journal Article']",,Spain,Semergen,Semergen,9610769,IM,"['Communicable Diseases/*diagnosis/epidemiology/microbiology', 'Emigrants and Immigrants', 'Female', 'Humans', 'Male', 'Microbiological Techniques/*methods', 'Primary Health Care/*methods', 'Socioeconomic Factors']",,,,2012/03/01 00:00,2012/03/01 00:01,['2014/06/05 06:00'],"['2014/06/05 06:00 [entrez]', '2012/03/01 00:00 [pubmed]', '2012/03/01 00:01 [medline]']",,ppublish,Semergen. 2012 Mar;38(2):72-8.,,,,,,,,,Estudio de las enfermedades infecciosas en un cupo de atencion primaria de mayoria inmigrante: aplicacion de tecnicas microbiologicas en la consulta de primaria.,,,,,,,,
9381790,NLM,MEDLINE,19971104,20061115,0302-6469 (Print) 0302-6469 (Linking),59,2,1997,"[Infectious diseases, the veritable pandora's box].",61-71,,"The past few years, much attention has been given to the problems regarding new and emerging infectious diseases. Four groups may be considered: (1) new agents discovered among the causes of classical medical syndromes, these do not constitute new dangers but decrease the proportion of unknown causes within these syndromes; (2) increased importance of infectious agents resulting from modified ways of living or production procedures; (3) the really new agents, the spread of which is generally favoured by the same factors and (4) organisms with acquired resistance against antibiotics and pesticides. There is need for extended epidemiological surveillance, that can be improved in our country by better collaboration between different organisations. Most importantly epidemiological surveillance should be organized on an European level with the entire support of our regional and federal authorities.",,"['Pattyn, S R']",['Pattyn SR'],"['Prins Leopold Instituut voor Tropische Geneeskunde, Antwerpen.']",['dut'],"['English Abstract', 'Journal Article']",,Belgium,Verh K Acad Geneeskd Belg,Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,0413210,IM,"['Communicable Diseases/*epidemiology/microbiology', 'Epidemiologic Studies', 'Europe/epidemiology', 'Humans']",,,,1997/01/01 00:00,1998/02/12 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1998/02/12 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Verh K Acad Geneeskd Belg. 1997;59(2):61-71.,,,,,,,,,"Infectieziekten, de onuitputtelijke doos van pandora.",,,,,,,,
24964704,NLM,MEDLINE,20140721,20140626,0125-2208 (Print) 0125-2208 (Linking),97 Suppl 5,,2014 May,A way forward for the evaluation of health technologies for infectious diseases.,S87-93,,"Recently, many researchers undertaking health technology assessment of screening or vaccination programs for infectious diseases have opted for dynamic transmission models for their analysis, rather than the typical static models (Markov and decision tree), as they are better at predicting the indirect effects of interventions, such as those that may affect disease transmission within the interested population or the ecology of the pathogen. Nevertheless, these models have not yet become part of the traditional tool box of health economists, due in part to the fact that the results are complex and difficult to analyze, requiring extensive computational skills. This paper aims to provide an overview of the concept of a dynamic transmission models and outline recommendations on how best to determine whether a dynamic approach is appropriate when evaluating health technologies and interventions for infectious diseases.",,"['Kingkaew, Pritaporn']",['Kingkaew P'],,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,IM,"['Communicable Diseases/*diagnosis/*transmission', 'Humans', '*Models, Statistical', 'Technology Assessment, Biomedical/*methods']",,,,2014/06/27 06:00,2014/07/22 06:00,['2014/06/27 06:00'],"['2014/06/27 06:00 [entrez]', '2014/06/27 06:00 [pubmed]', '2014/07/22 06:00 [medline]']",,ppublish,J Med Assoc Thai. 2014 May;97 Suppl 5:S87-93.,,,,,,,,,,,,,,,,,
4438277,NLM,MEDLINE,19750318,20190913,0091-7435 (Print) 0091-7435 (Linking),3,4,1974 Dec,Forum on recent advances in control of infectious diseases. Introduction.,431-5,,,,"['Davis, D J']",['Davis DJ'],,['eng'],['Journal Article'],,United States,Prev Med,Preventive medicine,0322116,IM,"['Absenteeism', 'Acute Disease', '*Communicable Disease Control', 'Communicable Diseases/epidemiology/mortality', 'Costs and Cost Analysis', 'Humans', '*Public Health', 'Time Factors', 'United States']",,,,1974/12/01 00:00,1974/12/01 00:01,['1974/12/01 00:00'],"['1974/12/01 00:00 [pubmed]', '1974/12/01 00:01 [medline]', '1974/12/01 00:00 [entrez]']",['10.1016/0091-7435(74)90002-4 [doi]'],ppublish,Prev Med. 1974 Dec;3(4):431-5. doi: 10.1016/0091-7435(74)90002-4.,,,,,,,,,,,,,,,,,
9575751,NLM,MEDLINE,19980609,20051116,0023-2149 (Print) 0023-2149 (Linking),76,3,1998,[Bronchopulmonary syndrome in differential diagnosis of infectious diseases].,52-7,,,,"['Bogomolov, B P']",['Bogomolov BP'],,['rus'],"['Case Reports', 'Journal Article', 'Review']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Bronchial Diseases/*diagnosis/etiology', 'Communicable Diseases/*diagnosis/etiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Male', 'Middle Aged', 'Pneumonia/*diagnosis/etiology', 'Syndrome']",,,,1998/05/12 00:00,1998/05/12 00:01,['1998/05/12 00:00'],"['1998/05/12 00:00 [pubmed]', '1998/05/12 00:01 [medline]', '1998/05/12 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1998;76(3):52-7.,,,,,,0,,,Bronkholegochnyi sindrom v differentsial'noi diagnostike infektsionnykh zabolevanii.,,,,,,,,
27999420,NLM,MEDLINE,20170807,20190109,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),13,12,2016 Dec 20,Spatiotemporal Frameworks for Infectious Disease Diffusion and Epidemiology.,,10.3390/ijerph13121261 [doi] 1261,"Emerging infectious diseases, and the resurgence of previously controlled infectious disease (e.g., malaria, tuberculosis), are a major focus for public health concern, as well as providing challenges for establishing aetiology and transmission. [...].",,"['Congdon, Peter']",['Congdon P'],"['School of Geography and Life Sciences Institute, Queen Mary University of London, Mile End, London E1 4NS, UK. p.congdon@qmul.ac.uk.']",['eng'],['Editorial'],20161220,Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,IM,"['Communicable Diseases/epidemiology/*transmission', 'Geographic Information Systems', '*Global Health', 'Humans', '*Spatio-Temporal Analysis']",PMC5201402,,,2016/12/22 06:00,2017/08/08 06:00,['2016/12/22 06:00'],"['2016/12/09 00:00 [received]', '2016/12/09 00:00 [revised]', '2016/12/15 00:00 [accepted]', '2016/12/22 06:00 [entrez]', '2016/12/22 06:00 [pubmed]', '2017/08/08 06:00 [medline]']","['ijerph13121261 [pii]', 'ijerph-13-01261 [pii]', '10.3390/ijerph13121261 [doi]']",epublish,Int J Environ Res Public Health. 2016 Dec 20;13(12):1261. doi: 10.3390/ijerph13121261.,['The author declares no conflict of interest.'],,,,,,,,,,,,,,,,
20204752,NLM,MEDLINE,20100330,20200407,0065-2598 (Print) 0065-2598 (Linking),659,,2010,Host biomarkers and paediatric infectious diseases: from molecular profiles to clinical application.,19-31,10.1007/978-1-4419-0981-7_2 [doi],"Infectious diseases are an important cause of death among children under the age of 5 (Stein et al., 2004). Most of these deaths are caused by preventable or curable infections. Limited access to medical care, antibiotics, and vaccinations remains a major problem in developing countries. But infectious diseases also continue to be an important public health issue in developed countries. With the help of modern technologies, some infections have been effectively controlled; however, new diseases such as SARS and West Nile virus infections are constantly emerging. In addition, other diseases such as malaria, tuberculosis, and bacterial pneumonia are increasingly resistant to antimicrobial treatment.",,"['Brand, H K', 'Hermans, P W M', 'de Groot, R']","['Brand HK', 'Hermans PW', 'de Groot R']","['Department of Pediatrics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['Biomarkers/*analysis/metabolism', 'Child', 'Child, Preschool', 'Communicable Diseases/*genetics/metabolism', '*Gene Expression Profiling', 'Humans', '*Pediatrics']",PMC7122846,,,2010/03/06 06:00,2010/03/31 06:00,['2010/03/06 06:00'],"['2010/03/06 06:00 [entrez]', '2010/03/06 06:00 [pubmed]', '2010/03/31 06:00 [medline]']","['2 [pii]', '10.1007/978-1-4419-0981-7_2 [doi]']",ppublish,Adv Exp Med Biol. 2010;659:19-31. doi: 10.1007/978-1-4419-0981-7_2.,,,['0 (Biomarkers)'],,,,,,,,,,,,,,
33309629,NLM,MEDLINE,20210624,20210624,1437-7780 (Electronic) 1341-321X (Linking),27,4,2021 Apr,Epidemiological trends of imported infectious diseases in Japan: Analysis of imported 2-year infectious disease registry data.,632-638,S1341-321X(20)30435-9 [pii] 10.1016/j.jiac.2020.11.028 [doi],"INTRODUCTION: The epidemiology of infectious diseases in Japan remains undefined despite the increasing tourism. GeoSentinel, an epidemiological surveillance system for reporting imported infectious diseases, has only two participating facilities in Japan. Although the number of infectious diseases is reported by the National Institute of Infectious Diseases, there is no detailed clinical information about these cases. Therefore, we established J-RIDA (Japan Registry for Infectious Diseases from Abroad) to clarify the status of imported infectious diseases in Japan and provide detailed information. METHODS: J-RIDA was started as a registry of imported infectious diseases. Case registration began in October 2017. Between October 2017 and September 2019, 15 medical institutions participated in this clinical study. The registry collected information about the patient's age, sex, nationality, chief complaint, consultation date, date of onset, whether visit was made to a travel clinic before travel, blood test results (if samples were collected), travel history, and final diagnosis. RESULTS: Of the 3046 cases included in this study, 46.7% to Southeast Asia, 13.0% to Africa, 13.7% to East Asia, 11.5% to South Asia, 7.5% to Europe, 3.8% to Central and South America, 4.6% to North America, 3.9% to Oceania, and 2.8% to Central and west Asia. More than 85% of chief complaints were fever and general symptoms, gastrointestinal symptoms, respiratory symptoms, or dermatologic problems. The most common diseases were travelers' diarrhea, animal bite, upper respiratory infection, influenza, and dengue fever. CONCLUSIONS: We summarized two-year cases registered in Japan's imported infectious disease registry. These results will significantly contribute to the epidemiology in Japan.","['Copyright (c) 2020 Japanese Society of Chemotherapy and The Japanese Association', 'for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.']","['Kutsuna, Satoshi', 'Asai, Yusuke', 'Yamamoto, Kei', 'Shirano, Michinori', 'Konishi, Keiji', 'Asaoka, Tomohiro', 'Yamato, Masaya', 'Katsuragi, Yukiko', 'Yamamoto, Yudai', 'Sahara, Toshinori', 'Tamiya, Aya', 'Nakamura-Uchiyama, Fukumi', 'Sakamoto, Naoya', 'Kosaka, Atsushi', 'Washino, Takuya', 'Hase, Ryota', 'Mito, Haruki', 'Kurita, Takashi', 'Shinohara, Koh', 'Shimizu, Tsunehiro', 'Kodama, Fumihiro', 'Nagasaka, Atsushi', 'Ogawa, Taku', 'Kasahara, Kei', 'Yoshimura, Yukihiro', 'Tachikawa, Natsuo', 'Yokota, Kyoko', 'Yuka Murai, N S', 'Sakamaki, Ippei', 'Hasegawa, Chihiro', 'Yoshimi, Yusuke', 'Toyoda, Kazuhiro', 'Mitsuhashi, Tatsuro', 'Ohmagari, Norio']","['Kutsuna S', 'Asai Y', 'Yamamoto K', 'Shirano M', 'Konishi K', 'Asaoka T', 'Yamato M', 'Katsuragi Y', 'Yamamoto Y', 'Sahara T', 'Tamiya A', 'Nakamura-Uchiyama F', 'Sakamoto N', 'Kosaka A', 'Washino T', 'Hase R', 'Mito H', 'Kurita T', 'Shinohara K', 'Shimizu T', 'Kodama F', 'Nagasaka A', 'Ogawa T', 'Kasahara K', 'Yoshimura Y', 'Tachikawa N', 'Yokota K', 'Yuka Murai NS', 'Sakamaki I', 'Hasegawa C', 'Yoshimi Y', 'Toyoda K', 'Mitsuhashi T', 'Ohmagari N']","['Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. Electronic address: skutsuna@hosp.ncgm.go.jp.', 'Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.', 'Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.', 'Osaka City General Hospital, 2-13-22, Miyakojima-hondori Miyakojima-ku, Osaka, 534-0021, Japan.', 'Osaka City General Hospital, 2-13-22, Miyakojima-hondori Miyakojima-ku, Osaka, 534-0021, Japan.', 'Osaka City General Hospital, 2-13-22, Miyakojima-hondori Miyakojima-ku, Osaka, 534-0021, Japan.', 'Rinku General Medical Center, Rinku Ourai Kita 2-23, Izumisanoshi, Osaka, 598-8577, Japan.', 'Rinku General Medical Center, Rinku Ourai Kita 2-23, Izumisanoshi, Osaka, 598-8577, Japan.', 'Rinku General Medical Center, Rinku Ourai Kita 2-23, Izumisanoshi, Osaka, 598-8577, Japan.', 'Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital, 3F 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.', 'Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital, 3F 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.', 'Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital, 3F 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.', 'Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo, 130-8575, Japan.', 'Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo, 130-8575, Japan.', 'Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo, 130-8575, Japan.', 'Japanese Red Cross Narita Hospital, 90-1, Iida-cho, Narita-shi, Chiba, 286-8523, Japan.', 'Japanese Red Cross Narita Hospital, 90-1, Iida-cho, Narita-shi, Chiba, 286-8523, Japan.', 'Japanese Red Cross Narita Hospital, 90-1, Iida-cho, Narita-shi, Chiba, 286-8523, Japan.', 'Kyoto City Hospital, 1-2 Mibuhigashitakadacho, Nakagyo Ward, Kyoto, 604-8845, Japan.', 'Kyoto City Hospital, 1-2 Mibuhigashitakadacho, Nakagyo Ward, Kyoto, 604-8845, Japan.', 'Sapporo City General Hospital, Kita 1 Nishi 2, Chuo-ku, Sapporo, 060-8611, Japan.', 'Sapporo City General Hospital, Kita 1 Nishi 2, Chuo-ku, Sapporo, 060-8611, Japan.', 'Nara Medical University Hospital, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.', 'Nara Medical University Hospital, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.', ""Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama City, Kanagawa, 221-0855, Japan."", ""Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama City, Kanagawa, 221-0855, Japan."", 'Kagawa Prefectural Central Hospital, 1-2-1, Asahicho, Takamatsu, Kagawa, 760-0065, Japan.', 'Kagawa Prefectural Central Hospital, 1-2-1, Asahicho, Takamatsu, Kagawa, 760-0065, Japan.', 'Toyama University Hospital, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan.', 'Nagoya City East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya-city, Aichi, 464-8547, Japan.', 'Japanese Red Cross Nagoya Daini Hospital, 9, Myokencho, Nagoya, Aichi, 466-8650, Japan.', 'Kyushu University Hospital, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.', 'Aomori Prefectural Central Hospital, Higashi Tukurimiti 2-1-1, Aomori, 030-8553, Japan.', 'Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.']",['eng'],['Journal Article'],20201210,Netherlands,J Infect Chemother,Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,9608375,IM,"['Animals', 'Asia', '*Communicable Diseases/epidemiology', '*Communicable Diseases, Imported/diagnosis/epidemiology', 'Diarrhea', 'Europe', 'Humans', 'Japan/epidemiology', 'North America', 'Registries', 'Travel']",,['NOTNLM'],"['Imported infectious diseases', 'Japan', 'Registry']",2020/12/15 06:00,2021/06/25 06:00,['2020/12/14 10:15'],"['2020/07/30 00:00 [received]', '2020/10/30 00:00 [revised]', '2020/11/30 00:00 [accepted]', '2020/12/15 06:00 [pubmed]', '2021/06/25 06:00 [medline]', '2020/12/14 10:15 [entrez]']","['S1341-321X(20)30435-9 [pii]', '10.1016/j.jiac.2020.11.028 [doi]']",ppublish,J Infect Chemother. 2021 Apr;27(4):632-638. doi: 10.1016/j.jiac.2020.11.028. Epub 2020 Dec 10.,['Declaration of competing interest None declared.'],,,,,,,,,,,,,,,,
30869318,NLM,MEDLINE,20190520,20190520,0035-2640 (Print) 0035-2640 (Linking),68,7,2018 Sep,[Emergent and reemergent infectious diseases].,721-726,,"Emergent and reemergent infectious diseases. The notion of emerging and re-emerging infection has been developed recently, even if it rests on an already former concept. The emergence is doubtless delicate to define but can globally be an infectious disease by which the real incidence increases for a population and a geographical zone given to a period of time. Numerous factors condition an emergence, very unknown or not mastered. They report the difficulty or the impossibility to plan in a reliable way a future phenomenon, which would be nevertheless desirable. Yet to assure a legitimate effective coverage, serious preliminary data is essential. The modern companies wish to get organized and to form themselves to fight at best. Diverse ways can be set up.",,"['Bricaire, Francois']",['Bricaire F'],"['Service de maladies infectieuses, groupe hospitalier La Pitie-Salpetriere, Sorbonne Universite, Paris-VI, Paris, France.']",['fre'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,IM,"['*Communicable Diseases, Emerging/drug therapy/epidemiology', 'Humans']",,['NOTNLM'],"['Emergent diseases', 'Infectious diseases']",2019/03/15 06:00,2019/05/21 06:00,['2019/03/15 06:00'],"['2019/03/15 06:00 [entrez]', '2019/03/15 06:00 [pubmed]', '2019/05/21 06:00 [medline]']",,ppublish,Rev Prat. 2018 Sep;68(7):721-726.,"[""F. Bricaire declare n'avoir aucun lien d'interets.""]",,,,,,,,Maladies infectieuses emergentes et reemergentes.,,,,,,,,
1169351,NLM,MEDLINE,19750818,20110727,0047-1852 (Print) 0047-1852 (Linking),33,3,1975 Mar 10,[Systemic lupus erythematosus and infectious diseases].,662-8,,,,"['Homma, M']",['Homma M'],,['jpn'],['Journal Article'],,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Adolescent', 'Adult', 'Communicable Diseases/*complications/immunology/microbiology', 'Female', 'Humans', 'Lupus Erythematosus, Systemic/*complications/immunology/microbiology', 'Male', 'Middle Aged']",,,,1975/03/10 00:00,1975/03/10 00:01,['1975/03/10 00:00'],"['1975/03/10 00:00 [pubmed]', '1975/03/10 00:01 [medline]', '1975/03/10 00:00 [entrez]']",,ppublish,Nihon Rinsho. 1975 Mar 10;33(3):662-8.,,,,,,,,,,,,,,,,,
24024575,NLM,MEDLINE,20140502,20211021,1557-8585 (Electronic) 1539-6851 (Print) 1539-6851 (Linking),11,3,2013 Sep,Lymphatic function and the immune response to microbial or viral infection.,116,10.1089/lrb.2013.0010 [doi],"The National Institute of Allergy and Infectious Diseases (NIAID) is the primary institute within the National Institutes of Health (NIH) that conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.",,"['Miller, Lara R']",['Miller LR'],"['Basic Immunology Branch, Division of Allergy, Immunology, and Transplantation, NIAID , NIH, DHHS, Bethesda, Maryland.']",['eng'],['Journal Article'],20130911,United States,Lymphat Res Biol,Lymphatic research and biology,101163587,IM,"['Biomedical Research/methods/trends', 'Communicable Diseases/*immunology/microbiology/virology', 'Humans', 'Immune System/*immunology', 'Lymphatic System/*immunology', 'National Institute of Allergy and Infectious Diseases (U.S.)', 'National Institutes of Health (U.S.)', 'United States']",PMC3780286,,,2013/09/13 06:00,2014/05/03 06:00,['2013/09/13 06:00'],"['2013/09/13 06:00 [entrez]', '2013/09/13 06:00 [pubmed]', '2014/05/03 06:00 [medline]']","['10.1089/lrb.2013.0010 [pii]', '10.1089/lrb.2013.0010 [doi]']",ppublish,Lymphat Res Biol. 2013 Sep;11(3):116. doi: 10.1089/lrb.2013.0010. Epub 2013 Sep 11.,,,,,,,,,,,,,,,,,
27063929,NLM,MEDLINE,20170612,20180213,1096-8644 (Electronic) 0002-9483 (Linking),160,3,2016 Jul,Neanderthal genomics suggests a pleistocene time frame for the first epidemiologic transition.,379-88,10.1002/ajpa.22985 [doi],"High quality Altai Neanderthal and Denisovan genomes are revealing which regions of archaic hominin DNA have persisted in the modern human genome. A number of these regions are associated with response to infection and immunity, with a suggestion that derived Neanderthal alleles found in modern Europeans and East Asians may be associated with autoimmunity. As such Neanderthal genomes are an independent line of evidence of which infectious diseases Neanderthals were genetically adapted to. Sympathetically, human genome adaptive introgression is an independent line of evidence of which infectious diseases were important for AMH coming in to Eurasia and interacting with Neanderthals. The Neanderthals and Denisovans present interesting cases of hominin hunter-gatherers adapted to a Eurasian rather than African infectious disease package. Independent sources of DNA-based evidence allow a re-evaluation of the first epidemiologic transition and how infectious disease affected Pleistocene hominins. By combining skeletal, archaeological and genetic evidence from modern humans and extinct Eurasian hominins, we question whether the first epidemiologic transition in Eurasia featured a new package of infectious diseases or a change in the impact of existing pathogens. Coupled with pathogen genomics, this approach supports the view that many infectious diseases are pre-Neolithic, and the list continues to expand. The transfer of pathogens between hominin populations, including the expansion of pathogens from Africa, may also have played a role in the extinction of the Neanderthals and offers an important mechanism to understand hominin-hominin interactions well back beyond the current limits for aDNA extraction from fossils alone. Am J Phys Anthropol 160:379-388, 2016. (c) 2016 Wiley Periodicals, Inc.","['(c) 2016 Wiley Periodicals, Inc.']","['Houldcroft, Charlotte J', 'Underdown, Simon J']","['Houldcroft CJ', 'Underdown SJ']","['Division of Biological Anthropology, Department of Archaeology & Anthropology, University of Cambridge, Cambridge, CB2 3QG, UK.', 'Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, WC1N 1EH, UK.', 'Human Origins and Palaeoenvironmental Research Group (HOPE), Department of Anthropology & Geography, Oxford Brookes University, Oxford, OX3 0BP, UK.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20160410,United States,Am J Phys Anthropol,American journal of physical anthropology,0400654,IM,"['Animals', 'Anthropology, Physical', 'Communicable Diseases/*genetics/history/*immunology/microbiology', 'Evolution, Molecular', 'Fossils', 'Genome/*genetics/*immunology', 'Genomics', 'History, Ancient', 'Humans', 'Neanderthals/*genetics/*immunology']",,['NOTNLM'],"['genetics', 'infectious disease', 'paleopathology']",2016/04/12 06:00,2017/06/13 06:00,['2016/04/12 06:00'],"['2015/07/14 00:00 [received]', '2016/02/10 00:00 [revised]', '2016/03/03 00:00 [accepted]', '2016/04/12 06:00 [entrez]', '2016/04/12 06:00 [pubmed]', '2017/06/13 06:00 [medline]']",['10.1002/ajpa.22985 [doi]'],ppublish,Am J Phys Anthropol. 2016 Jul;160(3):379-88. doi: 10.1002/ajpa.22985. Epub 2016 Apr 10.,,,,,,,,,,,,,,,,,
24635325,NLM,MEDLINE,20180129,20180129,1784-3286 (Print) 1784-3286 (Linking),68,6,2013 Nov-Dec,"Infectious diseases, from HCV to cpe how susceptible are we?",399-405,10.2143/ACB.3440 [doi],"Infectious diseases remain a leading cause of morbidity and mortality. Still, there is substantial variation in the individual outcome when humans are exposed to potentially pathogenic micro-organisms. At least, one of the factors involved in the individual susceptibility to infections, is the genetic diversity of the host's immune response. This article gives a concise overview of the actual knowledge on the genetic mechanisms underlying human susceptibility to infectious diseases and the methods that are used to investigate it.",,"['Lacor, P']",['Lacor P'],,['eng'],"['Journal Article', 'Review']",,England,Acta Clin Belg,Acta clinica Belgica,0370306,IM,"['*Communicable Diseases/epidemiology/genetics/immunology/mortality', 'Disease Susceptibility', 'Enterobacteriaceae Infections/*epidemiology/genetics/immunology', 'European Union/statistics & numerical data', 'Genome', 'HIV Infections/*epidemiology/virology', 'Hepatitis C/*epidemiology/virology', 'Hepatitis C, Chronic/epidemiology', 'Humans', 'Incidence', 'Malaria/*epidemiology/genetics', 'Meningococcal Infections/epidemiology', 'Polymorphism, Genetic']",,,,2014/03/19 06:00,2018/01/30 06:00,['2014/03/19 06:00'],"['2014/03/19 06:00 [entrez]', '2014/03/19 06:00 [pubmed]', '2018/01/30 06:00 [medline]']",['10.2143/ACB.3440 [doi]'],ppublish,Acta Clin Belg. 2013 Nov-Dec;68(6):399-405. doi: 10.2143/ACB.3440.,,,,,,,,,,,,,,,,,
16219328,NLM,MEDLINE,20061109,20061115,0022-5193 (Print) 0022-5193 (Linking),239,3,2006 Apr 7,Spreading disease with transport-related infection.,376-90,,"Transportation among regions is found as one of the main factors which affect the outbreak of diseases. It will change the disease dynamics and break infection out even if infectious diseases will go to extinction in each city without transport-related infection. In this paper, a mathematical model is proposed to demonstrate the dynamics of such disease propagation between two regions (or cities) due to the population dispersal and infection on transports. Further, our analysis shows that transport-related infection intensifies the disease spread if infectious diseases break out to cause an endemic situation in each region, in the sense that both the absolute and relative size of patients increase. This suggests that it is very essential to strengthen restrictions of passengers once we know infectious diseases appeared.",,"[""Cui, Jing'an"", 'Takeuchi, Yasuhiro', 'Saito, Yasuhisa']","['Cui J', 'Takeuchi Y', 'Saito Y']","['Department of Mathematics, Nanjing Normal University, Nanjing 210097,China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20051010,England,J Theor Biol,Journal of theoretical biology,0376342,IM,"['Communicable Disease Control', 'Communicable Diseases/epidemiology/*transmission', 'Disease Outbreaks', 'Disease Susceptibility', 'Humans', '*Models, Biological', 'Population Dynamics', '*Travel', 'Urban Health']",,,,2005/10/13 09:00,2006/11/11 09:00,['2005/10/13 09:00'],"['2005/03/06 00:00 [received]', '2005/08/01 00:00 [revised]', '2005/08/02 00:00 [accepted]', '2005/10/13 09:00 [pubmed]', '2006/11/11 09:00 [medline]', '2005/10/13 09:00 [entrez]']","['S0022-5193(05)00336-X [pii]', '10.1016/j.jtbi.2005.08.005 [doi]']",ppublish,J Theor Biol. 2006 Apr 7;239(3):376-90. doi: 10.1016/j.jtbi.2005.08.005. Epub 2005 Oct 10.,,,,,,,,,,,,,,,,,
11434743,NLM,MEDLINE,20010726,20190619,0003-4819 (Print) 0003-4819 (Linking),135,1,2001 Jul 3,Update in infectious diseases.,64,,,,"['Lodato, R J']",['Lodato RJ'],,['eng'],"['Comment', 'Letter']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['*Animal Feed', 'Anti-Bacterial Agents/*administration & dosage', 'Communicable Diseases/drug therapy/*microbiology', '*Drug Resistance, Microbial', 'Humans']",,,,2001/07/04 10:00,2001/07/28 10:01,['2001/07/04 10:00'],"['2001/07/04 10:00 [pubmed]', '2001/07/28 10:01 [medline]', '2001/07/04 10:00 [entrez]']","['200107030-00025 [pii]', '10.7326/0003-4819-135-1-200107030-00025 [doi]']",ppublish,Ann Intern Med. 2001 Jul 3;135(1):64. doi: 10.7326/0003-4819-135-1-200107030-00025.,,,['0 (Anti-Bacterial Agents)'],,,,,['Ann Intern Med. 2000 Aug 15;133(4):285-92. PMID: 10929170'],,,,,,,,,
11264047,NLM,MEDLINE,20010712,20041117,1058-4838 (Print) 1058-4838 (Linking),32,7,2001 Apr 1,Are enzyme-linked immunosorbent assay and immunoblot assay independent in immunodiagnosis of infectious diseases?,1114,,,,"['Katti, M K']",['Katti MK'],,['eng'],"['Comment', 'Letter']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Diseases/*diagnosis/immunology', 'Enzyme-Linked Immunosorbent Assay/*methods', 'Humans', 'Immunoblotting/*methods', 'Immunologic Tests']",,,,2001/03/27 10:00,2001/07/13 10:01,['2001/03/27 10:00'],"['2001/03/27 10:00 [pubmed]', '2001/07/13 10:01 [medline]', '2001/03/27 10:00 [entrez]']","['CID001244 [pii]', '10.1086/319611 [doi]']",ppublish,Clin Infect Dis. 2001 Apr 1;32(7):1114. doi: 10.1086/319611.,,,,,,,,['Clin Infect Dis. 2000 Mar;30(3):545-8. PMID: 10722442'],,,,,,,,,
33039158,NLM,MEDLINE,20210222,20210701,1872-8383 (Electronic) 0169-5347 (Print) 0169-5347 (Linking),35,11,2020 Nov,"Infectious Diseases, Livestock, and Climate: A Vicious Cycle?",959-962,S0169-5347(20)30227-5 [pii] 10.1016/j.tree.2020.08.012 [doi],"Ruminant livestock are a significant contributor to global methane emissions. Infectious diseases have the potential to exacerbate these contributions by elevating methane outputs associated with animal production. With the increasing spread of many infectious diseases, the emergence of a vicious climate-livestock-disease cycle is a looming threat.",['Copyright (c) 2020 Elsevier Ltd. All rights reserved.'],"['Ezenwa, Vanessa O', 'Civitello, David J', 'Barton, Brandon T', 'Becker, Daniel J', 'Brenn-White, Maris', 'Classen, Aimee T', 'Deem, Sharon L', 'Johnson, Zoe E', 'Kutz, Susan', 'Malishev, Matthew', 'Penczykowski, Rachel M', 'Preston, Daniel L', 'Vannatta, J Trevor', 'Koltz, Amanda M']","['Ezenwa VO', 'Civitello DJ', 'Barton BT', 'Becker DJ', 'Brenn-White M', 'Classen AT', 'Deem SL', 'Johnson ZE', 'Kutz S', 'Malishev M', 'Penczykowski RM', 'Preston DL', 'Vannatta JT', 'Koltz AM']","['Odum School of Ecology and Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30606, USA. Electronic address: vezenwa@uga.edu.', 'Department of Biology, Emory University, Atlanta, GA 30322, USA.', 'Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA.', 'Department of Biology, Indiana University, Bloomington, IN 47405, USA.', 'Institute for Conservation Medicine, Saint Louis Zoo, St. Louis, MO 63110, USA.', 'The Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor 48109, USA.', 'Institute for Conservation Medicine, Saint Louis Zoo, St. Louis, MO 63110, USA.', 'Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA.', 'Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.', 'Department of Biology, Emory University, Atlanta, GA 30322, USA.', 'Department of Biology, Washington University in St. Louis, St. Louis, MO 63130, USA.', 'Department of Forest and Wildlife Ecology, University of Wisconsin-Madison, Madison, WI 53706, USA.', 'Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.', 'Department of Biology, Washington University in St. Louis, St. Louis, MO 63130, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20201007,England,Trends Ecol Evol,Trends in ecology & evolution,8805125,IM,"['Animals', 'Climate', '*Communicable Diseases/epidemiology/veterinary', '*Livestock', 'Methane']",PMC7539894,,,2020/10/12 06:00,2021/02/23 06:00,['2020/10/11 20:21'],"['2020/06/15 00:00 [received]', '2020/08/18 00:00 [revised]', '2020/08/21 00:00 [accepted]', '2020/10/12 06:00 [pubmed]', '2021/02/23 06:00 [medline]', '2020/10/11 20:21 [entrez]']","['S0169-5347(20)30227-5 [pii]', '10.1016/j.tree.2020.08.012 [doi]']",ppublish,Trends Ecol Evol. 2020 Nov;35(11):959-962. doi: 10.1016/j.tree.2020.08.012. Epub 2020 Oct 7.,,,['OP0UW79H66 (Methane)'],,"['Trends Ecol Evol. 2021 Jul;36(7):576-577. PMID: 33648761', 'Trends Ecol Evol. 2021 Jul;36(7):578-579. PMID: 33966920']",,,,,,,,,,,,
17455589,NLM,MEDLINE,20070629,20141120,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[Usefulness of infectious disease information on the internet].,40-4,,,,"['Ueno, Kumi', 'Tanaka-Taya, Keiko']","['Ueno K', 'Tanaka-Taya K']","['Infectious Disease Surveillance Center, National Institute of Infectious Diseases.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Animals', '*Communicable Diseases/epidemiology/etiology', 'Databases, Factual', 'Global Health', 'Humans', '*Internet', 'Mass Media']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:40-4.,,,,,,3,,,,,,,,,,,
8979852,NLM,MEDLINE,19961211,20141120,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),1,4,1995 Oct-Dec,Emerging infectious diseases featured at ICAAC/IDSA meeting.,156,,,,,,,['eng'],['News'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/*epidemiology/etiology', 'Disease Outbreaks', 'Disease Reservoirs', '*Education, Medical', 'Global Health', 'Humans', 'Incidence', 'Prevalence', 'Societies, Scientific']",PMC2626895,,,1995/10/01 00:00,1995/10/01 00:01,['1995/10/01 00:00'],"['1995/10/01 00:00 [pubmed]', '1995/10/01 00:01 [medline]', '1995/10/01 00:00 [entrez]']",['10.3201/eid0104.950413 [doi]'],ppublish,Emerg Infect Dis. 1995 Oct-Dec;1(4):156. doi: 10.3201/eid0104.950413.,,,,,,,,,,,,,,,,,
13068726,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),44,10,1953 May 15,"MINISTRY of Health statistics of infectious diseases during April, 1953.",240,,,,,,,['eng'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/05/15 00:00,1953/05/15 00:01,['1953/05/15 00:00'],"['1953/05/15 00:00 [pubmed]', '1953/05/15 00:01 [medline]', '1953/05/15 00:00 [entrez]']",,ppublish,Harefuah. 1953 May 15;44(10):240.,,,,,,,,,,,,['CLML: 5324:39430:162'],,,,,
13052254,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),44,4,1953 Feb 15,[MINISTRY of Health; statistics of infectious diseases during January 1953].,94,,,,,,,['und'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/02/15 00:00,1953/02/15 00:01,['1953/02/15 00:00'],"['1953/02/15 00:00 [pubmed]', '1953/02/15 00:01 [medline]', '1953/02/15 00:00 [entrez]']",,ppublish,Harefuah. 1953 Feb 15;44(4):94.,,,,,,,,,,,,['CLML: 5324:22811:162'],,,,,
37528005,NLM,MEDLINE,20230803,20230803,0578-1310 (Print) 0578-1310 (Linking),61,8,2023 Aug 2,[Syndromic panel-based molecular testing for diagnosis and management of infectious diseases in pediatric patients].,675-678,10.3760/cma.j.cn112140-20230605-00376 [doi],,,"['Zheng, X T', 'Qian, Y']","['Zheng XT', 'Qian Y']","[""Department of Pathology and Laboratory Medicine, Akron Children's Hospital, Akron OH44308, USA."", 'Laboratory of Virology, Beijing Key Laboratory of Etiology of Viral Diseases in Children, Capital Institute of Pediatrics, Beijing 100020, China.']",['chi'],['Journal Article'],,China,Zhonghua Er Ke Za Zhi,Zhonghua er ke za zhi = Chinese journal of pediatrics,0417427,IM,"['Humans', 'Child', '*Communicable Diseases/diagnosis/therapy', 'Molecular Diagnostic Techniques', 'Genetic Testing']",,,,2023/08/02 01:07,2023/08/03 06:43,['2023/08/01 22:24'],"['2023/08/03 06:43 [medline]', '2023/08/02 01:07 [pubmed]', '2023/08/01 22:24 [entrez]']",['10.3760/cma.j.cn112140-20230605-00376 [doi]'],ppublish,Zhonghua Er Ke Za Zhi. 2023 Aug 2;61(8):675-678. doi: 10.3760/cma.j.cn112140-20230605-00376.,,,,,,,,,,,,,,,,,
34197934,NLM,MEDLINE,20220209,20220209,1469-0691 (Electronic) 1198-743X (Linking),27,9,2021 Sep,Infectious disease serology in 2021.,1204-1206,S1198-743X(21)00340-2 [pii] 10.1016/j.cmi.2021.06.020 [doi],,,"['Yusuf, Erlangga', 'Allerberger, Franz']","['Yusuf E', 'Allerberger F']","['Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: angga.yusuf@gmail.com.', 'Division of Public Health, Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.']",['eng'],['Editorial'],20210628,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['*Communicable Diseases/diagnosis/epidemiology', 'Humans', 'Serologic Tests']",,,,2021/07/02 06:00,2022/02/10 06:00,['2021/07/01 20:14'],"['2021/05/18 00:00 [received]', '2021/06/11 00:00 [revised]', '2021/06/12 00:00 [accepted]', '2021/07/02 06:00 [pubmed]', '2022/02/10 06:00 [medline]', '2021/07/01 20:14 [entrez]']","['S1198-743X(21)00340-2 [pii]', '10.1016/j.cmi.2021.06.020 [doi]']",ppublish,Clin Microbiol Infect. 2021 Sep;27(9):1204-1206. doi: 10.1016/j.cmi.2021.06.020. Epub 2021 Jun 28.,,,,,,,,,,,,,,,,,
26151394,NLM,MEDLINE,20160609,20190109,2150-5608 (Electronic) 2150-5594 (Print) 2150-5594 (Linking),6,6,2015,Our changing world: impacts on health and infectious diseases.,533-4,10.1080/21505594.2015.1062961 [doi],,,"['Patrozou, Eleni']",['Patrozou E'],"['a Alpert Medical School of Brown University ; Providence , RI USA.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Virulence,Virulence,101531386,IM,"['*Climate Change', 'Communicable Disease Control/*methods/*organization & administration', 'Communicable Diseases/*epidemiology/*transmission', '*Global Health', 'Humans']",PMC4720228,,,2015/07/08 06:00,2016/06/10 06:00,['2015/07/08 06:00'],"['2015/07/08 06:00 [entrez]', '2015/07/08 06:00 [pubmed]', '2016/06/10 06:00 [medline]']","['1062961 [pii]', '10.1080/21505594.2015.1062961 [doi]']",ppublish,Virulence. 2015;6(6):533-4. doi: 10.1080/21505594.2015.1062961.,,,,,,,,,,,,,,,,,
36789732,NLM,MEDLINE,20230518,20230519,1365-2915 (Electronic) 0269-283X (Linking),37,2,2023 Jun,Vector-borne bacterial diseases: a neglected field of infectious diseases research.,177-178,10.1111/mve.12646 [doi],,,"['Laroche, Maureen', 'Weeks, Emma N I']","['Laroche M', 'Weeks ENI']","['Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.', 'University of Florida Entomology and Nematology Department, Gainesville, Florida, USA.']",['eng'],['Editorial'],20230215,England,Med Vet Entomol,Medical and veterinary entomology,8708682,IM,"['Animals', '*Communicable Diseases/epidemiology/veterinary', 'Bacteria', '*Vector Borne Diseases/veterinary', '*Bacterial Infections/epidemiology/veterinary']",,,,2023/02/16 06:00,2023/05/18 06:42,['2023/02/15 04:23'],"['2023/05/18 06:42 [medline]', '2023/02/16 06:00 [pubmed]', '2023/02/15 04:23 [entrez]']",['10.1111/mve.12646 [doi]'],ppublish,Med Vet Entomol. 2023 Jun;37(2):177-178. doi: 10.1111/mve.12646. Epub 2023 Feb 15.,,,,,,,,,,,,,,,,,
9229617,NLM,MEDLINE,19970724,20051116,0023-2149 (Print) 0023-2149 (Linking),75,3,1997,[Meningeal syndrome in differential diagnosis of infectious diseases].,47-53,,,,"['Bogomolov, B P']",['Bogomolov BP'],"[""Medical Center of President's Affair, Moscow.""]",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Communicable Diseases/*diagnosis/etiology', 'Diagnosis, Differential', 'Humans', 'Meningism/*diagnosis/etiology', 'Meningitis/diagnosis/etiology', 'Syndrome']",,,,1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1997;75(3):47-53.,,,,,,0,,,Meningialnyi sindrom v differentsialnoi diagnostike infektsionnykh boleznei.,,,,,,,,
13894127,NLM,MEDLINE,19981101,20181201,,59,,1962 Apr 12,[Corticosteroid therapy and infectious diseases].,1151-6,,,,"['FORSGREN, E']",['FORSGREN E'],,['swe'],['Journal Article'],,Sweden,Sven Lakartidn,Svenska lakartidningen,0030130,OM,"['Adrenal Cortex Hormones/*therapy', 'Communicable Diseases/*therapy']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapy', '*COMMUNICABLE DISEASES/therapy']",1962/04/12 00:00,1962/04/12 00:01,['1962/04/12 00:00'],"['1962/04/12 00:00 [pubmed]', '1962/04/12 00:01 [medline]', '1962/04/12 00:00 [entrez]']",,ppublish,Sven Lakartidn. 1962 Apr 12;59:1151-6.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,,,,,,
21809647,NLM,MEDLINE,20110906,20200716,0372-9311 (Print) 0372-9311 (Linking),,3,2011 May-Jun,[Spread and features of chronic and recurrent infectious diseases in patients with primary headache].,61-7,,"AIM: Study of spread and clinical-immunologic features of chronic and recurrent infectious diseases in patients with primary headache. MATERIALS AND METHODS: 158 patients with migraine and 79 patients with tension headache were examined. Diagnostics of chronic and recurrent infectious diseases were carried out by the appropriate specialists according to the current standards. Immunologic studies included evaluation of cellular, humoral, innate immunity, cytokine status parameters. RESULTS: Spread of chronic and recurrent infectious diseases, that were considered as clinical manifestations of secondary immunodeficiency, in patients with primary headache exceeded the spread in the population of the region. In the patients with a combination of cephalgia and infectious pathology a tendency of leucopenia, lymphocyte subpopulation composition disorders, neutrophil functional activity, IgG level decrease, cytokine system imbalance were characteristic. In chronic primary headache course rate of occurrence of infectious diseases and intensity of immune status disorders were higher than in episodic course of these cephalgias. CONCLUSION: Results of these studies suggest a connection between chronic and recurrent infectious diseases within secondary immunodeficiency with primary headache.",,"['Karpova, M I', 'Shamurova, Iu S', 'Markova, V V', 'Pecherkin, V F']","['Karpova MI', 'Shamurova IuS', 'Markova VV', 'Pecherkin VF']",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Chronic Disease', 'Communicable Diseases/complications/*epidemiology/*immunology', 'Headache/*epidemiology/etiology', 'Humans', 'Immunologic Deficiency Syndromes/complications/immunology', 'Migraine Disorders/*epidemiology/etiology', 'Recurrence', 'Tension-Type Headache/*epidemiology/etiology']",,,,2011/08/04 06:00,2011/09/07 06:00,['2011/08/04 06:00'],"['2011/08/04 06:00 [entrez]', '2011/08/04 06:00 [pubmed]', '2011/09/07 06:00 [medline]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2011 May-Jun;(3):61-7.,,,,,,,,,,,,,,,,,
13432496,NLM,MEDLINE,20020501,20200923,0035-2640 (Print) 0035-2640 (Linking),7,7,1957 Mar 1,[Convalescence of infectious diseases].,695-700,,,,"['MORIN, M']",['MORIN M'],,['fre'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,OM,"['Communicable Diseases/*therapy', '*Convalescence', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*CONVALESCENCE']",1957/03/01 00:00,1957/03/01 00:01,['1957/03/01 00:00'],"['1957/03/01 00:00 [pubmed]', '1957/03/01 00:01 [medline]', '1957/03/01 00:00 [entrez]']",,ppublish,Rev Prat. 1957 Mar 1;7(7):695-700.,,,,,,,,,La convalescence des maladies infectieuses.,,,['CLML: 5732:30700'],,,,,
13206360,NLM,MEDLINE,20030501,20200716,0372-9311 (Print) 0372-9311 (Linking),8,,1954 Aug,"Microbiology, immunology, infectious diseases and epidemiology in the fourth quarter of 1953.",114-21,,,,"['IVANOV, B A']",['IVANOV BA'],,"['eng', 'rus']",['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['Communicable Diseases/*epidemiology', '*Microbiology']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology', '*MICROBIOLOGY']",1954/08/01 00:00,1954/08/01 00:01,['1954/08/01 00:00'],"['1954/08/01 00:00 [pubmed]', '1954/08/01 00:01 [medline]', '1954/08/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1954 Aug;8:114-21.,,,,,,,,,"Po voprosam mikrobiologi immunologii, infektsionnym bolezniam i epidemiologii za chetvertyi kvartal 1953 g.",,,['CLML: 5527:18056:120:292'],,,,,
13924065,NLM,MEDLINE,19981101,20200716,0372-9311 (Print) 0372-9311 (Linking),33,,1962 Feb,[On the organization of teaching of infectious diseases in medical institutes].,128-9,,,,"['UZHINOVA, E P', 'SUKHAREV, V M']","['UZHINOVA EP', 'SUKHAREV VM']",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['Communicable Diseases/*education', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/education'],1962/02/01 00:00,1962/02/01 00:01,['1962/02/01 00:00'],"['1962/02/01 00:00 [pubmed]', '1962/02/01 00:01 [medline]', '1962/02/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1962 Feb;33:128-9.,,,,,,,,,,,,,,,,,
18877622,NLM,MEDLINE,20081016,20190818,0025-7125 (Print) 0025-7125 (Linking),32,,1948 Jul,Recent trends in the treatment of infectious diseases.,1105-12,,,,"['NICHOLS, D R']",['NICHOLS DR'],,['eng'],['Journal Article'],,United States,Med Clin North Am,The Medical clinics of North America,2985236R,OM,"['Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1948/07/01 00:00,2008/10/24 09:00,['1948/07/01 00:00'],"['1948/07/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/07/01 00:00 [entrez]']","['S0025-7125(16)35670-X [pii]', '10.1016/s0025-7125(16)35670-x [doi]']",ppublish,Med Clin North Am. 1948 Jul;32:1105-12. doi: 10.1016/s0025-7125(16)35670-x.,,,,,,,,,,,,['CLML: 4815:918b'],,,,,
18841709,NLM,MEDLINE,20081124,20200407,0065-2598 (Print) 0065-2598 (Linking),635,,2008,The damage-response framework of microbial pathogenesis and infectious diseases.,135-46,10.1007/978-0-387-09550-9_11 [doi],"Historical and most currently held views of microbial pathogenesis and virulence are plagued by confusing and imprecise terminology and definitions that require revision and exceptions to accommodate new basic science and clinical information about microbes and infectious diseases. These views are also inherently unable to account for the ability of some microbes to cause disease in certain, but not other hosts, because they are grounded in singular, either microbe-or host-centric views. The damage-response framework is an integrated theory of microbial pathogenesis that puts forth the view that microbial pathogenesis reflects the outcome of an interaction between a host and a microbe, with each entity contributing to the nature of the outcome, which in turn depends on the amount of host damage that results from the host-microbe interaction. This view is able to accommodate new information and explain why infection with the same microbe can have different outcomes in different hosts. This chapter describes the origins and conceptual underpinnings of and the outcomes of infection put forth in, the damage-response framework.",,"['Pirofski, Liise-anne', 'Casadevall, Arturo']","['Pirofski LA', 'Casadevall A']","['Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York 10461, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['Animals', 'Communicable Diseases/*microbiology/*pathology', '*Host-Pathogen Interactions', 'Humans']",PMC7123708,,,2008/10/10 09:00,2008/12/17 09:00,['2008/10/10 09:00'],"['2008/10/10 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/10/10 09:00 [entrez]']","['11 [pii]', '10.1007/978-0-387-09550-9_11 [doi]']",ppublish,Adv Exp Med Biol. 2008;635:135-46. doi: 10.1007/978-0-387-09550-9_11.,,,,,,,,,,,,,,,,,
16222849,NLM,MEDLINE,20070426,20170330,0394-9001 (Print) 0394-9001 (Linking),16,2,2004,[The explicative power of the rules: the case of the Koch's postulates].,293-316,,"This article traces the emergence of the standard for evidence of causation in infectious diseases, from the scientific discoveries on contagion by Agostino Bassi, in the first half of the nineteenth century. However, only after the work of Robert Koch on anthrax and tuberculosis, a set of practical guidelines (Koch's postulates) were acknowledged, to establish rigorous criteria before a microbiologist could claim a strictly causal relationship between microbes and infectious diseases. The methodological and epistemological meaning of these guidelines, and their limits, are discussed in the light of the recent development of microbiology and medicine.",,"['Mazzarello, Paolo']",['Mazzarello P'],"[""Dipartimento di Medicina Sperimentale e Museo per la Storia dell' Universita di Pavia, I, Pavia, Italia.""]",['ita'],"['English Abstract', 'Historical Article', 'Journal Article']",,Italy,Med Secoli,Medicina nei secoli,0176472,,"['Anthrax/history/microbiology', 'Communicable Diseases/history/microbiology/transmission', 'History, 19th Century', 'Microbiological Techniques/history', 'Microbiology/*history', 'Tuberculosis/history/microbiology']",,,,2005/10/15 09:00,2007/04/27 09:00,['2005/10/15 09:00'],"['2005/10/15 09:00 [pubmed]', '2007/04/27 09:00 [medline]', '2005/10/15 09:00 [entrez]']",,ppublish,Med Secoli. 2004;16(2):293-316.,,,,,,,,,Il potere esplicativo delle regole: il caso dei postulati di Koch.,,,,,,,,
26709092,NLM,MEDLINE,20161104,20161230,1469-0691 (Electronic) 1198-743X (Linking),22,3,2016 Mar,Automation in bacteriology: a changing way to perform clinical diagnosis in infectious diseases.,215-6,S1198-743X(15)01037-X [pii] 10.1016/j.cmi.2015.12.011 [doi],,,"['Lina, G', 'Greub, G']","['Lina G', 'Greub G']","['IAI, Hospices Civils de Lyon, Lyon, France; Universite Lyon 1, Domaine de la Buire, Lyon, France; INSERM U1111, CIRI, Domaine de la Buire, Lyon, France. Electronic address: Gerard.lina@univ-lyon1.fr.', 'Institute of Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland. Electronic address: gilbert.greub@chuv.ch.']",['eng'],['Editorial'],20151218,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['*Automation', '*Bacteriological Techniques', '*Bacteriology', 'Communicable Diseases/*diagnosis/microbiology', 'Humans']",,['NOTNLM'],"['Automation', 'bacteriology', 'management', 'productivity', 'quality']",2015/12/29 06:00,2016/11/05 06:00,['2015/12/29 06:00'],"['2015/12/01 00:00 [received]', '2015/12/10 00:00 [accepted]', '2015/12/29 06:00 [entrez]', '2015/12/29 06:00 [pubmed]', '2016/11/05 06:00 [medline]']","['S1198-743X(15)01037-X [pii]', '10.1016/j.cmi.2015.12.011 [doi]']",ppublish,Clin Microbiol Infect. 2016 Mar;22(3):215-6. doi: 10.1016/j.cmi.2015.12.011. Epub 2015 Dec 18.,,,,,,,,,,,,,,,,,
20933144,NLM,MEDLINE,20110119,20211020,1878-1306 (Electronic) 0195-5616 (Print) 0195-5616 (Linking),40,6,2010 Nov,Molecular diagnostic assays for infectious diseases in cats.,1189-200,10.1016/j.cvsm.2010.07.012 [doi],"With the advent of more accessible polymerase chain reaction panels, the use of molecular techniques for the detection of infectious organisms has become more routine in veterinary medicine. The use of molecular diagnostics is best reserved for the detection of organisms that are difficult to detect or identify expediently. In this article, the fundamentals of molecular techniques are reviewed along with an examination of specific feline infectious diseases in which diagnosis via molecular techniques is advantageous.",['Copyright (c) 2010 Elsevier Inc. All rights reserved.'],"['Veir, Julia K', 'Lappin, Michael R']","['Veir JK', 'Lappin MR']","['Department of Clinical Sciences, Colorado State University, Campus Delivery 1620, Fort Collins, CO 80523, USA. jveir@colostate.edu']",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Small Anim Pract,The Veterinary clinics of North America. Small animal practice,7809942,IM,"['Animals', 'Cat Diseases/*diagnosis', 'Cats', 'Communicable Diseases/diagnosis/*veterinary', 'Molecular Diagnostic Techniques/*veterinary', 'Polymerase Chain Reaction/veterinary']",PMC7114846,,,2010/10/12 06:00,2011/01/20 06:00,['2010/10/12 06:00'],"['2010/10/12 06:00 [entrez]', '2010/10/12 06:00 [pubmed]', '2011/01/20 06:00 [medline]']","['S0195-5616(10)00099-9 [pii]', '10.1016/j.cvsm.2010.07.012 [doi]']",ppublish,Vet Clin North Am Small Anim Pract. 2010 Nov;40(6):1189-200. doi: 10.1016/j.cvsm.2010.07.012.,,,,,,,,,,,,,,,,,
20218122,NLM,MEDLINE,20100402,20100311,1020-3397 (Print) 1020-3397 (Linking),15,6,2009 Nov-Dec,Communicable diseases or infectious diseases are caused by pathogenic microorganisms.,1344-5,,,,,,,"['ara', 'eng']",['Editorial'],,Egypt,East Mediterr Health J,Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,9608387,IM,"['Communicable Disease Control/*organization & administration', '*Communicable Diseases/epidemiology/microbiology', 'Humans', 'Mediterranean Region/epidemiology', 'Organizational Objectives', 'Regional Medical Programs/*organization & administration', 'World Health Organization/*organization & administration']",,,,2010/03/12 06:00,2010/04/03 06:00,['2010/03/12 06:00'],"['2010/03/12 06:00 [entrez]', '2010/03/12 06:00 [pubmed]', '2010/04/03 06:00 [medline]']",,ppublish,East Mediterr Health J. 2009 Nov-Dec;15(6):1344-5.,,,,,,,,,,,,,,,,,
24020734,NLM,MEDLINE,20140331,20181202,1746-0921 (Electronic) 1746-0913 (Linking),8,9,2013 Sep,Meeting the challenge of invasive fungal infections: part 1.,1063-5,10.2217/fmb.13.96 [doi],"The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases, is now the world's largest conference on infectious diseases. This year, the meeting attracted a global attendance of more than 10,000 scientists and clinicians to share state-of-the-art information on infectious diseases. This article, the first of a two-part report on the ECCMID 2013 conference, reviews sessions on the increasing challenges and emerging new threats from invasive fungal infections.",,"['Maertens, Johan', 'Lyon, Sue']","['Maertens J', 'Lyon S']","['Department of Haematology, Universitaire Ziekenhuizen Campus Gasthuisberg, KU Leuven, Leuven, Belgium. johan.maertens@uzleuven.be.']",['eng'],"['Congress', ""Research Support, Non-U.S. Gov't""]",,England,Future Microbiol,Future microbiology,101278120,IM,"['Antifungal Agents/pharmacology/therapeutic use', 'Communicable Diseases, Emerging/diagnosis/*epidemiology/*microbiology/therapy', 'Drug Resistance, Fungal', 'Fungi/drug effects/isolation & purification', 'Humans', 'Mycoses/diagnosis/*epidemiology/*microbiology/therapy']",,,,2013/09/12 06:00,2014/04/01 06:00,['2013/09/12 06:00'],"['2013/09/12 06:00 [entrez]', '2013/09/12 06:00 [pubmed]', '2014/04/01 06:00 [medline]']",['10.2217/fmb.13.96 [doi]'],ppublish,Future Microbiol. 2013 Sep;8(9):1063-5. doi: 10.2217/fmb.13.96.,,,['0 (Antifungal Agents)'],,,,,,,,,,,,,,
24522318,NLM,MEDLINE,20140401,20181202,0716-1018 (Print) 0716-1018 (Linking),30,6,2013 Dec,"[Struggle against infectious diseases in children in the Magallanes Region: death, passion and life (Part I)].",683-9,S0716-10182013000600021 [pii] 10.4067/S0716-10182013000600021 [doi],"Historical background of infectious diseases of children in the Region of Magallanes is reviewed, with special emphasis on their impact on infant mortality. For purposes of publication, the research is divided into two parts. In this first one, we present a brief relation of the facts that led to the death of almost all of the Spanish colonizers of the Strait of Magellan, including children (1584-1590); following, a description of the available data on infectious diseases affecting Patagonian Indians before contact with white man. Finally we describe the health situation in Punta Arenas, from the foundation of Bulnes Fort until the end of the 19th century.",,"['Vieira, Matias']",['Vieira M'],,['spa'],"['Historical Article', 'Journal Article', 'Portrait']",,Chile,Rev Chilena Infectol,Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,9305754,IM,"['Child', 'Chile', 'Communicable Diseases/*history/mortality', 'History, 16th Century', 'Humans', 'Indians, South American/history']",,,,2014/02/14 06:00,2014/04/02 06:00,['2014/02/14 06:00'],"['2014/02/14 06:00 [entrez]', '2014/02/14 06:00 [pubmed]', '2014/04/02 06:00 [medline]']","['S0716-10182013000600021 [pii]', '10.4067/S0716-10182013000600021 [doi]']",ppublish,Rev Chilena Infectol. 2013 Dec;30(6):683-9. doi: 10.4067/S0716-10182013000600021.,,,,,,,,,"La lucha contra las enfermedades infecciosas de los ninos en la Region de Magallanes, Chile: Muerte, pasion y vida (Parte I).",,,,,,,,
27254625,NLM,MEDLINE,20170303,20170817,1439-4413 (Electronic) 0012-0472 (Linking),141,11,2016 Jun,[Health care of refugees - A short review with focus on infectious diseases].,772-6,10.1055/s-0042-107178 [doi],"Few guidelines for health care of refugees exist in Germany. Screening as a part of initial health checks as well as general organisation of early health care for refugees is very heterogenous across different regions. Current experience will be relevant to develop integrated health care models. Prevention and care of infectious diseases are an important part of early health care for refugees, even if non-communicable diseases and mental health conditions should also be considered in every effort to design early health care models. We are presenting a pragmatic review of current evidence for prevention and care of tuberculosis, HIV, chronic viral hepatitis and other infectious diseases. More evidence is needed to assess morbidity and efficacy of early health care interventions and integrated care models in refugees.",['(c) Georg Thieme Verlag KG Stuttgart . New York.'],"['Lange, Berit', 'Stete, Katarina', 'Bozorgmehr, Kayvan', 'Camp, Johannes', 'Kranzer, Katharina', 'Kern, Winfried', 'Rieg, Siegbert']","['Lange B', 'Stete K', 'Bozorgmehr K', 'Camp J', 'Kranzer K', 'Kern W', 'Rieg S']",,['ger'],"['Journal Article', 'Review']",20160602,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Comorbidity', '*Delivery of Health Care', 'Delivery of Health Care, Integrated', 'Early Medical Intervention', 'Germany', 'Guideline Adherence', 'Mass Screening', '*Refugees', 'Treatment Outcome']",,,,2016/06/03 06:00,2017/03/04 06:00,['2016/06/03 06:00'],"['2016/06/03 06:00 [entrez]', '2016/06/03 06:00 [pubmed]', '2017/03/04 06:00 [medline]']",['10.1055/s-0042-107178 [doi]'],ppublish,Dtsch Med Wochenschr. 2016 Jun;141(11):772-6. doi: 10.1055/s-0042-107178. Epub 2016 Jun 2.,,,,,,,,,Gesundheitsversorgung gefluchteter Menschen.,,,,,,,,
13810827,NLM,MEDLINE,19981101,20181201,0096-0632 (Print) 0096-0632 (Linking),172,,1959 Sep,The evolution of infectious diseases.,493-508,,,,"['COCKBURN, T A']",['COCKBURN TA'],,['eng'],['Journal Article'],,United States,Int Rec Med,International record of medicine,9427061,OM,"['*Biological Evolution', 'Communicable Diseases/*history', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/history'],1959/09/01 00:00,1959/09/01 00:01,['1959/09/01 00:00'],"['1959/09/01 00:00 [pubmed]', '1959/09/01 00:01 [medline]', '1959/09/01 00:00 [entrez]']",,ppublish,Int Rec Med. 1959 Sep;172:493-508.,,,,,,,,,,,,,,,,,
13173319,NLM,MEDLINE,20030501,20181201,0012-1320 (Print) 0012-1320 (Linking),5,8,1954 Apr 15,[Pathogenesis of relapse in infectious diseases].,200-3,,,,"['HORING, F O']",['HORING FO'],,['und'],['Journal Article'],,Germany,Dtsch Med J,Deutsches medizinisches Journal,0420573,OM,"['*Chronic Disease', 'Communicable Diseases/*complications', '*Recurrence']",,['NLM'],['*COMMUNICABLE DISEASES/complications'],1954/04/15 00:00,1954/04/15 00:01,['1954/04/15 00:00'],"['1954/04/15 00:00 [pubmed]', '1954/04/15 00:01 [medline]', '1954/04/15 00:00 [entrez]']",,ppublish,Dtsch Med J. 1954 Apr 15;5(8):200-3.,,,,,,,,,Pathogenese der Rezidive bei Infektionskrankheiten.,,,['CLML: 5426:36148:117'],,,,,
27874924,NLM,MEDLINE,20170529,20171011,1652-7518 (Electronic) 0023-7205 (Linking),113,,2016 Nov 22,[A provincial doctor and his fight against infectious diseases].,,ECH7 [pii],,,"['Robertsdotter Mard, Annette']",['Robertsdotter Mard A'],,['swe'],"['Biography', 'Historical Article', 'Journal Article']",20161122,Sweden,Lakartidningen,Lakartidningen,0027707,IM,"['Acetic Acid/history', '*Communicable Diseases/history/therapy', 'History, 19th Century', 'Humans', 'Physicians, Family/*history', 'Sweden']",,,,2016/11/23 06:00,2017/05/30 06:00,['2016/11/23 06:00'],"['2016/11/23 06:00 [entrez]', '2016/11/23 06:00 [pubmed]', '2017/05/30 06:00 [medline]']",['ECH7 [pii]'],epublish,Lakartidningen. 2016 Nov 22;113:ECH7.,,,['Q40Q9N063P (Acetic Acid)'],,,,,,En landsortsdoktor och hans kamp mot smittosamma sjukdomar.,,,,,,,['Gravander LF'],"['Gravander, Lars Fredrik']"
24579772,NLM,MEDLINE,20150114,20181202,1744-8336 (Electronic) 1478-7210 (Linking),12,4,2014 Apr,Developments in pediatric infectious diseases: a review of WSPID 2013.,419-22,10.1586/14787210.2014.894460 [doi],,,"['Eley, Brian S', 'Nuttall, James']","['Eley BS', 'Nuttall J']","[""Pediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Western Cape, South Africa.""]",['eng'],['Congress'],20140303,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,IM,"['Child', 'Child, Preschool', 'Communicable Diseases/drug therapy/*epidemiology', 'Drug Resistance, Bacterial', 'Humans', 'Infant', 'Infant, Newborn', 'Pediatrics/*trends', 'South Africa']",,,,2014/03/04 06:00,2015/01/15 06:00,['2014/03/04 06:00'],"['2014/03/04 06:00 [entrez]', '2014/03/04 06:00 [pubmed]', '2015/01/15 06:00 [medline]']",['10.1586/14787210.2014.894460 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2014 Apr;12(4):419-22. doi: 10.1586/14787210.2014.894460. Epub 2014 Mar 3.,,,,,,,,,,,,,,,,,
14970152,NLM,MEDLINE,20040303,20190619,1539-3704 (Electronic) 0003-4819 (Linking),140,4,2004 Feb 17,Update in infectious diseases.,290-5,,,,"['Sande, Merle A', 'Ronald, Allan R']","['Sande MA', 'Ronald AR']","['Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA. merle.sande@hsc.utah.edu']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Communicable Disease Control', '*Communicable Diseases/epidemiology/therapy', 'Humans', 'Vaccination', 'Vaccines/adverse effects']",,,,2004/02/19 05:00,2004/03/05 05:00,['2004/02/19 05:00'],"['2004/02/19 05:00 [pubmed]', '2004/03/05 05:00 [medline]', '2004/02/19 05:00 [entrez]']","['140/4/290 [pii]', '10.7326/0003-4819-140-4-200402170-00011 [doi]']",ppublish,Ann Intern Med. 2004 Feb 17;140(4):290-5. doi: 10.7326/0003-4819-140-4-200402170-00011.,,,['0 (Vaccines)'],['Ann Intern Med. 2004 Jun;140(11):939'],,2,,,,,,,,,,,
26352354,NLM,MEDLINE,20170206,20170206,1437-4331 (Electronic) 1434-6621 (Linking),54,5,2016 May,Capillary electrophoresis based on nucleic acid detection for diagnosing human infectious disease.,707-38,10.1515/cclm-2015-0096 [doi],"Rapid transmission, high morbidity, and mortality are the features of human infectious diseases caused by microorganisms, such as bacteria, fungi, and viruses. These diseases may lead within a short period of time to great personal and property losses, especially in regions where sanitation is poor. Thus, rapid diagnoses are vital for the prevention and therapeutic intervention of human infectious diseases. Several conventional methods are often used to diagnose infectious diseases, e.g. methods based on cultures or morphology, or biochemical tests based on metabonomics. Although traditional methods are considered gold standards and are used most frequently, they are laborious, time consuming, and tedious and cannot meet the demand for rapid diagnoses. Disease diagnosis using capillary electrophoresis methods has the advantages of high efficiency, high throughput, and high speed, and coupled with the different nucleic acid detection strategies overcomes the drawbacks of traditional identification methods, precluding many types of false positive and negative results. Therefore, this review focuses on the application of capillary electrophoresis based on nucleic detection to the diagnosis of human infectious diseases, and offers an introduction to the limitations, advantages, and future developments of this approach.",,"['Lian, Dong-Sheng', 'Zhao, Shu-Jin']","['Lian DS', 'Zhao SJ']",,['eng'],"['Journal Article', 'Review']",,Germany,Clin Chem Lab Med,Clinical chemistry and laboratory medicine,9806306,IM,"['Bacteria/genetics/isolation & purification', 'Communicable Diseases/*diagnosis/*microbiology', 'DNA/*analysis', 'Electrophoresis, Capillary', 'Humans']",,,,2015/09/10 06:00,2017/02/07 06:00,['2015/09/10 06:00'],"['2015/01/28 00:00 [received]', '2015/06/17 00:00 [accepted]', '2015/09/10 06:00 [entrez]', '2015/09/10 06:00 [pubmed]', '2017/02/07 06:00 [medline]']","['/j/cclm.ahead-of-print/cclm-2015-0096/cclm-2015-0096.xml [pii]', '10.1515/cclm-2015-0096 [doi]']",ppublish,Clin Chem Lab Med. 2016 May;54(5):707-38. doi: 10.1515/cclm-2015-0096.,,,['9007-49-2 (DNA)'],,,,,,,,,,,,,,
16237513,NLM,MEDLINE,20060601,20190831,0020-9554 (Print) 0020-9554 (Linking),47,2,2006 Feb,[Appropriate microbiological diagnostics].,171-80; quiz 181,,"In the industrialized world the threat of infectious diseases is mainly due to nosocomial infections and multi-resistant agents. In this context, microbiological evaluations have not only a benefit for the individual patient, but also allow to evaluate the local epidemiologic situation. However, quality and benefits are often compromised by incorrect specimen collection. This review attempts to summarize diagnostic procedures, collection and transport of appropriate specimens and relevant causative agents for prominent clinical manifestations of infectious diseases.",,"['Rodloff, A C', 'Schaumann, R', 'Blatz, R']","['Rodloff AC', 'Schaumann R', 'Blatz R']","['Institut fur Medizinische Mikrobiologie und Infektionsepidemiologie, Universitat Leipzig.']",['ger'],"['English Abstract', 'Journal Article', 'Review']",,Germany,Internist (Berl),Der Internist,0264620,IM,"['Communicable Diseases/*diagnosis/*microbiology', 'Humans', 'Microbiological Techniques/*methods', 'Practice Guidelines as Topic', ""Practice Patterns, Physicians'"", 'Specimen Handling/*methods']",,,,2005/10/21 09:00,2006/06/02 09:00,['2005/10/21 09:00'],"['2005/10/21 09:00 [pubmed]', '2006/06/02 09:00 [medline]', '2005/10/21 09:00 [entrez]']",['10.1007/s00108-005-1512-8 [doi]'],ppublish,Internist (Berl). 2006 Feb;47(2):171-80; quiz 181. doi: 10.1007/s00108-005-1512-8.,,,,,,29,,,Sinnvolle Mikrobiologische Diagnostik.,,,,,,,,
7039132,NLM,MEDLINE,19820527,20181113,0093-0415 (Print) 0093-0415 (Linking),135,6,1981 Dec,Important infections in elderly persons.,441-5,,"Elderly persons are prone to more frequent or greater morbidity and higher mortality from selected infectious diseases than the average population. Factors that may affect this increased predilection or poorer prognosis include environmental exposure, normal physiological changes of aging, coexistence of chronic diseases and alteration of host defense mechanisms. Infections to which the aged are particularly vulnerable are pneumonia, influenza, tuberculosis, urinary tract infection, Gram-negative bacteremia, intra-abdominal sepsis, soft tissue infection, infective endocarditis, bacterial meningitis, bacterial arthritis and herpes zoster infection.",,"['Yoshikawa, T T']",['Yoshikawa TT'],,['eng'],"['Journal Article', 'Review']",,United States,West J Med,The Western journal of medicine,0410504,IM,"['Aged', 'Aging', 'Communicable Diseases/*epidemiology/immunology/physiopathology', 'Environmental Exposure', 'Humans', 'Immunity, Innate', 'Middle Aged', 'Risk', 'United States']",PMC1273317,,,1981/12/01 00:00,1981/12/01 00:01,['1981/12/01 00:00'],"['1981/12/01 00:00 [pubmed]', '1981/12/01 00:01 [medline]', '1981/12/01 00:00 [entrez]']",,ppublish,West J Med. 1981 Dec;135(6):441-5.,,,,,,,,,,,,,,,,,
32080115,NLM,MEDLINE,20200309,20221005,1536-5964 (Electronic) 0025-7974 (Print) 0025-7974 (Linking),99,8,2020 Feb,"A Bayesian classification model for discriminating common infectious diseases in Zhejiang province, China.",e19218,10.1097/MD.0000000000019218 [doi] e19218,"To develop a classification model for accurately discriminating common infectious diseases in Zhejiang province, China.Symptoms and signs, abnormal lab test results, epidemiological features, as well as the incidence rates were treated as predictors, and were collected from the published literature and a national surveillance system of infectious disease. A classification model was established using naive Bayesian classifier. Dataset from historical outbreaks was applied for model validation, while sensitivity, specificity, accuracy, area under the receiver operating characteristic curve (AUC) and M-index were presented.A total of 146 predictors were included in the classification model, for discriminating 25 common infectious diseases. The sensitivity ranged from 44.44% for hepatitis E to 96.67% for measles. The specificity varied from 96.36% for dengue fever to 100% for 5 diseases. The median of total accuracy was 97.41% (range: 93.85%-99.04%). The AUCs exceeded 0.98 in 11 of 12 diseases, except in dengue fever (0.613). The M-index was 0.960 (95%CI 0.941-0.978).A novel classification model was constructed based on Bayesian approach to discriminate common infectious diseases in Zhejiang province, China. After entering symptoms and signs, abnormal lab test results, epidemiological features and city of disease origin, an output list of possible diseases ranked according to the calculated probabilities can be provided. The discrimination performance was reasonably good, making it useful in epidemiological applications.",,"['Li, Fudong', 'Shen, Yi', 'Lv, Duo', 'Lin, Junfen', 'Liu, Biyao', 'He, Fan', 'Wang, Zhen']","['Li F', 'Shen Y', 'Lv D', 'Lin J', 'Liu B', 'He F', 'Wang Z']","['Zhejiang Provincial Center for Disease Control and Prevention.', 'Department of Epidemiology and Health Statistics, School of Public Health, Zhejiang University.', ""The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China."", 'Zhejiang Provincial Center for Disease Control and Prevention.', 'Zhejiang Provincial Center for Disease Control and Prevention.', 'Zhejiang Provincial Center for Disease Control and Prevention.', 'Zhejiang Provincial Center for Disease Control and Prevention.']",['eng'],"['Journal Article', 'Observational Study']",,United States,Medicine (Baltimore),Medicine,2985248R,IM,"['*Artificial Intelligence', '*Bayes Theorem', 'China/epidemiology', 'Communicable Diseases/diagnosis/*epidemiology/*physiopathology', 'Diagnosis, Computer-Assisted/methods', 'Humans', 'Incidence', 'Reproducibility of Results']",PMC7034623,,,2020/02/23 06:00,2020/03/10 06:00,['2020/02/22 06:00'],"['2020/02/22 06:00 [entrez]', '2020/02/23 06:00 [pubmed]', '2020/03/10 06:00 [medline]']","['00005792-202002210-00045 [pii]', 'MD-D-19-07744 [pii]', '10.1097/MD.0000000000019218 [doi]']",ppublish,Medicine (Baltimore). 2020 Feb;99(8):e19218. doi: 10.1097/MD.0000000000019218.,['The authors declare that they have no conflicts of interests.'],,,,,,,,,,,,,,,,
11170940,NLM,MEDLINE,20011204,20220410,1058-4838 (Print) 1058-4838 (Linking),32,3,2001 Feb 1,Practice guidelines for the management of infectious diarrhea.,331-51,,,,"['Guerrant, R L', 'Van Gilder, T', 'Steiner, T S', 'Thielman, N M', 'Slutsker, L', 'Tauxe, R V', 'Hennessy, T', 'Griffin, P M', 'DuPont, H', 'Sack, R B', 'Tarr, P', 'Neill, M', 'Nachamkin, I', 'Reller, L B', 'Osterholm, M T', 'Bennish, M L', 'Pickering, L K']","['Guerrant RL', 'Van Gilder T', 'Steiner TS', 'Thielman NM', 'Slutsker L', 'Tauxe RV', 'Hennessy T', 'Griffin PM', 'DuPont H', 'Sack RB', 'Tarr P', 'Neill M', 'Nachamkin I', 'Reller LB', 'Osterholm MT', 'Bennish ML', 'Pickering LK']","['Division of Geographic and International Medicine, University of Virginia Health Sciences Center, Charlottesville, VA, USA. rlg9a@virginia.edu']",['eng'],"['Guideline', 'Journal Article', 'Practice Guideline']",20010130,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Anti-Infective Agents/*therapeutic use', 'Antidiarrheals/*therapeutic use', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/etiology/*therapy', 'Diagnosis, Differential', 'Diarrhea/diagnosis/etiology/*therapy', 'Feces/microbiology/parasitology', '*Fluid Therapy', 'Humans', 'Public Health']",,,,2001/02/15 11:00,2002/01/05 10:01,['2001/02/15 11:00'],"['2000/10/13 00:00 [received]', '2001/02/15 11:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/02/15 11:00 [entrez]']","['CID001387 [pii]', '10.1086/318514 [doi]']",ppublish,Clin Infect Dis. 2001 Feb 1;32(3):331-51. doi: 10.1086/318514. Epub 2001 Jan 30.,,,"['0 (Anti-Infective Agents)', '0 (Antidiarrheals)']",,,,,,,,['Infectious Diseases Society of America'],,,,,,
18447173,NLM,MEDLINE,20080529,20170330,0394-9001 (Print) 0394-9001 (Linking),19,1,2007,[Pre-judices versus rational observations in infectious diseases].,157-71,,"The article deals with the history of the concepts of epidemic diseases and contagion. The idea that illnesses could be transmitted from animals to humans and from humans to humans is totally absent in ancient medical theories, but present in the works of historicians, veterinaries, architects. Which is the idea that brings ancient medicine to the refusal of the idea of contagion? And can a supposed 'medical authority' still be a real obstacle toward the comprehension of the ethiology of infectious diseases?",,"['Angeletti, Luciana Rita']",['Angeletti LR'],"['Sezione di Storia della Medicina, Dip. Medicina Sperimentale, Universita degli Studi di Roma La Sapienza, I.']",['ita'],"['English Abstract', 'Historical Article', 'Journal Article']",,Italy,Med Secoli,Medicina nei secoli,0176472,,"['Acquired Immunodeficiency Syndrome/*history', 'Communicable Diseases/etiology/*history', 'Disease Transmission, Infectious/history', 'Epidemiology/*history', 'History, 20th Century', 'History, Ancient', 'History, Medieval', 'Humans', 'Observation/methods']",,,,2008/05/02 09:00,2008/05/30 09:00,['2008/05/02 09:00'],"['2008/05/02 09:00 [pubmed]', '2008/05/30 09:00 [medline]', '2008/05/02 09:00 [entrez]']",,ppublish,Med Secoli. 2007;19(1):157-71.,,,,,,,,,Pre-giudizi versus osservazione razionale nelle malattie trasmissibili-infettive: l'errore in agguato.,,,,,,,,
16522504,NLM,MEDLINE,20060504,20220321,1045-1870 (Print) 1045-1870 (Linking),17,1,2006 Jan,Infectious diseases that pose specific challenges after natural disasters: a review.,36-45,,"In a time span of less than one year, December 2004 to October 2005, several natural disasters of extreme proportions struck different areas of the world, causing unparalleled destruction and loss of lives and property. In each of these instances, the potential existed for acquisition of infectious diseases caused by bacteria, viruses, mold, and mildew and demonstrated that such disasters represent a public health concern, which is exacerbated by the fact that many factors may work synergistically to increase the risk of morbidity and mortality caused by communicable diseases. This article reviews causes, symptoms, and treatments of various infectious diseases that pose a threat in the event of a natural disaster.",,"['Ligon, B Lee']",['Ligon BL'],"['Baylor College of Medicine, Department of Pediatrics, Houston, Texas 77030, USA. bligon@bmc.tmc.edu']",['eng'],"['Journal Article', 'Review']",,United States,Semin Pediatr Infect Dis,Seminars in pediatric infectious diseases,9008093,IM,"['Child', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/*etiology', 'Disaster Planning', '*Disasters', 'Disease Outbreaks', 'Humans', 'Hygiene', '*Public Health', 'Risk Factors', 'Sanitation', 'Wounds and Injuries/complications']",,,,2006/03/09 09:00,2006/05/05 09:00,['2006/03/09 09:00'],"['2006/03/09 09:00 [pubmed]', '2006/05/05 09:00 [medline]', '2006/03/09 09:00 [entrez]']","['S1045-1870(06)00003-3 [pii]', '10.1053/j.spid.2006.01.002 [doi]']",ppublish,Semin Pediatr Infect Dis. 2006 Jan;17(1):36-45. doi: 10.1053/j.spid.2006.01.002.,,,,,,38,,,,,,,,,,,
2724569,NLM,MEDLINE,19890711,20110727,0047-1852 (Print) 0047-1852 (Linking),47,1,1989 Jan,[Internationalization and imported infectious diseases].,5-10,,,,"['Miwatani, T']",['Miwatani T'],,['jpn'],['Journal Article'],,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Africa', 'Aircraft', 'Asia', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology', 'Food Inspection', 'Foodborne Diseases/prevention & control', 'Humans', 'Japan', '*Quarantine', '*Travel']",,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Nihon Rinsho. 1989 Jan;47(1):5-10.,,,,,,,,,,,,,,,,,
2204753,NLM,MEDLINE,19901018,20151119,0023-2149 (Print) 0023-2149 (Linking),68,5,1990 May,[Experience with diagnosis and treatment of infectious diseases in extreme conditions (on the 45th anniversary of victory in World War II)].,14-9,,,,"['Ugriumov, B L']",['Ugriumov BL'],,['rus'],"['Case Reports', 'Historical Article', 'Journal Article']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Adult', '*Communicable Diseases/diagnosis/therapy', '*Disease Outbreaks', 'Female', 'History, 20th Century', 'Humans', 'Male', '*Military Medicine', '*Military Personnel', 'USSR', '*Warfare']",,,,1990/05/01 00:00,1990/05/01 00:01,['1990/05/01 00:00'],"['1990/05/01 00:00 [pubmed]', '1990/05/01 00:01 [medline]', '1990/05/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1990 May;68(5):14-9.,,,,,,,,,Opyt diagnostiki i lecheniia infektsionnykh boleznei v ekstremal'nykh usloviiakh (k 45-letiiu pobedy v Velikoi Otechestvennoi voine).,,,,,,,,
8933690,NLM,MEDLINE,19970227,20191122,0165-2176 (Print) 0165-2176 (Linking),18 Suppl 3,,1996,Emerging diseases with a worldwide impact and the consequences for veterinary curricula.,S124-6,,"Emerging infections are being recognized at an alarming rate. In the case of emerging viral infections involving free-ranging wildlife, the intrusion of urban and agricultural enterprises into wildlife habitats appears to be playing a major role in the exchange of infectious agents of domestic to wildlife species and vice-versa. It is important that the veterinary profession prepares itself to respond to the threatening challenges. Creation of a course which addressed the principles of infectious diseases, diagnostic medicine, epidemiology, public health, population medicine and control are all imperative. This paper attempts to address some of the principle subjects matter areas which should be included in the course offering.",,"['Osburn, B I']",['Osburn BI'],"['University of California, Davis School of Veterinary Medicine, USA.']",['eng'],"['Journal Article', 'Review']",,England,Vet Q,The veterinary quarterly,7909485,IM,"['Animals', '*Animals, Wild', 'Communicable Diseases/diagnosis/epidemiology/*veterinary', 'Curriculum/standards/*trends', 'Education, Veterinary/standards/*trends', '*Global Health', 'Information Services', 'Public Health']",,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Vet Q. 1996;18 Suppl 3:S124-6.,,,,,,0,,,,,,,,,,,
31743391,NLM,MEDLINE,20200908,20200908,2473-9537 (Electronic) 2473-9529 (Print) 2473-9529 (Linking),3,22,2019 Nov 26,Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study.,3602-3612,10.1182/bloodadvances.2019000634 [doi],"Hematopoietic cell transplantation (HCT) is potentially curative for patients with hematologic disorders, but carries significant risks of infection-related morbidity and mortality. Infectious diseases are the second most common cause of death in HCT recipients, surpassed only by progression of underlying disease. Many infectious diseases are difficult to diagnose and treat, and may only be first identified by autopsy. However, autopsy rates are decreasing despite their value. The clinical and autopsy records of adult HCT recipients at our center who underwent autopsy between 1 January 2000 and 31 December 2017 were reviewed. Discrepancies between premortem clinical diagnoses and postmortem autopsy diagnoses were evaluated. Of 185 patients who underwent autopsy, 35 patients (18.8%) had a total of 41 missed infections. Five patients (2.7%) had >1 missed infection. Of the 41 missed infections, 18 (43.9%) were viral, 16 (39.0%) were fungal, 5 (12.2%) were bacterial, and 2 (4.9%) were parasitic. According to the Goldman criteria, 31 discrepancies (75.6%) were class I, 5 (12.2%) were class II, 1 (2.4%) was class III, and 4 (9.8%) were class IV. Autopsies of HCT recipients frequently identify clinically significant infectious diseases that were not suspected premortem. Had these infections been suspected, a change in management might have improved patient survival in many of these cases. Autopsy is underutilized and should be performed regularly to help improve infection-related morbidity and mortality. Illustrative cases are presented and the lessons learned from them are also discussed.",['(c) 2019 by The American Society of Hematology.'],"['Multani, Ashrit', 'Allard, Libby S', 'Wangjam, Tamna', 'Sica, R Alejandro', 'Epstein, David J', 'Rezvani, Andrew R', 'Ho, Dora Y']","['Multani A', 'Allard LS', 'Wangjam T', 'Sica RA', 'Epstein DJ', 'Rezvani AR', 'Ho DY']","['Division of Infectious Diseases and Geographic Medicine, Department of Medicine.', 'Department of Pathology, and.', 'Division of Blood and Marrow Transplantation, Department of Medicine, School of Medicine, Stanford University, Stanford, CA.', 'Division of Blood and Marrow Transplantation, Department of Medicine, School of Medicine, Stanford University, Stanford, CA.', 'Division of Infectious Diseases and Geographic Medicine, Department of Medicine.', 'Division of Blood and Marrow Transplantation, Department of Medicine, School of Medicine, Stanford University, Stanford, CA.', 'Division of Infectious Diseases and Geographic Medicine, Department of Medicine.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",,United States,Blood Adv,Blood advances,101698425,IM,"['Aged', 'Autopsy', 'Communicable Diseases/*diagnosis/epidemiology/*etiology/mortality', 'Diagnostic Errors', 'Hematopoietic Stem Cell Transplantation/*adverse effects/methods', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Missed Diagnosis', 'Mortality', 'Patient Outcome Assessment', '*Transplant Recipients', 'Transplantation, Autologous', 'Transplantation, Homologous']",PMC6880905,,,2019/11/20 06:00,2020/09/09 06:00,['2019/11/20 06:00'],"['2019/06/26 00:00 [received]', '2019/10/10 00:00 [accepted]', '2019/11/20 06:00 [entrez]', '2019/11/20 06:00 [pubmed]', '2020/09/09 06:00 [medline]']","['428809 [pii]', '2019/ADV2019000634 [pii]', '10.1182/bloodadvances.2019000634 [doi]']",ppublish,Blood Adv. 2019 Nov 26;3(22):3602-3612. doi: 10.1182/bloodadvances.2019000634.,"['Conflict-of-interest disclosure: The authors declare no competing financial', 'interests.']",,,,['Blood Adv. 2020 Jan 28;4(2):420-421. PMID: 31990331'],,,,,,,,,,,,
30869011,NLM,MEDLINE,20200401,20200401,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),147,,2019 Jan,Does scientific effort reflect global need? A review of infectious disease publications over 100 years.,e114,10.1017/S0950268818003552 [doi] e114,"In a rational world, scientific effort would reflect society's needs. We tested this hypothesis using the area of infectious diseases, where the research response to emerging threats has obvious potential to save lives through informing interventions such as vaccination and prevention policies. Pathogens continue to evolve, emerge and re-emerge and infectious diseases that were once common become less so or their global distribution changes. A question remains as to whether scientific endeavours can adapt. Here, we identified papers on infectious diseases published in the four highest ranking, health-related journals over the 118 years from 1900. Focussing on outbreak-related and burden of disease-related metrics over the two time periods, 1990 to 2017 and 1900 to 2017, our analyses suggest that there is little underrepresentation of important infectious diseases among top ranked journals. Encouragingly our results suggest the scientific process is largely self-correcting.",,"['Hayman, D T S', 'Baker, M G']","['Hayman DTS', 'Baker MG']","['EpiLab, Infectious Diseases Research Centre, Massey University,Palmerston North 4442,New Zealand.', 'University of Otago,Wellington,New Zealand.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Epidemiol Infect,Epidemiology and infection,8703737,IM,"['Communicable Disease Control/*history', 'Communicable Diseases/*epidemiology/*history', '*Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Periodicals as Topic/*history', 'Publishing/*history']",PMC6518475,['NOTNLM'],"['DALY', 'emerging infectious diseases', 'global burden of disease', 'health equity', 'neglected tropical diseases']",2019/03/15 06:00,2020/04/02 06:00,['2019/03/15 06:00'],"['2019/03/15 06:00 [entrez]', '2019/03/15 06:00 [pubmed]', '2020/04/02 06:00 [medline]']","['S0950268818003552 [pii]', '00355 [pii]', '10.1017/S0950268818003552 [doi]']",ppublish,Epidemiol Infect. 2019 Jan;147:e114. doi: 10.1017/S0950268818003552.,,['ORCID: 0000-0003-0087-3015'],,,,,,,,,,,,,,,
24055181,NLM,MEDLINE,20140828,20140113,1879-0089 (Electronic) 0145-305X (Linking),43,2,2014 Apr,Preface to the special issue: immunity to infectious diseases of fish.,129,S0145-305X(13)00254-1 [pii] 10.1016/j.dci.2013.09.002 [doi],,,"['Belosevic, Miodrag Mike', 'Wiegertjes, Geert Frits']","['Belosevic MM', 'Wiegertjes GF']","['Department of Biological Sciences, CW-405 Biological Sciences, University of Alberta Edmonton, AB, T6G 2E9, Canada. Electronic address: mbelosev@ualberta.ca.', 'Wageningen Institute of Animal Sciences, Cell Biology and Immunology Group, Wageningen University, PO Box 338, 6700 AH Wageningen, Netherlands. Electronic address: geert.wiegertjes@wur.nl.']",['eng'],['Editorial'],20130918,United States,Dev Comp Immunol,Developmental and comparative immunology,7708205,IM,"['Animals', 'Communicable Diseases/microbiology/parasitology/*veterinary', 'Fish Diseases/*immunology/microbiology/parasitology', 'Fishes/*immunology/microbiology/parasitology', 'Host-Pathogen Interactions', 'Immunity']",,,,2013/09/24 06:00,2014/08/29 06:00,['2013/09/24 06:00'],"['2013/09/10 00:00 [received]', '2013/09/10 00:00 [revised]', '2013/09/10 00:00 [accepted]', '2013/09/24 06:00 [entrez]', '2013/09/24 06:00 [pubmed]', '2014/08/29 06:00 [medline]']","['S0145-305X(13)00254-1 [pii]', '10.1016/j.dci.2013.09.002 [doi]']",ppublish,Dev Comp Immunol. 2014 Apr;43(2):129. doi: 10.1016/j.dci.2013.09.002. Epub 2013 Sep 18.,,,,,,,,,,,,,,,,,
14416720,NLM,MEDLINE,19981101,20181201,0007-0947 (Print) 0007-0947 (Linking),13,,1959 Aug,Infectious diseases.,572-5,,,,"['LIBRACH, I M']",['LIBRACH IM'],,['eng'],['Journal Article'],,England,Br J Clin Pract,The British journal of clinical practice,0372546,OM,"['Communicable Diseases/*microbiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/microbiology'],1959/08/01 00:00,1959/08/01 00:01,['1959/08/01 00:00'],"['1959/08/01 00:00 [pubmed]', '1959/08/01 00:01 [medline]', '1959/08/01 00:00 [entrez]']",,ppublish,Br J Clin Pract. 1959 Aug;13:572-5.,,,,,,,,,,,,,,,,,
8711163,NLM,MEDLINE,19960909,20061101,0033-2100 (Print) 0033-2100 (Linking),50,1-2,1996,[Infectious diseases in Poland in 1994].,67-72,,,,"['Magdzik, W', 'Czarkowski, M P']","['Magdzik W', 'Czarkowski MP']",,['pol'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['Aged', 'Child', 'Child, Preschool', 'Communicable Diseases/*epidemiology/mortality', 'Humans', 'Incidence', 'Infant', 'Middle Aged', 'Poland/epidemiology']",,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1996;50(1-2):67-72.,,,,,,,,,Choroby zakazne w Polsce w 1994 roku.,,,,,,,,
10214200,NLM,MEDLINE,19991007,20051116,1088-5471 (Print) 1088-5471 (Linking),3,1,1999 Jan-Feb,Infectious disease causes of lymphadenopathy: localized versus diffuse.,19-38,,"Lymphadenopathy is commonly associated with numerous infectious diseases. The evaluation of lymphadenopathy may reveal local (regional) node involvement or diffuse (generalized) node involvement. Additional assessment factors used to evaluate the lymphadenopathy include the anatomic location, node characteristics, associated symptoms, medical and social history, and comprehensive physical examination fundings. Infectious diseases that cause generalized lymphadenopathy include HIV disease, toxoplasmosis, secondary syphilis, and tuberculosis. This article discusses the evaluation of lymphadenopathy, infectious causes of generalized lymphadenopathy, as well as those infections that cause regional lymphadenopathy.",,"['Heitman, B', 'Irizarry, A']","['Heitman B', 'Irizarry A']","['Miami Veterans Affairs Medical Center, FL 33125, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Lippincotts Prim Care Pract,Lippincott's primary care practice,9706704,,"['Biopsy', 'Communicable Diseases/*complications/*microbiology', 'Decision Trees', 'Diagnosis, Differential', 'Humans', 'Lymphatic Diseases/*diagnosis/*microbiology', 'Nurse Practitioners', 'Primary Health Care', 'Referral and Consultation']",,,,1999/04/24 00:00,1999/04/24 00:01,['1999/04/24 00:00'],"['1999/04/24 00:00 [pubmed]', '1999/04/24 00:01 [medline]', '1999/04/24 00:00 [entrez]']",,ppublish,Lippincotts Prim Care Pract. 1999 Jan-Feb;3(1):19-38.,,,,,,50,,,,,,,,,,,
30546101,NLM,MEDLINE,20190617,20200327,2058-5276 (Electronic) 2058-5276 (Linking),4,1,2019 Jan,Standing up to infectious disease.,1,10.1038/s41564-018-0331-3 [doi],"Despite major advances in dissecting how pathogens cause disease and the development of treatments to combat infection, infectious diseases remain a major cause of death today. This month's issue includes a special 'Focus on Infectious Disease', which highlights efforts to develop new ways to prevent, detect and treat infections.",,,,,['eng'],['Editorial'],,England,Nat Microbiol,Nature microbiology,101674869,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/mortality/*therapy', 'Humans', 'Mass Screening', 'Public Health/*methods']",PMC7097104,,,2018/12/14 06:00,2019/06/18 06:00,['2018/12/15 06:00'],"['2018/12/15 06:00 [entrez]', '2018/12/14 06:00 [pubmed]', '2019/06/18 06:00 [medline]']","['10.1038/s41564-018-0331-3 [pii]', '331 [pii]', '10.1038/s41564-018-0331-3 [doi]']",ppublish,Nat Microbiol. 2019 Jan;4(1):1. doi: 10.1038/s41564-018-0331-3.,,,,,,,,,,,,,,,,,
27534704,NLM,MEDLINE,20170613,20210109,1751-7915 (Electronic) 1751-7915 (Linking),9,5,2016 Sep,New vaccines: challenges of discovery.,549-52,10.1111/1751-7915.12397 [doi],"Vaccines have been a major component of preventing and controlling infectious diseases. The basis for discovery of what protects is reviewed as well as new attempts in utilizing Reverse Vaccinology, RNA-RNA methods and proteome analysis are adding significantly to our knowledge. The challenge of how to define protective and defined components of microbes is still hampering efforts to discover new vaccines. Recent excitement about immunotherapy of cancer opens the way to develop vaccines against multiple malignancies.","['(c) 2016 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd', 'and Society for Applied Microbiology.']","['Mahmoud, Adel']",['Mahmoud A'],"['Molecular Biology and Public Policy, Princeton University, Princeton, NJ, 08544, USA.']",['eng'],"['Journal Article', 'Review']",20160818,United States,Microb Biotechnol,Microbial biotechnology,101316335,IM,"['Animals', 'Communicable Diseases/epidemiology/*immunology/veterinary', 'Disease Transmission, Infectious/*prevention & control', 'Drug Discovery/*methods/trends', 'Humans', 'Vaccines/*immunology/*isolation & purification']",PMC4993171,,,2016/08/19 06:00,2017/06/14 06:00,['2016/08/19 06:00'],"['2016/07/11 00:00 [received]', '2016/07/11 00:00 [accepted]', '2016/08/19 06:00 [entrez]', '2016/08/19 06:00 [pubmed]', '2017/06/14 06:00 [medline]']","['MBT212397 [pii]', '10.1111/1751-7915.12397 [doi]']",ppublish,Microb Biotechnol. 2016 Sep;9(5):549-52. doi: 10.1111/1751-7915.12397. Epub 2016 Aug 18.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
7824690,NLM,MEDLINE,19950214,20141120,0391-9714 (Print) 0391-9714 (Linking),15,3,1993,[International health organizations facing the emergence of new infectious diseases].,435-57,,"Throughout history, international health collaboration gradually came into being to counteract the emergence of new diseases. This process went through five stages.: 1) Quarantine regulations were established for maritime commerce to safeguard public health. 2) Scientific data were studied to understand the causes of infectious diseases and their modes of transmission; a single solution to the problem was not sufficient because of the diversities of the various factors triggering these diseases. Furthermore, defensive and protective measures adopted in Europe were inadequate after the colonial expansion of European countries. 3) If 19th century international health politics were defensive, the aim in the 20th century was to fight infectious diseases and to eradicate them. This third phase saw the rise of international institutions. These agencies aimed at favouring better health organization in individual countries. 4) The World Health Organization was founded, the aim being to fight existing epidemics, little importance being given to 'emerging diseases'. 5) A series of new infectious diseases and the reemergence of old diseases (a consequence of major ecological changes) that were thought to be eradicated revealed the need for continuous surveillance.",,"['Fantini, B']",['Fantini B'],"[""Institut Louis Jeantet d'histoire de la medecine, Universite de Geneve, Switzerland.""]",['fre'],"['English Abstract', 'Historical Article', 'Journal Article']",,Switzerland,Hist Philos Life Sci,History and philosophy of the life sciences,8003052,IM,"['Communicable Disease Control/*history/organization & administration', 'Communicable Diseases/epidemiology/*history/transmission', '*Global Health', 'History, 19th Century', 'History, 20th Century', 'Humans', 'International Agencies/*history/organization & administration', 'Organizational Objectives', 'Quarantine/history/organization & administration', 'World Health Organization/history/organization & administration']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Hist Philos Life Sci. 1993;15(3):435-57.,,,,,,,,,Les organisations sanitaires internationales face a l'emergence de maladies infectieuses nouvelles.,,,,,,,,
8616190,NLM,MEDLINE,19960607,20191101,1035-7319 (Print) 1035-7319 (Linking),19,6,1995 Dec,Emerging infectious diseases: what should Australia do?,541-2,,,,"['Plant, A J', 'Rushworth, R L']","['Plant AJ', 'Rushworth RL']",,['eng'],['Editorial'],,Australia,Aust J Public Health,Australian journal of public health,9105166,IM,"['Australia/epidemiology', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/*epidemiology', 'Disease Outbreaks/*prevention & control', 'Humans', 'Population Surveillance']",,,,1995/12/01 00:00,1995/12/01 00:01,['1995/12/01 00:00'],"['1995/12/01 00:00 [pubmed]', '1995/12/01 00:01 [medline]', '1995/12/01 00:00 [entrez]']",['10.1111/j.1753-6405.1995.tb00454.x [doi]'],ppublish,Aust J Public Health. 1995 Dec;19(6):541-2. doi: 10.1111/j.1753-6405.1995.tb00454.x.,,,,,,,,,,,,,,,,,
18365447,NLM,MEDLINE,20080422,20080327,0016-9900 (Print) 0016-9900 (Linking),,1,2008 Jan-Feb,[The surveillance of nonspecific prevention of infectious diseases and the tasks of its improvement].,4-10,,"Provision of sanitary-and-epidemiological well-being in the Russian Federation is one of the major priorities of policy of the state. In the country, the implementation of a package of organizational, preventive, and antiepidemic measures has made the sanitary-and-epidemiological situation stable. In the Russian Federation, the national plan of measures for 2005-2007 has been approved and is being implemented by the joint WHO measles control program by 2010. The recent noticeable decrease in the morbidity of measles in the Russian Federation suggests that the disease may be the third infection, after smallpox and poliomyelitis, to be eradicated in Russia. The high incidence of tick-borne viral encephalitis is a result of not only the insufficient coverage of the population with vaccination, but also the reduction in the scope of antitick treatments and the use of ineffective and environmentally unstable agents for barrier ground treatments. In recent years, the tuberculosis epidemiological situation has recently remained to be of strain in the Russian Federation; socially dysadaptive population groups are on the rise; the socioeconomic standard of living of most sections of the population continues to be low. The requisite measures to optimize the prevention of infectious diseases are to improve the methodology of epidemiological surveillance of infectious and parasitic diseases, to perfect an epidemiological surveillance system during the epidemic spread of infections, to assess an epidemiological risk, to make a microbiological monitoring of the major pathogens of infectious diseases, and to elaborate and perfect the strategy and tactics of nonspecific prevention of extremely dangerous infectious diseases.",,"['Onishchenko, G G']",['Onishchenko GG'],,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Gig Sanit,Gigiena i sanitariia,0412700,IM,"['Communicable Diseases/epidemiology/*immunology/transmission', 'Health Services Administration', 'Humans', 'Population Surveillance/*methods', 'Russia', 'Vaccination/*trends']",,,,2008/03/28 09:00,2008/04/23 09:00,['2008/03/28 09:00'],"['2008/03/28 09:00 [pubmed]', '2008/04/23 09:00 [medline]', '2008/03/28 09:00 [entrez]']",,ppublish,Gig Sanit. 2008 Jan-Feb;(1):4-10.,,,,,,,,,,,,,,,,,
23824368,NLM,MEDLINE,20140113,20220330,1098-6618 (Electronic) 0893-8512 (Print) 0893-8512 (Linking),26,3,2013 Jul,Clinical application of volatile organic compound analysis for detecting infectious diseases.,462-75,10.1128/CMR.00020-13 [doi],"This review article introduces the significance of testing of volatile organic compounds (VOCs) in clinical samples and summarizes important features of some of the technologies. Compared to other human diseases such as cancer, studies on VOC analysis in cases of infectious diseases are limited. Here, we have described results of studies which have used some of the appropriate technologies to evaluate VOC biomarkers and biomarker profiles associated with infections. The publications reviewed include important infections of the respiratory tract, gastrointestinal tract, urinary tract, and nasal cavity. The results highlight the use of VOC biomarker profiles resulting from certain infectious diseases in discriminating between infected and healthy subjects. Infection-related VOC profiles measured in exhaled breath as well as from headspaces of feces or urine samples are a source of information with respect to disease detection. The volatiles emitted in clinical matrices may on the one hand represent metabolites of the infecting pathogen or on the other hand reflect pathogen-induced host responses or, indeed, a combination of both. Because exhaled-breath samples are easy to collect and online instruments are commercially available, VOC analysis in exhaled breath appears to be a promising tool for noninvasive detection and monitoring of infectious diseases.",,"['Sethi, Shneh', 'Nanda, Ranjan', 'Chakraborty, Trinad']","['Sethi S', 'Nanda R', 'Chakraborty T']","['Institute for Medical Microbiology, German Center for Infection Research DZIF, Justus-Liebig University Giessen, Giessen, Germany. shneh.sethi@mikrobio.med.uni-giessen.de']",['eng'],"['Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,IM,"['*Breath Tests', 'Communicable Diseases/*diagnosis/metabolism', 'Humans', 'Volatile Organic Compounds/*analysis']",PMC3719490,,,2013/07/05 06:00,2014/01/15 06:00,['2013/07/05 06:00'],"['2013/07/05 06:00 [entrez]', '2013/07/05 06:00 [pubmed]', '2014/01/15 06:00 [medline]']","['26/3/462 [pii]', '00020-13 [pii]', '10.1128/CMR.00020-13 [doi]']",ppublish,Clin Microbiol Rev. 2013 Jul;26(3):462-75. doi: 10.1128/CMR.00020-13.,,,['0 (Volatile Organic Compounds)'],,,,,,,,,,,,,,
16448839,NLM,MEDLINE,20060726,20200505,1286-4579 (Print) 1769-714X (Electronic) 1286-4579 (Linking),8,3,2006 Mar,Reasons for the increase in emerging and re-emerging viral infectious diseases.,905-16,,"In the past two decades, humans have faced many new viral infectious agents in emerging and re-emerging infectious diseases (EIDs). Many factors contribute to the appearance of EIDs. These factors are complex but can be classified into three different categories: virus factors, human factors, and ecological factors. The factors contributing to the cause of such viral infectious diseases will be systematically reviewed in this article.",,"['Hui, Eric Ka-Wai']",['Hui EK'],"['Department of Microbiology, Immunology and Molecular Genetics, UCLA School of Medicine, Los Angeles, CA 90095-1747, USA. ekwhui@ucla.edu']",['eng'],"['Journal Article', 'Review']",20060106,France,Microbes Infect,Microbes and infection,100883508,IM,"['Animals', 'Communicable Diseases, Emerging/*epidemiology/etiology/*virology', 'Ecology', 'Humans', 'Virus Diseases/*epidemiology/etiology/*virology']",PMC7110580,,,2006/02/02 09:00,2006/07/27 09:00,['2006/02/02 09:00'],"['2005/06/22 00:00 [received]', '2005/06/22 00:00 [accepted]', '2006/02/02 09:00 [pubmed]', '2006/07/27 09:00 [medline]', '2006/02/02 09:00 [entrez]']","['S1286-4579(05)00318-7 [pii]', '10.1016/j.micinf.2005.06.032 [doi]']",ppublish,Microbes Infect. 2006 Mar;8(3):905-16. doi: 10.1016/j.micinf.2005.06.032. Epub 2006 Jan 6.,,,,,,,,,,,,,,,,,
25770772,NLM,MEDLINE,20160727,20150613,1469-0691 (Electronic) 1198-743X (Linking),21,5,2015 May,Deadly infectious diseases such as Ebola: the parachute paradigm.,389-90,S1198-743X(15)00319-5 [pii] 10.1016/j.cmi.2015.02.027 [doi],,,"['Lagier, J-C', 'Raoult, D']","['Lagier JC', 'Raoult D']","['Unite de Recherche en Maladies Infectieuses et Tropicales Emergentes, Universite la Mediterranee, Aix Marseille Universite, Marseille, France.', 'Unite de Recherche en Maladies Infectieuses et Tropicales Emergentes, Universite la Mediterranee, Aix Marseille Universite, Marseille, France. Electronic address: didier.raoult@gmail.com.']",['eng'],['Journal Article'],20150312,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['*Clinical Trials as Topic', 'Communicable Diseases/*mortality/*therapy', 'Humans']",,['NOTNLM'],"['Ebola', 'parachute paradigm', 'randomized controlled trial']",2015/03/17 06:00,2016/07/28 06:00,['2015/03/16 06:00'],"['2015/02/26 00:00 [received]', '2015/02/27 00:00 [accepted]', '2015/03/16 06:00 [entrez]', '2015/03/17 06:00 [pubmed]', '2016/07/28 06:00 [medline]']","['S1198-743X(15)00319-5 [pii]', '10.1016/j.cmi.2015.02.027 [doi]']",ppublish,Clin Microbiol Infect. 2015 May;21(5):389-90. doi: 10.1016/j.cmi.2015.02.027. Epub 2015 Mar 12.,,,,,,,,,,,,,,,,,
17455586,NLM,MEDLINE,20070629,20110727,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[Infectious diseases in overseas travellers].,21-6,,,,"['Kano, Shigeyuki']",['Kano S'],"['Department of Appropriate Technology Development and Transfer, Research Institute, International Medical Center of Japan.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Animals', '*Communicable Disease Control', 'Communicable Diseases/epidemiology/*transmission', 'Disease Outbreaks/prevention & control', 'Humans', 'Risk', '*Travel', 'Zoonoses']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:21-6.,,,,,,13,,,,,,,,,,,
23492995,NLM,MEDLINE,20130828,20181023,1972-2680 (Electronic) 1972-2680 (Linking),7,3,2013 Mar 14,High throughput genomic and proteomic technologies in the fight against infectious diseases.,182-90,10.3855/jidc.3027 [doi],"New technologies have shown significant promise in the fight against infectious diseases, with the discovery of novel molecular targets for in vitro diagnostics and the improved design of vaccines. In developing countries, especially in areas of neglected diseases and resources-poor settings, a number of technological innovations are further needed, such as the integration of old and new biomarkers in suitable analysis platforms, the simplification of existing analysis systems, and the improvement of sample preservation and management. However, in these areas, identification of new biomarkers for infectious diseases is still a core issue in the diagnostic quest. Similarly, new technologies will allow scientists to design vaccines with improved immunogenicity, efficacy and safety in the local area, according to the circulating pathogenic strains and the genetic background of the population to be immunized. In this work we review the current omics-based technologies and their potential for accelerating the development of next generation vaccines and the identification of biomarkers suitable for point-of-care (POC) diagnostic applications.",,"['Tanca, Alessandro', 'Deligios, Massimo', 'Addis, Maria Filippa', 'Uzzau, Sergio']","['Tanca A', 'Deligios M', 'Addis MF', 'Uzzau S']","['Dipartimento di Scienze Biomediche, Universita di Sassari, Sassari, Italy. tanca@portocontericerche.it']",['eng'],"['Journal Article', 'Review']",20130314,Italy,J Infect Dev Ctries,Journal of infection in developing countries,101305410,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/*drug therapy/*immunology', 'Genomics/*methods/trends', 'Humans', 'Proteomics/*methods/trends']",,,,2013/03/16 06:00,2013/08/29 06:00,['2013/03/16 06:00'],"['2012/09/25 00:00 [received]', '2013/02/16 00:00 [accepted]', '2013/02/14 00:00 [revised]', '2013/03/16 06:00 [entrez]', '2013/03/16 06:00 [pubmed]', '2013/08/29 06:00 [medline]']",['10.3855/jidc.3027 [doi]'],epublish,J Infect Dev Ctries. 2013 Mar 14;7(3):182-90. doi: 10.3855/jidc.3027.,,,,,,,,,,,,,,,,,
8336085,NLM,MEDLINE,19930826,20191101,0303-6812 (Print) 0303-6812 (Linking),31,5,1993,Dose-dependent latent period and periodicity of infectious diseases.,487-94,,This paper presents a theoretical analysis of an SEIRS epidemiological model. It shows that nonlinearity due to a dose-dependent latent period can cause periodicity through a Hopf bifurcation.,,"['Liu, W M']",['Liu WM'],"['Department of Mathematical Sciences, Indiana University, Purdue University at Indianapolis 46205-2810.']",['eng'],['Journal Article'],,Germany,J Math Biol,Journal of mathematical biology,7502105,IM,"['Communicable Diseases/*epidemiology/*physiopathology', 'Humans', 'Mathematics', '*Models, Statistical', 'Time Factors']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.1007/BF00173888 [doi]'],ppublish,J Math Biol. 1993;31(5):487-94. doi: 10.1007/BF00173888.,,,,,,,,,,,,,,,,,
26627674,NLM,MEDLINE,20160324,20151202,1534-6080 (Electronic) 0041-1337 (Linking),99,12,2015 Dec,Infectious Diseases in Transplantation--Report of the 20th Nantes Actualites Transplantation Meeting.,2444-7,10.1097/TP.0000000000000997 [doi],"The 20th Nantes Actualites Transplantation (NAT) meeting was held on June 11, 2015, and June 12, 2015. This year, the local organizing committee selected an update on infectious diseases in solid organ and hematopoietic stem cell transplantation. With an attendance of close to 170 clinicians, researchers, students, engineers, technicians, invited speakers, and guests from North and South America, Germany, Switzerland, Netherlands, and France, the meeting was well attended. Invited speakers' expertise covered basic as well as translational microbiology, immunology, transplantation, and intensive care medicine. This report identifies a number of advances presented during the meeting in the care and management of infectious diseases in transplantation and immunocompromised patients. New antiviral immune responses and their modulation by pathogens in addition to novel antimicrobial therapeutic strategies, cell therapies, and genomic analysis were discussed.",,"['Haspot, Fabienne', 'Halary, Franck Albert']","['Haspot F', 'Halary FA']","['1 INSERM, UMR 1064-Center for Research in Transplantation and Immunology, Nantes, France. 2 ITUN, CHU Nantes, Nantes, France. 3 University of Nantes, Nantes, France.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Transplantation,Transplantation,0132144,IM,"['*Communicable Diseases/epidemiology/etiology/immunology', 'Congresses as Topic', 'Global Health', 'Hematopoietic Stem Cell Transplantation/*adverse effects', 'Humans', 'Immunocompromised Host/*immunology', 'Incidence', 'Organ Transplantation/*adverse effects', '*Transplantation Immunology']",,,,2015/12/03 06:00,2016/03/25 06:00,['2015/12/03 06:00'],"['2015/12/03 06:00 [entrez]', '2015/12/03 06:00 [pubmed]', '2016/03/25 06:00 [medline]']","['00007890-201512000-00007 [pii]', '10.1097/TP.0000000000000997 [doi]']",ppublish,Transplantation. 2015 Dec;99(12):2444-7. doi: 10.1097/TP.0000000000000997.,,,,,,,,,,,,,,,,,
25151484,NLM,MEDLINE,20150512,20211021,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),59 Suppl 2,Suppl 2,2014 Sep 15,Why infectious diseases.,S85-92,10.1093/cid/ciu441 [doi],"Infectious diseases is a broad discipline that is almost unique in contemporary medicine with its ability to cure and prevent disease, to identify specific disease causes (microbes), and to deal with diverse, sometimes massive outbreaks. The value of the infectious disease practitioner is now magnified by the crisis of antibiotic resistance, the expanding consequences of international travel, the introduction of completely new pathogen diagnostics, and healthcare reform with emphasis on infection prevention and cost in dollars and lives. Infectious disease careers have great personal rewards to the practitioner based on these observations. It is unfortunate that we have been so effective in our work, but relatively ineffective in convincing the healthcare system of this value.","['(c) The Author 2014. Published by Oxford University Press on behalf of the', 'Infectious Diseases Society of America. All rights reserved. For Permissions,', 'please e-mail: journals.permissions@oup.com.']","['Bartlett, John G']",['Bartlett JG'],"['Johns Hopkins University School of Medicine, Baltimore, Maryland.']",['eng'],"['Historical Article', 'Journal Article']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Biomedical Research', 'Communicable Disease Control', 'Communicable Diseases/epidemiology/*history', 'Epidemics', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Leadership']",PMC7108019,['NOTNLM'],"['antibiotic stewardship', 'epidemics', 'infection control', 'kinetics of the field']",2014/08/26 06:00,2015/05/13 06:00,['2014/08/25 06:00'],"['2014/08/25 06:00 [entrez]', '2014/08/26 06:00 [pubmed]', '2015/05/13 06:00 [medline]']","['ciu441 [pii]', '10.1093/cid/ciu441 [doi]']",ppublish,Clin Infect Dis. 2014 Sep 15;59 Suppl 2(Suppl 2):S85-92. doi: 10.1093/cid/ciu441.,,,,,,,,,,,,,,,,,
23580004,NLM,MEDLINE,20130712,20130507,1539-3704 (Electronic) 0003-4819 (Linking),158,9,2013 May 7,Update in infectious diseases: evidence published in 2012.,686-90,10.7326/0003-4819-158-9-201305070-00102 [doi],,,"['Lorber, Bennett']",['Lorber B'],"['Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. bennett.lorber@temple.edu']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Anti-Bacterial Agents/adverse effects/therapeutic use', 'Communicable Disease Control', '*Communicable Diseases/diagnosis/therapy', 'Evidence-Based Medicine', 'Humans']",,,,2013/04/13 06:00,2013/07/16 06:00,['2013/04/13 06:00'],"['2013/04/13 06:00 [entrez]', '2013/04/13 06:00 [pubmed]', '2013/07/16 06:00 [medline]']","['1676485 [pii]', '10.7326/0003-4819-158-9-201305070-00102 [doi]']",ppublish,Ann Intern Med. 2013 May 7;158(9):686-90. doi: 10.7326/0003-4819-158-9-201305070-00102.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
20593218,NLM,MEDLINE,20110412,20211020,1612-9210 (Electronic) 1612-9202 (Print) 1612-9202 (Linking),7,2,2010 Jun,Pathocenosis: a holistic approach to disease ecology.,237-41,10.1007/s10393-010-0326-x [doi],"The history of medicine describes the emergence and recognition of infectious diseases, and human attempts to stem them. It also throws light on the role of changing environmental conditions on disease emergence/re-emergence, establishment and, sometimes, disappearance. However, the dynamics of infectious diseases is also influenced by the relationships between the community of interacting infectious agents present at a given time in a given territory, a concept that Mirko Grmek, an historian of medicine, conceptualized with the word ""pathocenosis"". The spatial and temporal evolution of diseases, when observed at the appropriate scales, illustrates how a change in the pathocenosis, whether of ""natural"" or anthropic origin, can lead to the emergence and spread of diseases.",,"['Gonzalez, Jean-Paul', 'Guiserix, Micheline', 'Sauvage, Frank', 'Guitton, Jean-Sebastien', 'Vidal, Pierre', 'Bahi-Jaber, Narges', 'Louzir, Hechmi', 'Pontier, Dominique']","['Gonzalez JP', 'Guiserix M', 'Sauvage F', 'Guitton JS', 'Vidal P', 'Bahi-Jaber N', 'Louzir H', 'Pontier D']","['International Centre for Scientific Researches, Franceville (CIRMF), BP 2105, Libreville, Gabon. jean-paul.gonzalez@ird.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100701,United States,Ecohealth,EcoHealth,101222144,IM,"['Animals', 'Communicable Disease Control', 'Communicable Diseases/epidemiology/*transmission', 'Disease Vectors', '*Ecosystem', 'Holistic Health', 'Humans']",PMC3005112,,,2010/07/02 06:00,2011/04/13 06:00,['2010/07/02 06:00'],"['2009/05/30 00:00 [received]', '2010/06/01 00:00 [accepted]', '2010/05/31 00:00 [revised]', '2010/07/02 06:00 [entrez]', '2010/07/02 06:00 [pubmed]', '2011/04/13 06:00 [medline]']","['326 [pii]', '10.1007/s10393-010-0326-x [doi]']",ppublish,Ecohealth. 2010 Jun;7(2):237-41. doi: 10.1007/s10393-010-0326-x. Epub 2010 Jul 1.,,,,,,,,,,,,,,,,,
24965352,NLM,MEDLINE,20150601,20140927,1537-6591 (Electronic) 1058-4838 (Linking),59,8,2014 Oct 15,The opening and closing of empiric windows: the impact of rapid microbiologic diagnostics.,1199-200,10.1093/cid/ciu493 [doi],,,"['MacFadden, Derek R', 'Leis, Jerome A', 'Mubareka, Samira', 'Daneman, Nick']","['MacFadden DR', 'Leis JA', 'Mubareka S', 'Daneman N']","['Division of Infectious Diseases.', 'Division of Infectious Diseases Centre for Quality Improvement and Patient Safety.', 'Division of Infectious Diseases Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.', 'Division of Infectious Diseases Centre for Quality Improvement and Patient Safety.']",['eng'],['Letter'],20140625,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Clinical Laboratory Techniques/*methods', 'Communicable Diseases/*diagnosis/*drug therapy', 'Diagnostic Tests, Routine/*methods', 'Humans', 'Time Factors']",,,,2014/06/27 06:00,2015/06/02 06:00,['2014/06/27 06:00'],"['2014/06/27 06:00 [entrez]', '2014/06/27 06:00 [pubmed]', '2015/06/02 06:00 [medline]']","['ciu493 [pii]', '10.1093/cid/ciu493 [doi]']",ppublish,Clin Infect Dis. 2014 Oct 15;59(8):1199-200. doi: 10.1093/cid/ciu493. Epub 2014 Jun 25.,,,,,,,,,,,,,,,,,
30789129,NLM,MEDLINE,20190815,20220126,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),25,3,2019 Mar,"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015.",397-405,10.3201/eid2503.180708 [doi],"Workers in specific settings and activities are at increased risk for certain infectious diseases. When an infectious disease case occurs in a worker, investigators need to understand the mechanisms of disease propagation in the workplace. Few publications have explored these factors in the United States; a literature search yielded 66 investigations of infectious disease occurring in US workplaces during 2006-2015. Reported cases appear to be concentrated in specific industries and occupations, especially the healthcare industry, laboratory workers, animal workers, and public service workers. A hierarchy-of-controls approach can help determine how to implement effective preventive measures in workplaces. Consideration of occupational risk factors and control of occupational exposures will help prevent disease transmission in the workplace and protect workers' health.",,"['Su, Chia-Ping', 'de Perio, Marie A', 'Cummings, Kristin J', 'McCague, Anna-Binney', 'Luckhaupt, Sara E', 'Sweeney, Marie Haring']","['Su CP', 'de Perio MA', 'Cummings KJ', 'McCague AB', 'Luckhaupt SE', 'Sweeney MH']",,['eng'],"['Historical Article', 'Journal Article', 'Meta-Analysis']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/*etiology/history', 'History, 21st Century', 'Humans', 'Occupational Diseases/*epidemiology/*etiology/history/prevention & control', 'Occupational Exposure/*adverse effects', 'Occupational Health', 'Personal Protective Equipment', 'Risk Factors', 'United States/epidemiology', '*Workplace']",PMC6390751,['NOTNLM'],"['National Institute for Occupational Safety and Health', 'United States', 'bacteria', 'communicable diseases', 'disease outbreaks', 'epidemiologic studies', 'fungi', 'occupational exposure', 'occupational illnesses', 'parasites', 'viruses', 'workplaces']",2019/02/23 06:00,2019/08/16 06:00,['2019/02/22 06:00'],"['2019/02/22 06:00 [entrez]', '2019/02/23 06:00 [pubmed]', '2019/08/16 06:00 [medline]']","['18-0708 [pii]', '10.3201/eid2503.180708 [doi]']",ppublish,Emerg Infect Dis. 2019 Mar;25(3):397-405. doi: 10.3201/eid2503.180708.,,,,,,,,,,,,,,,,,
13383204,NLM,MEDLINE,20020501,20190501,0007-1447 (Print) 0007-1447 (Linking),1,5010,1957 Jan 12,Epidemiological aspects of common infectious diseases.,98-100,,,,"['JAMESON, J E']",['JAMESON JE'],,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans']",PMC1974055,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1957/01/12 00:00,1957/01/12 00:01,['1957/01/12 00:00'],"['1957/01/12 00:00 [pubmed]', '1957/01/12 00:01 [medline]', '1957/01/12 00:00 [entrez]']",['10.1136/bmj.1.5010.98 [doi]'],ppublish,Br Med J. 1957 Jan 12;1(5010):98-100. doi: 10.1136/bmj.1.5010.98.,,,,,,,,,,,,['CLML: 5731:29739'],,,,,
32923353,NLM,MEDLINE,20210705,20210705,2211-8179 (Electronic) 2211-8160 (Print) 2211-8160 (Linking),15,1,2020 Sep 1,Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design.,60,10.5334/gh.867 [doi] 60,"INTRODUCTION: Neglected tropical diseases (NTDs) are a group of infections that are prevalent in many of the tropical and sub-tropical developing countries where poverty is rampant. NTDs have remained largely unnoticed in the global health agenda. There is a substantial gap between the burden of disease for NTDs in cardiovascular diseases (CVD) and research devoted to the affected populations. We created a Latin-American initiative with emerging leaders (EL) from the Interamerican Society of Cardiology (IASC) with the objective to perform multiple systematic reviews of NTDs and other infectious diseases affecting the heart: The NET-Heart Project. OBJECTIVE: To describe the rationale and design considerations of the NET-Heart project. METHODS: The NET-Heart Project is a collaborative work of the IASC EL program. The main objective of the NET-Heart project is to systematically evaluate the available evidence of NTDs and other infectious diseases and their cardiovascular involvement. As a secondary objective, this initiative aims to offer recommendations and potential diagnostic and therapeutic algorithms that can aid the management of cardiovascular complications of these infectious diseases. After an expert discussion 17 initial infectious diseases were selected, for each disease we created one working group. The project was structured in different phases: Systematic review, brainstorming workshops, analysis and results, manuscript writing and recommendations and evaluation of clinical implications. CONCLUSION: The NET-Heart project is an innovative collaborative initiative created to assess burden and impact of NTDs and other infectious diseases in CVD. NTDs can no longer be ignored and must be prioritised on the health and research agenda. This project aims to review in depth the evidence regarding cardiac compromise of these serious conditions and to propose strategies to overcome barriers for efficient diagnosis and treatment of cardiovascular complications.",['Copyright: (c) 2020 The Author(s).'],"['Burgos, Lucrecia M', 'Farina, Juan', 'Liendro, Macarena Cousirat', 'Saldarriaga, Clara', 'Liprandi, Alvaro Sosa', 'Wyss, Fernando', 'Mendoza, Ivan', 'Baranchuk, Adrian']","['Burgos LM', 'Farina J', 'Liendro MC', 'Saldarriaga C', 'Liprandi AS', 'Wyss F', 'Mendoza I', 'Baranchuk A']","['Department of Heart Failure, Pulmonary Hypertension and Heart Transplant, Instituto Cardiovascular de Buenos Aires, Buenos Aires, AR.', 'Division of Cardiology, Clinica Olivos, Buenos Aires, AR.', 'Division of Cardiology, Hospital General de Agudos Carlos G. Durand, Buenos Aires, AR.', 'Department of Cardiology and Heart Failure Clinic, Cardiovascular Clinic Santa Maria, University of Antioquia, Medellin, CO.', 'Department of Cardiology, Sanatorio Guemes, Buenos Aires, AR.', 'Technology and Cardiovascular Service of Guatemala - Cardiosolutions, Guatemala City, GT.', 'Instituto de Medicina Tropical, Caracas, VE.', ""Division of Cardiology, Kingston Health Science Center, Queen's University, Kingston, Ontario, CA.""]",['eng'],"['Journal Article', 'Multicenter Study']",20200901,England,Glob Heart,Global heart,101584391,IM,"['Communicable Diseases/complications/economics/*epidemiology', 'Global Health', 'Heart Diseases/epidemiology/*etiology', 'Humans', 'Incidence', 'Poverty', '*Tropical Medicine']",PMC7473196,['NOTNLM'],"['cardiovascular disease', 'global health', 'neglected tropical diseases']",2020/09/15 06:00,2021/07/06 06:00,['2020/09/14 05:54'],"['2020/09/14 05:54 [entrez]', '2020/09/15 06:00 [pubmed]', '2021/07/06 06:00 [medline]']",['10.5334/gh.867 [doi]'],epublish,Glob Heart. 2020 Sep 1;15(1):60. doi: 10.5334/gh.867.,['The authors have no competing interests to declare.'],,,,,,,,,,"['Neglected Tropical Diseases and other Infectious Diseases affecting the Heart', '(NET-Heart project)']",,,,,,
13926489,NLM,MEDLINE,19981101,20181201,0042-5036 (Print) 0042-5036 (Linking),9,,1962 Feb 1,[Indications and limitations of therapy with corticosteroid hormones in infectious diseases].,115-23,,,,"['VOICULESCU, M', 'BRUCKNER, S']","['VOICULESCU M', 'BRUCKNER S']",,['rum'],['Journal Article'],,Romania,Viata Med,Viata medicala,7609485,OM,"['Adrenal Cortex Hormones/*therapy', 'Communicable Diseases/*therapy']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapy', '*COMMUNICABLE DISEASES/therapy']",1962/02/01 00:00,1962/02/01 00:01,['1962/02/01 00:00'],"['1962/02/01 00:00 [pubmed]', '1962/02/01 00:01 [medline]', '1962/02/01 00:00 [entrez]']",,ppublish,Viata Med. 1962 Feb 1;9:115-23.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,,,,,,
22432679,NLM,MEDLINE,20120727,20190902,1326-5377 (Electronic) 0025-729X (Linking),196,5,2012 Mar 19,Infectious diseases in the bigger picture.,358,,,,"['Anderson, Warwick H']",['Anderson WH'],"['Department of History, University of Sydney, Sydney, Australia. wanderson@usyd.edu.au']",['eng'],"['Historical Article', 'Journal Article']",,Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Communicable Diseases/epidemiology/*history', 'Epidemiology/*history', 'History, 20th Century', 'Humans', 'Microbiology/history', 'Sociology, Medical/history']",,,,2012/03/22 06:00,2012/07/28 06:00,['2012/03/22 06:00'],"['2012/02/02 00:00 [received]', '2012/02/24 00:00 [accepted]', '2012/03/22 06:00 [entrez]', '2012/03/22 06:00 [pubmed]', '2012/07/28 06:00 [medline]']","['and10216_fm [pii]', '10.5694/mja12.10216 [doi]']",ppublish,Med J Aust. 2012 Mar 19;196(5):358. doi: 10.5694/mja12.10216.,,,,,,,,,,,,,,,,,
13161054,NLM,MEDLINE,20030501,20181201,0528-9173 (Print) 0528-9173 (Linking),2,1,1953 Apr,[Classification of carriers of infectious diseases in natural foci].,32-8,,,,"['ROSICKY, B']",['ROSICKY B'],,['und'],['Journal Article'],,Czech Republic,Chekhoslovatskaia Biol,Chekhoslovatskaia biologiia,16120450R,OM,"['Communicable Diseases/*transmission', '*Disease Transmission, Infectious', '*Heterozygote', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/transmission'],1953/04/01 00:00,1953/04/01 00:01,['1953/04/01 00:00'],"['1953/04/01 00:00 [pubmed]', '1953/04/01 00:01 [medline]', '1953/04/01 00:00 [entrez]']",,ppublish,Chekhoslovatskaia Biol. 1953 Apr;2(1):32-8.,,,,,,,,,Klassifikatsiia perenoschikov v prirodnykh ochagakh transmissivnykh boleznei.,,,['CLML: 5426:23751:118'],,,,,
17665624,NLM,MEDLINE,20070828,20070801,0028-2162 (Print) 0028-2162 (Linking),151,24,2007 Jun 16,"[Recent changes in the epidemiology of infectious diseases in the Netherlands: the report 'Status of infectious diseases in the Netherlands, 2000-2005'].",1333-8,,"Based on the changes in the epidemiology of infectious diseases in the Netherlands in 2000-2005, it is possible to formulate a prediction for the immediate future. Developments that one may expect with a reasonable amount of certainty are a further rise in sexually transmitted diseases, continued vulnerability for infectious diseases for which the State Vaccination Programme distributes vaccines, a slow increase in bacterial resistance, an increase in opportunistic infections, and growing risks for the introduction of new micro-organisms via international travel and trade. Much less certain are the developments surrounding avian influenza A/H5N1, ticks and mosquitoes, the rise and spread of new diseases, and bioterrorism.",,"['Rahamat-Langendoen, J C', 'van Vliet, J A']","['Rahamat-Langendoen JC', 'van Vliet JA']","['Rijksinstituut voor Volksgezondheid en Milieu, Centrum Infectieziektebestrijding, Postvak 75, Postbus 1, 3720 BA Bilthoven. janette.rahamat@rivm.nl']",['dut'],"['English Abstract', 'Journal Article', 'Review']",,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Bioterrorism', 'Communicable Disease Control/*methods', 'Communicable Diseases/*epidemiology/transmission', 'Forecasting', 'Humans', 'Netherlands/epidemiology', '*Sentinel Surveillance', 'Travel']",,,,2007/08/02 09:00,2007/08/29 09:00,['2007/08/02 09:00'],"['2007/08/02 09:00 [pubmed]', '2007/08/29 09:00 [medline]', '2007/08/02 09:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 2007 Jun 16;151(24):1333-8.,,,,,,37,,,"Recente veranderingen in de epidemiologie van infectieziekten in Nederland: het rapport 'Staat van infectieziekten in Nederland, 2000-2005'.",,,,,,,,
23724903,NLM,MEDLINE,20131202,20211021,1545-293X (Electronic) 1527-8204 (Print) 1527-8204 (Linking),14,,2013,The genetic theory of infectious diseases: a brief history and selected illustrations.,215-43,10.1146/annurev-genom-091212-153448 [doi],"Until the mid-nineteenth century, life expectancy at birth averaged 20 years worldwide, owing mostly to childhood fevers. The germ theory of diseases then gradually overcame the belief that diseases were intrinsic. However, around the turn of the twentieth century, asymptomatic infection was discovered to be much more common than clinical disease. Paradoxically, this observation barely challenged the newly developed notion that infectious diseases were fundamentally extrinsic. Moreover, interindividual variability in the course of infection was typically explained by the emerging immunological (or somatic) theory of infectious diseases, best illustrated by the impact of vaccination. This powerful explanation is, however, best applicable to reactivation and secondary infections, particularly in adults; it can less easily account for interindividual variability in the course of primary infection during childhood. Population and clinical geneticists soon proposed a complementary hypothesis, a germline genetic theory of infectious diseases. Over the past century, this idea has gained some support, particularly among clinicians and geneticists, but has also encountered resistance, particularly among microbiologists and immunologists. We present here the genetic theory of infectious diseases and briefly discuss its history and the challenges encountered during its emergence in the context of the apparently competing but actually complementary microbiological and immunological theories. We also illustrate its recent achievements by highlighting inborn errors of immunity underlying eight life-threatening infectious diseases of children and young adults. Finally, we consider the far-reaching biological and clinical implications of the ongoing human genetic dissection of severe infectious diseases.",,"['Casanova, Jean-Laurent', 'Abel, Laurent']","['Casanova JL', 'Abel L']","['St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; email: casanova@rockefeller.edu.']",['eng'],"['Historical Article', 'Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",20130529,United States,Annu Rev Genomics Hum Genet,Annual review of genomics and human genetics,100911346,IM,"['Allergy and Immunology/history', 'Animals', 'Communicable Diseases/*genetics/*immunology/microbiology', 'Genetics/history', 'History, 19th Century', 'History, 20th Century', 'Humans']",PMC4980761,,,2013/06/04 06:00,2013/12/16 06:00,['2013/06/04 06:00'],"['2013/06/04 06:00 [entrez]', '2013/06/04 06:00 [pubmed]', '2013/12/16 06:00 [medline]']",['10.1146/annurev-genom-091212-153448 [doi]'],ppublish,Annu Rev Genomics Hum Genet. 2013;14:215-43. doi: 10.1146/annurev-genom-091212-153448. Epub 2013 May 29.,,,,,,,"['U01 AI088685/AI/NIAID NIH HHS/United States', 'HHMI/Howard Hughes Medical Institute/United States', 'R37 AI095983/AI/NIAID NIH HHS/United States', '8UL1TR000043/TR/NCATS NIH HHS/United States', 'R01 AI089970/AI/NIAID NIH HHS/United States', '5R01AI088364/AI/NIAID NIH HHS/United States', '5R01NS072381/NS/NINDS NIH HHS/United States', '5P01AI061093/AI/NIAID NIH HHS/United States', 'UL1 TR000043/TR/NCATS NIH HHS/United States', '5R01AI089970/AI/NIAID NIH HHS/United States', 'R01 NS072381/NS/NINDS NIH HHS/United States', '268777/ERC_/European Research Council/International', '5U01AI088685/AI/NIAID NIH HHS/United States', '5R37AI095983/AI/NIAID NIH HHS/United States', 'R01 AI088364/AI/NIAID NIH HHS/United States', 'P01 AI061093/AI/NIAID NIH HHS/United States']",,,['NIHMS806014'],,,,,,,
13726953,NLM,MEDLINE,19981101,20181130,0022-1732 (Print) 0022-1732 (Linking),4,,1960,The evolution of modern infectious diseases.,262-8,,,,"['MUROMZEV, S N']",['MUROMZEV SN'],,['eng'],['Journal Article'],,Czech Republic,J Hyg Epidemiol Microbiol Immunol,"Journal of hygiene, epidemiology, microbiology, and immunology",2985116R,OM,"['*Biological Evolution', 'Communicable Diseases/*history', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/history'],1960/01/01 00:00,1960/01/01 00:01,['1960/01/01 00:00'],"['1960/01/01 00:00 [pubmed]', '1960/01/01 00:01 [medline]', '1960/01/01 00:00 [entrez]']",,ppublish,J Hyg Epidemiol Microbiol Immunol. 1960;4:262-8.,,,,,,,,,,,,,,,,,
22584114,NLM,MEDLINE,20121024,20120703,1532-2742 (Electronic) 0163-4453 (Linking),65,2,2012 Aug,Using the NIHR Comprehensive Clinical Research Network for infectious diseases and microbiology research.,99-101,10.1016/j.jinf.2012.05.003 [doi],,,"['Read, Robert C', 'Carson, Gail']","['Read RC', 'Carson G']",,['eng'],['Editorial'],20120511,England,J Infect,The Journal of infection,7908424,IM,"['Biomedical Research/*economics/*organization & administration', '*Capital Financing', 'Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*therapy', 'England', 'Humans']",,,,2012/05/16 06:00,2012/10/25 06:00,['2012/05/16 06:00'],"['2012/05/16 06:00 [entrez]', '2012/05/16 06:00 [pubmed]', '2012/10/25 06:00 [medline]']","['S0163-4453(12)00129-6 [pii]', '10.1016/j.jinf.2012.05.003 [doi]']",ppublish,J Infect. 2012 Aug;65(2):99-101. doi: 10.1016/j.jinf.2012.05.003. Epub 2012 May 11.,,,,,,,,,,,,,,,,,
18903368,NLM,MEDLINE,20081016,20201005,0035-1636 (Print) 0035-1636 (Linking),48,593-594,1948 Jan-Feb,[Mating and transmission of infectious diseases; prophylaxis of venereal diseases by artificial insemination].,74-6,,,,"['BERTHELON, M']",['BERTHELON M'],,['fre'],['Journal Article'],,France,Rev Pathol Comp,Revue de pathologie comparee,0166253,OM,"['*Biomedical Research', 'Communicable Diseases/*transmission', '*Disease Transmission, Infectious', 'Humans', 'Sexually Transmitted Diseases/*prevention & control']",,['NLM'],"['*COMMUNICABLE DISEASES/transmission', '*VENEREAL DISEASES/prevention and control']",1948/01/01 00:00,2008/10/24 09:00,['1948/01/01 00:00'],"['1948/01/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/01/01 00:00 [entrez]']",,ppublish,Rev Pathol Comp. 1948 Jan-Feb;48(593-594):74-6.,,,,,,,,,Accouplement et transmission des maladies infectieuses; prophylaxie des maladies veneriennes par l'insemination artificielle.,,,['CLML: 4814:551l'],,,,,
8918943,NLM,MEDLINE,19961212,20041117,0022-2615 (Print) 0022-2615 (Linking),45,5,1996 Nov,Tropical medicine and infectious diseases in a shrinking world.,311-2,,,,"['De Cock, K M']",['De Cock KM'],,['eng'],['Editorial'],,England,J Med Microbiol,Journal of medical microbiology,0224131,IM,"['Africa South of the Sahara/epidemiology', '*Communicable Diseases/epidemiology/therapy', 'Developing Countries', 'Humans', 'Tropical Climate', 'Tropical Medicine/*trends']",,,,1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']",['10.1099/00222615-45-5-311 [doi]'],ppublish,J Med Microbiol. 1996 Nov;45(5):311-2. doi: 10.1099/00222615-45-5-311.,,,,,,,,,,,,,,,,,
13213388,NLM,MEDLINE,20030501,20201114,0025-729X (Print) 0025-729X (Linking),2,14,1954 Oct 2,Changes in infectivity of infectious diseases.,533-6,,,,"['McLORINAN, H']",['McLORINAN H'],,['eng'],['Journal Article'],,Australia,Med J Aust,The Medical journal of Australia,0400714,OM,"['Communicable Diseases/*epidemiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1954/10/02 00:00,1954/10/02 00:01,['1954/10/02 00:00'],"['1954/10/02 00:00 [pubmed]', '1954/10/02 00:01 [medline]', '1954/10/02 00:00 [entrez]']",['10.5694/j.1326-5377.1954.tb66748.x [doi]'],ppublish,Med J Aust. 1954 Oct 2;2(14):533-6. doi: 10.5694/j.1326-5377.1954.tb66748.x.,,,,,,,,,,,,['CLML: 5527:25167:120'],,,,,
13284122,NLM,MEDLINE,20030501,20181201,0021-2547 (Print) 0021-2547 (Linking),34,7-8,1955 Jul-Aug,[The general pathology of infectious diseases].,357-67,,,,"['RONDONI, P']",['RONDONI P'],,['ita'],['Journal Article'],,Italy,Boll Ist Sieroter Milan,Bollettino dell'Istituto sieroterapico milanese,17720040R,OM,"['Communicable Diseases/*pathology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/pathology'],1955/07/01 00:00,1955/07/01 00:01,['1955/07/01 00:00'],"['1955/07/01 00:00 [pubmed]', '1955/07/01 00:01 [medline]', '1955/07/01 00:00 [entrez]']",,ppublish,Boll Ist Sieroter Milan. 1955 Jul-Aug;34(7-8):357-67.,,,,,,,,,La patologia generale delle malattie infettive.,,,['CLML: 5629:36344'],,,,,
13744471,NLM,MEDLINE,19981101,20181130,0002-3027 (Print) 0002-3027 (Linking),16(2),,1961,[Hormonal therapy in infectious diseases].,21-31,,,,"['RUDNEV, G P', 'GURSKII, Iu N']","['RUDNEV GP', 'GURSKII IuN']",,['rus'],['Journal Article'],,Russia (Federation),Vestn Akad Med Nauk SSSR,Vestnik Akademii meditsinskikh nauk SSSR,7506153,OM,"['Communicable Diseases/*therapy', 'Hormones/*therapy']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*HORMONES/therapy']",1961/01/01 00:00,1961/01/01 00:01,['1961/01/01 00:00'],"['1961/01/01 00:00 [pubmed]', '1961/01/01 00:01 [medline]', '1961/01/01 00:00 [entrez]']",,ppublish,Vestn Akad Med Nauk SSSR. 1961;16(2):21-31.,,,['0 (Hormones)'],,,,,,,,,,,,,,
14460393,NLM,MEDLINE,19981101,20181201,0044-2542 (Print) 0044-2542 (Linking),16,,1961 Jul 1,[Greiz epidemic prophylaxis in 1770. Contribution to the history of infectious diseases].,573-4,,,,"['KUKOWKA, A']",['KUKOWKA A'],,['ger'],['Journal Article'],,Germany,Z Gesamte Inn Med,Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,21730470R,OM,"['Communicable Diseases/*history', '*Epidemics', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/history'],1961/07/01 00:00,1961/07/01 00:01,['1961/07/01 00:00'],"['1961/07/01 00:00 [pubmed]', '1961/07/01 00:01 [medline]', '1961/07/01 00:00 [entrez]']",,ppublish,Z Gesamte Inn Med. 1961 Jul 1;16:573-4.,,,,,,,,,,,,,,,,,
13266673,NLM,MEDLINE,20030501,20181201,0032-6518 (Print) 0032-6518 (Linking),175,1048,1955 Oct,Advances in the treatment of acute infectious diseases.,443-9,,,,"['BANKS, H S']",['BANKS HS'],,['eng'],['Journal Article'],,England,Practitioner,The Practitioner,0404245,OM,"['*Acute Disease', 'Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1955/10/01 00:00,1955/10/01 00:01,['1955/10/01 00:00'],"['1955/10/01 00:00 [pubmed]', '1955/10/01 00:01 [medline]', '1955/10/01 00:00 [entrez]']",,ppublish,Practitioner. 1955 Oct;175(1048):443-9.,,,,,,,,,,,,['CLML: 5629:18605'],,,,,
24278167,NLM,MEDLINE,20140918,20211021,1932-6203 (Electronic) 1932-6203 (Linking),8,11,2013,The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases.,e79740,10.1371/journal.pone.0079740 [doi] e79740,"In 2009, the European Centre for Disease Prevention and Control initiated the 'Burden of Communicable Diseases in Europe (BCoDE)' project to generate evidence-based and comparable burden-of-disease estimates of infectious diseases in Europe. The burden-of-disease metric used was the Disability-Adjusted Life Year (DALY), composed of years of life lost due to premature death (YLL) and due to disability (YLD). To better represent infectious diseases, a pathogen-based approach was used linking incident cases to sequelae through outcome trees. Health outcomes were included if an evidence-based causal relationship between infection and outcome was established. Life expectancy and disability weights were taken from the Global Burden of Disease Study and alternative studies. Disease progression parameters were based on literature. Country-specific incidence was based on surveillance data corrected for underestimation. Non-typhoidal Salmonella spp. and Campylobacter spp. were used for illustration. Using the incidence- and pathogen-based DALY approach the total burden for Salmonella spp. and Campylobacter spp. was estimated at 730 DALYs and at 1,780 DALYs per year in the Netherlands (average of 2005-2007). Sequelae accounted for 56% and 82% of the total burden of Salmonella spp. and Campylobacter spp., respectively. The incidence- and pathogen-based DALY methodology allows in the case of infectious diseases a more comprehensive calculation of the disease burden as subsequent sequelae are fully taken into account. Not considering subsequent sequelae would strongly underestimate the burden of infectious diseases. Estimates can be used to support prioritisation and comparison of infectious diseases and other health conditions, both within a country and between countries.",,"['Mangen, Marie-Josee J', 'Plass, Dietrich', 'Havelaar, Arie H', 'Gibbons, Cheryl L', 'Cassini, Alessandro', 'Muhlberger, Nikolai', 'van Lier, Alies', 'Haagsma, Juanita A', 'Brooke, R John', 'Lai, Taavi', 'de Waure, Chiara', 'Kramarz, Piotr', 'Kretzschmar, Mirjam E E']","['Mangen MJ', 'Plass D', 'Havelaar AH', 'Gibbons CL', 'Cassini A', 'Muhlberger N', 'van Lier A', 'Haagsma JA', 'Brooke RJ', 'Lai T', 'de Waure C', 'Kramarz P', 'Kretzschmar ME']","['Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20131120,United States,PLoS One,PloS one,101285081,IM,"['Campylobacter/pathogenicity', 'Communicable Diseases/*microbiology/mortality/physiopathology', 'Cost of Illness', 'Humans', 'Incidence', 'Netherlands', '*Quality-Adjusted Life Years', 'Salmonella/pathogenicity']",PMC3835936,,,2013/11/28 06:00,2014/09/19 06:00,['2013/11/27 06:00'],"['2013/07/08 00:00 [received]', '2013/09/23 00:00 [accepted]', '2013/11/27 06:00 [entrez]', '2013/11/28 06:00 [pubmed]', '2014/09/19 06:00 [medline]']","['PONE-D-13-28049 [pii]', '10.1371/journal.pone.0079740 [doi]']",epublish,PLoS One. 2013 Nov 20;8(11):e79740. doi: 10.1371/journal.pone.0079740. eCollection 2013.,['Competing Interests: The authors have declared that no competing interests exist.'],,,['PLoS One. 2013;8(12). doi:10.1371/annotation/caf33818-3453-4e30-b307-7526427b09b7'],,,,,,,['BCoDE consortium'],,"['Colzani, Edourdo', 'de Wit, G Ardine', 'Fevre, Eric', 'Franco, Elisabetta', 'Jahn, Beate', 'Kramer, Alexander', 'Longhi, Silvia', 'Matsi, Ardo', 'McDonald, Scott', 'Murianni, Laura', 'Pinheiro, Paulo', 'Ricciardi, Walter', 'Ruutel, Kristi', 'Siebert, Uwe']","['Colzani E', 'de Wit G', 'Fevre E', 'Franco E', 'Jahn B', 'Kramer A', 'Longhi S', 'Matsi A', 'McDonald S', 'Murianni L', 'Pinheiro P', 'Ricciardi W', 'Ruutel K', 'Siebert U']",,,
29917197,NLM,MEDLINE,20191111,20191111,2284-0729 (Electronic) 1128-3602 (Linking),22,11,2018 Jun,CRISPR technology: new paradigm to target the infectious disease pathogens.,3448-3452,15169 [pii] 10.26355/eurrev_201806_15169 [doi],"OBJECTIVE: Infectious diseases are one of the prime causes of death worldwide. An innovative sequence specific editing technology ""Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)"" has been tested on a broad range of microorganisms to target and destroy invading foreign DNA to human cells or tissues. This study aimed to discuss the mechanism and therapeutic usage of CRISPR/Cas9 genome editing technology in the management of various infectious disease pathogens. MATERIALS AND METHODS: We conducted a broad search of the English-language literature in ""PubMed"" using the search terms ""CRISPR"", ""Cas-9"", ""Genome editing"", ""Gene therapy"", ""infectious disease pathogens"". All the articles were reviewed and required information was recorded. RESULTS: CRISPR technology is used to modify and modulate the gene expression in biomedical research and therapeutic development. This technology facilitates the understanding of fundamental biology and broadens the horizon of treatments of germ-laden conditions. CONCLUSIONS: The applications of CRISPR technology are widely established in the diagnosis and treatment of various bacterial, viral, fungal and parasitic infectious diseases. CRISPR technology is a simple, efficient and tested on a broad range of microorganisms to rectify disease-associated genetic defects and destroy invading foreign DNA to human cells or tissues.",,"['Bakhrebah, M A', 'Nassar, M S', 'Alsuabeyl, M S', 'Zaher, W A', 'Meo, S A']","['Bakhrebah MA', 'Nassar MS', 'Alsuabeyl MS', 'Zaher WA', 'Meo SA']","['Life Science and Environmental Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia. sultanmeo@hotmail.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,Italy,Eur Rev Med Pharmacol Sci,European review for medical and pharmacological sciences,9717360,IM,"['*CRISPR-Cas Systems', 'Communicable Diseases/*genetics/microbiology/*therapy', 'Gene Editing/*methods', 'Genetic Therapy/*methods', 'Humans']",,,,2018/06/20 06:00,2019/11/12 06:00,['2018/06/20 06:00'],"['2018/06/20 06:00 [entrez]', '2018/06/20 06:00 [pubmed]', '2019/11/12 06:00 [medline]']","['15169 [pii]', '10.26355/eurrev_201806_15169 [doi]']",ppublish,Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3448-3452. doi: 10.26355/eurrev_201806_15169.,,,,,,,,,,,,,,,,,
14929757,NLM,MEDLINE,20040215,20181201,0032-6518 (Print) 0032-6518 (Linking),168,1006,1952 Apr,Emergencies in infectious diseases.,377-81,,,,"['KER, F L']",['KER FL'],,['eng'],['Journal Article'],,England,Practitioner,The Practitioner,0404245,OM,"['Communicable Diseases/*therapy', '*Emergencies', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1952/04/01 00:00,1952/04/01 00:01,['1952/04/01 00:00'],"['1952/04/01 00:00 [pubmed]', '1952/04/01 00:01 [medline]', '1952/04/01 00:00 [entrez]']",,ppublish,Practitioner. 1952 Apr;168(1006):377-81.,,,,,,,,,,,,['CLML: 5222:15750:114'],,,,,
19111872,NLM,MEDLINE,20090727,20181201,1878-3503 (Electronic) 0035-9203 (Linking),103,4,2009 Apr,"Proceedings of a joint meeting between the Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20 June 2008.",321-4,10.1016/j.trstmh.2008.11.010 [doi],"This paper presents the proceedings of a scientific meeting that was held between the Royal Society of Tropical Medicine and Hygiene and the Norwegian Infectious Diseases Society at Ulleval University Hospital, Oslo on 20 June 2008. Seven speakers updated the audience on recent advances in relevant issues, including international maternal and child health, podoconiosis, schistosomiasis and HIV, leprosy in the UK, rapid diagnostic tests for malaria, delayed diagnosis of tuberculosis and the Global Filariasis Programme. The meeting ended with a series of case presentations.",,"['Newport, Melanie J', 'Myrvang, Bjorn']","['Newport MJ', 'Myrvang B']","['Department of Medicine, Brighton and Sussex Medical School, Falmer, Sussex BN1 9PS, UK. m.j.newport@bsms.ac.uk']",['eng'],['Congress'],20081227,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,IM,"['*Communicable Diseases/diagnosis/etiology/therapy', 'Filariasis/prevention & control', 'Humans', 'Leprosy/diagnosis', 'Malaria/diagnosis', 'Maternal-Child Health Centers', 'Norway', 'Public Health', '*Tropical Medicine', 'Tuberculosis/diagnosis', 'United Kingdom']",,,,2008/12/30 09:00,2009/07/28 09:00,['2008/12/30 09:00'],"['2008/11/09 00:00 [received]', '2008/11/14 00:00 [accepted]', '2008/12/30 09:00 [entrez]', '2008/12/30 09:00 [pubmed]', '2009/07/28 09:00 [medline]']","['S0035-9203(08)00501-4 [pii]', '10.1016/j.trstmh.2008.11.010 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2009 Apr;103(4):321-4. doi: 10.1016/j.trstmh.2008.11.010. Epub 2008 Dec 27.,,,,,,,,,,,,,,,,,
19096894,NLM,MEDLINE,20090609,20090407,1522-9602 (Electronic) 0092-8240 (Linking),71,4,2009 May,Dynamics of indirectly transmitted infectious diseases with immunological threshold.,845-62,10.1007/s11538-008-9384-4 [doi],"There are numerous examples of human pathogens which persist in environmental reservoirs while infectious outbreaks remain rare. In this manuscript, we consider the dynamics of infectious diseases for which the primary mode of transmission is indirect and mediated by contact with a contaminated reservoir. We evaluate the realistic scenario in which the number of ingested pathogens must be above a critical threshold to cause infection in susceptible individuals. This minimal infectious dose is a consequence of the clearance effect of the innate immune system. Infected individuals shed pathogens back into the aquatic reservoir, indirectly increasing the transmittability of the pathogen to the susceptible. Building upon prior works in the study of cholera dynamics, we introduce and analyze a family of reservoir mediated SIR models with a threshold pathogen density for infection. Analyzing this family of models, we show that an outbreak can result from noninfinitesimal introductions of either infected individuals or additional pathogens in the reservoir. We devise two new measures of how likely it is that an environmentally persistent pathogen will cause an outbreak: (i) the minimum fraction of infected individuals; and (ii) the minimum fluctuation size of in-reservoir pathogens. We find an additional control parameter involving the shedding rate of infected individuals, which we term the pathogen enhancement ratio, which determines whether outbreaks lead to epidemics or endemic disease states. Thus, the ultimate outcome of disease is controlled by the strength of fluctuations and the global stability of a nonlinear dynamical system, as opposed to conventional analysis in which disease reflects the linear destabilization of a disease free equilibrium. Our model predicts that in the case of waterborne diseases, suppressing the pathogen density in aquatic reservoirs may be more effective than minimizing the number of infected individuals.",,"['Joh, Richard I', 'Wang, Hao', 'Weiss, Howard', 'Weitz, Joshua S']","['Joh RI', 'Wang H', 'Weiss H', 'Weitz JS']","['School of Physics, Georgia Institute of Technology, Atlanta, GA 30332, USA. ijoh3@gatech.edu']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",20081219,United States,Bull Math Biol,Bulletin of mathematical biology,0401404,IM,"['Communicable Diseases/epidemiology/*immunology/*transmission', 'Disease Outbreaks', '*Disease Reservoirs', 'Humans', '*Models, Immunological', 'Population Dynamics']",,,,2008/12/20 09:00,2009/06/10 09:00,['2008/12/20 09:00'],"['2008/04/15 00:00 [received]', '2008/12/02 00:00 [accepted]', '2008/12/20 09:00 [entrez]', '2008/12/20 09:00 [pubmed]', '2009/06/10 09:00 [medline]']",['10.1007/s11538-008-9384-4 [doi]'],ppublish,Bull Math Biol. 2009 May;71(4):845-62. doi: 10.1007/s11538-008-9384-4. Epub 2008 Dec 19.,,,,,,,,,,,,,,,,,
21460298,NLM,MEDLINE,20110608,20110404,1537-6591 (Electronic) 1058-4838 (Linking),52 Suppl 4,,2011 May,Drug-device trials for infectious diseases: CDRH perspective.,S367-72,10.1093/cid/cir053 [doi],"Assessing the performance of new diagnostic tests for infectious diseases has traditionally focused on comparing the new assay against a reference standard such as culture. In this paper, we suggest that clinical trial designs with both a diagnostic and therapeutic component may be necessary to evaluate the safety and effectiveness of nonmicrobiologically based assays, with a specific emphasis on the test/marker-stratified design. General design challenges for trials of infectious diseases that simultaneously study both diagnostic and therapeutic components (eg, both devices and drugs) are also discussed.",,"['Meier, Kristen L', 'Gitterman, Steven']","['Meier KL', 'Gitterman S']","['Division of Biostatistics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 66, Silver Spring, MD 20993-0002, USA. kristen.meier@fda.hhs.gov']",['eng'],"['Journal Article', 'Review']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*Clinical Trials as Topic', 'Communicable Diseases/*diagnosis/*drug therapy', 'Diagnostic Test Approval', 'Drug Approval', 'Humans', 'Research Design']",,,,2011/04/06 06:00,2011/06/09 06:00,['2011/04/05 06:00'],"['2011/04/05 06:00 [entrez]', '2011/04/06 06:00 [pubmed]', '2011/06/09 06:00 [medline]']","['cir053 [pii]', '10.1093/cid/cir053 [doi]']",ppublish,Clin Infect Dis. 2011 May;52 Suppl 4:S367-72. doi: 10.1093/cid/cir053.,,,,,,,,,,,,,,,,,
30476067,NLM,MEDLINE,20190607,20190607,2041-2657 (Electronic) 2041-2649 (Linking),17,6,2018 Nov 26,Emerging and threatening infectious diseases.,372-373,10.1093/bfgp/ely038 [doi],,,"['Basu, Subhadip', 'Plewczynski, Dariusz']","['Basu S', 'Plewczynski D']","['Department of Computer Science and Engineering, Jadavpur University, India.', 'Center of New Technologies, University of Warsaw, Warsaw, Poland.', 'Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Warsaw, Poland.']",['eng'],"['Editorial', 'Introductory Journal Article']",,England,Brief Funct Genomics,Briefings in functional genomics,101528229,IM,"['Communicable Diseases/*epidemiology/transmission', 'DNA Methylation/genetics', 'Epidemics', 'Host-Pathogen Interactions', 'Humans']",,,,2018/11/27 06:00,2019/06/08 06:00,['2018/11/27 06:00'],"['2018/08/17 00:00 [received]', '2018/10/19 00:00 [accepted]', '2018/11/27 06:00 [entrez]', '2018/11/27 06:00 [pubmed]', '2019/06/08 06:00 [medline]']","['5195505 [pii]', '10.1093/bfgp/ely038 [doi]']",ppublish,Brief Funct Genomics. 2018 Nov 26;17(6):372-373. doi: 10.1093/bfgp/ely038.,,,,,,,,,,,,,,,,,
11774093,NLM,MEDLINE,20020301,20151119,1537-6591 (Electronic) 1058-4838 (Linking),34,3,2002 Feb 1,Business aspects of infectious diseases.,420,,,,"['Tenenbaum, Marvin J', 'Petrak, Russell']","['Tenenbaum MJ', 'Petrak R']",,['eng'],"['Comment', 'Letter']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Anti-Bacterial Agents/economics/therapeutic use', '*Commerce', 'Communicable Diseases/drug therapy/*economics', 'Humans', 'Personnel Management', ""*Practice Patterns, Physicians'""]",,,,2002/01/05 10:00,2002/03/02 10:01,['2002/01/05 10:00'],"['2002/01/05 10:00 [pubmed]', '2002/03/02 10:01 [medline]', '2002/01/05 10:00 [entrez]']","['CID011181 [pii]', '10.1086/324577 [doi]']",ppublish,Clin Infect Dis. 2002 Feb 1;34(3):420. doi: 10.1086/324577.,,,['0 (Anti-Bacterial Agents)'],,,,,['Clin Infect Dis. 2001 Jan 15;32(2):255-62. PMID: 11170915'],,,,,,,,,
12866448,NLM,MEDLINE,20030904,20121115,0021-5384 (Print) 0021-5384 (Linking),92,6,2003 Jun 10,[Prevention of infectious diseases in patients with leukemia].,1018-24,,,,"['Yano, Kunio']",['Yano K'],,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Antibiotic Prophylaxis', '*Communicable Disease Control/methods', 'Communicable Diseases/*etiology/transmission', 'Environment, Controlled', 'Food Microbiology', 'Hand Disinfection', 'Humans', 'Immunocompromised Host', 'Infectious Disease Transmission, Professional-to-Patient', 'Leukemia/*complications', 'Life Style']",,,,2003/07/18 05:00,2003/09/05 05:00,['2003/07/18 05:00'],"['2003/07/18 05:00 [pubmed]', '2003/09/05 05:00 [medline]', '2003/07/18 05:00 [entrez]']",,ppublish,Nihon Naika Gakkai Zasshi. 2003 Jun 10;92(6):1018-24.,,,,,,,,,,,,,,,,,
32462426,NLM,MEDLINE,20200612,20220219,1432-1203 (Electronic) 0340-6717 (Print) 0340-6717 (Linking),139,6-7,2020 Jun,The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity?,681-694,10.1007/s00439-020-02184-w [doi],"Multicellular eukaryotes emerged late in evolution from an ocean of viruses, bacteria, archaea, and unicellular eukaryotes. These macroorganisms are exposed to and infected by a tremendous diversity of microorganisms. Those that are large enough can even be infected by multicellular fungi and parasites. Each interaction is unique, if only because it operates between two unique living organisms, in an infinite diversity of circumstances. This is neatly illustrated by the extraordinarily high level of interindividual clinical variability in human infections, even for a given pathogen, ranging from a total absence of clinical manifestations to death. We discuss here the idea that the determinism of human life-threatening infectious diseases can be governed by single-gene inborn errors of immunity, which are rarely Mendelian and frequently display incomplete penetrance. We briefly review the evidence in support of this notion obtained over the last two decades, referring to a number of focused and thorough reviews published by eminent colleagues in this issue of Human Genetics. It seems that almost any life-threatening infectious disease can be driven by at least one, and, perhaps, a great many diverse monogenic inborn errors, which may nonetheless be immunologically related. While the proportions of monogenic cases remain unknown, a picture in which genetic heterogeneity is combined with physiological homogeneity is emerging from these studies. A preliminary sketch of the human genetic architecture of severe infectious diseases is perhaps in sight.",,"['Casanova, Jean-Laurent', 'Abel, Laurent']","['Casanova JL', 'Abel L']","['St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. casanova@rockefeller.edu.', 'Howard Hughes Medical Institute, New York, NY, USA. casanova@rockefeller.edu.', 'Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France. casanova@rockefeller.edu.', 'Paris University, Imagine Institute, Paris, France. casanova@rockefeller.edu.', 'Pediatric Hematology and Immunology Unit, Necker Hospital for Sick Children, Paris, France. casanova@rockefeller.edu.', 'St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.', 'Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France.', 'Paris University, Imagine Institute, Paris, France.']",['eng'],['Editorial'],,Germany,Hum Genet,Human genetics,7613873,IM,"['Communicable Diseases/*genetics/immunology/*pathology', '*Genetic Heterogeneity', '*Genetic Predisposition to Disease', 'Humans', 'Models, Genetic']",PMC7251220,,,2020/05/29 06:00,2020/06/13 06:00,['2020/05/29 06:00'],"['2020/05/29 06:00 [pubmed]', '2020/06/13 06:00 [medline]', '2020/05/29 06:00 [entrez]']","['10.1007/s00439-020-02184-w [pii]', '2184 [pii]', '10.1007/s00439-020-02184-w [doi]']",ppublish,Hum Genet. 2020 Jun;139(6-7):681-694. doi: 10.1007/s00439-020-02184-w.,,,,,,,"['UL1 TR001866/TR/NCATS NIH HHS/United States', 'R21 AI137371/AI/NIAID NIH HHS/United States', 'R37 AI095983/AI/NIAID NIH HHS/United States', 'R01 AI127564/AI/NIAID NIH HHS/United States', 'R01 NS072381/NS/NINDS NIH HHS/United States', 'U19 AI111143/AI/NIAID NIH HHS/United States', 'R01 AI088364/AI/NIAID NIH HHS/United States', 'P01 AI061093/AI/NIAID NIH HHS/United States']",,,,,,,,,,
20224767,NLM,MEDLINE,20110111,20181113,1932-6203 (Electronic) 1932-6203 (Linking),5,3,2010 Mar 10,A PubMed-wide associational study of infectious diseases.,e9535,10.1371/journal.pone.0009535 [doi] e9535,"BACKGROUND: Computational discovery is playing an ever-greater role in supporting the processes of knowledge synthesis. A significant proportion of the more than 18 million manuscripts indexed in the PubMed database describe infectious disease syndromes and various infectious agents. This study is the first attempt to integrate online repositories of text-based publications and microbial genome databases in order to explore the dynamics of relationships between pathogens and infectious diseases. METHODOLOGY/PRINCIPAL FINDINGS: Herein we demonstrate how the knowledge space of infectious diseases can be computationally represented and quantified, and tracked over time. The knowledge space is explored by mapping of the infectious disease literature, looking at dynamics of literature deposition, zooming in from pathogen to genome level and searching for new associations. Syndromic signatures for different pathogens can be created to enable a new and clinically focussed reclassification of the microbial world. Examples of syndrome and pathogen networks illustrate how multilevel network representations of the relationships between infectious syndromes, pathogens and pathogen genomes can illuminate unexpected biological similarities in disease pathogenesis and epidemiology. CONCLUSIONS/SIGNIFICANCE: This new approach based on text and data mining can support the discovery of previously hidden associations between diseases and microbial pathogens, clinically relevant reclassification of pathogenic microorganisms and accelerate the translational research enterprise.",,"['Sintchenko, Vitali', 'Anthony, Stephen', 'Phan, Xuan-Hieu', 'Lin, Frank', 'Coiera, Enrico W']","['Sintchenko V', 'Anthony S', 'Phan XH', 'Lin F', 'Coiera EW']","['Centre for Health Informatics, University of New South Wales, Sydney, New South Wales, Australia. vitali.sintchenko@sydney.edu.au']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100310,United States,PLoS One,PloS one,101285081,IM,"['Algorithms', 'Communicable Diseases/*diagnosis/*epidemiology/microbiology', 'Computational Biology/methods', 'Data Mining/methods', 'Databases, Bibliographic', 'Genome', 'Humans', 'National Library of Medicine (U.S.)', 'PubMed', 'United States']",PMC2835740,,,2010/03/13 06:00,2011/01/12 06:00,['2010/03/13 06:00'],"['2009/11/26 00:00 [received]', '2010/02/11 00:00 [accepted]', '2010/03/13 06:00 [entrez]', '2010/03/13 06:00 [pubmed]', '2011/01/12 06:00 [medline]']","['09-PONE-RA-14512R1 [pii]', '10.1371/journal.pone.0009535 [doi]']",epublish,PLoS One. 2010 Mar 10;5(3):e9535. doi: 10.1371/journal.pone.0009535.,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,
27480226,NLM,MEDLINE,20190211,20200324,1432-184X (Electronic) 0095-3628 (Print) 0095-3628 (Linking),76,1,2018 Jul,The Threat and Response to Infectious Diseases (Revised).,19-36,10.1007/s00248-016-0806-9 [doi],"The threat from microorganisms is complex, and the approaches for reducing the challenges the world is facing are also multifaceted, but a combination approach including several simple steps can make a difference and reduce morbidity and mortality and the economic cost of fighting infectious diseases. This paper discusses the continually evolving infectious disease landscape, contributing factors in the rise of the threat, reasons for optimism, and the policies, technologies, actions, and institutions that might be harnessed to further reduce the dangers introduced by pathogens. It builds upon and updates the work of other authors that have recognized the dangers of emerging and re-emerging pathogens and have explored and documented potential solutions.",,"['Brower, Jennifer L']",['Brower JL'],"['Prometheus Inc., 103 Mansfield St., Sharon, MA, 02067, USA. jenn@prometheus-us.com.']",['eng'],"['Journal Article', 'Review']",20160801,United States,Microb Ecol,Microbial ecology,7500663,IM,"['Bioterrorism', 'Climate Change', 'Communicable Diseases, Emerging/economics/*etiology/*therapy/transmission', 'Disaster Planning', 'Disasters', 'Drug Misuse', 'Drug Resistance', 'Drug Users', 'Forecasting', 'Global Warming', 'Humans', 'Prescription Drug Overuse', 'Risk Factors', 'Sexual Behavior', 'Social Conditions', 'Travel', 'Urbanization', 'Vaccination']",PMC7080028,['NOTNLM'],"['Antibiotic resistance', 'Emerging infectious diseases', 'Strategic']",2016/08/03 06:00,2019/02/12 06:00,['2016/08/03 06:00'],"['2015/07/23 00:00 [received]', '2016/06/20 00:00 [accepted]', '2016/08/03 06:00 [pubmed]', '2019/02/12 06:00 [medline]', '2016/08/03 06:00 [entrez]']","['10.1007/s00248-016-0806-9 [pii]', '806 [pii]', '10.1007/s00248-016-0806-9 [doi]']",ppublish,Microb Ecol. 2018 Jul;76(1):19-36. doi: 10.1007/s00248-016-0806-9. Epub 2016 Aug 1.,,,,,,,,,,,,,,,,,
19195463,NLM,MEDLINE,20090508,20211020,0213-005X (Print) 1578-1852 (Electronic) 0213-005X (Linking),26 Suppl 15,,2008 Dec,[History of the infectious disease specialty in Spain].,6-14,,"This paper includes a brief summary of the clinical history of the diagnosis and treatment of infectious diseases in Spain. Firstly, the origins of a specialty arising from the need for specialists to attend to, in a practical and modern form, the different health problems of patients affected by infectious diseases, are described. Secondly, the appearance of AIDS, at the beginning of the 1980's, prompted the creation of specific units dedicated to the care of problems associated with human immunodeficiency virus (HIV) infection and the concomitant opportunistic infections arising from the immunodeficiency arising from the HIV infection. Thirdly, in the last decades and even today, nosocomial infections have appeared as an alarming problem, needing the presence of specialist physicians in this field. Finally, emigration and international travel require specialists in infectious diseases with specific expertise in international health, once more highlighting the importance of the specialty of Infectious Diseases.",,"['Aguado Garcia, Jose Maria', 'Iribarren Loyarte, Jose Antonio', 'Gomez Mateos, Jesus', 'Gutierrez Rodero, Felix', 'Segura Porta, Ferran']","['Aguado Garcia JM', 'Iribarren Loyarte JA', 'Gomez Mateos J', 'Gutierrez Rodero F', 'Segura Porta F']","['Unidad de Enfermedades Infecciosas, Hospital Universitario 12 de Octubre, Madrid, Espana. jaguadog@medynet.com']",['spa'],"['English Abstract', 'Historical Article', 'Journal Article']",,Spain,Enferm Infecc Microbiol Clin,Enfermedades infecciosas y microbiologia clinica,9104081,IM,"['AIDS-Related Opportunistic Infections/history', 'Communicable Diseases/*history/therapy', 'Communicable Diseases, Emerging/epidemiology', 'Cross Infection/epidemiology/prevention & control', 'HIV Infections/history', 'History, 15th Century', 'History, 16th Century', 'History, 20th Century', 'History, 21st Century', 'History, Medieval', 'Humans', 'Infection Control/history/legislation & jurisprudence/organization & administration', 'Infectious Disease Medicine/education/*history/organization & administration', 'Spain', 'Travel', 'Tropical Medicine']",PMC7130158,,,2009/02/07 09:00,2009/05/09 09:00,['2009/02/07 09:00'],"['2009/02/07 09:00 [entrez]', '2009/02/07 09:00 [pubmed]', '2009/05/09 09:00 [medline]']","['13131228 [pii]', '10.1016/s0213-005x(08)76595-9 [doi]']",ppublish,Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 15:6-14. doi: 10.1016/s0213-005x(08)76595-9.,,,,,,,,,Relato historico de la infectologia espanola.,,,,,,,,
35568481,NLM,MEDLINE,20220517,20220819,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),74,Suppl_3,2022 May 15,How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.,e23-e33,10.1093/cid/ciac081 [doi],"Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID-19) pandemic. This viewpoint by the Society of Infectious Diseases Pharmacists (SIDP) provides guidance on utilizing social media platforms to optimize infectious diseases pharmacotherapy. It includes tips for all levels of users but primarily serves a guide for the infectious diseases clinician who has not yet joined social media. It compares various social media platforms and suggests which to begin with based on user needs, recommends efficient curation of social media content, and outlines a stepwise approach (shown below) to increasing engagement over time. This summary will hopefully spur further quality content and engagement regarding drug information from the infectious diseases social media network.","['(c) The Author(s) 2022. Published by Oxford University Press for the Infectious', 'Diseases Society of America. All rights reserved. For permissions, e-mail:', 'journals.permissions@oup.com.']","['Cole, Kelli A', 'Zhou, Anna Y', 'Jones, Travis', 'Moore, W Justin', 'Chandler, Elisabeth L', 'Zafonte, Veronica B', 'Morrisette, Taylor', 'Gauthier, Timothy P', 'Kisgen, Jamie', 'Barner, Amanda', 'Johnson, Melissa D', 'Tagare, R Dawn', 'Justo, Julie Ann']","['Cole KA', 'Zhou AY', 'Jones T', 'Moore WJ', 'Chandler EL', 'Zafonte VB', 'Morrisette T', 'Gauthier TP', 'Kisgen J', 'Barner A', 'Johnson MD', 'Tagare RD', 'Justo JA']","['Medical Science Liaison, OH/MI/W. PA, ViiV Healthcare, Research Triangle Park, North Carolina, USA.', 'Department of Pharmacy, Loma Linda University Health, Loma Linda, California, USA.', 'Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.', 'Department of Pharmacy, Northwestern Medicine, Chicago, Illinois, USA.', 'Department of Pharmacy, Lee Health, Fort Myers, Florida, USA.', 'Department of Pharmacy, Jamaica Hospital Medical Center, Richmond Hill, New York, USA.', 'Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.', ""Department of Pharmacy Services, Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, USA."", 'Clinical Pharmacy Enterprise, Baptist Health South Florida, Miami, Florida, USA.', 'Department of Pharmacy, Sarasota Memorial Health Care System, Sarasota, Florida, USA.', 'Department of Pharmacy, Cambridge Health Alliance, Cambridge, Massachusetts, USA.', 'Division of Infectious Diseases & International Health, Duke University Medical Center, Durham, North Carolina, USA.', 'Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA.', 'Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['*COVID-19', '*Communicable Diseases/drug therapy/epidemiology', 'Humans', 'Pandemics', 'Pharmacists', '*Social Media']",PMC9384058,['NOTNLM'],"['anti-infective agents', 'communicable diseases', 'communication', 'drug information', 'social media']",2022/05/15 06:00,2022/05/18 06:00,['2022/05/14 21:12'],"['2021/12/09 00:00 [received]', '2022/05/14 21:12 [entrez]', '2022/05/15 06:00 [pubmed]', '2022/05/18 06:00 [medline]']","['6585965 [pii]', 'ciac081 [pii]', '10.1093/cid/ciac081 [doi]']",ppublish,Clin Infect Dis. 2022 May 15;74(Suppl_3):e23-e33. doi: 10.1093/cid/ciac081.,,"['ORCID: 0000-0002-1094-043X', 'ORCID: 0000-0002-4161-9577']",,,,,,,,,,,,,,,
8170896,NLM,MEDLINE,19940527,20190501,0032-5473 (Print) 1469-0756 (Electronic) 0032-5473 (Linking),70,820,1994 Feb,Infectious diseases.,74-85,,,,"['Welsby, P D']",['Welsby PD'],"['Department of Infectious Diseases, City Hospital, Edinburgh, UK.']",['eng'],"['Journal Article', 'Review']",,England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['AIDS-Related Opportunistic Infections', 'Antibodies, Monoclonal/therapeutic use', '*Communicable Diseases/microbiology/parasitology/therapy', 'Gastroenteritis/drug therapy', 'Health Personnel', 'Hepatitis A/prevention & control', 'Hepatitis A Virus, Human/immunology', 'Hepatitis B/transmission', 'Humans', 'Malaria/prevention & control', 'Meningitis, Bacterial', 'Tuberculosis, Multidrug-Resistant/therapy', 'Viral Vaccines']",PMC2397644,,,1994/02/01 00:00,1994/02/01 00:01,['1994/02/01 00:00'],"['1994/02/01 00:00 [pubmed]', '1994/02/01 00:01 [medline]', '1994/02/01 00:00 [entrez]']",['10.1136/pgmj.70.820.74 [doi]'],ppublish,Postgrad Med J. 1994 Feb;70(820):74-85. doi: 10.1136/pgmj.70.820.74.,,,"['0 (Antibodies, Monoclonal)', '0 (Viral Vaccines)']",,,,,,,,,,,,,,
15019592,NLM,MEDLINE,20040715,20101118,1567-1348 (Print) 1567-1348 (Linking),4,1,2004 Mar,Evolution and immunology of infectious diseases: what's new? An E-debate.,69-75,,,,"['Andre, Jean-Baptiste', 'Gupta, Sunetra', 'Frank, Steven', 'Tibayrenc, Michel']","['Andre JB', 'Gupta S', 'Frank S', 'Tibayrenc M']","['Laboratoire Genome, Populations, Interactions, Adaptation UMR 5171, USTL, Place Eugene Bataillon, 34095 Montpellier Cedex 5, France.']",['eng'],['Journal Article'],,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Animals', '*Biological Evolution', '*Communicable Diseases/immunology/physiopathology', 'Host-Parasite Interactions', 'Humans', 'Immune System/*physiology', 'Parasites/*physiology']",,,,2004/03/17 05:00,2004/07/16 05:00,['2004/03/17 05:00'],"['2004/03/17 05:00 [pubmed]', '2004/07/16 05:00 [medline]', '2004/03/17 05:00 [entrez]']","['S1567134803001291 [pii]', '10.1016/j.meegid.2003.12.002 [doi]']",ppublish,Infect Genet Evol. 2004 Mar;4(1):69-75. doi: 10.1016/j.meegid.2003.12.002.,,,,,,,,,,,,,,,,,
506318,NLM,MEDLINE,19800119,20041117,0044-2178 (Print) 0044-2178 (Linking),73,13-14,1979 Jul 15,[Etiology and incidence of introduced infectious diseases].,669-73,,,,"['Holzer, E', 'Steinruck, M', 'Padelt, H']","['Holzer E', 'Steinruck M', 'Padelt H']",,['ger'],['Journal Article'],,Germany,Z Arztl Fortbild (Jena),Zeitschrift fur arztliche Fortbildung,0414004,IM,"['Amebiasis/etiology', 'Bacterial Infections/etiology', 'Communicable Diseases/*epidemiology/etiology', 'Germany, East', 'Humans', 'Malaria/etiology', 'Mycoses/etiology', 'Travel', 'Tropical Climate', 'Virus Diseases/etiology']",,,,1979/07/15 00:00,1979/07/15 00:01,['1979/07/15 00:00'],"['1979/07/15 00:00 [pubmed]', '1979/07/15 00:01 [medline]', '1979/07/15 00:00 [entrez]']",,ppublish,Z Arztl Fortbild (Jena). 1979 Jul 15;73(13-14):669-73.,,,,,,,,,Atiologie und Haufigkeit eingeschleppter Infektionskrankheiten.,,,,,,,,
37818307,NLM,MEDLINE,20231102,20231102,2296-2565 (Electronic) 2296-2565 (Linking),11,,2023,Study on the regional risk classification method for the prevention and control of emerging infectious diseases based on directed graph theory.,1211291,10.3389/fpubh.2023.1211291 [doi] 1211291,"BACKGROUND: Emerging infectious diseases are a class of diseases that are spreading rapidly and are highly contagious. It seriously affects social stability and poses a significant threat to human health, requiring urgent measures to deal with them. Its outbreak will very easily lead to the large-scale spread of the virus, causing social problems such as work stoppages and traffic control, thereby causing social panic and psychological unrest, affecting human activities and social stability, and even endangering lives. It is essential to prevent and control the spread of infectious diseases effectively. PURPOSE: We aim to propose an effective method to classify the risk level of a new epidemic region by using graph theory and risk classification methods to provide a theoretical reference for the comprehensive evaluation and determination of epidemic prevention and control, as well as risk level classification. METHODS: Using the graph theory method, we first define the network structure of social groups and construct the risk transmission network of the new epidemic region. Then, combined with the risk classification method, the classification of high, medium, and low risk levels of the new epidemic region is discussed from two cases with common and looped graph nodes, respectively. Finally, the reasonableness of the classification method is verified by simulation data. RESULTS: The directed weighted scale-free network can better describe the transmission law of an epidemic. Moreover, the proposed method of classifying the risk level of a region by using the correlation function between two regions and the risk value of the regional nodes can effectively evaluate the risk level of different regions in the new epidemic region. The experiments show that the number of medium and high risk nodes shows no increasing trend. The number of high-risk regions is relatively small compared to medium-risk regions, and the number of low-risk regions is the largest. CONCLUSIONS: It is necessary to distinguish scientifically between the risk level of the epidemic area and the neighboring regions so that the constructed social network model of the epidemic region's spread risk can better describe the spread of the epidemic risk in the social network relations.","['Copyright (c) 2023 Liu, Wang and Zhang.']","['Liu, Yong', 'Wang, Xiao', 'Zhang, Chongqi']","['Liu Y', 'Wang X', 'Zhang C']","[""School of Science, Xi'an University of Architecture and Technology, Xi'an, China."", ""School of Science, Xi'an University of Architecture and Technology, Xi'an, China."", ""School of Science, Xi'an University of Architecture and Technology, Xi'an, China."", 'School of Economics and Statistics, Guangzhou University, Guangzhou, China.']",['eng'],['Journal Article'],20230925,Switzerland,Front Public Health,Frontiers in public health,101616579,IM,"['Humans', '*Communicable Diseases, Emerging/epidemiology/prevention & control', 'Disease Outbreaks/prevention & control', '*Communicable Diseases/epidemiology', '*Epidemics', 'Computer Simulation']",PMC10561095,['NOTNLM'],"['emerging infectious diseases', 'epidemic', 'grading and zoning', 'graph theory', 'scale-free network']",2023/10/11 06:45,2023/11/02 12:46,['2023/10/11 03:56'],"['2023/05/17 00:00 [received]', '2023/09/05 00:00 [accepted]', '2023/11/02 12:46 [medline]', '2023/10/11 06:45 [pubmed]', '2023/10/11 03:56 [entrez]']",['10.3389/fpubh.2023.1211291 [doi]'],epublish,Front Public Health. 2023 Sep 25;11:1211291. doi: 10.3389/fpubh.2023.1211291. eCollection 2023.,"['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",,,,,,,,,,,,,,,,
11186292,NLM,MEDLINE,20010531,20161020,0869-6047 (Print) 0869-6047 (Linking),,11,2000,[Significance of social factors in man-microorganism interaction. Role of public health care in prevention and treatment of infectious diseases].,7-11,,,,"['Shevchenko, Iu L']",['Shevchenko IuL'],,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Vestn Ross Akad Med Nauk,Vestnik Rossiiskoi akademii meditsinskikh nauk,9215641,IM,"['Communicable Diseases/epidemiology/*therapy', 'Disease Outbreaks/*prevention & control', 'Global Health', '*Health Services', 'Humans', 'Socioeconomic Factors']",,,,2001/02/24 12:00,2001/06/02 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/06/02 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Vestn Ross Akad Med Nauk. 2000;(11):7-11.,,,,,,0,,,Znachenie sotsial'nykh faktorov vo vzaimodeistvii cheloveka i mikroorganizmov. Rol' zdravookhraneniia v profilaktike i lechenii infektsionnykh boleznei.,,,,,,,,
9762643,NLM,MEDLINE,19981209,20170923,1099-3460 (Print) 1468-2869 (Electronic) 1099-3460 (Linking),75,3,1998 Sep,The future of infectious diseases.,463-70,,,,"['Lederberg, J']",['Lederberg J'],"['Rockefeller University, New York, NY 10021-6399, USA.']",['eng'],['Journal Article'],,United States,J Urban Health,Journal of urban health : bulletin of the New York Academy of Medicine,9809909,IM,"['Anti-Bacterial Agents/therapeutic use', 'Antiviral Agents/therapeutic use', 'Bacterial Infections/drug therapy/transmission', 'Communicable Disease Control', '*Communicable Diseases/epidemiology/microbiology/transmission', 'DNA/genetics', '*Forecasting', 'Humans', 'Mutation/genetics', 'Public Health', 'Virus Diseases/drug therapy']",PMC5587423,,,1998/10/08 00:00,1998/10/08 00:01,['1998/10/08 00:00'],"['1998/10/08 00:00 [pubmed]', '1998/10/08 00:01 [medline]', '1998/10/08 00:00 [entrez]']","['BF02427684 [pii]', '10.1007/BF02427684 [doi]']",ppublish,J Urban Health. 1998 Sep;75(3):463-70. doi: 10.1007/BF02427684.,,,"['0 (Anti-Bacterial Agents)', '0 (Antiviral Agents)', '9007-49-2 (DNA)']",,,,,,,,,,,,,,
36707203,NLM,MEDLINE,20230131,20230202,1876-1631 (Electronic) 1876-1623 (Linking),133,,2023,Exploring the role of secretory proteins in the human infectious diseases diagnosis and therapeutics.,231-269,S1876-1623(22)00069-4 [pii] 10.1016/bs.apcsb.2022.08.002 [doi],"Secretory proteins are playing important role during the host-pathogen interaction to develop the infection or protection into the cell. Pathogens developing infectious disease to human being are taken up by host macrophages or number of immune cells, play an important role in physiological, developmental and immunological function. At the same time, infectious agents are also secreting various proteins to neutralize the resistance caused by host cells and also helping the pathogens to develop the infection. Secretory proteins (secretome) are only developed at the time of host-pathogen interaction, therefore they become very important to develop the targeted and potential therapeutic strategies. Pathogen specific secretory proteins released during interaction with host cell provide opportunity to develop point of care and rapid diagnostic kits. Proteins secreted by pathogens at the time of interaction with host cell have also been found as immunogenic in nature and numbers of vaccines have been developed to control the spread of human infectious diseases. This chapter highlights the importance of secretory proteins in the development of diagnostic and therapeutic strategies to fight against human infectious diseases.",['Copyright (c) 2023 Elsevier Inc. All rights reserved.'],"['Kalita, Elora', 'Panda, Mamta', 'Rao, Abhishek', 'Prajapati, Vijay Kumar']","['Kalita E', 'Panda M', 'Rao A', 'Prajapati VK']","['Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.', 'Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.', 'Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.', 'Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India. Electronic address: vkprajapati@curaj.ac.in.']",['eng'],['Journal Article'],20221205,Netherlands,Adv Protein Chem Struct Biol,Advances in protein chemistry and structural biology,101497281,IM,"['Humans', 'Host-Pathogen Interactions', 'Macrophages', '*Vaccines', '*Communicable Diseases/diagnosis/therapy']",,['NOTNLM'],"['Diagnosis', 'Host-pathogen interaction', 'Secretory proteins', 'Therapeutics', 'Viral infection']",2023/01/28 06:00,2023/02/01 06:00,['2023/01/27 20:57'],"['2023/01/27 20:57 [entrez]', '2023/01/28 06:00 [pubmed]', '2023/02/01 06:00 [medline]']","['S1876-1623(22)00069-4 [pii]', '10.1016/bs.apcsb.2022.08.002 [doi]']",ppublish,Adv Protein Chem Struct Biol. 2023;133:231-269. doi: 10.1016/bs.apcsb.2022.08.002. Epub 2022 Dec 5.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
19486072,NLM,MEDLINE,20091105,20211020,1469-0691 (Electronic) 1198-743X (Print) 1198-743X (Linking),15,8,2009 Aug,Facing the threat of highly infectious diseases in Europe: the need for a networking approach.,706-10,10.1111/j.1469-0691.2009.02876.x [doi],"In recent years emerging and re-emerging infections, as well as the risk of bioterrorist events, have attracted increasing attention from health authorities because of the epidemic potential that renders some of them a real public health challenge. These highly infectious diseases (HIDs) are occurring more and more frequently in Europe, and despite the many initiatives in place to face them, many unsolved problems remain, and coordinated efforts for dealing with HIDs appear mandatory. Whereas uncoordinated measures would lead to only partial and poor responses to these emerging threats, networking represents a valuable approach to these diseases, in order to: (i) ensure a rapid and effective response; (ii) stimulate complementarity and prevent duplication; (iii) promote international cooperation, exchange of experience, good practice and protocols; and (iv) support the less prepared countries in the European Community.",,"['Ippolito, G', 'Fusco, F M', 'Di Caro, A', 'Nisii, C', 'Pompa, M G', 'Thinus, G', 'Pletschette, M', 'Capobianchi, M R']","['Ippolito G', 'Fusco FM', 'Di Caro A', 'Nisii C', 'Pompa MG', 'Thinus G', 'Pletschette M', 'Capobianchi MR']","['National Institute for Infectious Diseases L. Spallanzani, 00149, Rome, Italy - WHO Collaborating Centre for clinical care, diagnosis, response and training on Highly Infectious Diseases. ippolito@inmi.it']",['eng'],"['Journal Article', 'Review']",20090528,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/*epidemiology', 'Communicable Diseases, Emerging/*epidemiology', 'European Union', 'Humans', 'Information Services', '*International Cooperation']",PMC7128809,,,2009/06/03 09:00,2009/11/06 06:00,['2009/06/03 09:00'],"['2009/06/03 09:00 [entrez]', '2009/06/03 09:00 [pubmed]', '2009/11/06 06:00 [medline]']","['S1198-743X(14)60455-9 [pii]', '10.1111/j.1469-0691.2009.02876.x [doi]']",ppublish,Clin Microbiol Infect. 2009 Aug;15(8):706-10. doi: 10.1111/j.1469-0691.2009.02876.x. Epub 2009 May 28.,,,,,,,,,,,,,,,,,
8399883,NLM,MEDLINE,19931028,20190512,1058-4838 (Print) 1058-4838 (Linking),17,2,1993 Aug,Infectious diseases at the Boston City Hospital: the first 60 years.,276-82,,"During the 60 years that followed the opening of the Boston City Hospital in 1864, Boston experienced severe epidemics of diphtheria, scarlatina, and measles. The South Department was created to isolate patients, primarily children, who suffered from those diseases. Smallpox was a serious public health problem, and typhoid fever, pneumonia, and tuberculosis continued to cause high mortality. Diagnoses became more accurate and nursing care improved, although for most diseases treatment was not markedly better. The influenza epidemic in 1918 demonstrated how little could be done for patients. Nonetheless, the reputation of the hospital grew, and it gained increased acceptance in the community as medicine became more scientific.",,"['Kass, A M']",['Kass AM'],"['Department of Social Medicine, Harvard Medical School, Boston, Massachusetts 02115.']",['eng'],"['Historical Article', 'Journal Article']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Boston', 'Communicable Diseases/*history/mortality/therapy', 'History, 19th Century', 'History, 20th Century', 'Hospitals, Municipal/*history', 'Humans']",,,,1993/08/01 00:00,1993/08/01 00:01,['1993/08/01 00:00'],"['1993/08/01 00:00 [pubmed]', '1993/08/01 00:01 [medline]', '1993/08/01 00:00 [entrez]']",['10.1093/clinids/17.2.276 [doi]'],ppublish,Clin Infect Dis. 1993 Aug;17(2):276-82. doi: 10.1093/clinids/17.2.276.,,,,,,,,,,,,,,,,,
35005035,NLM,MEDLINE,20220324,20220324,2314-7156 (Electronic) 2314-8861 (Print) 2314-7156 (Linking),2021,,2021,"New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020.",9767464,10.1155/2021/9767464 [doi] 9767464,,,"['Sautto, Giuseppe A', 'Diotti, Roberta A', 'Kahle, Kristen M']","['Sautto GA', 'Diotti RA', 'Kahle KM']","['Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.', 'Laboratory of Medical Microbiology and Virology at ""Vita-Salute"" San Raffaele University, 20132 Milan, Italy.', 'Pomona Ricerca S.r.l., Turin, Italy.', 'Spark Therapeutics, Inc., Philadelphia, PA, USA.']",['eng'],"['Editorial', 'Introductory Journal Article']",20211230,Egypt,J Immunol Res,Journal of immunology research,101627166,IM,"['Animals', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/*immunology/therapy', 'Enzyme-Linked Immunosorbent Assay', 'Humans', 'Immunotherapy/*trends', 'Plant Defense Against Herbivory']",PMC8739921,,,2022/01/11 06:00,2022/03/25 06:00,['2022/01/10 09:28'],"['2021/12/06 00:00 [received]', '2021/12/06 00:00 [accepted]', '2022/01/10 09:28 [entrez]', '2022/01/11 06:00 [pubmed]', '2022/03/25 06:00 [medline]']",['10.1155/2021/9767464 [doi]'],epublish,J Immunol Res. 2021 Dec 30;2021:9767464. doi: 10.1155/2021/9767464. eCollection 2021.,"['The editors declare that they have no conflicts of interest regarding the', 'publication of this special issue.']","['ORCID: 0000-0002-0273-2235', 'ORCID: 0000-0002-7853-3224']",,,,,,,,,,,,,,,
14454334,NLM,MEDLINE,19981101,20191026,0022-9717 (Print) 0022-9717 (Linking),11,,1962 Mar,Steroid therapy in serious infectious diseases.,1-10,,,,"['KATSU, M', 'SAEKI, T', 'ABE, T']","['KATSU M', 'SAEKI T', 'ABE T']",,['eng'],['Journal Article'],,Japan,Keio J Med,The Keio journal of medicine,0376354,OM,"['Adrenal Cortex Hormones/*therapy', 'Communicable Diseases/*therapy']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapy', '*COMMUNICABLE DISEASES/therapy']",1962/03/01 00:00,1962/03/01 00:01,['1962/03/01 00:00'],"['1962/03/01 00:00 [pubmed]', '1962/03/01 00:01 [medline]', '1962/03/01 00:00 [entrez]']",['10.2302/kjm.11.1 [doi]'],ppublish,Keio J Med. 1962 Mar;11:1-10. doi: 10.2302/kjm.11.1.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,,,,,,
10230264,NLM,MEDLINE,19990602,20041117,0031-0808 (Print) 0031-0808 (Linking),41,1,1999 Mar,The major epidemic infections: a gift from the Old World to the New?,78-84,,"With the discovery of the New World, the Europeans flocked to America and with them spread infectious diseases. During long sea voyages the agents of these diseases increased their diffusion capacity in a suitable environment. Lack of hygiene, fatigue and privations, a diet without vitamins and many persons kept in confined spaces were the essential features of this environment. Sick persons, whose health conditions worsened during the journey to the New World, carried the germs of infectious diseases. The first disease to appear in the New World was smallpox described in 1518 in Hispaniola. From there the disease moved rapidly to Mexico in 1520, exterminating most of the Aztecs, Guatemala and to the territories of Incas from 1525-26, killing most of them and the King himself. The second disease, influenza, appeared in La Isabela, a few years later, causing a heavy epidemic between 1558 and 1559. Other diseases followed such as yellow fever and malaria. So Europeans and these invisible and mortal agents caused enormous destruction of American populations. In fact historians have estimated that beginning from early 1500, in only 50 years the population of Peru and Mexico fell from 60 to 10 million; in the latter country, in one century, the populations fell from an initial 10 million to only 2 million.",,"['Sessa, R', 'Palagiano, C', 'Scifoni, M G', 'di Pietro, M', 'Del Piano, M']","['Sessa R', 'Palagiano C', 'Scifoni MG', 'di Pietro M', 'Del Piano M']","['Interdivisional Centre for Social Diseases, Faculty of Medicine and Surgery, La Sapienza University, Rome, Italy.']",['eng'],"['Historical Article', 'Journal Article']",,Italy,Panminerva Med,Panminerva medica,0421110,IM,"['Americas', 'Communicable Diseases/epidemiology/*history/transmission', 'Disease Outbreaks/*history', 'Europe', 'History, 15th Century', 'History, 16th Century', 'History, 17th Century', 'Humans', 'Indians, North American/history', 'Population Dynamics']",,,,1999/05/07 00:00,1999/05/07 00:01,['1999/05/07 00:00'],"['1999/05/07 00:00 [pubmed]', '1999/05/07 00:01 [medline]', '1999/05/07 00:00 [entrez]']",,ppublish,Panminerva Med. 1999 Mar;41(1):78-84.,,,,,,,,,,,,,,,,,
18406975,NLM,MEDLINE,20080701,20211020,0733-8627 (Print) 1558-0539 (Electronic) 0733-8627 (Linking),26,2,2008 May,Rapidly fatal infections.,"259-79, vii",10.1016/j.emc.2008.01.003 [doi],"Emergency physicians are trained to separate ""sick"" from ""not sick"" patients during their training. Nevertheless, every emergency physician will face situations in which early intervention is critical to their patient's outcome. Infectious diseases are responsible for many of these potentially poor outcomes. This article discusses early identification and treatment for several rapidly fatal infections, including two newly identified travel-related illnesses.",,"['Hans, Diana', 'Kelly, Erin', 'Wilhelmson, Krista', 'Katz, Eric D']","['Hans D', 'Kelly E', 'Wilhelmson K', 'Katz ED']","['Department of Emergency Medicine, Maricopa Medical Center, 2601 E. Roosevelt, Phoenix, AZ 85008, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Emerg Med Clin North Am,Emergency medicine clinics of North America,8219565,IM,"['Acute Disease', '*Communicable Diseases/diagnosis/drug therapy/physiopathology', 'Community-Acquired Infections/drug therapy/physiopathology', 'Disease Progression', '*Emergency Service, Hospital', 'Humans', 'Practice Guidelines as Topic']",PMC7132742,,,2008/04/15 09:00,2008/07/02 09:00,['2008/04/15 09:00'],"['2008/04/15 09:00 [pubmed]', '2008/07/02 09:00 [medline]', '2008/04/15 09:00 [entrez]']","['S0733-8627(08)00004-7 [pii]', '10.1016/j.emc.2008.01.003 [doi]']",ppublish,"Emerg Med Clin North Am. 2008 May;26(2):259-79, vii. doi: 10.1016/j.emc.2008.01.003.",,,,,,,,,,,,,,,,,
17600748,NLM,MEDLINE,20080110,20220409,1201-9712 (Print) 1201-9712 (Linking),11,6,2007 Nov,Association of hemochromatosis with infectious diseases: expanding spectrum.,482-7,,"Withholding iron from potential pathogens is a host defense strategy. There is evidence that iron overload per se compromises the ability of phagocytes to kill microorganisms. Several hypotheses exist to explain the association of hemochromatosis with infection. A combination of mechanisms likely contributes to the increase in susceptibility to infection in these patients. A review of the current literature delineating various pathogens to which patients with hemochromatosis are potentially susceptible, and recent advances in the understanding of the association of hemochromatosis with infection, are discussed.",,"['Khan, Fida A', 'Fisher, Melanie A', 'Khakoo, Rashida A']","['Khan FA', 'Fisher MA', 'Khakoo RA']","['Department of Medicine, Section of Infectious Diseases, Ohio Valley Medical Center, 2000 Eoff Street, Wheeling, WV 26003, USA. fkhan@ovrh.org']",['eng'],"['Journal Article', 'Review']",20070627,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,IM,"['Anti-Bacterial Agents/therapeutic use', 'Communicable Diseases/*complications/drug therapy/microbiology', 'Hemochromatosis/*complications/metabolism', 'Humans', 'Iron']",,,,2007/06/30 09:00,2008/01/11 09:00,['2007/06/30 09:00'],"['2006/12/21 00:00 [received]', '2007/02/26 00:00 [revised]', '2007/04/05 00:00 [accepted]', '2007/06/30 09:00 [pubmed]', '2008/01/11 09:00 [medline]', '2007/06/30 09:00 [entrez]']","['S1201-9712(07)00081-1 [pii]', '10.1016/j.ijid.2007.04.007 [doi]']",ppublish,Int J Infect Dis. 2007 Nov;11(6):482-7. doi: 10.1016/j.ijid.2007.04.007. Epub 2007 Jun 27.,,,"['0 (Anti-Bacterial Agents)', 'E1UOL152H7 (Iron)']",,,72,,,,,,,,,,,
12387921,NLM,MEDLINE,20030117,20191025,0025-5564 (Print) 0025-5564 (Linking),180,,2002 Nov-Dec,Effects of quarantine in six endemic models for infectious diseases.,141-60,,"Thresholds, equilibria, and their stability are found for SIQS and SIQR epidemiology models with three forms of the incidence. For most of these models, the endemic equilibrium is asymptotically stable, but for the SIQR model with the quarantine-adjusted incidence, the endemic equilibrium is an unstable spiral for some parameter values and periodic solutions arise by Hopf bifurcation. The Hopf bifurcation surface and stable periodic solutions are found numerically.",,"['Hethcote, Herbert', 'Zhien, Ma', 'Shengbing, Liao']","['Hethcote H', 'Zhien M', 'Shengbing L']","['Department of Mathematics, University of Iowa, 14 MacLean Hall, Iowa City, IA 52242-1419, USA. herbert-hethcote@uiowa.edu']",['eng'],['Journal Article'],,United States,Math Biosci,Mathematical biosciences,0103146,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/transmission', '*Disease Transmission, Infectious', '*Endemic Diseases', 'Humans', 'Kinetics', '*Models, Theoretical', 'Numerical Analysis, Computer-Assisted', '*Quarantine']",,,,2002/10/22 04:00,2003/01/18 04:00,['2002/10/22 04:00'],"['2002/10/22 04:00 [pubmed]', '2003/01/18 04:00 [medline]', '2002/10/22 04:00 [entrez]']","['S0025556402001116 [pii]', '10.1016/s0025-5564(02)00111-6 [doi]']",ppublish,Math Biosci. 2002 Nov-Dec;180:141-60. doi: 10.1016/s0025-5564(02)00111-6.,,,,,,,,,,,,,,,,,
13785070,NLM,MEDLINE,19981101,20181202,0069-2328 (Print) 0069-2328 (Linking),16,,1961 Apr,[Foreign bodies in the respiratory tract simulating acute infectious diseases].,346-8,,,,"['WIEDERMANNOVA, D', 'KLUSKA, V', 'HONSIG, K']","['WIEDERMANNOVA D', 'KLUSKA V', 'HONSIG K']",,['cze'],['Journal Article'],,Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,OM,"['Communicable Diseases/*diagnosis', '*Foreign Bodies', '*Respiratory System', '*Skin Tests']",,['NLM'],"['*COMMUNICABLE DISEASES/diagnosis', '*RESPIRATORY SYSTEM/foreign bodies']",1961/04/01 00:00,1961/04/01 00:01,['1961/04/01 00:00'],"['1961/04/01 00:00 [pubmed]', '1961/04/01 00:01 [medline]', '1961/04/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1961 Apr;16:346-8.,,,,,,,,,,,,,,,,,
30900327,NLM,MEDLINE,20200930,20200930,1399-0012 (Electronic) 0902-0063 (Linking),33,9,2019 Sep,Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.,e13548,10.1111/ctr.13548 [doi],"This updated section of the guideline from the Infectious Diseases Community of Practice of the American Society of Transplantation reviews the screening of donor and candidate prior to solid organ transplantation. Screening of donor and candidate is vital for optimizing post-transplant outcomes. Risk assessment based on detailed history and appropriate diagnostic evaluation is essential. Serologic screening for certain viral infections is important and aids in immunization counseling and risk mitigation of recipients. In addition to serology, nucleic acid testing for hepatitis B, hepatitis C and human immunodeficiency virus has been required for deceased and living donors. Certain endemic exposure may warrant additional evaluation beyond recommended standard testing. Diagnosed infection in the donor or recipient warrants treatment as well as additional testing and/or prophylaxis to mitigate risk for post-transplant complications. Certain infections in the immediate pre-transplant period may warrant delay of transplantation.",['(c) 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],"['Malinis, Maricar', 'Boucher, Helen W']","['Malinis M', 'Boucher HW']","['Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.', 'Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts.']",['eng'],['Journal Article'],20190429,Denmark,Clin Transplant,Clinical transplantation,8710240,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*diagnosis/*drug therapy/etiology', 'Donor Selection/*standards', 'Humans', 'Organ Transplantation/*adverse effects', 'Practice Guidelines as Topic/*standards', 'Societies, Medical', 'Tissue Donors/*supply & distribution', 'Transplant Recipients']",,['NOTNLM'],"['candidate evaluation', 'donor evaluation', 'donor-derived infections', 'infection']",2019/03/23 06:00,2020/10/02 06:00,['2019/03/23 06:00'],"['2019/03/05 00:00 [received]', '2019/03/15 00:00 [accepted]', '2019/03/23 06:00 [pubmed]', '2020/10/02 06:00 [medline]', '2019/03/23 06:00 [entrez]']",['10.1111/ctr.13548 [doi]'],ppublish,Clin Transplant. 2019 Sep;33(9):e13548. doi: 10.1111/ctr.13548. Epub 2019 Apr 29.,,,['0 (Anti-Infective Agents)'],,,,,,,,['AST Infectious Diseases Community of Practice'],,,,,,
9553346,NLM,MEDLINE,19980605,20190816,0869-2084 (Print) 0869-2084 (Linking),,2,1998 Feb,[Polymerase chain reaction in diagnosis and treatment control of infectious diseases].,35-9,,,,"['Gintsburg, A L', 'Romanova, Iu M']","['Gintsburg AL', 'Romanova IuM']",,['rus'],"['Journal Article', 'Review']",,Russia (Federation),Klin Lab Diagn,Klinicheskaia laboratornaia diagnostika,9432021,IM,"['Animals', 'Bacteria/isolation & purification', 'Communicable Diseases/*diagnosis/drug therapy', 'Diagnostic Techniques and Procedures', 'Humans', 'Polymerase Chain Reaction/*methods', 'Viruses/isolation & purification']",,,,1998/04/29 00:00,1998/04/29 00:01,['1998/04/29 00:00'],"['1998/04/29 00:00 [pubmed]', '1998/04/29 00:01 [medline]', '1998/04/29 00:00 [entrez]']",,ppublish,Klin Lab Diagn. 1998 Feb;(2):35-9.,,,,,,13,,,Polimeraznaia tsepnaia reaktsiia v diagnostike i kontrole lecheniia unfektsionnykh zabolevanii.,,,,,,,,
13265168,NLM,MEDLINE,20030501,20181201,0025-8458 (Print) 0025-8458 (Linking),50,37,1955 Sep 16,[Dietetics. XII. Diet therapy in infectious diseases].,1564-6,,,,"['BOLLER, R']",['BOLLER R'],,['ger'],['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,OM,"['Communicable Diseases/*therapy', '*Diet', '*Dietetics', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*DIETS']",1955/09/16 00:00,1955/09/16 00:01,['1955/09/16 00:00'],"['1955/09/16 00:00 [pubmed]', '1955/09/16 00:01 [medline]', '1955/09/16 00:00 [entrez]']",,ppublish,Med Klin. 1955 Sep 16;50(37):1564-6.,,,,,,,,,Praktikum der Diat. XII. Zur diatetischen Therapie der Infektionskrankheiten.,,,['CLML: 5629:17099'],,,,,
17519036,NLM,MEDLINE,20070801,20230419,1471-2334 (Electronic) 1471-2334 (Linking),7,,2007 May 22,Pediatric malignancies presenting as a possible infectious disease.,44,,"BACKGROUND: The clinical, laboratory, and radiological features of malignancy can overlap with those of infection. The purpose of this study was to determine the findings in children who were initially thought to have an infectious disease but ultimately proved to have a malignancy. METHODS: The database of patients diagnosed with a malignancy in the Northern Alberta Children's Cancer Program (NACCP) January 1, 1993 to December 31, 2003 was merged with the database of inpatients referred to the infectious diseases service at the Stollery Children's Hospital and charts were reviewed on all patients referred to the infectious diseases consult service prior to the diagnosis of malignancy. RESULTS: An infectious diseases consultation for diagnosis was requested in 21 of 561 patients prior to the confirmation of malignancy, and 3 of these 21 patients had both infection and malignancy (leukemia (N = 13), lymphoma (N = 3), rhabdomyosarcoma (N = 1), Langerhan's cell histiocytosis (N = 1), fibrous histicocytosis (N = 1), ependymoma (N = 1), and neuroblastoma (N = 1). The most common reason for infectious diseases consultation was suspected muskuloskeletal infection (N = 9). A palpable or radiographically enlarged spleen was noted in 11 patients (52%). All but 2 patients had abnormal hematologic parameters while an elevated lactate dehydrogenase (LDH) occurred in 10 patients (48%). Delay of diagnosis because of investigation or therapy for an infectious disease occurred in only 2 patients. CONCLUSION: It is not common for treatment of pediatric malignancies to be delayed because infection is thought to be the primary diagnosis. However, pediatric infectious diseases physicians should consider malignancy in the differential diagnosis when they see patients with fever and bone pain, unexplained splenomegaly or abnormal complete blood cell counts. Other clues may include hepatomegaly or elevated LDH.",,"['Forgie, Sarah E', 'Robinson, Joan L']","['Forgie SE', 'Robinson JL']","[""Department of Pediatrics and Stollery Children's Hospital, Edmonton, Alberta, Canada. sarahforgie@cha.ab.ca""]",['eng'],['Journal Article'],20070522,England,BMC Infect Dis,BMC infectious diseases,100968551,IM,"['Adolescent', 'Alberta', 'Child', 'Child, Preschool', 'Communicable Diseases/complications/*diagnosis/*physiopathology', 'Databases, Factual', 'Diagnosis, Differential', 'Diagnostic Errors', 'Female', 'Fever', 'Humans', 'Infant', 'Male', 'Musculoskeletal Diseases/complications/diagnosis/physiopathology', 'Neoplasms/complications/*diagnosis/*physiopathology', 'Pain']",PMC1885437,,,2007/05/24 09:00,2007/08/02 09:00,['2007/05/24 09:00'],"['2006/08/01 00:00 [received]', '2007/05/22 00:00 [accepted]', '2007/05/24 09:00 [pubmed]', '2007/08/02 09:00 [medline]', '2007/05/24 09:00 [entrez]']","['1471-2334-7-44 [pii]', '10.1186/1471-2334-7-44 [doi]']",epublish,BMC Infect Dis. 2007 May 22;7:44. doi: 10.1186/1471-2334-7-44.,,,,,,,,,,,,,,,,,
11153234,NLM,MEDLINE,20010125,20190915,0014-2565 (Print) 0014-2565 (Linking),200,10,2000 Oct,[Travel to the tropics and infectious diseases].,531-2,,,,"['Lopez-Velez, R']",['Lopez-Velez R'],,['spa'],['Editorial'],,Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Cause of Death', 'Communicable Diseases/epidemiology/*transmission', 'Greenhouse Effect', 'Humans', 'Incidence', 'Risk Factors', 'Time Factors', '*Travel', 'Tropical Medicine']",,,,2001/01/12 11:00,2001/02/28 10:01,['2001/01/12 11:00'],"['2001/01/12 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2001/01/12 11:00 [entrez]']","['S0014-2565(00)70714-4 [pii]', '10.1016/s0014-2565(00)70714-4 [doi]']",ppublish,Rev Clin Esp. 2000 Oct;200(10):531-2. doi: 10.1016/s0014-2565(00)70714-4.,,,,,,,,,Viajes al tropico y enfermedades infecciosas.,,,,,,,,
15537851,NLM,MEDLINE,20050331,20181113,0032-5473 (Print) 1469-0756 (Electronic) 0032-5473 (Linking),80,949,2004 Nov,Avoiding laboratory pitfalls in infectious diseases.,660-2,,"In today's medical care environment, clinicians are challenged to order clinically relevant, cost effective laboratory tests and antibiotic therapy. Together, physicians and laboratories must have guidelines and strategies that can provide quality patient care, while minimising costs and preventing further emergence of antimicrobial drug resistance. Five clinical vignettes that demonstrate these principles are presented.",,"['Lo, T S', 'Smego, R A']","['Lo TS', 'Smego RA']","['Department of Medicine, University of North Dakota, School of Medicine and Health Sciences, 1919 Elm Street, Fargo, ND 58102, USA. tshienlo@medicine.nodak.edu']",['eng'],"['Case Reports', 'Journal Article', 'Review']",,England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Aged', 'Aged, 80 and over', 'Clinical Laboratory Techniques/standards', 'Communicable Diseases/*diagnosis/drug therapy/microbiology', 'Female', 'Health Services Misuse', 'Humans', 'Male', 'Middle Aged']",PMC1743141,,,2004/11/13 09:00,2005/04/01 09:00,['2004/11/13 09:00'],"['2004/11/13 09:00 [pubmed]', '2005/04/01 09:00 [medline]', '2004/11/13 09:00 [entrez]']","['80/949/660 [pii]', '10.1136/pgmj.2004.021170 [doi]']",ppublish,Postgrad Med J. 2004 Nov;80(949):660-2. doi: 10.1136/pgmj.2004.021170.,,,,,,,,,,,,,,,,,
13580419,NLM,MEDLINE,20000701,20181201,0370-9590 (Print) 0370-9590 (Linking),112,Suppl 8,1958 Jun 10,[Clinical diagnosis of infectious diseases; major infectious syndromes].,210-4 passim contd,,,,"['INK, J']",['INK J'],,['spa'],['Journal Article'],,Argentina,Sem Med,La Semana medica,0404403,OM,"['Communicable Diseases/*diagnosis', 'Humans', '*Skin Tests', '*Syndrome']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1958/06/10 00:00,1958/06/10 00:01,['1958/06/10 00:00'],"['1958/06/10 00:00 [pubmed]', '1958/06/10 00:01 [medline]', '1958/06/10 00:00 [entrez]']",,ppublish,Sem Med. 1958 Jun 10;112(Suppl 8):210-4 passim contd.,,,,,,,,,El diagnostico clinico en las enfermedades infecciosas; los grandes sindromes infecciosos.,,,['CLML: 5935:9757:151'],,,,,
13264981,NLM,MEDLINE,20030501,20181201,0375-9342 (Print) 0375-9342 (Linking),9,6,1955 Jun,[Heart in infectious diseases].,214-8,,,,"['ATANACKOVIC, A', 'JOSIPOVIC, V']","['ATANACKOVIC A', 'JOSIPOVIC V']",,['und'],['Journal Article'],,Serbia,Med Glas,Medicinski glasnik,0400723,OM,"['Communicable Diseases/*pathology', '*Heart', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/pathology', '*HEART']",1955/06/01 00:00,1955/06/01 00:01,['1955/06/01 00:00'],"['1955/06/01 00:00 [pubmed]', '1955/06/01 00:01 [medline]', '1955/06/01 00:00 [entrez]']",,ppublish,Med Glas. 1955 Jun;9(6):214-8.,,,,,,,,,Srce kod infektivnih bolesti.,,,['CLML: 5629:16912'],,,,,
13010166,NLM,MEDLINE,20030501,20181201,0367-1038 (Print) 0367-1038 (Linking),59,10,1952 Oct,Neurological complications of some infectious diseases.,492-502,,,,"['GRIFFITH, G']",['GRIFFITH G'],,['eng'],['Journal Article'],,Scotland,Edinb Med J,Edinburgh medical journal,0007305,OM,"['Communicable Diseases/*complications', 'Humans', '*Nervous System Diseases']",PMC5293875,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*NERVOUS SYSTEM/diseases']",1952/10/01 00:00,1952/10/01 00:01,['1952/10/01 00:00'],"['1952/10/01 00:00 [pubmed]', '1952/10/01 00:01 [medline]', '1952/10/01 00:00 [entrez]']",,ppublish,Edinb Med J. 1952 Oct;59(10):492-502.,,,,,,,,,,,,['CLML: 5323:34888:131:369'],,,,,
13348479,NLM,MEDLINE,20030501,20181201,,34,3,1956 Aug,The use of adrenal steroids in infectious diseases.,73-5,,,,"['ALLISON, F Jr']",['ALLISON F Jr'],,['eng'],['Journal Article'],,United States,Miss Doct,The Mississippi doctor,18730470R,OM,"['*Adrenal Cortex', '*Adrenal Cortex Hormones', 'Communicable Diseases/*therapy', '*Steroids']",,['NLM'],"['*ADRENAL CORTEX/hormones', '*COMMUNICABLE DISEASES/therapy']",1956/08/01 00:00,1956/08/01 00:01,['1956/08/01 00:00'],"['1956/08/01 00:00 [pubmed]', '1956/08/01 00:01 [medline]', '1956/08/01 00:00 [entrez]']",,ppublish,Miss Doct. 1956 Aug;34(3):73-5.,,,"['0 (Adrenal Cortex Hormones)', '0 (Steroids)']",,,,,,,,,['CLML: 5630:57060'],,,,,
13599784,NLM,MEDLINE,20000701,20181201,0025-729X (Print) 0025-729X (Linking),45,15,1958 Oct 11,The seed and the soil: host susceptibility in infectious diseases.,477-82,,,,"['FENNER, F']",['FENNER F'],,['eng'],['Journal Article'],,Australia,Med J Aust,The Medical journal of Australia,0400714,OM,"['Communicable Diseases/*transmission', '*Disease Susceptibility', '*Disease Transmission, Infectious', '*Soil']",,['NLM'],['*COMMUNICABLE DISEASES/transmission'],1958/10/11 00:00,1958/10/11 00:01,['1958/10/11 00:00'],"['1958/10/11 00:00 [pubmed]', '1958/10/11 00:01 [medline]', '1958/10/11 00:00 [entrez]']",,ppublish,Med J Aust. 1958 Oct 11;45(15):477-82.,,,['0 (Soil)'],,,,,,,,,['CLML: 5935:29292:152'],,,,,
14690775,NLM,MEDLINE,20040405,20191108,1201-9712 (Print) 1201-9712 (Linking),8,1,2004 Jan,Infectious diseases in the 21st century: old challenges and new opportunities.,5-12,,"Infectious diseases are the confrontation of two worlds, the microbial world and the world of human physiology. Although these two worlds are as a whole governed by the same laws of nature, they show substantial differences: the microbiological world is 1000 times older, and was initiated by the development of the archaea, the 'living organisms of the extreme': its biomass and its diversity are immense - two to three billion species or 60% of the total biomass of the planet. The number of pathogens that adapted to man, however, is extremely limited - barely 1000. Thus, over billions of years, an evolution of the microbial world took place from 'early life', characterized by chemosynthesis, to the 'modern pathogens', and entailed a dramatic 'concentration' of life conditions and an adaptation towards a narrow range of requirements - those allowing survival in the human body. Within the last two centuries, these two slowly evolving systems, microbial life and human life, were profoundly modified in an unprecedented manner by a third player, human civilization, with its global impact on the environment through physical, chemical, societal, and climatic determinants. An appreciation of the evolution of infectious diseases in the 21st century and of the development of new diagnostic and therapeutic strategies therefore requires a full understanding of these three domains: human physiology, microbiology, and the environment. This review will put major emphasis on the environmental role of civilization on infectious diseases before considering new opportunities to combat them through novel and creative solutions.",,"['Waldvogel, Francis A']",['Waldvogel FA'],"['Medical Clinic 2, University Hospital, 1211 Geneva 14, Switzerland. francis.waldvogel@hcuge.ch']",['eng'],"['Journal Article', 'Review']",,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,IM,"['*Civilization', 'Communicable Diseases/*epidemiology/etiology', '*Ecosystem', '*Global Health', 'Humans']",,,,2003/12/24 05:00,2004/04/06 05:00,['2003/12/24 05:00'],"['2003/12/24 05:00 [pubmed]', '2004/04/06 05:00 [medline]', '2003/12/24 05:00 [entrez]']","['S1201971203000109 [pii]', '10.1016/j.ijid.2003.01.001 [doi]']",ppublish,Int J Infect Dis. 2004 Jan;8(1):5-12. doi: 10.1016/j.ijid.2003.01.001.,,,,,,29,,,,,,,,,,,
13339125,NLM,MEDLINE,20030501,20181201,,15,4,1956 Apr,Infectious diseases in Israel in 1955.,121-7,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['Communicable Diseases/*epidemiology', 'Humans', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1956/04/01 00:00,1956/04/01 00:01,['1956/04/01 00:00'],"['1956/04/01 00:00 [pubmed]', '1956/04/01 00:01 [medline]', '1956/04/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1956 Apr;15(4):121-7.,,,,,,,,,,,,['CLML: 5630:47667'],,,,,
13258155,NLM,MEDLINE,20030501,20181201,,14,6,1955 Jun,Infectious diseases in Israel in 1954.,174-8,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['Communicable Diseases/*epidemiology', 'Humans', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1955/06/01 00:00,1955/06/01 00:01,['1955/06/01 00:00'],"['1955/06/01 00:00 [pubmed]', '1955/06/01 00:01 [medline]', '1955/06/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1955 Jun;14(6):174-8.,,,,,,,,,,,,['CLML: 5629:10057'],,,,,
18033649,NLM,MEDLINE,20071128,20071122,1439-4413 (Electronic) 0012-0472 (Linking),132,48,2007 Nov,[More infectious diseases due to global warming: a real danger or much ado about nothing?].,2557,,,,"['Hassler, D']",['Hassler D'],,['ger'],"['Comment', 'Editorial']",,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Animals', 'Arthropod Vectors/growth & development', 'Communicable Diseases/*epidemiology/etiology', 'Europe/epidemiology', '*Greenhouse Effect', 'Humans', 'Tropical Climate']",,,,2007/11/23 09:00,2007/12/06 09:00,['2007/11/23 09:00'],"['2007/11/23 09:00 [pubmed]', '2007/12/06 09:00 [medline]', '2007/11/23 09:00 [entrez]']",['10.1055/s-2007-993096 [doi]'],ppublish,Dtsch Med Wochenschr. 2007 Nov;132(48):2557. doi: 10.1055/s-2007-993096.,,,,,,,,['Dtsch Med Wochenschr. 2007 Nov;132(48):2583-9. PMID: 18033654'],Mehr Infektionskrankheiten durch globale Erwarmung: echte Gefahr oder Rauschen im Blatterwald?,,,,,,,,
29406985,NLM,MEDLINE,20190130,20190130,1557-9824 (Electronic) 0891-5520 (Linking),32,1,2018 Mar,Old and New Infections of Childhood.,xiii-xiv,S0891-5520(17)30114-9 [pii] 10.1016/j.idc.2017.12.001 [doi],,,"['Schuster, Jennifer E', 'Newland, Jason G']","['Schuster JE', 'Newland JG']","[""Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, 2401 Gillham Road, Kansas City, MO 64108, USA. Electronic address: jeschuster@cmh.edu."", 'Division of Pediatric Infectious Diseases, Washington University in St. Louis School of Medicine, Campus Box 8116, 660 South Euclid Avenue, St Louis, MO 63110, USA. Electronic address: jgnewland@wustl.edu.']",['eng'],"['Editorial', 'Introductory Journal Article']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,IM,"['Child', 'Child, Preschool', '*Communicable Disease Control', '*Communicable Diseases/microbiology/virology', 'Humans']",,,,2018/02/07 06:00,2019/01/31 06:00,['2018/02/07 06:00'],"['2018/02/07 06:00 [entrez]', '2018/02/07 06:00 [pubmed]', '2019/01/31 06:00 [medline]']","['S0891-5520(17)30114-9 [pii]', '10.1016/j.idc.2017.12.001 [doi]']",ppublish,Infect Dis Clin North Am. 2018 Mar;32(1):xiii-xiv. doi: 10.1016/j.idc.2017.12.001.,,,,,,,,,,,,,,,,,
37566891,NLM,MEDLINE,20230925,20231011,1532-0987 (Electronic) 0891-3668 (Linking),42,10,2023 Oct 1,Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022.,e369-e376,10.1097/INF.0000000000004041 [doi],"The members of the Japanese Society for Pediatric Infectious Diseases and the Japanese Society of Pediatric Pulmonology have developed Guidelines for the Management of Respiratory Infectious Diseases in Children with the objective of facilitating appropriate diagnosis, treatment and prevention of respiratory infections in children. The first edition was published in 2004 and the fifth edition was published in 2022. The Guideline 2022 consists of 2 parts, clinical questions and commentary, and includes general respiratory infections and specific infections in children with underlying diseases and severe infections. This executive summary outlines the clinical questions in the Guidelines 2022, with reference to the Japanese Medical Information Distribution Service Manual. All recommendations are supported by a systematic search for relevant evidence and are followed by the strength of the recommendation and the quality of the evidence statements.","['Copyright (c) 2023 Wolters Kluwer Health, Inc. All rights reserved.']","['Ishiwada, Naruhiko', 'Shinjoh, Masayoshi', 'Kusama, Yoshiki', 'Arakawa, Hirokazu', 'Ohishi, Tomohiro', 'Saitoh, Akihiko', 'Suzuki, Akira', 'Tsutsumi, Hiroyuki', 'Nishi, Junichiro', 'Hoshino, Tadashi', 'Mitsuda, Toshihiro', 'Miyairi, Isao', 'Iwamoto-Kinoshita, Noriko', 'Kobayashi, Hisato', 'Satoh, Kouichiro', 'Shimizu, Akihiko', 'Takeshita, Kenichi', 'Tanaka, Takaaki', 'Tamura, Daisuke', 'Tokunaga, Osamu', 'Tomita, Kentaro', 'Nagasawa, Koo', 'Funaki, Takanori', 'Furuichi, Muhehiro', 'Miyata, Ippei', 'Yaginuma, Mizuki', 'Yamaguchi, Yoshio', 'Yamamoto, Shota', 'Uehara, Suzuko', 'Kurosaki, Tomomichi', 'Okada, Kenji', 'Ouchi, Kazunobu']","['Ishiwada N', 'Shinjoh M', 'Kusama Y', 'Arakawa H', 'Ohishi T', 'Saitoh A', 'Suzuki A', 'Tsutsumi H', 'Nishi J', 'Hoshino T', 'Mitsuda T', 'Miyairi I', 'Iwamoto-Kinoshita N', 'Kobayashi H', 'Satoh K', 'Shimizu A', 'Takeshita K', 'Tanaka T', 'Tamura D', 'Tokunaga O', 'Tomita K', 'Nagasawa K', 'Funaki T', 'Furuichi M', 'Miyata I', 'Yaginuma M', 'Yamaguchi Y', 'Yamamoto S', 'Uehara S', 'Kurosaki T', 'Okada K', 'Ouchi K']","['From the Editor of the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Committee member for English journals for the Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan.', 'From the Editor of the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Committee member for English journals for the Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Committee member for English journals for the Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Committee member for English journals for the Japanese Society for Pediatric Infectious Diseases, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Collaborator for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.', 'Editorial committee member for the Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022, Tokyo, Japan.']",['eng'],"['Journal Article', 'Practice Guideline']",20230808,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,IM,"['Child', 'Humans', '*Communicable Diseases/diagnosis/epidemiology/therapy', 'Japan/epidemiology', '*Respiratory Tract Infections/diagnosis/drug therapy/epidemiology']",,,,2023/08/11 18:42,2023/09/22 06:42,['2023/08/11 17:13'],"['2023/09/22 06:42 [medline]', '2023/08/11 18:42 [pubmed]', '2023/08/11 17:13 [entrez]']","['00006454-202310000-00019 [pii]', '10.1097/INF.0000000000004041 [doi]']",ppublish,Pediatr Infect Dis J. 2023 Oct 1;42(10):e369-e376. doi: 10.1097/INF.0000000000004041. Epub 2023 Aug 8.,,['ORCID: 0000-0002-7072-2338'],,,,,,,,,,,,,,,
15081500,NLM,MEDLINE,20040803,20210119,0891-5520 (Print) 1557-9824 (Electronic) 0891-5520 (Linking),18,1,2004 Mar,Evolution of virulence.,1-15,,"At the close of the 19th century, the germ theory had generated a new understanding of the causes of acute infectious diseases and revealed new directions for study. This understanding contributed to the greatest improvements in health in the history of medicine. At the end of the 20th century, the second stage of this disciplinary development is occurring. The old germ theory is being expanded into a new germ theory, which, by integrated the full spectrum of biologic disciplines. This new germ theory is emphasizing how environments and human activities influence the characteristics of infectious agents and the broader role of infection as a cause of chronic diseases.",,"['Ewald, Paul W']",['Ewald PW'],"['Department of Biology, University of Louisville, Louisville, KY 40292, USA.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,IM,"['Animals', 'Bacteria/pathogenicity', '*Biological Evolution', 'Communicable Diseases/history/microbiology/parasitology', 'Fungi/pathogenicity', 'History, 20th Century', 'History, 21st Century', 'Host-Parasite Interactions/physiology', 'Humans', 'Parasites/pathogenicity', 'Sexually Transmitted Diseases/etiology/*history', 'Vaccines/genetics', '*Virulence/physiology', 'Viruses/pathogenicity']",PMC7118948,,,2004/04/15 05:00,2004/08/04 05:00,['2004/04/15 05:00'],"['2004/04/15 05:00 [pubmed]', '2004/08/04 05:00 [medline]', '2004/04/15 05:00 [entrez]']","['S0891552003000990 [pii]', '10.1016/S0891-5520(03)00099-0 [doi]']",ppublish,Infect Dis Clin North Am. 2004 Mar;18(1):1-15. doi: 10.1016/S0891-5520(03)00099-0.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
25625224,NLM,MEDLINE,20151009,20220318,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),21,2,2015 Feb,Entry screening for infectious diseases in humans.,197-201,10.3201/eid2102.131610 [doi],"In response to the severe acute respiratory syndrome (SARS) pandemic of 2003 and the influenza pandemic of 2009, many countries instituted border measures as a means of stopping or slowing the spread of disease. The measures, usually consisting of a combination of border entry/exit screening, quarantine, isolation, and communications, were resource intensive, and modeling and observational studies indicate that border screening is not effective at detecting infectious persons. Moreover, border screening has high opportunity costs, financially and in terms of the use of scarce public health staff resources during a time of high need. We discuss the border-screening experiences with SARS and influenza and propose an approach to decision-making for future pandemics. We conclude that outbreak-associated communications for travelers at border entry points, together with effective communication with clinicians and more effective disease control measures in the community, may be a more effective approach to the international control of communicable diseases.",,"['Selvey, Linda A', 'Antao, Catarina', 'Hall, Robert']","['Selvey LA', 'Antao C', 'Hall R']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/*diagnosis/*epidemiology/etiology', 'Human Migration', 'Humans', 'Mass Screening/*methods']",PMC4313627,,,2015/01/28 06:00,2015/10/10 06:00,['2015/01/28 06:00'],"['2015/01/28 06:00 [entrez]', '2015/01/28 06:00 [pubmed]', '2015/10/10 06:00 [medline]']","['13-1610 [pii]', '10.3201/eid2102.131610 [doi]']",ppublish,Emerg Infect Dis. 2015 Feb;21(2):197-201. doi: 10.3201/eid2102.131610.,,,,,,,,,,,,,,,,,
12775814,NLM,MEDLINE,20030616,20101118,1095-9203 (Electronic) 0036-8075 (Linking),300,5624,2003 May 30,"Infectious diseases. Taming pathogens: an elegant idea, but does it work?",1362-4,,,,"['Zimmer, Carl']",['Zimmer C'],,['eng'],['News'],,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Animals', '*Biological Evolution', 'Cholera/epidemiology/microbiology/transmission', 'Communicable Disease Control', 'Communicable Diseases/*microbiology/*parasitology/transmission/virology', 'Humans', 'Influenza, Human/epidemiology/transmission/virology', '*Models, Biological', 'Myxoma virus/pathogenicity', 'Sanitation', 'Vibrio cholerae/pathogenicity', '*Virulence']",,,,2003/05/31 05:00,2003/06/17 05:00,['2003/05/31 05:00'],"['2003/05/31 05:00 [pubmed]', '2003/06/17 05:00 [medline]', '2003/05/31 05:00 [entrez]']","['300/5624/1362 [pii]', '10.1126/science.300.5624.1362 [doi]']",ppublish,Science. 2003 May 30;300(5624):1362-4. doi: 10.1126/science.300.5624.1362.,,,,,,,,,,,,,,,,,
28584175,NLM,MEDLINE,20180309,20190129,1471-2970 (Electronic) 0962-8436 (Print) 0962-8436 (Linking),372,1725,2017 Jul 19,"One Health, emerging infectious diseases and wildlife: two decades of progress?",,10.1098/rstb.2016.0167 [doi] 20160167,"Infectious diseases affect people, domestic animals and wildlife alike, with many pathogens being able to infect multiple species. Fifty years ago, following the wide-scale manufacture and use of antibiotics and vaccines, it seemed that the battle against infections was being won for the human population. Since then, however, and in addition to increasing antimicrobial resistance among bacterial pathogens, there has been an increase in the emergence of, mostly viral, zoonotic diseases from wildlife, sometimes causing fatal outbreaks of epidemic proportions. Concurrently, infectious disease has been identified as an increasing threat to wildlife conservation. A synthesis published in 2000 showed common anthropogenic drivers of disease threats to biodiversity and human health, including encroachment and destruction of wildlife habitat and the human-assisted spread of pathogens. Almost two decades later, the situation has not changed and, despite improved knowledge of the underlying causes, little has been done at the policy level to address these threats. For the sake of public health and wellbeing, human-kind needs to work better to conserve nature and preserve the ecosystem services, including disease regulation, that biodiversity provides while also understanding and mitigating activities which lead to disease emergence. We consider that holistic, One Health approaches to the management and mitigation of the risks of emerging infectious diseases have the greatest chance of success.This article is part of the themed issue 'One Health for a changing world: zoonoses, ecosystems and human well-being'.",['(c) 2017 The Authors.'],"['Cunningham, Andrew A', 'Daszak, Peter', 'Wood, James L N']","['Cunningham AA', 'Daszak P', 'Wood JLN']","[""Institute of Zoology, Zoological Society of London, Regent's Park, London NW1 4RY, UK a.cunningham@ioz.ac.uk."", 'Ecohealth Alliance, 460 West 34th Street, New York, NY 10001, USA.', 'Department of Veterinary Medicine, Disease Dynamics Unit, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.']",['eng'],"['Journal Article', 'Review']",,England,Philos Trans R Soc Lond B Biol Sci,"Philosophical transactions of the Royal Society of London. Series B, Biological sciences",7503623,IM,"['Animals', 'Animals, Wild', 'Biodiversity', 'Communicable Diseases, Emerging/epidemiology/etiology/transmission/veterinary', 'Ecosystem', 'Humans', '*One Health', 'Zoonoses/*epidemiology/etiology/transmission']",PMC5468692,['NOTNLM'],"['One Health', 'ecosystem services', 'emerging infectious disease', 'policy', 'wildlife disease', 'zoonoses']",2017/06/07 06:00,2018/03/10 06:00,['2017/06/07 06:00'],"['2017/04/03 00:00 [accepted]', '2017/06/07 06:00 [entrez]', '2017/06/07 06:00 [pubmed]', '2018/03/10 06:00 [medline]']","['rstb.2016.0167 [pii]', 'rstb20160167 [pii]', '10.1098/rstb.2016.0167 [doi]']",ppublish,Philos Trans R Soc Lond B Biol Sci. 2017 Jul 19;372(1725):20160167. doi: 10.1098/rstb.2016.0167.,"['We declare we have no competing interests. A.A.C. and J.L.N.W. are Guest Editors', 'of the issue.']",['ORCID: 0000-0002-3543-6504'],,,,,,,,,,,,,,,
23214006,NLM,MEDLINE,20130116,20121207,0023-2149 (Print) 0023-2149 (Linking),90,9,2012,[The contribution of S.P. Botkin to the study and diagnostics of infectious diseases].,17-9,,,,"['Bogomolov, B P']",['Bogomolov BP'],,['rus'],"['Bibliography', 'Biography', 'Historical Article', 'Journal Article']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Clinical Medicine/education/history', '*Communicable Diseases/diagnosis/history', 'Diagnostic Techniques and Procedures/*history', 'History, 19th Century', 'Humans', 'Russia (Pre-1917)']",,,,2012/12/12 06:00,2013/01/17 06:00,['2012/12/11 06:00'],"['2012/12/11 06:00 [entrez]', '2012/12/12 06:00 [pubmed]', '2013/01/17 06:00 [medline]']",,ppublish,Klin Med (Mosk). 2012;90(9):17-9.,,,,,,,,,,,,,,,,['Botkin SP'],"['Botkin, S P']"
10313847,NLM,MEDLINE,19780828,20191210,0191-6246 (Print) 0191-6246 (Linking),14,12,1978 Jun 15,Infectious diseases held not 'under control'.,"1, 24-5",,,,,,,['eng'],['Journal Article'],,United States,US Med,U. S. medicine,0243631,,"['Centers for Disease Control and Prevention, U.S.', 'Communicable Diseases/economics/*epidemiology', 'Cross Infection/epidemiology', 'Humans', 'United States']",,,,1978/05/26 00:00,1978/05/26 00:01,['1978/05/26 00:00'],"['1978/05/26 00:00 [pubmed]', '1978/05/26 00:01 [medline]', '1978/05/26 00:00 [entrez]']",,ppublish,"US Med. 1978 Jun 15;14(12):1, 24-5.",,,,,,,,,,,,,,,,,
13592352,NLM,MEDLINE,20000701,20181201,0370-9590 (Print) 0370-9590 (Linking),112,Suppl 9,1958 Jun 20,[Clinical diagnosis of infectious diseases; severe infectious syndromes].,234-8 passim concl,,,,"['INK, J']",['INK J'],,['spa'],['Journal Article'],,Argentina,Sem Med,La Semana medica,0404403,OM,"['Communicable Diseases/*diagnosis', 'Humans', '*Skin Tests', '*Syndrome']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1958/06/20 00:00,1958/06/20 00:01,['1958/06/20 00:00'],"['1958/06/20 00:00 [pubmed]', '1958/06/20 00:01 [medline]', '1958/06/20 00:00 [entrez]']",,ppublish,Sem Med. 1958 Jun 20;112(Suppl 9):234-8 passim concl.,,,,,,,,,El diagnostico clinico en las enfermedades infecciosas; los grandes sindromes infecciosos.,,,['CLML: 5935:21765:151'],,,,,
32892785,NLM,MEDLINE,20210115,20210115,1475-2654 (Electronic) 1466-2523 (Linking),21,1,2020 Jun,Development of a systematic mapping review protocol for the most recent evidence on ruminant infectious disease frequency and disease-associated mortality: Ethiopia as a case study.,96-102,10.1017/S1466252319000203 [doi],"Almost 19% of the GDP of Ethiopia results from livestock production. Ruminants, in particular, form the majority of the national herd and are a critical source of income for smallholder farmers. Infectious diseases have been identified as a major cause of reduced livestock productivity in low- and middle-income countries (LMICs); therefore, a sound and comprehensive understanding of the relevant evidence would be beneficial in order to enable decision making on disease control policies. However, livestock disease data from sub-Saharan Africa is variable and disparate, which poses a challenge for evidence synthesis. This paper describes a protocol for a systematic mapping review of the recent available evidence on ruminant disease prevalence and associated mortality in Ethiopia. Literature sources will be identified using database search strategies. The titles, abstracts and, subsequently, full texts will be screened for inclusion based on predefined eligibility criteria. Specific data will be extracted and a preliminary qualitative assessment of the evidence will be performed using predefined indicators. The planned systematic map will be the first to provide a large-scale overview of the available ruminant disease evidence in Ethiopia; the final output will be an interactive dashboard tool to inform critical stakeholders in policy and research.",,"['Tsouloufi, Theodora K', 'Donnison, Louise M', 'Smyth, Karen L', 'Peters, Andrew R']","['Tsouloufi TK', 'Donnison LM', 'Smyth KL', 'Peters AR']","['Supporting Evidence Based Interventions, the Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.', 'Supporting Evidence Based Interventions, the Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.', 'Supporting Evidence Based Interventions, the Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.', 'Supporting Evidence Based Interventions, the Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Systematic Review']",20200907,England,Anim Health Res Rev,Animal health research reviews,101083072,IM,"['Animals', 'Communicable Diseases/epidemiology/mortality/*veterinary', 'Ethiopia/epidemiology', 'Prevalence', '*Ruminants']",,['NOTNLM'],"['Cattle', 'infectious diseases', 'morbidity', 'small ruminants', 'sub-Saharan Africa', 'systematic map']",2020/09/08 06:00,2021/01/16 06:00,['2020/09/07 05:26'],"['2020/09/08 06:00 [pubmed]', '2021/01/16 06:00 [medline]', '2020/09/07 05:26 [entrez]']","['S1466252319000203 [pii]', '10.1017/S1466252319000203 [doi]']",ppublish,Anim Health Res Rev. 2020 Jun;21(1):96-102. doi: 10.1017/S1466252319000203. Epub 2020 Sep 7.,,['ORCID: 0000-0002-4032-0338'],,,,,,,,,,,,,,,
34598414,NLM,MEDLINE,20211124,20211230,1988-9518 (Electronic) 0214-3429 (Print) 0214-3429 (Linking),34 Suppl 1,Suppl1,2021 Sep,What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?,8-11,10.37201/req/s01.02.2021 [doi],"The year 2020 was the year of infectious diseases with the arrival of SARS-CoV-2, which represented a profound change in the world we knew. However, we present a brief description of some of the top infectious diseases articles from 2020 not related with SARS-CoV-2. We reviewed a selection of the most important and relevant achievements in diagnosis and therapy related to bacteremia, nosocomial pneumonia, skin and soft tissue infections, infections by Clostridioides difficile, mycobacterial infections and invasive fungal infections. This year entailed a significant step forward in the indisputable value of the health care stewardship programs.",,"['Mormeneo Bayo, S', 'Garcia-Lechuz Moya, J M']","['Mormeneo Bayo S', 'Garcia-Lechuz Moya JM']","['Juan M. Garcia-Lechuz, Servicio de Microbiologia Clinica. Hospital Universitario Miguel Servet. Zaragoza, Spain. jmgarcialechuz@salud.aragon.es.']",['eng'],"['Journal Article', 'Review']",20210930,Spain,Rev Esp Quimioter,Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,9108821,IM,"['*Bacteremia', '*COVID-19', '*Clostridium Infections', '*Communicable Diseases/drug therapy/epidemiology', 'Humans', 'SARS-CoV-2']",PMC8682998,,,2021/10/03 06:00,2021/11/25 06:00,['2021/10/02 03:10'],"['2021/10/02 03:10 [entrez]', '2021/10/03 06:00 [pubmed]', '2021/11/25 06:00 [medline]']","['revespquimioter-34-suppl-1-08 [pii]', '10.37201/req/s01.02.2021 [doi]']",ppublish,Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):8-11. doi: 10.37201/req/s01.02.2021. Epub 2021 Sep 30.,['The authors declare no conflicts of interest'],,,,,,,,,,,,,,,,
33744370,NLM,MEDLINE,20220128,20220128,1873-5169 (Electronic) 0196-9781 (Linking),140,,2021 Jun,Modulation of cathelicidin and defensins by histone deacetylase inhibitors: A potential treatment for multi-drug resistant infectious diseases.,170527,S0196-9781(21)00035-8 [pii] 10.1016/j.peptides.2021.170527 [doi],"Infectious diseases are an important growing public health problem, which perspective has worsened due to the increasing number of drug-resistant strains in the last few years. Although diverse solutions have been proposed, one viable solution could be the use of immune system modulators. The induction of the immune response can be increased by histone deacetylase inhibitors (iHDAC), which in turn modulate the chromatin and increase the activation of different cellular pathways and nuclear factors such as STAT3, HIF-1alpha NF-kB, C/EBPalpha and, AP-1. These pathways are capable to promote several immune response-related molecules including those with antimicrobial properties such as antimicrobial peptides (AMPs) that lead to the elimination of pathogens including multi drug-resistant strains.",['Copyright (c) 2021 Elsevier Inc. All rights reserved.'],"['Rodriguez-Carlos, Adrian', 'Jacobo-Delgado, Yolanda M', 'Santos-Mena, Alan O', 'Rivas-Santiago, Bruno']","['Rodriguez-Carlos A', 'Jacobo-Delgado YM', 'Santos-Mena AO', 'Rivas-Santiago B']","['Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.', 'Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.', 'Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.', 'Medical Research Unit-Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico. Electronic address: rondo_vm@yahoo.com.']",['eng'],"['Journal Article', 'Review']",20210317,United States,Peptides,Peptides,8008690,IM,"['Animals', 'Anti-Infective Agents/*pharmacology', 'Cathelicidins/*metabolism', 'Communicable Diseases/*drug therapy/microbiology/pathology', 'Defensins/*metabolism', 'Drug Resistance, Multiple', 'Histone Deacetylase Inhibitors/*pharmacology', 'Humans']",,['NOTNLM'],"['Antimicrobial peptides', 'Cathelicidin', 'Defensins', 'Histone deacetylase inhibitors', 'Infectious diseases']",2021/03/22 06:00,2022/01/29 06:00,['2021/03/21 20:56'],"['2020/10/30 00:00 [received]', '2021/02/26 00:00 [revised]', '2021/03/09 00:00 [accepted]', '2021/03/22 06:00 [pubmed]', '2022/01/29 06:00 [medline]', '2021/03/21 20:56 [entrez]']","['S0196-9781(21)00035-8 [pii]', '10.1016/j.peptides.2021.170527 [doi]']",ppublish,Peptides. 2021 Jun;140:170527. doi: 10.1016/j.peptides.2021.170527. Epub 2021 Mar 17.,,,"['0 (Anti-Infective Agents)', '0 (Cathelicidins)', '0 (Defensins)', '0 (Histone Deacetylase Inhibitors)']",,,,,,,,,,,,,,
18473905,NLM,MEDLINE,20080715,20191110,1871-5265 (Print) 1871-5265 (Linking),8,1,2008 Mar,The use of proteomics to study infectious diseases.,31-45,,"Technology surrounding genomics, or the study of an organism's genome and its gene use, has advanced rapidly resulting in an abundance of readily available genomic data. Although genomics is extremely valuable, proteins are ultimately responsible for controlling most aspects of cellular function. The field of proteomics, or the study of the full array of proteins produced by an organism, has become the premier arena for the identification and characterization of proteins. Yet the task of characterizing a proteomic profile is more complex, in part because many unique proteins can be produced by the same gene product and because proteins have more diverse chemical structures making sequencing and identification more difficult. Proteomic profiles of a particular organism, tissue or cell are influenced by a variety of environmental stimuli, including those brought on by infectious disease. The intent of this review is to highlight applications of proteomics used in the study of pathogenesis, etiology and pathology of infectious disorders. While many infectious agents have been the target of proteomic studies, this review will focus on those infectious diseases which rank among the highest in worldwide mortalities, such as HIV/AIDS, tuberculosis, malaria, measles, and hepatitis.",,"['List, E O', 'Berryman, D E', 'Bower, B', 'Sackmann-Sala, L', 'Gosney, E', 'Ding, J', 'Okada, S', 'Kopchick, J J']","['List EO', 'Berryman DE', 'Bower B', 'Sackmann-Sala L', 'Gosney E', 'Ding J', 'Okada S', 'Kopchick JJ']","['Edison Biotechnology Institute, College of and Health and Human Services, Department of Biomedical Sciences, Ohio University, Athens, Ohio 45701, USA. list@ohio.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",,United Arab Emirates,Infect Disord Drug Targets,Infectious disorders drug targets,101269158,IM,"['Animals', 'Anti-Infective Agents/pharmacology', 'Communicable Diseases/drug therapy/etiology/*physiopathology', 'Drug Delivery Systems', 'Genomics/methods', 'Humans', 'Proteomics/*methods']",,,,2008/05/14 09:00,2008/07/17 09:00,['2008/05/14 09:00'],"['2008/05/14 09:00 [pubmed]', '2008/07/17 09:00 [medline]', '2008/05/14 09:00 [entrez]']",['10.2174/187152608784139640 [doi]'],ppublish,Infect Disord Drug Targets. 2008 Mar;8(1):31-45. doi: 10.2174/187152608784139640.,,,['0 (Anti-Infective Agents)'],,,158,['DK064905/DK/NIDDK NIH HHS/United States'],,,,,,,,,,
15174311,NLM,MEDLINE,20050912,20040603,0040-3660 (Print) 0040-3660 (Linking),76,4,2004,[Infectious diseases in Russian Federation: problems and solutions].,5-9,,,,"['Maleev, V V', 'Pokrovskii, V I']","['Maleev VV', 'Pokrovskii VI']",,['rus'],['Editorial'],,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Communicable Diseases/*epidemiology/mortality', 'Humans', 'Russia/epidemiology', 'Virus Diseases/*epidemiology/mortality/*prevention & control']",,,,2004/06/04 05:00,2005/09/13 09:00,['2004/06/04 05:00'],"['2004/06/04 05:00 [pubmed]', '2005/09/13 09:00 [medline]', '2004/06/04 05:00 [entrez]']",,ppublish,Ter Arkh. 2004;76(4):5-9.,,,,,,,,,Infektsionnye bolezni v Rossii: problemy i puti ikh resheniia.,,,,,,,,
251467,NLM,MEDLINE,19790223,20061115,0379-8577 (Print) 0379-8577 (Linking),1,2,1978 Sep,[The modern approach to infectious diseases].,4-8,,,,"['Prozesky, O W']",['Prozesky OW'],,['afr'],"['English Abstract', 'Journal Article']",,South Africa,Curationis,Curationis,7901092,,"['Bacteria/isolation & purification', '*Communicable Disease Control', 'Communicable Diseases/microbiology/transmission', 'Epidemiologic Methods', 'Humans', 'Immunization', 'South Africa', 'Vaccines/standards']",,,,1978/09/01 00:00,1978/09/01 00:01,['1978/09/01 00:00'],"['1978/09/01 00:00 [pubmed]', '1978/09/01 00:01 [medline]', '1978/09/01 00:00 [entrez]']",,ppublish,Curationis. 1978 Sep;1(2):4-8.,,,['0 (Vaccines)'],,,,,,Die moderne benadering tot infeksiesiektes.,,,,,,,,
15771149,NLM,MEDLINE,20050429,20211203,0147-3956 (Print) 0147-3956 (Linking),,352,2005 Mar 9,"Seroprevalence of six infectious diseases among adults in the United States by race/ethnicity: data from the third national health and nutrition examination survey, 1988--94.",1-9,,"OBJECTIVE: To provide seroprevalence estimates for six selected infectious agents by various sociodemographic and risk behavior variables stratified by race/ethnicity for adults age 20 years or more. METHODS: Seroprevalence estimates for hepatitis A, B, and C, Toxoplasma gondii, Helicobacter pylori, and Herpes simplex-2 were calculated from data in the third National Health and Nutrition Examination Survey, 1988-94 utilizing weights to account for differential oversampling by race/ethnicity and nonresponse to the interview and examination. Standard errors and 95% confidence intervals were calculated taking into account the complex sample design. RESULTS: Age-adjusted prevalence estimates and 95% confidence intervals are presented for three enteric infectious diseases hepatitis A, Toxoplasma gondii, Helicobacter pylori, as well as three blood-borne/sexually transmitted diseases, hepatitis B, hepatitis C, and Herpes simplex-2 stratified by race/ethnicity and by various demographic factors including gender, poverty index, population size of area of residence, country of birth, household crowding, and years of education. In addition, estimates are presented for the three blood-borne/sexually transmitted diseases by various risk behaviors that include marital status, age at first sexual intercourse, number of lifetime sexual partners, cocaine use, and marijuana use.",,"['Kruszon-Moran, Deanna', 'McQuillan, Geraldine M']","['Kruszon-Moran D', 'McQuillan GM']",['Division of Health Examination Statistics.'],['eng'],"['Comparative Study', 'Journal Article']",,United States,Adv Data,Advance data,7703830,,"['Adult', 'Communicable Diseases/blood/classification/*epidemiology/ethnology', 'Data Collection', '*Ethnicity', 'Female', 'Humans', 'Male', 'Middle Aged', '*Racial Groups', '*Seroepidemiologic Studies', 'United States/epidemiology']",,,,2005/03/18 09:00,2005/04/30 09:00,['2005/03/18 09:00'],"['2005/03/18 09:00 [pubmed]', '2005/04/30 09:00 [medline]', '2005/03/18 09:00 [entrez]']",,ppublish,Adv Data. 2005 Mar 9;(352):1-9.,,,,,,,,,,,,,,,,,
20427329,NLM,MEDLINE,20101019,20211020,1744-957X (Electronic) 1744-9561 (Print) 1744-9561 (Linking),6,4,2010 Aug 23,Emerging diseases in Chiroptera: why bats?,438-40,10.1098/rsbl.2010.0267 [doi],"A conference entitled '2nd International Berlin Bat Meeting: Bat Biology and Infectious Diseases' was held between the 19 and 21 of February 2010 in Berlin, Germany. Researchers from two major disciplines, bat biologists and disease specialists, met for the first time in an interdisciplinary event to share their knowledge about bat-associated diseases. The focus of the meeting was to understand why in particular bats are the hosts of so many of the most virulent diseases globally. During several sessions, key note speakers and participants discussed infectious diseases associated with bats, including viral diseases caused by Henipa-, Filo-, Corona- and Lyssaviruses, the spread of white-nose syndrome in North American bats, bat immunology/immunogenetics, bat parasites, and finally, conservation and human health issues.",,"['Wibbelt, Gudrun', 'Moore, Marianne S', 'Schountz, Tony', 'Voigt, Christian C']","['Wibbelt G', 'Moore MS', 'Schountz T', 'Voigt CC']","['Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100428,England,Biol Lett,Biology letters,101247722,IM,"['Animals', '*Biodiversity', '*Chiroptera', 'Communicable Diseases, Emerging/*immunology/microbiology/*veterinary/virology', 'Conservation of Natural Resources/*methods', 'Immunogenetics/*methods']",PMC2942877,,,2010/04/30 06:00,2010/10/20 06:00,['2010/04/30 06:00'],"['2010/04/30 06:00 [entrez]', '2010/04/30 06:00 [pubmed]', '2010/10/20 06:00 [medline]']","['rsbl.2010.0267 [pii]', 'rsbl20100267 [pii]', '10.1098/rsbl.2010.0267 [doi]']",ppublish,Biol Lett. 2010 Aug 23;6(4):438-40. doi: 10.1098/rsbl.2010.0267. Epub 2010 Apr 28.,,,,,,,,,,,,,,,,,
17455585,NLM,MEDLINE,20070629,20110727,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,"[Emerging, re-emerging infectious diseases].",15-20,,,,"['Seki, Masafumi', 'Kohno, Shigeru']","['Seki M', 'Kohno S']","['Department of Molecular Microbiology and Immunology (2nd Internal Medicine), Graduate School of Biomedical Sciences, Nagasaki University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Animals', 'Communicable Diseases, Emerging/*epidemiology/etiology/prevention & control/transmission', 'Humans', 'Zoonoses/epidemiology/transmission']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:15-20.,,,,,,12,,,,,,,,,,,
13071913,NLM,MEDLINE,20030501,20181201,0026-4806 (Print) 0026-4806 (Linking),44,22,1953 Mar 17,[Treatment of the site in therapy of acute infectious diseases].,719-20,,,,"['CAYREL, M']",['CAYREL M'],,['und'],['Journal Article'],,Italy,Minerva Med,Minerva medica,0400732,OM,"['*Acute Disease', 'Communicable Diseases/*therapy', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1953/03/17 00:00,1953/03/17 00:01,['1953/03/17 00:00'],"['1953/03/17 00:00 [pubmed]', '1953/03/17 00:01 [medline]', '1953/03/17 00:00 [entrez]']",,ppublish,Minerva Med. 1953 Mar 17;44(22):719-20.,,,,,,,,,La cura del terreno nella terapia delle malattie infettive acute.,,,['CLML: 5324:42616:162'],,,,,
1769194,NLM,MEDLINE,19920227,20051116,0098-8243 (Print) 0098-8243 (Linking),17,9,1991 Sep,Prevention of infectious diseases in children.,22-6,,,,"['Isaacs, D']",['Isaacs D'],"[""Department of Immunology & Infectious Diseases, Children's Hospital, Camperdown, New South Wales, Australia.""]",['eng'],"['Journal Article', 'Review']",,United States,Compr Ther,Comprehensive therapy,7605837,IM,"['Age Factors', 'Child', 'Communicable Disease Control/*methods', 'Communicable Diseases/microbiology/mortality', 'Developing Countries', 'Female', 'Humans', '*Immunization', 'Infant, Newborn', 'Pregnancy', 'Risk Factors', 'Vaccines']",,,,1991/09/01 00:00,1991/09/01 00:01,['1991/09/01 00:00'],"['1991/09/01 00:00 [pubmed]', '1991/09/01 00:01 [medline]', '1991/09/01 00:00 [entrez]']",,ppublish,Compr Ther. 1991 Sep;17(9):22-6.,,,['0 (Vaccines)'],,,16,,,,,,,,,,,
17455607,NLM,MEDLINE,20070629,20111117,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 2 Pt. 1,,2007 Feb 28,[How to diagnose infectious diseases at the first visit of a patient--signs and symptoms which are suggestive of an infectious disease and appropriate timing of laboratory examination].,143-50,,,,"['Sakaue, Yoshihiro']",['Sakaue Y'],"['Division of Infectious Diseases, Osaka City General Hospital.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['*Ambulatory Care', 'Central Nervous System Diseases/etiology', '*Clinical Laboratory Techniques', 'Communicable Diseases/complications/*diagnosis', 'Diagnosis, Differential', 'Digestive System Diseases/etiology', 'Fever/etiology', 'Humans', 'Leukocyte Count', 'Polymerase Chain Reaction', '*Primary Health Care', 'Respiratory Tract Diseases/etiology', 'Time']",,,,2007/04/26 09:00,2007/06/30 09:00,['2007/04/26 09:00'],"['2007/04/26 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/04/26 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:143-50.,,,,,,2,,,,,,,,,,,
9297283,NLM,MEDLINE,19970915,20181130,0040-3660 (Print) 0040-3660 (Linking),69,6,1997,[Kidney involvement in infectious diseases].,70-2,,,,"['Bogomolov, B P']",['Bogomolov BP'],,['rus'],"['Case Reports', 'Journal Article', 'Lecture']",,Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Communicable Diseases/*complications/diagnosis/physiopathology', 'Hepatorenal Syndrome/diagnosis/etiology/physiopathology', 'Humans', 'Kidney/physiopathology', 'Kidney Diseases/diagnosis/*etiology/physiopathology', 'Male', 'Middle Aged']",,,,1997/01/01 00:00,1997/09/20 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/09/20 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1997;69(6):70-2.,,,,,,,,,Porazhenie pochek pri infektsionnykh bolezniakh.,,,,,,,,
25540282,NLM,MEDLINE,20160218,20190108,1471-2954 (Electronic) 0962-8452 (Print) 0962-8452 (Linking),282,1800,2015 Feb 7,Paradoxical effects of coupling infectious livestock populations and imposing transport restrictions.,20142805,10.1098/rspb.2014.2805 [doi] 20142805,"Spatial heterogeneity of a host population of mobile agents has been shown to be a crucial determinant of many aspects of disease dynamics, ranging from the proliferation of diseases to their persistence and to vaccination strategies. In addition, the importance of regional and structural differences grows in our modern world. Little is known, though, about the consequences when traits of a disease vary regionally. In this paper, we study the effect of a spatially varying per capita infection rate on the behaviour of livestock diseases. We show that the prevalence of an infectious livestock disease in a community of animals can paradoxically decrease owing to transport connections to other communities in which the risk of infection is higher. We study the consequences for the design of livestock transportation restriction measures and establish exact criteria to discriminate those connections that increase the level of infection in the community from those that decrease it.",['(c) 2014 The Author(s) Published by the Royal Society. All rights reserved.'],"['Lamouroux, David', 'Nagler, Jan', 'Geisel, Theo', 'Eule, Stephan']","['Lamouroux D', 'Nagler J', 'Geisel T', 'Eule S']","['Max Planck Institute for Dynamics and Self-Organization, Gottingen 37077, Germany.', 'Max Planck Institute for Dynamics and Self-Organization, Gottingen 37077, Germany Computational Physics, IfB, ETH Zurich, Zurich 8093, Switzerland.', 'Max Planck Institute for Dynamics and Self-Organization, Gottingen 37077, Germany.', 'Max Planck Institute for Dynamics and Self-Organization, Gottingen 37077, Germany eule@nld.ds.mpg.de.']",['eng'],['Journal Article'],,England,Proc Biol Sci,Proceedings. Biological sciences,101245157,IM,"['Animal Diseases/epidemiology/*prevention & control/transmission', 'Animals', 'Cattle', 'Communicable Diseases/epidemiology/transmission/*veterinary', 'Disease Outbreaks/prevention & control/*veterinary', 'Disease Transmission, Infectious/veterinary', '*Livestock', 'Models, Theoretical', '*Transportation']",PMC4298214,['NOTNLM'],"['infectious diseases', 'population dynamics', 'theoretical ecology', 'transport restrictions']",2014/12/30 06:00,2016/02/19 06:00,['2014/12/26 06:00'],"['2014/12/26 06:00 [entrez]', '2014/12/30 06:00 [pubmed]', '2016/02/19 06:00 [medline]']","['rspb.2014.2805 [pii]', 'rspb20142805 [pii]', '10.1098/rspb.2014.2805 [doi]']",ppublish,Proc Biol Sci. 2015 Feb 7;282(1800):20142805. doi: 10.1098/rspb.2014.2805.,,,,,,,,,,,,,,,,,
9713887,NLM,MEDLINE,19980914,20190921,0253-1933 (Print) 0253-1933 (Linking),17,2,1998 Aug,National and international veterinary reference laboratories for infectious diseases.,418-25,,"Reference laboratories play an increasingly important role in the harmonisation of laboratory diagnostic tests and the standardisation of veterinary vaccines. This is particularly important in building confidence between international trading partners. The authors review aspects of the organisation, designation and support of reference laboratories for infectious diseases of animals and discuss the principal activities which such laboratories would normally perform. These activities include advice and consultancy, publications and communication, training, research, disease surveillance, maintenance of culture collections, evaluation of reference methods, preparation of reference materials and organisation of inter-laboratory comparisons.",,"['Edwards, S', 'Alexander, D']","['Edwards S', 'Alexander D']","['Virology Department, Central Veterinary Labortory (Weybridge), New Haw, Addlestone, Surrey, United Kingdom.']",['eng'],"['Journal Article', 'Review']",,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', 'Communicable Diseases/diagnosis/epidemiology/*veterinary', 'Equipment and Supplies', 'Financial Support', 'Global Health', '*Laboratories/economics/organization & administration/standards', 'Medical Laboratory Personnel/education/standards', 'Quality Control', 'Reference Standards', 'Referral and Consultation', 'Research', '*Veterinary Medicine']",,,,1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']",['10.20506/rst.17.2.1107 [doi]'],ppublish,Rev Sci Tech. 1998 Aug;17(2):418-25. doi: 10.20506/rst.17.2.1107.,,,,,,12,,,,,,,,,,,
21473714,NLM,MEDLINE,20110830,20151119,1752-0371 (Electronic) 1752-0363 (Linking),5,2,2011 Apr,Biomarkers that reflect immune activation or dysfunction will be important in the management of infectious diseases.,109-12,10.2217/bmm.11.22 [doi],,,"['Gaudieri, Silvana']",['Gaudieri S'],"['School of Anatomy & Human Biology, Center for Forensic Science, University of Western Australia, Nedlands Western Australia, Australia. silvana.gaudieri@uwa.edu.au']",['eng'],['Introductory Journal Article'],,England,Biomark Med,Biomarkers in medicine,101312535,IM,"['Biomarkers/*metabolism', 'Chemokines/immunology', 'Communicable Diseases/*immunology/physiopathology/*therapy', 'HIV Infections/diagnosis/immunology/therapy', 'Hepatitis C/immunology/therapy', 'Humans', 'Immune System/*immunology', 'Sepsis/immunology', 'Treatment Outcome']",,,,2011/04/09 06:00,2011/08/31 06:00,['2011/04/09 06:00'],"['2011/04/09 06:00 [entrez]', '2011/04/09 06:00 [pubmed]', '2011/08/31 06:00 [medline]']",['10.2217/bmm.11.22 [doi]'],ppublish,Biomark Med. 2011 Apr;5(2):109-12. doi: 10.2217/bmm.11.22.,,,"['0 (Biomarkers)', '0 (Chemokines)']",,,,,,,,,,,,,,
30547435,NLM,MEDLINE,20190610,20190613,1940-6029 (Electronic) 1064-3745 (Linking),1903,,2019,Repurposing Drugs Based on Evolutionary Relationships Between Targets of Approved Drugs and Proteins of Interest.,45-59,10.1007/978-1-4939-8955-3_3 [doi],"Drug repurposing has garnered much interest as an effective method for drug development among biopharmaceutical companies. The availability of information on complete sequences of genomes and their associated biological data, genotype-phenotype-disease relationships, and properties of small molecules offers opportunities to explore the repurpose-able potential of existing pharmacopoeia. This method gains further importance, especially, in the context of development of drugs against infectious diseases, some of which pose serious complications due to emergence of drug-resistant pathogens. In this article, we describe computational means to achieve potential repurpose-able drug candidates that may be used against infectious diseases by exploring evolutionary relationships between established targets of FDA-approved drugs and proteins of pathogen of interest.",,"['Chakraborti, Sohini', 'Ramakrishnan, Gayatri', 'Srinivasan, Narayanaswamy']","['Chakraborti S', 'Ramakrishnan G', 'Srinivasan N']","['Molecular Biophysics Unit, Indian Institute of Science, Bangalore, Karnataka, India.', 'Molecular Biophysics Unit, Indian Institute of Science, Bangalore, Karnataka, India.', 'Indian Institute of Science Mathematics Initiative, Indian Institute of Science, Bangalore, India.', ""Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA."", 'Molecular Biophysics Unit, Indian Institute of Science, Bangalore, Karnataka, India. ns@iisc.ac.in.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Methods Mol Biol,"Methods in molecular biology (Clifton, N.J.)",9214969,IM,"['Biological Evolution', 'Communicable Diseases/drug therapy/etiology/metabolism', '*Computational Biology/methods', 'Databases, Pharmaceutical', '*Drug Repositioning/methods', 'Humans', '*Ligands', 'Markov Chains', 'Proteins/*chemistry/genetics/metabolism', '*Quantitative Structure-Activity Relationship', 'Software', 'Workflow']",,['NOTNLM'],"['Computational approach', 'Drug repurposing', 'Hidden Markov model', 'Infectious diseases', 'Protein evolution']",2018/12/14 06:00,2019/06/14 06:00,['2018/12/15 06:00'],"['2018/12/15 06:00 [entrez]', '2018/12/14 06:00 [pubmed]', '2019/06/14 06:00 [medline]']",['10.1007/978-1-4939-8955-3_3 [doi]'],ppublish,Methods Mol Biol. 2019;1903:45-59. doi: 10.1007/978-1-4939-8955-3_3.,,,"['0 (Ligands)', '0 (Proteins)']",,,,,,,,,,,,,,
9638798,NLM,MEDLINE,19980713,20190921,0253-1933 (Print) 0253-1933 (Linking),17,1,1998 Apr,Resolving the genetics of resistance to infectious diseases.,17-25,,"The genetics of resistance to disease is an area of great interest in agriculturally important plant and animal species. Selective breeding for resistance to pathogens in plants, animals and insects has demonstrated that resistance and susceptibility to pathogens are controlled by both genetic and environmental factors. The immune loci causally involved in susceptibility and resistance to disease are currently unknown. However, novel enabling molecular technologies promise to assist in unravelling the genetics of the host response to infectious diseases in new ways, and ultimately to improve seed stock genetics.",,"['Hawken, R J', 'Beattie, C W', 'Schook, L B']","['Hawken RJ', 'Beattie CW', 'Schook LB']","['Program in Comparative Genomics, College of Veterinary Medicine, University of Minnesota, St Paul, MN 55108, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",,France,Rev Sci Tech,Revue scientifique et technique (International Office of Epizootics),8712301,IM,"['Animals', 'Animals, Domestic/*genetics/immunology', 'Breeding', 'Communicable Diseases/genetics/immunology/*veterinary', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Humans', 'Immunity, Innate/*genetics', 'Selection, Genetic']",,,,1998/06/25 00:00,1998/06/25 00:01,['1998/06/25 00:00'],"['1998/06/25 00:00 [pubmed]', '1998/06/25 00:01 [medline]', '1998/06/25 00:00 [entrez]']",['10.20506/rst.17.1.1098 [doi]'],ppublish,Rev Sci Tech. 1998 Apr;17(1):17-25. doi: 10.20506/rst.17.1.1098.,,,['0 (Genetic Markers)'],,,75,,,,,,,,,,,
14489684,NLM,MEDLINE,19981101,20181201,0033-2100 (Print) 0033-2100 (Linking),16,,1962,[Use of cortical steroids in clinical infectious diseases].,55-62,,,,"['RACHON, K']",['RACHON K'],,['pol'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,OM,"['Adrenal Cortex Hormones/*therapy', 'Communicable Diseases/*therapy', 'Poland']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapy', '*COMMUNICABLE DISEASES/therapy']",1962/01/01 00:00,1962/01/01 00:01,['1962/01/01 00:00'],"['1962/01/01 00:00 [pubmed]', '1962/01/01 00:01 [medline]', '1962/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1962;16:55-62.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,,,,,,
20621217,NLM,MEDLINE,20100812,20100712,1557-8194 (Electronic) 0011-5029 (Linking),56,7,2010 Jul,Blood-borne infections and the athlete.,436-42,10.1016/j.disamonth.2010.05.004 [doi],,,"['Gutierrez, Ramiro L', 'Decker, Catherine F']","['Gutierrez RL', 'Decker CF']","['Division of Infectious Diseases, Department of Internal Medicine, National Naval Medical Center, Bethesda, Maryland, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Dis Mon,Disease-a-month : DM,0370657,IM,"['*Athletes', 'Blood-Borne Pathogens', '*Communicable Disease Control', 'Communicable Diseases/*epidemiology/microbiology/*transmission', 'Humans', 'Risk Factors', 'Social Behavior', '*Sports']",,,,2010/07/14 06:00,2010/08/13 06:00,['2010/07/13 06:00'],"['2010/07/13 06:00 [entrez]', '2010/07/14 06:00 [pubmed]', '2010/08/13 06:00 [medline]']","['S0011-5029(10)00067-2 [pii]', '10.1016/j.disamonth.2010.05.004 [doi]']",ppublish,Dis Mon. 2010 Jul;56(7):436-42. doi: 10.1016/j.disamonth.2010.05.004.,,,,,,25,,,,,,,,,,,
24665586,NLM,MEDLINE,20140521,20161201,0387-5911 (Print) 0387-5911 (Linking),88,1,2014 Jan,[The JAID/JSC Guideline to Clinical Management of Infectious Diseases (Respiratory infections)].,1-109,,,,"['Mikasa, Keiichi', 'Aoki, Nobuki', 'Aoki, Yosuke', 'Abe, Shuichi', 'Iwata, Satoshi', 'Ouchi, Kazunobu', 'Kasahara, Kei', 'Kadota, Junichi', 'Kishida, Naoki', 'Kobayashi, Osamu', 'Sakata, Hiroshi', 'Seki, Masahumi', 'Tsukada, Hiroki', 'Tokue, Yutaka', 'Nakamura-Uchiyama, Fukumi', 'Higa, Futoshi', 'Maeda, Koichi', 'Yanagihara, Katsunori', 'Yoshida, Koichiro']","['Mikasa K', 'Aoki N', 'Aoki Y', 'Abe S', 'Iwata S', 'Ouchi K', 'Kasahara K', 'Kadota J', 'Kishida N', 'Kobayashi O', 'Sakata H', 'Seki M', 'Tsukada H', 'Tokue Y', 'Nakamura-Uchiyama F', 'Higa F', 'Maeda K', 'Yanagihara K', 'Yoshida K']",,['jpn'],"['Journal Article', 'Practice Guideline']",,Japan,Kansenshogaku Zasshi,Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,0236671,IM,"['Communicable Diseases/diagnosis/*drug therapy', 'Humans', 'Japan', 'Respiratory Tract Infections/diagnosis/*drug therapy/prevention & control', 'Risk Factors']",,,,2014/03/29 06:00,2014/05/23 06:00,['2014/03/27 06:00'],"['2014/03/27 06:00 [entrez]', '2014/03/29 06:00 [pubmed]', '2014/05/23 06:00 [medline]']",,ppublish,Kansenshogaku Zasshi. 2014 Jan;88(1):1-109.,,,,,,,,,,,['Japanese Association for infectious diseases'],,,,,,
10847810,NLM,MEDLINE,20000607,20110727,0047-1852 (Print) 0047-1852 (Linking),58,2,2000 Feb,[Infectious diseases].,477-84,,,,"['Matsumoto, K']",['Matsumoto K'],,['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Anti-Bacterial Agents', 'Antiviral Agents', '*Communicable Diseases/microbiology/virology', 'Disease Outbreaks', 'Humans', 'Influenza A virus', 'Influenza, Human/epidemiology', 'Viral Vaccines']",,,,2000/06/10 00:00,2000/06/10 00:01,['2000/06/10 00:00'],"['2000/06/10 00:00 [pubmed]', '2000/06/10 00:01 [medline]', '2000/06/10 00:00 [entrez]']",,ppublish,Nihon Rinsho. 2000 Feb;58(2):477-84.,,,"['0 (Anti-Bacterial Agents)', '0 (Antiviral Agents)', '0 (Viral Vaccines)']",,,23,,,,,,,,,,,
9545606,NLM,MEDLINE,19980423,20170214,0009-9228 (Print) 0009-9228 (Linking),37,3,1998 Mar,Infectious diseases presentations of Munchausen syndrome by proxy: case report and review of the literature.,179-85,,"Munchausen syndrome by proxy is a form of abuse, usually of a child by a parent, in which a factitious illness is reported or produced in the child, resulting in unnecessary medical evaluations and treatments. A dramatic case of a 17-month-old infant with recurrent polymicrobial bacteremia prompted a review of cases diagnosed by the Pediatric Infectious Diseases consultation service at our referral children's hospital and a review of the infectious diseases presentations in the medical literature. The infectious diseases presentations of the syndrome as well as criteria for the diagnosis are reviewed and discussed.",,"['Goldfarb, J', 'Lawry, K W', 'Steffen, R', 'Sabella, C']","['Goldfarb J', 'Lawry KW', 'Steffen R', 'Sabella C']","[""Division of Pediatrics and Adolescent Medicine, Cleveland Clinic Children's Hospital, Ohio, USA.""]",['eng'],"['Case Reports', 'Journal Article', 'Review']",,United States,Clin Pediatr (Phila),Clinical pediatrics,0372606,IM,"['Child', 'Child, Preschool', 'Communicable Diseases/*diagnosis/microbiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Infant', 'Male', 'Mothers', '*Munchausen Syndrome by Proxy/diagnosis/psychology']",,,,1998/04/18 00:00,1998/04/18 00:01,['1998/04/18 00:00'],"['1998/04/18 00:00 [pubmed]', '1998/04/18 00:01 [medline]', '1998/04/18 00:00 [entrez]']",['10.1177/000992289803700304 [doi]'],ppublish,Clin Pediatr (Phila). 1998 Mar;37(3):179-85. doi: 10.1177/000992289803700304.,,,,,,14,,,,,,,,,,,
10270090,NLM,MEDLINE,19850419,20161123,0017-9132 (Print) 0017-9132 (Linking),17,1,1985 Feb,The incidence of common infectious diseases: the weekly returns service of the Royal College of General Practitioners.,13-6,,"This article summarizes the information collected on morbidity due to infectious disease in the UK between 1967 and 1983 by the Weekly Returns Service (WRS) of the Royal College of General Practitioners. The population data base used for this purpose now exceeds 200,000 and 40 general practices and 106 principals are included. Where comparisons are available incidence rates derived from the WRS are higher than those obtained in official notifications.",,"['Fleming, D M', 'Crombie, D L']","['Fleming DM', 'Crombie DL']",,['eng'],['Journal Article'],,England,Health Trends,Health trends,0233525,,"['Communicable Diseases/diagnosis/*epidemiology', 'Humans', 'Morbidity', '*Registries', 'United Kingdom']",,,,1985/01/10 00:00,1985/01/10 00:01,['1985/01/10 00:00'],"['1985/01/10 00:00 [pubmed]', '1985/01/10 00:01 [medline]', '1985/01/10 00:00 [entrez]']",,ppublish,Health Trends. 1985 Feb;17(1):13-6.,,,,,,,,,,,,,,,,,
14380370,NLM,MEDLINE,20030501,20181201,0014-9772 (Print) 0014-9772 (Linking),4,,1955 Apr,Contemporary methods of diagnosing major severe infectious diseases.,25-33,,,,"['BUNIN, K V']",['BUNIN KV'],,['eng'],['Journal Article'],,Russia (Federation),Feldsher Akush,Fel'dsher i akusherka,16930040R,OM,"['Communicable Diseases/*diagnosis', 'Humans', '*Skin Tests']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1955/04/01 00:00,1955/04/01 00:01,['1955/04/01 00:00'],"['1955/04/01 00:00 [pubmed]', '1955/04/01 00:01 [medline]', '1955/04/01 00:00 [entrez]']",,ppublish,Feldsher Akush. 1955 Apr;4:25-33.,,,,,,,,,Sovremennye metody diagnostiki vazhneishikh ostrykh infektsionnykh boleznei.,,,['CLML: 5528:31408:151'],,,,,
10488636,NLM,MEDLINE,19991012,20070724,0341-6593 (Print) 0341-6593 (Linking),106,8,1999 Aug,[Wild animals as transmitters of infectious diseases].,325-8,,"The present contribution contains a summarized overview of current literature dealing with the most important zoonoses that can be transmitted directly or indirectly from indigenous wildlife to man. Following Weber (1994) the diseases are classified according to the species of pathogen. Ways of infection are shown and the importance of these zoonoses is discussed with regard to the frequency of occurrence, the degree of sickness and the risk for man.",,"['Pohlmeyer, K']",['Pohlmeyer K'],"['Institut fur Wildtierforschung, Tierarztlichen Hochschule Hannover.']",['ger'],"['English Abstract', 'Journal Article', 'Review']",,Germany,Dtsch Tierarztl Wochenschr,DTW. Deutsche tierarztliche Wochenschrift,7706565,IM,"['Animals', '*Animals, Wild', 'Communicable Diseases/*transmission/*veterinary', 'Humans', 'Zoonoses/*transmission']",,,,1999/09/17 00:00,1999/09/17 00:01,['1999/09/17 00:00'],"['1999/09/17 00:00 [pubmed]', '1999/09/17 00:01 [medline]', '1999/09/17 00:00 [entrez]']",,ppublish,Dtsch Tierarztl Wochenschr. 1999 Aug;106(8):325-8.,,,,,,7,,,Wildtiere als Ubertrager von Infektionen.,,,,,,,,
24796118,NLM,MEDLINE,20140618,20190724,0021-5384 (Print) 0021-5384 (Linking),103,3,2014 Mar 10,"[The 41st Scientific Meeting: perspectives of internal medicine; lessons from the disaster of the Great East Japan earthquake; 3. Medical disease learned from the Great East Japan earthquake--feature, treatment and prevention-; 5) Total management for infectious diseases].",572-80,,,,"['Kaku, Mitsuo']",['Kaku M'],,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['*Communicable Disease Control', 'Communicable Diseases/epidemiology/*etiology/therapy', '*Disaster Medicine', '*Disaster Victims', 'Disease Outbreaks/*prevention & control', '*Earthquakes', 'Emergency Shelter', 'Female', 'Health Education', 'Humans', 'Infection Control', '*Internal Medicine', 'Japan', 'Male', '*Patient Care Team', 'Risk Assessment']",,,,2014/05/07 06:00,2014/06/19 06:00,['2014/05/07 06:00'],"['2014/05/07 06:00 [entrez]', '2014/05/07 06:00 [pubmed]', '2014/06/19 06:00 [medline]']",['10.2169/naika.103.572 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):572-80. doi: 10.2169/naika.103.572.,,,,,,,,,,,,,,,,,
14425368,NLM,MEDLINE,19981101,20181201,0009-0522 (Print) 0009-0522 (Linking),9,,1960 Jul,[The problem of the development of infectious diseases during the present time].,370-5,,,,"['MUROMCEV, S M']",['MUROMCEV SM'],,['cze'],['Journal Article'],,Czech Republic,Cesk Epidemiol Mikrobiol Imunol,"Ceskoslovenska epidemiologie, mikrobiologie, imunologie",2984708R,OM,"['Communicable Diseases/*epidemiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1960/07/01 00:00,1960/07/01 00:01,['1960/07/01 00:00'],"['1960/07/01 00:00 [pubmed]', '1960/07/01 00:01 [medline]', '1960/07/01 00:00 [entrez]']",,ppublish,Cesk Epidemiol Mikrobiol Imunol. 1960 Jul;9:370-5.,,,,,,,,,,,,,,,,,
13267251,NLM,MEDLINE,20030501,20181201,0370-629X (Print) 0370-629X (Linking),10,17,1955 Sep 1,"[Infectious diseases at home and abroad; epidemiological summary from July 10-23, 1955].",534-5,,,,,,,['fre'],['Journal Article'],,Belgium,Rev Med Liege,Revue medicale de Liege,0404317,OM,"['Communicable Diseases/*epidemiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1955/09/01 00:00,1955/09/01 00:01,['1955/09/01 00:00'],"['1955/09/01 00:00 [pubmed]', '1955/09/01 00:01 [medline]', '1955/09/01 00:00 [entrez]']",,ppublish,Rev Med Liege. 1955 Sep 1;10(17):534-5.,,,,,,,,,MALADIES infectieuses dans le pays et a l'etranger; releve epidemiologique du 10 au 23 Juillet 1955.,,,['CLML: 5629:19184'],,,,,
13120719,NLM,MEDLINE,20030501,20181201,0032-745X (Print) 0032-745X (Linking),40,46,1953 Nov 13,[Therapeutic progress in internal medicine in 1952; infectious diseases].,3109-21,,,,"['DREYER, M S']",['DREYER MS'],,['und'],['Journal Article'],,Argentina,Prensa Med Argent,Prensa medica argentina,0204056,OM,"['Communicable Diseases/*therapy', 'Humans', '*Internal Medicine']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1953/11/13 00:00,1953/11/13 00:01,['1953/11/13 00:00'],"['1953/11/13 00:00 [pubmed]', '1953/11/13 00:01 [medline]', '1953/11/13 00:00 [entrez]']",,ppublish,Prensa Med Argent. 1953 Nov 13;40(46):3109-21.,,,,,,,,,"Progresos terapeuticos en medicina interna, durante el ano 1952; enfermedades infecciosas.",,,['CLML: 5425:41930:117'],,,,,
18448964,NLM,MEDLINE,20081112,20081121,0951-7375 (Print) 0951-7375 (Linking),21,3,2008 Jun,Recently identified factors predisposing children to infectious diseases.,217-22,10.1097/QCO.0b013e3282fa1824 [doi],"PURPOSE OF REVIEW: To identify articles published between January 2006 and January 2008 that have significantly enhanced our understanding of why some children are prone to severe or recurrent infectious diseases. RECENT FINDINGS: Significant inroads into the genetic basis of immune disorders leading to severe and recurrent infections in children have been made over the last few years. We now understand the specific susceptibility to herpes simplex virus encephalitis, the underlying cause of hyper IgE and Hermansky-Pudlak type 2 syndromes, as well as further explanations for the genotypic/phenotypic variations in severe combined immunodeficiency, common variable immunodeficiency and congenital neutropenia syndromes. Virulence factors for Staphylococcus aureus and Plasmodium falciparum have also been identified, and disease pathophysiology of respiratory syncytial virus related bronchiolitis and of acute pyelonephritis are better understood. SUMMARY: Progress in this area continues to be rapid. Clinicians now have the knowledge and techniques to explain why many children develop infectious diseases.",,"['Arkwright, Peter D', 'Abinun, Mario']","['Arkwright PD', 'Abinun M']","['Paediatric Immunology, University of Manchester, UK. peter_arkwright@lineone.net']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Infect Dis,Current opinion in infectious diseases,8809878,IM,"['Bacterial Outer Membrane Proteins/genetics/immunology', 'Child', 'Child, Preschool', 'Communicable Diseases/*etiology/genetics/*immunology/microbiology', 'Disease Susceptibility/immunology', 'Genetic Predisposition to Disease', 'Humans', 'Immunity, Innate/*genetics', 'Infant', 'Mutation/genetics', 'Polymorphism, Genetic', 'Risk Factors', 'Virulence Factors']",,,,2008/05/02 09:00,2008/11/13 09:00,['2008/05/02 09:00'],"['2008/05/02 09:00 [pubmed]', '2008/11/13 09:00 [medline]', '2008/05/02 09:00 [entrez]']","['00001432-200806000-00002 [pii]', '10.1097/QCO.0b013e3282fa1824 [doi]']",ppublish,Curr Opin Infect Dis. 2008 Jun;21(3):217-22. doi: 10.1097/QCO.0b013e3282fa1824.,,,"['0 (Bacterial Outer Membrane Proteins)', '0 (TLR protein, bacteria)', '0 (Virulence Factors)']",,,49,,,,,,,,,,,
24191416,NLM,MEDLINE,20131230,20131106,1660-9379 (Print) 1660-9379 (Linking),9,401,2013 Oct 9,[Infectious complications in elderly with chronic hematological malignancies].,1821-6,,"Chronic blood malignancies in the elderly remain incurable diseases. However, recent advances in therapies allow not only to extend treatment at advanced ages and in presence of significant comorbidities, but also to induce prolonged remissions. However, this is achieved at the cost of increased risk of infectious diseases, due to disease--and treatment-related immunosuppression. This article will review the infectious diseases associated with chronic lymphatic leukemia, myelodysplastic syndrome and multiple myeloma. Furthermore we will discuss the recommendation of anti-infectious prophylaxis and vaccination for each of the conditions listed above.",,"['Berlier, C', 'Erard, V']","['Berlier C', 'Erard V']","['Departement de medecine interne, HFR-Fribourg--Hopital cantonal, 1708 Fribourg. charlotte.berlier@h-fr.ch']",['fre'],"['English Abstract', 'Journal Article', 'Review']",,Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,IM,"['Aged', 'Aged, 80 and over', 'Chronic Disease', 'Communicable Diseases/epidemiology/*etiology/immunology', 'Hematologic Neoplasms/*complications/epidemiology/immunology', 'Humans', 'Immunity, Innate/physiology', 'Vaccination/statistics & numerical data']",,,,2013/11/07 06:00,2014/01/01 06:00,['2013/11/07 06:00'],"['2013/11/07 06:00 [entrez]', '2013/11/07 06:00 [pubmed]', '2014/01/01 06:00 [medline]']",,ppublish,Rev Med Suisse. 2013 Oct 9;9(401):1821-6.,,,,,,,,,Complications infectieuses chez la personne agee presentant une hemopathie maligne chronique.,,,,,,,,
1900907,NLM,MEDLINE,19910425,20190912,0361-929X (Print) 0361-929X (Linking),16,1,1991 Jan-Feb,An overview of maternal-child infectious diseases (1976-1990).,58,,,,"['Sharts-Engel, N C']",['Sharts-Engel NC'],"['Villanova University College of Nursing, Pennsylvania.']",['eng'],['Journal Article'],,United States,MCN Am J Matern Child Nurs,MCN. The American journal of maternal child nursing,7605941,IM,"['Child', 'Communicable Disease Control/*methods', 'Communicable Diseases/epidemiology/*nursing', 'Humans', 'Maternal-Child Nursing/*methods', 'United States/epidemiology']",,,,1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",['10.1097/00005721-199101000-00017 [doi]'],ppublish,MCN Am J Matern Child Nurs. 1991 Jan-Feb;16(1):58. doi: 10.1097/00005721-199101000-00017.,,,,,,,,,,,,,,,,,
31833463,NLM,MEDLINE,20191226,20200108,1875-5607 (Electronic) 1389-5575 (Linking),19,19,2019,Multi-Scale Modeling in Drug Discovery Against Infectious Diseases.,1560-1563,10.2174/138955751919191024110000 [doi],"This work discusses the idea that drug discovery, instead of being performed through a series of filtering-based stages, should be viewed as a multi-scale optimization problem. Here, the most promising multi-scale models are analyzed in terms of their applications, advantages, and limitations in the search for more potent and safer chemicals against infectious diseases. Multi-scale de novo drug design is highlighted as an emerging paradigm, able to accelerate the discovery of more effective antimicrobial agents.","['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.net.']","['Speck-Planche, Alejandro']",['Speck-Planche A'],"['Department of Chemistry, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Trubetskaya str., 8, b. 2, 119992, Moscow, Russian Federation.']",['eng'],['Journal Article'],,Netherlands,Mini Rev Med Chem,Mini reviews in medicinal chemistry,101094212,IM,"['Anti-Infective Agents/*chemistry/therapeutic use', 'Communicable Diseases/*drug therapy/pathology', '*Drug Design', 'Humans', '*Models, Biological', 'Quantitative Structure-Activity Relationship']",,['NOTNLM'],"['Antimicrobial', 'infectious diseases', 'mtk-QSBER', 'multi-scale de novo drug design', 'pharmacokinetic', 'toxicity.']",2019/12/14 06:00,2019/12/27 06:00,['2019/12/14 06:00'],"['2019/01/11 00:00 [received]', '2019/01/13 00:00 [revised]', '2019/01/29 00:00 [accepted]', '2019/12/14 06:00 [entrez]', '2019/12/14 06:00 [pubmed]', '2019/12/27 06:00 [medline]']","['MRMC-EPUB-101854 [pii]', '10.2174/138955751919191024110000 [doi]']",ppublish,Mini Rev Med Chem. 2019;19(19):1560-1563. doi: 10.2174/138955751919191024110000.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
27621349,NLM,MEDLINE,20180709,20180709,0029-2559 (Print) 0029-2559 (Linking),77,5,2016 Sep-Oct,School Notes: Managing Infectious Diseases in School and Child Care Settings.,355-8,10.18043/ncm.77.5.355 [doi],"The decision to exclude a child from day care or school leads to widespread educational, social, and economic ramifications for affected families. By understanding and improving how these decisions are made, health care providers and policy makers can promote child well-being throughout the state.","['(c)2016 by the North Carolina Institute of Medicine and The Duke Endowment. All', 'rights reserved.']","['Hill, David L']",['Hill DL'],"['adjunct assistant professor, Department of Pediatrics, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; associate medical director, KidzCare Pediatrics, Fayetteville, North Carolina David_Hill@med.unc.edu.']",['eng'],['Journal Article'],,United States,N C Med J,North Carolina medical journal,2984805R,IM,"['Absenteeism', 'Child', 'Clinical Decision-Making/*methods', '*Communicable Diseases/diagnosis/economics/transmission', '*Cost of Illness', 'Humans', 'Pediatrics/methods', 'Population', 'School Health Services/*organization & administration']",,,,2016/09/14 06:00,2018/07/10 06:00,['2016/09/14 06:00'],"['2016/09/14 06:00 [entrez]', '2016/09/14 06:00 [pubmed]', '2018/07/10 06:00 [medline]']","['77/5/355 [pii]', '10.18043/ncm.77.5.355 [doi]']",ppublish,N C Med J. 2016 Sep-Oct;77(5):355-8. doi: 10.18043/ncm.77.5.355.,,,,,,,,,,,,,,,,,
30634443,NLM,MEDLINE,20190529,20231104,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),16,2,2019 Jan 9,"Analysis of Epidemiological Characteristics of Notifiable Diseases Reported in Children Aged 0(-)14 Years from 2008 to 2017 in Zhejiang Province, China.",,10.3390/ijerph16020168 [doi] 168,"This study aims to learn the characteristics of morbidity and mortality of notifiable diseases reported in children aged 0(-)14 years in Zhejiang Province in 2008(-)2017. We collated data from the China Information System for Disease Control and Prevention in Zhejiang province between 1 January 2008 and 31 December 2017 of children aged 0(-)14 years. From 2008 to 2017, a total of 32 types and 1,994,740 cases of notifiable diseases were reported in children aged 0(-)14 years, including 266 deaths in Zhejiang Province. The annual average morbidity was 2502.87/100,000, and the annual average mortality was 0.33/100,000. Male morbidity was 2886.98/100,000, and female morbidity was 2072.16/100,000, with the male morbidity rate higher than the female morbidity rate (chi(2) = 54,033.12, p < 0.01). No Class A infectious diseases were reported. The morbidity of Class B infectious diseases showed a downward trend, but that of Class C infectious diseases showed an upward trend. There were 72,041 cases in 22 kinds of Class B infectious disease and 138 death cases, with a morbidity rate of 90.39/100,000, and a mortality rate of 0.17/100,000. There were 1,922,699 cases in 10 kinds of Class C infectious disease and 128 death cases, with a morbidity rate of 2412.47/100,000, and a mortality rate of 0.16/100,000. The main high-prevalence diseases included hand-foot-and-mouth disease (1430.38/100,000), other infectious diarrheal diseases (721.40/100,000), mumps (168.83/100,000), and influenza (47.40/100,000). We should focus on the prevention and control of hand-foot and mouth disease, other infectious diarrheal diseases, mumps and influenza in children aged 0(-)14 years in Zhejiang Province. It is recommended to strengthen epidemic surveillance and undertake early prevention and control measures in order to reduce the younger children incidence rate of infectious diseases. Immunization planning vaccines can help achieve a significant preventive decline of infectious diseases.",,"['Lu, Qinbao', 'Ding, Zheyuan', 'Wu, Chen', 'Wu, Haocheng', 'Lin, Junfen']","['Lu Q', 'Ding Z', 'Wu C', 'Wu H', 'Lin J']","['Department of Public Health Surveillance & Advisory, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Binjiang District, Hangzhou 310051, China. qblu@cdc.zj.cn.', 'Department of Public Health Surveillance & Advisory, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Binjiang District, Hangzhou 310051, China. zhyding@cdc.zj.cn.', 'Department of Public Health Surveillance & Advisory, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Binjiang District, Hangzhou 310051, China. chenwu@cdc.zj.cn.', 'Department of Public Health Surveillance & Advisory, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Binjiang District, Hangzhou 310051, China. hchwu@cdc.zj.cn.', 'Department of Public Health Surveillance & Advisory, Zhejiang Provincial Center for Disease Control and Prevention, 3399 Binsheng Road, Binjiang District, Hangzhou 310051, China. jflin@cdc.zj.cn.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20190109,Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,IM,"['Adolescent', 'Child', 'Child, Preschool', 'China/epidemiology', 'Communicable Diseases/classification/*epidemiology/history/mortality', 'Epidemiological Monitoring', 'Female', 'History, 21st Century', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Morbidity/trends', 'Prevalence']",PMC6352024,['NOTNLM'],"['children', 'epidemic characteristics', 'infectious diseases']",2019/01/13 06:00,2019/05/30 06:00,['2019/01/13 06:00'],"['2018/11/30 00:00 [received]', '2019/01/04 00:00 [revised]', '2019/01/05 00:00 [accepted]', '2019/01/13 06:00 [entrez]', '2019/01/13 06:00 [pubmed]', '2019/05/30 06:00 [medline]']","['ijerph16020168 [pii]', 'ijerph-16-00168 [pii]', '10.3390/ijerph16020168 [doi]']",epublish,Int J Environ Res Public Health. 2019 Jan 9;16(2):168. doi: 10.3390/ijerph16020168.,['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,
20807653,NLM,MEDLINE,20101021,20220223,1877-1173 (Print) 1877-1173 (Linking),93,,2010,Diverse functions of glycosaminoglycans in infectious diseases.,373-94,10.1016/S1877-1173(10)93016-0 [doi],"Glycosaminoglycans (GAGs) are complex carbohydrates that are expressed ubiquitously and abundantly on the cell surface and in the extracellular matrix (ECM). The extraordinary structural diversity of GAGs enables them to interact with a wide variety of biological molecules. Through these interactions, GAGs modulate various biological processes, such as cell adhesion, proliferation and migration, ECM assembly, tissue repair, coagulation, and immune responses, among many others. Studies during the last several decades have indicated that GAGs also interact with microbial pathogens. GAG-pathogen interactions affect most, if not all, the key steps of microbial pathogenesis, including host cell attachment and invasion, cell-cell transmission, systemic dissemination and infection of secondary organs, and evasion of host defense mechanisms. These observations indicate that GAG-pathogen interactions serve diverse functions that affect the pathogenesis of infectious diseases.",['Copyright (c) 2010 Elsevier Inc. All rights reserved.'],"['Aquino, Rafael S', 'Lee, Eui Seung', 'Park, Pyong Woo']","['Aquino RS', 'Lee ES', 'Park PW']","[""Children's Hospital, Harvard Medical School, Boston, MA, USA.""]",['eng'],"['Journal Article', 'Review']",,Netherlands,Prog Mol Biol Transl Sci,Progress in molecular biology and translational science,101498165,IM,"['Animals', 'Communicable Diseases/*metabolism/*pathology', 'Glycosaminoglycans/*metabolism', 'Humans']",,,,2010/09/03 06:00,2010/10/22 06:00,['2010/09/03 06:00'],"['2010/09/03 06:00 [entrez]', '2010/09/03 06:00 [pubmed]', '2010/10/22 06:00 [medline]']","['S1877-1173(10)93016-0 [pii]', '10.1016/S1877-1173(10)93016-0 [doi]']",ppublish,Prog Mol Biol Transl Sci. 2010;93:373-94. doi: 10.1016/S1877-1173(10)93016-0.,,,['0 (Glycosaminoglycans)'],,,,,,,,,,,,,,
19905355,NLM,MEDLINE,20100113,20091112,1550-2376 (Electronic) 1539-3755 (Linking),80,4 Pt 1,2009 Oct,Analysis and Monte Carlo simulations of a model for the spread of infectious diseases in heterogeneous metapopulations.,041920,,We present a study of the continuous-time equations governing the dynamics of a susceptible-infected-susceptible model on heterogeneous metapopulations. These equations have been recently proposed as an alternative formulation for the spread of infectious diseases in metapopulations in a continuous-time framework. Individual-based Monte Carlo simulations of epidemic spread in uncorrelated networks are also performed revealing a good agreement with analytical predictions under the assumption of simultaneous transmission or recovery and migration processes.,,"['Juher, David', 'Ripoll, Jordi', 'Saldana, Joan']","['Juher D', 'Ripoll J', 'Saldana J']","[""Departament d'Informatica i Matematica Aplicada, Universitat de Girona, 17071 Girona, Spain. juher@ima.udg.edu""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20091020,United States,Phys Rev E Stat Nonlin Soft Matter Phys,"Physical review. E, Statistical, nonlinear, and soft matter physics",101136452,IM,"['Communicable Diseases/epidemiology/*transmission', 'Diffusion', 'Disease Outbreaks', 'Endemic Diseases', '*Models, Biological', '*Monte Carlo Method']",,,,2009/11/13 06:00,2010/01/14 06:00,['2009/11/13 06:00'],"['2009/06/26 00:00 [received]', '2009/09/03 00:00 [revised]', '2009/11/13 06:00 [entrez]', '2009/11/13 06:00 [pubmed]', '2010/01/14 06:00 [medline]']",['10.1103/PhysRevE.80.041920 [doi]'],ppublish,Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Oct;80(4 Pt 1):041920. doi: 10.1103/PhysRevE.80.041920. Epub 2009 Oct 20.,,,,,,,,,,,,,,,,,
13516077,NLM,MEDLINE,20000701,20181201,0025-7869 (Print) 0025-7869 (Linking),9,12,1957 Dec,[Hormone therapy of infectious diseases].,1849-58,,,,"['NEUMAN, M']",['NEUMAN M'],,['rum'],['Journal Article'],,Romania,Med Interna (Bucur),Medicina interna,7503144,OM,"['Adrenal Cortex Hormones/*therapeutic use', 'Communicable Diseases/*therapy']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapeutic use', '*COMMUNICABLE DISEASES/therapy']",1957/12/01 00:00,1957/12/01 00:01,['1957/12/01 00:00'],"['1957/12/01 00:00 [pubmed]', '1957/12/01 00:01 [medline]', '1957/12/01 00:00 [entrez]']",,ppublish,Med Interna (Bucur). 1957 Dec;9(12):1849-58.,,,['0 (Adrenal Cortex Hormones)'],,,,,,Tratamentul hormonal in bolile infectioase.,,,['CLML: 5834:8449:15:155'],,,,,
25920492,NLM,MEDLINE,20160418,20181113,1435-4373 (Electronic) 0934-9723 (Linking),34,8,2015 Aug,A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand.,1589-92,10.1007/s10096-015-2391-0 [doi],"The objective of this paper is to describe paediatric infectious diseases consultations across Australia and New Zealand. We surveyed infectious diseases physicians at 51 hospitals over a period of 2 weeks in 2012. Compared with adult consults, paediatric consults were more frequently received from general paediatricians/physicians and intensive care, yet less frequently from surgeons and emergency. Respiratory, skin/soft tissue and bone/joint infections were the most frequent consultations in children. These data demonstrate the breadth of formal infectious diseases consults in children. Differences between paediatric and infectious diseases consultations need to be considered when planning both paediatric and adult physician training and future curriculum development.",,"['Blyth, C C', 'Walls, T', 'Cheng, A C', 'Murray, R J', 'Fisher, D A', 'Ingram, P R', 'Davis, J S']","['Blyth CC', 'Walls T', 'Cheng AC', 'Murray RJ', 'Fisher DA', 'Ingram PR', 'Davis JS']","['School of Paediatrics and Child Health, University of Western Australia, Perth, Australia.']",['eng'],"['Comparative Study', 'Journal Article']",20150429,Germany,Eur J Clin Microbiol Infect Dis,European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,8804297,IM,"['Adult', 'Australia', 'Child', 'Child, Preschool', 'Communicable Diseases/*diagnosis/*drug therapy', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'New Zealand', 'Prospective Studies', '*Referral and Consultation']",,,,2015/04/30 06:00,2016/04/19 06:00,['2015/04/30 06:00'],"['2015/03/03 00:00 [received]', '2015/04/15 00:00 [accepted]', '2015/04/30 06:00 [entrez]', '2015/04/30 06:00 [pubmed]', '2016/04/19 06:00 [medline]']",['10.1007/s10096-015-2391-0 [doi]'],ppublish,Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1589-92. doi: 10.1007/s10096-015-2391-0. Epub 2015 Apr 29.,,,,,,,,,,,"['Australasian Society for Infectious Diseases Clinical Research Network', 'Australian New Zealand Paediatric Infectious Diseases Research Network']",,,,,,
2695472,NLM,MEDLINE,19900323,20190510,0300-5771 (Print) 0300-5771 (Linking),18,4,1989 Dec,On the course of epidemics of some infectious diseases.,749-55,,,,"[""En'ko, P D""]","[""En'ko PD""]",,['eng'],"['Biography', 'Historical Article', 'Journal Article']",,England,Int J Epidemiol,International journal of epidemiology,7802871,IM,"['Communicable Diseases/*epidemiology/immunology', 'Disease Outbreaks/*statistics & numerical data', 'History, 19th Century', 'Humans', 'Russia (Pre-1917)/epidemiology']",,,,1989/12/01 00:00,1989/12/01 00:01,['1989/12/01 00:00'],"['1989/12/01 00:00 [pubmed]', '1989/12/01 00:01 [medline]', '1989/12/01 00:00 [entrez]']",['10.1093/ije/18.4.749 [doi]'],ppublish,Int J Epidemiol. 1989 Dec;18(4):749-55. doi: 10.1093/ije/18.4.749.,,,,,,,,,,,,,,,,"[""En'ko PD""]","[""En'ko, P D""]"
24168861,NLM,MEDLINE,20150416,20140107,1544-2217 (Electronic) 0300-9858 (Linking),51,1,2014 Jan,Molecular localization techniques in the diagnosis and characterization of nonhuman primate infectious diseases.,110-26,10.1177/0300985813509386 [doi],"Molecular localization techniques remain important diagnostic and research tools for the pathologist evaluating nonhuman primate tissues. In situ hybridization and immunohistochemistry protocols have been developed for many important pathogens of nonhuman primates, including RNA and DNA viruses, prions, and bacterial, protozoal, and fungal pathogens. Such techniques will remain critical in defining the impact and relevance of novel agents on animal health and disease. A comparative pathology perspective often provides valuable insight to the best strategy for reagent development and can also facilitate interpretation of molecular localization patterns. Such a perspective is grounded in a firm understanding of microbe-host pathobiology. This review summarizes current molecular localization protocols used in the diagnosis of selected primate infectious diseases.",,"['Mansfield, K G', 'Sasseville, V G', 'Westmoreland, S V']","['Mansfield KG', 'Sasseville VG', 'Westmoreland SV']","['Novartis Institutes for Biomedical Research, Cambridge, MA, USA. Email: Keith.Mansfield@Novartis.com.']",['eng'],"['Journal Article', 'Review']",20131029,United States,Vet Pathol,Veterinary pathology,0312020,IM,"['Animals', 'Antibodies', 'Communicable Diseases/*diagnosis/microbiology/parasitology', 'Immunohistochemistry/veterinary', 'In Situ Hybridization/veterinary', 'Pathology, Molecular/*methods', 'Pathology, Veterinary/*methods', 'Primate Diseases/*diagnosis/microbiology/parasitology', 'Primates', 'Sensitivity and Specificity']",,['NOTNLM'],"['cross-reactivity/cross-reactive', 'immunohistochemistry', 'infectious diseases', 'nonhuman primates']",2013/10/31 06:00,2015/04/17 06:00,['2013/10/31 06:00'],"['2013/10/31 06:00 [entrez]', '2013/10/31 06:00 [pubmed]', '2015/04/17 06:00 [medline]']","['0300985813509386 [pii]', '10.1177/0300985813509386 [doi]']",ppublish,Vet Pathol. 2014 Jan;51(1):110-26. doi: 10.1177/0300985813509386. Epub 2013 Oct 29.,,,['0 (Antibodies)'],,,,,,,,,,,,,,
11413779,NLM,MEDLINE,20011207,20181113,0065-7778 (Print) 0065-7778 (Linking),112,,2001,Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash.,235-51; discussion 251-2,,,,"['Sanders, C V', 'Lopez, F A']","['Sanders CV', 'Lopez FA']","['Department of Medicine, LSU School of Medicine, 1542 Tulane Ave., Room 421, New Orleans, LA 70112, USA.']",['eng'],['Journal Article'],,United States,Trans Am Clin Climatol Assoc,Transactions of the American Clinical and Climatological Association,7507559,IM,"['Communicable Diseases/*complications/*diagnosis', 'Diagnosis, Differential', 'Exanthema/*diagnosis/*etiology', 'Fever/*etiology', 'Humans', 'Risk Factors']",PMC2194418,,,2001/06/21 10:00,2002/01/05 10:01,['2001/06/21 10:00'],"['2001/06/21 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/06/21 10:00 [entrez]']",,ppublish,Trans Am Clin Climatol Assoc. 2001;112:235-51; discussion 251-2.,,,,,,,,,,,,,,,,,
23642862,NLM,MEDLINE,20130710,20181202,1558-4232 (Electronic) 1094-9194 (Linking),16,2,2013 May,Selected emerging infectious diseases of ornamental fish.,261-82,S1094-9194(13)00016-9 [pii] 10.1016/j.cvex.2013.01.006 [doi],"Several emerging infectious diseases have serious implications for the trade and husbandry of ornamental fish. Although many of these diseases have been well studied and described in certain species, there are still many diseases that are not well understood. The following discussion focuses on select important emerging infectious diseases that affect ornamental fish in the aquarium and aquaculture industries: goldfish herpesvirus, koi herpesvirus, Ranavirus, Megalocytivirus, Betanodavirus, Francisella, Cryptobia iubilans, and Exophiala. When possible, the known species affected, clinical signs, diagnosis, treatment, disinfection, and prevention modalities for each disease are discussed.",['Copyright (c) 2013 Elsevier Inc. All rights reserved.'],"['McDermott, Colin', 'Palmeiro, Brian']","['McDermott C', 'Palmeiro B']","['National Aquarium in Baltimore, Pier 3, Baltimore, MD 21202, USA. Cmcd.vmd@gmail.com']",['eng'],"['Journal Article', 'Review']",20130316,United States,Vet Clin North Am Exot Anim Pract,The veterinary clinics of North America. Exotic animal practice,9815628,IM,"['Animals', '*Aquaculture', 'Communicable Diseases, Emerging/diagnosis/prevention & control/*veterinary', 'Fish Diseases/diagnosis/microbiology/parasitology/*prevention & control', 'Fishes', '*Goldfish']",,,,2013/05/07 06:00,2013/07/11 06:00,['2013/05/07 06:00'],"['2013/05/07 06:00 [entrez]', '2013/05/07 06:00 [pubmed]', '2013/07/11 06:00 [medline]']","['S1094-9194(13)00016-9 [pii]', '10.1016/j.cvex.2013.01.006 [doi]']",ppublish,Vet Clin North Am Exot Anim Pract. 2013 May;16(2):261-82. doi: 10.1016/j.cvex.2013.01.006. Epub 2013 Mar 16.,,,,,,,,,,,,,,,,,
35860922,NLM,MEDLINE,20220722,20220722,0033-2100 (Print) 0033-2100 (Linking),76,1,2022,"How sex and gender matter in infectious diseases - outcomes of the first Polish conference ""A woman in an infectious diseases circle"".",19-28,10.32394/pe.76.03 [doi],"Occurrence of infectious disease in a woman is an interdisciplinary area of medicine. The common problem of lower recruitment of women to clinical trials leads to the necessity to rely in clinical practice on the exchange of practical experiences, specialist consultations and individualization of treatment. As the COVID-19 pandemic shows, there is a close relationship between infectious diseases and civilization diseases. People suffering from chronic diseases are both more susceptible to infection and the more severe course of an infectious disease. On the other hand, infection may accelerate or initiate the onset of a noncommunicable disease. Women, especially those living with HIV, are a group with an underestimated risk of high blood pressure or some cancers. Therefore, one of the main goals of the conference is to break the stereotypes of thinking about health, in which gender is the main determinant of some screening tests. Late presentation of women to medical care is a significant problem that is of great importance in the diagnosis and treatment of both communicable and non-communicable diseases. Women put family and professional responsibilities in the first place, and they are known to downplay their own health problems. It leads to the diagnosis of cardiovascular diseases or cancer at the stage of advanced changes, limiting the possibilities of effective therapy. Understanding gender attributed differences in the etiology and epidemiology of diseases allows for the improvement of patient care, as well as determines the right direction of reforms in the area of healthcare. It is essential to build models of care based on an interdisciplinary and patient-centered approach, with broad support from both stakeholders and NGOs. Each contact of the patient with the health care system should be seen as an opportunity for screening both in the area of civilization diseases, women's health, and infectious diseases corresponding to her lifestyle.",['(c) National Institute of Public Health NIH - National Research Institute.'],"['Kowalska, Justyna D', 'Matlosz, Bartlomiej', 'Przychodzen, Sebastian', 'Pogoda, Katarzyna', 'Horban, Andrzej', 'Rosinska, Magdalena']","['Kowalska JD', 'Matlosz B', 'Przychodzen S', 'Pogoda K', 'Horban A', 'Rosinska M']","['Department of Infectious Diseases for Adults, Medical University of Warsaw.', 'Preventive and Treatment Outpatient Clinic, Provincial Infectious Hospital in Warsaw.', 'Preventive and Treatment Outpatient Clinic, Provincial Infectious Hospital in Warsaw.', 'Preventive and Treatment Outpatient Clinic, Provincial Infectious Hospital in Warsaw.', 'Department of Cardiovascular Diseases, Medical Center of Postgraduate Education.', 'Department of Breast Cancer and Reconstructive Surgery, National Institute of Oncology Maria Sklodowskiej-Curie - National Research Institute.', 'Department of Infectious Diseases for Adults, Medical University of Warsaw.', 'Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute.']",['eng'],['Journal Article'],,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,IM,"['*COVID-19', '*Communicable Diseases/epidemiology/therapy', 'Female', 'Humans', 'Male', 'Pandemics', 'Poland', ""Women's Health""]",,['NOTNLM'],"['HIV', 'HPV', 'sexually transmitted infections', ""women's health""]",2022/07/22 06:00,2022/07/23 06:00,['2022/07/21 03:29'],"['2022/07/21 03:29 [entrez]', '2022/07/22 06:00 [pubmed]', '2022/07/23 06:00 [medline]']",['10.32394/pe.76.03 [doi]'],ppublish,Przegl Epidemiol. 2022;76(1):19-28. doi: 10.32394/pe.76.03.,,,,,,,,,,,,,,,,,
26363622,NLM,MEDLINE,20160727,20151020,1618-0607 (Electronic) 1438-4221 (Linking),305,7,2015 Oct,Twenty years of National Reference and Consultant laboratories for infectious diseases in Germany.,591-4,S1438-4221(15)00069-7 [pii] 10.1016/j.ijmm.2015.08.006 [doi],,,"['Vogel, Ulrich', 'Beermann, Sandra', 'Gerlich, Wolfram', 'Hamouda, Osamah', 'Kempf, Volkhard A J', 'Slack, Mary']","['Vogel U', 'Beermann S', 'Gerlich W', 'Hamouda O', 'Kempf VA', 'Slack M']","['University of Wurzburg, Institute for Hygiene and Microbiology, National Reference Centre for Meningococci and Haemophilus influenzae, Josef-Schneider-Str. 2 (E1), 97080 Wurzburg, Germany. Electronic address: vogel_u@ukw.de.', 'Robert Koch Institute, Department of Infectious Diseases Epidemiology, Berlin, Germany.', 'Justus Liebig University Giessen, Institute for Medical Virology, National Reference Centre for Hepatitis B and D, Giessen, Germany.', 'Robert Koch Institute, Department of Infectious Diseases Epidemiology, Berlin, Germany.', 'University Hospital of Frankfurt am Main, Institute for Medical Microbiology and Infection Control, National Consultant Laboratory for Bartonella spp., Frankfurt am Main, Germany.', 'School of Medicine, Griffith University, Gold Coast Campus, Southport, QLD, Australia.']",['eng'],['Editorial'],20150821,Germany,Int J Med Microbiol,International journal of medical microbiology : IJMM,100898849,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*epidemiology', '*Consultants', 'Germany/epidemiology', 'Humans', '*Laboratories', 'Microbiological Techniques/*methods/*standards']",,['NOTNLM'],"['Infectious diseases', 'Public health microbiology', 'Reference laboratories']",2015/09/14 06:00,2016/07/28 06:00,['2015/09/14 06:00'],"['2015/09/14 06:00 [entrez]', '2015/09/14 06:00 [pubmed]', '2016/07/28 06:00 [medline]']","['S1438-4221(15)00069-7 [pii]', '10.1016/j.ijmm.2015.08.006 [doi]']",ppublish,Int J Med Microbiol. 2015 Oct;305(7):591-4. doi: 10.1016/j.ijmm.2015.08.006. Epub 2015 Aug 21.,,,,,,,,,,,,,,,,,
9559100,NLM,MEDLINE,19980529,20180608,0895-3988 (Print) 0895-3988 (Linking),11,1,1998 Mar,Infectious disease surveillance in China.,31-7,,"A national system of infectious disease surveillance was established in 1959 in China. Now it consists of three subunits, namely, national disease reporting system (NDRS), nationwide disease surveillance points (DSPs), and surveillance network for specific infectious diseases. There are 35 notifiable infectious diseases, which are divided into Classes A, B, and C. The functions of the surveillance include explaining the natural history of infectious diseases, describing the distribution of case occurrence, triggering disease-control effort, monitoring epidemic of infectious diseases during natural disasters, predicting and controlling epidemics and providing the base of policy adjustment.",,"['Zeng, G', 'Zhang, J K', 'Rou, K M', 'Xu, C', 'Cheng, Y K', 'Qi, G M']","['Zeng G', 'Zhang JK', 'Rou KM', 'Xu C', 'Cheng YK', 'Qi GM']","['Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine, Beijing, China.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,China,Biomed Environ Sci,Biomedical and environmental sciences : BES,8909524,IM,"['China/epidemiology', 'Communicable Diseases/classification/*epidemiology', 'Cross-Sectional Studies', 'Disasters', 'Disease Notification', 'History, 20th Century', 'Humans', '*Population Surveillance', 'Risk Assessment']",,,,1998/04/29 00:00,1998/04/29 00:01,['1998/04/29 00:00'],"['1998/04/29 00:00 [pubmed]', '1998/04/29 00:01 [medline]', '1998/04/29 00:00 [entrez]']",,ppublish,Biomed Environ Sci. 1998 Mar;11(1):31-7.,,,,,,5,,,,,,,,,,,
14419388,NLM,MEDLINE,19981101,20181201,,29,,1959,[Clinical significance of artificial respiration in infectious diseases].,1431-44,,,,"['MACH, B']",['MACH B'],,['pol'],['Journal Article'],,Poland,Pol Arch Med Wewn,Polskie Archiwum Medycyny Wewnetrznej,0401225,OM,"['Communicable Diseases/*therapy', 'Humans', '*Respiration, Artificial']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*RESPIRATION, ARTIFICIAL']",1959/01/01 00:00,1959/01/01 00:01,['1959/01/01 00:00'],"['1959/01/01 00:00 [pubmed]', '1959/01/01 00:01 [medline]', '1959/01/01 00:00 [entrez]']",,ppublish,Pol Arch Med Wewn. 1959;29:1431-44.,,,,,,,,,,,,,,,,,
17462726,NLM,MEDLINE,20070918,20071115,0093-691X (Print) 0093-691X (Linking),68,3,2007 Aug,Relative risks and approaches to biosecurity in the use of embryo technologies in livestock.,298-307,,"Embryo technologies have been integrated into production systems for a variety of livestock species. As relates to transmission of infectious diseases, our working hypothesis has been that use of embryo transfer for distribution of germ plasm within and between herds and flocks is likely safer than the movement of postnatal animals. Indeed, research and experience generally have been supportive of this hypothesis. However, the relative risks of transmitting infectious agents via embryo transfer vary among donor species. Further, different methods of producing embryos appear to present different risks. This paper provides a comparative overview of the risks of transmitting infectious diseases via transfer of both in vivo- and in vitro-derived embryos in common domesticated livestock species. Also discussed are universal approaches to biosecurity in embryo production and transfer.",,"['Givens, M Daniel', 'Gard, Julie A', 'Stringfellow, David A']","['Givens MD', 'Gard JA', 'Stringfellow DA']","['Department of Pathobiology, College of Veterinary Medicine, Auburn University, AL 36849, USA. givenmd@vetmed.auburn.edu']",['eng'],"['Comparative Study', 'Journal Article']",20070425,United States,Theriogenology,Theriogenology,0421510,IM,"['Animals', 'Animals, Domestic/*embryology/*microbiology/physiology', 'Cattle', 'Communicable Diseases/embryology/transmission/*veterinary', 'Embryo Transfer/*veterinary', 'Embryo, Mammalian/*microbiology', 'Risk Assessment']",,,,2007/04/28 09:00,2007/09/19 09:00,['2007/04/28 09:00'],"['2007/04/28 09:00 [pubmed]', '2007/09/19 09:00 [medline]', '2007/04/28 09:00 [entrez]']","['S0093-691X(07)00132-X [pii]', '10.1016/j.theriogenology.2007.04.004 [doi]']",ppublish,Theriogenology. 2007 Aug;68(3):298-307. doi: 10.1016/j.theriogenology.2007.04.004. Epub 2007 Apr 25.,,,,,,,,,,,,,,,,,
13204719,NLM,MEDLINE,20030501,20181201,0014-2565 (Print) 0014-2565 (Linking),54,1,1954 Jul 15,[Thorn's test and its modification in infectious diseases].,13-9,,,,"['ROMERO, E', 'PATON, C', 'SOLOAGA, A']","['ROMERO E', 'PATON C', 'SOLOAGA A']",,['spa'],['Journal Article'],,Spain,Rev Clin Esp,Revista clinica espanola,8608576,OM,"['*Adrenal Cortex', '*Adrenal Cortex Function Tests', 'Communicable Diseases/*diagnosis']",,['NLM'],"['*ADRENAL CORTEX/function tests', '*COMMUNICABLE DISEASES/diagnosis']",1954/07/15 00:00,1954/07/15 00:01,['1954/07/15 00:00'],"['1954/07/15 00:00 [pubmed]', '1954/07/15 00:01 [medline]', '1954/07/15 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1954 Jul 15;54(1):13-9.,,,,,,,,,La prueba de Thorn y modificacion a la misma en las enfermedades infecciosas.,,,['CLML: 5527:16389:12:120'],,,,,
30387413,NLM,MEDLINE,20190301,20200309,2165-0497 (Electronic) 2165-0497 (Linking),6,6,2018 Nov,"Advances in Molecular Epidemiology of Infectious Diseases: Definitions, Approaches, and Scope of the Field.",,10.1128/microbiolspec.AME-0001-2018 [doi],"Molecular epidemiology is a discipline that uses molecular microbiology tools to study the distribution and determinants of diseases in human populations and veterinary animals. Our understanding of epidemiology of infectious diseases has evolved with technological advancements made in molecular biology that refine our perception of the identity and dynamics of microorganisms. This review is an introduction to the Microbiology Spectrum Curated Collection: Advances in Molecular Epidemiology of Infectious Diseases that will discuss how these advancements have contributed to investigations of infectious disease outbreaks/epidemics, surveillance, transmission dynamics, risk factor identification, pathogenesis, and etiologic attribution of bacterial, viral, protozoan, and helminthic pathogens to a disease. Here we define ""molecular epidemiology"" and distinguish it from other disciplines that use many of the same molecular biology tools-taxonomy, phylogenetics, and molecular evolution of microorganisms. The Curated Collection will be spread throughout multiple issues of Microbiology Spectrum and will be divided into four general sections: (i) laboratory methods used to strain type microbial pathogens, (ii) methods used to analyze genotyping data, (iii) examples of molecular epidemiologic investigations of bacterial, viral, and parasitic diseases, and (iv) applications of molecular epidemiology to address new research questions in communicable and noncommunicable diseases. The major theme of this Curated Collection is to address the following question frequently asked by clinicians, clinical microbiologists, and public health professionals: what is the advantage or unique contribution of molecular epidemiology in solving infectious disease problems in the clinical and public health arenas? *This article is part of a curated collection.",,"['Riley, Lee W', 'Blanton, Ronald E']","['Riley LW', 'Blanton RE']","['Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720.', 'Center for Global Health & Diseases, Case Western Reserve University, Cleveland, OH 44106.']",['eng'],"['Journal Article', 'Review']",,United States,Microbiol Spectr,Microbiology spectrum,101634614,IM,"['Animals', 'Clinical Laboratory Techniques/methods', 'Communicable Diseases/*diagnosis/*epidemiology/transmission', 'Evolution, Molecular', 'Humans', 'Molecular Epidemiology/*methods', 'Phylogeny', 'Public Health', 'Risk Factors']",PMC6343655,,,2018/11/06 06:00,2019/03/02 06:00,['2018/11/03 06:00'],"['2018/11/03 06:00 [entrez]', '2018/11/06 06:00 [pubmed]', '2019/03/02 06:00 [medline]']",['10.1128/microbiolspec.AME-0001-2018 [doi]'],ppublish,Microbiol Spectr. 2018 Nov;6(6):10.1128/microbiolspec.AME-0001-2018. doi: 10.1128/microbiolspec.AME-0001-2018.,,,,,,,['R01 AI121330/AI/NIAID NIH HHS/United States'],,,['NIHMS1002194'],,,,,,,
11545564,NLM,MEDLINE,20011025,20061115,0163-4453 (Print) 0163-4453 (Linking),42,4,2001 May,Apoptotic cell death in the pathogenesis of infectious diseases.,227-34,,"Apoptosis is a physiological process critical for tissue homeostasis. It is essential for the regulation of immune responses. A series of molecules transduce apoptoic signals and induce the characteristic morphological appearances of apoptotic cells. Infectious diseases modulate apoptosis and this contributes to disease pathogenesis. Infection with HIV results in enhanced levels of CD4 T-lymphocyte apoptosis in both directly infected cells and in uninfected bystander cells. A variety of HIV proteins including gp120 contribute to this process. A number of different pathways induce HIV-associated CD4 T-lymphocyte apoptosis and apoptosis of uninfected bystander cells is particularly associated with increased susceptibility to Fas. Other viruses including hepatitis viruses and the human herpesviruses also modulate apoptosis. Bacterial infection induces apoptosis which is frequently mediated by the direct activation of caspases in the absence of death receptor ligation. Bacterial induction of apoptosis may either be due to bacterial factors such as the invasin IpaB of Shigella flexneri or be the result of host immune responses which control infection as demonstrated in infections due to Mycobacterium spp. Apoptosis may be modulated by therapeutic strategies, such as antiretroviral therapy, and an improved understanding of infection-associated apoptosis modulation will aid the design of novel therapeutic approaches to control infectious diseases.",['Copyright 2001 The British Infection Society.'],"['Dockrell, D H']",['Dockrell DH'],"['Division of Genomic Medicine, University of Sheffield Medical School, Department of Infectious Diseases, Royal Hallamshire Hospital, Sheffield, UK. d.h.dockrell@shef.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,J Infect,The Journal of infection,7908424,IM,"['*Apoptosis/immunology', 'CD4-Positive T-Lymphocytes/metabolism', 'Communicable Diseases/enzymology/immunology/*metabolism', 'HIV Infections/metabolism', 'Humans', 'Virus Diseases/metabolism']",,,,2001/09/08 10:00,2001/10/26 10:01,['2001/09/08 10:00'],"['2001/09/08 10:00 [pubmed]', '2001/10/26 10:01 [medline]', '2001/09/08 10:00 [entrez]']","['S0163-4453(01)90836-9 [pii]', '10.1053/jinf.2001.0836 [doi]']",ppublish,J Infect. 2001 May;42(4):227-34. doi: 10.1053/jinf.2001.0836.,,,,,,87,,,,,,,,,,,
29908327,NLM,MEDLINE,20230517,20230517,1873-0442 (Electronic) 1477-8939 (Linking),24,,2018 Jul-Aug,Football fever in Russia: Infectious disease risks and the FIFA world cup 2018.,4-6,S1477-8939(18)30145-5 [pii] 10.1016/j.tmaid.2018.06.010 [doi],,,"['Pshenichnaya, Natalia', 'Petersen, Eskild', 'Patel, Dipti', 'Gautret, Philippe', 'Schlagenhauf, Patricia']","['Pshenichnaya N', 'Petersen E', 'Patel D', 'Gautret P', 'Schlagenhauf P']","['Department of Infectious Diseases, Rostov State Medical University, Rostov-on-Don, Russia; Department of Infectious Diseases and Parasitology, Rostov Scientific Research Institute of Microbiology and Parasitology, Rostov-on-Don, Russia. Electronic address: natalia-pshenichnaya@yandex.ru.', 'Institute for Clinical Medicine, University of Aarhus, Denmark and Department of Infectious Diseases, The Royal Hospital, Muscat, Oman.', 'National Travel Health Network and Centre (NaTHNaC), UCLH NHS Foundation Trust, London NW1 2PG, UK.', 'Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Mediterranee Infection, Marseille, France.', ""University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001 Zurich, Switzerland.""]",['eng'],['Editorial'],20180613,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,IM,"['Humans', 'Climate', 'Communicable Disease Control', '*Communicable Diseases/epidemiology/transmission', '*Crowding', 'Risk Factors', 'Russia', 'Sexually Transmitted Diseases/epidemiology/prevention & control/transmission', '*Soccer']",,,,2018/06/17 06:00,2018/11/22 06:00,['2018/06/17 06:00'],"['2018/06/12 00:00 [received]', '2018/06/12 00:00 [accepted]', '2018/06/17 06:00 [pubmed]', '2018/11/22 06:00 [medline]', '2018/06/17 06:00 [entrez]']","['S1477-8939(18)30145-5 [pii]', '10.1016/j.tmaid.2018.06.010 [doi]']",ppublish,Travel Med Infect Dis. 2018 Jul-Aug;24:4-6. doi: 10.1016/j.tmaid.2018.06.010. Epub 2018 Jun 13.,,,,,,,,,,,,,,,,,
17507975,NLM,MEDLINE,20070605,20231113,1476-4687 (Electronic) 0028-0836 (Print) 0028-0836 (Linking),447,7142,2007 May 17,Origins of major human infectious diseases.,279-83,,"Many of the major human infectious diseases, including some now confined to humans and absent from animals, are 'new' ones that arose only after the origins of agriculture. Where did they come from? Why are they overwhelmingly of Old World origins? Here we show that answers to these questions are different for tropical and temperate diseases; for instance, in the relative importance of domestic animals and wild primates as sources. We identify five intermediate stages through which a pathogen exclusively infecting animals may become transformed into a pathogen exclusively infecting humans. We propose an initiative to resolve disputed origins of major diseases, and a global early warning system to monitor pathogens infecting individuals exposed to wild animals.",,"['Wolfe, Nathan D', 'Dunavan, Claire Panosian', 'Diamond, Jared']","['Wolfe ND', 'Dunavan CP', 'Diamond J']","['Department of Epidemiology, School of Public Health, University of California, Los Angeles 90095-1772, USA. nwolfe@ucla.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",,England,Nature,Nature,0410462,IM,"['Animals', '*Biological Evolution', 'Climate', 'Communicable Diseases/microbiology/parasitology/*transmission/virology', 'Disease Reservoirs/microbiology/parasitology/veterinary/virology', 'Geography', 'Humans', 'Zoonoses/microbiology/parasitology/*transmission/virology']",PMC7095142,,,2007/05/18 09:00,2007/06/06 09:00,['2007/05/18 09:00'],"['2006/09/08 00:00 [received]', '2007/03/22 00:00 [accepted]', '2007/05/18 09:00 [pubmed]', '2007/06/06 09:00 [medline]', '2007/05/18 09:00 [entrez]']","['nature05775 [pii]', 'BFnature05775 [pii]', '10.1038/nature05775 [doi]']",ppublish,Nature. 2007 May 17;447(7142):279-83. doi: 10.1038/nature05775.,"['Reprints and permissions information is available at www.nature.com/reprints. The', 'authors declare no competing financial interests.']",,,,,,,,,,,,,,,,
1405829,NLM,MEDLINE,19921112,20190817,0025-7125 (Print) 0025-7125 (Linking),76,6,1992 Nov,Tropical diseases in immigrants and internationally adopted children.,1463-80,,"Immigrants, particularly those from the developing world, make up a significant number of tropical disease cases seen in a temperate climate. Internationally adopted children are another group in which tropical and other infectious diseases must be considered. The differential diagnoses of various syndromes in these populations in relation to relatively more common tropical diseases are reviewed.",,"['Wolfe, M S']",['Wolfe MS'],"[""Traveler's Medical Service, Washington, DC.""]",['eng'],"['Journal Article', 'Review']",,United States,Med Clin North Am,The Medical clinics of North America,2985236R,IM,"['*Adoption', 'Child', '*Communicable Diseases/diagnosis/therapy', 'Diagnosis, Differential', '*Emigration and Immigration', 'Humans', '*Tropical Medicine', 'United States']",,,,1992/11/01 00:00,1992/11/01 00:01,['1992/11/01 00:00'],"['1992/11/01 00:00 [pubmed]', '1992/11/01 00:01 [medline]', '1992/11/01 00:00 [entrez]']","['S0025-7125(16)30297-8 [pii]', '10.1016/s0025-7125(16)30297-8 [doi]']",ppublish,Med Clin North Am. 1992 Nov;76(6):1463-80. doi: 10.1016/s0025-7125(16)30297-8.,,,,,,84,,,,,,,,,,,
28051192,NLM,MEDLINE,20170825,20220410,2008-6814 (Electronic) 2008-6520 (Print) 2008-6520 (Linking),8,1,2017 Jan,Global Warming and Its Health Impact.,7-20,10.15171/ijoem.2017.963 [doi],"Since the mid-19th century, human activities have increased greenhouse gases such as carbon dioxide, methane, and nitrous oxide in the Earth's atmosphere that resulted in increased average temperature. The effects of rising temperature include soil degradation, loss of productivity of agricultural land, desertification, loss of biodiversity, degradation of ecosystems, reduced fresh-water resources, acidification of the oceans, and the disruption and depletion of stratospheric ozone. All these have an impact on human health, causing non-communicable diseases such as injuries during natural disasters, malnutrition during famine, and increased mortality during heat waves due to complications in chronically ill patients. Direct exposure to natural disasters has also an impact on mental health and, although too complex to be quantified, a link has even been established between climate and civil violence. Over time, climate change can reduce agricultural resources through reduced availability of water, alterations and shrinking arable land, increased pollution, accumulation of toxic substances in the food chain, and creation of habitats suitable to the transmission of human and animal pathogens. People living in low-income countries are particularly vulnerable. Climate change scenarios include a change in distribution of infectious diseases with warming and changes in outbreaks associated with weather extreme events. After floods, increased cases of leptospirosis, campylobacter infections and cryptosporidiosis are reported. Global warming affects water heating, rising the transmission of water-borne pathogens. Pathogens transmitted by vectors are particularly sensitive to climate change because they spend a good part of their life cycle in a cold-blooded host invertebrate whose temperature is similar to the environment. A warmer climate presents more favorable conditions for the survival and the completion of the life cycle of the vector, going as far as to speed it up as in the case of mosquitoes. Diseases transmitted by mosquitoes include some of the most widespread worldwide illnesses such as malaria and viral diseases. Tick-borne diseases have increased in the past years in cold regions, because rising temperatures accelerate the cycle of development, the production of eggs, and the density and distribution of the tick population. The areas of presence of ticks and diseases that they can transmit have increased, both in terms of geographical extension than in altitude. In the next years the engagement of the health sector would be working to develop prevention and adaptation programs in order to reduce the costs and burden of climate change.",,"['Rossati, Antonella']",['Rossati A'],"['Department of Infectious Diseases, University Hospital ""Maggiore della Carita"", Novara, Italy. arossati@yahoo.com.']",['eng'],['Journal Article'],,Iran,Int J Occup Environ Med,The international journal of occupational and environmental medicine,101535763,IM,"['Agriculture', 'Climate Change', 'Communicable Diseases/epidemiology/etiology/transmission', 'Disasters', '*Environmental Health', '*Global Warming', 'Humans', '*Public Health']",PMC6679631,['NOTNLM'],"['Climate change', 'Communicable diseases, emerging', 'Global warming', 'Infectious disease medicine', 'Temperature', 'Tick-borne diseases', 'Weather']",2017/01/05 06:00,2017/08/26 06:00,['2017/01/05 06:00'],"['2016/11/21 00:00 [received]', '2016/11/29 00:00 [accepted]', '2017/01/05 06:00 [entrez]', '2017/01/05 06:00 [pubmed]', '2017/08/26 06:00 [medline]']","['963 [pii]', '10.15171/ijoem.2017.963 [doi]']",ppublish,Int J Occup Environ Med. 2017 Jan;8(1):7-20. doi: 10.15171/ijoem.2017.963.,['None declared.'],,,,,,,,,,,,,,,,
8080145,NLM,MEDLINE,19941005,20190717,0196-0644 (Print) 0196-0644 (Linking),24,3,1994 Sep,The role of new antibiotics for the treatment of infections in the emergency department.,473-89,,Treatment of infectious diseases comprises a large part of emergency medicine practice. The management of infectious diseases in the emergency department is often different than in other settings because of the types of infectious presentations and the frequent necessity of empiric treatment decisions. This paper examines the new antimicrobials and their role for the treatment of infections in the ED.,,"['Talan, D A']",['Talan DA'],"['Department of Emergency Medicine, Olive View-UCLA Medical Center, Sylmar.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Emerg Med,Annals of emergency medicine,8002646,IM,"['Anti-Bacterial Agents/classification/economics/pharmacology/*therapeutic use', 'Clinical Protocols', 'Communicable Diseases/diagnosis/*drug therapy/microbiology', 'Decision Making', 'Drug Costs', 'Drug Resistance, Microbial', 'Emergency Service, Hospital', 'Forecasting', 'Humans', 'Microbial Sensitivity Tests', 'Patient Compliance', 'Tissue Distribution']",,,,1994/09/01 00:00,1994/09/01 00:01,['1994/09/01 00:00'],"['1994/09/01 00:00 [pubmed]', '1994/09/01 00:01 [medline]', '1994/09/01 00:00 [entrez]']","['S0196064494001812 [pii]', '10.1016/s0196-0644(94)70186-5 [doi]']",ppublish,Ann Emerg Med. 1994 Sep;24(3):473-89. doi: 10.1016/s0196-0644(94)70186-5.,,,['0 (Anti-Bacterial Agents)'],,,154,,,,,,,,,,,
13630124,NLM,MEDLINE,20000701,20181201,0012-0472 (Print) 0012-0472 (Linking),84,7,1959 Feb 13,[Role of general biological laws in the pathogenesis of infectious diseases].,255-7,,,,"['HORING, F O']",['HORING FO'],,['ger'],['Journal Article'],,Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,OM,"['Communicable Diseases/*etiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/etiology and pathogenesis'],1959/02/13 00:00,1959/02/13 00:01,['1959/02/13 00:00'],"['1959/02/13 00:00 [pubmed]', '1959/02/13 00:01 [medline]', '1959/02/13 00:00 [entrez]']",['10.1055/s-0028-1113585 [doi]'],ppublish,Dtsch Med Wochenschr. 1959 Feb 13;84(7):255-7. doi: 10.1055/s-0028-1113585.,,,,,,,,,Aligemein-biologische Gesetzmassigkeiten in der Pathogenese der Infektionskrankheiten.,,,['CLML: 5936:3946:140'],,,,,
26583380,NLM,MEDLINE,20160404,20181113,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),9,11,2015 Nov,Arthropod Vectors and Disease Transmission: Translational Aspects.,e0004107,10.1371/journal.pntd.0004107 [doi] e0004107,,,"['Leitner, Wolfgang W', 'Wali, Tonu', 'Kincaid, Randall', 'Costero-Saint Denis, Adriana']","['Leitner WW', 'Wali T', 'Kincaid R', 'Costero-Saint Denis A']","['Division on Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.']",['eng'],"['Consensus Development Conference, NIH', 'Journal Article', 'Research Support, N.I.H., Extramural']",20151119,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,IM,"['Animals', '*Arthropod Vectors', 'Communicable Disease Control/*methods', 'Communicable Diseases/*epidemiology/*transmission', 'Disease Transmission, Infectious/*prevention & control', 'Humans']",PMC4652900,,,2015/11/20 06:00,2016/04/05 06:00,['2015/11/20 06:00'],"['2015/11/20 06:00 [entrez]', '2015/11/20 06:00 [pubmed]', '2016/04/05 06:00 [medline]']","['PNTD-D-15-00734 [pii]', '10.1371/journal.pntd.0004107 [doi]']",epublish,PLoS Negl Trop Dis. 2015 Nov 19;9(11):e0004107. doi: 10.1371/journal.pntd.0004107. eCollection 2015 Nov.,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,
22356189,NLM,MEDLINE,20120619,20190918,1875-5607 (Electronic) 1389-5575 (Linking),12,3,2012 Mar,Editorial: looking beyond the obvious: search for novel targets and drugs for reducing the burden of infectious diseases.,185-6,,,,"['Arora, Neelima', 'Banerjee, Amit Kumar']","['Arora N', 'Banerjee AK']",,['eng'],"['Editorial', 'Introductory Journal Article']",,Netherlands,Mini Rev Med Chem,Mini reviews in medicinal chemistry,101094212,IM,"['Anti-Infective Agents/chemistry/*pharmacology', 'Communicable Diseases/*drug therapy/epidemiology', '*Drug Discovery/methods', 'Humans']",,,,2012/02/24 06:00,2012/06/20 06:00,['2012/02/24 06:00'],"['2012/02/24 06:00 [entrez]', '2012/02/24 06:00 [pubmed]', '2012/06/20 06:00 [medline]']","['CRMC-12-3-185 [pii]', '10.2174/1389557511209030185 [doi]']",ppublish,Mini Rev Med Chem. 2012 Mar;12(3):185-6. doi: 10.2174/1389557511209030185.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
5695750,NLM,MEDLINE,19681124,20031114,0043-535X (Print) 0043-535X (Linking),55,2,1968,[Pathogenesis and control of infectious diseases of calves in the nonatal phase special regard to prevention of infection by artificial inoculation of bacteria].,65-83,,,,"['Mayr, A']",['Mayr A'],,['ger'],['Journal Article'],,Austria,Wien Tierarztl Monatsschr,Wiener tierarztliche Monatsschrift,0413611,IM,"['Animals', 'Animals, Newborn/*immunology', 'Bacteria/immunology', 'Cattle', 'Cattle Diseases/etiology/*prevention & control', 'Communicable Disease Control', 'Communicable Diseases/etiology/*veterinary']",,,,1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,Wien Tierarztl Monatsschr. 1968;55(2):65-83.,,,,,,,,,Pathogenese und Bekampfung der infektiosen Kalbererkrankungen in der Neugeborenen-Phase unter besonderer Berucksichtigung einer infektionsprophylaxe durch kunstliche Keimbesidlung.,,,,,,,,
19587590,NLM,MEDLINE,20091216,20141120,1473-6527 (Electronic) 0951-7375 (Linking),22,5,2009 Oct,Emerging clinical issues in refugees.,436-42,10.1097/QCO.0b013e32832f14a4 [doi],"PURPOSE OF REVIEW: The world's population is becoming increasing mobile. Each mobile population (e.g. immigrants, refugees, travelers) has certain characteristics that determine public health risk and infectious disease burden. Refugees present unique challenges to public health officials and infectious disease specialists. RECENT FINDINGS: Refugee migration to the United States represents the most controlled population movement between countries from a health perspective. Medical screening and programs that provide presumptive treatment for highly prevalent infectious diseases both prior to and after migration alter the infectious disease epidemiology in these populations. SUMMARY: Infectious disease specialists must recognize that different characteristics of distinct mobile populations will alter infectious disease burden. This article specifically highlights how recent public health approaches have altered the epidemiology and clinical presentation of malaria, intestinal parasites and tuberculosis in refugee populations.",,"['Stauffer, William M', 'Weinberg, Michelle']","['Stauffer WM', 'Weinberg M']","['Department of Medicine and Pediatrics, Infectious Diseases and International Health, University of Minnesota, Minneapolis, Minnesota 55455, USA. stauf005@umn.edu']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Infect Dis,Current opinion in infectious diseases,8809878,IM,"['Communicable Diseases/*epidemiology/ethnology', 'Global Health', 'Humans', '*Refugees']",,,,2009/07/10 09:00,2009/12/17 06:00,['2009/07/10 09:00'],"['2009/07/10 09:00 [entrez]', '2009/07/10 09:00 [pubmed]', '2009/12/17 06:00 [medline]']",['10.1097/QCO.0b013e32832f14a4 [doi]'],ppublish,Curr Opin Infect Dis. 2009 Oct;22(5):436-42. doi: 10.1097/QCO.0b013e32832f14a4.,,,,,,37,,,,,,,,,,,
13123796,NLM,MEDLINE,20030501,20181201,,12,11,1953 Nov,Neurological complications in infectious diseases.,279-87,,,,"['FALK, W']",['FALK W'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['*Central Nervous System Depressants', 'Communicable Diseases/*complications', '*Nervous System', '*Nervous System Diseases']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*NERVOUS SYSTEM']",1953/11/01 00:00,1953/11/01 00:01,['1953/11/01 00:00'],"['1953/11/01 00:00 [pubmed]', '1953/11/01 00:01 [medline]', '1953/11/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1953 Nov;12(11):279-87.,,,['0 (Central Nervous System Depressants)'],,,,,,,,,['CLML: 5425:45170:117:317'],,,,,
13396273,NLM,MEDLINE,20020501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,5015,1957 Feb 16,GRAPHS of infectious diseases.,412-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', 'Humans']",PMC1974390,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1957/02/16 00:00,1957/02/16 00:01,['1957/02/16 00:00'],"['1957/02/16 00:00 [pubmed]', '1957/02/16 00:01 [medline]', '1957/02/16 00:00 [entrez]']",,ppublish,Br Med J. 1957 Feb 16;1(5015):412-3.,,,,,,,,,,,,['CLML: 5731:42895'],,,,,
13052239,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),44,2,1953 Jan 15,[STATISTICS of infectious diseases during December 1952].,48,,,,,,,['und'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/01/15 00:00,1953/01/15 00:01,['1953/01/15 00:00'],"['1953/01/15 00:00 [pubmed]', '1953/01/15 00:01 [medline]', '1953/01/15 00:00 [entrez]']",,ppublish,Harefuah. 1953 Jan 15;44(2):48.,,,,,,,,,,,,['CLML: 5324:22796:162'],,,,,
13105265,NLM,MEDLINE,20030501,20181201,0066-4219 (Print) 0066-4219 (Linking),4,,1953,Infectious diseases.,1-20,,,,"['TILLETT, W S']",['TILLETT WS'],,['eng'],['Journal Article'],,United States,Annu Rev Med,Annual review of medicine,2985151R,OM,"['*Anti-Bacterial Agents', 'Communicable Diseases/*therapy', '*Drug Therapy', 'Humans']",,['NLM'],"['*ANTIBIOTICS', '*CHEMOTHERAPY', '*COMMUNICABLE DISEASES/therapy']",1953/01/01 00:00,1953/01/01 00:01,['1953/01/01 00:00'],"['1953/01/01 00:00 [pubmed]', '1953/01/01 00:01 [medline]', '1953/01/01 00:00 [entrez]']",['10.1146/annurev.me.04.020153.000245 [doi]'],ppublish,Annu Rev Med. 1953;4:1-20. doi: 10.1146/annurev.me.04.020153.000245.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,['CLML: 5425:26423:33:103:117'],,,,,
30859623,NLM,MEDLINE,20200930,20200930,1399-0012 (Electronic) 0902-0063 (Linking),33,9,2019 Sep,"Travel medicine, transplant tourism, and the solid organ transplant recipient-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.",e13529,10.1111/ctr.13529 [doi],"These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review recommendations for prevention and management of travel-related infection in solid organ transplant (SOT) recipients as well as risks associated with transplant tourism. Counseling regarding travel post-transplant should be included during the pre-transplant evaluation, and all SOT recipients should be seen by a travel medicine specialist prior to traveling to destinations with higher rates of infection. Patients should be advised on vaccine-preventable illnesses as well as any need for prophylaxis (ie, malaria) based on their individual travel itineraries. Information with regards to specific recommendations for vaccines and prophylactic medications, along with drug-drug interactions, is summarized. Counseling should be provided for modifiable risks and exposures (ie, food and water safety, and insect bite prevention) as well as non-infectious travel topics. These guidelines also briefly address risks associated with transplant tourism and specific infections to consider if patients seek care for transplants done in foreign countries.",['(c) 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],"['Buchan, C Arianne', 'Kotton, Camille Nelson']","['Buchan CA', 'Kotton CN']","['Division of Infectious Diseases, The Ottawa Hospital, Ottawa, Ontario, Canada.', 'Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.', 'The University of Ottawa, Ottawa, Ontario, Canada.', 'The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.', 'Transplant Infectious Disease and Compromised Host Program, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts.', ""Travelers' Advice and Immunization Center, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts."", 'Department of Medicine, Harvard Medical School, Boston, Massachusetts.']",['eng'],['Journal Article'],20190414,Denmark,Clin Transplant,Clinical transplantation,8710240,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*diagnosis/*drug therapy/etiology', 'Humans', 'Medical Tourism/*statistics & numerical data', 'Organ Transplantation/*adverse effects', 'Practice Guidelines as Topic/*standards', 'Societies, Medical', 'Transplant Recipients', 'Travel Medicine/*statistics & numerical data', '*Travel-Related Illness']",,['NOTNLM'],"['solid organ transplant', 'travel medicine', 'vaccinations', 'vaccines']",2019/03/13 06:00,2020/10/02 06:00,['2019/03/13 06:00'],"['2019/02/10 00:00 [received]', '2019/02/26 00:00 [accepted]', '2019/03/13 06:00 [pubmed]', '2020/10/02 06:00 [medline]', '2019/03/13 06:00 [entrez]']",['10.1111/ctr.13529 [doi]'],ppublish,Clin Transplant. 2019 Sep;33(9):e13529. doi: 10.1111/ctr.13529. Epub 2019 Apr 14.,,['ORCID: 0000-0001-7320-2234'],['0 (Anti-Infective Agents)'],,,,,,,,['AST Infectious Diseases Community of Practice'],,,,,,
13506717,NLM,MEDLINE,20000701,20181201,0256-9574 (Print),31,49,1957 Dec 7,Immune globulin and its use in prophylaxis and therapy of infectious diseases.,1242-4,,,,"['POLSON, A']",['POLSON A'],,['eng'],['Journal Article'],,South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,OM,"['Communicable Diseases/*therapy', 'Humans', '*Immunoglobulins']",,['NLM'],['*COMMUNICABLE DISEASES/therapy'],1957/12/07 00:00,1957/12/07 00:01,['1957/12/07 00:00'],"['1957/12/07 00:00 [pubmed]', '1957/12/07 00:01 [medline]', '1957/12/07 00:00 [entrez]']",,ppublish,S Afr Med J. 1957 Dec 7;31(49):1242-4.,,,['0 (Immunoglobulins)'],,,,,,,,,['CLML: 5833:49834:135'],,,,,
8358644,NLM,MEDLINE,19930930,20191101,0749-0739 (Print) 0749-0739 (Linking),9,2,1993 Aug,Application of epidemiologic principles and methods to investigating and controlling equine infectious diseases.,247-55,,Epidemiology is a tool much like any other diagnostic tool that the practitioner uses as an aid in the complete physical examination of the group of animals. It can be used to generate a specific differential diagnosis list. Epidemiology is especially useful to design a disease control and prevention program by helping to elucidate the key determinants of disease occurrence.,,"['Dargatz, D A', 'Salman, M D']","['Dargatz DA', 'Salman MD']","['Center for Epidemiology, United States Department of Agriculture, Fort Collins, Colorado.']",['eng'],"['Journal Article', 'Review']",,United States,Vet Clin North Am Equine Pract,The Veterinary clinics of North America. Equine practice,8511904,IM,"['Animals', 'Communicable Disease Control', 'Communicable Diseases/diagnosis/epidemiology/*veterinary', 'Disease Outbreaks/*veterinary', 'Epidemiologic Methods/*veterinary', 'Female', 'Horse Diseases/diagnosis/*epidemiology/prevention & control', 'Horses', 'Male', 'Prevalence']",,,,1993/08/01 00:00,1993/08/01 00:01,['1993/08/01 00:00'],"['1993/08/01 00:00 [pubmed]', '1993/08/01 00:01 [medline]', '1993/08/01 00:00 [entrez]']","['S0749-0739(17)30394-2 [pii]', '10.1016/s0749-0739(17)30394-2 [doi]']",ppublish,Vet Clin North Am Equine Pract. 1993 Aug;9(2):247-55. doi: 10.1016/s0749-0739(17)30394-2.,,,,,,5,,,,,,,,,,,
21287729,NLM,MEDLINE,20110208,20181201,0040-7453 (Print) 0040-7453 (Linking),135,24,2010 Dec 15,[Emerging infectious diseases and antibiotic resistance].,974-5,,,,,,,['dut'],['Congress'],,Netherlands,Tijdschr Diergeneeskd,Tijdschrift voor diergeneeskunde,0031550,IM,"['Animals', 'Communicable Diseases, Emerging/epidemiology/*transmission/*veterinary', '*Drug Resistance, Bacterial', 'Humans', 'Netherlands/epidemiology', '*Zoonoses']",,,,2011/02/04 06:00,2011/02/09 06:00,['2011/02/04 06:00'],"['2011/02/04 06:00 [entrez]', '2011/02/04 06:00 [pubmed]', '2011/02/09 06:00 [medline]']",,ppublish,Tijdschr Diergeneeskd. 2010 Dec 15;135(24):974-5.,,,,,,,,,Opkomende infectieziekten en antibioticaresistentie.,,,,,,,,
420180,NLM,MEDLINE,19790425,20190716,0002-922X (Print) 0002-922X (Linking),133,2,1979 Feb,Priorities for government-sponsored research in pediatric infectious diseases.,132-3,,,,"['Nelson, J D']",['Nelson JD'],,['eng'],['Journal Article'],,United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Child', '*Communicable Diseases/diagnosis/immunology', 'Diarrhea/microbiology', 'Humans', '*National Institutes of Health (U.S.)', '*Research Support as Topic', 'United States', 'Vaccines']",,,,1979/02/01 00:00,1979/02/01 00:01,['1979/02/01 00:00'],"['1979/02/01 00:00 [pubmed]', '1979/02/01 00:01 [medline]', '1979/02/01 00:00 [entrez]']",['10.1001/archpedi.1979.02130020022003 [doi]'],ppublish,Am J Dis Child. 1979 Feb;133(2):132-3. doi: 10.1001/archpedi.1979.02130020022003.,,,['0 (Vaccines)'],,,,,,,,,,,,,,
13173334,NLM,MEDLINE,20030501,20191210,0096-0217 (Print) 0096-0217 (Linking),26,1,1954 Jul,Modern chemotherapy of infectious diseases; implications and significance.,1-14,,,,"['FELDMAN, W H']",['FELDMAN WH'],,['eng'],['Journal Article'],,United States,Dis Chest,Diseases of the chest,0231342,OM,"['Communicable Diseases/*therapy', '*Drug Therapy', 'Humans', 'Infections/*therapy']",,['NLM'],"['*CHEMOTHERAPY', '*COMMUNICABLE DISEASES/therapy', '*INFECTION/therapy']",1954/07/01 00:00,1954/07/01 00:01,['1954/07/01 00:00'],"['1954/07/01 00:00 [pubmed]', '1954/07/01 00:01 [medline]', '1954/07/01 00:00 [entrez]']",['10.1378/chest.26.1.1 [doi]'],ppublish,Dis Chest. 1954 Jul;26(1):1-14. doi: 10.1378/chest.26.1.1.,,,,,,,,,,,,['CLML: 5426:36163:103:118:231'],,,,,
13071410,NLM,MEDLINE,20030501,20181201,0025-8458 (Print) 0025-8458 (Linking),48,15,1953 Apr 10,The nervous system and the mind in infectious diseases.,493-5,,,,"['HORING, F O']",['HORING FO'],,"['eng', 'und']",['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,OM,"['Communicable Diseases/*complications', 'Humans', '*Nervous System']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*NERVOUS SYSTEM']",1953/04/10 00:00,1953/04/10 00:01,['1953/04/10 00:00'],"['1953/04/10 00:00 [pubmed]', '1953/04/10 00:01 [medline]', '1953/04/10 00:00 [entrez]']",,ppublish,Med Klin. 1953 Apr 10;48(15):493-5.,,,,,,,,,Nervensystem und Psyche bei Infektionskrankheiten.,,,['CLML: 5324:42113:161:435'],,,,,
13257819,NLM,MEDLINE,20030501,20200716,0372-9311 (Print) 0372-9311 (Linking),,8,1955 Aug,[New methods of early diagnosis of infectious diseases].,54-9,,,,"[""GAL'PERIN, M E""]","[""GAL'PERIN ME""]",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['Communicable Diseases/*diagnosis', '*Early Diagnosis', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1955/08/01 00:00,1955/08/01 00:01,['1955/08/01 00:00'],"['1955/08/01 00:00 [pubmed]', '1955/08/01 00:01 [medline]', '1955/08/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1955 Aug;(8):54-9.,,,,,,,,,Novye puti rannei diagnostiki infektsionnykh zabolevanii.,,,['CLML: 5629:9683'],,,,,
27131142,NLM,MEDLINE,20171213,20200410,1527-3296 (Electronic) 0196-6553 (Print) 0196-6553 (Linking),44,5 Suppl,2016 May 2,"Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9).",e91-e100,S0196-6553(15)01183-9 [pii] 10.1016/j.ajic.2015.11.018 [doi],"Over the past several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. New and emerging infectious diseases which are both transmissible from patient-to-patient and virulent with a high mortality include novel coronaviruses (SARS-CoV, MERS-CV), hemorrhagic fever viruses (Lassa, Ebola), and highly pathogenic avian influenza A viruses, A(H5N1) and A(H7N9). All healthcare facilities need to have policies and plans in place for early identification of patients with a highly communicable diseases which are highly virulent, ability to immediately isolate such patients, and provide proper management (e.g., training and availability of personal protective equipment) to prevent transmission to healthcare personnel, other patients and visitors to the healthcare facility.","['Copyright (c) 2016 Association for Professionals in Infection Control and', 'Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.']","['Weber, David J', 'Rutala, William A', 'Fischer, William A', 'Kanamori, Hajime', 'Sickbert-Bennett, Emily E']","['Weber DJ', 'Rutala WA', 'Fischer WA', 'Kanamori H', 'Sickbert-Bennett EE']","['Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: dweber@unch.unc.edu.', 'Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC.', 'Division of Pulmonary and Critical Care Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.', 'Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC.', 'Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,United States,Am J Infect Control,American journal of infection control,8004854,IM,"['Communicable Diseases, Emerging/diagnosis/*epidemiology/*prevention & control/therapy', 'Global Health', 'Humans', 'Infection Control/*methods', 'Organizational Policy', 'Virus Diseases/diagnosis/*epidemiology/*prevention & control/therapy']",PMC7132650,['NOTNLM'],"['Ebola viral disease', 'Emerging infectious diseases', 'Lassa fever', 'Middle East respiratory syndrome', 'health care-associated infections', 'infection control', 'novel influenza viruses', 'occupational health', 'severe acute respiratory disease']",2016/05/01 06:00,2017/12/14 06:00,['2016/05/01 06:00'],"['2015/11/10 00:00 [received]', '2015/11/11 00:00 [accepted]', '2016/05/01 06:00 [entrez]', '2016/05/01 06:00 [pubmed]', '2017/12/14 06:00 [medline]']","['S0196-6553(15)01183-9 [pii]', '10.1016/j.ajic.2015.11.018 [doi]']",ppublish,Am J Infect Control. 2016 May 2;44(5 Suppl):e91-e100. doi: 10.1016/j.ajic.2015.11.018.,,,,,['Am J Infect Control. 2017 Jul 1;45(7):815-816. PMID: 28410826'],,['U54 CK000164/CK/NCEZID CDC HHS/United States'],,,,,,,,,,
17566557,NLM,MEDLINE,20070710,20070614,0029-2559 (Print) 0029-2559 (Linking),68,2,2007 Mar-Apr,Molecular diagnosis of infectious diseases.,115-8,,,,"['Miller, Melissa B']",['Miller MB'],"['Molecular Microbiology Laboratory, School of Medicine, University of North Carolina at Chapel Hill, NC 27599, USA. MBMiller@unch.unc.edu']",['eng'],['Journal Article'],,United States,N C Med J,North Carolina medical journal,2984805R,IM,"['Bacteriology', 'Communicable Diseases/*diagnosis/genetics', 'Humans', 'Molecular Biology/*methods', '*Molecular Diagnostic Techniques', '*Nucleic Acid Amplification Techniques', 'Virology']",,,,2007/06/15 09:00,2007/07/11 09:00,['2007/06/15 09:00'],"['2007/06/15 09:00 [pubmed]', '2007/07/11 09:00 [medline]', '2007/06/15 09:00 [entrez]']",,ppublish,N C Med J. 2007 Mar-Apr;68(2):115-8.,,,,,,,,,,,,,,,,,
14037905,NLM,MEDLINE,19981101,20181201,0494-2736 (Print) 0494-2736 (Linking),27,,1961 Aug,[Infectious diseases in Turkey].,372-84,,,,"['UNAT, E K']",['UNAT EK'],,['tur'],['Journal Article'],,Turkey,Turk Tip Cemiy Mecm,Turk Tip Cemiyeti mecmuasi,7600196,OM,"['Communicable Diseases/*epidemiology', 'Humans', 'Turkey']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1961/08/01 00:00,1961/08/01 00:01,['1961/08/01 00:00'],"['1961/08/01 00:00 [pubmed]', '1961/08/01 00:01 [medline]', '1961/08/01 00:00 [entrez]']",,ppublish,Turk Tip Cemiy Mecm. 1961 Aug;27:372-84.,,,,,,,,,,,,,,,,,
28374593,NLM,MEDLINE,20190405,20190405,1210-7913 (Print) 1210-7913 (Linking),66,1,2017 Winter,[Infectious diseases and laboratory diagnosisin the Terezin Jewish Ghetto].,8-14,,"The article is a historical review study which deals with the epidemiological situation in the Terezin Jewish Ghetto, including the possibilities for laboratory diagnosis and remembrance of important medical personalities. Valid primary data (monographs, memoirs, archival collections, photographs, and daily orders) were retrieved based on source criticism to be processed using a document content analysis approach. In conclusion, the findings are briefly compared with the respective data from the Warsaw and Lodz ghettos.",,"['Horackova, K', 'Hrstka, Z', 'Grulich, P', 'Hlavackova, E']","['Horackova K', 'Hrstka Z', 'Grulich P', 'Hlavackova E']",,['cze'],"['Historical Article', 'Journal Article']",,Czech Republic,Epidemiol Mikrobiol Imunol,"Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne",9431736,IM,"['*Communicable Diseases/diagnosis/epidemiology/history', 'History, 20th Century', '*Holocaust/history', 'Humans', '*Jews/history/statistics & numerical data', 'Poland/epidemiology', '*Poverty Areas']",,['NOTNLM'],"['Terezin Jewish Ghetto - epidemic - infectious disease - vaccination - laboratory', 'diagnosis.']",2017/04/05 06:00,2019/04/06 06:00,['2017/04/05 06:00'],"['2017/04/05 06:00 [entrez]', '2017/04/05 06:00 [pubmed]', '2019/04/06 06:00 [medline]']",['60667 [pii]'],ppublish,Epidemiol Mikrobiol Imunol. 2017 Winter;66(1):8-14.,,,,,,,,,Infekcni choroby a laboratorni diagnostika v podminkach Zidovskeho ghetta Terezin.,,,,,,,,
13870564,NLM,MEDLINE,19981101,20181201,0031-3939 (Print) 0031-3939 (Linking),36,,1961 Oct,[Corticotherapy in acute infectious diseases of childhood].,1061-6,,,,"['BOGDANOWICZ, J', 'KRAJEWSKA, B']","['BOGDANOWICZ J', 'KRAJEWSKA B']",,['pol'],['Journal Article'],,Poland,Pediatr Pol,Pediatria polska,2985039R,OM,"['*Acute Disease', 'Adrenal Cortex Hormones/*therapy', 'Communicable Diseases/*therapy']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapy', '*COMMUNICABLE DISEASES/therapy']",1961/10/01 00:00,1961/10/01 00:01,['1961/10/01 00:00'],"['1961/10/01 00:00 [pubmed]', '1961/10/01 00:01 [medline]', '1961/10/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1961 Oct;36:1061-6.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,,,,,,
13048160,NLM,MEDLINE,20030501,20181201,0035-3655 (Print) 0035-3655 (Linking),72,12,1952 Dec,[Some new notions and ideas concerning infectious diseases].,865-77,,,,"['ROCH, M']",['ROCH M'],,['und'],['Journal Article'],,Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,OM,"['Communicable Diseases/*statistics & numerical data', 'Humans', '*Thinking']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1952/12/01 00:00,1952/12/01 00:01,['1952/12/01 00:00'],"['1952/12/01 00:00 [pubmed]', '1952/12/01 00:01 [medline]', '1952/12/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1952 Dec;72(12):865-77.,,,,,,,,,Quelques notions et idees nouvelles sur les maladies infectieuses.,,,['CLML: 5324:18567:161'],,,,,
13753447,NLM,MEDLINE,19981101,20181130,0022-1732 (Print) 0022-1732 (Linking),5,,1961,Time trends in certain acute infectious diseases during the last thirty years (world situation).,40-51,,,,"['KOSTRZEWSKI, J']",['KOSTRZEWSKI J'],,['eng'],['Journal Article'],,Czech Republic,J Hyg Epidemiol Microbiol Immunol,"Journal of hygiene, epidemiology, microbiology, and immunology",2985116R,OM,"['Communicable Diseases/*epidemiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1961/01/01 00:00,1961/01/01 00:01,['1961/01/01 00:00'],"['1961/01/01 00:00 [pubmed]', '1961/01/01 00:01 [medline]', '1961/01/01 00:00 [entrez]']",,ppublish,J Hyg Epidemiol Microbiol Immunol. 1961;5:40-51.,,,,,,,,,,,,,,,,,
13634723,NLM,MEDLINE,20000701,20181201,0370-629X (Print) 0370-629X (Linking),14,1,1959 Jan 1,"[Infectious diseases in the country and in overseas territories; epidemiological report of 23 November to 6 December, 1958].",31-2,,,,,,,['fre'],['Journal Article'],,Belgium,Rev Med Liege,Revue medicale de Liege,0404317,OM,"['Communicable Diseases/*epidemiology', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1959/01/01 00:00,1959/01/01 00:01,['1959/01/01 00:00'],"['1959/01/01 00:00 [pubmed]', '1959/01/01 00:01 [medline]', '1959/01/01 00:00 [entrez]']",,ppublish,Rev Med Liege. 1959 Jan 1;14(1):31-2.,,,,,,,,,MALADIES infectieuses dans le pays et a l'etranger; releve epidemiologique du 23 novembre au 6 decembre 1958.,,,['CLML: 5936:8554:140'],,,,,
10396299,NLM,MEDLINE,19990720,20051116,0002-9173 (Print) 0002-9173 (Linking),112,1 Suppl 1,1999 Jul,Molecular diagnostics for existing and emerging infections. Complementary tools for a new era of clinical microbiology.,S33-9,,"Diagnostic molecular methods have had a large effect on diagnosis and management of infectious diseases. These tools have been developed in response to diagnostic methods that lack sensitivity, specificity, or rapid turnaround time, to assist with identification of agents that are difficult to cultivate or classify or as methods for assessing the effects of antiviral or antimicrobial agents in chronic infection. Molecular methods have also enabled microbiologists to define disease by the presence of virulence, toxin, or antimicrobial resistance genes and to identify potentially important clones of organisms responsible for outbreaks of infection. Early outcome-based studies suggest that molecular methods may provide substantial reductions in per patient costs. Nucleic acid diagnostic methods will continue to be used in infectious disease and microbiology, and increasingly appear to be complementary tools with important diagnostic, patient management, and health care cost benefits for the laboratory and health care systems.",,"['Dumler, J S', 'Valsamakis, A']","['Dumler JS', 'Valsamakis A']","['Department of Pathology, John Hopkins Medical Institutions, Baltimore, MD 21287, USA.']",['eng'],"['Journal Article', 'Review']",,England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Communicable Diseases/*diagnosis/economics/*genetics', '*Genetic Techniques', 'Genetics, Microbial/*methods', 'Humans', '*Microbiological Techniques']",,,,1999/07/09 00:00,1999/07/09 00:01,['1999/07/09 00:00'],"['1999/07/09 00:00 [pubmed]', '1999/07/09 00:01 [medline]', '1999/07/09 00:00 [entrez]']",,ppublish,Am J Clin Pathol. 1999 Jul;112(1 Suppl 1):S33-9.,,,,,,57,,,,,,,,,,,
37805887,NLM,MEDLINE,20231102,20231102,1512-0112 (Print) 1512-0112 (Linking),,340-341,2023 Jul-Aug,"THE IMPACT OF CLIMATE CHANGE ON INFECTIOUS DISEASES: A COMPREHENSIVE ANALYSIS OF VECTOR-BORNE DISEASES, WATER-BORNE DISEASES, AND PUBLIC HEALTH STRATEGIES.",136-142,,"Climate change is long-term modifications to weather patterns and a rise in extreme weather events. It might modify the hazard to human health and exacerbate current problems. The article explores the scientific data in a description of the effects of Infectious diseases in humans and climate change. It identifies scientific advancements and gaps in potential responses from human civilization and how it might prepare for the changes that come with it by adjusting to them. The impact reflects three aspects, such as climate variables, selected infectious diseases, and infectious disease components. This study demonstrates how vulnerable people are to any ill consequences that climate change may have on their health. Humans can actively influence controllable correlated health impacts by taking proactive measures, such as increasing our understanding of the detrimental effects associated with specific diseases and the patterns in climate change. We can also carefully distribute technology and resources, encouraging exercise and public awareness. It is advised to take the following adaption measures: Considering how infectious diseases and climate change are not the only things that science has discovered and create locally efficient early warning systems for those effects to produce more scientific justifications and go beyond scientific reports. Improve prediction of the spatiotemporal processes behind climate change and changes in infectious illnesses connected at different temporal and spatial scales.",,"['Patel M, G', 'Nidhi, -', 'Gupta, K', 'Gupta, M', 'Gupta, S', 'Krupa, S']","['Patel M G', 'Nidhi -', 'Gupta K', 'Gupta M', 'Gupta S', 'Krupa S']","['1Department of Community Medicine, Parul University, PO Limda, Tal.Waghodia, District Vadodara, Gujarat, India.', '2Department of Nursing, IIMT University, Meerut, Uttar Pradesh, India.', '3Department of Ayurveda, Sanskriti University, Mathura, Uttar Pradesh, India.', '4Department of Pharmacy, Vivekananda Global University, Jaipur, India.', '5Department of Community Medicine, TeerthankerMahaveer University, Moradabad, Uttar Pradesh, India.', '6Department of Chemistry & Biochemistry, School of Sciences, JAIN (Deemed-to-be University), Karnataka, India.']",['eng'],['Journal Article'],,Georgia (Republic),Georgian Med News,Georgian medical news,101218222,IM,"['Humans', 'Public Health', 'Climate Change', '*Communicable Diseases/epidemiology/etiology', '*Vector Borne Diseases', 'Water']",,,,2023/10/08 12:41,2023/10/08 12:42,['2023/10/08 07:23'],"['2023/10/08 12:42 [medline]', '2023/10/08 12:41 [pubmed]', '2023/10/08 07:23 [entrez]']",,ppublish,Georgian Med News. 2023 Jul-Aug;(340-341):136-142.,,,['059QF0KO0R (Water)'],,,,,,,,,,,,,,
9610668,NLM,MEDLINE,19980612,20190826,0165-5728 (Print) 0165-5728 (Linking),83,1-2,1998 Mar 15,Opiates and infection.,4-18,,"This review on the effects of opiate use on infectious diseases discusses the complete spectrum of infections in the opiate user, including those of the lung, the GI tract, the skin, the skeletal system, and the CNS. There is both increased prevalence and increased severity of bacterial and viral infections in injection drug users with the outcome of increased morbidity and mortality. The experimental administration of opiates has lead to a greater understanding of the effects on susceptibility to and progression of infectious diseases. Animal models of opiate dependence and infection are reviewed with specific attention to cases in which the opiate-mediated effects are harmful and in which cases they are beneficial.",,"['Risdahl, J M', 'Khanna, K V', 'Peterson, P K', 'Molitor, T W']","['Risdahl JM', 'Khanna KV', 'Peterson PK', 'Molitor TW']","['University of Minnesota, Department of Clinical and Population Sciences, Veterinary Teaching Hospital, St. Paul 55108, USA.']",['eng'],"['Journal Article', 'Review']",,Netherlands,J Neuroimmunol,Journal of neuroimmunology,8109498,IM,"['Communicable Diseases/*epidemiology/immunology/transmission', 'Humans', 'Opioid-Related Disorders/*epidemiology/microbiology/virology', 'Risk Factors', 'Virus Diseases/*epidemiology/immunology/transmission']",,,,1998/06/04 02:06,2000/06/01 09:00,['1998/06/04 02:06'],"['1998/06/04 02:06 [pubmed]', '2000/06/01 09:00 [medline]', '1998/06/04 02:06 [entrez]']","['S0165-5728(97)00216-6 [pii]', '10.1016/s0165-5728(97)00216-6 [doi]']",ppublish,J Neuroimmunol. 1998 Mar 15;83(1-2):4-18. doi: 10.1016/s0165-5728(97)00216-6.,,,,,,195,,,,,,,,,,,
29066404,NLM,MEDLINE,20180524,20180524,1873-0442 (Electronic) 1477-8939 (Linking),20,,2017 Nov-Dec,One-sixth of inpatients in a Danish infectious disease ward have imported diseases: A cross-sectional analysis.,43-48,S1477-8939(17)30167-9 [pii] 10.1016/j.tmaid.2017.10.012 [doi],"BACKGROUND: The aim of the study was to describe travel demographics and disease patterns of patients hospitalized with travel-related diseases, and assess risk factors to improve pre-travel information and post-travel diagnostics and treatment. METHODS: The study included all patients hospitalized with travel-related diseases in 2015 at a Danish infectious diseases ward. Patient data was extracted from the in-patient hospital registry. was analyzed regarding diagnoses, destination, purpose of travel and pre-travel information. RESULTS: 240 patients were hospitalized with a total of 289 travel-related diseases, accounting for 16.6% (240/1450) of all admissions. Febrile illnesses were the most common (39.5%, 114/289) followed by respiratory (19.7%, 57/289) and gastrointestinal diagnoses (19.0%, 55/289). Most of the diseases were acquired in Sub-Saharan Africa (35.6%, 103/289) followed by South East Asia (27.0%, 78/289), and 60.0% (144/240) of the patients were tourists. One-third (36.3%, 81/223) of the non-migrants had received pre-travel information. The lowest rate was seen in people visiting friends and relatives (18.2%, 6/32). CONCLUSION: Travel-related diseases are common among patients admitted to this Danish infectious disease ward. Malaria is the most common disease among both travelers and immigrants. In approximately one third of all the patients in our study etiology was unknown.",['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],"['Dam Larsen, Fredrikke', 'Jespersen, Sanne', 'Wejse, Christian', 'Petersen, Eskild', 'Larsen, Carsten Schade']","['Dam Larsen F', 'Jespersen S', 'Wejse C', 'Petersen E', 'Larsen CS']","['Department of Infectious Diseases, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark. Electronic address: frelarse@rm.dk.', 'Department of Infectious Diseases, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark. Electronic address: sanne.jespersen@clin.au.dk.', 'Department of Infectious Diseases, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark; GloHAU, Department of Public Health, Section of Global Health, Aarhus University, Bartholins Alle 2-Building 1260, 8000 Aarhus C, Denmark. Electronic address: wejse@dadlnet.dk.', 'Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark; Department of Infectious Diseases, The Royal Hospital, Muscat, Oman. Electronic address: eskildp@dadlnet.dk.', 'Department of Infectious Diseases, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark. Electronic address: carsten.schade.larsen@dadlnet.dk.']",['eng'],['Journal Article'],20171021,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Communicable Diseases/diagnosis/*epidemiology', 'Communicable Diseases, Imported/diagnosis/*epidemiology/prevention & control', 'Cross-Sectional Studies', 'Denmark/epidemiology', 'Drug Resistance, Microbial', 'Female', 'Hospitals/*statistics & numerical data', 'Humans', 'Male', 'Middle Aged', 'Pre-Exposure Prophylaxis/statistics & numerical data', 'Transients and Migrants/statistics & numerical data', 'Travel Medicine/*statistics & numerical data', '*Travel-Related Illness', 'Vaccination/statistics & numerical data', 'Young Adult']",,['NOTNLM'],"['Disease', 'Febrile', 'Infection', 'Migration', 'Travel']",2017/10/27 06:00,2018/05/25 06:00,['2017/10/26 06:00'],"['2017/05/07 00:00 [received]', '2017/10/15 00:00 [revised]', '2017/10/20 00:00 [accepted]', '2017/10/27 06:00 [pubmed]', '2018/05/25 06:00 [medline]', '2017/10/26 06:00 [entrez]']","['S1477-8939(17)30167-9 [pii]', '10.1016/j.tmaid.2017.10.012 [doi]']",ppublish,Travel Med Infect Dis. 2017 Nov-Dec;20:43-48. doi: 10.1016/j.tmaid.2017.10.012. Epub 2017 Oct 21.,,,,,,,,,,,,,,,,,
27922750,NLM,MEDLINE,20170817,20180124,1746-0921 (Electronic) 1746-0913 (Linking),12,,2017 Jan,Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions.,51-58,10.2217/fmb-2016-0120 [doi],"Infectious disease point-of-care test (ID-POCT) devices are becoming widely available, and in this respect, international quality standards and guidelines are available for consultation once ID-POCT has been implemented into medical institutions. However, specific guidelines for consultation during the initial pre-implementation decision-making process are currently lacking. Further, there exist pre-implementation issues specific to ID-POCT. Here we present pre-implementation guidelines for consultation when considering the implementation of ID-POCT in medical institutions.",,"['van der Eijk, Annemiek A', 'Tintu, Andrei N', 'Hays, John P']","['van der Eijk AA', 'Tintu AN', 'Hays JP']","['Department of Viroscience, Erasmus University Medical Center Rotterdam (Erasmus MC), Rotterdam, the Netherlands.', 'Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam (Erasmus MC), Rotterdam, the Netherlands.', 'Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam (Erasmus MC), Rotterdam, the Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20161206,England,Future Microbiol,Future microbiology,101278120,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Guidelines as Topic', 'Humans', 'Point-of-Care Testing/*standards']",,['NOTNLM'],"['guidelines', 'infectious diseases', 'point-of-care testing']",2016/12/07 06:00,2017/08/18 06:00,['2016/12/07 06:00'],"['2016/12/07 06:00 [pubmed]', '2017/08/18 06:00 [medline]', '2016/12/07 06:00 [entrez]']",['10.2217/fmb-2016-0120 [doi]'],ppublish,Future Microbiol. 2017 Jan;12:51-58. doi: 10.2217/fmb-2016-0120. Epub 2016 Dec 6.,,,,,,,,,,,,,,,,,
1008114,NLM,MEDLINE,19770216,20190514,0090-0036 (Print) 1541-0048 (Electronic) 0090-0036 (Linking),66,12,1976 Dec,The effect of antibiotics on mortality from infectious diseases in Sweden and Finland.,1180-4,,"A study was carried out to determine whether the preexisting decline in mortality rates from infectious diseases accelerated after the introduction of antibiotic and chemotherapeutic drugs. Linear regression curves showed that in Sweden mortality rates declined faster in septicemia, syphilis, and non-memingococcal meningitis after the introduction of these drugs. By contrast, for the ten other infectious diseases studied, (scarlet fever, erysipelas, acute rheumatic fever, puerperal sepsis, meningococcal infection, bronchitis, pneumonia, tuberculosis, typhoid fever, and acute gastroenteritis) no such accelerated decline in mortality could be detected. The findings suggest that antibiotic and chemotherapeutic drugs have not had the dramatic effect of the mortality of infectious diseases popularly attributed to them.",,"['Hemminki, E', 'Paakkulainen, A']","['Hemminki E', 'Paakkulainen A']",,['eng'],"['Comparative Study', 'Journal Article']",,United States,Am J Public Health,American journal of public health,1254074,IM,"['Age Factors', 'Anti-Bacterial Agents/*therapeutic use', 'Child, Preschool', 'Communicable Diseases/drug therapy/*mortality', 'Female', 'Finland', 'Humans', 'Infant', 'Infant, Newborn', 'Infant, Newborn, Diseases/mortality', 'Sweden']",PMC1653532,,,1976/12/01 00:00,1976/12/01 00:01,['1976/12/01 00:00'],"['1976/12/01 00:00 [pubmed]', '1976/12/01 00:01 [medline]', '1976/12/01 00:00 [entrez]']",['10.2105/ajph.66.12.1180 [doi]'],ppublish,Am J Public Health. 1976 Dec;66(12):1180-4. doi: 10.2105/ajph.66.12.1180.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
2816184,NLM,MEDLINE,19891212,20200716,0372-9311 (Print) 0372-9311 (Linking),,7,1989 Jul,[Conducting epidemiologic surveillance of infectious diseases in Great Britain].,49-53,,,,"['Sokhin, A A']",['Sokhin AA'],,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality', 'Humans', '*Population Surveillance/methods', 'United Kingdom', 'Vaccination']",,,,1989/07/01 00:00,1989/07/01 00:01,['1989/07/01 00:00'],"['1989/07/01 00:00 [pubmed]', '1989/07/01 00:01 [medline]', '1989/07/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1989 Jul;(7):49-53.,,,,,,,,,Provedenie epidemiologicheskogo nadzora za infektsionnymi zabolevaniiami v Velikobritanii.,,,,,,,,
13817358,NLM,MEDLINE,19981101,20181201,0043-5341 (Print) 0043-5341 (Linking),110,,1960 Feb 20,[Development of chemotherapy of infectious diseases in the past 30 years and the future prospects for chemotherapy of cancer].,131-4,,,,"['DOMAGK, G']",['DOMAGK G'],,['ger'],['Journal Article'],,Austria,Wien Med Wochenschr,Wiener medizinische Wochenschrift (1946),8708475,OM,"['Communicable Diseases/*therapy', 'Humans', 'Neoplasms/*therapy']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*NEOPLASMS/therapy']",1960/02/20 00:00,1960/02/20 00:01,['1960/02/20 00:00'],"['1960/02/20 00:00 [pubmed]', '1960/02/20 00:01 [medline]', '1960/02/20 00:00 [entrez]']",,ppublish,Wien Med Wochenschr. 1960 Feb 20;110:131-4.,,,,,,,,,,,,,,,,,
24535887,NLM,MEDLINE,20150330,20140721,2049-632X (Electronic) 2049-632X (Linking),71,2,2014 Jul,Communication and computing technology in biocontainment laboratories using the NEIDL as a model.,96-101,10.1111/2049-632X.12159 [doi],"The National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, is a globally unique biocontainment research facility housing biosafety level 2 (BSL-2), BSL-3, and BSL-4 laboratories. Located in the BioSquare area at the University's Medical Campus, it is part of a national network of secure facilities constructed to study infectious diseases of major public health concern. The NEIDL allows for basic, translational, and clinical phases of research to be carried out in a single facility with the overall goal of accelerating understanding, treatment, and prevention of infectious diseases. The NEIDL will also act as a center of excellence providing training and education in all aspects of biocontainment research. Within every detail of NEIDL operations is a primary emphasis on safety and security. The ultramodern NEIDL has required a new approach to communications technology solutions in order to ensure safety and security and meet the needs of investigators working in this complex building. This article discusses the implementation of secure wireless networks and private cloud computing to promote operational efficiency, biosecurity, and biosafety with additional energy-saving advantages. The utilization of a dedicated data center, virtualized servers, virtualized desktop integration, multichannel secure wireless networks, and a NEIDL-dedicated Voice over Internet Protocol (VoIP) network are all discussed.","['(c) 2014 Federation of European Microbiological Societies. Published by John Wiley', '& Sons Ltd. All rights reserved.']","['McCall, John', 'Hardcastle, Kath']","['McCall J', 'Hardcastle K']","['Information Technology and Telecommunications National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",20140610,United States,Pathog Dis,Pathogens and disease,101595366,IM,"['Biomedical Research/methods', 'Communicable Diseases, Emerging/diagnosis/drug therapy/etiology', '*Computing Methodologies', '*Containment of Biohazards', 'Humans', '*Laboratories', 'Occupational Health', '*Telecommunications']",,['NOTNLM'],"['BSL3', 'BSL4', 'biocontainment', 'communications']",2014/02/19 06:00,2015/03/31 06:00,['2014/02/19 06:00'],"['2013/11/15 00:00 [received]', '2014/02/05 00:00 [revised]', '2014/02/06 00:00 [accepted]', '2014/02/19 06:00 [entrez]', '2014/02/19 06:00 [pubmed]', '2015/03/31 06:00 [medline]']",['10.1111/2049-632X.12159 [doi]'],ppublish,Pathog Dis. 2014 Jul;71(2):96-101. doi: 10.1111/2049-632X.12159. Epub 2014 Jun 10.,,,,,,,,,,,,,,,,,
22133523,NLM,MEDLINE,20120202,20200131,0023-7213 (Print) 0023-7213 (Linking),97,12,2011 Dec,[Neglected tropical diseases - review].,693-7,10.17992/lbl.2011.12.404 [doi],"Neglected tropical diseases include a variety of infectious diseases. This review shortly describes the most common diseases. Those infected usually live at a low socioeconomic status and rarely have access to satisfactory health care. The neglected diseases are common and have a high burden of disease. In comparison to HIV, malaria and tuberculosis this group of diseases is in fact neglected. Certain diseases within the group are more neglected than others. Investment for research does not appear to be decided in proportion to burden of disease. Much can be gained by extermination of these diseases. The solution is to integrate improvement of living standards and battling diseases. Iceland has a role to play.",,"['Kristjansson, Julius', 'Gudmundsson, Sigurdur']","['Kristjansson J', 'Gudmundsson S']","['Laeknadeild, Haskola Islands. juk2@hi.is']",['ice'],"['English Abstract', 'Journal Article', 'Review']",,Iceland,Laeknabladid,Laeknabladid,7901326,IM,"['*Communicable Diseases/diagnosis/epidemiology/therapy', 'Health Services Accessibility', 'Humans', '*Neglected Diseases/diagnosis/epidemiology/therapy', 'Risk Factors', 'Socioeconomic Factors', '*Tropical Medicine']",,,,2011/12/03 06:00,2012/02/03 06:00,['2011/12/03 06:00'],"['2011/12/03 06:00 [entrez]', '2011/12/03 06:00 [pubmed]', '2012/02/03 06:00 [medline]']",['10.17992/lbl.2011.12.404 [doi]'],ppublish,Laeknabladid. 2011 Dec;97(12):693-7. doi: 10.17992/lbl.2011.12.404.,,,,,,,,,Vanraektir sjukdomar throunarlanda - yfirlit.,,,,,,,,
19967129,NLM,MEDLINE,20100222,20091207,2567-689X (Electronic) 0340-6245 (Linking),102,6,2009 Dec,Between microbial attack and defence: the endothelium as a vulnerable player in infectious diseases.,1011-3,10.1160/TH09-11-0760 [doi],,,"['Schnittler, Hans', 'Preissner, Klaus T']","['Schnittler H', 'Preissner KT']",,['eng'],"['Editorial', 'Introductory Journal Article']",,Germany,Thromb Haemost,Thrombosis and haemostasis,7608063,IM,"['Animals', 'Bacterial Infections/immunology', 'Communicable Diseases/*etiology/immunology/*microbiology', 'Endothelium, Vascular/immunology/*microbiology/parasitology', 'Host-Parasite Interactions', 'Host-Pathogen Interactions', 'Humans', 'Systems Biology', 'Virus Internalization']",,,,2009/12/08 06:00,2010/02/23 06:00,['2009/12/08 06:00'],"['2009/12/08 06:00 [entrez]', '2009/12/08 06:00 [pubmed]', '2010/02/23 06:00 [medline]']","['09-11-0760 [pii]', '10.1160/TH09-11-0760 [doi]']",ppublish,Thromb Haemost. 2009 Dec;102(6):1011-3. doi: 10.1160/TH09-11-0760.,,,,,,,,,,,,,,,,,
16127992,NLM,MEDLINE,20051006,20190816,0869-2084 (Print) 0869-2084 (Linking),,7,2005 Jul,"[Genodiagnosis of the pathogens of infectious diseases and a search for specific ""risk genes"" (a lecture)].",21-36,,,,"['Chukhlovin, A B']",['Chukhlovin AB'],,['rus'],['Journal Article'],,Russia (Federation),Klin Lab Diagn,Klinicheskaia laboratornaia diagnostika,9432021,IM,"['Communicable Diseases/*diagnosis/genetics', 'Genetic Predisposition to Disease/*genetics', '*Genetic Techniques', 'Humans', 'Risk Factors']",,,,2005/09/01 09:00,2005/10/07 09:00,['2005/09/01 09:00'],"['2005/09/01 09:00 [pubmed]', '2005/10/07 09:00 [medline]', '2005/09/01 09:00 [entrez]']",,ppublish,Klin Lab Diagn. 2005 Jul;(7):21-36.,,,,,,,,,,,,,,,,,
30209913,NLM,MEDLINE,20190122,20231104,1988-9518 (Electronic) 0214-3429 (Print) 0214-3429 (Linking),31 Suppl 1,Suppl 1,2018 Sep,Update in Infectious Diseases 2018.,1-8,,"VIII Updating Course of Antimicrobials and Infectious Diseases has reviewed useful microbiological, epidemiological and clinical aspects for a current approach of infectious pathology. Present manuscript summarizes a chronicle about the main infection related meetings during 2017 (ECCMID, IAS, ASM and ID Week). In addition, the course proposed a practical approach for understanding different type of pathogens and our selected topics this year were the epidemiology of bacterial nosocomial infection, a practical approach to Clostridium difficile infection patients, a two year selection of the top ten papers about fungal infection and an update in fungal biofilms. Finally, proffesors made a practical approach by main clinical syndromes like sepsis, infections in oncohematological patients, CNS infections in immunosuppressed patients and reviewed the top ten papers in transplant infectious diseases and infection control during the last two years.",,"['Candel, F J', 'Emilov, T', 'Diaz de la Torre, I', 'Ruedas, A', 'Vinuela Prieto, J M', 'Visiedo, C', 'Martinez-Jordan, J', 'Lopez-Gonzalez, L', 'Matesanz, M', 'Arribi, A']","['Candel FJ', 'Emilov T', 'Diaz de la Torre I', 'Ruedas A', 'Vinuela Prieto JM', 'Visiedo C', 'Martinez-Jordan J', 'Lopez-Gonzalez L', 'Matesanz M', 'Arribi A']","['Francisco Javier Candel Gonzalez, Department of Clinical Microbiology. Health Research Institute (IdISSC). Hospital Clinico Universitario San Carlos. UCM. Avda Profesor Martin Lagos S/N. 28040. Madrid. Spain. fj.candel@gmail.com.']",['eng'],['Introductory Journal Article'],,Spain,Rev Esp Quimioter,Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,9108821,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*drug therapy/microbiology', 'Humans']",PMC6459573,,,2018/09/14 06:00,2019/01/23 06:00,['2018/09/14 06:00'],"['2018/09/14 06:00 [entrez]', '2018/09/14 06:00 [pubmed]', '2019/01/23 06:00 [medline]']","['00 [pii]', 'revespquimioter-31-suppl-1-01 [pii]']",ppublish,Rev Esp Quimioter. 2018 Sep;31 Suppl 1(Suppl 1):1-8.,,,['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
23928631,NLM,MEDLINE,20140925,20130809,0253-9624 (Print) 0253-9624 (Linking),47,4,2013 Apr,[Applications of ecological niche models in risk predictions of infectious diseases].,294-6,,,,"['Lin, Xiao-ling', 'Xiao, Hong', 'Tian, Huai-yu']","['Lin XL', 'Xiao H', 'Tian HY']",,['chi'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,China,Zhonghua Yu Fang Yi Xue Za Zhi,Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],7904962,IM,"['Communicable Diseases/*epidemiology/*transmission', 'Environmental Monitoring', 'Epidemiologic Factors', 'Forecasting', 'Humans', '*Models, Theoretical', 'Risk Assessment']",,,,2013/08/10 06:00,2014/09/26 06:00,['2013/08/10 06:00'],"['2013/08/10 06:00 [entrez]', '2013/08/10 06:00 [pubmed]', '2014/09/26 06:00 [medline]']",,ppublish,Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Apr;47(4):294-6.,,,,,,,,,,,,,,,,,
18666608,NLM,MEDLINE,20080909,20130715,0025-8105 (Print) 0025-8105 (Linking),60,11-12,2007 Nov-Dec,[On the development of the infectology service in Novi Sad].,625-8,,"INTRODUCTION: Infectious diseases are a part of the history of this region. Devastating epidemics of plague, smallpox, and cholera were frequent during the 18th and the 19th centuries. Other infectious diseases were a serious problem as well: alimentary tract infections, scarlet fever, diphtheria, whooping cough. Geographic position, climate, migrations, as well as the tradition and lack of medical staff and medications, affected the frequency and outcome of infections. THE HISTORY OF THE TREATMENT OF INFECTIOUS DISEASES: Patients with infectious diseases were first treated at home. Later, a hospital in Visarion street was opened as an isolation facility and a hospital for homeless patients. The development of science and the education of medical personnel exerted the greatest influence on the control and later treatment of infectious diseases. These measures resulted in the establishment of the first specialized medical institutions in Novi Sad during the cholera outbreak in 1884. After that, temporary pediatric units were organized for the treatment of scarlet fever, diphtheria and smallpox. A ward for infectious diseases was founded in the The Great City Hospital in the second half of the 19th century (1892). The 20th century was a period of control and eradication of infectious diseases in Vojvodina (smallpox, malaria, diphtheria, polio). MODERN INFECTIOUS DISEASES: Nowdays, major infectious deseases include respiratory, alimentary and parasitic infections. However, new diseases are being registered as well - hemorrhagic fevers, Lyme disease, HIV infection. The Infectologic Service in Novi Sad was developed from an Infectology Departement as part of the Departement of Internal Diseases in the new Provincial Hospital (1909) to the independent Departement for Infectious Diseases (1945). Today, Clinic of lnfectious Diseases is an integral part of the Clinical Center of Vojvodina. DEPARTMENT OF INFECTIOUS DISEASES: The Department of Infectious Diseases of the Faculty of Medicine in Novi Sad was founded in 1960. Undergraduate studies started in 1963/64 for students of medicine and in 1978/79 jor dentistry students. Today. the faculty of the Department takes part in undergraduate studies of medicine, dentistry, health care, as well as in graduate programs. The faculty members are also taking part in specialization programs at the Faculty of Medicine. Infectious disease physicians are involved in the activities of the Infectology Section (founded in 1979) of the Society of Physicians of Vojvodine of the Medical Society of Serbia. The first president of the Infectology Section was Dr. Vera Mudric, professor, infectologists, whereas Dr. Grozdana Canak, professor, was the vice-president from 2000-2004. The Infectology Section collaborates with various national and international societies for infectious diseases.",,"['Canak, Grozdana', 'Vukadinov, Jovan', 'Brkic, Snezana', 'Svarc, Daniela', 'Ruzic, Maja', 'Kovacevic, Nadica', 'Fabri, Milotka', 'Jovanovic, Jovana', 'Klasnja, Biljana', 'Cvjetkovic, Dejan', 'Doder, Radoslava', 'Sevic, Sinisa', 'Turkulov, Vesna', 'Stefan-Mikic, Sandra', 'Knezevic, Koviljka', 'Aleksic-Dordevic, Mirjana', 'Preveden, Tomislav']","['Canak G', 'Vukadinov J', 'Brkic S', 'Svarc D', 'Ruzic M', 'Kovacevic N', 'Fabri M', 'Jovanovic J', 'Klasnja B', 'Cvjetkovic D', 'Doder R', 'Sevic S', 'Turkulov V', 'Stefan-Mikic S', 'Knezevic K', 'Aleksic-Dordevic M', 'Preveden T']","['Klinika za infektivne bolesti, Klinicki centar Vojvodine, Novi Sad. nsinfekt@eunet.yu']",['srp'],"['English Abstract', 'Historical Article', 'Journal Article']",,Serbia,Med Pregl,Medicinski pregled,2985249R,IM,"['Communicable Diseases/*history/therapy', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Yugoslavia']",,,,2008/08/01 09:00,2008/09/10 09:00,['2008/08/01 09:00'],"['2008/08/01 09:00 [pubmed]', '2008/09/10 09:00 [medline]', '2008/08/01 09:00 [entrez]']",,ppublish,Med Pregl. 2007 Nov-Dec;60(11-12):625-8.,,,,,,,,,,,,,,,,,
13051601,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4827,1953 Jul 11,INFECTIOUS diseases and vital statistics.,103-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2028455,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/07/11 00:00,1953/07/11 00:01,['1953/07/11 00:00'],"['1953/07/11 00:00 [pubmed]', '1953/07/11 00:01 [medline]', '1953/07/11 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jul 11;2(4827):103-4.,,,,,,,,,,,,['CLML: 5324:22138:162:700'],,,,,
13042250,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4823,1953 Jun 13,INFECTIOUS diseases and vital statistics.,1340,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016590,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/06/13 00:00,1953/06/13 00:01,['1953/06/13 00:00'],"['1953/06/13 00:00 [pubmed]', '1953/06/13 00:01 [medline]', '1953/06/13 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jun 13;1(4823):1340.,,,,,,,,,,,,['CLML: 5324:12589:162:700'],,,,,
13032603,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4817,1953 May 2,INFECTIOUS diseases and vital statistics.,1001-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016717,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/05/02 00:00,1953/05/02 00:01,['1953/05/02 00:00'],"['1953/05/02 00:00 [pubmed]', '1953/05/02 00:01 [medline]', '1953/05/02 00:00 [entrez]']",,ppublish,Br Med J. 1953 May 2;1(4817):1001-3.,,,,,,,,,,,,['CLML: 5324:2743:161:700'],,,,,
13032571,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4816,1953 Apr 25,INFECTIOUS diseases and vital statistics.,947-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016357,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/04/25 00:00,1953/04/25 00:01,['1953/04/25 00:00'],"['1953/04/25 00:00 [pubmed]', '1953/04/25 00:01 [medline]', '1953/04/25 00:00 [entrez]']",,ppublish,Br Med J. 1953 Apr 25;1(4816):947-9.,,,,,,,,,,,,['CLML: 5324:2711:161:700'],,,,,
13032547,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4815,1953 Apr 18,INFECTIOUS diseases and vital statistics.,892-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016042,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/04/18 00:00,1953/04/18 00:01,['1953/04/18 00:00'],"['1953/04/18 00:00 [pubmed]', '1953/04/18 00:01 [medline]', '1953/04/18 00:00 [entrez]']",,ppublish,Br Med J. 1953 Apr 18;1(4815):892-3.,,,,,,,,,,,,['CLML: 5324:2687:161:700'],,,,,
13032483,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4812,1953 Mar 28,INFECTIOUS diseases and vital statistics.,737-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2015654,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/03/28 00:00,1953/03/28 00:01,['1953/03/28 00:00'],"['1953/03/28 00:00 [pubmed]', '1953/03/28 00:01 [medline]', '1953/03/28 00:00 [entrez]']",,ppublish,Br Med J. 1953 Mar 28;1(4812):737-9.,,,,,,,,,,,,['CLML: 5324:2623:161:700'],,,,,
14435727,NLM,MEDLINE,19981101,20181201,0027-2973 (Print) 0027-2973 (Linking),101,,1959 Nov 20,[Cerebral complications of infectious diseases].,2163-71,,,,"['RADL, H']",['RADL H'],,['ger'],['Journal Article'],,Germany,Munch Med Wochenschr,Munchener medizinische Wochenschrift (1950),7801802,OM,"['*Brain', '*Brain Diseases', 'Communicable Diseases/*complications', 'Humans']",,['NLM'],"['*BRAIN/diseases', '*COMMUNICABLE DISEASES/complications']",1959/11/20 00:00,1959/11/20 00:01,['1959/11/20 00:00'],"['1959/11/20 00:00 [pubmed]', '1959/11/20 00:01 [medline]', '1959/11/20 00:00 [entrez]']",,ppublish,Munch Med Wochenschr. 1959 Nov 20;101:2163-71.,,,,,,,,,,,,,,,,,
18959050,NLM,MEDLINE,20081125,20171116,0024-3477 (Print) 0024-3477 (Linking),129 Suppl 3,,2007 May,Developing a risk assessment process for current and emerging infectious diseases.,5,,,,"['Eglin, Roger']",['Eglin R'],,['eng'],['Journal Article'],,Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,IM,"['Blood-Borne Pathogens', 'Communicable Diseases, Emerging/etiology/microbiology/*transmission', 'Humans', 'Risk Assessment', '*Transfusion Reaction']",,,,2008/10/31 09:00,2008/12/17 09:00,['2008/10/31 09:00'],"['2008/10/31 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/10/31 09:00 [entrez]']",,ppublish,Lijec Vjesn. 2007 May;129 Suppl 3:5.,,,,,,,,,,,,,,,,,
12718163,NLM,MEDLINE,20030623,20200716,0372-9311 (Print) 0372-9311 (Linking),,6 Suppl,2001 Nov-Dec,[Emerging infections and infectious diseases as the cause of extreme situation].,9-15,,"Information on unexpectedly emerging and newly appearing infectious diseases in the world, based on materials contained in WHO weekly reviews for the period of 1991-2000, is presented. Opinions of researchers on the causes and factors giving rise to this complex situation in different regions and on different continents are cited. In cases of insufficient training of the medical personnel, the specialists of diagnostic laboratories and the antiepidemic service the outbreak of these infections may assume the character of emergency situations. The importance of the development, introduction and ensuring the availability of the methods for the rapid diagnostics of infectious diseases, as well as the improvement of the system of epidemiological surveillance and operative exchange in information on so-called ""new"" infectious diseases, is emphasized.",,"['Briukhanova, G D', 'Grizhebovskii, G M', 'Beier, A P']","['Briukhanova GD', 'Grizhebovskii GM', 'Beier AP']","['WHO Collaborating Center for Research and Information on Plague, Research Institute for Plague Control, Stavropol, Russia.']",['rus'],"['Journal Article', 'Review']",,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['Communicable Disease Control', 'Communicable Diseases, Emerging/diagnosis/epidemiology/prevention & control', '*Disasters', '*Global Health', 'Humans', 'Infections/diagnosis/*epidemiology', 'Virus Diseases/diagnosis/*epidemiology/prevention & control']",,,,2003/04/30 05:00,2003/06/24 05:00,['2003/04/30 05:00'],"['2003/04/30 05:00 [pubmed]', '2003/06/24 05:00 [medline]', '2003/04/30 05:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2001 Nov-Dec;(6 Suppl):9-15.,,,,,,9,,,Neozhidanno voznikaiushchie i vnov' poiavliaiushchiesia infektsionnye zabolevaniia kak prichina chrezvychainykh situatsii.,,,,,,,,
18175437,NLM,MEDLINE,20080201,20110726,0549-3323 (Print) 0549-3323 (Linking),53,2,2007 Jun,[Acute infectious diseases in occupied Japan].,229-48,,"Japan's health statistics system, considered among the best in the world today, continually complies and organizes information about various infectious diseases. However, systematic surveillance was not conducted by the Ministry of Health and Welfare between World War II and the postwar period, creating a gap in health data. In contrast, the GHQ/SCAP/PHW. which was closely involved in health and medical reform during the Occupation, thoroughly investigated the health conditions of the Japanese people during this period. This article describes the trends in acute infectious diseases in Occupied Japan by using statistical records listed in the appendices of the ""Weekly Bulletin"", an official document of the GHQ/SCAP that is currently kept in the National Diet Library Modern Japanese Political History Materials Room.",,"['Tanaka, Seiji', 'Sugita, Satoru', 'Moriyama, Takako', 'Marui, Eiji']","['Tanaka S', 'Sugita S', 'Moriyama T', 'Marui E']",,['jpn'],"['English Abstract', 'Historical Article', 'Journal Article']",,Japan,Nihon Ishigaku Zasshi,Nihon ishigaku zasshi. [Journal of Japanese history of medicine],0165261,,"['Acute Disease', 'Communicable Diseases/epidemiology/*history', 'History, 20th Century', 'Humans', 'Japan/epidemiology', '*Population Surveillance', 'World War II']",,,,2008/01/08 09:00,2008/02/02 09:00,['2008/01/08 09:00'],"['2008/01/08 09:00 [pubmed]', '2008/02/02 09:00 [medline]', '2008/01/08 09:00 [entrez]']",,ppublish,Nihon Ishigaku Zasshi. 2007 Jun;53(2):229-48.,,,,,,,,,,,,,,,,,
13059473,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4830,1953 Aug 1,INFECTIOUS diseases and vital statistics.,292-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2029113,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/08/01 00:00,1953/08/01 00:01,['1953/08/01 00:00'],"['1953/08/01 00:00 [pubmed]', '1953/08/01 00:01 [medline]', '1953/08/01 00:00 [entrez]']",,ppublish,Br Med J. 1953 Aug 1;2(4830):292-3.,,,,,,,,,,,,['CLML: 5324:30118:162:700'],,,,,
13032501,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4813,1953 Apr 4,INFECTIOUS diseases and vital statistics.,789-91,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2015897,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/04/04 00:00,1953/04/04 00:01,['1953/04/04 00:00'],"['1953/04/04 00:00 [pubmed]', '1953/04/04 00:01 [medline]', '1953/04/04 00:00 [entrez]']",,ppublish,Br Med J. 1953 Apr 4;1(4813):789-91.,,,,,,,,,,,,['CLML: 5324:2641:161:700'],,,,,
18898205,NLM,MEDLINE,20081016,20201005,,55,5,1947 Sep-Oct,[The practical importance of sternomyeloculture in the diagnosis of infectious diseases].,226-31,,,,"['OLIVARI, G']",['OLIVARI G'],,['ita'],['Journal Article'],,Italy,Med Int (Milano),La Medicina internazionale,2985244R,OM,"['Communicable Diseases/*diagnosis', 'Humans', '*Skin Tests']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1947/09/01 00:00,2008/10/24 09:00,['1947/09/01 00:00'],"['1947/09/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1947/09/01 00:00 [entrez]']",,ppublish,Med Int (Milano). 1947 Sep-Oct;55(5):226-31.,,,,,,,,,L'importanza pratica della sternomielocultura nella diagnosi delle malattie infettive.,,,['CLML: 4814:336l'],,,,,
13838417,NLM,MEDLINE,19981101,20200716,0372-9311 (Print) 0372-9311 (Linking),31,,1960 Jan,[Reaction of rise of the phage titer as a method of diagnosis in infectious diseases and indication of pathogenic bacteria].,5-10,,,,"['TIMAKOV, V D', ""GOL'DFARB, D M""]","['TIMAKOV VD', ""GOL'DFARB DM""]",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['*Bacteria', '*Bacteriophages', 'Communicable Diseases/*diagnosis', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1960/01/01 00:00,1960/01/01 00:01,['1960/01/01 00:00'],"['1960/01/01 00:00 [pubmed]', '1960/01/01 00:01 [medline]', '1960/01/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1960 Jan;31:5-10.,,,,,,,,,,,,,,,,,
13569941,NLM,MEDLINE,20000701,20181201,0042-8833 (Print) 0042-8833 (Linking),17,2,1958 Mar-Apr,[The efficacy of nonspecific diet N5 during reconvalescence from serious infectious diseases].,42-7,,,,"['SHARPENAK, A E', 'DOVZHIK, M A', 'POPKOVA, V N', 'VORONINA, L M']","['SHARPENAK AE', 'DOVZHIK MA', 'POPKOVA VN', 'VORONINA LM']",,['rus'],['Journal Article'],,Russia (Federation),Vopr Pitan,Voprosy pitaniia,2984870R,OM,"['Communicable Diseases/*therapy', '*Diet', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*DIETS']",1958/03/01 00:00,1958/03/01 00:01,['1958/03/01 00:00'],"['1958/03/01 00:00 [pubmed]', '1958/03/01 00:01 [medline]', '1958/03/01 00:00 [entrez]']",,ppublish,Vopr Pitan. 1958 Mar-Apr;17(2):42-7.,,,,,,,,,Effektivnost' nespetsificheskoi diety N5 v period rekonvalestsentsii posle tiazhelykh infektsionnykh zabolevanii.,,,['CLML: 5834:62718:155:182'],,,,,
13361076,NLM,MEDLINE,20020501,20181201,0041-6959 (Print) 0041-6959 (Linking),85,7,1956 Jul,[Current status of acute infectious diseases].,814-6,,,,"['CHAREST, G']",['CHAREST G'],,['fre'],['Journal Article'],,Canada,Union Med Can,L'union medicale du Canada,0030444,OM,"['*Acute Disease', 'Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1956/07/01 00:00,1956/07/01 00:01,['1956/07/01 00:00'],"['1956/07/01 00:00 [pubmed]', '1956/07/01 00:01 [medline]', '1956/07/01 00:00 [entrez]']",,ppublish,Union Med Can. 1956 Jul;85(7):814-6.,,,,,,,,,La situation actuelle des maladies contagieuses aigues.,,,['CLML: 5731:7137'],,,,,
12206973,NLM,MEDLINE,20020919,20191106,1473-3099 (Print) 1473-3099 (Linking),2,9,2002 Sep,Kenya rises to infectious diseases challenge.,574-5,,,,"['Sansom, Clare', 'Koech, Davy']","['Sansom C', 'Koech D']","['Kenya Medical Research Institute, Kenya. c.sansom@mail.cryst.bbk.ac.uk']",['eng'],['Journal Article'],,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Academies and Institutes/economics/*organization & administration', '*Communicable Diseases/drug therapy/epidemiology', 'Humans', 'Kenya/epidemiology']",,,,2002/09/11 10:00,2002/09/20 10:01,['2002/09/11 10:00'],"['2002/09/11 10:00 [pubmed]', '2002/09/20 10:01 [medline]', '2002/09/11 10:00 [entrez]']","['S1473309902003730 [pii]', '10.1016/s1473-3099(02)00373-0 [doi]']",ppublish,Lancet Infect Dis. 2002 Sep;2(9):574-5. doi: 10.1016/s1473-3099(02)00373-0.,,,,,,,,,,,,,,,,,
26613688,NLM,MEDLINE,20160307,20181113,1557-8240 (Electronic) 0031-3955 (Print) 0031-3955 (Linking),63,1,2016 Feb,Infectious Diseases of Poverty in Children: A Tale of Two Worlds.,37-66,S0031-3955(15)00142-X [pii] 10.1016/j.pcl.2015.08.002 [doi],"""Infectious diseases of poverty"" (IDoP) describes infectious diseases that are more prevalent among poor and vulnerable populations, namely human immunodeficiency virus (HIV) infection, tuberculosis (TB), malaria, and neglected tropical diseases (NTDs). In 2013, 190,000 children died of HIV-related causes and there were 550,000 cases and 80,000 TB deaths in children. Children under age 5 account for 78% of malaria deaths annually. NTDs remain a public health challenge in low- and middle-income countries. This article provides an overview of the major IDoP that affect children. Clinicians must be familiar with the epidemiology and clinical manifestations to ensure prompt diagnosis and treatment.",['Copyright (c) 2016 Elsevier Inc. All rights reserved.'],"['Hansen, Caitlin', 'Paintsil, Elijah']","['Hansen C', 'Paintsil E']","['Department of Pediatrics, Yale University School of Medicine, 464 Congress Ave, New Haven, CT 06520, USA.', 'Department of Pediatrics, Yale University School of Medicine, 464 Congress Ave, New Haven, CT 06520, USA; Department of Pharmacology, Yale University School of Medicine, 464 Congress Avenue, New Haven, CT 06520, USA; Department of Public Health, Yale University School of Medicine, 464 Congress Avenue, New Haven, CT 06520, USA. Electronic address: elijah.paintsil@yale.edu.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Clin North Am,Pediatric clinics of North America,0401126,IM,"['Anti-Retroviral Agents/therapeutic use', 'Child', 'Child Mortality', '*Communicable Diseases/diagnosis/economics/therapy', 'Global Health', 'HIV Infections/diagnosis/drug therapy', 'Healthcare Disparities/*economics', 'Humans', 'Malaria/diagnosis/therapy', 'Neglected Diseases', '*Poverty', 'Tropical Medicine', 'Tuberculosis/diagnosis/drug therapy']",PMC4663017,['NOTNLM'],"['Children', 'HIV/AIDS', 'Infectious diseases', 'Malaria', 'Neglected tropical diseases', 'Poverty', 'Tuberculosis']",2015/11/29 06:00,2016/03/08 06:00,['2015/11/29 06:00'],"['2015/11/29 06:00 [entrez]', '2015/11/29 06:00 [pubmed]', '2016/03/08 06:00 [medline]']","['S0031-3955(15)00142-X [pii]', '10.1016/j.pcl.2015.08.002 [doi]']",ppublish,Pediatr Clin North Am. 2016 Feb;63(1):37-66. doi: 10.1016/j.pcl.2015.08.002.,,,['0 (Anti-Retroviral Agents)'],,,,"['P30 MH062294/MH/NIMH NIH HHS/United States', 'R01 HD074253/HD/NICHD NIH HHS/United States']",,,['NIHMS721174'],,,,,,,
20966445,NLM,MEDLINE,20120229,20211020,1470-2738 (Electronic) 0143-005X (Linking),65,1,2011 Jan,The ABC of terms used in mathematical models of infectious diseases.,87-94,10.1136/jech.2009.097113 [doi],"Mathematical models that incorporate a dynamic risk of infection figure prominently in the study of infectious diseases epidemiology as a tool to inform public health policy. In recent years, their use has expanded to address methodological questions, inform and validate study design and evaluate interventions. This glossary briefly highlights the applications of transmission dynamics modelling, explains different modelling methodologies and defines commonly encountered terms to provide an introductory and conceptual understanding of the vocabulary and frameworks used in the literature.",,"['Mishra, Sharmistha', 'Fisman, David N', 'Boily, Marie-Claude']","['Mishra S', 'Fisman DN', 'Boily MC']","[""Division of Infectious Diseases, St. Michael's Hospital, University of Toronto, Toronto, Canada.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20101021,England,J Epidemiol Community Health,Journal of epidemiology and community health,7909766,IM,"['*Communicable Diseases/epidemiology/transmission', 'Dictionaries as Topic', '*Epidemiologic Studies', 'Feedback', 'Humans', '*Models, Theoretical', 'Nonlinear Dynamics', 'Public Health']",,,,2010/10/23 06:00,2012/03/01 06:00,['2010/10/23 06:00'],"['2010/10/23 06:00 [entrez]', '2010/10/23 06:00 [pubmed]', '2012/03/01 06:00 [medline]']","['jech.2009.097113 [pii]', '10.1136/jech.2009.097113 [doi]']",ppublish,J Epidemiol Community Health. 2011 Jan;65(1):87-94. doi: 10.1136/jech.2009.097113. Epub 2010 Oct 21.,,,,,,,['88223-1/CAPMC/CIHR/Canada'],,,,,,,,,,
11017829,NLM,MEDLINE,20001222,20141120,1058-4838 (Print) 1058-4838 (Linking),31,3,2000 Sep,Population mobility and infectious diseases: the diminishing impact of classical infectious diseases and new approaches for the 21st century.,776-80,,"In an increasingly globalized world, rapid population mobility and migration is reducing the differences in infectious disease epidemiology between regions of the world. The movement and relocation of populations between locations where the prevalence and incidence of infections are markedly different poses current and future challenges to those involved in clinical infectious diseases and public health program management. Historically, international attention has focused on the screening and treatment of acute infections of epidemic potential, but, as immigration significantly changes the demography of many nations, chronic infections will require increased attention. In countries with large mobile populations, the population-based burden of infections with long latency periods or significant noninfectious sequelae will make up an increasing amount of the infectious disease caseload and will require more-modern approaches than the traditional screening of arrivals. The globalization of chronic infectious disease epidemiology will require corresponding development of integrated programs to anticipate and manage these diseases in response to an increasingly mobile patient population.",,"['Gushulak, B D', 'MacPherson, D W']","['Gushulak BD', 'MacPherson DW']","['Medical Services, International Organization for Migration, Geneva, Switzerland. bgushulak@iom.int']",['eng'],['Journal Article'],20001004,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Communicable Disease Control/*methods/trends', 'Communicable Diseases/microbiology/*transmission', 'Forecasting', 'Global Health', 'Humans', 'Population Surveillance']",,,,2000/10/06 11:00,2001/02/28 10:01,['2000/10/06 11:00'],"['2000/03/02 00:00 [received]', '2000/10/06 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/10/06 11:00 [entrez]']","['CID000272 [pii]', '10.1086/313998 [doi]']",ppublish,Clin Infect Dis. 2000 Sep;31(3):776-80. doi: 10.1086/313998. Epub 2000 Oct 4.,,,,,,,,,,,,,,,,,
35458537,NLM,MEDLINE,20220426,20220524,1999-4915 (Electronic) 1999-4915 (Linking),14,4,2022 Apr 13,Special Issue: Emerging Wildlife Viral Diseases.,,10.3390/v14040807 [doi] 807,The past several decades have seen the emergences of novel viral infectious diseases increase steadily in wildlife populations globally [...].,,"['Sarker, Subir']",['Sarker S'],"['Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, VIC 3086, Australia.']",['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",20220413,Switzerland,Viruses,Viruses,101509722,IM,"['Animals', 'Animals, Wild', '*Communicable Diseases', '*Communicable Diseases, Emerging/epidemiology/veterinary', '*Virus Diseases/epidemiology/veterinary', 'Zoonoses']",PMC9026112,,,2022/04/24 06:00,2022/04/27 06:00,['2022/04/23 01:15'],"['2022/04/08 00:00 [received]', '2022/04/10 00:00 [accepted]', '2022/04/23 01:15 [entrez]', '2022/04/24 06:00 [pubmed]', '2022/04/27 06:00 [medline]']","['v14040807 [pii]', 'viruses-14-00807 [pii]', '10.3390/v14040807 [doi]']",epublish,Viruses. 2022 Apr 13;14(4):807. doi: 10.3390/v14040807.,['The author declares no conflict of interest.'],['ORCID: 0000-0002-2685-8377'],,,,,,,,,,,,,,,
28494592,NLM,MEDLINE,20190626,20190626,2373-8227 (Electronic) 2373-8227 (Linking),3,5,2017 May 12,ACS Infectious Diseases Special Issue Focused on Drug Discovery for Global Health.,329,10.1021/acsinfecdis.7b00050 [doi],,,"['Aldrich, Courtney C', 'Calderon, Felix']","['Aldrich CC', 'Calderon F']","['Department of Medicinal Chemistry, College of Pharmacy, 8-174 Weaver-Densford Hall, University of Minnesota , 308 Harvard Street S.E., Minneapolis, Minneosta 55455, United States.', 'GSK, R&D, Tres Cantos Medicines Development Center , C/Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.']",['eng'],['Editorial'],,United States,ACS Infect Dis,ACS infectious diseases,101654580,IM,"['Communicable Diseases/drug therapy/*epidemiology', '*Drug Discovery/methods/standards', 'Global Health', 'Humans']",,,,2017/05/13 06:00,2019/06/27 06:00,['2017/05/13 06:00'],"['2017/05/13 06:00 [entrez]', '2017/05/13 06:00 [pubmed]', '2019/06/27 06:00 [medline]']",['10.1021/acsinfecdis.7b00050 [doi]'],ppublish,ACS Infect Dis. 2017 May 12;3(5):329. doi: 10.1021/acsinfecdis.7b00050.,,,,,,,,,,,,,,,,,
13282491,NLM,MEDLINE,20030501,20200716,0372-9311 (Print) 0372-9311 (Linking),,10,1955 Oct,[Sources and living vectors of causative agents of infectious diseases].,93-7,,,,"['TINKER, I S', 'SHIRIAEV, D T']","['TINKER IS', 'SHIRIAEV DT']",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['Animals', 'Communicable Diseases/*transmission', '*Disease Transmission, Infectious', '*Genetic Vectors', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/transmission'],1955/10/01 00:00,1955/10/01 00:01,['1955/10/01 00:00'],"['1955/10/01 00:00 [pubmed]', '1955/10/01 00:01 [medline]', '1955/10/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1955 Oct;(10):93-7.,,,,,,,,,Ob istochnikakh i zhivykh perenoschikakh vozbuditelei infektsionnykh boleznei.,,,['CLML: 5629:34632'],,,,,
9032960,NLM,MEDLINE,19970328,20051116,0026-2633 (Print) 0026-2633 (Linking),87,351,1996,Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review.,113-21,,"The reliability of tests for the identification of low avidity specific IgG in infectious diseases was investigated. The IgG antibody avidity assays were proposed in order to examine the probable aetiology, the accurate moment of primary infection and to distinguish between reactivation, reinfection or primary infection, in cases with false positive IgM or without specific IgM response. Such assays improve the usual serological techniques.",,"['Gutierrez, J', 'Maroto, C']","['Gutierrez J', 'Maroto C']","[""Department of Microbiology, St Cecil's Hospital, University of Granada, Spain.""]",['eng'],"['Journal Article', 'Review']",,England,Microbios,Microbios,0207257,IM,"['Antibody Affinity/*immunology', 'Communicable Diseases/*diagnosis/etiology/*immunology', 'Humans', 'Immunoglobulin G/*immunology', 'Immunoglobulin M/immunology', 'Reproducibility of Results', 'Sensitivity and Specificity', 'Serologic Tests/*methods']",,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Microbios. 1996;87(351):113-21.,,,"['0 (Immunoglobulin G)', '0 (Immunoglobulin M)']",,,40,,,,,,,,,,,
8903192,NLM,MEDLINE,19961211,20111117,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),1,4,1995 Oct-Dec,"Southeast Asia intercountry consultative meeting on prevention and control of new, emerging, and reemerging infectious diseases.",158,,,,"['Plianbangchang, S']",['Plianbangchang S'],,['eng'],['News'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Asia, Southeastern/epidemiology', 'Clinical Laboratory Techniques/economics/methods', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/economics/*epidemiology', 'Disease Outbreaks/prevention & control', 'Education, Medical', 'Government Agencies', 'Humans', 'Laboratories/economics', 'Population Surveillance', 'United Nations', 'World Health Organization']",PMC2626888,,,1995/10/01 00:00,1995/10/01 00:01,['1995/10/01 00:00'],"['1995/10/01 00:00 [pubmed]', '1995/10/01 00:01 [medline]', '1995/10/01 00:00 [entrez]']",['10.3201/eid0104.950416 [doi]'],ppublish,Emerg Infect Dis. 1995 Oct-Dec;1(4):158. doi: 10.3201/eid0104.950416.,,,,,,,,,,,,,,,,,
14378348,NLM,MEDLINE,20030501,20181201,0376-6209 (Print) 0376-6209 (Linking),18,86,1955 Jan,[Arterial hypotension in infectious diseases].,29-32,,,,"['ROMERO, E']",['ROMERO E'],,['spa'],['Journal Article'],,Spain,Bol Cult Inf Cons Gen Col Med Esp,Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana,7607103,OM,"['Communicable Diseases/*complications', 'Hypotension/*etiology']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*HYPOTENSION/etiology and pathogenesis']",1955/01/01 00:00,1955/01/01 00:01,['1955/01/01 00:00'],"['1955/01/01 00:00 [pubmed]', '1955/01/01 00:01 [medline]', '1955/01/01 00:00 [entrez]']",,ppublish,Bol Cult Inf Cons Gen Col Med Esp. 1955 Jan;18(86):29-32.,,,,,,,,,Contribucion al estudio de la hipotension arterial en el enfermo infeccioso.,,,['CLML: 5528:29384:151:288'],,,,,
13042313,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4825,1953 Jun 27,INFECTIOUS diseases and vital statistics.,1455-7,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016601,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/06/27 00:00,1953/06/27 00:01,['1953/06/27 00:00'],"['1953/06/27 00:00 [pubmed]', '1953/06/27 00:01 [medline]', '1953/06/27 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jun 27;1(4825):1455-7.,,,,,,,,,,,,['CLML: 5324:12652:162:700'],,,,,
13042278,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4824,1953 Jun 20,INFECTIOUS diseases and vital statistics.,1399-400,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016671,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/06/20 00:00,1953/06/20 00:01,['1953/06/20 00:00'],"['1953/06/20 00:00 [pubmed]', '1953/06/20 00:01 [medline]', '1953/06/20 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jun 20;1(4824):1399-400.,,,,,,,,,,,,['CLML: 5324:12617:162:700'],,,,,
13042224,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4822,1953 Jun 6,INFECTIOUS diseases and vital statistics.,1285-6,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016158,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/06/06 00:00,1953/06/06 00:01,['1953/06/06 00:00'],"['1953/06/06 00:00 [pubmed]', '1953/06/06 00:01 [medline]', '1953/06/06 00:00 [entrez]']",,ppublish,Br Med J. 1953 Jun 6;1(4822):1285-6.,,,,,,,,,,,,['CLML: 5324:12563:162:700'],,,,,
13042158,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4819,1953 May 16,INFECTIOUS diseases and vital statistics.,1117-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016476,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/05/16 00:00,1953/05/16 00:01,['1953/05/16 00:00'],"['1953/05/16 00:00 [pubmed]', '1953/05/16 00:01 [medline]', '1953/05/16 00:00 [entrez]']",,ppublish,Br Med J. 1953 May 16;1(4819):1117-9.,,,,,,,,,,,,['CLML: 5324:12497:161:700'],,,,,
13121766,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),3,30,1953 Nov 21,[Infectious diseases transmitted by milk; prophylaxis].,2191-8,,,,"['NEVOT, A']",['NEVOT A'],,['und'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,OM,"['Communicable Diseases/*transmission', '*Disease Transmission, Infectious', 'Humans', '*Milk']",,['NLM'],"['*COMMUNICABLE DISEASES/transmission', '*MILK']",1953/11/21 00:00,1953/11/21 00:01,['1953/11/21 00:00'],"['1953/11/21 00:00 [pubmed]', '1953/11/21 00:01 [medline]', '1953/11/21 00:00 [entrez]']",,ppublish,Rev Prat. 1953 Nov 21;3(30):2191-8.,,,,,,,,,Les maladies infectieuses transmises par le lait; leur prophylaxie.,,,['CLML: 5425:43009:117:295'],,,,,
13746774,NLM,MEDLINE,19981101,20190616,0077-8923 (Print) 0077-8923 (Linking),85,,1960 May 12,The roles of infectious and non-infectious diseases in monkey health.,866-88,,,,"['SAUER, R M', 'FEGLEY, H C']","['SAUER RM', 'FEGLEY HC']",,['eng'],['Journal Article'],,United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,OM,"['Animals', 'Communicable Diseases/*veterinary', '*Haplorhini', '*Health', 'Humans', '*Monkey Diseases']",,['NLM'],"['*COMMUNICABLE DISEASES/veterinary', '*MONKEYS/diseases']",1960/05/12 00:00,1960/05/12 00:01,['1960/05/12 00:00'],"['1960/05/12 00:00 [pubmed]', '1960/05/12 00:01 [medline]', '1960/05/12 00:00 [entrez]']",['10.1111/j.1749-6632.1960.tb50009.x [doi]'],ppublish,Ann N Y Acad Sci. 1960 May 12;85:866-88. doi: 10.1111/j.1749-6632.1960.tb50009.x.,,,,,,,,,,,,,,,,,
18839860,NLM,MEDLINE,20081202,20170214,1010-5395 (Print) 1010-5395 (Linking),16,1,2004,Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration.,1-2,,,,"['Kamarulzaman, Adeeba']",['Kamarulzaman A'],,['eng'],['Editorial'],,China,Asia Pac J Public Health,Asia-Pacific journal of public health,8708538,IM,"['Asia/epidemiology', 'Communicable Diseases/epidemiology', 'Communicable Diseases, Emerging/*prevention & control', 'Humans', '*International Cooperation', 'Pacific Islands/epidemiology']",,,,2008/10/09 09:00,2008/12/17 09:00,['2008/10/09 09:00'],"['2008/10/09 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/10/09 09:00 [entrez]']",['10.1177/101053950401600101 [doi]'],ppublish,Asia Pac J Public Health. 2004;16(1):1-2. doi: 10.1177/101053950401600101.,,,,,,,,,,,,,,,,,
32373224,NLM,MEDLINE,20210513,20231113,1838-7640 (Electronic) 1838-7640 (Linking),10,12,2020,Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing.,5501-5513,10.7150/thno.45554 [doi],"Metagenomic next-generation sequencing (mNGS) of microbial cell-free DNA (mcfDNA sequencing) is becoming an attractive diagnostic modality for infectious diseases, allowing broad-range pathogen detection, noninvasive sampling, and rapid diagnosis. At this key juncture in the translation of metagenomics into clinical practice, an integrative perspective is needed to understand the significance of emerging mcfDNA sequencing technology. In this review, we summarized the actual performance of the mcfDNA sequencing tests recently used in health care settings for the diagnosis of a variety of infectious diseases and further focused on the practice considerations (challenges and solutions) for improving the accuracy and clinical relevance of the results produced by this evolving technique. Such knowledge will be helpful for physicians, microbiologists and researchers to understand what is going on in this quickly progressing field of non-invasive pathogen diagnosis by mcfDNA sequencing and promote the routine implementation of this technique in the diagnosis of infectious disease.",['(c) The author(s).'],"['Han, Dongsheng', 'Li, Rui', 'Shi, Jiping', 'Tan, Ping', 'Zhang, Rui', 'Li, Jinming']","['Han D', 'Li R', 'Shi J', 'Tan P', 'Zhang R', 'Li J']","['National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.', 'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.', 'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.', 'Peking University Fifth School of Clinical Medicine, National Center for Clinical Laboratories, National Center of Gerontology, Beijing Hospital, Beijing, China.', 'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.', 'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.', 'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China.', 'Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China.', 'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20200407,Australia,Theranostics,Theranostics,101552395,IM,"['Cell-Free Nucleic Acids/*blood/genetics', 'Communicable Diseases/blood/*diagnosis/genetics/microbiology', 'DNA, Bacterial/*blood/genetics', 'High-Throughput Nucleotide Sequencing/*methods', 'Humans', 'Liquid Biopsy/*methods', 'Metagenomics/*methods']",PMC7196304,['NOTNLM'],"['cell-free DNA sequencing', 'metagenomics', 'microbial cfDNA', 'microbiology.', 'next-generation sequencing']",2020/05/07 06:00,2021/05/14 06:00,['2020/05/07 06:00'],"['2020/03/02 00:00 [received]', '2020/03/29 00:00 [accepted]', '2020/05/07 06:00 [entrez]', '2020/05/07 06:00 [pubmed]', '2021/05/14 06:00 [medline]']","['thnov10p5501 [pii]', '10.7150/thno.45554 [doi]']",epublish,Theranostics. 2020 Apr 7;10(12):5501-5513. doi: 10.7150/thno.45554. eCollection 2020.,['Competing Interests: The authors have declared that no competing interest exists.'],,"['0 (Cell-Free Nucleic Acids)', '0 (DNA, Bacterial)']",,,,,,,,,,,,,,
18894529,NLM,MEDLINE,20081020,20201005,0036-7672 (Print) 0036-7672 (Linking),78,41,1948 Oct 16,[Active specific therapy of allergic and infectious diseases].,1014,,,,"['SZABLICS, E']",['SZABLICS E'],,['ger'],['Journal Article'],,Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,OM,"['Anaphylaxis/*therapy', 'Communicable Diseases/*therapy', 'Hypersensitivity/*therapy', '*Immune System Diseases']",,['NLM'],"['*ALLERGY AND ANAPHYLAXIS/therapy', '*COMMUNICABLE DISEASES/therapy']",1948/10/16 00:00,2008/10/31 09:00,['1948/10/16 00:00'],"['1948/10/16 00:00 [pubmed]', '2008/10/31 09:00 [medline]', '1948/10/16 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1948 Oct 16;78(41):1014.,,,,,,,,,Die aktive spezifische Therapie der allergischen und Infektionskrankheiten.,,,['CLML: 4815:1646h'],,,,,
26464102,NLM,MEDLINE,20170303,20181113,1439-0973 (Electronic) 0300-8126 (Linking),44,3,2016 Jun,"The ""Choosing Wisely"": initiative in infectious diseases.",283-90,10.1007/s15010-015-0848-9 [doi],"PURPOSE: ""Choosing Wisely"" is a growing international campaign aiming on practice changes to improve patient health through avoidance of unnecessary diagnostic and therapeutic procedures. Our objective was to give an overview on recommendations related to diagnostic and therapeutic issues in infectious diseases from the ""Top Five"" lists of different medical societies and countries. METHODS: 11 countries featuring specific interest in ""Choosing Wisely"" met in 2014 to learn from each other about their specific campaigns. These countries were checked for released ""Top Five"" lists and subsequently screened for issues related to infectious diseases (ID). Recommendations containing the terms ""infection"", ""antibiotics"", ""antimicrobials"", ""antifungals"", ""antivirals"", ""vaccination"", ""resistance"" and ""cultures"" were defined as related to ID. RESULTS: In 7 out of 11 countries ""Top Five"" lists have been released. Topics of infectious diseases were related to treatment, diagnostics and prevention and present in 51 out of 628 recommendations (8 %) in all countries except Japan. Notably, unnecessary use of antibiotics in upper respiratory tract infections and asymptomatic bacteriuria were cited by several societies from different countries. CONCLUSIONS: Several societies include topics referring to ID in their recommendations which reflect the high relevance for this field with the overuse of antibiotics as the major concern.",,"['Jung, Norma', 'Lehmann, Clara', 'Fatkenheuer, Gerd']","['Jung N', 'Lehmann C', 'Fatkenheuer G']","['First Department of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50934, Cologne, Germany. norma.jung@uk-koeln.de.', 'First Department of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50934, Cologne, Germany.', 'German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.', 'First Department of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50934, Cologne, Germany.', 'German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.']",['eng'],"['Journal Article', 'Review']",20151013,Germany,Infection,Infection,0365307,IM,"['Communicable Diseases/*diagnosis/*therapy', 'Delivery of Health Care', '*Global Health', '*Health Promotion', 'Humans', 'Internationality', 'Unnecessary Procedures/*statistics & numerical data']",,['NOTNLM'],"['Choosing Wisely campaign', 'Infectious diseases', 'Overuse']",2015/10/16 06:00,2017/03/04 06:00,['2015/10/15 06:00'],"['2015/07/15 00:00 [received]', '2015/09/21 00:00 [accepted]', '2015/10/15 06:00 [entrez]', '2015/10/16 06:00 [pubmed]', '2017/03/04 06:00 [medline]']","['10.1007/s15010-015-0848-9 [pii]', '10.1007/s15010-015-0848-9 [doi]']",ppublish,Infection. 2016 Jun;44(3):283-90. doi: 10.1007/s15010-015-0848-9. Epub 2015 Oct 13.,,,,,,,,,,,,,,,,,
13751578,NLM,MEDLINE,19981101,20200716,0372-9311 (Print) 0372-9311 (Linking),32,,1961 May,[Studies on natural focus infectious diseases by Tomsk researchers].,3-8,,,,"['KARPOV, S P']",['KARPOV SP'],,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,OM,"['Communicable Diseases/*epidemiology', 'Humans', '*Research Personnel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1961/05/01 00:00,1961/05/01 00:01,['1961/05/01 00:00'],"['1961/05/01 00:00 [pubmed]', '1961/05/01 00:01 [medline]', '1961/05/01 00:00 [entrez]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 1961 May;32:3-8.,,,,,,,,,,,,,,,,,
13367753,NLM,MEDLINE,20020501,20181201,0025-7524 (Print) 0025-7524 (Linking),53,10,1956 Oct,The changing picture in infectious diseases; role of the contagious disease hospital.,518-9,,,,"['SMITH, E L']",['SMITH EL'],,['eng'],['Journal Article'],,United States,J Med Soc N J,The Journal of the Medical Society of New Jersey,7503084,OM,"['Communicable Diseases/*statistics & numerical data', '*Hospitals', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*HOSPITALS']",1956/10/01 00:00,1956/10/01 00:01,['1956/10/01 00:00'],"['1956/10/01 00:00 [pubmed]', '1956/10/01 00:01 [medline]', '1956/10/01 00:00 [entrez]']",,ppublish,J Med Soc N J. 1956 Oct;53(10):518-9.,,,,,,,,,,,,['CLML: 5731:13896'],,,,,
11583821,NLM,MEDLINE,20011204,20191105,0300-2977 (Print) 0300-2977 (Linking),59,3,2001 Sep,"Infectious diseases, host defence and the training of residents in internal medicine.",87-9,,,,"[""van 't Wout, J W"", 'van Dissel, J T']","[""van 't Wout JW"", 'van Dissel JT']",,['eng'],['Editorial'],,Netherlands,Neth J Med,The Netherlands journal of medicine,0356133,IM,"['Allergy and Immunology/education', 'Clinical Competence/standards', '*Communicable Diseases/diagnosis/immunology/therapy', 'Curriculum', 'Education, Medical, Graduate/*organization & administration', 'Humans', 'Immunity, Cellular/immunology', 'Internal Medicine/*education', 'Internship and Residency/*organization & administration']",,,,2001/10/05 10:00,2002/01/05 10:01,['2001/10/05 10:00'],"['2001/10/05 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/10/05 10:00 [entrez]']","['S0300297701001462 [pii]', '10.1016/s0300-2977(01)00146-2 [doi]']",ppublish,Neth J Med. 2001 Sep;59(3):87-9. doi: 10.1016/s0300-2977(01)00146-2.,,,,,,,,,,,,,,,,,
29689649,NLM,MEDLINE,20190612,20190613,1606-7916 (Electronic) 0036-3634 (Linking),60,1,2018 Jan-Feb,[[CISEI: A reference in research on infectious diseases for the twenty-first century]].,1-2,10.21149/9234 [doi],,,"['Santos Preciado, Jose Ignacio']",['Santos Preciado JI'],"['Facultad de Medicina, Universidad Nacional Autonoma de Mexico. Ciudad de Mexico. Mexico.']",['spa'],['Editorial'],,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,IM,"['*Academies and Institutes/organization & administration', 'Communicable Diseases/*epidemiology', 'Communicable Diseases, Emerging/epidemiology', 'Global Health', 'Humans', 'Mexico']",,,,2018/04/25 06:00,2019/06/14 06:00,['2018/04/25 06:00'],"['2018/04/25 06:00 [entrez]', '2018/04/25 06:00 [pubmed]', '2019/06/14 06:00 [medline]']",['10.21149/9234 [doi]'],ppublish,Salud Publica Mex. 2018 Jan-Feb;60(1):1-2. doi: 10.21149/9234.,,,,,,,,,El CISEI: referente en investigacion sobre enfermedades infecciosas en el siglo XXI.,,,,,,,,
17148204,NLM,MEDLINE,20070123,20181113,1744-9561 (Print) 1744-957X (Electronic) 1744-9561 (Linking),1,3,2005 Sep 22,Epidemiological implications of the contact network structure for cattle farms and the 20-80 rule.,350-2,,"The network of movements of cattle between farm holdings is an important determinant of the potential rates and patterns of spread of infectious diseases. Because cattle movements are uni-directional, the network is unusual in that the risks of acquiring infection (by importing cattle) and of passing infection on (by exporting cattle) can be clearly distinguished, and there turns out to be no statistically significant correlation between the two. This means that the high observed degree of heterogeneity in numbers of contacts does not result in an increase in the basic reproduction number, R0, in contrast to findings from studies of other contact networks. Despite this, it is still the case that just 20% of holdings contribute at least 80% of the value of R0.",,"['Woolhouse, M E J', 'Shaw, D J', 'Matthews, L', 'Liu, W-C', 'Mellor, D J', 'Thomas, M R']","['Woolhouse ME', 'Shaw DJ', 'Matthews L', 'Liu WC', 'Mellor DJ', 'Thomas MR']","['Centre for Infectious Diseases, College of Medicine and Veterinary Medicine, University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian EH25 9RG, UK. mark.woolhouse@ed.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Biol Lett,Biology letters,101247722,IM,"['*Agriculture', 'Animals', 'Cattle', 'Cattle Diseases/*epidemiology/transmission', 'Communicable Diseases/*epidemiology/transmission/veterinary', 'Disease Transmission, Infectious/*prevention & control/veterinary', 'Reproduction/physiology', 'Risk Factors', 'Space-Time Clustering', '*Transportation']",PMC1617140,,,2006/12/07 09:00,2007/01/24 09:00,['2006/12/07 09:00'],"['2006/12/07 09:00 [pubmed]', '2007/01/24 09:00 [medline]', '2006/12/07 09:00 [entrez]']","['JBWP7T3V7MG83TG7 [pii]', 'rsbl20050331 [pii]', '10.1098/rsbl.2005.0331 [doi]']",ppublish,Biol Lett. 2005 Sep 22;1(3):350-2. doi: 10.1098/rsbl.2005.0331.,,,,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,
13399996,NLM,MEDLINE,20020501,20181201,0026-4946 (Print) 0026-4946 (Linking),8,50,1956 Dec 15,[The electrocardiogram in infectious diseases in children].,1585-92,,,,"['FIONE, E', 'GRANATA, G']","['FIONE E', 'GRANATA G']",,['ita'],['Journal Article'],,Italy,Minerva Pediatr,Minerva pediatrica,0400740,OM,"['Communicable Diseases/*pathology', '*Electrocardiography', 'Humans']",,['NLM'],"['*COMMUNICABLE DISEASES/pathology', '*ELECTROCARDIOGRAPHY']",1956/12/15 00:00,1956/12/15 00:01,['1956/12/15 00:00'],"['1956/12/15 00:00 [pubmed]', '1956/12/15 00:01 [medline]', '1956/12/15 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1956 Dec 15;8(50):1585-92.,,,,,,,,,L'elettrocardiogramma nelle malattie infettive dell'infanzia.,,,['CLML: 5731:46625'],,,,,
16940862,NLM,MEDLINE,20061114,20220409,0951-7375 (Print) 0951-7375 (Linking),19,5,2006 Oct,Infectious diseases of severe weather-related and flood-related natural disasters.,408-14,,"PURPOSE OF REVIEW: The present review will focus on some of the possible infectious disease consequences of disastrous natural phenomena and severe weather, with a particular emphasis on infections associated with floods and the destruction of infrastructure. RECENT FINDINGS: The risk of infectious diseases after weather or flood-related natural disasters is often specific to the event itself and is dependent on a number of factors, including the endemicity of specific pathogens in the affected region before the disaster, the type of disaster itself, the impact of the disaster on water and sanitation systems, the availability of shelter, the congregating of displaced persons, the functionality of the surviving public health infrastructure, the availability of healthcare services, and the rapidity, extent, and sustainability of the response after the disaster. Weather events and floods may also impact disease vectors and animal hosts in a complex system. SUMMARY: Weather or flood-related natural disasters may be associated with an increased risk of soft tissue, respiratory, diarrheal, and vector-borne infectious diseases among survivors and responders.",,"['Ivers, Louise C', 'Ryan, Edward T']","['Ivers LC', 'Ryan ET']","[""Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital, Boston, Massachusetts, USA.""]",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Infect Dis,Current opinion in infectious diseases,8809878,IM,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/*etiology', '*Disasters', 'Humans', 'Risk Factors', '*Weather']",,,,2006/08/31 09:00,2006/11/15 09:00,['2006/08/31 09:00'],"['2006/08/31 09:00 [pubmed]', '2006/11/15 09:00 [medline]', '2006/08/31 09:00 [entrez]']","['00001432-200610000-00003 [pii]', '10.1097/01.qco.0000244044.85393.9e [doi]']",ppublish,Curr Opin Infect Dis. 2006 Oct;19(5):408-14. doi: 10.1097/01.qco.0000244044.85393.9e.,,,,,,93,,,,,,,,,,,
19673155,NLM,MEDLINE,20091104,20190923,1528-3984 (Electronic) 0197-4572 (Linking),30,4,2009 Jul-Aug,An evidence-based review of infectious diseases.,272-86,,,,"['Kang, Youngmi', 'Crogan, Neva L']","['Kang Y', 'Crogan NL']",,['eng'],['Journal Article'],,United States,Geriatr Nurs,"Geriatric nursing (New York, N.Y.)",8309633,,"['Aged', 'Aging/physiology', 'Anti-Bacterial Agents/pharmacokinetics', 'Communicable Diseases/*epidemiology/nursing', 'Geriatric Nursing', 'Humans', 'Risk Factors']",,,,2009/08/14 09:00,2009/11/05 06:00,['2009/08/14 09:00'],"['2009/08/14 09:00 [entrez]', '2009/08/14 09:00 [pubmed]', '2009/11/05 06:00 [medline]']","['S0197-4572(09)00222-5 [pii]', '10.1016/j.gerinurse.2009.06.005 [doi]']",ppublish,Geriatr Nurs. 2009 Jul-Aug;30(4):272-86. doi: 10.1016/j.gerinurse.2009.06.005.,,,['0 (Anti-Bacterial Agents)'],,,,,,,,,,,,,,
18256681,NLM,MEDLINE,20080408,20131121,1745-8358 (Electronic) 1745-834X (Linking),4,2,2008 Feb,Drug Insight: steroids in CNS infectious diseases--new indications for an old therapy.,97-104,10.1038/ncpneuro0713 [doi],"Infectious diseases of the CNS lead to overwhelming inflammatory processes within the brain and spinal cord that contribute substantially to patient morbidity and mortality. Pharmacological strategies to modulate inflammation have been investigated, although the resulting guidelines have sometimes been contradictory. Steroids have been proposed as adjunctive treatments for bacterial meningitis, tuberculous meningitis and herpes simplex virus encephalitis. Well-designed randomized controlled trials have established dexamethasone as an adjunctive therapy for adult patients receiving antibiotics for bacterial meningitis, and physicians prescribing the initial antibiotics need to be aware of current guidelines. Morbidity and mortality in patients with tuberculous meningitis exceeds 50%. Steroid treatments reduce mortality through an as yet unknown mechanism, although their effects on morbidity are less clear. Herpes simplex virus encephalitis is also associated with considerable morbidity and mortality. Despite a lack of randomized trials, there is some evidence that steroids used alongside antiviral therapy might be beneficial in this condition. As we discuss in this Review, systemic steroid treatment is an important aspect of treatment regimens for CNS infectious diseases, and the recent literature provides guidelines for the use of steroids in combination with appropriate antimicrobial therapy.",,"['Fitch, Michael T', 'van de Beek, Diederik']","['Fitch MT', 'van de Beek D']","['Department of Neurology, Center of Infection and Immunity Amsterdam, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Nat Clin Pract Neurol,Nature clinical practice. Neurology,101261799,IM,"['Animals', 'Central Nervous System Diseases/*drug therapy/microbiology/mortality', 'Communicable Diseases/*drug therapy/microbiology/mortality', 'Dexamethasone/therapeutic use', 'Humans', 'Steroids/*therapeutic use']",,,,2008/02/08 09:00,2008/04/09 09:00,['2008/02/08 09:00'],"['2007/08/10 00:00 [received]', '2007/11/08 00:00 [accepted]', '2008/02/08 09:00 [pubmed]', '2008/04/09 09:00 [medline]', '2008/02/08 09:00 [entrez]']","['ncpneuro0713 [pii]', '10.1038/ncpneuro0713 [doi]']",ppublish,Nat Clin Pract Neurol. 2008 Feb;4(2):97-104. doi: 10.1038/ncpneuro0713.,,,"['0 (Steroids)', '7S5I7G3JQL (Dexamethasone)']",,,61,,,,,,,,,,,
37290475,NLM,MEDLINE,20230731,20230802,1474-4457 (Electronic) 1473-3099 (Print) 1473-3099 (Linking),23,8,2023 Aug,Leveraging the positives from the pandemic to strengthen infectious disease care in low-income and middle-income countries.,890-892,S1473-3099(23)00354-7 [pii] 10.1016/S1473-3099(23)00354-7 [doi],,,"['Titanji, Boghuma K', 'Pai, Madhukar']","['Titanji BK', 'Pai M']","['Division of Infectious Disease, Emory University School of Medicine, Emory University, Atlanta, GA, USA.', 'School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada; Manipal McGill Program in Infectious Diseases, Manipal Center for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India. Electronic address: madhukar.pai@mcgill.ca.']",['eng'],"['Comment', 'Journal Article']",20230605,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,IM,"['Humans', '*Developing Countries', 'Pandemics/prevention & control', '*Communicable Diseases/epidemiology/therapy', 'Poverty']",PMC10241487,,,2023/06/09 01:09,2023/07/31 06:43,['2023/06/08 18:53'],"['2023/05/21 00:00 [received]', '2023/05/22 00:00 [accepted]', '2023/07/31 06:43 [medline]', '2023/06/09 01:09 [pubmed]', '2023/06/08 18:53 [entrez]']","['S1473-3099(23)00354-7 [pii]', '10.1016/S1473-3099(23)00354-7 [doi]']",ppublish,Lancet Infect Dis. 2023 Aug;23(8):890-892. doi: 10.1016/S1473-3099(23)00354-7. Epub 2023 Jun 5.,"['MP serves as an advisor to non-profits organisations namely WHO, Stop TB', 'Partnership, Bill & Melinda Gates Foundation, and Foundation for Innovative New', 'Diagnostics. None of these organisations were involved in this Comment. We', 'declare no competing interests.']",,,,,,,"['Lancet Infect Dis. 2023 Aug;23(8):e288-e300. PMID: 37290473', 'Lancet Infect Dis. 2023 Aug;23(8):e310-e317. PMID: 37290474', 'Lancet Infect Dis. 2023 Aug;23(8):e301-e309. PMID: 37290476']",,,,,,,,,
2693574,NLM,MEDLINE,19900315,20190503,0143-005X (Print) 1470-2738 (Electronic) 0143-005X (Linking),43,4,1989 Dec,Epidemiology in search of infectious diseases: methods in outbreak investigation.,311-4,,,,"['Palmer, S R']",['Palmer SR'],"['Communicable Disease Surveillance Centre (Welsh Unit), Cardiff Royal Infirmary, UK.']",['eng'],"['Journal Article', 'Review']",,England,J Epidemiol Community Health,Journal of epidemiology and community health,7909766,IM,"['Bias', 'Causality', 'Communicable Diseases/*epidemiology/etiology', '*Disease Outbreaks', '*Epidemiologic Methods', 'Humans', 'Incidence', 'Risk Factors', 'United Kingdom/epidemiology']",PMC1052866,,,1989/12/01 00:00,1989/12/01 00:01,['1989/12/01 00:00'],"['1989/12/01 00:00 [pubmed]', '1989/12/01 00:01 [medline]', '1989/12/01 00:00 [entrez]']",['10.1136/jech.43.4.311 [doi]'],ppublish,J Epidemiol Community Health. 1989 Dec;43(4):311-4. doi: 10.1136/jech.43.4.311.,,,,,,,,,,,,,,,,,
31740558,NLM,MEDLINE,20210104,20210104,1098-6596 (Electronic) 0066-4804 (Print) 0066-4804 (Linking),64,2,2020 Jan 27,Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage.,,10.1128/AAC.01800-19 [doi] e01800-19,"By design, antimicrobial agents act directly on microbial targets. These drugs aim to eliminate microbes and are remarkably effective against susceptible organisms. Nonetheless, some patients succumb to infectious diseases despite appropriate antimicrobial therapy. Today, with very few exceptions, physicians select antimicrobial therapy based on its activity against the targeted organism without consideration of how the regimen affects patients' immune responses. An important concept to emerge in the past few decades is that immune responses to microbes can be detrimental by enhancing host damage, which can translate into clinical disease. A central tenet of the damage-response framework (DRF) of microbial pathogenesis is that the relevant outcome of host-microbe interaction is the damage that occurs in the host, which can be due to microbial factors, host factors, or both. Given that host damage can make patients sick, reducing it should be a goal of treating infectious diseases. Inflammation and damage that stem from the host response to an infectious disease can increase during therapy with some antimicrobial agents and decrease during therapy with others. When a patient cannot eliminate a microbe with their own immune response, antimicrobial therapy is essential for microbial elimination, and yet it can affect the inflammatory response. In this essay, we discuss antimicrobial therapy in the context of the DRF and propose that consideration of the DRF may help tailor therapy to a patient's need to augment or reduce inflammation.",['Copyright (c) 2020 American Society for Microbiology.'],"['Pirofski, Liise-Anne', 'Casadevall, Arturo']","['Pirofski LA', 'Casadevall A']","['Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.', 'Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA Acasade1@jhu.edu.']",['eng'],"['Journal Article', 'Review']",20200127,United States,Antimicrob Agents Chemother,Antimicrobial agents and chemotherapy,0315061,IM,"['Anti-Infective Agents/*therapeutic use', 'Communicable Diseases/*drug therapy/immunology/microbiology', 'Host-Pathogen Interactions', 'Humans', 'Immunity/*drug effects', 'Inflammation/*prevention & control']",PMC6985739,['NOTNLM'],"['antimicrobial', 'damage', 'immunity']",2019/11/20 06:00,2021/01/05 06:00,['2019/11/20 06:00'],"['2019/11/20 06:00 [pubmed]', '2021/01/05 06:00 [medline]', '2019/11/20 06:00 [entrez]']","['AAC.01800-19 [pii]', '01800-19 [pii]', '10.1128/AAC.01800-19 [doi]']",epublish,Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01800-19. doi: 10.1128/AAC.01800-19. Print 2020 Jan 27.,,['ORCID: 0000-0002-9402-9167'],['0 (Anti-Infective Agents)'],,,,,,,,,,,,,,
13493453,NLM,MEDLINE,20000701,20181201,0027-2973 (Print) 0027-2973 (Linking),99,47,1957 Nov 22,[Critical evaluation of microbiological laboratory findings in the diagnosis of infectious diseases].,1770-4,,,,"['BRAND, G']",['BRAND G'],,['ger'],['Journal Article'],,Germany,Munch Med Wochenschr,Munchener medizinische Wochenschrift (1950),7801802,OM,"['Communicable Diseases/*diagnosis', 'Humans', '*Skin Tests']",,['NLM'],['*COMMUNICABLE DISEASES/diagnosis'],1957/11/22 00:00,1957/11/22 00:01,['1957/11/22 00:00'],"['1957/11/22 00:00 [pubmed]', '1957/11/22 00:01 [medline]', '1957/11/22 00:00 [entrez]']",,ppublish,Munch Med Wochenschr. 1957 Nov 22;99(47):1770-4.,,,,,,,,,Die kritische Auswertung mikrobiologischer Laboratoriumsbefunde bei der Diagnose von Infektionskrankheiten.,,,['CLML: 5833:36512:135'],,,,,
13059532,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),2,4832,1953 Aug 15,INFECTIOUS diseases and vital statistics.,401-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2029178,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/08/15 00:00,1953/08/15 00:01,['1953/08/15 00:00'],"['1953/08/15 00:00 [pubmed]', '1953/08/15 00:01 [medline]', '1953/08/15 00:00 [entrez]']",,ppublish,Br Med J. 1953 Aug 15;2(4832):401-3.,,,,,,,,,,,,['CLML: 5324:30176:162:700'],,,,,
19754728,NLM,MEDLINE,20091105,20090916,1469-0691 (Electronic) 1198-743X (Linking),15,8,2009 Aug,What will 21th-century hospitals for the care of patients with highly infectious diseases look like?,699,10.1111/j.1469-0691.2009.02942.x [doi],,,"['Raoult, D']",['Raoult D'],,['eng'],"['Editorial', 'Introductory Journal Article']",,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Diseases/drug therapy/*therapy', 'Hospitals, Isolation/organization & administration/standards/*trends', 'Humans']",,,,2009/09/17 06:00,2009/11/06 06:00,['2009/09/17 06:00'],"['2009/09/17 06:00 [entrez]', '2009/09/17 06:00 [pubmed]', '2009/11/06 06:00 [medline]']","['S1198-743X(14)60453-5 [pii]', '10.1111/j.1469-0691.2009.02942.x [doi]']",ppublish,Clin Microbiol Infect. 2009 Aug;15(8):699. doi: 10.1111/j.1469-0691.2009.02942.x.,,,,,,,,,,,,,,,,,
16955679,NLM,MEDLINE,20061003,20060906,1472-4472 (Print) 1472-4472 (Linking),7,8,2006 Aug,Targeting infectious diseases in the genomics era.,695-8,,,,"['Bagnoli, Fabio', 'Rappuoli, Rino']","['Bagnoli F', 'Rappuoli R']",,['eng'],['Editorial'],,England,Curr Opin Investig Drugs,"Current opinion in investigational drugs (London, England : 2000)",100965718,IM,"['Communicable Diseases/*microbiology/*therapy', '*Drug Design', 'Genomics/*methods', 'Humans', 'Molecular Sequence Data', 'Vaccines, DNA/genetics']",,,,2006/09/08 09:00,2006/10/04 09:00,['2006/09/08 09:00'],"['2006/09/08 09:00 [pubmed]', '2006/10/04 09:00 [medline]', '2006/09/08 09:00 [entrez]']",,ppublish,Curr Opin Investig Drugs. 2006 Aug;7(8):695-8.,,,"['0 (Vaccines, DNA)']",,,,,,,,,,,,,,
17255931,NLM,MEDLINE,20070405,20181113,0261-4189 (Print) 1460-2075 (Electronic) 0261-4189 (Linking),26,4,2007 Feb 21,Human genetics of infectious diseases: a unified theory.,915-22,,"Since the early 1950s, the dominant paradigm in the human genetics of infectious diseases postulates that rare monogenic immunodeficiencies confer vulnerability to multiple infectious diseases (one gene, multiple infections), whereas common infections are associated with the polygenic inheritance of multiple susceptibility genes (one infection, multiple genes). Recent studies, since 1996 in particular, have challenged this view. A newly recognised group of primary immunodeficiencies predisposing the individual to a principal or single type of infection is emerging. In parallel, several common infections have been shown to reflect the inheritance of one major susceptibility gene, at least in some populations. This novel causal relationship (one gene, one infection) blurs the distinction between patient-based Mendelian genetics and population-based complex genetics, and provides a unified conceptual frame for exploring the molecular genetic basis of infectious diseases in humans.",,"['Casanova, Jean-Laurent', 'Abel, Laurent']","['Casanova JL', 'Abel L']","['Laboratory of Human Genetics of Infectious Diseases, University of Paris Rene Descartes, INSERM, U550, Necker Medical School, Paris, France. casanova@necker.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20070125,England,EMBO J,The EMBO journal,8208664,IM,"['Communicable Diseases/*genetics/*immunology', '*Genetic Predisposition to Disease', '*Genetic Variation', '*Genetics, Medical', 'Humans', '*Models, Immunological']",PMC1852849,,,2007/01/27 09:00,2007/04/06 09:00,['2007/01/27 09:00'],"['2006/11/10 00:00 [received]', '2006/12/20 00:00 [accepted]', '2007/01/27 09:00 [pubmed]', '2007/04/06 09:00 [medline]', '2007/01/27 09:00 [entrez]']","['7601558 [pii]', '10.1038/sj.emboj.7601558 [doi]']",ppublish,EMBO J. 2007 Feb 21;26(4):915-22. doi: 10.1038/sj.emboj.7601558. Epub 2007 Jan 25.,,,,,,,,,,,,,,,,,
13042201,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4821,1953 May 30,INFECTIOUS diseases and vital statistics.,1229-30,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016304,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/05/30 00:00,1953/05/30 00:01,['1953/05/30 00:00'],"['1953/05/30 00:00 [pubmed]', '1953/05/30 00:01 [medline]', '1953/05/30 00:00 [entrez]']",,ppublish,Br Med J. 1953 May 30;1(4821):1229-30.,,,,,,,,,,,,['CLML: 5324:12540:162:700'],,,,,
13042182,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4820,1953 May 23,INFECTIOUS diseases and vital statistics.,1173-4,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016123,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/05/23 00:00,1953/05/23 00:01,['1953/05/23 00:00'],"['1953/05/23 00:00 [pubmed]', '1953/05/23 00:01 [medline]', '1953/05/23 00:00 [entrez]']",,ppublish,Br Med J. 1953 May 23;1(4820):1173-4.,,,,,,,,,,,,['CLML: 5324:12521:161:700'],,,,,
13032626,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4818,1953 May 9,INFECTIOUS diseases and vital statistics.,1057-9,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2016399,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/05/09 00:00,1953/05/09 00:01,['1953/05/09 00:00'],"['1953/05/09 00:00 [pubmed]', '1953/05/09 00:01 [medline]', '1953/05/09 00:00 [entrez]']",,ppublish,Br Med J. 1953 May 9;1(4818):1057-9.,,,,,,,,,,,,['CLML: 5324:2766:161:700'],,,,,
13032453,NLM,MEDLINE,20030501,20181201,0007-1447 (Print) 0007-1447 (Linking),1,4811,1953 Mar 21,INFECTIOUS diseases and vital statistics.,681-3,,,,,,,['eng'],['Journal Article'],,England,Br Med J,British medical journal,0372673,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC2015746,['NLM'],"['*COMMUNICABLE DISEASES/statistics', '*VITAL STATISTICS']",1953/03/21 00:00,1953/03/21 00:01,['1953/03/21 00:00'],"['1953/03/21 00:00 [pubmed]', '1953/03/21 00:01 [medline]', '1953/03/21 00:00 [entrez]']",,ppublish,Br Med J. 1953 Mar 21;1(4811):681-3.,,,,,,,,,,,,['CLML: 5324:2593:161:700'],,,,,
27102452,NLM,MEDLINE,20160510,20160422,1095-9203 (Electronic) 0036-8075 (Linking),352,6284,2016 Apr 22,INFECTIOUS DISEASES. Refugee crisis brings new health challenges.,391-2,10.1126/science.352.6284.391 [doi],,,"['Kupferschmidt, Kai']",['Kupferschmidt K'],,['eng'],['News'],20160421,United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Animals', 'Communicable Diseases/diagnosis/*epidemiology/etiology', 'Echinococcosis/diagnosis/epidemiology', 'Echinococcus/isolation & purification', '*Emigration and Immigration', 'Europe', 'Humans', 'Mass Screening', 'Methicillin Resistance', 'Methicillin-Resistant Staphylococcus aureus/isolation & purification', '*Refugees']",,,,2016/04/23 06:00,2016/05/11 06:00,['2016/04/23 06:00'],"['2016/04/23 06:00 [entrez]', '2016/04/23 06:00 [pubmed]', '2016/05/11 06:00 [medline]']","['352/6284/391 [pii]', '10.1126/science.352.6284.391 [doi]']",ppublish,Science. 2016 Apr 22;352(6284):391-2. doi: 10.1126/science.352.6284.391. Epub 2016 Apr 21.,,,,,,,,,,,,,,,,,
16758542,NLM,MEDLINE,20060608,20060606,0256-1859 (Print) 0256-1859 (Linking),16,3,1995 Sep,"New, emerging, and re-emerging infectious diseases.",1-7,,,,,,,['eng'],['Journal Article'],,United States,Epidemiol Bull,Epidemiological bulletin,8011598,IM,"['Communicable Diseases, Emerging/diagnosis/*epidemiology/prevention & control', 'Latin America/epidemiology', 'Population Surveillance/methods']",,,,1995/09/01 00:00,1995/09/01 00:01,['1995/09/01 00:00'],"['1995/09/01 00:00 [pubmed]', '1995/09/01 00:01 [medline]', '1995/09/01 00:00 [entrez]']",,ppublish,Epidemiol Bull. 1995 Sep;16(3):1-7.,,,,,,,,,,,,,,,,,
35810142,NLM,MEDLINE,20230110,20230412,2529-993X (Electronic) 2529-993X (Linking),41,1,2023 Jan,Application of telemedicine in infectious diseases.,36-39,S2529-993X(22)00142-3 [pii] 10.1016/j.eimce.2022.06.012 [doi],"INTRODUCTION: Infectious pathologies can benefit from the application of Telemedicine (TM). This study provides a description of the infectious pathology treated by the Telemedicine Service of the Hospital Central de la Defensa Gomez Ulla (STM-HCDGU). METHODS: Analysis of the e-consultations made by members of the Armed Forces (FA) of Spain displaced to the area of operations (ZO) in the period between 01/1/2015 and 31/12/2018 who developed infectious symptoms. RESULTS: 127 infectious diseases were diagnosed, the most frequent being those of respiratory etiology and later malaria. Geographically Africa and embarked contingents were the most significant. It was necessary to evacuate 18 patients to the HCDGU, being the diagnosis of malaria the most frequent reason for evacuation, cause of the only fatal case. CONCLUSIONS: infectious diseases benefit from the application of TM, being an important tool for the diagnosis and treatment of these, constituting an opportunity to expand to other displaced or remote populations.","['Copyright (c) 2021 Sociedad Espanola de Enfermedades Infecciosas y Microbiologia', 'Clinica. Published by Elsevier Espana, S.L.U. All rights reserved.']","['Monfort-Vinuesa, Carlos', 'Gil-Lopez, Pedro', 'Ramirez-Olivencia, German', 'Chivato-Perez, Tomas', 'Coca-Benito, David', 'Mata-Forte, Tatiana']","['Monfort-Vinuesa C', 'Gil-Lopez P', 'Ramirez-Olivencia G', 'Chivato-Perez T', 'Coca-Benito D', 'Mata-Forte T']","['FEA Medicina Interna, Hospital La Fuenfria, SERMAS, Cercedilla, Madrid, Spain. Electronic address: carlos.monfort@salud.madrid.org.', 'Teniente Coronel Medico, Jefe Servicio de Telemedicina, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain.', 'FEA Medicina Interna, UAAN, Seccion de Infecciosas, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain.', 'Facultad de Medicina, Universidad San Pablo CEU, Madrid, Spain.', 'Comandante Medico, Adjunto Servicio de Urgencias, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain.', 'Capitan Medico, Servicio de Medicina Interna, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain.']",['eng'],['Journal Article'],20220707,Spain,Enferm Infecc Microbiol Clin (Engl Ed),Enfermedades infecciosas y microbiologia clinica (English ed.),101777541,IM,"['Humans', '*Communicable Diseases/diagnosis/therapy', '*Telemedicine', '*Malaria', 'Hospitals', '*Military Personnel']",,['NOTNLM'],"['Enfermedad infecciosa', 'Infectious disease', 'Militar', 'Military', 'Telemedicina', 'Telemedicine']",2022/07/10 06:00,2023/01/11 06:00,['2022/07/09 22:12'],"['2021/01/23 00:00 [received]', '2021/03/09 00:00 [revised]', '2021/03/12 00:00 [accepted]', '2022/07/10 06:00 [pubmed]', '2023/01/11 06:00 [medline]', '2022/07/09 22:12 [entrez]']","['S2529-993X(22)00142-3 [pii]', '10.1016/j.eimce.2022.06.012 [doi]']",ppublish,Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan;41(1):36-39. doi: 10.1016/j.eimce.2022.06.012. Epub 2022 Jul 7.,,,,,,,,,,,,,,,,,
31331269,NLM,MEDLINE,20191002,20200225,1471-2334 (Electronic) 1471-2334 (Linking),19,1,2019 Jul 22,Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review.,653,10.1186/s12879-019-4285-8 [doi] 653,"BACKGROUND: The differential diagnosis of Fever of Unknown Origin (FUO) is very extensive, and includes infectious diseases (ID), neoplasms and noninfectious inflammatory diseases (NIID). Many FUO remain undiagnosed. Factors influencing the final diagnosis of FUO are unclear. METHODS: To identify factors associated with FUO diagnostic categories, we performed a systematic review of classical FUO case-series published in 2005-2015 and including patients from 2000. Moreover, to explore changing over time, we compared these case-series with those published in 1995-2004. RESULTS: Eighteen case-series, including 3164 patients, were included. ID were diagnosed in 37.8% of patients, NIID in 20.9%, and neoplasm in 11.6%, FUO were undiagnosed in 23.2%. NIIDs significantly increased over time. An association exists between study country income level and ID (increasing when the income decreases) and undiagnosed FUO (increasing when the income increases); even if not significant, the use of a pre-defined Minimal Diagnostic Work-up to qualify a fever as FUO seems to correlate with a lower prevalence of infections and a higher prevalence of undiagnosed FUO. The multivariate regression analysis shows significant association between geographic area, with ID being more frequent in Asia and Europe having the higher prevalence of undiagnosed FUO. Significant associations were found with model of study and FUO defining criteria, also. CONCLUSIONS: Despite advances in diagnostics, FUO still remains a challenge, with ID still representing the first cause. The main factors influencing the diagnostic categories are the income and the geographic position of the study country.",,"['Fusco, Francesco Maria', 'Pisapia, Raffaella', 'Nardiello, Salvatore', 'Cicala, Stefano Domenico', 'Gaeta, Giovanni Battista', 'Brancaccio, Giuseppina']","['Fusco FM', 'Pisapia R', 'Nardiello S', 'Cicala SD', 'Gaeta GB', 'Brancaccio G']","[""Infectious Diseases Unit 1, S. Maria Annunziata Hospital, Central Tuscany Health Unit, Via dell'Antella 54, 50012, Bagno a Ripoli, FI, Italy. francescomaria.fusco@uslcentro.toscana.it."", 'Epidemiology and Pre-clinical Research Department, National Institute for Infectious Diseases ""L. Spallanzani"", Rome, Italy.', 'Infectious Diseases and Viral Hepatitis, Department of Mental and Physical Health and Preventive Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy.', 'Infectious Diseases, Azienda Ospedaliera, University of Campania ""Luigi Vanvitelli"", Naples, Italy.', 'Infectious Diseases, Department of Mental and Physical Health and Preventive Medicine, University of Campania ""Luigi Vanvitelli"", Naples, Italy.', 'Department of Molecular Medicine, Infectious Diseases, University of Padua, Padua, Italy.']",['eng'],"['Journal Article', 'Systematic Review']",20190722,England,BMC Infect Dis,BMC infectious diseases,100968551,IM,"['Adult', 'Asia', 'Communicable Diseases/*diagnosis/epidemiology/etiology', 'Diagnosis, Differential', 'Europe', 'Female', 'Fever of Unknown Origin/*diagnosis', 'Humans', 'Inflammation/*diagnosis/etiology', 'Male', 'Middle Aged', 'Neoplasms/complications/diagnosis', 'Prevalence']",PMC6647059,['NOTNLM'],"['Diagnostic outcomes', 'Fever of unknown origin', 'Infectious diseases', 'Neoplasms', 'Noninfectious inflammatory diseases']",2019/07/25 06:00,2019/10/03 06:00,['2019/07/24 06:00'],"['2019/02/14 00:00 [received]', '2019/07/12 00:00 [accepted]', '2019/07/24 06:00 [entrez]', '2019/07/25 06:00 [pubmed]', '2019/10/03 06:00 [medline]']","['10.1186/s12879-019-4285-8 [pii]', '4285 [pii]', '10.1186/s12879-019-4285-8 [doi]']",epublish,BMC Infect Dis. 2019 Jul 22;19(1):653. doi: 10.1186/s12879-019-4285-8.,"['All authors declare that they have no competing interests. One of the author', '(FMF) is Associated Editor for BMC Infectious Diseases.']",['ORCID: 0000-0002-1293-5976'],,,,,,,,,,,,,,,
13068713,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),44,8,1953 Apr 15,"[MINISTRY of Health statistics of infectious diseases during March, 1953].",192,,,,,,,['und'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/04/15 00:00,1953/04/15 00:01,['1953/04/15 00:00'],"['1953/04/15 00:00 [pubmed]', '1953/04/15 00:01 [medline]', '1953/04/15 00:00 [entrez]']",,ppublish,Harefuah. 1953 Apr 15;44(8):192.,,,,,,,,,,,,['CLML: 5324:39418:162'],,,,,
9735085,NLM,MEDLINE,19980910,20190619,0003-4819 (Print) 0003-4819 (Linking),129,6,1998 Sep 15,Update in infectious diseases.,464-71,,,,"['Bartlett, J G']",['Bartlett JG'],"['Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Antiviral Agents/therapeutic use', 'Communicable Diseases/*drug therapy/epidemiology', 'Drug Resistance, Microbial', 'HIV Infections/drug therapy/epidemiology', 'Humans', 'United States/epidemiology']",,,,1998/09/12 00:00,1998/09/12 00:01,['1998/09/12 00:00'],"['1998/09/12 00:00 [pubmed]', '1998/09/12 00:01 [medline]', '1998/09/12 00:00 [entrez]']",['10.7326/0003-4819-129-6-199809150-00008 [doi]'],ppublish,Ann Intern Med. 1998 Sep 15;129(6):464-71. doi: 10.7326/0003-4819-129-6-199809150-00008.,,,['0 (Antiviral Agents)'],,,21,,,,,,,,,,,
19945087,NLM,MEDLINE,20100308,20231113,1946-9837 (Electronic) 1938-9736 (Print) 1946-9837 (Linking),24,4,2009 Nov,Infectious hepatopathies in dogs and cats.,189-98,10.1053/j.tcam.2009.06.004 [doi],"This article serves to review the various infectious diseases that affect the liver primarily or as a part of systemic infection. Although bacterial infections are probably the most common cause of infectious hepatitis, the clinician should be aware of other potential organisms and other commonly involved systems. Therefore, this article includes a description of common bacterial, mycobacterial, viral, fungal, protozoal, parasitic, and rickettsial diseases in dogs and cats.",,"['Kearns, Shawn']",['Kearns S'],"['Angell Animal Medical Center-Boston, Boston, MA, USA. skearns@mspca.org']",['eng'],"['Journal Article', 'Review']",,United States,Top Companion Anim Med,Topics in companion animal medicine,101465592,IM,"['Animals', 'Bacterial Infections/veterinary', 'Cat Diseases/*microbiology/parasitology', 'Cats', 'Communicable Diseases/microbiology/parasitology/*veterinary', 'Dog Diseases/*microbiology/parasitology', 'Dogs', 'Liver/microbiology/parasitology', 'Liver Diseases/microbiology/parasitology/*veterinary', 'Mycoses/veterinary', 'Protozoan Infections, Animal']",PMC7104989,,,2009/12/01 06:00,2010/03/10 06:00,['2009/12/01 06:00'],"['2009/06/05 00:00 [received]', '2009/06/05 00:00 [accepted]', '2009/12/01 06:00 [entrez]', '2009/12/01 06:00 [pubmed]', '2010/03/10 06:00 [medline]']","['S1938-9736(09)00072-5 [pii]', '10.1053/j.tcam.2009.06.004 [doi]']",ppublish,Top Companion Anim Med. 2009 Nov;24(4):189-98. doi: 10.1053/j.tcam.2009.06.004.,,,,,,,,,,,,,,,,,
21615975,NLM,MEDLINE,20111027,20161021,1475-2654 (Electronic) 1466-2523 (Linking),12,1,2011 Jun,The role of wildlife in transboundary animal diseases.,95-111,10.1017/S1466252311000041 [doi],"This paper identifies some of the more important diseases at the wildlife-livestock interface and the role wildlife plays in disease transmission. Domestic livestock, wildlife and humans share many similar pathogens. Pathogens of wild or domestic animal origin that can cause infections in humans are known as zoonotic organisms and the converse are termed as anthroponotic organisms. Seventy-seven percent of livestock pathogens and 91% of domestic carnivore pathogens are known to infect multiple hosts, including wildlife. Understanding this group of pathogens is critical to public health safety, because they infect a wide range of hosts and are most likely to emerge as novel causes of infection in humans and domestic animals. Diseases at the wildlife-livestock interface, particularly those that are zoonotic, must be an area of focus for public health programs and surveillance for emerging infectious diseases. Additionally, understanding wildlife and their role is a vital part of understanding the epidemiology and ecology of diseases. To do this, a multi-faceted approach combining capacity building and training, wildlife disease surveillance, wildlife-livestock interface and disease ecology studies, data and information sharing and outbreak investigation are needed.",,"['Siembieda, J L', 'Kock, R A', 'McCracken, T A', 'Newman, S H']","['Siembieda JL', 'Kock RA', 'McCracken TA', 'Newman SH']","['Food and Agriculture Organization of the United Nations, Emergency Prevention System (EMPRES) for Transboundary Animal and Plant Pests and Diseases, Wildlife Health and Ecology Unit, Animal Production and Health Division, Rome, Italy.']",['eng'],"['Journal Article', 'Review']",20110527,England,Anim Health Res Rev,Animal health research reviews,101083072,IM,"['Animals', '*Animals, Wild', 'Communicable Diseases/epidemiology/microbiology/transmission/*veterinary', 'Disease Reservoirs/*veterinary', '*Livestock']",,,,2011/05/28 06:00,2011/10/28 06:00,['2011/05/28 06:00'],"['2011/05/28 06:00 [entrez]', '2011/05/28 06:00 [pubmed]', '2011/10/28 06:00 [medline]']","['S1466252311000041 [pii]', '10.1017/S1466252311000041 [doi]']",ppublish,Anim Health Res Rev. 2011 Jun;12(1):95-111. doi: 10.1017/S1466252311000041. Epub 2011 May 27.,,,,,,,,,,,,,,,,,
2674644,NLM,MEDLINE,19891017,20091021,0025-8326 (Print) 0025-8326 (Linking),,3,1989 May-Jun,[The gray rat (Rattus norvegicus) as a carrier of infectious causative agents in Siberia and the Far East].,73-7,,"Literary data and antiplague institutions' reports demonstrate that Norway rats carry over 24 nosological forms and groups of infectious diseases: plague, tularemia, pseudotuberculosis, intestinal yersiniosis, salmonellosis, erysipeloid, listeriosis, leptospirosis, pasteurellosis, brucellosis, dysentery, paratuberculosis, hemorrhagic nephroso-nephritis, Omsk hemorrhagic fever and Q fever, tick-borne and Japanese encephalitis, lymphocytic choriomeningitis, tick-borne rickettsiosis and rickettsial pox, murine typhus, tsutsugamushi disease and toxoplasmosis.",,"[""Ol'iakova, N V"", 'Antoniuk, V Ia']","[""Ol'iakova NV"", 'Antoniuk VIa']",,['rus'],"['English Abstract', 'Journal Article', 'Review']",,Russia (Federation),Med Parazitol (Mosk),Meditsinskaia parazitologiia i parazitarnye bolezni,0376635,IM,"['Animals', 'Carrier State/microbiology/transmission/veterinary', 'Communicable Diseases/microbiology/*transmission/veterinary', '*Disease Vectors', 'Humans', 'Rats/*microbiology', 'Rodent Diseases/microbiology/transmission', 'Siberia']",,,,1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']",,ppublish,Med Parazitol (Mosk). 1989 May-Jun;(3):73-7.,,,,,,61,,,Seraia krysa (Rattus norvegicus) kak nositel' vozbuditelei infektsii v Sibiri i Dal'nem Vostoke.,,,,,,,,
20722266,NLM,MEDLINE,20101005,20100820,1042-7260 (Print) 1042-7260 (Linking),41,1,2010 Mar,Serologic survey for selected infectious diseases in free-ranging Brazilian tapirs (Tapirus terrestris) in the cerrado of central Brazil.,133-6,,"From September 2000 to January 2002, a serologic survey was conducted in a population of free-ranging Brazilian tapirs (Tapirus terrestris) inhabiting Emas National Park and surrounding areas in Goias state, central Brazil, as part of an ecologic study. Ten tapirs were immobilized with a tiletamine-zolazepam combination, and blood samples were collected. All sera were negative for Leptospira spp., Brucella abortus, and equine infectious anemia; and one of 10 animals was positive for Toxoplasma gondii. This report represents the first serologic survey for selected infectious diseases in a free-ranging population of Brazilians tapirs in central Brazil.",,"['Furtado, Mariana Malzoni', 'Jacomo, Anah Tereza de Almeida', 'Kashivakura, Cyntia Kayo', 'Torres, Natalia Mundim', 'Marvulo, Maria Fernanda Vianna', 'Ragozo, Alessandra Mara Alves', 'de Souza, Silvio Luis Pereira', 'Neto, Jose Soares Ferreira', 'Vasconcellos, Silvio Arruda', 'Morais, Zenaide Maria', 'Cortez, Adriana', 'Richtzenhain, Leonardo Jose', 'Silva, Jean Carlos Ramos', 'Silveira, Leandro']","['Furtado MM', 'Jacomo AT', 'Kashivakura CK', 'Torres NM', 'Marvulo MF', 'Ragozo AM', 'de Souza SL', 'Neto JS', 'Vasconcellos SA', 'Morais ZM', 'Cortez A', 'Richtzenhain LJ', 'Silva JC', 'Silveira L']","['Jaguar Conservation Fund, Caixa Postal 193, CEP 75830-000, Mineiros-GO, Brazil. marianafurtado@jaguar.org.br']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,J Zoo Wildl Med,Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,8915208,IM,"['Animals', 'Brazil/epidemiology', 'Communicable Diseases/blood/epidemiology/*veterinary', '*Ecosystem', 'Perissodactyla/*blood', 'Serologic Tests']",,,,2010/08/21 06:00,2010/10/06 06:00,['2010/08/21 06:00'],"['2010/08/21 06:00 [entrez]', '2010/08/21 06:00 [pubmed]', '2010/10/06 06:00 [medline]']",['10.1638/2007-0087.1 [doi]'],ppublish,J Zoo Wildl Med. 2010 Mar;41(1):133-6. doi: 10.1638/2007-0087.1.,,,,,,,,,,,,,,,,,
14389617,NLM,MEDLINE,20030501,20190516,0007-0912 (Print) 0007-0912 (Linking),27,6,1955 Jun,Positive pressure respiration in infectious diseases.,303-12,,,,"['WISLICKI, L']",['WISLICKI L'],,['eng'],['Journal Article'],,England,Br J Anaesth,British journal of anaesthesia,0372541,OM,"['Communicable Diseases/*complications', '*Positive-Pressure Respiration', '*Respiration', '*Respiration, Artificial']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*RESPIRATION, ARTIFICIAL']",1955/06/01 00:00,1955/06/01 00:01,['1955/06/01 00:00'],"['1955/06/01 00:00 [pubmed]', '1955/06/01 00:01 [medline]', '1955/06/01 00:00 [entrez]']","['S0007-0912(17)44367-4 [pii]', '10.1093/bja/27.6.303 [doi]']",ppublish,Br J Anaesth. 1955 Jun;27(6):303-12. doi: 10.1093/bja/27.6.303.,,,,,,,,,,,,['CLML: 5528:40778:151:491'],,,,,
31519225,NLM,MEDLINE,20200617,20200617,2769-6677 (Electronic) 1559-6109 (Print) 1559-6109 (Linking),58,6,2019 Nov 1,Multiplex Immunochromatographic Assay for Serologic Diagnosis of Major Infectious Diseases in Laboratory Mice.,790-795,10.30802/AALAS-JAALAS-19-000008 [doi],"Serologic monitoring of infectious diseases is important for microbial control in colonies of laboratory mice. Rapid and simple tests that do not require killing animals are valuable for this purpose. In this study, we developed a multiplex immunochromatographic assay (ICA) for detection of antibodies to mouse hepatitis virus (MHV), Sendai virus (also known as hemagglutinating virus of Japan [HVJ]), and Clostridium piliforme (The pathogen that causes Tyzzer disease), which are major infectious diseases in mice. For this assay, an ICA strip was put into a microtube containing 150 muL PBS and either 0.75 muL mouse serum or 1.5 muL whole blood. Binding antibodies were visualized by using protein A-conjugated colloidal gold. Under these conditions, multiplex ICA simultaneously and specifically detected antibodies to multiple antigens. To evaluate the sensitivity and specificity of multiplex ICA, positive serum samples for each infectious disease were used. Sensitivities of the multiplex ICA test for MHV, HVJ, and C. piliforme were 100%, 100%, and 90%, respectively. No nonspecific reaction was observed in any of the 30 positive sera. In addition, 10 samples of uninfected sera did not show any bands except for the control line. These observations indicate high specificity of the multiplex ICA test. Moreover, the multiplex ICA could be applied to diluted blood. These results indicate that the multiplex ICA is appropriate for rapid, simple, and safe serologic testing of laboratory mice.",,"['Tosa, Noriko', 'Ishida, Tomoko', 'Yoshimatsu, Kumiko', 'Hayashimoto, Nobuhito', 'Shiokawa, Kanae', 'Takakura, Akira', 'Arikawa, Jiro']","['Tosa N', 'Ishida T', 'Yoshimatsu K', 'Hayashimoto N', 'Shiokawa K', 'Takakura A', 'Arikawa J']","['Institute for Animal Experimentation, Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.', 'ICLAS Monitoring Center, Central Institute for Experimental Animals, Kawasaki, Japan.', 'Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan;, Email: yosimatu@med.hokudai.ac.jp.', 'Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.', 'Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.', 'ICLAS Monitoring Center, Central Institute for Experimental Animals, Kawasaki, Japan.', 'Institute for Animal Experimentation, Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Department of Microbiology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20190913,United States,J Am Assoc Lab Anim Sci,Journal of the American Association for Laboratory Animal Science : JAALAS,101269489,IM,"['Animals', 'Animals, Laboratory', 'Communicable Diseases/blood/diagnosis/*veterinary', 'Immunoassay/methods/*veterinary', 'Laboratory Animal Science', 'Mice', 'Rodent Diseases/blood/*diagnosis', 'Sensitivity and Specificity']",PMC6926397,,,2019/09/15 06:00,2020/06/18 06:00,['2019/09/15 06:00'],"['2019/09/15 06:00 [pubmed]', '2020/06/18 06:00 [medline]', '2019/09/15 06:00 [entrez]']","['2019000790 [pii]', '10.30802/AALAS-JAALAS-19-000008 [doi]']",ppublish,J Am Assoc Lab Anim Sci. 2019 Nov 1;58(6):790-795. doi: 10.30802/AALAS-JAALAS-19-000008. Epub 2019 Sep 13.,,,,,,,,,,,,,,,,,
32987400,NLM,MEDLINE,20210624,20210624,1878-3503 (Electronic) 0035-9203 (Linking),115,1,2021 Jan 7,Active support after natural disasters: a review of a microbiologist's role.,110-116,10.1093/trstmh/traa099 [doi],"In the aftermath of a natural disaster, multispecialty rapid response teams are deployed to support health-related relief work. Microbiologists are often part of such teams, along with public health specialists, clinicians and entomologists, and can contribute to the response in multiple ways. The role of a microbiologist is critical not only for laboratory diagnosis of infectious diseases, but also for situational analysis and evaluation, planning, prevention and control. The task begins with risk assessment, specifically for identification of diseases epidemic and endemic to the area. Evaluation of existing laboratory setups and establishment of services where none exist is a priority, including facilitation of a tiered laboratory system. Training of laboratory staff at short notice in field settings, biosafety and biomedical waste management are niche areas where microbiologists can contribute. Emerging focus areas include establishment of modular laboratories, infection prevention and control in community evacuation centres and considerations for reopening of healthcare facilities closed due to extensive natural damage. A trained and efficient microbiologist will prove a valuable asset to provide timely and useful support for infectious disease diagnosis, prevention, control and management in the wake of natural disasters.","['(c) The Author(s) 2020. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene.']","['Viswanathan, Rajlakshmi', 'Chakrabarty, Alok', 'Basu, Sulagna']","['Viswanathan R', 'Chakrabarty A', 'Basu S']","['Scientist D, Bacteriology Group, ICMR-National Institute of Virology, Microbial Containment Complex, 130/1, Sus Road, Pune 411021, Maharashtra, India.', 'Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme XM, Beliaghata, Kolkata 700010, India.', 'Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme XM, Beliaghata, Kolkata 700010, India.']",['eng'],"['Journal Article', 'Review']",,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,IM,"['*Communicable Diseases/diagnosis/epidemiology/therapy', '*Disaster Planning', 'Humans', '*Natural Disasters']",,['NOTNLM'],"['infection prevention', 'microbiologist', 'modular laboratory', 'natural disaster', 'rapid diagnostics', 'risk assessment']",2020/09/29 06:00,2021/06/25 06:00,['2020/09/28 20:18'],"['2020/07/15 00:00 [received]', '2020/09/04 00:00 [revised]', '2020/09/11 00:00 [accepted]', '2020/09/29 06:00 [pubmed]', '2021/06/25 06:00 [medline]', '2020/09/28 20:18 [entrez]']","['5912609 [pii]', '10.1093/trstmh/traa099 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2021 Jan 7;115(1):110-116. doi: 10.1093/trstmh/traa099.,,,,,,,,,,,,,,,,,
25942798,NLM,MEDLINE,20150707,20190715,1533-4880 (Print) 1533-4880 (Linking),14,10,2014 Oct,Nanotechnology for diagnosis and treatment of infectious diseases.,7374-87,,"The emergence of co-infections and the evolution of drug-resistant pathogens limit the utility of current therapies against infections, and developing countries in particular are facing a great challenge in combating infectious disease. Moreover, any failure to control the spread of infectious diseases would also represent a threat to developed countries. Recent developments in nanotechnology allow us to address this issue at two levels: diagnostics and treatment. Prevention of the spread of infectious pathogens requires rapid and accurate identification of the infectious agents for proper treatment. Recently developed fluorescent nanoparticles are so sensitive that even a single nanoparticle is capable of emitting a strong enough signal to be captured, thus enabling early identification of infections. Proper and effective treatment not only saves the patient, but also prevents the spread of the pathogens. Specific nanoparticle vehicles developed to encapsulate therapeutic agents and deliver them to a target site represent a promising strategy to boost immune responses for vaccination and boost the efficacy of drugs for treatment. Here, we describe a variety of nanotechnologies for use in applications such as immune response modulation, drug delivery, diagnostics, and treatment, which are especially needed in developing countries.",,"['Qasim, Muhammad', 'Lim, Dong-Jin', 'Park, Hansoo', 'Na, Dokyun']","['Qasim M', 'Lim DJ', 'Park H', 'Na D']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,J Nanosci Nanotechnol,Journal of nanoscience and nanotechnology,101088195,IM,"['Communicable Diseases/*diagnosis/immunology/*therapy', 'Drug Carriers/pharmacology/therapeutic use', 'Humans', 'Immunomodulation/drug effects', 'Nanoparticles/therapeutic use', 'Nanotechnology/*methods', 'Vaccination']",,,,2015/05/07 06:00,2015/07/08 06:00,['2015/05/07 06:00'],"['2015/05/07 06:00 [entrez]', '2015/05/07 06:00 [pubmed]', '2015/07/08 06:00 [medline]']",['10.1166/jnn.2014.9578 [doi]'],ppublish,J Nanosci Nanotechnol. 2014 Oct;14(10):7374-87. doi: 10.1166/jnn.2014.9578.,,,['0 (Drug Carriers)'],,,,,,,,,,,,,,
13175820,NLM,MEDLINE,20030501,20181201,,80,6,1954 Jun,New thoughts on infectious diseases; measures of control.,647-50,,,,"['PAUL, H']",['PAUL H'],,['eng'],['Journal Article'],,England,Med World,Medical world,0170272,OM,"['*Communicable Disease Control', 'Communicable Diseases/*prevention & control', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/prevention and control'],1954/06/01 00:00,1954/06/01 00:01,['1954/06/01 00:00'],"['1954/06/01 00:00 [pubmed]', '1954/06/01 00:01 [medline]', '1954/06/01 00:00 [entrez]']",,ppublish,Med World. 1954 Jun;80(6):647-50.,,,,,,,,,,,,['CLML: 5426:38696:117'],,,,,
12942660,NLM,MEDLINE,20030924,20041117,0580-7247 (Print) 0580-7247 (Linking),35,8,2003 Aug,The impact of point-of-care testing on the diagnosis of infectious diseases.,36-7,,,,"['Weiner, Robin G', 'Tyler, Julia K']","['Weiner RG', 'Tyler JK']","['Quidel Corp., San Diego, USA.']",['eng'],['Journal Article'],,United States,MLO Med Lab Obs,MLO: medical laboratory observer,0225602,,"['Communicable Diseases/*diagnosis/mortality', 'Diagnostic Tests, Routine', 'Humans', '*Point-of-Care Systems', 'Quality of Health Care', 'Treatment Outcome', 'United States/epidemiology']",,,,2003/08/29 05:00,2003/09/25 05:00,['2003/08/29 05:00'],"['2003/08/29 05:00 [pubmed]', '2003/09/25 05:00 [medline]', '2003/08/29 05:00 [entrez]']",,ppublish,MLO Med Lab Obs. 2003 Aug;35(8):36-7.,,,,,,,,,,,,,,,,,
11577066,NLM,MEDLINE,20011101,20190503,0093-0415 (Print) 0093-0415 (Linking),175,4,2001 Oct,Immigrant women's health: Infectious diseases - Part 2.,277-9,,,,"['Avery, R']",['Avery R'],"['Department of Infectious Diseases, Desk S-32, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. averyr@ccf.org']",['eng'],"['Journal Article', 'Review']",,United States,West J Med,The Western journal of medicine,0410504,IM,"['Communicable Disease Control/*methods', 'Communicable Diseases/*diagnosis/*epidemiology', '*Emigration and Immigration', 'Female', 'Gastrointestinal Diseases/epidemiology/microbiology', 'HIV Infections/diagnosis/epidemiology', 'Humans', 'Incidence', 'Mass Screening', 'Parasitic Diseases/diagnosis/epidemiology', 'Pregnancy', 'Prognosis', 'Risk Assessment', 'Sexually Transmitted Diseases/diagnosis/epidemiology', ""*Women's Health""]",PMC1071583,,,2001/09/29 10:00,2001/11/03 10:01,['2001/09/29 10:00'],"['2001/09/29 10:00 [pubmed]', '2001/11/03 10:01 [medline]', '2001/09/29 10:00 [entrez]']","['1750277 [pii]', '10.1136/ewjm.175.4.277 [doi]']",ppublish,West J Med. 2001 Oct;175(4):277-9. doi: 10.1136/ewjm.175.4.277.,,,,,,,,,,,,,,,,,
12973637,NLM,MEDLINE,20031023,20141120,0042-9686 (Print) 0042-9686 (Linking),81,7,2003,Molecular epidemiology of infectious diseases: a case for increased surveillance.,474,,,,"['Hasnain, Seyed E']",['Hasnain SE'],,['eng'],['Editorial'],20030903,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,IM,"['Communicable Diseases/*epidemiology/genetics', 'Disease Outbreaks/prevention & control', 'Global Health', 'Humans', '*Molecular Epidemiology', '*Population Surveillance']",PMC2572505,,,2003/09/16 05:00,2003/10/24 05:00,['2003/09/16 05:00'],"['2003/09/16 05:00 [pubmed]', '2003/10/24 05:00 [medline]', '2003/09/16 05:00 [entrez]']",['S0042-96862003000700003 [pii]'],ppublish,Bull World Health Organ. 2003;81(7):474. Epub 2003 Sep 3.,,,,,,,,,,,,,,,,,
9928868,NLM,MEDLINE,19990401,20190905,0393-2990 (Print) 0393-2990 (Linking),14,8,1998 Dec,Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications.,749-54,,"Two rate ratios indicating the disappearance of infections and the growth of tumours, respectively, were simultaneously plotted against the calendar years of occurrence in a period during which mortality rates were reasonably comparable to incidences. The transformation used gave upward trend time variations for infectious diseases, providing strong evidence that in Italy during the first half of this century variations in infectious diseases preceded variations in cancer. While some bacteria and viruses are known to be cancer agents, sparse studies indicate that a host's immune response to infection may destroy cancer cells. With a decreasing mortality from infectious illnesses, there may have been a reduction in the activation of immunological mechanisms against transformed cells in early phases of carcinogenesis. If cancer growth is a consequence of a lower exposure to chronic sublethal doses of microbial agents, bacterial derivates could be potentially useful in cancer chemoprevention.",,"['Mastrangelo, G', 'Fadda, E', 'Milan, G']","['Mastrangelo G', 'Fadda E', 'Milan G']","['Institute of Occupational Medicine, University of Padua, Italy. mastran1@ux1.unipd.it']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Netherlands,Eur J Epidemiol,European journal of epidemiology,8508062,IM,"['Adult', 'Algorithms', 'Bacterial Infections/immunology', 'Cell Transformation, Neoplastic/immunology', 'Chemoprevention', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/etiology/immunology/mortality', 'Female', 'Humans', 'Incidence', 'Italy/epidemiology', 'Linear Models', 'Male', 'Neoplasms/*epidemiology/etiology/immunology/mortality/prevention & control', 'Sex Factors', 'Smoking/epidemiology']",,,,1999/02/03 00:00,1999/02/03 00:01,['1999/02/03 00:00'],"['1999/02/03 00:00 [pubmed]', '1999/02/03 00:01 [medline]', '1999/02/03 00:00 [entrez]']",['10.1023/a:1007560709013 [doi]'],ppublish,Eur J Epidemiol. 1998 Dec;14(8):749-54. doi: 10.1023/a:1007560709013.,,,,,,,,,,,,,,,,,
13524819,NLM,MEDLINE,20000701,20181201,,11,1,1958,The use of cortisone and its derivatives in infectious diseases.,1-16,,,,"['WEISSBECKER, L']",['WEISSBECKER L'],,['eng'],['Journal Article'],,Sweden,Hormoner,Hormoner,17420080R,OM,"['Communicable Diseases/*therapy', 'Cortisone/*therapeutic use']",,['NLM'],"['*COMMUNICABLE DISEASES/therapy', '*CORTISONE/therapeutic use']",1958/01/01 00:00,1958/01/01 00:01,['1958/01/01 00:00'],"['1958/01/01 00:00 [pubmed]', '1958/01/01 00:01 [medline]', '1958/01/01 00:00 [entrez]']",,ppublish,Hormoner. 1958;11(1):1-16.,,,['V27W9254FZ (Cortisone)'],,,,,,,,,['CLML: 5834:17266:155:163'],,,,,
13897925,NLM,MEDLINE,19981101,20181201,0025-8512 (Print) 0025-8512 (Linking),50,,1961 Dec 16,[Characteristics of epidemics and morphological changes of serious infectious diseases in their significance in the present time].,2632 passim,,,,"['GERFELDT, E']",['GERFELDT E'],,['ger'],['Journal Article'],,Germany,Med Welt,Die Medizinische Welt,0376641,OM,"['Communicable Diseases/*epidemiology', '*Epidemics', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1961/12/16 00:00,1961/12/16 00:01,['1961/12/16 00:00'],"['1961/12/16 00:00 [pubmed]', '1961/12/16 00:01 [medline]', '1961/12/16 00:00 [entrez]']",,ppublish,Med Welt. 1961 Dec 16;50:2632 passim.,,,,,,,,,,,,,,,,,
13084080,NLM,MEDLINE,20030501,20181201,0017-7768 (Print) 0017-7768 (Linking),45,3,1953 Aug 2,"[MINISTRY of Health statistics of infectious diseases, June 1953].",72,,,,,,,['und'],['Journal Article'],,Israel,Harefuah,Harefuah,0034351,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/08/02 00:00,1953/08/02 00:01,['1953/08/02 00:00'],"['1953/08/02 00:00 [pubmed]', '1953/08/02 00:01 [medline]', '1953/08/02 00:00 [entrez]']",,ppublish,Harefuah. 1953 Aug 2;45(3):72.,,,,,,,,,,,,['CLML: 5425:4831:117'],,,,,
8261248,NLM,MEDLINE,19940127,20220410,0962-2802 (Print) 0962-2802 (Linking),2,1,1993,The estimation of the basic reproduction number for infectious diseases.,23-41,,"The basic reproduction number R0 is the number of secondary cases which one case would produce in a completely susceptible population. It depends on the duration of the infectious period, the probability of infecting a susceptible individual during one contact, and the number of new susceptible individuals contacted per unit of time. Therefore R0 may vary considerably for different infectious diseases but also for the same disease in different populations. The key threshold result of epidemic theory associates the outbreaks of epidemics and the persistence of endemic levels with basic reproduction numbers greater than one. Because the magnitude of R0 allows one to determine the amount of effort which is necessary either to prevent an epidemic or to eliminate an infection from a population, it is crucial to estimate R0 for a given disease in a particular population. The present paper gives a survey about the various estimation methods available.",,"['Dietz, K']",['Dietz K'],"['Department of Medical Biometry, University of Tubingen, Germany.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,England,Stat Methods Med Res,Statistical methods in medical research,9212457,IM,"['Acquired Immunodeficiency Syndrome/prevention & control/transmission', 'Adolescent', 'Adult', 'Basic Reproduction Number', 'Communicable Disease Control/methods', 'Communicable Diseases/drug therapy/epidemiology/microbiology/*transmission', 'Demography', 'Disease Outbreaks/*prevention & control', 'Female', 'Humans', 'Male', 'Middle Aged', '*Models, Biological', '*Models, Statistical', 'Prevalence', 'Probability', 'Vaccination']",,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.1177/096228029300200103 [doi]'],ppublish,Stat Methods Med Res. 1993;2(1):23-41. doi: 10.1177/096228029300200103.,,,,,,62,['NIDA DA04722/DA/NIDA NIH HHS/United States'],,,,,,,,,,
13060748,NLM,MEDLINE,20030501,20181201,0367-4800 (Print) 0367-4800 (Linking),34,6,1953 Jun,"INFECTIOUS diseases and epidemiological notes; vital statistics for 4 weeks ending 30th May, 1953.",280,,,,,,,['eng'],['Journal Article'],,Scotland,Glasgow Med J,Glasgow medical journal,17140140R,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', '*Vital Statistics']",PMC5981759,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1953/06/01 00:00,1953/06/01 00:01,['1953/06/01 00:00'],"['1953/06/01 00:00 [pubmed]', '1953/06/01 00:01 [medline]', '1953/06/01 00:00 [entrez]']",,ppublish,Glasgow Med J. 1953 Jun;34(6):280.,,,,,,,,,,,,['CLML: 5324:31395:161'],,,,,
24494809,NLM,MEDLINE,20150722,20220317,1469-0691 (Electronic) 1198-743X (Linking),20,10,2014 Oct,"What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore.",O737-44,10.1111/1469-0691.12581 [doi],"The practice of an infectious diseases (ID) physician is evolving. A contemporary understanding of the frequency and variety of patients and syndromes seen by ID services has implications for training, service development and setting research priorities. We performed a 2-week prospective survey of formal ID physician activities related to direct inpatient care, encompassing 53 hospitals throughout Australia, New Zealand and Singapore, and documented 1722 inpatient interactions. Infections involving the skin and soft tissue, respiratory tract and bone/joints together accounted for 49% of all consultations. Suspected/confirmed pathogens were primarily bacterial (60%), rather than viral (6%), fungal (4%), mycobacterial (2%) or parasitic (1%). Staphylococcus aureus was implicated in 409 (24%) episodes, approximately four times more frequently than the next most common pathogen. The frequency of healthcare-related infections (35%), immunosuppression (21%), diabetes mellitus (19%), prosthesis-related infections (13%), multiresistant pathogens (13%) and non-infectious diagnoses (9%) was high, although consultation characteristics varied between geographical settings and hospital types. Our study highlights the diversity of inpatient-related ID activities and should direct future teaching and research. ID physicians' ability to offer beneficial consultative advice requires broad understanding of, and ability to interact with, a wide range of referring specialities.","['(c) 2014 The Authors Clinical Microbiology and Infection (c) 2014 European Society of', 'Clinical Microbiology and Infectious Diseases.']","['Ingram, P R', 'Cheng, A C', 'Murray, R J', 'Blyth, C C', 'Walls, T', 'Fisher, D A', 'Davis, J S']","['Ingram PR', 'Cheng AC', 'Murray RJ', 'Blyth CC', 'Walls T', 'Fisher DA', 'Davis JS']","['Department of Microbiology and Infectious Diseases, Royal Perth Hospital, Perth, Australia; School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, Non-U.S. Gov't""]",20140306,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Australia/epidemiology', 'Communicable Diseases/classification/epidemiology/etiology/*therapy', 'Data Collection', 'Hospital Departments', 'Humans', 'Inpatients', 'New Zealand/epidemiology', ""*Physician's Role"", 'Physicians', 'Prospective Studies', 'Risk Factors', 'Singapore/epidemiology', 'Time']",,['NOTNLM'],"['Australia', 'New Zealand', 'Singapore', 'consultations', 'infectious diseases']",2014/02/06 06:00,2015/07/23 06:00,['2014/02/06 06:00'],"['2013/10/03 00:00 [received]', '2014/01/23 00:00 [revised]', '2014/01/28 00:00 [accepted]', '2014/02/06 06:00 [entrez]', '2014/02/06 06:00 [pubmed]', '2015/07/23 06:00 [medline]']","['S1198-743X(14)65414-8 [pii]', '10.1111/1469-0691.12581 [doi]']",ppublish,Clin Microbiol Infect. 2014 Oct;20(10):O737-44. doi: 10.1111/1469-0691.12581. Epub 2014 Mar 6.,,,,,,,,,,,['Australasian Society for Infectious Diseases Clinical Research Network'],,"['Bak, Narin', 'Chen, Sharon', 'Cheng, Allen', 'Cooley, Louise', 'Davis, Josh', 'Gordon, David', 'Howden, Ben', 'McBryde, Emma', 'Murdoch, David', 'Murray, Ronan', 'Paterson, David', 'Peleg, Anton', 'Ralph, Anna', 'Robinson, Owen', 'Slavin, Monica', 'Sorrell, Tania', 'Tong, Steve', 'Walls, Tony', 'Woolley, Ian', 'Abbott, Iain', 'Kanapathipillai, Rupa', 'Madigan, Victoria', 'McLellan, Duncan', 'Briggs, Simon', 'King, Claire', 'Hurley, James', 'Lim, Lyn-Li', 'Kennedy, Karina', 'Wilson, Heather', 'Evans, Thomas', 'Maze, Michael', 'Pithie, Alan', 'Chong, Lauren', 'Leung, Grace', 'McCann, Sarah', 'Lee, Lai-yang', 'Wolfgang, Jill', 'Day, Thomas', 'De Silva, Gustinna', 'Martinello, Marianne', 'Gliddon, Thomas', 'Wilson, Moira', 'Athan, Eugene', 'Pollard, James', 'Harris, Patrick', 'Pachchigar, Rajesh', 'Wehrhahn, Michael', 'Moriarty, Paul', 'Holland, David', 'Langlands, Andrew', 'McBride, Stephen', 'Sherif, Moayid', 'Lim, Kate', 'Choong, Keat', 'Henderson, Andrew', 'Sowden, David', 'Everts, Richard', 'Manon, Manesh', 'Sud, Archana', 'Read, Kerry', 'Yap, Rudyard', 'Bursle, Evan', 'Gluer, Robert', 'Siebert, David', 'Cross, Gail', 'Francis, Joshua', 'Booth, Cameron', 'Dalton, Simon', 'Ooi, Eng Lee', 'Chih, Desmond', 'Dyer, John', 'Clarke, Julia', 'Grimwood, Keith', 'Gwee, Amanda', 'Commons, Robert', 'Majumdar, Suman', ""O'Hern, Jen"", 'Warren, Sanchia', 'Manners, David', 'Raby, Edward', 'Radhakrishnan, Devi', 'Keighley, Caitlin', 'Dotel, Ravindra', 'Paterson, David', 'Best, Emma', 'Aung, Ar Kar', 'Paterson, Tim', 'Hassell, Marilyn', 'Newcombe, Jim', 'Llorin, Ryan', 'Lye, David', 'Giola, Massimo', 'Yew, Haur Sen', 'Taylor, James', 'Iredell, Jon', 'Pollett, Simon', 'Garg, Lokesh', 'Jennings, Zoe', 'Kapur, Amit', 'Miyakis, Spiros', 'Parshuramkar, Dhananjay', 'Thu, Kyaw Myo', 'Rasiah, Kavita']","['Bak N', 'Chen S', 'Cheng A', 'Cooley L', 'Davis J', 'Gordon D', 'Howden B', 'McBryde E', 'Murdoch D', 'Murray R', 'Paterson D', 'Peleg A', 'Ralph A', 'Robinson O', 'Slavin M', 'Sorrell T', 'Tong S', 'Walls T', 'Woolley I', 'Abbott I', 'Kanapathipillai R', 'Madigan V', 'McLellan D', 'Briggs S', 'King C', 'Hurley J', 'Lim LL', 'Kennedy K', 'Wilson H', 'Evans T', 'Maze M', 'Pithie A', 'Chong L', 'Leung G', 'McCann S', 'Lee LY', 'Wolfgang J', 'Day T', 'De Silva G', 'Martinello M', 'Gliddon T', 'Wilson M', 'Athan E', 'Pollard J', 'Harris P', 'Pachchigar R', 'Wehrhahn M', 'Moriarty P', 'Holland D', 'Langlands A', 'McBride S', 'Sherif M', 'Lim K', 'Choong K', 'Henderson A', 'Sowden D', 'Everts R', 'Manon M', 'Sud A', 'Read K', 'Yap R', 'Bursle E', 'Gluer R', 'Siebert D', 'Cross G', 'Francis J', 'Booth C', 'Dalton S', 'Ooi EL', 'Chih D', 'Dyer J', 'Clarke J', 'Grimwood K', 'Gwee A', 'Commons R', 'Majumdar S', ""O'Hern J"", 'Warren S', 'Manners D', 'Raby E', 'Radhakrishnan D', 'Keighley C', 'Dotel R', 'Paterson D', 'Best E', 'Aung AK', 'Paterson T', 'Hassell M', 'Newcombe J', 'Llorin R', 'Lye D', 'Giola M', 'Yew HS', 'Taylor J', 'Iredell J', 'Pollett S', 'Garg L', 'Jennings Z', 'Kapur A', 'Miyakis S', 'Parshuramkar D', 'Thu KM', 'Rasiah K']",,,
24091192,NLM,MEDLINE,20140731,20161125,1532-2742 (Electronic) 0163-4453 (Linking),68 Suppl 1,,2014 Jan,"Hot topics in infection and immunity in children--Papers from the 10th annual IIC meeting, Oxford, UK, 2012. Preface.",S1,S0163-4453(13)00275-2 [pii] 10.1016/j.jinf.2013.09.008 [doi],,,"['Curtis, Nigel', 'Pollard, Andrew J', 'Finn, Adam']","['Curtis N', 'Pollard AJ', 'Finn A']","[""Department of Paediatrics, The University of Melbourne; Infectious Diseases Unit, The Royal Children's Hospital Melbourne; Infectious Diseases & Microbiology Group, Murdoch Children's Research Institute, Parkville, Australia. Electronic address: nigel.curtis@rch.org.au.""]",['eng'],"['Editorial', 'Introductory Journal Article']",20131003,England,J Infect,The Journal of infection,7908424,IM,"['Adolescent', 'Allergy and Immunology/*trends', 'Child', 'Child, Preschool', 'Communicable Disease Control/*methods/*trends', 'Communicable Diseases/*diagnosis/immunology/*therapy', 'Humans', 'Infant', 'Infant, Newborn', 'Pediatrics/*methods/*trends', 'United Kingdom']",,,,2013/10/05 06:00,2014/08/01 06:00,['2013/10/05 06:00'],"['2013/10/05 06:00 [entrez]', '2013/10/05 06:00 [pubmed]', '2014/08/01 06:00 [medline]']","['S0163-4453(13)00275-2 [pii]', '10.1016/j.jinf.2013.09.008 [doi]']",ppublish,J Infect. 2014 Jan;68 Suppl 1:S1. doi: 10.1016/j.jinf.2013.09.008. Epub 2013 Oct 3.,,,,,,,,,,,,,,,,,
8842258,NLM,MEDLINE,19961220,20190512,1058-4838 (Print) 1058-4838 (Linking),23,2,1996 Aug,The importance of the autopsy in emerging and reemerging infectious diseases.,248-54,,,,"['Schwartz, D A', 'Herman, C J']","['Schwartz DA', 'Herman CJ']",,['eng'],"['Comment', 'Editorial', 'Historical Article']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Autopsy/*history', 'Communicable Diseases/*history/pathology', 'Disease Outbreaks', 'Forecasting', 'History, 17th Century', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans']",,,,1996/08/01 00:00,1996/08/01 00:01,['1996/08/01 00:00'],"['1996/08/01 00:00 [pubmed]', '1996/08/01 00:01 [medline]', '1996/08/01 00:00 [entrez]']",['10.1093/clinids/23.2.248 [doi]'],ppublish,Clin Infect Dis. 1996 Aug;23(2):248-54. doi: 10.1093/clinids/23.2.248.,,,,,,,,['Clin Infect Dis. 1996 Aug;23(2):241-7. PMID: 8842257'],,,,,,,,,
13250949,NLM,MEDLINE,20030501,20181201,0012-0219 (Print) 0012-0219 (Linking),10,31,1955 Aug 4,[The recognition of infectious diseases (except tuberculosis) as occupational diseases].,1051-2,,,,['PFEFFER'],['PFEFFER'],,['ger'],['Journal Article'],,Germany,Dtsch Gesundheitsw,Das Deutsche Gesundheitswesen,0433572,OM,"['Communicable Diseases/*epidemiology', 'Humans', '*Occupational Diseases', '*Tuberculosis']",,['NLM'],"['*COMMUNICABLE DISEASES/epidemiology', '*OCCUPATIONAL DISEASES']",1955/08/04 00:00,1955/08/04 00:01,['1955/08/04 00:00'],"['1955/08/04 00:00 [pubmed]', '1955/08/04 00:01 [medline]', '1955/08/04 00:00 [entrez]']",,ppublish,Dtsch Gesundheitsw. 1955 Aug 4;10(31):1051-2.,,,,,,,,,Uber die Anerkennung von Infektionskrankheiten (ausser Tuberkulose) als Berufskrankheiten.,,,['CLML: 5629:2752'],,,,,
13558739,NLM,MEDLINE,20000701,20190916,0888-2479 (Print) 0888-2479 (Linking),102,1,1958 Jul,Adrenocorticosteroids and the management of infectious diseases.,1-4,,,,"['KASS, E H']",['KASS EH'],,['eng'],['Journal Article'],,United States,AMA Arch Intern Med,A.M.A. archives of internal medicine,14470100R,OM,"['Adrenal Cortex Hormones/*therapeutic use', 'Communicable Diseases/*therapy', '*Disease Management']",,['NLM'],"['*ADRENAL CORTEX HORMONES/therapeutic use', '*COMMUNICABLE DISEASES/therapy']",1958/07/01 00:00,1958/07/01 00:01,['1958/07/01 00:00'],"['1958/07/01 00:00 [pubmed]', '1958/07/01 00:01 [medline]', '1958/07/01 00:00 [entrez]']",['10.1001/archinte.1958.00260190003001 [doi]'],ppublish,AMA Arch Intern Med. 1958 Jul;102(1):1-4. doi: 10.1001/archinte.1958.00260190003001.,,,['0 (Adrenal Cortex Hormones)'],,,,,,,,,['CLML: 5834:51447:15:155'],,,,,
16355875,NLM,MEDLINE,20060207,20200407,0939-1983 (Print) 0939-1983 (Linking),,19,2005,Emerging infectious diseases: the public's view of the problem and what should be expected from the public health community.,207-13,,,,"['Hughes, J M']",['Hughes JM'],"['National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. jmh2@cdc.gov']",['eng'],['Journal Article'],,Austria,Arch Virol Suppl,Archives of virology. Supplementum,9214275,IM,"['Animals', 'Communicable Diseases, Emerging/epidemiology/*physiopathology/prevention & control/therapy', 'Disease Outbreaks', 'Disease Reservoirs', 'Humans', 'Public Health/*legislation & jurisprudence/trends', 'Public Health Administration']",PMC7121075,,,2005/12/17 09:00,2006/02/08 09:00,['2005/12/17 09:00'],"['2005/12/17 09:00 [pubmed]', '2006/02/08 09:00 [medline]', '2005/12/17 09:00 [entrez]']","['17 [pii]', '10.1007/3-211-29981-5_17 [doi]']",ppublish,Arch Virol Suppl. 2005;(19):207-13. doi: 10.1007/3-211-29981-5_17.,,,,,,,,,,,,,,,,,
13313041,NLM,MEDLINE,20030501,20181201,0365-3285 (Print) 0365-3285 (Linking),10,8,1955 Aug,[Liver cirrhosis in the pathology of the infectious diseases; relation of liver cirrhosis to various highly important infectious diseases].,217-21; contd,,,,"['TEDESCHI, G']",['TEDESCHI G'],,['ita'],['Journal Article'],,Italy,Acta Med Ital Mal Infett Parassit,Acta medica Italica di malattie infettive e parassitarie,14540070R,OM,"['Communicable Diseases/*complications', 'Humans', 'Liver Cirrhosis/*etiology']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*LIVER CIRRHOSIS/etiology and pathogenesis']",1955/08/01 00:00,1955/08/01 00:01,['1955/08/01 00:00'],"['1955/08/01 00:00 [pubmed]', '1955/08/01 00:01 [medline]', '1955/08/01 00:00 [entrez]']",,ppublish,Acta Med Ital Mal Infett Parassit. 1955 Aug;10(8):217-21; contd.,,,,,,,,,La cirrosi del fegato nella patologia infettiva; rapporti tra cirrosi epatica ed alcune tra le piu importanti malattie infettive.,,,['CLML: 5630:21338'],,,,,
5093510,NLM,MEDLINE,19711130,20041117,0034-9887 (Print) 0034-9887 (Linking),99,7,1971 Jul,[Infectious diseases in Chile. Analytical study of the current situation].,495-501,,,,"['Kaempffer, A M', 'Medina, E', 'Yrarrazaval, M', 'Molina, R', 'Margozzini, J', 'Toporowicz, M']","['Kaempffer AM', 'Medina E', 'Yrarrazaval M', 'Molina R', 'Margozzini J', 'Toporowicz M']",,['spa'],['Journal Article'],,Chile,Rev Med Chil,Revista medica de Chile,0404312,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Chile', 'Communicable Disease Control', 'Communicable Diseases/*epidemiology/mortality', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Pregnancy']",,,,1971/07/01 00:00,1971/07/01 00:01,['1971/07/01 00:00'],"['1971/07/01 00:00 [pubmed]', '1971/07/01 00:01 [medline]', '1971/07/01 00:00 [entrez]']",,ppublish,Rev Med Chil. 1971 Jul;99(7):495-501.,,,,,,,,,Enfermedades infecciosas en Chile. Estudio analitico de la situacion actual.,,,,,,,,
27818036,NLM,MEDLINE,20170302,20181202,1873-1457 (Electronic) 1571-0645 (Linking),19,,2016 Dec,"Understanding spatial spread of emerging infectious diseases in contemporary populations: Comment on ""Pattern transitions in spatial epidemics: Mechanisms and emergent properties"" by Gui-Quan Sun et al.",95-97,S1571-0645(16)30125-7 [pii] 10.1016/j.plrev.2016.10.008 [doi],,,"['Li, Hui-Jia', 'Cheng, Qing', 'Wang, Lin']","['Li HJ', 'Cheng Q', 'Wang L']","['School of Management Science and Engineering, Central University of Finance and Economics, Beijing 100080, China.', 'Science and Technology on Information Systems Engineering Laboratory, National University of Defense Technology, Changsha 410073, China.', 'WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: sph.linwang@hku.hk.']",['eng'],"['Comment', 'Journal Article']",20161025,Netherlands,Phys Life Rev,Physics of life reviews,101229718,IM,"['Communicable Diseases/epidemiology', 'Communicable Diseases, Emerging/*epidemiology', '*Epidemics', 'Humans']",,['NOTNLM'],"['Dynamics', 'Epidemiology', 'Mathematical modeling', 'Pattern formation']",2016/11/08 06:00,2017/03/03 06:00,['2016/11/08 06:00'],"['2016/10/12 00:00 [received]', '2016/10/21 00:00 [accepted]', '2016/11/08 06:00 [pubmed]', '2017/03/03 06:00 [medline]', '2016/11/08 06:00 [entrez]']","['S1571-0645(16)30125-7 [pii]', '10.1016/j.plrev.2016.10.008 [doi]']",ppublish,Phys Life Rev. 2016 Dec;19:95-97. doi: 10.1016/j.plrev.2016.10.008. Epub 2016 Oct 25.,,,,,['Phys Life Rev. 2016 Dec;19:103-106. PMID: 27866922'],,,['Phys Life Rev. 2016 Dec;19:43-73. PMID: 27567502'],,,,,,,,,
19486074,NLM,MEDLINE,20091105,20090916,1469-0691 (Electronic) 1198-743X (Linking),15,8,2009 Aug,EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey.,711-9,10.1111/j.1469-0691.2009.02874.x [doi],"Healthcare settings have been identified as preferential for the transmission of many agents causing highly infectious diseases (HIDs). Infection control procedures strongly reduce the risk of transmission of HIDs in hospital settings, when adequately applied. The main objective of the European Network for Highly Infectious Diseases (EuroNHID), a network co-funded by the European Commission, is to assess the current capabilities for dealing with HIDs in Europe, specifically in the context of infection control and healthcare worker (HCW) safety, through conducting an on-the-field survey of high-level isolation units (HLIUs)/referral centres for the management of HIDs in participating countries. During the first year of the project's activities, specifically designed, evidence-based checklists were developed. This review introduces the EuroNHID checklists as a standard tool for the assessment of hospital capabilities concerning infection control and HCW safety in the management of patients with HIDs, and presents preliminary results from five HLIUs.",,"['Fusco, F M', 'Schilling, S', 'Puro, V', 'Brodt, H-R', 'Follin, P', 'Jarhall, B', 'Bannister, B', 'Maltezou, H C', 'Thomson, G', 'Brouqui, P', 'Ippolito, G']","['Fusco FM', 'Schilling S', 'Puro V', 'Brodt HR', 'Follin P', 'Jarhall B', 'Bannister B', 'Maltezou HC', 'Thomson G', 'Brouqui P', 'Ippolito G']","['National Institute for Infectious Diseases L. Spallanzani, 00149, Rome, Italy. fusco@inmi.it']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20090528,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Communicable Diseases/diagnosis/*epidemiology/therapy', 'Disease Transmission, Infectious/prevention & control', 'European Union', 'Health Services Research/*methods', 'Hospitals, Isolation/*organization & administration', 'Humans', 'Infection Control/*standards', 'Occupational Diseases/prevention & control', 'Patient Isolation/*organization & administration']",,,,2009/06/03 09:00,2009/11/06 06:00,['2009/06/03 09:00'],"['2009/06/03 09:00 [entrez]', '2009/06/03 09:00 [pubmed]', '2009/11/06 06:00 [medline]']","['S1198-743X(14)60456-0 [pii]', '10.1111/j.1469-0691.2009.02874.x [doi]']",ppublish,Clin Microbiol Infect. 2009 Aug;15(8):711-9. doi: 10.1111/j.1469-0691.2009.02874.x. Epub 2009 May 28.,,,,,,12,,,,,['EuroNHID Study Group'],,"['Adrami, O', 'Borg, Michael', 'Gottschalk, R', 'Hemmer, R', 'Horban, A', 'Kojouharova, M', 'Perronne, C', 'Lambert, J', 'Siikamaki, H', 'Skinhoj, P', 'Strle, F', 'Trilla, A', 'Vetter, N']","['Adrami O', 'Borg M', 'Gottschalk R', 'Hemmer R', 'Horban A', 'Kojouharova M', 'Perronne C', 'Lambert J', 'Siikamaki H', 'Skinhoj P', 'Strle F', 'Trilla A', 'Vetter N']",,,
13206674,NLM,MEDLINE,20030501,20181201,,13,7-8,1954 Jul-Aug,Infectious diseases in Israel in the second half and the whole year 1953.,148-50,,,,"['KALLNER, G']",['KALLNER G'],,['eng'],['Journal Article'],,Israel,Acta Med Orient,Acta medica Orientalia,14540100R,OM,"['Communicable Diseases/*epidemiology', 'Humans', 'Israel']",,['NLM'],['*COMMUNICABLE DISEASES/epidemiology'],1954/07/01 00:00,1954/07/01 00:01,['1954/07/01 00:00'],"['1954/07/01 00:00 [pubmed]', '1954/07/01 00:01 [medline]', '1954/07/01 00:00 [entrez]']",,ppublish,Acta Med Orient. 1954 Jul-Aug;13(7-8):148-50.,,,,,,,,,,,,['CLML: 5527:18413:120'],,,,,
927368,NLM,MEDLINE,19780127,20091021,0025-8326 (Print) 0025-8326 (Linking),46,4,1977 Jul-Aug,[Clinical characteristics of imported infectious diseases].,397-402,,,,"['Pokrovskii, V I', ""Astaf'eva, N V""]","['Pokrovskii VI', ""Astaf'eva NV""]",,['rus'],"['English Abstract', 'Journal Article']",,Russia (Federation),Med Parazitol (Mosk),Meditsinskaia parazitologiia i parazitarnye bolezni,0376635,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Communicable Diseases/epidemiology/*transmission', 'Female', 'Humans', 'Intestinal Diseases/epidemiology/transmission', 'Male', 'Middle Aged', 'Moscow', 'Travel']",,,,1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Med Parazitol (Mosk). 1977 Jul-Aug;46(4):397-402.,,,,,,,,,Klinicheskie osobennosti zavoznykh infektsionnykh boleznei.,,,,,,,,
25418061,NLM,MEDLINE,20150714,20220129,1474-760X (Electronic) 1465-6906 (Print) 1474-7596 (Linking),15,11,2014 Nov 15,Engineering the control of mosquito-borne infectious diseases.,535,10.1186/s13059-014-0535-7 [doi] 535,Recent advances in genetic engineering are bringing new promise for controlling mosquito populations that transmit deadly pathogens. Here we discuss past and current efforts to engineer mosquito strains that are refractory to disease transmission or are suitable for suppressing wild disease-transmitting populations.,,"['Gabrieli, Paolo', 'Smidler, Andrea', 'Catteruccia, Flaminia']","['Gabrieli P', 'Smidler A', 'Catteruccia F']",,['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",20141115,England,Genome Biol,Genome biology,100960660,IM,"['Animals', 'Communicable Diseases/*genetics/microbiology/parasitology/*transmission/virology', 'Culicidae/microbiology/parasitology/virology', '*Genetic Engineering', 'Humans', 'Mosquito Control']",PMC4282146,,,2014/11/25 06:00,2015/07/15 06:00,['2014/11/25 06:00'],"['2014/11/25 06:00 [entrez]', '2014/11/25 06:00 [pubmed]', '2015/07/15 06:00 [medline]']","['s13059-014-0535-7 [pii]', '535 [pii]', '10.1186/s13059-014-0535-7 [doi]']",epublish,Genome Biol. 2014 Nov 15;15(11):535. doi: 10.1186/s13059-014-0535-7.,,,,,,,"['T32 AI049928/AI/NIAID NIH HHS/United States', '260897/ERC_/European Research Council/International', '1R01AI104956-01A1/AI/NIAID NIH HHS/United States', '093553/WT_/Wellcome Trust/United Kingdom', 'R01 AI104956/AI/NIAID NIH HHS/United States']",,,,,,,,,,
22133217,NLM,MEDLINE,20120329,20111202,1558-5646 (Electronic) 0014-3820 (Linking),65,12,2011 Dec,Bridging scales in the evolution of infectious disease life histories: theory.,3448-61,10.1111/j.1558-5646.2011.01394.x [doi],"A significant goal of recent theoretical research on pathogen evolution has been to develop theory that bridges within- and between-host dynamics. The main approach used to date is one that nests within-host models of pathogen replication in models for the between-host spread of infectious diseases. Although this provides an elegant approach, it nevertheless suffers from some practical difficulties. In particular, the information required to satisfactorily model the mechanistic details of the within-host dynamics is not often available. Here, we present a theoretical approach that circumvents these difficulties by quantifying the relevant within-host factors in an empirically tractable way. The approach is closely related to quantitative genetic models for function-valued traits, and it also allows for the prediction of general characteristics of disease life history, including the timing of virulence, transmission, and host recovery. In a companion paper, we illustrate the approach by applying it to data from a model system of malaria.",['(c) 2011 The Author(s). Evolution(c) 2011 The Society for the Study of Evolution.'],"['Day, Troy', 'Alizon, Samuel', 'Mideo, Nicole']","['Day T', 'Alizon S', 'Mideo N']","[""Department of Mathematics and Statistics, Jeffery Hall, Queen's University, Kingston, ON, K7L 3N6, Canada. tday@mast.queensu.ca""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20110719,United States,Evolution,Evolution; international journal of organic evolution,0373224,IM,"['Animals', '*Biological Evolution', 'Communicable Diseases/*epidemiology/genetics/transmission', 'Epidemics', 'Models, Genetic', '*Models, Theoretical', 'Population Dynamics', 'Time Factors', 'Virulence']",,,,2011/12/03 06:00,2012/03/30 06:00,['2011/12/03 06:00'],"['2011/12/03 06:00 [entrez]', '2011/12/03 06:00 [pubmed]', '2012/03/30 06:00 [medline]']",['10.1111/j.1558-5646.2011.01394.x [doi]'],ppublish,Evolution. 2011 Dec;65(12):3448-61. doi: 10.1111/j.1558-5646.2011.01394.x. Epub 2011 Jul 19.,,,,,,,,,,,,,,,,,
13670875,NLM,MEDLINE,20000701,20210526,0005-3678 (Print) 0005-3678 (Linking),23,2,1959 Jun,Immunity to infectious diseases: review of some concepts of Metchnikoff.,48-60,,,,"['HIRSCH, J G']",['HIRSCH JG'],,['eng'],['Journal Article'],,United States,Bacteriol Rev,Bacteriological reviews,0370620,OM,"['Communicable Diseases/*immunology', 'Humans', '*Immunity']",PMC180984,['NLM'],['*COMMUNICABLE DISEASES/immunology'],1959/06/01 00:00,1959/06/01 00:01,['1959/06/01 00:00'],"['1959/06/01 00:00 [pubmed]', '1959/06/01 00:01 [medline]', '1959/06/01 00:00 [entrez]']",['10.1128/br.23.2.48-60.1959 [doi]'],ppublish,Bacteriol Rev. 1959 Jun;23(2):48-60. doi: 10.1128/br.23.2.48-60.1959.,,,,,,,,,,,,['CLML: 5936:45010:140'],,,,,
13254918,NLM,MEDLINE,20030501,20181201,0033-2240 (Print) 0033-2240 (Linking),11,4,1955,[Infectious diseases and the vegetative nervous system in current research].,103-6,,,,"['LIWSZYC, S']",['LIWSZYC S'],,['pol'],['Journal Article'],,Poland,Przegl Lek,Przeglad lekarski,19840720R,OM,"['*Autonomic Nervous System', 'Communicable Diseases/*physiology', 'Humans', '*Research']",,['NLM'],"['*AUTONOMIC NERVOUS SYSTEM', '*COMMUNICABLE DISEASES/physiology']",1955/01/01 00:00,1955/01/01 00:01,['1955/01/01 00:00'],"['1955/01/01 00:00 [pubmed]', '1955/01/01 00:01 [medline]', '1955/01/01 00:00 [entrez]']",,ppublish,Przegl Lek. 1955;11(4):103-6.,,,,,,,,,Choroby zakazne a uklad wegetatywno-nerwowy w swietle nowych badan.,,,['CLML: 5629:6770'],,,,,
18870881,NLM,MEDLINE,20081016,20201005,0257-8190 (Print) 0257-8190 (Linking),20,17,1948 May 1,[Theoretical foundations and requirements of isolation and disinfection for infectious diseases].,37-50,,,,"['GRUMBACH, A']",['GRUMBACH A'],,['ger'],['Journal Article'],,Switzerland,Bull Switz,Bulletin. Switzerland. Eidgenossisches Gesundheitsamt,0422127,OM,"['*Communicable Disease Control', 'Communicable Diseases/*prevention & control', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/prevention and control'],1948/05/01 00:00,2008/10/24 09:00,['1948/05/01 00:00'],"['1948/05/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/05/01 00:00 [entrez]']",,ppublish,Bull Switz. 1948 May 1;20(17):37-50.,,,,,,,,,Theoretische Grundlagen und Erfordernisse der Isolierung und Desinfektion bei ansteckenden Krankheiten.,,,['CLML: 4815:629l'],,,,,
4184747,NLM,MEDLINE,19690930,20131121,0043-535X (Print) 0043-535X (Linking),56,6,1969,[The use of a commercial preparation combining bovine colostral gamma-globulin and chloramphenicol in the treatment of infectious diseases of calves].,237-43,,,,"['Fluckiger, U', 'Hofer, A', 'Gonin, P', 'Walzl, H L']","['Fluckiger U', 'Hofer A', 'Gonin P', 'Walzl HL']",,['ger'],['Journal Article'],,Austria,Wien Tierarztl Monatsschr,Wiener tierarztliche Monatsschrift,0413611,IM,"['Animals', 'Cattle', 'Cattle Diseases/*drug therapy', 'Chloramphenicol/*therapeutic use', '*Colostrum', 'Communicable Diseases/drug therapy/*veterinary', 'gamma-Globulins/*therapeutic use']",,,,1969/01/01 00:00,1969/01/01 00:01,['1969/01/01 00:00'],"['1969/01/01 00:00 [pubmed]', '1969/01/01 00:01 [medline]', '1969/01/01 00:00 [entrez]']",,ppublish,Wien Tierarztl Monatsschr. 1969;56(6):237-43.,,,"['0 (gamma-Globulins)', '66974FR9Q1 (Chloramphenicol)']",,,,,,Die Anwendung eines kolostralen Rinder-Gammaglobulin-Chloramphebicol-Kombinations-praparates zur Bekampfung von Kalberaufzuchtskrankheiten.,,,,,,,,
18033595,NLM,MEDLINE,20080221,20191110,1040-841X (Print) 1040-841X (Linking),33,4,2007,The human/animal interface: emergence and resurgence of zoonotic infectious diseases.,243-99,,"Emerging infectious diseases, most of which are considered zoonotic in origin, continue to exact a significant toll on society. The origins of major human infectious diseases are reviewed and the factors underlying disease emergence explored. Anthropogenic changes, largely in land use and agriculture, are implicated in the apparent increased frequency of emergence and re-emergence of zoonoses in recent decades. Special emphasis is placed on the pathogen with likely the greatest zoonotic potential, influenza virus A.",,"['Greger, Michael']",['Greger M'],"['The Humane Society of the United States, Washington, DC 20037, USA. mgh1@cornell.edu']",['eng'],"['Journal Article', 'Review']",,England,Crit Rev Microbiol,Critical reviews in microbiology,8914274,IM,"['Animals', 'Bacterial Infections/veterinary', '*Communicable Diseases, Emerging/microbiology/transmission/virology', 'Disease Reservoirs', 'Humans', 'Influenza A virus/pathogenicity', 'Zoonoses/*transmission']",,,,2007/11/23 09:00,2008/02/22 09:00,['2007/11/23 09:00'],"['2007/11/23 09:00 [pubmed]', '2008/02/22 09:00 [medline]', '2007/11/23 09:00 [entrez]']","['786990395 [pii]', '10.1080/10408410701647594 [doi]']",ppublish,Crit Rev Microbiol. 2007;33(4):243-99. doi: 10.1080/10408410701647594.,,,,,,914,,,,,,,,,,,
30695457,NLM,MEDLINE,20190219,20200716,0372-9311 (Print) 0372-9311 (Linking),,3,2016 May,[PROCUREMENT OF SANITARY AND EPIDEMIOLOGICAL WELFARE IN THE REGION OF-CITY-RESORT SOCHI FOR DANGEROUS AND NATURAL-FOCI INFECTIOUS DIS- EASES IN 2015].,74-80,,"AIM: Analysis ofresults of epidemiologic monitoring especially dangerous, natural-foci and other infectious diseases, asill as epizootologic activity of natural foci of infection on,the terri- tory, of city-resort Sochi. MATERIALS AND METHODS: Laboratory studies of 820. samples by PCR; im- mune- and bacteriologic methods were carried out, among those 344 - clinical material, 12 - water from open bodies and 321 - field material. Molecular-genetic identification of-143 strains of Vibrio-cholerae, isolated from open water bodies of city-resort Sochi, was-carried out,. RESULTS: Circulation of causative agents of Q fever, tularemia and hemorrhagic fever with renal syndrome of Dobrava-Adler genotypes was established, -as well as rickettsia of tick spotted fever group Predomination of rotaviruses (70.9%) was detected during study of samples of clinical material in etiologic structure of sporadically emerging acute intestine infections. Relatively high temperature values of river water during summer months (from 18, to 30 C), exit of sulfide mineral waters into the riverbed, that create-alkaline medium, seasonal reduction of river debit and speed of water current facilitated sustenance of contamination of water of Agura river by V.cholerae. CONCLUSION: Activity of natural foci of the infectious disease and contamination of Agura iver by V.cholerae Omicron1, (atoxigenic) gives evidence on the necessity of constant control of epidemiologic situation by dangerous and natural-foci infectious diseases on the territory of city-resort Sochi, as well as study regional features, of their causative agents, including using genetic methods.",,"['Popova, A Yu', 'Kulichenko, A N', 'Maletskaya, O V', 'Dubyansky, V M', 'Ryazanova, A G', 'Prislegina, D A', 'Shaposhnikova, L I', 'Manin, E A', 'Yunicheva, Yu V', 'Vasilenko, L E', 'Agaptiov, D S', 'Saveliev, V N', 'Degtyarev, D Yu', 'Gerasimenko, E V', 'Lazarenko, E V', 'Zhiltsova, A Yu', 'Volynkina, A S', 'Kotenev, E S', 'Savelieva, I V', 'Khachaturova, A A', 'Kuznetsova, I V', 'Zharnikova, I V', 'Evchenko, Yu M', 'Zaitsev, A A', 'Antonenko, A D', 'Orobey, V G']","['Popova AY', 'Kulichenko AN', 'Maletskaya OV', 'Dubyansky VM', 'Ryazanova AG', 'Prislegina DA', 'Shaposhnikova LI', 'Manin EA', 'Yunicheva YV', 'Vasilenko LE', 'Agaptiov DS', 'Saveliev VN', 'Degtyarev DY', 'Gerasimenko EV', 'Lazarenko EV', 'Zhiltsova AY', 'Volynkina AS', 'Kotenev ES', 'Savelieva IV', 'Khachaturova AA', 'Kuznetsova IV', 'Zharnikova IV', 'Evchenko YM', 'Zaitsev AA', 'Antonenko AD', 'Orobey VG']",,['rus'],['Journal Article'],,Russia (Federation),Zh Mikrobiol Epidemiol Immunobiol,"Zhurnal mikrobiologii, epidemiologii i immunobiologii",0415217,IM,"['*Communicable Disease Control', 'Communicable Diseases/*epidemiology/genetics/*microbiology', '*Epidemiological Monitoring', 'Humans', 'Russia', '*Water Microbiology']",,,,2016/05/01 00:00,2016/05/01 00:01,['2019/01/30 06:00'],"['2019/01/30 06:00 [entrez]', '2016/05/01 00:00 [pubmed]', '2016/05/01 00:01 [medline]']",,ppublish,Zh Mikrobiol Epidemiol Immunobiol. 2016 May;(3):74-80.,,,,,,,,,,,,,,,,,
17140360,NLM,MEDLINE,20070108,20061204,1744-8336 (Electronic) 1478-7210 (Linking),4,5,2006 Oct,The use of fluoroquinolones in children: recent advances.,853-60,,"Fluoroquinolones are an important group of antibiotics that are used widely in the treatment of various infectious diseases in adults as a result of their excellent spectrum of activity, significant tissue penetration and convenient routes of administration. Their use in children, however, has been limited until recently as a result of possible fluoroquinolone-induced joint toxicity. Nevertheless, this group of antibiotics is rapidly gaining consideration for use in children as new agents are emerging with a wide antimicrobial range of action and minimal toxicity, even in young children. This review presents the pharmacokinetics, clinical indications and possible toxicity of fluoroquinolones in children, as well as the newer agents and their safety profile in pediatrics.",,"['Velissariou, Ioanna M']",['Velissariou IM'],"[""Pediatric Infectious Diseases, University of Athens, P and A Kyriakou Children's Hospital, 2nd Department of Pediatrics, Athens, Greece. jane_vel@hotmail.com""]",['eng'],"['Journal Article', 'Review']",,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,IM,"['Child', 'Communicable Diseases/drug therapy/metabolism/microbiology', 'Fluoroquinolones/*adverse effects/pharmacokinetics/*therapeutic use', 'Humans']",,,,2006/12/05 09:00,2007/01/09 09:00,['2006/12/05 09:00'],"['2006/12/05 09:00 [pubmed]', '2007/01/09 09:00 [medline]', '2006/12/05 09:00 [entrez]']",['10.1586/14787210.4.5.853 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2006 Oct;4(5):853-60. doi: 10.1586/14787210.4.5.853.,,,['0 (Fluoroquinolones)'],,,52,,,,,,,,,,,
13634303,NLM,MEDLINE,20000701,20181201,0033-3506 (Print) 0033-3506 (Linking),73,6,1959 Mar,World trends in infectious diseases.,2-9,,,,"['GEAR, H S']",['GEAR HS'],,['eng'],['Journal Article'],,Netherlands,Public Health,Public health,0376507,OM,"['*Communicable Disease Control', 'Communicable Diseases/*prevention & control', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/prevention and control'],1959/03/01 00:00,1959/03/01 00:01,['1959/03/01 00:00'],"['1959/03/01 00:00 [pubmed]', '1959/03/01 00:01 [medline]', '1959/03/01 00:00 [entrez]']",,ppublish,Public Health. 1959 Mar;73(6):2-9.,,,,,,,,,,,,['CLML: 5936:8134:140'],,,,,
13544892,NLM,MEDLINE,20000701,20181201,0001-6187 (Print) 0001-6187 (Linking),5,1,1958,The influence of age in some infectious diseases.,59-73,,,,"['BARSY, G', 'RUDNAI, O']","['BARSY G', 'RUDNAI O']",,['eng'],['Journal Article'],,Hungary,Acta Microbiol Acad Sci Hung,Acta microbiologica Academiae Scientiarum Hungaricae,0370333,OM,"['*Biometry', 'Communicable Diseases/*statistics & numerical data', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/statistics'],1958/01/01 00:00,1958/01/01 00:01,['1958/01/01 00:00'],"['1958/01/01 00:00 [pubmed]', '1958/01/01 00:01 [medline]', '1958/01/01 00:00 [entrez]']",,ppublish,Acta Microbiol Acad Sci Hung. 1958;5(1):59-73.,,,,,,,,,,,,['CLML: 5834:37472:155'],,,,,
20822459,NLM,MEDLINE,20110104,20211020,1537-6591 (Electronic) 1058-4838 (Print) 1058-4838 (Linking),51,8,2010 Oct 15,Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation.,931-6,10.1086/656411 [doi],"The global population is aging. With the high prevalence of dementia and functional decline in older Americans, many aging adults with disabilities reside in nursing homes in their final stage of life. Immunosenescence, multiple comorbid diseases, and grouped quarter living all coalesce in nursing home residents to increase the risk for infectious disease. The unique issues involved with diagnosis, prognosis, and management of infectious diseases in nursing home residents make research based in the nursing home setting both necessary and exciting for the physician investigator. This review discusses the opportunities and challenges involved with research of the evolving public health problem of infections among nursing home residents.",,"['Juthani-Mehta, Manisha', 'Quagliarello, Vincent J']","['Juthani-Mehta M', 'Quagliarello VJ']","['Infectious Diseases Section, Yale University School of Medicine, New Haven, Connecticut, USA. manisha.juthanimehta@yale.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,IM,"['Aged', 'Aged, 80 and over', 'Biomedical Research/methods', 'Communicable Disease Control/*methods', 'Communicable Diseases/diagnosis/drug therapy/*epidemiology', 'Humans', 'Nursing Homes', 'Randomized Controlled Trials as Topic', 'United States/epidemiology']",PMC3083824,,,2010/09/09 06:00,2011/01/05 06:00,['2010/09/09 06:00'],"['2010/09/09 06:00 [entrez]', '2010/09/09 06:00 [pubmed]', '2011/01/05 06:00 [medline]']",['10.1086/656411 [doi]'],ppublish,Clin Infect Dis. 2010 Oct 15;51(8):931-6. doi: 10.1086/656411.,"['Potential Conflicts of Interest: V.Q. has served as an educational speaker for', 'Pri-Med in partnership with the American College of Physicians, and is a', 'consultant to the Center for Medical Excellence and Research Experts.']",,,,,,"['UL1 RR024139/RR/NCRR NIH HHS/United States', 'P30 AG21342/AG/NIA NIH HHS/United States', 'K23 AG028691/AG/NIA NIH HHS/United States', 'K23 AG028691-03/AG/NIA NIH HHS/United States', 'P30 AG021342/AG/NIA NIH HHS/United States', 'R01 AG030575/AG/NIA NIH HHS/United States', 'K07 AG030093/AG/NIA NIH HHS/United States']",,,['NIHMS289818'],,,,,,,
18992258,NLM,MEDLINE,20090305,20090112,1095-8541 (Electronic) 0022-5193 (Linking),256,3,2009 Feb 7,Information-related changes in contact patterns may trigger oscillations in the endemic prevalence of infectious diseases.,473-8,10.1016/j.jtbi.2008.10.005 [doi],"It is well known that behavioral changes in contact patterns may significantly affect the spread of an epidemic outbreak. Here we focus on simple endemic models for recurrent epidemics, by modelling the social contact rate as a function of the available information on the present and the past disease prevalence. We show that social behavior change alone may trigger sustained oscillations. This indicates that human behavior might be a critical explaining factor of oscillations in time-series of endemic diseases. Finally, we briefly show how the inclusion of seasonal variations in contacts may imply chaos.",,"[""d'Onofrio, Alberto"", 'Manfredi, Piero']","[""d'Onofrio A"", 'Manfredi P']","['Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy. alberto.donofrio@ieo.it']",['eng'],['Journal Article'],20081017,England,J Theor Biol,Journal of theoretical biology,0376342,IM,"['Animals', 'Communicable Diseases/*epidemiology/psychology/transmission', 'Disease Outbreaks', 'Humans', 'Models, Biological', '*Models, Statistical', 'Prevalence', 'Seasons', '*Social Behavior']",,,,2008/11/11 09:00,2009/03/06 09:00,['2008/11/11 09:00'],"['2008/08/26 00:00 [received]', '2008/10/08 00:00 [revised]', '2008/10/08 00:00 [accepted]', '2008/11/11 09:00 [pubmed]', '2009/03/06 09:00 [medline]', '2008/11/11 09:00 [entrez]']","['S0022-5193(08)00537-7 [pii]', '10.1016/j.jtbi.2008.10.005 [doi]']",ppublish,J Theor Biol. 2009 Feb 7;256(3):473-8. doi: 10.1016/j.jtbi.2008.10.005. Epub 2008 Oct 17.,,,,,,,,,,,,,,,,,
31734357,NLM,MEDLINE,20201106,20201106,1469-0691 (Electronic) 1198-743X (Linking),26,4,2020 Apr,Sniffing animals as a diagnostic tool in infectious diseases.,431-435,S1198-743X(19)30591-9 [pii] 10.1016/j.cmi.2019.10.036 [doi],"BACKGROUND: Scents and odours characterize some microbes when grown in the laboratory, and experienced clinicians can diagnose patients with some infectious diseases based on their smell. Animal sniffing is an innate behaviour, and animals' olfactory acuity is used for detecting people, weapons, bombs, narcotics and food. OBJECTIVES: We briefly summarized current knowledge regarding the use of sniffing animals to diagnose some infectious diseases and the potential use of scent-based diagnostic instruments in microbiology. SOURCES: Information was sought through PubMed and extracted from peer-reviewed literature published between January 2000 and September 2019 and from reliable online news. The search terms 'odour', 'scent', 'bacteria', 'diagnostics', 'tuberculosis', 'malaria' and 'volatile compounds' were used. CONTENT: Four major areas of using sniffing animals are summarized. Dogs have been used to reliably detect stool associated with toxigenic Clostridioides difficile and for surveillance. Dogs showed high sensitivity and moderate specificity for detecting urinary tract infections in comparison to culture, especially for Escherichia coli. African giant pouched rats showed superiority for diagnosing tuberculosis over microscopy, but inferiority to culture/molecular methods. Several approaches for detecting malaria by analysing host skin odour or exhaled breath have been explored successfully. Some microbial infections produce specific volatile organic compounds (VOCs), which can be analysed by spectrometry, metabolomics or other analytical approaches to replace animal sniffing. IMPLICATIONS: The results of sniffing animal studies are fascinating, and animal sniffing can provide intermediate diagnostic solutions for some infectious diseases. Lack of reproducibility, and cost of animal training and housing are major drawbacks for wider implementation of sniffing animals. The ultimate goal is to understand the biological background of this animal ability and to characterize the specific VOCs that animals are recognizing. VOC identification, improvement of odour sampling methods and development of point-of-care instruments could allow implementation of scent-based tests for major human pathogens.",['Copyright (c) 2019. Published by Elsevier Ltd.'],"['Cambau, E', 'Poljak, M']","['Cambau E', 'Poljak M']","['AP-HP, Groupe hospitalier Lariboisiere - Fernand-Widal, Service de Bacteriologie, Paris, France; Universite de Paris, INSERM, IAME UMR1137, Paris, France. Electronic address: emmanuelle.cambau@aphp.fr.', 'Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.']",['eng'],"['Journal Article', 'Review']",20191114,England,Clin Microbiol Infect,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,9516420,IM,"['Animals', 'Breath Tests', 'Communicable Diseases/*diagnosis/microbiology/parasitology', '*Dogs', 'Feces/microbiology', 'Humans', 'Malaria/diagnosis', 'Microbiological Techniques', '*Odorants', '*Rats', 'Sensitivity and Specificity', '*Smell', 'Volatile Organic Compounds/analysis']",,['NOTNLM'],"['Bacteria', 'Diagnostics', 'Malaria', 'Odour', 'Scent', 'Tuberculosis', 'Volatile organic compounds']",2019/11/18 06:00,2020/11/11 06:00,['2019/11/18 06:00'],"['2019/09/30 00:00 [received]', '2019/10/25 00:00 [revised]', '2019/10/29 00:00 [accepted]', '2019/11/18 06:00 [pubmed]', '2020/11/11 06:00 [medline]', '2019/11/18 06:00 [entrez]']","['S1198-743X(19)30591-9 [pii]', '10.1016/j.cmi.2019.10.036 [doi]']",ppublish,Clin Microbiol Infect. 2020 Apr;26(4):431-435. doi: 10.1016/j.cmi.2019.10.036. Epub 2019 Nov 14.,,,['0 (Volatile Organic Compounds)'],,,,,,,,,,,,,,
9716953,NLM,MEDLINE,19981020,20201209,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),4,3,1998 Jul-Sep,Explaining the unexplained in clinical infectious diseases: looking forward.,395-7,,,,"['Perkins, B A', 'Relman, D']","['Perkins BA', 'Relman D']","['Centers for Disease Control and Prevention, Atlanta, Georgia, USA.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Communicable Diseases/*diagnosis/microbiology', 'Forecasting', 'Genetics, Microbial', 'Hemorrhage', 'Humans', 'Lung Diseases/microbiology', 'Pneumonia/microbiology', 'Respiratory Distress Syndrome/microbiology', 'Toxins, Biological']",PMC2640293,,,1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']",['10.3201/eid0403.980312 [doi]'],ppublish,Emerg Infect Dis. 1998 Jul-Sep;4(3):395-7. doi: 10.3201/eid0403.980312.,,,"['0 (Toxins, Biological)']",,,,,,,,,,,,,,
12798011,NLM,MEDLINE,20030731,20191107,1567-1348 (Print) 1567-1348 (Linking),1,4,2002 Jul,INSERM fosters researches on infectious diseases.,311-2,,,,"['Brechot, Christian']",['Brechot C'],"['Institut National de la Sante et de la Recherche Medicale, INSERM, 101 rue de Tolbiac, 75654 Paris Cedex 13, France. porteret@tolbiac.inserm.fr']",['eng'],"['Journal Article', 'Portrait']",,Netherlands,Infect Genet Evol,"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases",101084138,IM,"['Biomedical Research', '*Communicable Diseases/genetics/microbiology', 'France', 'Genetic Predisposition to Disease', 'Government Agencies', '*Government Programs', 'Humans', 'International Cooperation', '*Research Support as Topic']",,,,2003/06/12 05:00,2003/08/02 05:00,['2003/06/12 05:00'],"['2003/06/12 05:00 [pubmed]', '2003/08/02 05:00 [medline]', '2003/06/12 05:00 [entrez]']","['S1567134802000643 [pii]', '10.1016/s1567-1348(02)00064-3 [doi]']",ppublish,Infect Genet Evol. 2002 Jul;1(4):311-2. doi: 10.1016/s1567-1348(02)00064-3.,,,,,,,,,,,,,,,,,
20595738,NLM,MEDLINE,20110527,20100702,1120-9763 (Print) 1120-9763 (Linking),34,1-2,2010 Jan-Apr,[Mathematical models of infection transmission].,56-60,,"The investigation of distribution, determinants and transmission of infectious diseases is largely based on the development of mathematical models of ecological nature suitable to capture the dynamics of infectious diseases epidemiology. In this paper the essential aspects of the dynamic models of infection transmission are described. These models are increasingly being adopted to investigate and control epidemic and endemic infections, but also cancers of infectious aetiology.",,"['Baussano, Iacopo', 'Bianco, Selene', 'Lazzarato, Fulvio']","['Baussano I', 'Bianco S', 'Lazzarato F']","['SCDU Epidemiologia dei tumori, servizio di Statistica medica, CPO Piemonte, Universita del Piemonte orientale, via Solaroli 17, 28100 Novara, Italy. iacopo.baussano@cpo.it']",['ita'],"['English Abstract', 'Journal Article']",,Italy,Epidemiol Prev,Epidemiologia e prevenzione,8902507,IM,"['Communicable Diseases/epidemiology/*transmission', 'Humans', 'Mathematical Computing', 'Models, Biological', '*Models, Statistical', 'Models, Theoretical', 'Risk Assessment', 'Risk Factors', 'Stochastic Processes']",,,,2010/07/03 06:00,2011/05/28 06:00,['2010/07/03 06:00'],"['2010/07/03 06:00 [entrez]', '2010/07/03 06:00 [pubmed]', '2011/05/28 06:00 [medline]']",['394 [pii]'],ppublish,Epidemiol Prev. 2010 Jan-Apr;34(1-2):56-60.,,,,,,,,,Modelli matematici della trasmissione delle infezioni.,,,,,,,,
8762613,NLM,MEDLINE,19961218,20061115,0034-9887 (Print) 0034-9887 (Linking),124,1,1996 Jan,[Emergent infectious diseases: a new problem?].,7-10,,"Are the emergent pathogenic microbes, persistent bacteria that have changed their virulence or new diagnostic techniques now allow their recognition? Or, have they found a new possibility of transmission due to ecological, social or cultural changes? The present Editorial analyses the geographical distribution, features and host factors that favor infections by Helicobacter pylorii, Enterohemorrhagic E. Coli, invasive Streptococcus pyogenes and Borrelia Burgdorferi. The surveillance and care of infections caused by emergent germs requires laboratory learning programs as those established in the United States.",,"['Prado, V']",['Prado V'],,['spa'],"['Editorial', 'English Abstract']",,Chile,Rev Med Chil,Revista medica de Chile,0404312,IM,"['Bacterial Infections/*transmission', 'Communicable Diseases/etiology/*transmission', 'Humans', 'Virulence']",,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Rev Med Chil. 1996 Jan;124(1):7-10.,,,,,,,,,Enfermedades infecciosas emergentes: un problema nuevo?,,,,,,,,
13308524,NLM,MEDLINE,20030501,20201114,0025-729X (Print) 0025-729X (Linking),43,4,1956 Jan 28,Control of infectious diseases.,123-7,,,,"['JOHNSON, D W']",['JOHNSON DW'],,['eng'],['Journal Article'],,Australia,Med J Aust,The Medical journal of Australia,0400714,OM,"['*Communicable Disease Control', 'Communicable Diseases/*prevention & control', 'Humans']",,['NLM'],['*COMMUNICABLE DISEASES/prevention and control'],1956/01/28 00:00,1956/01/28 00:01,['1956/01/28 00:00'],"['1956/01/28 00:00 [pubmed]', '1956/01/28 00:01 [medline]', '1956/01/28 00:00 [entrez]']",['10.5694/j.1326-5377.1955.tb48854.x [doi]'],ppublish,Med J Aust. 1956 Jan 28;43(4):123-7. doi: 10.5694/j.1326-5377.1955.tb48854.x.,,,,,,,,,,,,['CLML: 5630:16734'],,,,,
13313044,NLM,MEDLINE,20030501,20181201,0365-3285 (Print) 0365-3285 (Linking),10,9,1955 Sep,[Liver cirrhosis in the pathology of the infectious diseases; relation of liver cirrhosis to various highly important infectious diseases].,247-52; concl,,,,"['TEDESCHI, G']",['TEDESCHI G'],,['ita'],['Journal Article'],,Italy,Acta Med Ital Mal Infett Parassit,Acta medica Italica di malattie infettive e parassitarie,14540070R,OM,"['Communicable Diseases/*complications', 'Humans', 'Liver Cirrhosis/*etiology']",,['NLM'],"['*COMMUNICABLE DISEASES/complications', '*LIVER CIRRHOSIS/etiology and pathogenesis']",1955/09/01 00:00,1955/09/01 00:01,['1955/09/01 00:00'],"['1955/09/01 00:00 [pubmed]', '1955/09/01 00:01 [medline]', '1955/09/01 00:00 [entrez]']",,ppublish,Acta Med Ital Mal Infett Parassit. 1955 Sep;10(9):247-52; concl.,,,,,,,,,La cirrosi del fegato nella patologia infettiva; rapporti tra cirrosi epatica ed alcune tra le piu importanti malattie infettive.,,,['CLML: 5630:21341'],,,,,
16706745,NLM,MEDLINE,20060717,20061115,1744-8352 (Electronic) 1473-7159 (Linking),6,3,2006 May,Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.,433-50,,"The molecular diagnosis of infectious diseases is currently going through a revolution sustained by the regulatory approval of amplification tests that have been shown to be equivalent or superior to existing gold standard methods. The recent approval of a microarray system for the pharmacogenomic profiling of cytochrome P450-mediated drug metabolism is paving the way to novel, rapid, sensitive, robust and economical microfabricated systems for point-of-care diagnostics, which are utilized closer and closer to the patient's bedside. These systems will enable the multiparametric genetic evaluation of several medical conditions, including infectious diseases. This forecoming revolution will position molecular theranostics in a broader integrated view of personalized medicine, which exploits genetic information from microbes and human hosts to optimize patient management and disease treatment.",,"['Bissonnette, Luc', 'Bergeron, Michel G']","['Bissonnette L', 'Bergeron MG']","['Departement de Biologie Medicale (Microbiologie), Faculte de Medecine, Universite Laval, Quebec City, Canada. luc.bissonnette@crchul.ulaval.ca']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Expert Rev Mol Diagn,Expert review of molecular diagnostics,101120777,IM,"['Communicable Diseases/*diagnosis/*genetics/metabolism', 'Cytochrome P-450 Enzyme System/metabolism', 'Drug Design', 'Electrophoresis, Capillary', 'Genetics, Medical', 'Humans', '*Molecular Diagnostic Techniques', 'Oligonucleotide Array Sequence Analysis/methods', 'Personal Health Services', 'Pharmaceutical Preparations', 'Pharmacogenetics/*methods']",,,,2006/05/19 09:00,2006/07/18 09:00,['2006/05/19 09:00'],"['2006/05/19 09:00 [pubmed]', '2006/07/18 09:00 [medline]', '2006/05/19 09:00 [entrez]']",['10.1586/14737159.6.3.433 [doi]'],ppublish,Expert Rev Mol Diagn. 2006 May;6(3):433-50. doi: 10.1586/14737159.6.3.433.,,,"['0 (Pharmaceutical Preparations)', '9035-51-2 (Cytochrome P-450 Enzyme System)']",,,184,,,,,,,,,,,
30550666,NLM,MEDLINE,20190501,20190501,0047-1852 (Print) 0047-1852 (Linking),74,12,2016 Dec,[Case management of ill travelers with infectious diseases].,2052-2056,,"Recent increase of international travelers raises awareness of travel-related infections. Travelers' diarrhea is the most common and caused by diarrheagenic E. coli and other patho- gens. Undifferentiated fever challenges physicians to correctly diagnose and includes ma- laria, dengue, and enteric fever. The pre-test probability for a disease which causes undiffer- entiated fever largely depends on the travel destination. Malaria is most common in travelers returning from sub-Saharan Africa while dengue is most common those returning from Southeast Asia and Latin America. Screening for asymptomatic travelers is not generally rec- ommended, but for long-term travelers and immigrants. Following outbreaks of highly infectious diseases in the past decades, hospital prepared- ness for travel-related infections focuses on infection prevention and control. Emerging viral pneumonias such as Middle East respiratory syndrome (MERS) and avian influenza H7N9 are major concerns. As seen in the largest outbreak of Ebola virus disease in West Africa, imported viral hemorrhagic fever such as Lassa fever is another concern. Since multidrug resistant bacteria silently spread globally by infected travelers, it would be of help to install appropriate isolation precaution for travelers with history of hospital admission abroad.",,"['Kato, Yasuyuki']",['Kato Y'],,['jpn'],['Journal Article'],,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Case Management', '*Communicable Diseases/therapy/transmission', 'Humans', '*Travel']",,,,2016/12/01 00:00,2016/12/01 00:01,['2018/12/15 06:00'],"['2018/12/15 06:00 [entrez]', '2016/12/01 00:00 [pubmed]', '2016/12/01 00:01 [medline]']",,ppublish,Nihon Rinsho. 2016 Dec;74(12):2052-2056.,,,,,,,,,,,,,,,,,
12643844,NLM,MEDLINE,20030513,20231105,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),9,3,2003 Mar,"Emerging human infectious diseases: anthroponoses, zoonoses, and sapronoses.",403-4,,,,"['Hubalek, Zdenek']",['Hubalek Z'],,['eng'],['Letter'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Animals', 'Communicable Diseases, Emerging/*classification/epidemiology/transmission', 'Humans', 'Zoonoses/classification/epidemiology/transmission']",PMC2958532,,,2003/03/20 04:00,2003/05/14 05:00,['2003/03/20 04:00'],"['2003/03/20 04:00 [pubmed]', '2003/05/14 05:00 [medline]', '2003/03/20 04:00 [entrez]']","['02-0208 [pii]', '10.3201/eid0903.020208 [doi]']",ppublish,Emerg Infect Dis. 2003 Mar;9(3):403-4. doi: 10.3201/eid0903.020208.,,,,,,,,"['LederbergJ . Infectious disease as an evolutionary paradigm. Emerg Infect Dis.', '1997;3:417-23. 10.3201/eid0304.970402. PMID: 9366592']",,,,,,,,,
32031431,NLM,MEDLINE,20211004,20211004,1744-8352 (Electronic) 1473-7159 (Linking),20,6,2020 Jun,Companion and complementary diagnostics for infectious diseases.,619-636,10.1080/14737159.2020.1724784 [doi],"INTRODUCTION: Companion diagnostics (CDx) are important in oncology therapeutic decision-making, but specific regulatory-approved CDx for infectious disease treatment are officially lacking. While not approved as CDx, several ID diagnostics are used as CDx. The diagnostics community, manufacturers, and regulatory agencies have made major efforts to ensure that diagnostics for new antimicrobials are available at or near release of new agents. AREAS COVERED: This review highlights the status of Complementary and companion diagnostic (c/CDx) in the infectious disease literature, with a focus on genotypic antimicrobial resistance testing against pathogens as a class of diagnostic tests. EXPERT OPINION: CRISPR, sepsis markers, and narrow spectrum antimicrobials, in addition to current and emerging technologies, present opportunities for infectious disease c/CDx. Challenges include slow guideline revision, high costs for regulatory approval, lengthy buy in by agencies, discordant pharmaceutical/diagnostic partnerships, and higher treatment costs. The number of patients and available medications used to treat different infectious diseases is well suited to support competing diagnostic tests. However, newer approaches to treatment (for example, narrow spectrum antibiotics), may be well suited for a small number of patients, i.e. a niche market in support of a CDx. The current emphasis is rapid and point-of-care (POC) diagnostic platforms as well as changes in treatment.",,"['Dailey, Peter J', 'Elbeik, Tarek', 'Holodniy, Mark']","['Dailey PJ', 'Elbeik T', 'Holodniy M']","['School of Public Health, University of California, Berkeley , Berkeley, CA, USA.', 'The Foundation for Innovative New Diagnostics (FIND) , Geneva, Switzerland.', 'VA Palo Alto Health Care System, Department of Veterans Affairs , Palo Alto, CA, USA.', 'VA Palo Alto Health Care System, Department of Veterans Affairs , Palo Alto, CA, USA.', 'Division of Infectious Diseases and Geographic Medicine, Stanford University , Stanford, CA, USA.']",['eng'],"['Journal Article', 'Review']",20200213,England,Expert Rev Mol Diagn,Expert review of molecular diagnostics,101120777,IM,"['Anti-Bacterial Agents/pharmacology/therapeutic use', 'Anti-Infective Agents/pharmacology/*therapeutic use', 'Antiviral Agents/pharmacology/therapeutic use', 'CRISPR-Cas Systems', 'Communicable Diseases/diagnosis/*drug therapy/microbiology/virology', 'Device Approval', 'Drug Approval', 'Drug Development', 'Drug Resistance, Microbial/*genetics', 'Genotyping Techniques', 'Humans', '*Microbial Sensitivity Tests', '*Molecular Diagnostic Techniques', '*Point-of-Care Testing', 'Precision Medicine/*methods', 'United States', 'United States Food and Drug Administration']",,['NOTNLM'],"['Infectious diseases', 'anti-infective agents', 'antimicrobial drug resistance', 'diagnostics']",2020/02/08 06:00,2021/10/05 06:00,['2020/02/08 06:00'],"['2020/02/08 06:00 [pubmed]', '2021/10/05 06:00 [medline]', '2020/02/08 06:00 [entrez]']",['10.1080/14737159.2020.1724784 [doi]'],ppublish,Expert Rev Mol Diagn. 2020 Jun;20(6):619-636. doi: 10.1080/14737159.2020.1724784. Epub 2020 Feb 13.,,,"['0 (Anti-Bacterial Agents)', '0 (Anti-Infective Agents)', '0 (Antiviral Agents)']",,,,,,,,,,,,,,
23525811,NLM,MEDLINE,20130521,20161125,2042-7670 (Electronic) 0042-4900 (Linking),172,12,2013 Mar 23,Awareness raised at equine infectious diseases seminar.,306,10.1136/vr.f1276 [doi],,,,,,['eng'],['News'],,England,Vet Rec,The Veterinary record,0031164,IM,"['Animals', '*Awareness', 'Communicable Disease Control', 'Communicable Diseases/epidemiology/*veterinary', 'Horse Diseases/*epidemiology/prevention & control', 'Horses', 'Humans', 'Sentinel Surveillance/*veterinary', 'United Kingdom/epidemiology']",,,,2013/03/26 06:00,2013/05/23 06:00,['2013/03/26 06:00'],"['2013/03/26 06:00 [entrez]', '2013/03/26 06:00 [pubmed]', '2013/05/23 06:00 [medline]']","['vr.f1276 [pii]', '10.1136/vr.f1276 [doi]']",ppublish,Vet Rec. 2013 Mar 23;172(12):306. doi: 10.1136/vr.f1276.,,,,,,,,,,,,,,,,,
9621185,NLM,MEDLINE,19980901,20181113,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),4,2,1998 Apr-Jun,Wild primate populations in emerging infectious disease research: the missing link?,149-58,,"Wild primate populations, an unexplored source of information regarding emerging infectious disease, may hold valuable clues to the origins and evolution of some important pathogens. Primates can act as reservoirs for human pathogens. As members of biologically diverse habitats, they serve as sentinels for surveillance of emerging pathogens and provide models for basic research on natural transmission dynamics. Since emerging infectious diseases also pose serious threats to endangered and threatened primate species, studies of these diseases in primate populations can benefit conservation efforts and may provide the missing link between laboratory studies and the well-recognized needs of early disease detection, identification, and surveillance.",,"['Wolfe, N D', 'Escalante, A A', 'Karesh, W B', 'Kilbourn, A', 'Spielman, A', 'Lal, A A']","['Wolfe ND', 'Escalante AA', 'Karesh WB', 'Kilbourn A', 'Spielman A', 'Lal AA']","['Harvard School of Public Health, Boston, Massachusetts, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,IM,"['Animals', '*Animals, Wild', 'Communicable Diseases/epidemiology/transmission/*veterinary', 'Disease Reservoirs', 'Humans', 'Phylogeny', '*Primate Diseases/diagnosis/epidemiology/transmission', 'Primates', 'Research', 'Sentinel Surveillance']",PMC2640138,,,1998/06/11 00:00,1998/06/11 00:01,['1998/06/11 00:00'],"['1998/06/11 00:00 [pubmed]', '1998/06/11 00:01 [medline]', '1998/06/11 00:00 [entrez]']",['10.3201/eid0402.980202 [doi]'],ppublish,Emerg Infect Dis. 1998 Apr-Jun;4(2):149-58. doi: 10.3201/eid0402.980202.,,,,,,,,,,,,,,,,,
